group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00001,1.3241858213922355,FUN_000185-T1,Peve_00037402,Pocillopora_meandrina_HIv1___RNAseq.g28886.t1,three_way,71.059,FUN_000185-T1,Q32LQ0,AMPE_BOVIN,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Bos taurus (Bovine),41.5,881.0,1.4e-197,691.4,sp|Q32LQ0|AMPE_BOVIN Glutamyl aminopeptidase OS=Bos taurus OX=9913 GN=ENPEP PE=2 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00002,2.421650461791709,FUN_000189-T1,Peve_00038462,Pocillopora_meandrina_HIv1___RNAseq.g28888.t3,three_way,68.72583333333334,FUN_000189-T1,Q9DCT6,,,,,38.0,171.0,4.6e-18,92.8,sp|Q9DCT6|BAP18_MOUSE BPTF-associated chromatin complex component 1 OS=Mus musculus OX=10090 GN=Bacc1 PE=1 SV=1,,,,,,
OG_00007,1.686142733391748,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_00010,1.8330135100135336,FUN_000198-T1,Peve_00027181,Pocillopora_meandrina_HIv1___RNAseq.g28902.t1,three_way,59.28266666666666,,,,,,,,,,,,,,,,,
OG_00015,1.04072254383349,FUN_000208-T1,Peve_00027726,Pocillopora_meandrina_HIv1___RNAseq.g28911.t2,three_way,63.83766666666666,FUN_000208-T1,Q6NXR4,TTI2_HUMAN,,TELO2-interacting protein 2,Homo sapiens (Human),42.4,184.0,9.700000000000001e-34,144.8,sp|Q6NXR4|TTI2_HUMAN TELO2-interacting protein 2 OS=Homo sapiens OX=9606 GN=TTI2 PE=1 SV=1,GO:0005634; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821],nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_00017,1.1427496985137315,FUN_000212-T1,Peve_00007289,Pocillopora_meandrina_HIv1___RNAseq.g28915.t1,three_way,63.1635,FUN_000212-T1,Q95334,AMPE_PIG,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Sus scrofa (Pig),37.8,898.0,2.4999999999999997e-173,610.9,sp|Q95334|AMPE_PIG Glutamyl aminopeptidase OS=Sus scrofa OX=9823 GN=ENPEP PE=1 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00018,1.851911773594329,FUN_000213-T2,Peve_00002451,Pocillopora_meandrina_HIv1___RNAseq.g28916.t1,three_way,60.77916666666667,FUN_000213-T2,Q8LHH9,,,,,38.3,830.0,2.1000000000000001e-134,482.6,sp|Q8LHH9|SHL2_ORYSJ Probable RNA-dependent RNA polymerase SHL2 OS=Oryza sativa subsp. japonica OX=39947 GN=SHL2 PE=2 SV=1,,,,,,
OG_00019,2.3303561084530093,FUN_000215-T1,Peve_00002445,Pocillopora_meandrina_HIv1___RNAseq.g28918.t1,three_way,61.82416666666666,FUN_000215-T1,P15541,,,,,34.2,918.0,1.8e-142,508.4,sp|P15541|AMPN_RABIT Aminopeptidase N OS=Oryctolagus cuniculus OX=9986 GN=ANPEP PE=1 SV=4,,,,,,
OG_00020,4.045608347406942,FUN_000216-T1,Peve_00018873,Pocillopora_meandrina_HIv1___RNAseq.g28926.t1,three_way,52.28366666666667,,,,,,,,,,,,,,,,,
OG_00024,2.0982733283024704,FUN_000223-T1,Peve_00012031,Pocillopora_meandrina_HIv1___RNAseq.g28933.t1,three_way,77.22633333333333,FUN_000223-T1,Q80UY1,,,,,52.0,358.0,2.1e-107,390.6,sp|Q80UY1|CARME_MOUSE Carnosine N-methyltransferase OS=Mus musculus OX=10090 GN=Carnmt1 PE=1 SV=1,,,,,,
OG_00028,1.1153330182330583,FUN_000231-T1,Peve_00012025,Pocillopora_meandrina_HIv1___RNAseq.g28946.t1,three_way,54.33083333333334,FUN_000231-T1,Q1ZXH8,GXCDD_DICDI,,Guanine exchange factor for Rac 30,Dictyostelium discoideum (Social amoeba),36.5,203.0,4.3e-26,122.5,sp|Q1ZXH8|GXCDD_DICDI Guanine exchange factor for Rac 30 OS=Dictyostelium discoideum OX=44689 GN=gxcDD PE=4 SV=3,GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0008270; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early phagosome [GO:0032009]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670],"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0005856; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,cytoskeleton; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00034,2.217492221936659,FUN_000240-T1,Peve_00033355,Pocillopora_meandrina_HIv1___TS.g6176.t1,three_way,44.82333333333333,,,,,,,,,,,,,,,,,
OG_00037,1.129166813965241,FUN_000247-T2,Peve_00033364,Pocillopora_meandrina_HIv1___RNAseq.g28974.t1,three_way,71.2625,FUN_000247-T2,P22045,,,,,36.9,271.0,1.1e-36,157.1,"sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3",,,,,,
OG_00038,1.3948764530052606,FUN_000260-T1,Peve_00027791,Pocillopora_meandrina_HIv1___RNAseq.g28975.t1,three_way,62.275,FUN_000260-T1,Q3KPL3,,,,,33.9,165.0,2.7e-12,74.3,sp|Q3KPL3|LYSM2_XENLA LysM and putative peptidoglycan-binding domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=lysmd2 PE=2 SV=2,,,,,,
OG_00039,1.433722357796318,FUN_000261-T1,Peve_00027784,Pocillopora_meandrina_HIv1___RNAseq.g28976.t1,three_way,77.24933333333334,,,,,,,,,,,,,,,,,
OG_00040,1.6600612136889543,FUN_000263-T1,Peve_00027785,Pocillopora_meandrina_HIv1___RNAseq.g28977.t2,three_way,82.65166666666667,FUN_000263-T1,Q5ZLW3,,,,,49.3,690.0,7.099999999999997e-175,615.5,sp|Q5ZLW3|DYM_CHICK Dymeclin OS=Gallus gallus OX=9031 GN=DYM PE=2 SV=1,,,,,,
OG_00047,1.5933796393760358,FUN_000283-T1,Peve_00033555,Pocillopora_meandrina_HIv1___RNAseq.g29073.t1,three_way,79.09333333333333,FUN_000283-T1,Q9I8C7,,,,,46.3,322.0,4.6e-86,320.1,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00051,1.733856458130724,FUN_000320-T1,Peve_00033574,Pocillopora_meandrina_HIv1___RNAseq.g29014.t1,three_way,81.34316666666668,FUN_000320-T1,Q9Y4E6,,,,,41.7,1189.0,5.3e-228,792.7,sp|Q9Y4E6|WDR7_HUMAN WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7 PE=1 SV=2,,,,,,
OG_00056,1.229941249623634,FUN_000334-T1,Peve_00033540,Pocillopora_meandrina_HIv1___RNAseq.g29089.t1,three_way,52.14833333333333,FUN_000334-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),25.8,419.0,1.4e-16,90.9,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00062,1.5122307839840308,FUN_000372-T1,Peve_00033530,Pocillopora_meandrina_HIv1___RNAseq.g29118.t1,three_way,91.26166666666668,FUN_000372-T1,P55258,RAB8A_MOUSE,,Ras-related protein Rab-8A (EC 3.6.5.2) (Oncogene c-mel),Mus musculus (Mouse),79.6,186.0,1.1e-80,300.8,sp|P55258|RAB8A_MOUSE Ras-related protein Rab-8A OS=Mus musculus OX=10090 GN=Rab8a PE=1 SV=2,GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005764; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0010008; GO:0010506; GO:0015629; GO:0019003; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031267; GO:0031489; GO:0032869; GO:0034451; GO:0036064; GO:0043005; GO:0043025; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098978; GO:0099003; GO:1990782,"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]",actin cytoskeleton [GO:0015629]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network transport vesicle [GO:0030140],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005654; GO:0005730; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0061024; GO:0072659,catalytic activity; GTPase activity; nucleoplasm; nucleolus; lysosome; endosome; vacuole; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; intracellular protein transport; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_00063,2.9869378417989134,FUN_000374-T1,Peve_00033526,Pocillopora_meandrina_HIv1___TS.g6338.t1,three_way,32.86933333333334,FUN_000374-T1,Q96EQ9,,,,,33.5,254.0,3.2e-30,136.7,sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2,,,,,,
OG_00066,1.0154070890293332,FUN_000384-T1,Peve_00033599,Pocillopora_meandrina_HIv1___RNAseq.g29126.t1,three_way,70.015,FUN_000384-T1,O43586,PPIP1_HUMAN,,Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP),Homo sapiens (Human),35.0,428.0,1.0000000000000001e-65,252.3,sp|O43586|PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens OX=9606 GN=PSTPIP1 PE=1 SV=1,GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471,cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931],identical protein binding [GO:0042802],GO:0002376; GO:0005829; GO:0005856; GO:0005886; GO:0006954; GO:0007155; GO:0016192; GO:0043226; GO:0098542,immune system process; cytosol; cytoskeleton; plasma membrane; inflammatory response; cell adhesion; vesicle-mediated transport; organelle; defense response to other organism
OG_00070,1.24909327794588,FUN_000392-T1,Peve_00033592,Pocillopora_meandrina_HIv1___RNAseq.g2526.t1b,three_way,74.39316666666667,,,,,,,,,,,,,,,,,
OG_00074,2.44683287495332,FUN_000398-T1,Peve_00033583,Pocillopora_meandrina_HIv1___RNAseq.g2535.t1,three_way,88.96866666666666,FUN_000398-T1,P52657,T2AG_HUMAN,,Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (TFIIA p12 subunit) (TFIIA-12) (TFIIAS) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma),Homo sapiens (Human),79.4,107.0,6.799999999999999e-43,174.5,sp|P52657|T2AG_HUMAN Transcription initiation factor IIA subunit 2 OS=Homo sapiens OX=9606 GN=GTF2A2 PE=1 SV=1,GO:0001091; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0006367; GO:0016251; GO:0017025; GO:0042803; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629,positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025],GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0043226; GO:0065003; GO:0140223,nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; general transcription initiation factor activity
OG_00077,3.4094342528268022,FUN_000402-T1,Peve_00033527,Pocillopora_meandrina_HIv1___RNAseq.g2543.t1,three_way,81.73866666666666,FUN_000402-T1,Q9NYL9,,,,,46.9,130.0,2.2e-23,110.2,sp|Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1,,,,,,
OG_00080,2.021210106710224,FUN_000408-T1,Peve_00033593,Pocillopora_meandrina_HIv1___RNAseq.g2518.t1,three_way,59.73233333333334,FUN_000408-T1,Q8BP40,,,,,33.6,390.0,5.7e-51,203.4,sp|Q8BP40|PPA6_MOUSE Lysophosphatidic acid phosphatase type 6 OS=Mus musculus OX=10090 GN=Acp6 PE=1 SV=1,,,,,,
OG_00087,2.340511797746536,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_00090,1.0226737813820337,FUN_000448-T1,Peve_00019115,Pocillopora_meandrina_HIv1___RNAseq.g2336.t1,three_way,72.33566666666667,FUN_000448-T1,Q8N945,,,,,42.6,176.0,6e-33,142.1,sp|Q8N945|PRLD2_HUMAN PRELI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PRELID2 PE=1 SV=1,,,,,,
OG_00095,1.149231753963476,FUN_000470-T1,Peve_00005610,Pocillopora_meandrina_HIv1___RNAseq.g2424.t1,three_way,78.67266666666667,,,,,,,,,,,,,,,,,
OG_00100,1.3820866061260748,FUN_000483-T1,Peve_00038235,Pocillopora_meandrina_HIv1___RNAseq.g2342.t1,three_way,68.861,FUN_000483-T1,Q8CFV2,,,,,27.0,559.0,5.399999999999999e-31,137.5,sp|Q8CFV2|F149A_MOUSE Protein FAM149A OS=Mus musculus OX=10090 GN=Fam149a PE=2 SV=1,,,,,,
OG_00103,1.0542702446860854,FUN_000489-T1,Peve_00043825,Pocillopora_meandrina_HIv1___TS.g4918.t1,three_way,64.97083333333333,FUN_000489-T1,Q12923,,,,,26.7,2887.0,7.2e-210,733.8,sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2,,,,,,
OG_00104,1.9822053586111672,FUN_000490-T1,Peve_00043823,Pocillopora_meandrina_HIv1___RNAseq.g2411.t1,three_way,66.018,,,,,,,,,,,,,,,,,
OG_00107,2.095059662074325,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_00117,1.6588224816197448,FUN_000535-T1,Peve_00039805,Pocillopora_meandrina_HIv1___TS.g4883.t1,three_way,45.208,FUN_000535-T1,Q9Z2D7,,,,,27.8,399.0,2.5e-21,104.4,sp|Q9Z2D7|MBD4_MOUSE Methyl-CpG-binding domain protein 4 OS=Mus musculus OX=10090 GN=Mbd4 PE=1 SV=1,,,,,,
OG_00118,1.4904469039106647,FUN_000536-T1,Peve_00039803,Pocillopora_meandrina_HIv1___TS.g4882.t1,three_way,81.95033333333333,FUN_000536-T1,Q921G8,,,,,55.2,944.0,5.600000000000001e-277,955.3,sp|Q921G8|GCP2_MOUSE Gamma-tubulin complex component 2 OS=Mus musculus OX=10090 GN=Tubgcp2 PE=1 SV=2,,,,,,
OG_00119,3.547505999309561,FUN_000537-T1,Peve_00039797,Pocillopora_meandrina_HIv1___RNAseq.g2375.t1,three_way,66.51866666666668,FUN_000537-T1,Q56A06,,,,,51.3,710.0,5.7e-140,500.0,sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1,,,,,,
OG_00137,1.5337050266235634,FUN_000574-T1,Peve_00034745,Pocillopora_meandrina_HIv1___TS.g4950.t1,three_way,68.503,FUN_000574-T1,Q54KD0,,,,,25.7,904.0,1.7e-76,289.7,sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1,,,,,,
OG_00143,1.667903034842937,FUN_000585-T1,Peve_00034705,Pocillopora_meandrina_HIv1___RNAseq.g29297.t1,three_way,50.52733333333334,FUN_000585-T1,Q6TLH3,,,,,33.4,326.0,2.6999999999999997e-31,137.5,sp|Q6TLH3|CUED2_DANRE CUE domain-containing protein 2 OS=Danio rerio OX=7955 GN=cuedc2 PE=2 SV=1,,,,,,
OG_00158,1.5738332838256337,FUN_000614-T1,Peve_00036774,Pocillopora_meandrina_HIv1___RNAseq.g1715.t1,three_way,67.67916666666667,FUN_000614-T1,Q5ZLL7,,,,,44.8,397.0,5.2999999999999996e-92,340.1,sp|Q5ZLL7|WDR91_CHICK WD repeat-containing protein 91 OS=Gallus gallus OX=9031 GN=WDR91 PE=2 SV=1,,,,,,
OG_00160,1.1220883019110877,FUN_000617-T3,Peve_00036770,Pocillopora_meandrina_HIv1___RNAseq.g1710.t1,three_way,72.46133333333333,FUN_000617-T3,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),41.7,762.0,2.4e-155,550.8,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_00163,1.2591041660761368,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_00164,1.66247915003485,FUN_000639-T1,Peve_00011494,Pocillopora_meandrina_HIv1___RNAseq.g1868.t2,three_way,79.212,FUN_000639-T1,Q9EQQ9,,,,,39.0,918.0,1.2000000000000001e-180,635.2,sp|Q9EQQ9|OGA_MOUSE Protein O-GlcNAcase OS=Mus musculus OX=10090 GN=Oga PE=1 SV=2,,,,,,
OG_00171,1.5189414896092004,FUN_000857-T1,Peve_00004526,Pocillopora_meandrina_HIv1___RNAseq.g1863.t1,three_way,95.30166666666666,FUN_000857-T1,P61162,,,,,85.9,376.0,7.4e-198,691.0,sp|P61162|ACTZ_CANLF Alpha-centractin OS=Canis lupus familiaris OX=9615 GN=ACTR1A PE=2 SV=1,,,,,,
OG_00173,1.611311448948601,FUN_000861-T1,Peve_00004523,Pocillopora_meandrina_HIv1___RNAseq.g1861.t1,three_way,52.99133333333333,,,,,,,,,,,,,,,,,
OG_00174,1.934042307954371,FUN_000862-T1,Peve_00004534,Pocillopora_meandrina_HIv1___RNAseq.g1860.t1,three_way,73.89966666666666,FUN_000862-T1,Q9NTM9,CUTC_HUMAN,,Copper homeostasis protein cutC homolog,Homo sapiens (Human),62.0,245.0,3.3e-85,316.2,sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070,copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],copper ion binding [GO:0005507],GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0065003,nucleus; nucleoplasm; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_00178,2.066239375655213,FUN_000871-T1,Peve_00002056,Pocillopora_meandrina_HIv1___RNAseq.g1814.t1,three_way,62.229,FUN_000871-T1,A6QPC8,,,,,34.4,323.0,5.6e-35,149.8,sp|A6QPC8|EID3_BOVIN EP300-interacting inhibitor of differentiation 3 OS=Bos taurus OX=9913 GN=EID3 PE=2 SV=1,,,,,,
OG_00181,1.826859451255248,FUN_000876-T1,Peve_00039671,Pocillopora_meandrina_HIv1___RNAseq.g29425.t1,three_way,67.38333333333334,FUN_000876-T1,Q6PFL8,,,,,72.5,171.0,1.4e-71,270.8,sp|Q6PFL8|THYN1_DANRE Thymocyte nuclear protein 1 OS=Danio rerio OX=7955 GN=thyn1 PE=2 SV=1,,,,,,
OG_00193,1.063763269718452,FUN_000899-T1,Peve_00009739,Pocillopora_meandrina_HIv1___RNAseq.g29450.t1,three_way,81.587,,,,,,,,,,,,,,,,,
OG_00195,1.724550916855311,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00196,1.8911681336358608,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_00200,1.044911255694848,FUN_000914-T1,Peve_00033029,Pocillopora_meandrina_HIv1___RNAseq.g29486.t1,three_way,88.95466666666667,FUN_000914-T1,Q6DCV0,WIPI4_XENLA,,WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45),Xenopus laevis (African clawed frog),60.8,352.0,4.8e-127,455.7,sp|Q6DCV0|WIPI4_XENLA WD repeat domain phosphoinositide-interacting protein 4 OS=Xenopus laevis OX=8355 GN=wdr45 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025; GO:1901981; GO:2000786,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; positive regulation of autophagosome assembly [GO:2000786]; protein localization to phagophore assembly site [GO:0034497],cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674]",GO:0005829; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; molecular adaptor activity
OG_00201,2.1638534440557136,FUN_000915-T1,Peve_00044966,Pocillopora_meandrina_HIv1___RNAseq.g29485.t1,three_way,71.85666666666667,,,,,,,,,,,,,,,,,
OG_00207,1.737798391078207,FUN_000926-T1,Peve_00009718,Pocillopora_meandrina_HIv1___RNAseq.g29467.t1,three_way,63.42333333333334,FUN_000926-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),29.5,319.0,9.100000000000001e-33,142.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_00209,1.4561044518604596,FUN_000928-T1,Peve_00009720,Pocillopora_meandrina_HIv1___RNAseq.g29465.t1,three_way,77.15533333333333,FUN_000928-T1,B8A5I7,SSBP_DANRE,,"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB)",Danio rerio (Zebrafish) (Brachydanio rerio),34.8,141.0,6.4e-17,88.6,"sp|B8A5I7|SSBP_DANRE Single-stranded DNA-binding protein, mitochondrial OS=Danio rerio OX=7955 GN=ssbp1 PE=1 SV=1",GO:0000002; GO:0003697; GO:0006260; GO:0008047; GO:0042645; GO:0090297,DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; positive regulation of mitochondrial DNA replication [GO:0090297],mitochondrial nucleoid [GO:0042645],enzyme activator activity [GO:0008047]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0006260; GO:0043226; GO:0098772,DNA binding; DNA replication; organelle; molecular function regulator activity
OG_00217,1.2620638573879563,FUN_000943-T1,Peve_00010048,Pocillopora_meandrina_HIv1___RNAseq.g29499.t1,three_way,73.82233333333333,FUN_000943-T1,Q791V5,MTCH2_MOUSE,,Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein),Mus musculus (Mouse),41.5,284.0,2.7e-60,233.8,sp|Q791V5|MTCH2_MOUSE Mitochondrial carrier homolog 2 OS=Mus musculus OX=10090 GN=Mtch2 PE=1 SV=1,GO:0005739; GO:0005741; GO:0005743; GO:0006089; GO:0010635; GO:0010917; GO:0032977; GO:0035701; GO:0042775; GO:0043065; GO:0045040; GO:0045820; GO:0055088; GO:0061484; GO:0070585; GO:0071478; GO:0090152; GO:0097284; GO:1902108; GO:1902231; GO:2000738,cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; lipid homeostasis [GO:0055088]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],membrane insertase activity [GO:0032977],GO:0005739; GO:0006091; GO:0007005; GO:0012501; GO:0043226; GO:0048870; GO:0061024; GO:0140104,mitochondrion; generation of precursor metabolites and energy; mitochondrion organization; programmed cell death; organelle; cell motility; membrane organization; molecular carrier activity
OG_00219,1.2563055214195704,FUN_000945-T1,Peve_00010050,Pocillopora_meandrina_HIv1___RNAseq.g29501.t1,three_way,70.498,,,,,,,,,,,,,,,,,
OG_00220,1.1327809853900654,FUN_000946-T1,Peve_00031012,Pocillopora_meandrina_HIv1___TS.g6689.t1a,three_way,71.169,,,,,,,,,,,,,,,,,
OG_00229,1.077226094989292,FUN_000972-T1,Peve_00007807,Pocillopora_meandrina_HIv1___RNAseq.g29135.t2,three_way,69.94616666666667,FUN_000972-T1,Q99PL6,,,,,37.3,472.0,5.2e-68,260.0,sp|Q99PL6|UBXN6_MOUSE UBX domain-containing protein 6 OS=Mus musculus OX=10090 GN=Ubxn6 PE=1 SV=1,,,,,,
OG_00234,4.47814348623384,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_00238,1.2291821658245992,FUN_000994-T1,Peve_00004444,Pocillopora_meandrina_HIv1___RNAseq.g29192.t1,three_way,83.734,,,,,,,,,,,,,,,,,
OG_00239,1.5416458825414552,FUN_000995-T1,Peve_00004445,Pocillopora_meandrina_HIv1___RNAseq.g29191.t1,three_way,42.72733333333333,,,,,,,,,,,,,,,,,
OG_00240,2.6084733598390484,FUN_000996-T1,Peve_00004446,Pocillopora_meandrina_HIv1___RNAseq.g29189.t1,three_way,48.307833333333335,,,,,,,,,,,,,,,,,
OG_00242,2.2140593122365515,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_00243,3.579065017289375,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_00246,2.6065452451847406,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_00247,1.2432574841435329,FUN_001010-T1,Peve_00041051,Pocillopora_meandrina_HIv1___RNAseq.g29165.t1,three_way,58.97366666666667,FUN_001010-T1,Q5E9Y6,,,,,36.6,402.0,8.4e-51,202.6,sp|Q5E9Y6|PRUN1_BOVIN Exopolyphosphatase PRUNE1 OS=Bos taurus OX=9913 GN=PRUNE1 PE=2 SV=1,,,,,,
OG_00249,1.6356918978143324,FUN_001012-T1,Peve_00041036,Pocillopora_meandrina_HIv1___TS.g6378.t1,three_way,76.26333333333334,FUN_001012-T1,P49641,MA2A2_HUMAN,,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",Homo sapiens (Human),44.9,1158.0,9.3e-292,1004.6,sp|P49641|MA2A2_HUMAN Alpha-mannosidase 2x OS=Homo sapiens OX=9606 GN=MAN2A2 PE=1 SV=3,GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0016799; GO:0030246; GO:0046872,mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]",GO:0003824; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:1901135,catalytic activity; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; carbohydrate derivative metabolic process
OG_00252,3.819867283922614,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_00253,3.0140403124051445,FUN_001017-T2,Peve_00041044,Pocillopora_meandrina_HIv1___RNAseq.g29159.t1,three_way,66.55,,,,,,,,,,,,,,,,,
OG_00255,1.9454294676556632,FUN_001019-T1,Peve_00041047,Pocillopora_meandrina_HIv1___RNAseq.g29550.t1,three_way,74.728,FUN_001019-T1,E1C1R4,,,,,44.2,1361.0,1.6999999999999999e-301,1036.9,sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1,,,,,,
OG_00258,2.13952570156932,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_00259,1.7681761171471186,FUN_001028-T1,Peve_00041059,Pocillopora_meandrina_HIv1___RNAseq.g29614.t1,three_way,51.323,,,,,,,,,,,,,,,,,
OG_00275,1.3677909972813072,FUN_001059-T1,Peve_00030107,Pocillopora_meandrina_HIv1___RNAseq.g29647.t1,three_way,70.47333333333333,FUN_001059-T1,P57093,PAHX_RAT,,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)",Rattus norvegicus (Rat),61.6,284.0,3.6e-103,376.3,"sp|P57093|PAHX_RAT Phytanoyl-CoA dioxygenase, peroxisomal OS=Rattus norvegicus OX=10116 GN=Phyh PE=1 SV=2",GO:0001561; GO:0003824; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731,2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089],9+0 non-motile cilium [GO:0097731]; peroxisome [GO:0005777],carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244],GO:0003824; GO:0005777; GO:0005929; GO:0006629; GO:0016491; GO:0043226,catalytic activity; peroxisome; cilium; lipid metabolic process; oxidoreductase activity; organelle
OG_00280,2.814130535854893,FUN_001066-T1,Peve_00018849,Pocillopora_meandrina_HIv1___RNAseq.g29655.t1,three_way,63.10516666666666,FUN_001066-T1,P22758,,,,,39.4,695.0,3.2e-132,474.2,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00281,2.927892088491451,FUN_001067-T1,Peve_00029706,Pocillopora_meandrina_HIv1___RNAseq.g29656.t1,three_way,64.9165,FUN_001067-T1,A0AVK6,E2F8_HUMAN,,Transcription factor E2F8 (E2F-8),Homo sapiens (Human),40.1,304.0,1.1e-41,173.3,sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837,cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0000278; GO:0003677; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,mitotic cell cycle; DNA binding; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00283,1.161695279938615,FUN_001071-T1,Peve_00019958,Pocillopora_meandrina_HIv1___RNAseq.g29659.t2,three_way,62.99216666666667,FUN_001071-T1,Q8BUG5,,,,,37.3,434.0,2.1e-78,295.0,sp|Q8BUG5|CAYP2_MOUSE Calcyphosin-2 OS=Mus musculus OX=10090 GN=Caps2 PE=2 SV=2,,,,,,
OG_00285,1.4423013765568626,FUN_001075-T1,Peve_00011328,Pocillopora_meandrina_HIv1___RNAseq.g29662.t2,three_way,73.35966666666667,FUN_001075-T1,O22719,,,,,23.3,430.0,5.6e-17,90.5,sp|O22719|LHTL3_ARATH Lysine histidine transporter-like 3 OS=Arabidopsis thaliana OX=3702 GN=At1g61270 PE=3 SV=2,,,,,,
OG_00286,2.058116006291415,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.3999999999999999e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_00287,1.2692955873646743,FUN_001077-T1,Peve_00037392,Pocillopora_meandrina_HIv1___TS.g5224.t1,three_way,47.706,FUN_001077-T1,P13233,CN37_RAT,,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",Rattus norvegicus (Rat),28.8,416.0,1e-38,162.9,"sp|P13233|CN37_RAT 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Rattus norvegicus OX=10116 GN=Cnp PE=1 SV=2",GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005902; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0042995; GO:0043209; GO:0046902; GO:0048471; GO:0048709,adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143],"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0005615; GO:0007005; GO:0016787; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0061024,RNA binding; catalytic activity; extracellular space; mitochondrion organization; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; membrane organization
OG_00290,1.721897944214137,FUN_001081-T1,Peve_00037397,Pocillopora_meandrina_HIv1___RNAseq.g2712.t1,three_way,88.91366666666667,FUN_001081-T1,Q13557,,,,,72.0,468.0,8.2e-197,688.0,sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=3,,,,,,
OG_00291,2.178094882578532,FUN_001082-T1,Peve_00037398,Pocillopora_meandrina_HIv1___RNAseq.g2711.t1,three_way,87.09333333333333,FUN_001082-T1,Q6DKC0,,,,,71.6,327.0,1.3000000000000002e-124,447.6,sp|Q6DKC0|ERL2B_XENLA Erlin-2-B OS=Xenopus laevis OX=8355 GN=erlin2-b PE=2 SV=1,,,,,,
OG_00304,1.553577449566761,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00305,2.1041572807907127,FUN_001107-T1,Peve_00029366,Pocillopora_meandrina_HIv1___RNAseq.g29366.t1,three_way,86.59933333333333,FUN_001107-T1,Q9GZN1,ARP6_HUMAN,,Actin-related protein 6 (hArp6) (hARPX),Homo sapiens (Human),60.3,398.0,3.2e-143,509.6,sp|Q9GZN1|ARP6_HUMAN Actin-related protein 6 OS=Homo sapiens OX=9606 GN=ACTR6 PE=1 SV=1,GO:0000786; GO:0000812; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006338; GO:0006355; GO:0007000; GO:0016479; GO:0031491; GO:0045943,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleolus organization [GO:0007000]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812],nucleosome binding [GO:0031491],GO:0005634; GO:0005730; GO:0005856; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; chromatin organization; regulation of DNA-templated transcription; organelle
OG_00313,1.8516639851803616,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00314,1.1064072717189184,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_00320,2.1066555076144557,FUN_001139-T1,Peve_00029334,Pocillopora_meandrina_HIv1___RNAseq.g29336.t1,three_way,78.20866666666667,FUN_001139-T1,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),46.3,609.0,5.5e-158,559.3,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_00328,2.7397044269199813,FUN_001148-T1,Peve_00002869,Pocillopora_meandrina_HIv1___RNAseq.g29326.t1,three_way,83.11733333333333,FUN_001148-T1,Q99LI7,,,,,55.9,709.0,2.5e-234,813.1,sp|Q99LI7|CSTF3_MOUSE Cleavage stimulation factor subunit 3 OS=Mus musculus OX=10090 GN=Cstf3 PE=1 SV=1,,,,,,
OG_00334,1.0253853327002962,FUN_001155-T1,Peve_00002861,Pocillopora_meandrina_HIv1___RNAseq.g29319.t1,three_way,85.69133333333333,FUN_001155-T1,O08734,BAK_MOUSE,,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK),Mus musculus (Mouse),46.4,112.0,3.0999999999999997e-24,113.2,sp|O08734|BAK_MOUSE Bcl-2 homologous antagonist/killer OS=Mus musculus OX=10090 GN=Bak1 PE=1 SV=3,GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1901029; GO:1901030; GO:1902262,animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],BAK complex [GO:0097145]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930],BH domain binding [GO:0051400]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0005215; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0012501; GO:0022414; GO:0043226; GO:0048856; GO:0055085; GO:0061024,immune system process; transporter activity; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; programmed cell death; reproductive process; organelle; anatomical structure development; transmembrane transport; membrane organization
OG_00336,1.1998766547504756,FUN_001157-T1,Peve_00002857,Pocillopora_meandrina_HIv1___RNAseq.g29317.t1,three_way,83.7075,FUN_001157-T1,Q6DGV1,CELF4_DANRE,,CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4),Danio rerio (Zebrafish) (Brachydanio rerio),46.6,513.0,4.2e-108,393.3,sp|Q6DGV1|CELF4_DANRE CUGBP Elav-like family member 4 OS=Danio rerio OX=7955 GN=celf4 PE=2 SV=1,GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904,"mRNA splice site recognition [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]",cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0043226; GO:0065003,RNA binding; nucleus; organelle; protein-containing complex assembly
OG_00337,1.3182371178942325,FUN_001158-T1,Peve_00043471,Pocillopora_meandrina_HIv1___RNAseq.g29220.t1,three_way,76.751,FUN_001158-T1,Q7ZXG7,,,,,68.5,232.0,3.9e-96,352.4,sp|Q7ZXG7|GAMTA_XENLA Guanidinoacetate N-methyltransferase A OS=Xenopus laevis OX=8355 GN=gamt-a PE=2 SV=1,,,,,,
OG_00342,2.141718252402629,FUN_001167-T1,Peve_00015996,Pocillopora_meandrina_HIv1___RNAseq.g29154.t1,three_way,76.15266666666666,FUN_001167-T1,Q01617,,,,,51.7,172.0,6.1e-35,149.4,sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4,,,,,,
OG_00346,1.6558937350267398,FUN_001173-T1,Peve_00034800,Pocillopora_meandrina_HIv1___RNAseq.g29145.t1,three_way,74.758,FUN_001173-T1,Q8IV38,,,,,51.8,417.0,3.2e-86,320.5,sp|Q8IV38|ANKY2_HUMAN Ankyrin repeat and MYND domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKMY2 PE=1 SV=1,,,,,,
OG_00347,1.0279511618851538,FUN_001174-T1,Peve_00002993,Pocillopora_meandrina_HIv1___RNAseq.g29214.t1,three_way,71.508,FUN_001174-T1,P00377,,,,,41.3,184.0,6.499999999999997e-41,168.7,sp|P00377|DYR_PIG Dihydrofolate reductase OS=Sus scrofa OX=9823 GN=DHFR PE=1 SV=1,,,,,,
OG_00348,2.1976543748602677,FUN_001175-T1,Peve_00015994,Pocillopora_meandrina_HIv1___RNAseq.g29156.t1,three_way,64.6045,FUN_001175-T1,Q1LUQ4,,,,,24.8,568.0,1.6e-35,152.5,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_00349,1.199679714899298,FUN_001176-T1,Peve_00015993,Pocillopora_meandrina_HIv1___TS.g6373.t1,three_way,71.25133333333333,FUN_001176-T1,O43451,MGA_HUMAN,,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",Homo sapiens (Human),48.8,853.0,2.6e-247,856.7,sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6,GO:0000025; GO:0003824; GO:0004339; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027,dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; oligo-1,6-glucosidase activity [GO:0004574]",GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0043226,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; organelle
OG_00352,1.8806514113242028,FUN_001180-T1,Peve_00018946,Pocillopora_meandrina_HIv1___RNAseq.g29544.t1,three_way,57.39666666666667,FUN_001180-T1,E9Q7E2,ARID2_MOUSE,,AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200),Mus musculus (Mouse),33.1,834.0,1.3e-106,390.2,sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819,cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0043226; GO:0048856,DNA binding; nucleoplasm; plasma membrane; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_00361,3.1748001059533943,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_00362,1.437728572985562,FUN_001197-T1,Peve_00022306,Pocillopora_meandrina_HIv1___RNAseq.g29523.t1,three_way,67.18616666666667,FUN_001197-T1,Q2YDF6,RT35_BOVIN,,"Small ribosomal subunit protein mS35 (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt)",Bos taurus (Bovine),52.7,182.0,1.4e-49,198.0,sp|Q2YDF6|RT35_BOVIN Small ribosomal subunit protein mS35 OS=Bos taurus OX=9913 GN=MRPS35 PE=1 SV=1,GO:0003735; GO:0005743; GO:0005763; GO:0005829; GO:0032543,mitochondrial translation [GO:0032543],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005829,structural molecule activity; cytosol
OG_00365,1.6439699532835514,FUN_001204-T1,Peve_00033826,Pocillopora_meandrina_HIv1___RNAseq.g29520.t1,three_way,71.753,FUN_001204-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),40.4,396.0,2.8000000000000002e-89,330.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_00370,1.2653872321577937,FUN_001211-T1,Peve_00033815,Pocillopora_meandrina_HIv1___RNAseq.g29514.t2c,three_way,72.93533333333333,FUN_001211-T1,Q9VZS6,,,,,40.4,275.0,2.8e-55,217.6,sp|Q9VZS6|NSMA_DROME Putative neutral sphingomyelinase OS=Drosophila melanogaster OX=7227 GN=nSMase PE=2 SV=2,,,,,,
OG_00371,1.527241439441159,FUN_001212-T1,Peve_00033814,Pocillopora_meandrina_HIv1___RNAseq.g29513.t1,three_way,80.26333333333334,,,,,,,,,,,,,,,,,
OG_00373,1.0926058724349792,FUN_001215-T1,Peve_00009931,Pocillopora_meandrina_HIv1___RNAseq.g29508.t1,three_way,74.34766666666667,FUN_001215-T1,O08684,,,,,42.6,975.0,8.6e-222,771.9,sp|O08684|PLD1_CRIGR Phospholipase D1 OS=Cricetulus griseus OX=10029 GN=PLD1 PE=2 SV=1,,,,,,
OG_00389,1.8012948547828798,FUN_001244-T1,Peve_00037040,Pocillopora_meandrina_HIv1___RNAseq.g2296.t1,three_way,77.55366666666667,FUN_001244-T1,Q5MNH6,,,,,28.5,253.0,1e-20,102.1,sp|Q5MNH6|LOLO2_EPIUN 2-oxoglutarate-dependent dioxygenase lolO2 OS=Epichloe uncinata OX=5050 GN=lolO2 PE=1 SV=1,,,,,,
OG_00399,1.2984353942663047,FUN_001270-T1,Peve_00008764,Pocillopora_meandrina_HIv1___RNAseq.g2183.t1,three_way,76.675,FUN_001270-T1,Q9NWT6,HIF1N_HUMAN,,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase),Homo sapiens (Human),59.9,319.0,1.2e-120,434.5,sp|Q9NWT6|HIF1N_HUMAN Hypoxia-inducible factor 1-alpha inhibitor OS=Homo sapiens OX=9606 GN=HIF1AN PE=1 SV=2,GO:0000122; GO:0003714; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0019826; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061629; GO:0062101; GO:0071532; GO:2001214,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],[protein]-asparagine 3-dioxygenase activity [GO:0036140]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0016491; GO:0060090; GO:0098772; GO:0140096; GO:0140110; GO:0140299,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; oxidoreductase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity; molecular sensor activity"
OG_00400,2.277878947412717,FUN_001271-T1,Peve_00008757,Pocillopora_meandrina_HIv1___RNAseq.g2184.t1,three_way,83.30966666666667,FUN_001271-T1,P0C605,KGP1_MOUSE,,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),Mus musculus (Mouse),58.6,630.0,9.7e-210,731.5,sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1,GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224,cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003012; GO:0003824; GO:0005654; GO:0005794; GO:0005886; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"muscle system process; catalytic activity; nucleoplasm; Golgi apparatus; plasma membrane; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00412,1.6329052034123253,FUN_001310-T1,Peve_00036984,Pocillopora_meandrina_HIv1___RNAseq.g2249.t1,three_way,83.714,FUN_001310-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),38.1,252.0,1.3e-50,201.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_00417,2.285836343584145,FUN_001320-T1,Peve_00005008,Pocillopora_meandrina_HIv1___RNAseq.g5443.t1,three_way,65.57416666666667,,,,,,,,,,,,,,,,,
OG_00421,1.531385752193278,FUN_001328-T1,Peve_00036956,Pocillopora_meandrina_HIv1___RNAseq.g2270.t1b,three_way,79.90283333333333,FUN_001328-T1,Q5F471,,,,,41.4,903.0,8.500000000000001e-174,612.5,sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1,,,,,,
OG_00428,1.085059587651261,FUN_001336-T1,Peve_00036943,Pocillopora_meandrina_HIv1___RNAseq.g2286.t1,three_way,80.96633333333334,FUN_001336-T1,Q86UD5,SL9B2_HUMAN,,Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Homo sapiens (Human),47.8,485.0,6.2e-115,416.0,sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2,GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility; transmembrane transport
OG_00429,1.371084292834892,FUN_001337-T1,Peve_00036942,Pocillopora_meandrina_HIv1___RNAseq.g2287.t1,three_way,75.98033333333333,FUN_001337-T1,C3ZWH9,,,,,45.1,133.0,1.7e-30,133.7,sp|C3ZWH9|CID2A_BRAFL CDGSH iron-sulfur domain-containing protein 2 homolog A OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_285975 PE=3 SV=1,,,,,,
OG_00434,3.228382806597057,FUN_001344-T1,Peve_00037041,Pocillopora_meandrina_HIv1___TS.g4804.t1,three_way,84.807,FUN_001344-T1,Q9DGA5,CDK1_ORYCU,,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),Oryzias curvinotus (Hynann ricefish) (Aplocheilus curvinotus),68.6,299.0,4.0999999999999997e-120,432.6,sp|Q9DGA5|CDK1_ORYCU Cyclin-dependent kinase 1 OS=Oryzias curvinotus OX=104658 GN=cdk1 PE=2 SV=1,GO:0000086; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0008353; GO:0051301; GO:0106310,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint signaling [GO:0007095],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00443,2.037764232100868,FUN_001356-T1,Peve_00005527,Pocillopora_meandrina_HIv1___RNAseq.g2154.t1,three_way,89.02,FUN_001356-T1,Q571I9,,,,,42.8,828.0,1.5e-185,651.4,sp|Q571I9|A16A1_MOUSE Aldehyde dehydrogenase family 16 member A1 OS=Mus musculus OX=10090 GN=Aldh16a1 PE=1 SV=2,,,,,,
OG_00449,1.0747605142272545,FUN_001369-T1,Peve_00035683,Pocillopora_meandrina_HIv1___RNAseq.g2141.t1,three_way,82.50766666666667,FUN_001369-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),50.5,876.0,2.8e-243,843.2,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_00457,1.1054704599823937,FUN_001388-T1,Peve_00019354,Pocillopora_meandrina_HIv1___RNAseq.g2127.t1,three_way,77.53466666666667,FUN_001388-T1,Q62739,RAB3I_RAT,,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),Rattus norvegicus (Rat),39.6,217.0,1.2e-33,145.6,sp|Q62739|RAB3I_RAT Rab-3A-interacting protein OS=Rattus norvegicus OX=10116 GN=Rab3ip PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0015031; GO:0030027; GO:0031267; GO:0042802; GO:0045724; GO:0048471; GO:0051020; GO:0051490; GO:0120229; GO:1990635,negative regulation of filopodium assembly [GO:0051490]; positive regulation of cilium assembly [GO:0045724]; protein localization to motile cilium [GO:0120229]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031],centrosome [GO:0005813]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proximal dendrite [GO:1990635],GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0043226; GO:0098772,nucleus; nucleoplasm; microtubule organizing center; cytosol; organelle; molecular function regulator activity
OG_00460,1.678127269234805,FUN_001392-T1,Peve_00019358,Pocillopora_meandrina_HIv1___RNAseq.g2123.t1,three_way,90.084,,,,,,,,,,,,,,,,,
OG_00462,1.24356472642923,FUN_001394-T1,Peve_00019360,Pocillopora_meandrina_HIv1___RNAseq.g2121.t1,three_way,76.95333333333333,FUN_001394-T1,A9JRD8,BTB6A_DANRE,,BTB/POZ domain-containing protein 6-A,Danio rerio (Zebrafish) (Brachydanio rerio),32.9,389.0,1.7e-56,222.2,sp|A9JRD8|BTB6A_DANRE BTB/POZ domain-containing protein 6-A OS=Danio rerio OX=7955 GN=btbd6a PE=1 SV=2,GO:0005634; GO:0005829; GO:0022008; GO:0050767,neurogenesis [GO:0022008]; regulation of neurogenesis [GO:0050767],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0030154; GO:0043226,nucleus; cytosol; cell differentiation; organelle
OG_00465,1.575743491983145,FUN_001401-T1,Peve_00008770,Pocillopora_meandrina_HIv1___RNAseq.g2113.t1,three_way,79.55216666666666,FUN_001401-T1,Q8C8M1,SHCAF_MOUSE,,SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein),Mus musculus (Mouse),43.0,235.0,2.4e-40,167.2,sp|Q8C8M1|SHCAF_MOUSE SIN3-HDAC complex-associated factor OS=Mus musculus OX=10090 GN=Sinhcaf PE=1 SV=1,GO:0000122; GO:0005634; GO:0008284; GO:0030336; GO:0030512; GO:0045596; GO:0070822; GO:1902455; GO:1902459,negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459],nucleus [GO:0005634]; Sin3-type complex [GO:0070822],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_00466,1.5348323750673232,FUN_001402-T1,Peve_00008766,Pocillopora_meandrina_HIv1___TS.g4618.t1,three_way,89.81483333333334,FUN_001402-T1,P38976,,,,,74.9,195.0,1.2000000000000001e-74,280.8,sp|P38976|RAS2_HYDVU Ras-like protein RAS2 OS=Hydra vulgaris OX=6087 GN=RAS2 PE=2 SV=1,,,,,,
OG_00471,1.1359703099667968,FUN_001407-T1,Peve_00008758,Pocillopora_meandrina_HIv1___RNAseq.g2106.t1,three_way,80.07066666666667,FUN_001407-T1,Q8NFH4,NUP37_HUMAN,,Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37),Homo sapiens (Human),46.6,322.0,3.4e-82,306.6,sp|Q8NFH4|NUP37_HUMAN Nucleoporin Nup37 OS=Homo sapiens OX=9606 GN=NUP37 PE=1 SV=1,GO:0000776; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301,cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0043226,nucleus; nuclear envelope; nucleoplasm; cytosol; nucleocytoplasmic transport; chromosome segregation; organelle
OG_00473,1.8486739070285163,FUN_001412-T1,Peve_00008754,Pocillopora_meandrina_HIv1___RNAseq.g2102.t1,three_way,75.09233333333333,FUN_001412-T1,O35972,,,,,50.4,115.0,8.4e-27,121.3,sp|O35972|RM23_MOUSE Large ribosomal subunit protein uL23m OS=Mus musculus OX=10090 GN=Mrpl23 PE=1 SV=1,,,,,,
OG_00476,1.577090265725953,FUN_001415-T1,Peve_00008745,Pocillopora_meandrina_HIv1___RNAseq.g2099.t2,three_way,70.42699999999999,FUN_001415-T1,Q9NQ34,,,,,30.7,179.0,6e-14,79.0,sp|Q9NQ34|TMM9B_HUMAN Transmembrane protein 9B OS=Homo sapiens OX=9606 GN=TMEM9B PE=1 SV=1,,,,,,
OG_00482,2.479659831934293,FUN_001424-T1,Peve_00008792,Pocillopora_meandrina_HIv1___TS.g4679.t3,three_way,67.32566666666666,,,,,,,,,,,,,,,,,
OG_00486,1.6032692406272266,FUN_001452-T1,Peve_00018443,Pocillopora_meandrina_HIv1___RNAseq.g1955.t1,three_way,69.77166666666668,FUN_001452-T1,O08983,HPS1_MOUSE,,BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein homolog),Mus musculus (Mouse),24.2,615.0,2.3e-23,112.1,sp|O08983|HPS1_MOUSE BLOC-3 complex member HPS1 OS=Mus musculus OX=10090 GN=Hps1 PE=2 SV=2,GO:0000902; GO:0003016; GO:0005085; GO:0005737; GO:0006629; GO:0006882; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0009306; GO:0010467; GO:0016192; GO:0030318; GO:0030324; GO:0031085; GO:0031410; GO:0032816; GO:0033299; GO:0043473; GO:0046907; GO:0048069; GO:0055088; GO:0060041; GO:0060155; GO:0060425; GO:1903232,blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; protein secretion [GO:0009306]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003016; GO:0006629; GO:0006954; GO:0007040; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0098772,respiratory system process; lipid metabolic process; inflammatory response; lysosome organization; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00492,1.211414566687251,FUN_001462-T1,Peve_00027129,Pocillopora_meandrina_HIv1___RNAseq.g1962.t1,three_way,78.42083333333333,FUN_001462-T1,Q7ZYZ7,PCGF1_DANRE,,Polycomb group RING finger protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),49.2,244.0,2.4e-59,230.3,sp|Q7ZYZ7|PCGF1_DANRE Polycomb group RING finger protein 1 OS=Danio rerio OX=7955 GN=pcgf1 PE=3 SV=1,GO:0000122; GO:0006338; GO:0008270; GO:0021915; GO:0031519; GO:0035102; GO:0048589; GO:1990841,chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915],PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102],promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0006325; GO:0006355; GO:0048856,chromatin organization; regulation of DNA-templated transcription; anatomical structure development
OG_00493,1.8127430948162464,FUN_001463-T1,Peve_00027128,Pocillopora_meandrina_HIv1___RNAseq.g1963.t1,three_way,62.418,FUN_001463-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),28.8,2337.0,8.6e-257,889.4,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00496,1.1446855746800313,FUN_001466-T1,Peve_00027123,Pocillopora_meandrina_HIv1___RNAseq.g1967.t1,three_way,67.97266666666667,FUN_001466-T1,A0JNK3,HTRA2_BOVIN,,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108)",Bos taurus (Bovine),47.0,334.0,1.0999999999999999e-75,285.4,"sp|A0JNK3|HTRA2_BOVIN Serine protease HTRA2, mitochondrial OS=Bos taurus OX=9913 GN=HTRA2 PE=2 SV=1",GO:0004252; GO:0005739; GO:0005758; GO:0006508; GO:0006915; GO:0012501; GO:0031966; GO:0043065,apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508],mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005739; GO:0012501; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00500,2.4013317630368776,FUN_001473-T1,Peve_00029354,Pocillopora_meandrina_HIv1___TS.g4480.t1,three_way,91.325,FUN_001473-T1,Q5ZLT0,,,,,70.9,1080.0,0.0,1511.1,sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1,,,,,,
OG_00514,2.5236484169937774,FUN_001507-T1,Peve_00012118,Pocillopora_meandrina_HIv1___TS.g4396.t1a,three_way,54.123666666666665,FUN_001507-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),42.2,398.0,5.3e-88,328.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00518,1.0632092025287192,FUN_001515-T1,Peve_00012126,Pocillopora_meandrina_HIv1___RNAseq.g1884.t1,three_way,81.4485,FUN_001515-T1,A2A259,PK2L1_MOUSE,,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Mus musculus (Mouse),21.7,300.0,3.4e-09,65.5,sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1,GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0009415; GO:0015269; GO:0015629; GO:0031410; GO:0034703; GO:0034704; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0051262; GO:0051289; GO:0051371; GO:0060170; GO:0071467; GO:0071468; GO:0097730; GO:0098662; GO:0160128; GO:1990760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; smoothened signaling pathway [GO:0007224],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,transporter activity; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_00522,1.7163414084793325,FUN_001522-T1,Peve_00042518,Pocillopora_meandrina_HIv1___RNAseq.g2040.t1,three_way,96.534,FUN_001522-T1,B1WBM3,,,,,57.6,99.0,1e-20,100.9,sp|B1WBM3|TM138_RAT Transmembrane protein 138 OS=Rattus norvegicus OX=10116 GN=Tmem138 PE=2 SV=1,,,,,,
OG_00530,2.218061705938476,FUN_001535-T1,Peve_00014195,Pocillopora_meandrina_HIv1___RNAseq.g2057.t1,three_way,71.78833333333333,FUN_001535-T1,Q9Y4D2,,,,,34.3,829.0,1.0999999999999999e-127,459.5,sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3,,,,,,
OG_00535,1.3442044620929314,FUN_001550-T1,Peve_00003916,Pocillopora_meandrina_HIv1___RNAseq.g2091.t1,three_way,65.51033333333334,FUN_001550-T1,Q54I58,,,,,32.0,219.0,6.2e-26,119.4,sp|Q54I58|NIPSN_DICDI Protein NipSnap homolog OS=Dictyostelium discoideum OX=44689 GN=nipsnap PE=3 SV=1,,,,,,
OG_00537,3.087924777435029,FUN_001553-T1,Peve_00003908,Pocillopora_meandrina_HIv1___RNAseq.g1998.t1,three_way,60.30766666666667,FUN_001553-T1,Q9UQF2,JIP1_HUMAN,,C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1),Homo sapiens (Human),40.5,242.0,1.5e-50,201.8,sp|Q9UQF2|JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=MAPK8IP1 PE=1 SV=1,GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043025; GO:0043508; GO:0044294; GO:0044295; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243,"JNK cascade [GO:0007254]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of DNA-templated transcription [GO:0006355]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]",axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202],JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0043226; GO:0060090; GO:0098772,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; organelle; molecular adaptor activity; molecular function regulator activity
OG_00542,1.469693072898075,FUN_001573-T1,Peve_00010783,Pocillopora_meandrina_HIv1___RNAseq.g2028.t1,three_way,70.1815,FUN_001573-T1,A7T1N0,TMP2L_NEMVE,,Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2),Nematostella vectensis (Starlet sea anemone),30.8,1292.0,5.1e-158,560.5,sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1,GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604,calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725],plasma membrane [GO:0005886],ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport
OG_00549,2.380508617204954,FUN_001590-T1,Peve_00023229,Pocillopora_meandrina_HIv1___RNAseq.g1994.t1,three_way,58.80866666666667,FUN_001590-T1,Q9VAN6,SLBP_DROME,,Histone RNA hairpin-binding protein (Histone stem-loop-binding protein),Drosophila melanogaster (Fruit fly),46.8,79.0,1.9e-16,88.2,sp|Q9VAN6|SLBP_DROME Histone RNA hairpin-binding protein OS=Drosophila melanogaster OX=7227 GN=Slbp PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006398; GO:0007076; GO:0035613; GO:0051028; GO:0071204; GO:0071207; GO:1990825,mitotic chromosome condensation [GO:0007076]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028],cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleus [GO:0005634],histone pre-mRNA stem-loop binding [GO:0071207]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_00551,1.8222753506822915,FUN_001592-T1,Peve_00023231,Pocillopora_meandrina_HIv1___RNAseq.g1991.t1,three_way,51.281666666666666,FUN_001592-T1,O35144,TERF2_MOUSE,,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),Mus musculus (Mouse),20.8,457.0,4.8e-06,54.3,sp|O35144|TERF2_MOUSE Telomeric repeat-binding factor 2 OS=Mus musculus OX=10090 GN=Terf2 PE=1 SV=3,GO:0000723; GO:0000781; GO:0000782; GO:0001673; GO:0001701; GO:0003691; GO:0003720; GO:0005654; GO:0016233; GO:0016604; GO:0019899; GO:0030424; GO:0031627; GO:0031848; GO:0032206; GO:0032208; GO:0032211; GO:0042162; GO:0042803; GO:0044877; GO:0061820; GO:0070187; GO:0070198; GO:0098505; GO:0099088; GO:1904354; GO:1904430; GO:1905839; GO:2000773,"axonal transport of messenger ribonucleoprotein complex [GO:0099088]; in utero embryonic development [GO:0001701]; negative regulation of cellular senescence [GO:2000773]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomere cap complex [GO:0000782]",double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomerase activity [GO:0003720]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0007018; GO:0016740; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule-based movement; transferase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_00554,2.2145307519553388,FUN_001599-T1,Peve_00004146,Pocillopora_meandrina_HIv1___RNAseq.g1982.t1,three_way,81.72066666666667,FUN_001599-T1,Q9Y2D4,EXC6B_HUMAN,,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),Homo sapiens (Human),50.0,800.0,4.7e-223,775.8,sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3,GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],exocyst [GO:0000145],,GO:0000910; GO:0006886; GO:0016192; GO:0061024,cytokinesis; intracellular protein transport; vesicle-mediated transport; membrane organization
OG_00559,1.211213734765906,FUN_001613-T1,Peve_00045310,Pocillopora_meandrina_HIv1___TS.g4484.t1,three_way,71.21433333333333,FUN_001613-T1,P97931,UNG_MOUSE,,Uracil-DNA glycosylase (UDG) (EC 3.2.2.27),Mus musculus (Mouse),55.3,311.0,6.6e-91,335.5,sp|P97931|UNG_MOUSE Uracil-DNA glycosylase OS=Mus musculus OX=10090 GN=Ung PE=1 SV=3,GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016446; GO:0016447; GO:0043024; GO:0045190; GO:0097510,"base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_00562,1.6177062041636576,FUN_001616-T1,Peve_00045298,Pocillopora_meandrina_HIv1___RNAseq.g1944.t1,three_way,70.12516666666666,FUN_001616-T1,Q9HCL2,GPAT1_HUMAN,,"Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15)",Homo sapiens (Human),32.5,764.0,1.4999999999999999e-105,385.6,"sp|Q9HCL2|GPAT1_HUMAN Glycerol-3-phosphate acyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GPAM PE=1 SV=3",GO:0001817; GO:0004366; GO:0005739; GO:0005741; GO:0005886; GO:0006631; GO:0006637; GO:0006650; GO:0006651; GO:0006654; GO:0006655; GO:0006924; GO:0009749; GO:0016024; GO:0019432; GO:0040018; GO:0042104; GO:0050798; GO:0051607; GO:0055089; GO:0055091; GO:0070236,activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cytokine production [GO:0001817]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],glycerol-3-phosphate O-acyltransferase activity [GO:0004366],GO:0002376; GO:0003824; GO:0005739; GO:0005886; GO:0006629; GO:0006790; GO:0012501; GO:0016740; GO:0043226; GO:0055086,immune system process; catalytic activity; mitochondrion; plasma membrane; lipid metabolic process; sulfur compound metabolic process; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_00564,1.0414293238525796,FUN_001619-T1,Peve_00045303,Pocillopora_meandrina_HIv1___RNAseq.g1947.t1,three_way,70.21316666666667,FUN_001619-T1,Q9BPX3,CND3_HUMAN,,Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G) (hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog),Homo sapiens (Human),41.5,959.0,1.3e-181,638.6,sp|Q9BPX3|CND3_HUMAN Condensin complex subunit 3 OS=Homo sapiens OX=9606 GN=NCAPG PE=1 SV=1,GO:0000779; GO:0000793; GO:0000794; GO:0000796; GO:0005634; GO:0005737; GO:0005829; GO:0007076; GO:0016020; GO:0051301; GO:0051984; GO:1905820; GO:1905821,cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820],"condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]",,GO:0000228; GO:0005634; GO:0005694; GO:0005829; GO:0043226,nuclear chromosome; nucleus; chromosome; cytosol; organelle
OG_00570,3.1756668692762604,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_00596,2.7557296133137448,FUN_001733-T1,Peve_00007896,Pocillopora_meandrina_HIv1___RNAseq.g2642.t1,three_way,61.95166666666667,FUN_001733-T1,P27544,CERS1_HUMAN,,Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299),Homo sapiens (Human),43.5,269.0,6.9e-55,216.1,sp|P27544|CERS1_HUMAN Ceramide synthase 1 OS=Homo sapiens OX=9606 GN=CERS1 PE=1 SV=1,GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016020; GO:0030148; GO:0036146; GO:0043231; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526,brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],sphingosine N-acyltransferase activity [GO:0050291],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; anatomical structure development
OG_00597,1.7279383300138162,FUN_001735-T1,Peve_00025009,Pocillopora_meandrina_HIv1___RNAseq.g2644.t1,three_way,79.81366666666666,FUN_001735-T1,P04464,,,,,36.7,147.0,4e-22,105.9,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_00599,2.290945354753615,FUN_001747-T1,Peve_00023224,Pocillopora_meandrina_HIv1___RNAseq.13551_t,three_way,50.601,,,,,,,,,,,,,,,,,
OG_00604,1.5609758240607066,FUN_001765-T1,Peve_00023733,Pocillopora_meandrina_HIv1___RNAseq.13574_t,three_way,60.79216666666667,,,,,,,,,,,,,,,,,
OG_00605,1.9845641230681887,FUN_001766-T1,Peve_00023732,Pocillopora_meandrina_HIv1___RNAseq.g2675.t1,three_way,76.47133333333333,,,,,,,,,,,,,,,,,
OG_00608,2.4189969851836293,FUN_001771-T1,Peve_00035574,Pocillopora_meandrina_HIv1___RNAseq.g2680.t1,three_way,97.479,FUN_001771-T1,Q6P4J8,,,,,83.6,482.0,7.6e-166,585.1,sp|Q6P4J8|SMU1_XENTR WD40 repeat-containing protein SMU1 OS=Xenopus tropicalis OX=8364 GN=smu1 PE=2 SV=1,,,,,,
OG_00616,1.7090676748503038,FUN_001782-T1,Peve_00011614,Pocillopora_meandrina_HIv1___RNAseq.g2693.t1,three_way,67.33749999999999,FUN_001782-T1,Q08DU8,BL1S6_BOVIN,,Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein homolog) (Pallidin),Bos taurus (Bovine),35.2,88.0,1.2e-13,77.8,sp|Q08DU8|BL1S6_BOVIN Biogenesis of lysosome-related organelles complex 1 subunit 6 OS=Bos taurus OX=9913 GN=BLOC1S6 PE=1 SV=1,GO:0001725; GO:0001726; GO:0001822; GO:0002936; GO:0003016; GO:0003158; GO:0005737; GO:0005768; GO:0005925; GO:0006536; GO:0006541; GO:0006605; GO:0006644; GO:0007596; GO:0007613; GO:0008089; GO:0009410; GO:0010467; GO:0014823; GO:0021542; GO:0021854; GO:0030133; GO:0030318; GO:0031083; GO:0031175; GO:0031201; GO:0031941; GO:0032402; GO:0032816; GO:0033299; GO:0033484; GO:0035264; GO:0035646; GO:0042311; GO:0042745; GO:0042803; GO:0043227; GO:0044291; GO:0046034; GO:0046085; GO:0046907; GO:0048286; GO:0048490; GO:0048872; GO:0050942; GO:0051015; GO:0051017; GO:0055088; GO:0060090; GO:0060271; GO:0061025; GO:0070938; GO:0071364; GO:0071806; GO:1904115; GO:1905144; GO:1990742,actin filament bundle assembly [GO:0051017]; adenosine metabolic process [GO:0046085]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; ATP metabolic process [GO:0046034]; blood coagulation [GO:0007596]; bradykinin biosynthetic process [GO:0002936]; cellular response to epidermal growth factor stimulus [GO:0071364]; cilium assembly [GO:0060271]; circadian sleep/wake cycle [GO:0042745]; dentate gyrus development [GO:0021542]; endosome to melanosome transport [GO:0035646]; endothelium development [GO:0003158]; gene expression [GO:0010467]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; homeostasis of number of cells [GO:0048872]; hypothalamus development [GO:0021854]; intracellular nitric oxide homeostasis [GO:0033484]; intracellular transport [GO:0046907]; kidney development [GO:0001822]; lipid homeostasis [GO:0055088]; lung alveolus development [GO:0048286]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neuron projection development [GO:0031175]; phospholipid metabolic process [GO:0006644]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; protein targeting [GO:0006605]; protein transmembrane transport [GO:0071806]; respiratory system process [GO:0003016]; response to acetylcholine [GO:1905144]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299]; vasodilation [GO:0042311],axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell-cell contact zone [GO:0044291]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; endosome [GO:0005768]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane-bounded organelle [GO:0043227]; microvesicle [GO:1990742]; ruffle [GO:0001726]; SNARE complex [GO:0031201]; stress fiber [GO:0001725]; transport vesicle [GO:0030133],actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0003016; GO:0005768; GO:0006520; GO:0006629; GO:0007018; GO:0008092; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0055085; GO:0055086; GO:0060090; GO:0061024; GO:1901135,circulatory system process; respiratory system process; endosome; amino acid metabolic process; lipid metabolic process; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; nervous system process; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; carbohydrate derivative metabolic process
OG_00619,1.3928235041498511,FUN_001787-T1,Peve_00008715,Pocillopora_meandrina_HIv1___RNAseq.g2639.t1,three_way,71.26766666666667,FUN_001787-T1,Q9HCE0,EPG5_HUMAN,,Ectopic P granules protein 5 homolog,Homo sapiens (Human),30.6,2484.0,0.0,1120.1,sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2,GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0002376; GO:0005764; GO:0005773; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226,immune system process; lysosome; vacuole; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle
OG_00623,1.3701864136466912,FUN_001794-T1,Peve_00037091,Pocillopora_meandrina_HIv1___RNAseq.g15131.t1,three_way,57.70583333333334,FUN_001794-T1,P05183,CP3A2_RAT,,Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase),Rattus norvegicus (Rat),39.3,504.0,7.0000000000000015e-90,332.8,sp|P05183|CP3A2_RAT Cytochrome P450 3A2 OS=Rattus norvegicus OX=10116 GN=Cyp3a2 PE=1 SV=2,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006706; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0032451; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021,alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_00626,2.164354628746593,FUN_001842-T1,Peve_00006790,Pocillopora_meandrina_HIv1___RNAseq.g2620.t1,three_way,88.205,FUN_001842-T1,Q9GKQ9,,,,,60.2,558.0,1.9e-172,607.1,sp|Q9GKQ9|SMAD4_PIG Mothers against decapentaplegic homolog 4 OS=Sus scrofa OX=9823 GN=SMAD4 PE=2 SV=1,,,,,,
OG_00629,2.680569590764479,FUN_001847-T1,Peve_00025829,Pocillopora_meandrina_HIv1___RNAseq.g2613.t1,three_way,82.766,FUN_001847-T1,O88576,S6A18_MOUSE,,Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),Mus musculus (Mouse),51.0,486.0,7.500000000000001e-145,515.4,sp|O88576|S6A18_MOUSE Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Mus musculus OX=10090 GN=Slc6a18 PE=1 SV=1,GO:0003333; GO:0005886; GO:0006836; GO:0015175; GO:0015804; GO:0016324; GO:0031526; GO:0140931; GO:1990297,amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; renal amino acid absorption [GO:1990297],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium:chloride symporter activity [GO:0140931],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_00631,3.008919346598102,FUN_001853-T1,Peve_00018078,Pocillopora_meandrina_HIv1___RNAseq.g2603.t1,three_way,57.54833333333333,FUN_001853-T1,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),32.9,237.0,3.9e-29,130.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_00638,1.8025415095463493,FUN_001867-T1,Peve_00030491,Pocillopora_meandrina_HIv1___RNAseq.g2595.t1,three_way,85.47733333333333,FUN_001867-T1,Q02241,KIF23_HUMAN,,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),Homo sapiens (Human),44.4,967.0,2.9e-197,690.3,sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3,GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149,microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467],centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003774; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00640,1.3347537966237764,FUN_001879-T1,Peve_00030499,Pocillopora_meandrina_HIv1___RNAseq.g2593.t1,three_way,62.20333333333333,FUN_001879-T1,Q6NTR1,,,,,38.1,691.0,1.8e-112,408.3,sp|Q6NTR1|EFNMT_XENLA eEF1A lysine and N-terminal methyltransferase OS=Xenopus laevis OX=8355 GN=mettl13 PE=2 SV=1,,,,,,
OG_00642,1.0364216716663694,FUN_001883-T1,Peve_00030486,Pocillopora_meandrina_HIv1___RNAseq.g2592.t1,three_way,67.79133333333333,FUN_001883-T1,P55814,,,,,55.6,90.0,3.9e-23,109.8,sp|P55814|OAZ1_XENLA Ornithine decarboxylase antizyme 1 OS=Xenopus laevis OX=8355 GN=oaz1 PE=2 SV=2,,,,,,
OG_00645,1.1181504807698115,FUN_001898-T1,Peve_00018649,Pocillopora_meandrina_HIv1___RNAseq.g2575.t1,three_way,94.408,FUN_001898-T1,Q32LN7,SKI8_BOVIN,,"Superkiller complex protein 8 (Ski8) (WD repeat-containing protein 61) [Cleaved into: Superkiller complex protein 8, N-terminally processed (WD repeat-containing protein 61, N-terminally processed)]",Bos taurus (Bovine),62.2,119.0,2.0000000000000002e-44,181.0,sp|Q32LN7|SKI8_BOVIN Superkiller complex protein 8 OS=Bos taurus OX=9913 GN=SKIC8 PE=2 SV=1,GO:0000791; GO:0005634; GO:0005737; GO:0006368; GO:0016055; GO:0016593; GO:0045638; GO:0055087; GO:0070478; GO:0072344,"negative regulation of myeloid cell differentiation [GO:0045638]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055]",Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleus [GO:0005634]; Ski complex [GO:0055087],,GO:0005634; GO:0016071; GO:0043226,nucleus; mRNA metabolic process; organelle
OG_00648,1.2114775149647288,FUN_001901-T1,Peve_00018643,Pocillopora_meandrina_HIv1___TS.g5085.t1,three_way,66.03566666666667,,,,,,,,,,,,,,,,,
OG_00649,1.603442281084984,FUN_001904-T1,Peve_00013091,Pocillopora_meandrina_HIv1___RNAseq.g2569.t1,three_way,67.893,FUN_001904-T1,Q9SF91,,,,,41.7,211.0,8.3e-40,165.2,sp|Q9SF91|RAE1E_ARATH Ras-related protein RABE1e OS=Arabidopsis thaliana OX=3702 GN=RABE1E PE=1 SV=1,,,,,,
OG_00654,1.8876569398394785,FUN_001940-T1,Peve_00024481,Pocillopora_meandrina_HIv1___RNAseq.20168_t,three_way,77.20733333333334,FUN_001940-T1,Q87PP5,,,,,35.6,547.0,4.6e-98,360.5,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_00662,1.4836863412398502,FUN_001955-T1,Peve_00041246,Pocillopora_meandrina_HIv1___RNAseq.g2487.t1,three_way,54.437666666666665,,,,,,,,,,,,,,,,,
OG_00677,2.5075143557981803,FUN_002092-T1,Peve_00004296,Pocillopora_meandrina_HIv1___RNAseq.g1730.t2,three_way,68.856,FUN_002092-T1,H3BCW1,ADPRS_LATCH,,ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (LchARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-),Latimeria chalumnae (Coelacanth),40.8,355.0,2.2e-61,237.7,sp|H3BCW1|ADPRS_LATCH ADP-ribosylhydrolase ARH3 OS=Latimeria chalumnae OX=7897 GN=adprs PE=1 SV=1,GO:0000287; GO:0004649; GO:0005634; GO:0005694; GO:0005759; GO:0006281; GO:0060546; GO:0140290; GO:0140292,DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290],chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634],ADP-ribosylserine hydrolase activity [GO:0140292]; magnesium ion binding [GO:0000287]; poly(ADP-ribose) glycohydrolase activity [GO:0004649],GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; DNA repair; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00679,3.54278854532321,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_00681,1.0803322464845786,FUN_002115-T1,Peve_00035152,Pocillopora_meandrina_HIv1___RNAseq.g1741.t1,three_way,74.249,FUN_002115-T1,Q8BP78,,,,,63.8,163.0,1.6e-60,234.2,sp|Q8BP78|F10C1_MOUSE Protein FRA10AC1 homolog OS=Mus musculus OX=10090 GN=Fra10ac1 PE=1 SV=3,,,,,,
OG_00692,2.0779899733336493,FUN_002379-T1,Peve_00034020,Pocillopora_meandrina_HIv1___RNAseq.g20.t2,three_way,83.75166666666667,FUN_002379-T1,Q00537,CDK17_HUMAN,,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),Homo sapiens (Human),57.9,525.0,3.6e-160,566.2,sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987,protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00693,1.7322262564510331,FUN_002382-T1,Peve_00034022,Pocillopora_meandrina_HIv1___RNAseq.g14908.t1,three_way,68.7255,FUN_002382-T1,Q4R2Y9,ABHD2_MACFA,,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Triacylglycerol lipase) (EC 3.1.1.79),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.2,408.0,1.7e-86,321.2,sp|Q4R2Y9|ABHD2_MACFA Monoacylglycerol lipase ABHD2 OS=Macaca fascicularis OX=9541 GN=ABHD2 PE=2 SV=1,GO:0001669; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0032570; GO:0036126; GO:0042562; GO:0043401; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524; GO:0120516,acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone receptor signaling pathway [GO:0043401],acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524],acetylesterase activity [GO:0008126]; diacylglycerol lipase activity [GO:0120516]; hormone binding [GO:0042562]; monoacylglycerol lipase activity [GO:0047372]; nuclear steroid receptor activity [GO:0003707]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005886; GO:0005929; GO:0006629; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0060089; GO:0140110,catalytic activity; plasma membrane; cilium; lipid metabolic process; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; cell motility; molecular transducer activity; transcription regulator activity
OG_00694,1.412810033034131,FUN_002404-T1,Peve_00034027,Pocillopora_meandrina_HIv1___RNAseq.g14812.t1,three_way,68.69066666666666,FUN_002404-T1,G5E8P0,,,,,33.2,1574.0,2.5e-156,555.1,sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1,,,,,,
OG_00701,1.171366819827062,FUN_002451-T1,Peve_00043794,Pocillopora_meandrina_HIv1___RNAseq.g14889.t1,three_way,85.959,FUN_002451-T1,P47897,SYQ_HUMAN,,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),Homo sapiens (Human),62.5,778.0,1.2e-290,1000.3,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234,brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860],GO:0003824; GO:0005829; GO:0006355; GO:0006399; GO:0006520; GO:0016874; GO:0048856; GO:0098772; GO:0140098,"catalytic activity; cytosol; regulation of DNA-templated transcription; tRNA metabolic process; amino acid metabolic process; ligase activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on RNA"
OG_00706,3.2924822126672115,FUN_002463-T1,Peve_00034010,Pocillopora_meandrina_HIv1___RNAseq.g14902.t1,three_way,92.76133333333334,FUN_002463-T1,P55861,,,,,73.9,789.0,7.3e-312,1070.8,sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2,,,,,,
OG_00714,1.03556592778264,FUN_002582-T1,Peve_00002778,Pocillopora_meandrina_HIv1___RNAseq.g25727.t1,three_way,60.239666666666665,,,,,,,,,,,,,,,,,
OG_00717,1.356640367481741,FUN_002649-T1,Peve_00040095,Pocillopora_meandrina_HIv1___RNAseq.g25705.t1,three_way,67.51933333333334,,,,,,,,,,,,,,,,,
OG_00718,1.4074303598074596,FUN_002650-T1,Peve_00040096,Pocillopora_meandrina_HIv1___RNAseq.g25706.t1,three_way,65.42783333333333,FUN_002650-T1,Q8K2I9,FBH1_MOUSE,,F-box DNA helicase 1 (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18),Mus musculus (Mouse),38.3,757.0,1.4000000000000002e-124,449.5,sp|Q8K2I9|FBH1_MOUSE F-box DNA helicase 1 OS=Mus musculus OX=10090 GN=Fbh1 PE=1 SV=1,GO:0000724; GO:0000785; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042,DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429],chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00725,1.3482716620281214,FUN_002670-T1,Peve_00005202,Pocillopora_meandrina_HIv1___TS.g27719.t1,three_way,57.01833333333333,FUN_002670-T1,Q2KJ34,,,,,30.4,184.0,6.3e-13,76.6,sp|Q2KJ34|HBP1_BOVIN HMG box-containing protein 1 OS=Bos taurus OX=9913 GN=HBP1 PE=2 SV=1,,,,,,
OG_00746,1.7999900510139126,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.3999999999999999e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00749,2.2094712522043265,FUN_002806-T2,Peve_00044239,Pocillopora_meandrina_HIv1___RNAseq.g14970.t1b,three_way,71.58233333333334,,,,,,,,,,,,,,,,,
OG_00751,1.729045502050126,FUN_002808-T1,Peve_00044269,Pocillopora_meandrina_HIv1___RNAseq.g14968.t1,three_way,67.566,FUN_002808-T1,Q9UNF1,MAGD2_HUMAN,,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),Homo sapiens (Human),35.8,201.0,2.1000000000000002e-32,141.0,sp|Q9UNF1|MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2,GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294,female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294],cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093],,GO:0003014; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0043226,renal system process; extracellular region; nucleus; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle
OG_00753,1.3974223631556186,FUN_002811-T1,Peve_00025579,Pocillopora_meandrina_HIv1___RNAseq.g14963.t1,three_way,63.69916666666666,FUN_002811-T1,Q6DDT4,APEX2_XENLA,,DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.11.2),Xenopus laevis (African clawed frog),48.5,546.0,1.8e-136,487.6,sp|Q6DDT4|APEX2_XENLA DNA-(apurinic or apyrimidinic site) endonuclease 2 OS=Xenopus laevis OX=8355 GN=apex2.L PE=1 SV=1,GO:0003677; GO:0003906; GO:0004519; GO:0005634; GO:0005694; GO:0005739; GO:0006284; GO:0008081; GO:0008270; GO:0008311,base-excision repair [GO:0006284],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; chromosome; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_00757,2.181092538166546,FUN_003163-T1,Peve_00013072,Pocillopora_meandrina_HIv1___RNAseq.g6226.t1,three_way,84.06066666666666,FUN_003163-T1,P54996,,,,,66.8,479.0,3.9e-200,699.1,sp|P54996|G6PD_TAKRU Glucose-6-phosphate 1-dehydrogenase OS=Takifugu rubripes OX=31033 GN=g6pd PE=3 SV=1,,,,,,
OG_00758,1.072204636878177,FUN_003164-T1,Peve_00019151,Pocillopora_meandrina_HIv1___RNAseq.g6225.t1,three_way,73.69,,,,,,,,,,,,,,,,,
OG_00763,1.1243941159654205,FUN_003432-T1,Peve_00013657,Pocillopora_meandrina_HIv1___RNAseq.g22188.t1,three_way,69.05233333333334,FUN_003432-T1,Q9HC36,MRM3_HUMAN,,"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)",Homo sapiens (Human),33.2,313.0,7.499999999999997e-41,169.1,"sp|Q9HC36|MRM3_HUMAN rRNA methyltransferase 3, mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2",GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0042802; GO:0070039,rRNA 2'-O-methylation [GO:0000451]; rRNA processing [GO:0006364],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039],GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00769,2.7371185635152844,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.4999999999999996e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00770,2.262995593265107,FUN_003718-T1,Peve_00001366,Pocillopora_meandrina_HIv1___RNAseq.g26671.t1,three_way,75.134,FUN_003718-T1,P37193,,,,,70.1,134.0,2.9999999999999995e-54,213.0,"sp|P37193|ADXH1_DROME Adrenodoxin-like protein 1, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx1 PE=2 SV=3",,,,,,
OG_00771,1.7713657792446964,FUN_003839-T1,Peve_00042654,Pocillopora_meandrina_HIv1___RNAseq.g11160.t1,three_way,68.94483333333334,FUN_003839-T1,Q9Z254,GIPC1_RAT,,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin),Rattus norvegicus (Rat),59.0,290.0,3.8e-93,343.2,sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2,GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098793; GO:0098794; GO:0098978; GO:0099171,cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167],brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102],GO:0005829; GO:0008092; GO:0023052; GO:0031410; GO:0043226; GO:0048870,cytosol; cytoskeletal protein binding; signaling; cytoplasmic vesicle; organelle; cell motility
OG_00772,2.7924015813679044,FUN_003840-T1,Peve_00003890,Pocillopora_meandrina_HIv1___RNAseq.g11708.t1,three_way,63.461333333333336,FUN_003840-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),31.0,1540.0,1.8000000000000001e-162,575.5,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_00775,1.5371829127247838,FUN_003847-T1,Peve_00009243,Pocillopora_meandrina_HIv1___RNAseq.g11165.t1,three_way,62.71566666666666,FUN_003847-T1,Q80TL4,PHF24_MOUSE,,PHD finger protein 24,Mus musculus (Mouse),30.2,268.0,2.8e-31,137.9,sp|Q80TL4|PHF24_MOUSE PHD finger protein 24 OS=Mus musculus OX=10090 GN=Phf24 PE=1 SV=2,GO:0007214; GO:0008270; GO:0008277; GO:0030672; GO:0032228; GO:0050966; GO:0098978,"detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",glutamatergic synapse [GO:0098978]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0023052,signaling
OG_00780,1.6832814478160567,FUN_003878-T1,Peve_00009218,Pocillopora_meandrina_HIv1___RNAseq.g11578.t2,three_way,60.194833333333335,FUN_003878-T1,Q7TT28,,,,,47.5,438.0,1.0999999999999998e-105,385.2,sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1,,,,,,
OG_00781,1.7134868166051571,FUN_003881-T1,Peve_00023686,Pocillopora_meandrina_HIv1___RNAseq.g11577.t1,three_way,74.771,FUN_003881-T1,Q66KE8,,,,,30.9,459.0,4.3e-50,201.4,sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1,,,,,,
OG_00784,1.0303968958110634,FUN_003894-T1,Peve_00015142,Pocillopora_meandrina_HIv1___RNAseq.g11707.t1,three_way,79.82766666666667,FUN_003894-T1,P35574,,,,,51.0,1345.0,0.0,1379.0,sp|P35574|GDE_RABIT Glycogen debranching enzyme OS=Oryctolagus cuniculus OX=9986 GN=AGL PE=1 SV=1,,,,,,
OG_00786,1.3537945314368829,FUN_003899-T1,Peve_00015155,Pocillopora_meandrina_HIv1___RNAseq.g11681.t1,three_way,79.42999999999999,FUN_003899-T1,Q9V0D5,,,,,38.2,353.0,3.400000000000001e-65,250.4,sp|Q9V0D5|MDH_PYRAB Malate dehydrogenase OS=Pyrococcus abyssi (strain GE5 / Orsay) OX=272844 GN=mdh PE=3 SV=1,,,,,,
OG_00787,2.9132870773263178,FUN_003900-T1,Peve_00025157,Pocillopora_meandrina_HIv1___RNAseq.g17184.t1,three_way,80.535,FUN_003900-T1,Q69ZJ7,RIC1_MOUSE,,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1),Mus musculus (Mouse),40.0,1396.0,3.9000000000000003e-284,979.5,sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0006886; GO:0016192; GO:0098772,cytosol; intracellular protein transport; vesicle-mediated transport; molecular function regulator activity
OG_00788,1.0019242582289287,FUN_003901-T1,Peve_00012083,Pocillopora_meandrina_HIv1___RNAseq.g17185.t1,three_way,78.26033333333334,FUN_003901-T1,Q4KM73,KCY_RAT,,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),Rattus norvegicus (Rat),58.6,191.0,3.2e-57,223.0,sp|Q4KM73|KCY_RAT UMP-CMP kinase OS=Rattus norvegicus OX=10116 GN=Cmpk1 PE=1 SV=2,GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0006227; GO:0006240; GO:0009041; GO:0018963; GO:0022602; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0050145,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; dCDP biosynthetic process [GO:0006240]; dUDP biosynthetic process [GO:0006227]; ovulation cycle process [GO:0022602]; phthalate metabolic process [GO:0018963]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; UMP/dUMP kinase activity [GO:0009041],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; reproductive process; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00790,1.7228697718823889,FUN_003935-T1,Peve_00041379,Pocillopora_meandrina_HIv1___RNAseq.g11752.t1,three_way,90.497,FUN_003935-T1,Q2M2T6,,,,,72.6,84.0,2.0000000000000002e-29,129.4,sp|Q2M2T6|ASTER_BOVIN PAT complex subunit Asterix OS=Bos taurus OX=9913 GN=WDR83OS PE=3 SV=1,,,,,,
OG_00792,3.477507564575049,FUN_003938-T1,Peve_00041389,Pocillopora_meandrina_HIv1___TS.g7868.t1,three_way,40.8085,,,,,,,,,,,,,,,,,
OG_00793,1.785601964423223,FUN_003940-T1,Peve_00038457,Pocillopora_meandrina_HIv1___RNAseq.g11757.t1,three_way,58.294,FUN_003940-T1,Q6DG99,,,,,53.7,95.0,7.6e-19,96.3,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_00796,1.9582171738898737,FUN_003982-T1,Peve_00038451,Pocillopora_meandrina_HIv1___TS.g7876.t1,three_way,62.93233333333333,,,,,,,,,,,,,,,,,
OG_00805,2.289750338997352,FUN_004003-T1,Peve_00034340,Pocillopora_meandrina_HIv1___RNAseq.g11702.t1,three_way,76.87066666666666,FUN_004003-T1,O35819,,,,,73.6,106.0,5.5e-11,70.1,sp|O35819|KLF6_RAT Krueppel-like factor 6 OS=Rattus norvegicus OX=10116 GN=Klf6 PE=2 SV=2,,,,,,
OG_00808,2.423673917349297,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_00810,2.1942036458556755,FUN_004010-T1,Peve_00044898,Pocillopora_meandrina_HIv1___RNAseq.g11691.t1,three_way,58.72366666666667,FUN_004010-T1,Q9BYK8,,,,,26.8,1587.0,5.9e-113,411.4,sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7,,,,,,
OG_00815,1.1518806645395951,FUN_004028-T1,Peve_00003960,Pocillopora_meandrina_HIv1___RNAseq.g12640.t1,three_way,59.62266666666667,FUN_004028-T1,Q8R1P4,,,,,37.8,209.0,4.8e-29,129.4,sp|Q8R1P4|ATG10_MOUSE Ubiquitin-like-conjugating enzyme ATG10 OS=Mus musculus OX=10090 GN=Atg10 PE=1 SV=1,,,,,,
OG_00816,2.118776224056475,FUN_004029-T1,Peve_00003922,Pocillopora_meandrina_HIv1___TS.g18515.t2,three_way,93.10066666666664,FUN_004029-T1,Q9R050,,,,,40.6,414.0,1.6999999999999998e-53,211.5,sp|Q9R050|SSBP3_RAT Single-stranded DNA-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ssbp3 PE=1 SV=1,,,,,,
OG_00820,1.7572361094805489,FUN_004038-T1,Peve_00008961,Pocillopora_meandrina_HIv1___RNAseq.g11549.t1,three_way,96.45366666666666,FUN_004038-T1,Q2KJ81,AP1M1_BOVIN,,AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin),Bos taurus (Bovine),81.5,422.0,8.299999999999998e-206,717.6,sp|Q2KJ81|AP1M1_BOVIN AP-1 complex subunit mu-1 OS=Bos taurus OX=9913 GN=AP1M1 PE=1 SV=3,GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0035615,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794],clathrin adaptor activity [GO:0035615],GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090,Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_00821,2.1796326797444188,FUN_004039-T1,Peve_00008962,Pocillopora_meandrina_HIv1___RNAseq.g11550.t1,three_way,79.03166666666667,FUN_004039-T1,D3YXK1,SAMD1_MOUSE,,Sterile alpha motif domain-containing protein 1 (SAM domain-containing protein 1) (Atherin),Mus musculus (Mouse),54.7,75.0,7.5e-17,90.1,sp|D3YXK1|SAMD1_MOUSE Sterile alpha motif domain-containing protein 1 OS=Mus musculus OX=10090 GN=Samd1 PE=1 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0051260; GO:0090077; GO:0160217,chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; protein homooligomerization [GO:0051260],chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; low-density lipoprotein particle binding [GO:0030169],GO:0003677; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0043226; GO:0065003,DNA binding; extracellular space; nucleus; chromosome; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_00825,1.7351152898138078,FUN_004054-T1,Peve_00003957,Pocillopora_meandrina_HIv1___RNAseq.g12636.t1,three_way,93.765,FUN_004054-T1,Q28DV3,HDAC3_XENTR,,Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),70.9,423.0,2.2e-182,639.8,sp|Q28DV3|HDAC3_XENTR Histone deacetylase 3 OS=Xenopus tropicalis OX=8364 GN=hdac3 PE=2 SV=1,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0017053; GO:0032922; GO:0033558; GO:0042752; GO:0046872; GO:0141221; GO:0160008; GO:0160009; GO:0160010; GO:0160216,circadian regulation of gene expression [GO:0032922]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein decrotonylase activity [GO:0160008]; protein lysine deacetylase activity [GO:0033558]; protein lysine delactylase activity [GO:0160216]; transcription corepressor activity [GO:0003714]",GO:0003824; GO:0005634; GO:0005694; GO:0005829; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; cytosol; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00826,1.1610506528911928,FUN_004055-T1,Peve_00004708,Pocillopora_meandrina_HIv1___TS.g18498.t1,three_way,83.49266666666666,FUN_004055-T1,Q29RZ2,,,,,66.3,596.0,1e-236,820.8,sp|Q29RZ2|PPWD1_BOVIN Peptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=PPWD1 PE=2 SV=1,,,,,,
OG_00832,1.0610618954403936,FUN_004073-T1,Peve_00006663,Pocillopora_meandrina_HIv1___RNAseq.g17238.t1,three_way,67.30466666666666,FUN_004073-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),26.8,313.0,3.7e-23,110.5,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_00833,3.05836492754567,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,9.999999999999999e-64,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_00837,1.4269067215001223,FUN_004087-T1,Peve_00024026,Pocillopora_meandrina_HIv1___RNAseq.g12612.t1,three_way,69.48666666666666,FUN_004087-T1,Q8NE22,,,,,43.2,294.0,6.8e-60,232.3,sp|Q8NE22|SETD9_HUMAN SET domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SETD9 PE=1 SV=2,,,,,,
OG_00840,1.0996615598914323,FUN_004090-T1,Peve_00040112,Pocillopora_meandrina_HIv1___RNAseq.g13727.t1,three_way,62.88,FUN_004090-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),28.1,424.0,3.3e-32,142.5,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_00844,2.044370870874669,FUN_004095-T1,Peve_00028986,Pocillopora_meandrina_HIv1___RNAseq.g11568.t1,three_way,55.16966666666666,FUN_004095-T1,Q96S53,TESK2_HUMAN,,Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2),Homo sapiens (Human),50.5,287.0,5.2e-76,287.0,sp|Q96S53|TESK2_HUMAN Dual specificity testis-specific protein kinase 2 OS=Homo sapiens OX=9606 GN=TESK2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310,actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0007010; GO:0016740; GO:0022414; GO:0034330; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton organization; transferase activity; reproductive process; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_00851,1.595630270546094,FUN_004110-T1,Peve_00015644,Pocillopora_meandrina_HIv1___RNAseq.g11664.t1,three_way,73.29766666666667,FUN_004110-T1,Q5ZL21,MMAC_CHICK,,Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC),Gallus gallus (Chicken),51.5,233.0,3.2e-64,246.5,sp|Q5ZL21|MMAC_CHICK Cyanocobalamin reductase / alkylcobalamin dealkylase OS=Gallus gallus OX=9031 GN=MMACHC PE=2 SV=1,GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0016491; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0043295; GO:0070988; GO:0071949,cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829],cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) (NADP+) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740,catalytic activity; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity
OG_00854,1.3458627890109391,FUN_004117-T1,Peve_00038521,Pocillopora_meandrina_HIv1___RNAseq.g11674.t1,three_way,85.43533333333333,FUN_004117-T1,F1Q8K0,RAD54_DANRE,,DNA repair and recombination protein RAD54-like (EC 3.6.4.12),Danio rerio (Zebrafish) (Brachydanio rerio),66.8,744.0,3.7000000000000004e-292,1005.4,sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131],nucleus [GO:0005634],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00864,1.7085567785977336,FUN_004129-T1,Peve_00021773,Pocillopora_meandrina_HIv1___RNAseq.g16787.t1,three_way,36.23266666666667,,,,,,,,,,,,,,,,,
OG_00866,3.018551158781006,FUN_004140-T2,Peve_00009429,Pocillopora_meandrina_HIv1___RNAseq.g11564.t1,three_way,92.6315,FUN_004140-T2,Q07343,PDE4B_HUMAN,,"3',5'-cyclic-AMP phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) (cAMP-specific phosphodiesterase 4B)",Homo sapiens (Human),56.3,551.0,1.1000000000000001e-168,595.1,"sp|Q07343|PDE4B_HUMAN 3',5'-cyclic-AMP phosphodiesterase 4B OS=Homo sapiens OX=9606 GN=PDE4B PE=1 SV=1",GO:0000930; GO:0001780; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0008021; GO:0014069; GO:0019933; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0047555; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0071878; GO:0086004; GO:1901898; GO:1902514,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of type II interferon production [GO:0032729]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; T cell receptor signaling pathway [GO:0050852],centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]",GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0055086; GO:0098772; GO:1901135,immune system process; catalytic activity; microtubule organizing center; cytosol; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; nucleobase-containing small molecule metabolic process; molecular function regulator activity; carbohydrate derivative metabolic process
OG_00867,2.406995026482869,FUN_004142-T1,Peve_00004368,Pocillopora_meandrina_HIv1___RNAseq.g144.t1,three_way,51.94683333333333,FUN_004142-T1,Q5T890,ER6L2_HUMAN,,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2),Homo sapiens (Human),31.5,1000.0,5.9999999999999986e-93,344.0,sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3,GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680,cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140657,DNA binding; catalytic activity; nucleus; mitochondrion; microtubule organizing center; DNA repair; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00868,2.125509630024571,FUN_004150-T1,Peve_00021770,Pocillopora_meandrina_HIv1___RNAseq.g16785.t1,three_way,52.79866666666667,,,,,,,,,,,,,,,,,
OG_00869,1.913244263575008,FUN_004156-T1,Peve_00031561,Pocillopora_meandrina_HIv1___RNAseq.g16776.t1,three_way,93.97166666666666,FUN_004156-T1,Q5F359,,,,,67.0,188.0,1.2e-68,260.8,sp|Q5F359|TPPC5_CHICK Trafficking protein particle complex subunit 5 OS=Gallus gallus OX=9031 GN=TRAPPC5 PE=2 SV=1,,,,,,
OG_00873,1.8131824801190664,FUN_004162-T1,Peve_00031559,Pocillopora_meandrina_HIv1___RNAseq.24438_t,three_way,37.080333333333336,,,,,,,,,,,,,,,,,
OG_00877,2.3714790583041023,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_00881,1.7935394575362027,FUN_004196-T2,Peve_00030899,Pocillopora_meandrina_HIv1___RNAseq.g17013.t1,three_way,51.406666666666666,FUN_004196-T2,Q60988,STIL_MOUSE,,SCL-interrupting locus protein homolog,Mus musculus (Mouse),25.4,1322.0,1.7e-66,256.5,sp|Q60988|STIL_MOUSE SCL-interrupting locus protein homolog OS=Mus musculus OX=10090 GN=Stil PE=1 SV=2,GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005938; GO:0006915; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0033504; GO:0035264; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905515; GO:1905832,apoptotic process [GO:0006915]; centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224],cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099],,GO:0005815; GO:0005829; GO:0007010; GO:0012501; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; cytoskeleton organization; programmed cell death; organelle; cilium organization; anatomical structure development
OG_00885,1.3374578211910533,FUN_004200-T1,Peve_00030913,Pocillopora_meandrina_HIv1___RNAseq.g17022.t1,three_way,70.74116666666667,FUN_004200-T1,Q5ZJ32,,,,,41.7,103.0,4.3e-11,68.9,sp|Q5ZJ32|SOSSC_CHICK SOSS complex subunit C OS=Gallus gallus OX=9031 GN=INIP PE=3 SV=1,,,,,,
OG_00886,1.0565464208977258,FUN_004201-T1,Peve_00030920,Pocillopora_meandrina_HIv1___RNAseq.g17023.t1,three_way,67.14383333333333,,,,,,,,,,,,,,,,,
OG_00887,3.446703520003268,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_00889,1.1875634249966114,FUN_004204-T1,Peve_00018652,Pocillopora_meandrina_HIv1___RNAseq.g16708.t1,three_way,74.196,FUN_004204-T1,Q96LT7,CI072_HUMAN,,Guanine nucleotide exchange factor C9orf72,Homo sapiens (Human),32.5,459.0,9.2e-60,232.6,sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2,GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0043231; GO:0044295; GO:0044304; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785,autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063],autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005615; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0098772,extracellular space; nucleus; lysosome; endosome; vacuole; cytosol; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity
OG_00890,1.083914814559624,FUN_004205-T1,Peve_00027996,Pocillopora_meandrina_HIv1___RNAseq.g11214.t1,three_way,62.80466666666667,FUN_004205-T1,Q8WWF8,,,,,38.6,184.0,4.4e-29,129.4,sp|Q8WWF8|CAPSL_HUMAN Calcyphosin-like protein OS=Homo sapiens OX=9606 GN=CAPSL PE=1 SV=4,,,,,,
OG_00891,1.3562802454050291,FUN_004206-T1,Peve_00011052,Pocillopora_meandrina_HIv1___RNAseq.g11215.t1,three_way,57.277,FUN_004206-T1,F4INN2,,,,,33.9,165.0,2e-17,90.9,sp|F4INN2|GGP4_ARATH Gamma-glutamyl peptidase 4 OS=Arabidopsis thaliana OX=3702 GN=GGP4 PE=3 SV=1,,,,,,
OG_00893,3.1009156251788523,FUN_004208-T2,Peve_00011048,Pocillopora_meandrina_HIv1___RNAseq.g11218.t1,three_way,83.40266666666666,FUN_004208-T2,P51688,SPHM_HUMAN,,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),Homo sapiens (Human),63.4,432.0,4.3e-168,592.4,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062,determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_00899,1.5487088485226728,FUN_004222-T1,Peve_00008875,Pocillopora_meandrina_HIv1___RNAseq.g11224.t1,three_way,60.746833333333335,,,,,,,,,,,,,,,,,
OG_00902,1.400752952098146,FUN_004225-T1,Peve_00008866,Pocillopora_meandrina_HIv1___RNAseq.g11227.t1,three_way,81.6255,FUN_004225-T1,Q8BHI9,,,,,63.7,366.0,7.2e-134,478.8,sp|Q8BHI9|NIM1_MOUSE Serine/threonine-protein kinase NIM1 OS=Mus musculus OX=10090 GN=Nim1k PE=2 SV=1,,,,,,
OG_00906,1.265672992380216,FUN_004233-T1,Peve_00004620,Pocillopora_meandrina_HIv1___RNAseq.g12556.t1,three_way,86.73,FUN_004233-T1,P80363,,,,,44.2,199.0,5.6999999999999995e-46,185.7,sp|P80363|CCB23_FAXLI Crustacean calcium-binding protein 23 OS=Faxonius limosus OX=28379 PE=1 SV=1,,,,,,
OG_00908,1.4718878771294233,FUN_004236-T1,Peve_00037955,Pocillopora_meandrina_HIv1___RNAseq.g11535.t1,three_way,62.013666666666666,FUN_004236-T1,Q8R507,FKTN_MOUSE,,Ribitol-5-phosphate transferase FKTN (EC 2.7.8.-) (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase),Mus musculus (Mouse),52.7,292.0,6.3e-92,339.3,sp|Q8R507|FKTN_MOUSE Ribitol-5-phosphate transferase FKTN OS=Mus musculus OX=10090 GN=Fktn PE=1 SV=1,GO:0000139; GO:0001764; GO:0005634; GO:0005783; GO:0005794; GO:0005801; GO:0006486; GO:0006493; GO:0007420; GO:0008285; GO:0016780; GO:0021695; GO:0021987; GO:0035269; GO:0046329; GO:0060049; GO:0071711; GO:0098528,basement membrane organization [GO:0071711]; brain development [GO:0007420]; cerebellar cortex development [GO:0021695]; cerebral cortex development [GO:0021987]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of JNK cascade [GO:0046329]; neuron migration [GO:0001764]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]; skeletal muscle fiber differentiation [GO:0098528],cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],"phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0006486; GO:0009101; GO:0016740; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:1901135,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; protein glycosylation; glycoprotein biosynthetic process; transferase activity; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; carbohydrate derivative metabolic process
OG_00909,1.0082064759389766,FUN_004237-T1,Peve_00017641,Pocillopora_meandrina_HIv1___RNAseq.g11534.t1,three_way,79.0,,,,,,,,,,,,,,,,,
OG_00920,1.6211386263648702,FUN_004261-T1,Peve_00008971,Pocillopora_meandrina_HIv1___RNAseq.g11410.t1,three_way,69.04033333333334,FUN_004261-T1,Q2F7Z7,,,,,32.3,297.0,9.2e-29,129.0,sp|Q2F7Z7|TMM59_PIG Transmembrane protein 59 OS=Sus scrofa OX=9823 GN=TMEM59 PE=2 SV=1,,,,,,
OG_00921,1.18343699887453,FUN_004263-T1,Peve_00008934,Pocillopora_meandrina_HIv1___RNAseq.g11364.t1,three_way,72.5965,,,,,,,,,,,,,,,,,
OG_00922,1.0423279750964305,FUN_004264-T1,Peve_00008933,Pocillopora_meandrina_HIv1___RNAseq.g11655.t1,three_way,77.1215,FUN_004264-T1,P53349,M3K1_MOUSE,,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),Mus musculus (Mouse),36.4,1345.0,9.2e-204,712.2,sp|P53349|M3K1_MOUSE Mitogen-activated protein kinase kinase kinase 1 OS=Mus musculus OX=10090 GN=Map3k1 PE=1 SV=3,GO:0002011; GO:0003382; GO:0004672; GO:0004706; GO:0004708; GO:0005524; GO:0005829; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008637; GO:0030334; GO:0030838; GO:0031941; GO:0042060; GO:0043010; GO:0061029; GO:0070160; GO:0106310,apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of actin filament polymerization [GO:0030838]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060],cytosol [GO:0005829]; filamentous actin [GO:0031941]; tight junction [GO:0070160],ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0007005; GO:0008092; GO:0016740; GO:0042060; GO:0048856; GO:0140096,"catalytic activity; cytosol; mitochondrion organization; cytoskeletal protein binding; transferase activity; wound healing; anatomical structure development; catalytic activity, acting on a protein"
OG_00930,1.66810988821915,FUN_004275-T1,Peve_00008946,Pocillopora_meandrina_HIv1___RNAseq.g12553.t1,three_way,69.154,FUN_004275-T1,Q7ZVP8,TM38B_DANRE,,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),Danio rerio (Zebrafish) (Brachydanio rerio),35.1,251.0,9.999999999999999e-32,138.7,sp|Q7ZVP8|TM38B_DANRE Trimeric intracellular cation channel type B OS=Danio rerio OX=7955 GN=tmem38b PE=2 SV=1,GO:0005267; GO:0005783; GO:0005789; GO:0030500; GO:0031101; GO:0042802; GO:0051279; GO:1903010,fin regeneration [GO:0031101]; regulation of bone development [GO:1903010]; regulation of bone mineralization [GO:0030500]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],identical protein binding [GO:0042802]; potassium channel activity [GO:0005267],GO:0005215; GO:0005783; GO:0043226; GO:0048856,transporter activity; endoplasmic reticulum; organelle; anatomical structure development
OG_00940,1.788846685087361,FUN_004291-T1,Peve_00008388,Pocillopora_meandrina_HIv1___RNAseq.g11769.t1,three_way,79.22033333333333,FUN_004291-T1,Q6NYT1,,,,,50.8,195.0,5.1e-46,186.0,sp|Q6NYT1|MED8_DANRE Mediator of RNA polymerase II transcription subunit 8 OS=Danio rerio OX=7955 GN=med8 PE=2 SV=1,,,,,,
OG_00941,1.501882855257383,FUN_004292-T1,Peve_00008379,Pocillopora_meandrina_HIv1___RNAseq.g11770.t1,three_way,65.67333333333333,FUN_004292-T1,Q08CD5,RXLT1_DANRE,,"Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,332.0,1.6e-100,367.9,sp|Q08CD5|RXLT1_DANRE Ribitol-5-phosphate xylosyltransferase 1 OS=Danio rerio OX=7955 GN=rxylt1 PE=2 SV=2,GO:0000139; GO:0005794; GO:0035269; GO:0120053,protein O-linked mannosylation [GO:0035269],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"ribitol beta-1,4-xylosyltransferase activity [GO:0120053]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_00942,1.7385515141294348,FUN_004293-T1,Peve_00008382,Pocillopora_meandrina_HIv1___RNAseq.g11771.t1,three_way,62.1905,FUN_004293-T1,A2A9C3,SZT2_MOUSE,,KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR),Mus musculus (Mouse),30.2,3639.0,0.0,1353.6,sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1,GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667],GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777],,GO:0005777; GO:0043226; GO:0048856,peroxisome; organelle; anatomical structure development
OG_00944,1.308758283636018,FUN_004298-T1,Peve_00018886,Pocillopora_meandrina_HIv1___RNAseq.g11773.t1,three_way,95.47533333333332,FUN_004298-T1,P25228,RAB3_DROME,,Ras-related protein Rab-3,Drosophila melanogaster (Fruit fly),80.5,221.0,7.7e-102,371.3,sp|P25228|RAB3_DROME Ras-related protein Rab-3 OS=Drosophila melanogaster OX=7227 GN=Rab3 PE=1 SV=1,GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0015031; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790,cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192],endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; myosin V binding [GO:0031489],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0007010; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0034330; GO:0043226,catalytic activity; GTPase activity; endosome; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; cell junction organization; organelle
OG_00945,2.4268148790610407,FUN_004302-T1,Peve_00033935,Pocillopora_meandrina_HIv1___RNAseq.g11774.t1,three_way,84.65366666666667,FUN_004302-T1,Q90988,SMC2_CHICK,,Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII),Gallus gallus (Chicken),61.0,1173.0,6.6999999999999996e-264,912.1,sp|Q90988|SMC2_CHICK Structural maintenance of chromosomes protein 2 OS=Gallus gallus OX=9031 GN=SMC2 PE=2 SV=1,GO:0000785; GO:0000793; GO:0000796; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0007076; GO:0016887; GO:0051301,cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682],GO:0003824; GO:0005634; GO:0005694; GO:0016787; GO:0043226,catalytic activity; nucleus; chromosome; hydrolase activity; organelle
OG_00948,3.94040568779167,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00950,1.454551129406758,FUN_004310-T1,Peve_00033937,Pocillopora_meandrina_HIv1___RNAseq.g16984.t1,three_way,77.72666666666666,FUN_004310-T1,Q9JJT0,,,,,62.3,374.0,1.7e-141,503.8,sp|Q9JJT0|RCL1_MOUSE RNA 3'-terminal phosphate cyclase-like protein OS=Mus musculus OX=10090 GN=Rcl1 PE=2 SV=1,,,,,,
OG_00953,3.0756765113007143,FUN_004313-T1,Peve_00033929,Pocillopora_meandrina_HIv1___RNAseq.g16987.t1,three_way,67.48483333333334,FUN_004313-T1,Q90693,,,,,37.8,1339.0,2e-235,817.8,sp|Q90693|PTC1_CHICK Protein patched homolog 1 OS=Gallus gallus OX=9031 GN=PTCH1 PE=1 SV=1,,,,,,
OG_00961,2.724256501068912,FUN_004330-T1,Peve_00016550,Pocillopora_meandrina_HIv1___RNAseq.g12529.t1,three_way,89.566,FUN_004330-T1,A6QPA3,,,,,37.2,277.0,1.1999999999999999e-41,171.8,sp|A6QPA3|BTBDJ_BOVIN BTB/POZ domain-containing protein 19 OS=Bos taurus OX=9913 GN=BTBD19 PE=2 SV=1,,,,,,
OG_00962,1.6067706786773326,FUN_004331-T1,Peve_00016476,Pocillopora_meandrina_HIv1___TS.g18404.t1,three_way,55.634,FUN_004331-T1,Q9V9S7,,,,,33.4,347.0,5.9e-43,177.9,sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2,,,,,,
OG_00969,1.7228640570814102,FUN_004342-T1,Peve_00016486,Pocillopora_meandrina_HIv1___RNAseq.g12543.t1,three_way,62.193333333333335,FUN_004342-T1,Q9Y5Q9,,,,,36.5,824.0,3.8999999999999996e-142,507.3,sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,,,,,,
OG_00977,1.4557400619223315,FUN_004356-T1,Peve_00016494,Pocillopora_meandrina_HIv1___RNAseq.g12547.t1,three_way,92.93433333333331,FUN_004356-T1,Q9R1K5,FZR1_MOUSE,,Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog),Mus musculus (Mouse),72.8,500.0,3.4e-203,709.1,sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1,GO:0005654; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051603; GO:0070306; GO:0097027; GO:1904668; GO:1990756; GO:2000773,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020],nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],anaphase-promoting complex binding [GO:0010997]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005654; GO:0006281; GO:0030154; GO:0030163; GO:0060090; GO:0098772,nucleoplasm; DNA repair; cell differentiation; protein catabolic process; molecular adaptor activity; molecular function regulator activity
OG_00986,3.3368773754342413,FUN_004373-T2,Peve_00007253,Pocillopora_meandrina_HIv1___TS.g17451.t1,three_way,60.50866666666667,FUN_004373-T2,P16621,,,,,38.6,2020.0,0.0,1295.0,sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2,,,,,,
OG_00989,1.0442738212317475,FUN_004376-T1,Peve_00024391,Pocillopora_meandrina_HIv1___RNAseq.g16803.t2,three_way,67.07766666666667,FUN_004376-T1,B0UYI1,,,,,44.7,208.0,3.2e-36,153.3,sp|B0UYI1|TEAN2_DANRE Transcription elongation factor A N-terminal and central domain-containing protein 2 OS=Danio rerio OX=7955 GN=tceanc2 PE=3 SV=1,,,,,,
OG_00997,2.135647923221022,FUN_004406-T1,Peve_00017185,Pocillopora_meandrina_HIv1___RNAseq.g4937.t1,three_way,59.73633333333333,FUN_004406-T1,Q9BUJ2,,,,,50.9,389.0,1.8e-111,404.8,sp|Q9BUJ2|HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2,,,,,,
OG_00998,2.119124706946412,FUN_004407-T1,Peve_00017184,Pocillopora_meandrina_HIv1___RNAseq.g4936.t1,three_way,80.429,FUN_004407-T1,Q96KB5,,,,,50.2,303.0,6.2e-71,269.2,sp|Q96KB5|TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens OX=9606 GN=PBK PE=1 SV=3,,,,,,
OG_01002,2.846103237327615,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_01007,1.8132028962943163,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01014,1.4969205123030156,FUN_004442-T1,Peve_00033209,Pocillopora_meandrina_HIv1___RNAseq.g11479.t1,three_way,73.821,FUN_004442-T1,A7MB63,CTNS_BOVIN,,Cystinosin,Bos taurus (Bovine),50.5,333.0,2.9e-91,337.0,sp|A7MB63|CTNS_BOVIN Cystinosin OS=Bos taurus OX=9913 GN=CTNS PE=2 SV=1,GO:0005765; GO:0015031; GO:0015184; GO:0015295; GO:0015811; GO:0033162; GO:0042438; GO:0042470; GO:0048021,L-cystine transport [GO:0015811]; melanin biosynthetic process [GO:0042438]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021],lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162],L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_01017,2.6150727494381183,FUN_004446-T1,Peve_00024328,Pocillopora_meandrina_HIv1___RNAseq.g12519.t3,three_way,72.83733333333333,FUN_004446-T1,Q6DCD1,,,,,55.2,554.0,3.5000000000000005e-180,632.9,sp|Q6DCD1|FGGY_XENLA FGGY carbohydrate kinase domain-containing protein OS=Xenopus laevis OX=8355 GN=fggy PE=2 SV=2,,,,,,
OG_01018,1.70915602421809,FUN_004447-T1,Peve_00024327,Pocillopora_meandrina_HIv1___RNAseq.g11246.t1,three_way,84.03683333333333,FUN_004447-T1,Q9UPU5,UBP24_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),Homo sapiens (Human),45.2,2673.0,0.0,2190.2,sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01019,1.1808576245086797,FUN_004448-T1,Peve_00024324,Pocillopora_meandrina_HIv1___RNAseq.g11247.t1,three_way,61.9365,FUN_004448-T1,Q3UVK0,ERMP1_MOUSE,,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Mus musculus (Mouse),39.5,837.0,2.0000000000000003e-164,581.3,sp|Q3UVK0|ERMP1_MOUSE Endoplasmic reticulum metallopeptidase 1 OS=Mus musculus OX=10090 GN=Ermp1 PE=1 SV=2,GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872,cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508],endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_01023,1.6364137821674456,FUN_004455-T1,Peve_00024319,Pocillopora_meandrina_HIv1___RNAseq.g4970.t1,three_way,67.10066666666667,FUN_004455-T1,Q16651,PRSS8_HUMAN,,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],Homo sapiens (Human),39.0,249.0,2.0999999999999999e-41,173.3,sp|Q16651|PRSS8_HUMAN Prostasin OS=Homo sapiens OX=9606 GN=PRSS8 PE=1 SV=1,GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0010765; GO:0070062,positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01024,1.7369432294346316,FUN_004456-T1,Peve_00028023,Pocillopora_meandrina_HIv1___RNAseq.g4969.t1,three_way,72.8845,FUN_004456-T1,A2VDD2,,,,,28.7,178.0,1.5e-13,77.8,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_01031,1.7313322602443193,FUN_004466-T1,Peve_00007163,Pocillopora_meandrina_HIv1___RNAseq.g4955.t1,three_way,66.68966666666667,,,,,,,,,,,,,,,,,
OG_01033,1.4546657945434298,FUN_004468-T1,Peve_00007166,Pocillopora_meandrina_HIv1___RNAseq.g4953.t1,three_way,63.32233333333333,FUN_004468-T1,P23727,P85A_BOVIN,,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Bos taurus (Bovine),32.1,636.0,1.2e-79,299.7,sp|P23727|P85A_BOVIN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Bos taurus OX=9913 GN=PIK3R1 PE=1 SV=1,GO:0001678; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005942; GO:0005943; GO:0008286; GO:0015031; GO:0032869; GO:0033120; GO:0034446; GO:0034976; GO:0035014; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043560; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0140767; GO:0141038; GO:1900103; GO:1903078,cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular glucose homeostasis [GO:0001678]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446],"nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0006355; GO:0006629; GO:0007155; GO:0043226; GO:0060090; GO:0098772,nucleus; regulation of DNA-templated transcription; lipid metabolic process; cell adhesion; organelle; molecular adaptor activity; molecular function regulator activity
OG_01037,1.2996853748895447,FUN_004472-T1,Peve_00007171,Pocillopora_meandrina_HIv1___RNAseq.g4949.t1,three_way,82.363,FUN_004472-T1,Q13042,,,,,53.3,533.0,1.6e-165,584.3,sp|Q13042|CDC16_HUMAN Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2,,,,,,
OG_01041,1.0559069559924736,FUN_004481-T1,Peve_00008403,Pocillopora_meandrina_HIv1___RNAseq.g11617.t2,three_way,80.77366666666667,FUN_004481-T1,Q96LB3,,,,,39.8,553.0,9.4e-89,329.3,sp|Q96LB3|IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens OX=9606 GN=IFT74 PE=1 SV=1,,,,,,
OG_01054,2.228614995694189,FUN_004506-T1,Peve_00044059,Pocillopora_meandrina_HIv1___RNAseq.g11391.t1,three_way,79.72433333333333,FUN_004506-T1,Q96NR8,RDH12_HUMAN,,Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),Homo sapiens (Human),54.7,298.0,9.599999999999999e-82,305.1,sp|Q96NR8|RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens OX=9606 GN=RDH12 PE=1 SV=3,GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095,cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342],11-cis-retinol dehydrogenase activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0006629; GO:0016491; GO:0050877; GO:0098754,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process; detoxification
OG_01062,1.607152404149461,FUN_004517-T1,Peve_00044062,Pocillopora_meandrina_HIv1___RNAseq.g11317.t1,three_way,69.30250000000001,FUN_004517-T1,Q5R5M5,ENPP3_PONAB,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.5,766.0,1.2e-133,478.8,sp|Q5R5M5|ENPP3_PONAB Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Pongo abelii OX=9601 GN=ENPP3 PE=2 SV=1,GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0070667,ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; pyrimidine nucleotide metabolic process [GO:0006220],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01065,1.1747715078900456,FUN_004525-T1,Peve_00003214,Pocillopora_meandrina_HIv1___RNAseq.g11634.t1,three_way,83.67433333333334,FUN_004525-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),49.4,857.0,3.6999999999999996e-242,839.3,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_01067,1.1562775172222883,FUN_004547-T1,Peve_00042940,Pocillopora_meandrina_HIv1___RNAseq.g7627.t1,three_way,64.15966666666667,FUN_004547-T1,Q8IPH9,SLOB_DROME,,Slowpoke-binding protein,Drosophila melanogaster (Fruit fly),34.8,342.0,2.8e-48,194.5,sp|Q8IPH9|SLOB_DROME Slowpoke-binding protein OS=Drosophila melanogaster OX=7227 GN=Slob PE=1 SV=2,GO:0004672; GO:0005737; GO:0007274; GO:0042391; GO:0042594; GO:0045202; GO:0050804,modulation of chemical synaptic transmission [GO:0050804]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594],cytoplasm [GO:0005737]; synapse [GO:0045202],protein kinase activity [GO:0004672],GO:0003824; GO:0016740; GO:0023052; GO:0140096,"catalytic activity; transferase activity; signaling; catalytic activity, acting on a protein"
OG_01068,1.342219205243906,FUN_004549-T1,Peve_00042944,Pocillopora_meandrina_HIv1___RNAseq.15379_t,three_way,64.58533333333334,FUN_004549-T1,P9WIT2,,,,,20.5,493.0,1.5e-10,69.3,"sp|P9WIT2|GULDH_MYCTO L-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT1821 PE=3 SV=1",,,,,,
OG_01072,1.9757370563135388,FUN_004554-T1,Peve_00016046,Pocillopora_meandrina_HIv1___RNAseq.g8234.t1,three_way,72.76433333333334,FUN_004554-T1,P20700,LMNB1_HUMAN,,Lamin-B1,Homo sapiens (Human),33.0,542.0,1.7e-60,235.3,sp|P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=2,GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0016020; GO:0016363; GO:0031507; GO:0031965; GO:0043274; GO:0051664; GO:0090435; GO:0160123; GO:1990837,heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435],lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123],GO:0003677; GO:0005198; GO:0005634; GO:0005635; GO:0005654; GO:0006325; GO:0043226; GO:0061024,DNA binding; structural molecule activity; nucleus; nuclear envelope; nucleoplasm; chromatin organization; organelle; membrane organization
OG_01074,1.114117921729879,FUN_004560-T1,Peve_00016042,Pocillopora_meandrina_HIv1___RNAseq.g8228.t1,three_way,65.01533333333333,FUN_004560-T1,Q16595,,,,,60.7,117.0,2.1000000000000002e-36,153.7,"sp|Q16595|FRDA_HUMAN Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2",,,,,,
OG_01081,1.942554626460841,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.2999999999999997e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,1.942554626460841,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01083,1.1642679201537136,FUN_004573-T1,Peve_00041481,Pocillopora_meandrina_HIv1___RNAseq.g6645.t1,three_way,57.525666666666666,FUN_004573-T1,P12394,,,,,34.0,509.0,1.3e-72,275.4,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_01093,1.4050662068530402,FUN_004589-T1,Peve_00012398,Pocillopora_meandrina_HIv1___RNAseq.g6595.t2,three_way,64.044,,,,,,,,,,,,,,,,,
OG_01098,1.806576732863424,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_01099,1.937566832204502,FUN_004599-T1,Peve_00012408,Pocillopora_meandrina_HIv1___RNAseq.g6587.t1,three_way,88.329,FUN_004599-T1,Q7Z7E8,UB2Q1_HUMAN,,Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1),Homo sapiens (Human),48.1,397.0,5.3e-95,349.4,sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1,GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459,embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967],cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01100,1.5867772121285124,FUN_004601-T1,Peve_00020781,Pocillopora_meandrina_HIv1___RNAseq.g6777.t1,three_way,49.251333333333335,,,,,,,,,,,,,,,,,
OG_01105,1.9167695932281708,FUN_004624-T1,Peve_00039250,Pocillopora_meandrina_HIv1___RNAseq.g8088.t1,three_way,67.861,FUN_004624-T1,Q3UHC2,LRRK1_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),Mus musculus (Mouse),29.8,1808.0,4.400000000000001e-211,737.6,sp|Q3UHC2|LRRK1_MOUSE Leucine-rich repeat serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Lrrk1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533,bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005739; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; plasma membrane; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01107,2.735000277673329,FUN_004626-T1,Peve_00039247,Pocillopora_meandrina_HIv1___TS.g19833.t1,three_way,41.262166666666666,,,,,,,,,,,,,,,,,
OG_01110,1.5840937187820776,FUN_004641-T1,Peve_00039266,Pocillopora_meandrina_HIv1___RNAseq.g7601.t1,three_way,84.26666666666667,FUN_004641-T1,Q0MQA3,,,,,61.3,119.0,7e-36,151.4,sp|Q0MQA3|NDUA6_PONPY NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 OS=Pongo pygmaeus OX=9600 GN=NDUFA6 PE=2 SV=3,,,,,,
OG_01136,1.3977725624709745,FUN_004714-T1,Peve_00005079,Pocillopora_meandrina_HIv1___RNAseq.g8807.t1,three_way,78.63366666666667,FUN_004714-T1,Q5R5N8,,,,,54.3,1021.0,0.0,1082.0,sp|Q5R5N8|DI3L1_PONAB DIS3-like exonuclease 1 OS=Pongo abelii OX=9601 GN=DIS3L PE=2 SV=1,,,,,,
OG_01147,2.624892049971553,FUN_004740-T1,Peve_00007775,Pocillopora_meandrina_HIv1___RNAseq.g8829.t1,three_way,86.16033333333334,FUN_004740-T1,Q92963,RIT1_HUMAN,,GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1),Homo sapiens (Human),61.7,196.0,1.0999999999999999e-62,241.1,sp|Q92963|RIT1_HUMAN GTP-binding protein Rit1 OS=Homo sapiens OX=9606 GN=RIT1 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003,Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165],plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; plasma membrane; hydrolase activity; molecular function regulator activity
OG_01159,2.387900541334488,FUN_004777-T1,Peve_00037749,Pocillopora_meandrina_HIv1___RNAseq.g6694.t2,three_way,76.02633333333334,FUN_004777-T1,P46859,,,,,34.6,179.0,1.2e-21,104.8,sp|P46859|GNTK_ECOLI Thermoresistant gluconokinase OS=Escherichia coli (strain K12) OX=83333 GN=gntK PE=1 SV=4,,,,,,
OG_01160,3.1701913083997866,FUN_004779-T1,Peve_00037747,Pocillopora_meandrina_HIv1___RNAseq.g6693.t1,three_way,80.62566666666666,FUN_004779-T1,A2A2Y4,FRMD3_HUMAN,,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),Homo sapiens (Human),49.3,341.0,6.399999999999999e-96,352.8,sp|A2A2Y4|FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FRMD3 PE=1 SV=1,GO:0005856; GO:0008092; GO:0016020; GO:0031032,actomyosin structure organization [GO:0031032],cytoskeleton [GO:0005856]; membrane [GO:0016020],cytoskeletal protein binding [GO:0008092],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_01163,1.932914037478485,FUN_004783-T1,Peve_00037741,Pocillopora_meandrina_HIv1___RNAseq.g8518.t1,three_way,78.20333333333333,FUN_004783-T1,Q95KV7,NDUAD_BOVIN,,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit),Bos taurus (Bovine),55.0,120.0,5.7e-33,141.7,sp|Q95KV7|NDUAD_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Bos taurus OX=9913 GN=NDUFA13 PE=1 SV=3,GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0006915; GO:0008137; GO:0045271; GO:0045892,apoptotic process [GO:0006915]; negative regulation of DNA-templated transcription [GO:0045892],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; respiratory chain complex I [GO:0045271],NADH dehydrogenase (ubiquinone) activity [GO:0008137],GO:0005215; GO:0005654; GO:0005739; GO:0006355; GO:0012501; GO:0043226,transporter activity; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; programmed cell death; organelle
OG_01165,2.0386212454211763,FUN_004785-T1,Peve_00037753,Pocillopora_meandrina_HIv1___RNAseq.g27039.t1,three_way,60.36183333333333,FUN_004785-T1,Q9CQX4,PAF15_MOUSE,,PCNA-associated factor (HCV NS5A-transactivated protein 9 homolog) (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor),Mus musculus (Mouse),37.6,109.0,9e-08,57.8,sp|Q9CQX4|PAF15_MOUSE PCNA-associated factor OS=Mus musculus OX=10090 GN=Pclaf PE=1 SV=1,GO:0003682; GO:0005634; GO:0005813; GO:0006260; GO:0006974; GO:0007098; GO:0009411; GO:0019985; GO:0048471; GO:0051726; GO:0060090,centrosome cycle [GO:0007098]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],centrosome [GO:0005813]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],GO:0005634; GO:0005815; GO:0006260; GO:0006281; GO:0043226; GO:0060090,nucleus; microtubule organizing center; DNA replication; DNA repair; organelle; molecular adaptor activity
OG_01167,1.9197706638448,FUN_004787-T1,Peve_00010251,Pocillopora_meandrina_HIv1___RNAseq.g8521.t1,three_way,75.73400000000001,FUN_004787-T1,Q6TFL3,,,,,37.2,807.0,6.2e-84,313.9,sp|Q6TFL3|CC171_HUMAN Coiled-coil domain-containing protein 171 OS=Homo sapiens OX=9606 GN=CCDC171 PE=1 SV=1,,,,,,
OG_01172,2.1068971070799227,FUN_004797-T1,Peve_00010271,Pocillopora_meandrina_HIv1___RNAseq.g8564.t1,three_way,55.6755,FUN_004797-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),28.0,633.0,1.8e-62,242.3,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_01173,1.3046043558486211,FUN_004799-T1,Peve_00027138,Pocillopora_meandrina_HIv1___TS.g20303.t1b,three_way,56.354,FUN_004799-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),29.2,343.0,6.6e-28,127.9,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01183,1.114827523024334,FUN_004833-T1,Peve_00041797,Pocillopora_meandrina_HIv1___RNAseq.g8607.t1,three_way,66.8355,FUN_004833-T1,Q6JAN0,AGRV1_DANRE,,Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,6348.0,0.0,2524.2,sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1,GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007194; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171],adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787],GO:0003824; GO:0016787; GO:0048856; GO:0050877; GO:0060089; GO:0098772,catalytic activity; hydrolase activity; anatomical structure development; nervous system process; molecular transducer activity; molecular function regulator activity
OG_01184,1.520831744883192,FUN_004834-T1,Peve_00019417,Pocillopora_meandrina_HIv1___RNAseq.g8609.t1,three_way,70.38799999999999,FUN_004834-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),45.7,924.0,7.5e-249,862.1,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01187,1.615510539944982,FUN_004838-T1,Peve_00019421,Pocillopora_meandrina_HIv1___RNAseq.g8612.t1b,three_way,74.21666666666667,FUN_004838-T1,P43681,ACHA4_HUMAN,,Neuronal acetylcholine receptor subunit alpha-4,Homo sapiens (Human),41.8,325.0,5.9e-75,283.1,sp|P43681|ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens OX=9606 GN=CHRNA4 PE=1 SV=2,GO:0001508; GO:0001666; GO:0005886; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0019233; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080; GO:0095500; GO:0098878,"acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0002376; GO:0005215; GO:0005886; GO:0006281; GO:0023052; GO:0050877; GO:0055085; GO:0060089,immune system process; transporter activity; plasma membrane; DNA repair; signaling; nervous system process; transmembrane transport; molecular transducer activity
OG_01194,1.4060078385093642,FUN_004852-T1,Peve_00043740,Pocillopora_meandrina_HIv1___RNAseq.g8639.t1,three_way,66.92133333333334,FUN_004852-T1,P70473,AMACR_RAT,,Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase),Rattus norvegicus (Rat),53.2,280.0,6.7e-82,305.4,sp|P70473|AMACR_RAT Alpha-methylacyl-CoA racemase OS=Rattus norvegicus OX=10116 GN=Amacr PE=1 SV=3,GO:0005737; GO:0005739; GO:0005777; GO:0006631; GO:0006699; GO:0008111; GO:0008206,bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],alpha-methylacyl-CoA racemase activity [GO:0008111],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016853; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; isomerase activity; organelle
OG_01199,1.7820707672398095,FUN_004862-T1,Peve_00043709,Pocillopora_meandrina_HIv1___RNAseq.g8631.t2,three_way,66.93066666666667,FUN_004862-T1,Q9JJQ0,,,,,43.5,540.0,3.3e-122,440.3,"sp|Q9JJQ0|PIGB_MOUSE GPI alpha-1,2-mannosyltransferase 3 OS=Mus musculus OX=10090 GN=Pigb PE=2 SV=2",,,,,,
OG_01201,3.3826160479559837,FUN_004865-T1,Peve_00043712,Pocillopora_meandrina_HIv1___RNAseq.g8628.t1,three_way,55.48716666666667,FUN_004865-T1,Q5F416,,,,,38.2,228.0,8.000000000000001e-29,129.8,sp|Q5F416|TIPIN_CHICK TIMELESS-interacting protein OS=Gallus gallus OX=9031 GN=TIPIN PE=2 SV=1,,,,,,
OG_01202,2.4871193964188705,FUN_004866-T1,Peve_00043716,Pocillopora_meandrina_HIv1___RNAseq.g8626.t1,three_way,62.815333333333335,FUN_004866-T1,Q1JV40,HVCN1_CIOIN,,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis),45.6,114.0,9.8e-18,91.7,sp|Q1JV40|HVCN1_CIOIN Voltage-gated hydrogen channel 1 OS=Ciona intestinalis OX=7719 GN=HVCN1 PE=2 SV=1,GO:0005886; GO:0030171; GO:0034702; GO:0071294; GO:0071467; GO:1902600,cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],voltage-gated proton channel activity [GO:0030171],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01204,1.8815192098239328,FUN_004870-T1,Peve_00043738,Pocillopora_meandrina_HIv1___RNAseq.g8641.t1,three_way,89.86433333333333,FUN_004870-T1,Q1ZXJ0,,,,,32.5,873.0,3.9e-114,414.1,sp|Q1ZXJ0|CLCD_DICDI Chloride channel protein D OS=Dictyostelium discoideum OX=44689 GN=clcD PE=3 SV=1,,,,,,
OG_01209,1.5917277485315993,FUN_004882-T1,Peve_00043725,Pocillopora_meandrina_HIv1___TS.g20387.t1,three_way,68.81266666666667,FUN_004882-T1,Q6DH02,RM24_DANRE,,"Large ribosomal subunit protein uL24m (39S ribosomal protein L24, mitochondrial) (L24mt) (MRP-L24)",Danio rerio (Zebrafish) (Brachydanio rerio),51.2,168.0,1.8e-43,177.6,sp|Q6DH02|RM24_DANRE Large ribosomal subunit protein uL24m OS=Danio rerio OX=7955 GN=mrpl24 PE=2 SV=1,GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006754; GO:0045333,ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; translation [GO:0006412],mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005739; GO:0006091; GO:0043226; GO:0055086; GO:1901135,RNA binding; structural molecule activity; mitochondrion; generation of precursor metabolites and energy; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01210,4.607605748615571,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01212,1.2184548775331745,FUN_004891-T1,Peve_00043723,Pocillopora_meandrina_HIv1___RNAseq.g8663.t1,three_way,69.44433333333333,FUN_004891-T1,Q7T381,BOKB_DANRE,,Bcl-2-related ovarian killer protein homolog B (zBok2),Danio rerio (Zebrafish) (Brachydanio rerio),37.4,107.0,7.8e-10,65.5,sp|Q7T381|BOKB_DANRE Bcl-2-related ovarian killer protein homolog B OS=Danio rerio OX=7955 GN=bokb PE=2 SV=1,GO:0005741; GO:0006915; GO:0015267; GO:0042981,apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981],mitochondrial outer membrane [GO:0005741],channel activity [GO:0015267],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_01219,1.3252395397406764,FUN_004900-T1,Peve_00015870,Pocillopora_meandrina_HIv1___TS.g20400.t1,three_way,76.45466666666667,FUN_004900-T1,Q9QYV8,DPOG1_RAT,,DNA polymerase subunit gamma-1 (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (5'-deoxyribose-phosphate lyase) (EC 4.2.99.-) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),Rattus norvegicus (Rat),49.4,1219.0,0.0,1146.7,sp|Q9QYV8|DPOG1_RAT DNA polymerase subunit gamma-1 OS=Rattus norvegicus OX=10116 GN=Polg PE=2 SV=1,GO:0000262; GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006284; GO:0006287; GO:0008310; GO:0008340; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0045004; GO:0046872; GO:0051575; GO:0055093; GO:0071333,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; determination of adult lifespan [GO:0008340]; DNA replication proofreading [GO:0045004]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]",gamma DNA polymerase complex [GO:0005760]; mitochondrial chromosome [GO:0000262]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195],3'-5' exonuclease activity [GO:0008408]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA repair; transferase activity; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_01223,1.6169205021530226,FUN_004905-T1,Peve_00028658,Pocillopora_meandrina_HIv1___RNAseq.g8333.t1,three_way,69.76066666666667,FUN_004905-T1,Q61555,FBN2_MOUSE,,Fibrillin-2 [Cleaved into: Placensin],Mus musculus (Mouse),53.2,2537.0,9.1e-126,454.5,sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2,GO:0001527; GO:0005179; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023,bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; hormone activity [GO:0005179],GO:0005576; GO:0048018; GO:0048856; GO:0098772,extracellular region; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01227,1.5955393749712925,FUN_004909-T1,Peve_00026333,Pocillopora_meandrina_HIv1___RNAseq.g8343.t1,three_way,58.292,FUN_004909-T1,Q5T7B8,KIF24_HUMAN,,Kinesin-like protein KIF24,Homo sapiens (Human),42.5,631.0,7.1e-116,419.9,sp|Q5T7B8|KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens OX=9606 GN=KIF24 PE=1 SV=2,GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018,cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_01228,2.437931965741627,FUN_004910-T1,Peve_00028228,Pocillopora_meandrina_HIv1___TS.g20086.t1,three_way,85.51783333333333,FUN_004910-T1,Q16959,,,,,63.3,654.0,2.4999999999999998e-231,803.1,"sp|Q16959|DYI2_HELCR Dynein intermediate chain 2, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1",,,,,,
OG_01229,1.433974824745923,FUN_004913-T1,Peve_00034774,Pocillopora_meandrina_HIv1___RNAseq.g8346.t1,three_way,79.94333333333333,FUN_004913-T1,Q99M01,,,,,55.9,401.0,7.4e-133,475.3,"sp|Q99M01|SYFM_MOUSE Phenylalanine--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Fars2 PE=1 SV=1",,,,,,
OG_01235,1.5935545401253146,FUN_004920-T1,Peve_00044504,Pocillopora_meandrina_HIv1___RNAseq.g8353.t1,three_way,57.138666666666666,FUN_004920-T1,Q06441,,,,,45.8,938.0,1.4e-86,322.8,sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1,,,,,,
OG_01241,1.445344998810406,FUN_004929-T1,Peve_00034771,Pocillopora_meandrina_HIv1___RNAseq.g8368.t1,three_way,72.67233333333333,,,,,,,,,,,,,,,,,
OG_01243,1.9195165298692944,FUN_004933-T1,Peve_00014403,Pocillopora_meandrina_HIv1___RNAseq.g8373.t1,three_way,72.1075,,,,,,,,,,,,,,,,,
OG_01246,1.420467730138275,FUN_004941-T1,Peve_00024450,Pocillopora_meandrina_HIv1___TS.g20127.t1,three_way,74.99733333333333,FUN_004941-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),28.9,249.0,2.1e-16,88.6,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_01249,2.2744520039350773,FUN_004949-T1,Peve_00043273,Pocillopora_meandrina_HIv1___RNAseq.g8396.t1,three_way,89.491,FUN_004949-T1,P50211,,,,,57.0,335.0,2.3e-100,367.1,sp|P50211|ISL1_CHICK Insulin gene enhancer protein ISL-1 OS=Gallus gallus OX=9031 GN=ISL1 PE=1 SV=1,,,,,,
OG_01255,1.2314152083594931,FUN_004986-T1,Peve_00015856,Pocillopora_meandrina_HIv1___RNAseq.g7569.t1,three_way,84.39133333333334,FUN_004986-T1,P97390,,,,,66.1,564.0,1.8000000000000003e-214,746.9,sp|P97390|VPS45_MOUSE Vacuolar protein sorting-associated protein 45 OS=Mus musculus OX=10090 GN=Vps45 PE=1 SV=1,,,,,,
OG_01261,4.605019185318716,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_01276,3.106372779090368,FUN_005056-T1,Peve_00016747,Pocillopora_meandrina_HIv1___RNAseq.g8303.t1,three_way,56.921,FUN_005056-T1,P42568,AF9_HUMAN,,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),Homo sapiens (Human),38.0,92.0,2.1e-09,65.1,sp|P42568|AF9_HUMAN Protein AF-9 OS=Homo sapiens OX=9606 GN=MLLT3 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0042393; GO:0045893; GO:0060090; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:0140044; GO:0140072; GO:0140119; GO:1902275; GO:2000035; GO:2000096,"anterior/posterior pattern specification [GO:0009952]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; segment specification [GO:0007379]",chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; histone H3K9ac reader activity [GO:0140072]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090],GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; chromosome; cytosol; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; molecular adaptor activity
OG_01277,2.608152754218766,FUN_005057-T1,Peve_00016734,Pocillopora_meandrina_HIv1___RNAseq.g8302.t1,three_way,72.20533333333333,FUN_005057-T1,Q8K596,NAC2_MOUSE,,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),Mus musculus (Mouse),37.3,499.0,1.4e-72,275.8,sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1,GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015085; GO:0016323; GO:0035725; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808],axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],calcium ion transmembrane transporter activity [GO:0015085]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; cell junction organization; organelle; nervous system process; transmembrane transport
OG_01278,1.026421937017103,FUN_005058-T1,Peve_00016724,Pocillopora_meandrina_HIv1___RNAseq.g8301.t1,three_way,65.66266666666667,,,,,,,,,,,,,,,,,
OG_01282,1.4569039743881051,FUN_005063-T1,Peve_00030190,Pocillopora_meandrina_HIv1___RNAseq.g8293.t1,three_way,74.4175,FUN_005063-T1,B2RR83,YTDC2_MOUSE,,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),Mus musculus (Mouse),47.1,1526.0,0.0,1282.7,sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1,GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247,"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0003824; GO:0005783; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0140098; GO:0140657,"RNA binding; catalytic activity; endoplasmic reticulum; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01283,1.956753462854568,FUN_005101-T1,Peve_00007482,Pocillopora_meandrina_HIv1___RNAseq.g8276.t1,three_way,63.833666666666666,FUN_005101-T1,P20585,MSH3_HUMAN,,DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1),Homo sapiens (Human),44.8,859.0,3.4e-194,680.2,sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4,GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664,DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447],membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01293,1.661612981565818,FUN_005117-T1,Peve_00007460,Pocillopora_meandrina_HIv1___RNAseq.g8265.t1,three_way,71.62033333333333,FUN_005117-T1,O88801,HOME2_RAT,,Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2),Rattus norvegicus (Rat),49.3,221.0,4.7e-47,190.3,sp|O88801|HOME2_RAT Homer protein homolog 2 OS=Rattus norvegicus OX=10116 GN=Homer2 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0070885; GO:0098978; GO:2001256,behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160],GO:0005886; GO:0008092; GO:0043226; GO:0050877; GO:0060090,plasma membrane; cytoskeletal protein binding; organelle; nervous system process; molecular adaptor activity
OG_01295,2.031934908572772,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_01299,2.7424635331894853,FUN_005133-T1,Peve_00026671,Pocillopora_meandrina_HIv1___RNAseq.g8258.t1,three_way,85.96366666666667,FUN_005133-T1,Q05116,,,,,70.0,377.0,4.3e-148,525.8,sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis OX=8355 GN=map2k1 PE=1 SV=2,,,,,,
OG_01305,2.2625280191762696,FUN_005160-T1,Peve_00031230,Pocillopora_meandrina_HIv1___RNAseq.g8085.t1,three_way,81.42233333333333,FUN_005160-T1,Q9DC69,,,,,48.7,374.0,2.7e-90,334.0,"sp|Q9DC69|NDUA9_MOUSE NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial OS=Mus musculus OX=10090 GN=Ndufa9 PE=1 SV=2",,,,,,
OG_01309,1.2048360606577917,FUN_005171-T1,Peve_00004281,Pocillopora_meandrina_HIv1___RNAseq.g7588.t1,three_way,75.09433333333332,,,,,,,,,,,,,,,,,
OG_01312,1.1649896190123772,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01315,1.8384286206171483,FUN_005178-T1,Peve_00022721,Pocillopora_meandrina_HIv1___RNAseq.g7585.t1,three_way,63.69316666666666,FUN_005178-T1,Q5ZM55,,,,,28.4,627.0,5.7e-31,137.5,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_01317,3.549147758838646,FUN_005182-T1,Peve_00023411,Pocillopora_meandrina_HIv1___RNAseq.g8094.t1,three_way,60.54366666666667,FUN_005182-T1,Q9UGM3,,,,,32.5,830.0,4.1999999999999995e-95,352.1,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_01318,1.1399903028370963,FUN_005183-T2,Peve_00017162,Pocillopora_meandrina_HIv1___RNAseq.g8095.t1,three_way,55.7445,FUN_005183-T2,A0JMF1,,,,,26.8,358.0,7.6e-14,81.6,sp|A0JMF1|CTC1_DANRE CST complex subunit CTC1 OS=Danio rerio OX=7955 GN=ctc1 PE=2 SV=1,,,,,,
OG_01319,1.0172321048791697,FUN_005184-T3,Peve_00017161,Pocillopora_meandrina_HIv1___RNAseq.g8096.t1,three_way,72.63616666666667,FUN_005184-T3,Q9TU19,,,,,39.0,515.0,1.1e-103,379.0,sp|Q9TU19|NPHP1_CANLF Nephrocystin-1 (Fragment) OS=Canis lupus familiaris OX=9615 GN=NPHP1 PE=1 SV=1,,,,,,
OG_01330,4.713298537286232,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01332,1.8464719115107693,FUN_005226-T1,Peve_00035495,Pocillopora_meandrina_HIv1___RNAseq.g8118.t1,three_way,70.23566666666666,FUN_005226-T1,Q91W67,,,,,35.7,336.0,9.3e-22,105.9,sp|Q91W67|UBL7_MOUSE Ubiquitin-like protein 7 OS=Mus musculus OX=10090 GN=Ubl7 PE=1 SV=2,,,,,,
OG_01333,2.09871801496735,FUN_005230-T1,Peve_00042881,Pocillopora_meandrina_HIv1___RNAseq.g8115.t1,three_way,67.631,FUN_005230-T1,Q8C9M2,,,,,67.3,49.0,1.1e-13,79.7,sp|Q8C9M2|CCD15_MOUSE Coiled-coil domain-containing protein 15 OS=Mus musculus OX=10090 GN=Ccdc15 PE=2 SV=2,,,,,,
OG_01337,1.5495861722258075,FUN_005234-T1,Peve_00042867,Pocillopora_meandrina_HIv1___RNAseq.g8111.t1,three_way,51.85633333333333,,,,,,,,,,,,,,,,,
OG_01351,3.3730217480800957,FUN_005258-T1,Peve_00003357,Pocillopora_meandrina_HIv1___RNAseq.g8150.t1,three_way,89.47800000000001,FUN_005258-T1,Q7ZYG4,,,,,59.9,212.0,7.4e-46,185.3,sp|Q7ZYG4|OSTF1_XENLA Osteoclast-stimulating factor 1 OS=Xenopus laevis OX=8355 GN=ostf1 PE=2 SV=1,,,,,,
OG_01352,1.7048870291616558,FUN_005260-T1,Peve_00003354,Pocillopora_meandrina_HIv1___RNAseq.g8151.t1,three_way,68.60516666666666,FUN_005260-T1,Q6PCN7,HLTF_MOUSE,,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (P113) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3) (TNF-response element-binding protein),Mus musculus (Mouse),43.8,843.0,2.9e-177,624.4,sp|Q6PCN7|HLTF_MOUSE Helicase-like transcription factor OS=Mus musculus OX=10090 GN=Hltf PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0008094; GO:0008270; GO:0016363; GO:0016567; GO:0016740; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0090575,chromatin organization [GO:0006325]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006325; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; nucleolus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01357,1.0569078738598354,FUN_005271-T1,Peve_00003340,Pocillopora_meandrina_HIv1___RNAseq.g8161.t2,three_way,41.66616666666667,,,,,,,,,,,,,,,,,
OG_01358,1.2697374228902385,FUN_005272-T1,Peve_00003339,Pocillopora_meandrina_HIv1___RNAseq.g8162.t1,three_way,71.95033333333333,,,,,,,,,,,,,,,,,
OG_01366,3.3660384109057264,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01370,1.4601836938753705,FUN_005320-T1,Peve_00003308,Pocillopora_meandrina_HIv1___RNAseq.g8181.t1,three_way,77.714,FUN_005320-T1,Q9GZV8,PRD14_HUMAN,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Homo sapiens (Human),41.4,116.0,6.2e-22,107.1,sp|Q9GZV8|PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens OX=9606 GN=PRDM14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0043231; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]",intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_01375,1.3803657217323162,FUN_005331-T1,Peve_00003302,Pocillopora_meandrina_HIv1___TS.g19933.t1,three_way,77.45716666666667,FUN_005331-T1,A0JN62,CE120_BOVIN,,Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100),Bos taurus (Bovine),42.1,525.0,8.4e-83,309.3,sp|A0JN62|CE120_BOVIN Centrosomal protein of 120 kDa OS=Bos taurus OX=9913 GN=CEP120 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951,astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development
OG_01385,1.9079407879025605,FUN_005354-T1,Peve_00016052,Pocillopora_meandrina_HIv1___TS.g19952.t1,three_way,78.38366666666667,FUN_005354-T1,A4FUY7,,,,,63.4,145.0,1.7e-48,193.7,sp|A4FUY7|MOC2B_BOVIN Molybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2,,,,,,
OG_01386,1.4386605506178771,FUN_005355-T1,Peve_00016031,Pocillopora_meandrina_HIv1___RNAseq.g8213.t1,three_way,76.06266666666666,FUN_005355-T1,Q2TBL4,,,,,45.5,534.0,9.5e-119,428.7,sp|Q2TBL4|RPC3_BOVIN DNA-directed RNA polymerase III subunit RPC3 OS=Bos taurus OX=9913 GN=POLR3C PE=2 SV=1,,,,,,
OG_01389,1.5223727095760764,FUN_005363-T1,Peve_00016035,Pocillopora_meandrina_HIv1___RNAseq.g8221.t1,three_way,93.72233333333334,FUN_005363-T1,Q7L5Y6,DET1_HUMAN,,DET1 homolog (De-etiolated-1 homolog),Homo sapiens (Human),66.1,481.0,1.1e-185,651.0,sp|Q7L5Y6|DET1_HUMAN DET1 homolog OS=Homo sapiens OX=9606 GN=DET1 PE=1 SV=2,GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleus [GO:0005634],protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0043226; GO:0060090; GO:0065003,nucleus; organelle; molecular adaptor activity; protein-containing complex assembly
OG_01391,1.8632393016983853,FUN_005366-T1,Peve_00041492,Pocillopora_meandrina_HIv1___RNAseq.g6638.t1,three_way,90.41666666666669,FUN_005366-T1,Q9CR47,,,,,71.3,174.0,1.5999999999999999e-62,240.7,sp|Q9CR47|NSA2_MOUSE Ribosome biogenesis protein NSA2 homolog OS=Mus musculus OX=10090 GN=Nsa2 PE=2 SV=1,,,,,,
OG_01392,1.605287124266526,FUN_005367-T1,Peve_00041491,Pocillopora_meandrina_HIv1___RNAseq.g6637.t3,three_way,81.581,,,,,,,,,,,,,,,,,
OG_01393,1.2996298350308872,FUN_005369-T1,Peve_00041469,Pocillopora_meandrina_HIv1___RNAseq.g6632.t2,three_way,79.86133333333333,FUN_005369-T1,Q9UPW5,CBPC1_HUMAN,,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1),Homo sapiens (Human),42.5,1201.0,9.6e-233,808.5,sp|Q9UPW5|CBPC1_HUMAN Cytosolic carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=AGTPBP1 PE=1 SV=3,GO:0001754; GO:0004181; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006508; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0034451; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060,adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007005; GO:0007018; GO:0008092; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; mitochondrion organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_01397,1.446135663191675,FUN_005373-T1,Peve_00041490,Pocillopora_meandrina_HIv1___RNAseq.g6636.t1,three_way,82.66833333333334,FUN_005373-T1,Q9H857,,,,,47.5,457.0,6.1e-121,436.0,sp|Q9H857|NT5D2_HUMAN 5'-nucleotidase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NT5DC2 PE=1 SV=1,,,,,,
OG_01405,1.7695987659590098,FUN_005473-T1,Peve_00002044,Pocillopora_meandrina_HIv1___RNAseq.g6627.t2,three_way,52.35033333333333,FUN_005473-T1,Q5N8Z0,,,,,28.4,278.0,5.1e-06,55.1,sp|Q5N8Z0|DRB1_ORYSJ Double-stranded RNA-binding protein 1 OS=Oryza sativa subsp. japonica OX=39947 GN=DRB1 PE=2 SV=1,,,,,,
OG_01407,3.5272382921433265,FUN_005476-T1,Peve_00041489,Pocillopora_meandrina_HIv1___RNAseq.g6630.t1,three_way,45.82566666666667,,,,,,,,,,,,,,,,,
OG_01411,1.704664179389213,FUN_005697-T1,Peve_00008482,Pocillopora_meandrina_HIv1___RNAseq.g19565.t1,three_way,83.81866666666667,FUN_005697-T1,O93308,,,,,50.9,1241.0,1.7e-278,960.7,sp|O93308|SMC1A_XENLA Structural maintenance of chromosomes protein 1A OS=Xenopus laevis OX=8355 GN=smc1a PE=1 SV=1,,,,,,
OG_01413,2.89211213929225,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_01418,2.6132161747393776,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_01425,1.6233975878046731,FUN_005812-T1,Peve_00039600,Pocillopora_meandrina_HIv1___RNAseq.g19558.t1,three_way,91.84433333333334,FUN_005812-T1,Q8WXX0,DYH7_HUMAN,,Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2),Homo sapiens (Human),54.7,4000.0,0.0,4338.5,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729,cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_01426,1.5706672516639446,FUN_005814-T1,Peve_00004967,Pocillopora_meandrina_HIv1___RNAseq.g19530.t1,three_way,80.68183333333334,FUN_005814-T1,Q06187,BTK_HUMAN,,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),Homo sapiens (Human),41.3,658.0,7.8e-147,522.3,sp|Q06187|BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens OX=9606 GN=BTK PE=1 SV=3,GO:0001780; GO:0001805; GO:0001812; GO:0002250; GO:0002344; GO:0002553; GO:0002639; GO:0002721; GO:0002755; GO:0002902; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007498; GO:0008270; GO:0016004; GO:0018108; GO:0019722; GO:0030167; GO:0030889; GO:0030890; GO:0031410; GO:0032496; GO:0032693; GO:0032755; GO:0032760; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043123; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0048469; GO:0048471; GO:0050766; GO:0050852; GO:0050853; GO:0051092; GO:0061516; GO:0071226; GO:0097190; GO:0098761; GO:0141111; GO:0150153; GO:1900227; GO:1901647; GO:1990959,adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008289; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0098542; GO:0098772; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid binding; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01428,2.13007525490324,FUN_005821-T1,Peve_00034064,Pocillopora_meandrina_HIv1___TS.g29038.t2,three_way,69.24366666666667,FUN_005821-T1,Q9JLG8,,,,,50.0,640.0,1.2000000000000001e-182,641.7,sp|Q9JLG8|CAN15_MOUSE Calpain-15 OS=Mus musculus OX=10090 GN=Capn15 PE=1 SV=1,,,,,,
OG_01430,1.168824102701982,FUN_005823-T1,Peve_00034061,Pocillopora_meandrina_HIv1___RNAseq.g19654.t2,three_way,62.922666666666665,FUN_005823-T1,Q2ABP2,,,,,44.8,210.0,3.1e-41,170.2,sp|Q2ABP2|PGAP2_CRIGR Acyltransferase PGAP2 OS=Cricetulus griseus OX=10029 GN=Pgap2 PE=1 SV=1,,,,,,
OG_01431,1.0808102424358923,FUN_005824-T1,Peve_00034060,Pocillopora_meandrina_HIv1___RNAseq.g19655.t1,three_way,78.75233333333333,FUN_005824-T1,Q5R9T6,,,,,43.8,297.0,1.8e-72,274.2,sp|Q5R9T6|WDR55_PONAB WD repeat-containing protein 55 OS=Pongo abelii OX=9601 GN=WDR55 PE=2 SV=1,,,,,,
OG_01434,1.0394148973115045,FUN_005833-T1,Peve_00034072,Pocillopora_meandrina_HIv1___RNAseq.g19671.t1,three_way,61.641,,,,,,,,,,,,,,,,,
OG_01435,2.304650660292877,FUN_005856-T1,Peve_00034053,Pocillopora_meandrina_HIv1___TS.g29054.t1,three_way,52.05916666666666,FUN_005856-T1,P41221,WNT5A_HUMAN,,Protein Wnt-5a,Homo sapiens (Human),41.0,376.0,1.5e-79,298.1,sp|P41221|WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens OX=9606 GN=WNT5A PE=1 SV=2,GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001843; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003281; GO:0003283; GO:0003323; GO:0003344; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006954; GO:0007200; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010463; GO:0010595; GO:0010628; GO:0010631; GO:0010742; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043410; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051216; GO:0051885; GO:0051897; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060809; GO:0060907; GO:0061036; GO:0062009; GO:0070062; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090090; GO:0090103; GO:0097325; GO:0098685; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099170; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1900020; GO:1902035; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904948; GO:2000049; GO:2000052; GO:2001235,"anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to type II interferon [GO:0071346]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inflammatory response [GO:0006954]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midbrain dopaminergic neuron differentiation [GO:1904948]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; pericardium morphogenesis [GO:0003344]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventricular septum development [GO:0003281]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]",cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115],GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0006954; GO:0007163; GO:0008289; GO:0012501; GO:0022414; GO:0023052; GO:0030154; GO:0030312; GO:0031012; GO:0034330; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140013,extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; inflammatory response; establishment or maintenance of cell polarity; lipid binding; programmed cell death; reproductive process; signaling; cell differentiation; external encapsulating structure; extracellular matrix; cell junction organization; wound healing; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; meiotic nuclear division
OG_01436,2.151835076683516,FUN_005858-T1,Peve_00015774,Pocillopora_meandrina_HIv1___RNAseq.g19665.t1,three_way,77.938,FUN_005858-T1,Q8IV35,,,,,25.4,906.0,2.2e-77,292.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_01437,4.886398965368861,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_01443,1.3137443744493809,FUN_005883-T1,Peve_00015767,Pocillopora_meandrina_HIv1___RNAseq.g19677.t1,three_way,79.88083333333334,FUN_005883-T1,Q6XPS3,TPTE2_HUMAN,,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)",Homo sapiens (Human),46.4,468.0,6e-103,376.3,"sp|Q6XPS3|TPTE2_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens OX=9606 GN=TPTE2 PE=1 SV=2",GO:0000139; GO:0005216; GO:0005737; GO:0005789; GO:0005829; GO:0006661; GO:0016314; GO:0051800,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],"monoatomic ion channel activity [GO:0005216]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]",GO:0003824; GO:0005215; GO:0005829; GO:0006629; GO:0016787,catalytic activity; transporter activity; cytosol; lipid metabolic process; hydrolase activity
OG_01446,1.2872209841717543,FUN_005894-T1,Peve_00035818,Pocillopora_meandrina_HIv1___RNAseq.g19682.t1,three_way,75.725,FUN_005894-T1,Q9BVK2,ALG8_HUMAN,,"Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",Homo sapiens (Human),55.1,296.0,6.5e-84,312.4,"sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2",GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_01447,3.5873910918919507,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_01451,1.2782968915659112,FUN_005905-T1,Peve_00033233,Pocillopora_meandrina_HIv1___RNAseq.g19576.t1,three_way,48.1295,FUN_005905-T1,Q8JI28,,,,,24.0,271.0,2.7e-13,77.8,sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1,,,,,,
OG_01452,1.8593264507290463,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_01458,1.319033603610645,FUN_005970-T1,Peve_00015060,Pocillopora_meandrina_HIv1___RNAseq.g19790.t1,three_way,78.61566666666667,FUN_005970-T1,A7RPT4,NNRE_NEMVE,,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase),Nematostella vectensis (Starlet sea anemone),71.1,228.0,3.5e-98,359.4,sp|A7RPT4|NNRE_NEMVE NAD(P)H-hydrate epimerase OS=Nematostella vectensis OX=45351 GN=v1g228490 PE=3 SV=1,GO:0000166; GO:0005739; GO:0046872; GO:0052856,,mitochondrion [GO:0005739],metal ion binding [GO:0046872]; NAD(P)HX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166],GO:0003824; GO:0005739; GO:0016853; GO:0043226,catalytic activity; mitochondrion; isomerase activity; organelle
OG_01460,1.2275599647071405,FUN_005994-T2,Peve_00008882,Pocillopora_meandrina_HIv1___RNAseq.g19943.t1,three_way,67.73166666666667,FUN_005994-T2,Q6YBV0,S36A4_HUMAN,,Neutral amino acid uniporter 4 (Solute carrier family 36 member 4),Homo sapiens (Human),43.1,418.0,7.6e-86,319.3,sp|Q6YBV0|S36A4_HUMAN Neutral amino acid uniporter 4 OS=Homo sapiens OX=9606 GN=SLC36A4 PE=1 SV=1,GO:0003333; GO:0005765; GO:0005774; GO:0005886; GO:0015180; GO:0015193; GO:0015196; GO:0015293; GO:0015808; GO:0015824; GO:0015827; GO:1904271; GO:1904556,amino acid transmembrane transport [GO:0003333]; L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827],lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01462,2.056986833116639,FUN_005996-T1,Peve_00036051,Pocillopora_meandrina_HIv1___TS.g29328.t1,three_way,73.044,FUN_005996-T1,Q6GMK0,MGT4B_DANRE,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,508.0,6e-143,509.2,"sp|Q6GMK0|MGT4B_DANRE Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Danio rerio OX=7955 GN=mgat4bQ9UQ53 PE=2 SV=1",GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0008375; GO:0008454; GO:0046872,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0005783; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01463,1.5785039824104234,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01475,3.975036842301037,FUN_006038-T1,Peve_00023433,Pocillopora_meandrina_HIv1___RNAseq.g20251.t1,three_way,65.71133333333333,FUN_006038-T1,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,686.0,1.8e-115,418.3,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01479,2.886482225181296,FUN_006042-T1,Peve_00017140,Pocillopora_meandrina_HIv1___RNAseq.g20180.t1,three_way,75.429,FUN_006042-T1,Q99JW2,,,,,59.5,393.0,1.2e-140,501.1,sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1,,,,,,
OG_01488,1.3564868705674364,FUN_006164-T1,Peve_00023606,Pocillopora_meandrina_HIv1___RNAseq.g20425.t1,three_way,70.08466666666666,FUN_006164-T1,Q9X1H7,,,,,41.6,173.0,2.1e-27,124.4,sp|Q9X1H7|ENGB_THEMA Probable GTP-binding protein EngB OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=engB PE=1 SV=1,,,,,,
OG_01489,3.4529203707152805,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_01490,1.8402886931308835,FUN_006166-T1,Peve_00021031,Pocillopora_meandrina_HIv1___RNAseq.g20430.t1,three_way,77.292,FUN_006166-T1,Q9VQ37,RIM2_DROME,,Mitochondrial carrier protein Rim2,Drosophila melanogaster (Fruit fly),46.1,345.0,5.000000000000001e-78,292.7,sp|Q9VQ37|RIM2_DROME Mitochondrial carrier protein Rim2 OS=Drosophila melanogaster OX=7227 GN=Rim2 PE=2 SV=2,GO:0000002; GO:0005739; GO:0005743; GO:0006390; GO:0007005; GO:0015218; GO:0030302; GO:0040011; GO:0045333; GO:0048311; GO:1990519,cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial genome maintenance [GO:0000002]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],pyrimidine nucleotide transmembrane transporter activity [GO:0015218],GO:0005215; GO:0005739; GO:0006091; GO:0006351; GO:0007005; GO:0043226; GO:0055085,transporter activity; mitochondrion; generation of precursor metabolites and energy; DNA-templated transcription; mitochondrion organization; organelle; transmembrane transport
OG_01491,2.7565616162254343,FUN_006167-T2,Peve_00021030,Pocillopora_meandrina_HIv1___RNAseq.g20429.t1,three_way,75.59433333333334,FUN_006167-T2,Q06S87,,,,,54.3,116.0,2.3e-27,125.6,sp|Q06S87|HIUH_DANRE 5-hydroxyisourate hydrolase OS=Danio rerio OX=7955 GN=urah PE=1 SV=1,,,,,,
OG_01496,1.5772528917590116,FUN_006220-T1,Peve_00020217,Pocillopora_meandrina_HIv1___RNAseq.g20437.t1,three_way,69.87716666666667,FUN_006220-T1,P83094,STIM_DROME,,Stromal interaction molecule homolog,Drosophila melanogaster (Fruit fly),37.4,390.0,8.200000000000001e-59,229.9,sp|P83094|STIM_DROME Stromal interaction molecule homolog OS=Drosophila melanogaster OX=7227 GN=Stim PE=1 SV=1,GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016020; GO:0022416; GO:0048763; GO:0051924; GO:0140268,chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular calcium ion homeostasis [GO:0006874]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279],GO:0005215; GO:0005783; GO:0005886; GO:0043226; GO:0048856; GO:0098772,transporter activity; endoplasmic reticulum; plasma membrane; organelle; anatomical structure development; molecular function regulator activity
OG_01498,3.177307718200029,FUN_006222-T1,Peve_00020211,Pocillopora_meandrina_HIv1___RNAseq.g20439.t1,three_way,85.01766666666667,FUN_006222-T1,P56560,,,,,53.5,505.0,2.2e-152,540.4,sp|P56560|AOFB_BOVIN Amine oxidase [flavin-containing] B OS=Bos taurus OX=9913 GN=MAOB PE=1 SV=4,,,,,,
OG_01503,3.038605038195181,FUN_006230-T1,Peve_00002942,Pocillopora_meandrina_HIv1___RNAseq.g20449.t1,three_way,69.12416666666667,FUN_006230-T1,Q5SZK8,FREM2_HUMAN,,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),Homo sapiens (Human),41.5,1242.0,4.8e-265,916.0,sp|Q5SZK8|FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens OX=9606 GN=FREM2 PE=1 SV=3,GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0042733; GO:0046872; GO:0048839; GO:0062023; GO:0070062,anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],metal ion binding [GO:0046872],GO:0005886; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048856,plasma membrane; cell adhesion; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_01504,1.6610719891431367,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_01506,1.3100106658798183,FUN_006238-T1,Peve_00011450,Pocillopora_meandrina_HIv1___RNAseq.g20446.t1,three_way,77.295,FUN_006238-T1,P52875,,,,,63.8,229.0,1.2e-68,261.5,sp|P52875|TM165_MOUSE Putative divalent cation/proton antiporter TMEM165 OS=Mus musculus OX=10090 GN=Tmem165 PE=1 SV=2,,,,,,
OG_01507,2.399679508281632,FUN_006242-T1,Peve_00011455,Pocillopora_meandrina_HIv1___RNAseq.g20444.t1,three_way,65.56483333333334,FUN_006242-T1,Q6GQJ2,JADE1_XENLA,,Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17),Xenopus laevis (African clawed frog),44.8,511.0,5.6e-120,433.7,sp|Q6GQJ2|JADE1_XENLA Protein Jade-1 OS=Xenopus laevis OX=8355 GN=jade1 PE=2 SV=1,GO:0000123; GO:0005634; GO:0005737; GO:0005856; GO:0006357; GO:0006915; GO:0008270; GO:0042995,apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0005856; GO:0006355; GO:0012501; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; programmed cell death; organelle
OG_01510,2.9361345621489847,FUN_006245-T1,Peve_00002946,Pocillopora_meandrina_HIv1___RNAseq.g20390.t1b,three_way,45.26566666666667,,,,,,,,,,,,,,,,,
OG_01521,1.1978097978672233,FUN_006275-T1,Peve_00019725,Pocillopora_meandrina_HIv1___RNAseq.g20370.t1,three_way,75.4355,FUN_006275-T1,Q8R3S6,,,,,43.7,924.0,1.3e-200,701.4,sp|Q8R3S6|EXOC1_MOUSE Exocyst complex component 1 OS=Mus musculus OX=10090 GN=Exoc1 PE=1 SV=4,,,,,,
OG_01524,1.3091972232471765,FUN_006320-T1,Peve_00021264,Pocillopora_meandrina_HIv1___RNAseq.g20359.t1,three_way,67.9575,FUN_006320-T1,Q8BV79,,,,,30.9,2660.0,1.4999999999999998e-286,988.8,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_01533,1.5740049084046035,FUN_006336-T1,Peve_00026066,Pocillopora_meandrina_HIv1___TS.g29722.t1,three_way,94.48533333333332,FUN_006336-T1,Q3ZC01,CNOT7_BOVIN,,CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1),Bos taurus (Bovine),73.1,208.0,6.8000000000000015e-87,321.6,sp|Q3ZC01|CNOT7_BOVIN CCR4-NOT transcription complex subunit 7 OS=Bos taurus OX=9913 GN=CNOT7 PE=2 SV=1,GO:0000175; GO:0000288; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0004532; GO:0004535; GO:0006417; GO:0008284; GO:0008285; GO:0016607; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0034584; GO:0035279; GO:0045070; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0140297; GO:0140991; GO:1900153,"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]",CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA exonuclease activity [GO:0004532]; transcription corepressor activity [GO:0003714],GO:0003723; GO:0003824; GO:0006355; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_01534,3.1491755166321163,FUN_006339-T1,Peve_00026068,Pocillopora_meandrina_HIv1___RNAseq.g20341.t1,three_way,67.9555,FUN_006339-T1,Q8NHP6,MSPD2_HUMAN,,Motile sperm domain-containing protein 2,Homo sapiens (Human),34.7,473.0,2.8e-65,251.5,sp|Q8NHP6|MSPD2_HUMAN Motile sperm domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MOSPD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0006935; GO:0012505; GO:0016020; GO:0033149; GO:0035579; GO:0044232; GO:0051260; GO:0090023; GO:0090026; GO:0140042; GO:0140284,chemotaxis [GO:0006935]; lipid droplet formation [GO:0140042]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein homooligomerization [GO:0051260],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],FFAT motif binding [GO:0033149],GO:0005783; GO:0005886; GO:0043226; GO:0065003,endoplasmic reticulum; plasma membrane; organelle; protein-containing complex assembly
OG_01536,2.7537908296373788,FUN_006367-T1,Peve_00007381,Pocillopora_meandrina_HIv1___TS.g29719.t1,three_way,89.19266666666667,FUN_006367-T1,Q6DKM1,,,,,59.0,261.0,2.3e-78,293.5,sp|Q6DKM1|UN50A_XENLA Protein unc-50 homolog A OS=Xenopus laevis OX=8355 GN=unc50-a PE=2 SV=1,,,,,,
OG_01541,1.3769284197412224,FUN_006411-T1,Peve_00018195,Pocillopora_meandrina_HIv1___RNAseq.g20262.t1,three_way,76.773,FUN_006411-T1,Q9NTJ4,,,,,49.9,1007.0,1.9e-293,1010.0,sp|Q9NTJ4|MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens OX=9606 GN=MAN2C1 PE=1 SV=1,,,,,,
OG_01546,1.37754673348104,FUN_006421-T1,Peve_00043551,Pocillopora_meandrina_HIv1___RNAseq.g20280.t2,three_way,73.73433333333334,FUN_006421-T1,A7RS11,,,,,57.5,207.0,3.2e-66,253.1,sp|A7RS11|HPF1_NEMVE Histone PARylation factor 1 OS=Nematostella vectensis OX=45351 GN=HPF1 PE=1 SV=1,,,,,,
OG_01550,2.016353665171584,FUN_006425-T1,Peve_00043546,Pocillopora_meandrina_HIv1___TS.g29666.t1,three_way,69.39816666666667,FUN_006425-T1,Q96P50,,,,,30.0,253.0,1.1e-26,124.4,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01558,1.9204106227248623,FUN_006439-T1,Peve_00038430,Pocillopora_meandrina_HIv1___RNAseq.g20296.t1,three_way,83.673,,,,,,,,,,,,,,,,,
OG_01564,1.1932383650959184,FUN_006446-T2,Peve_00038423,Pocillopora_meandrina_HIv1___RNAseq.g20305.t1,three_way,34.80533333333334,,,,,,,,,,,,,,,,,
OG_01566,1.3024052032578637,FUN_006448-T1,Peve_00038420,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1a,three_way,70.55933333333333,,,,,,,,,,,,,,,,,
OG_01572,1.091554339027521,FUN_006572-T1,Peve_00011458,Pocillopora_meandrina_HIv1___RNAseq.g20312.t1,three_way,75.527,FUN_006572-T1,A7RFT2,,,,,58.7,346.0,7.7e-117,421.8,sp|A7RFT2|CD123_NEMVE Cell division cycle protein 123 homolog OS=Nematostella vectensis OX=45351 GN=cdc123 PE=3 SV=1,,,,,,
OG_01573,2.201507028954285,FUN_006573-T1,Peve_00011457,Pocillopora_meandrina_HIv1___RNAseq.g20313.t1,three_way,82.19833333333334,FUN_006573-T1,P46850,RTCB_ECOLI,,RNA-splicing ligase RtcB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase),Escherichia coli (strain K12),60.3,401.0,8.1e-135,481.9,sp|P46850|RTCB_ECOLI RNA-splicing ligase RtcB OS=Escherichia coli (strain K12) OX=83333 GN=rtcB PE=1 SV=3,GO:0003909; GO:0005525; GO:0006281; GO:0006396; GO:0006974; GO:0030145; GO:0042245; GO:0170057,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; RNA processing [GO:0006396]; RNA repair [GO:0042245],,DNA ligase activity [GO:0003909]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; RNA ligase (GTP) activity [GO:0170057],GO:0003824; GO:0006281; GO:0016874; GO:0140097; GO:0140098,"catalytic activity; DNA repair; ligase activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_01578,1.0977005487218658,FUN_006602-T1,Peve_00044173,Pocillopora_meandrina_HIv1___RNAseq.g1176.t1,three_way,76.88266666666667,FUN_006602-T1,O60733,PLPL9_HUMAN,,85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9),Homo sapiens (Human),42.7,822.0,1.3000000000000002e-133,478.8,sp|O60733|PLPL9_HUMAN 85/88 kDa calcium-independent phospholipase A2 OS=Homo sapiens OX=9606 GN=PLA2G6 PE=1 SV=2,GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0015630; GO:0016607; GO:0016787; GO:0017171; GO:0019731; GO:0031143; GO:0034638; GO:0035774; GO:0035965; GO:0038096; GO:0042802; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0052816; GO:2000304,antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; serine hydrolase activity [GO:0017171],GO:0002376; GO:0003824; GO:0005615; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006629; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; extracellular space; mitochondrion; cytosol; cytoskeleton; plasma membrane; lipid metabolic process; hydrolase activity; organelle; defense response to other organism
OG_01579,1.6834570132419917,FUN_006613-T2,Peve_00023430,Pocillopora_meandrina_HIv1___RNAseq.g20254.t1,three_way,74.73116666666667,FUN_006613-T2,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),34.5,730.0,3.7e-114,414.1,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01581,1.489036520300835,FUN_006617-T1,Peve_00040861,Pocillopora_meandrina_HIv1___RNAseq.g20508.t1,three_way,60.46966666666667,,,,,,,,,,,,,,,,,
OG_01591,1.4449565965280675,FUN_006631-T1,Peve_00040841,Pocillopora_meandrina_HIv1___TS.g29548.t1a,three_way,67.0835,,,,,,,,,,,,,,,,,
OG_01593,2.2726450505482387,FUN_006634-T1,Peve_00040843,Pocillopora_meandrina_HIv1___TS.g29546.t1b,three_way,57.3695,FUN_006634-T1,Q9NY47,,,,,30.1,951.0,1.1e-87,326.2,sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2,,,,,,
OG_01598,1.494739879056039,FUN_006640-T1,Peve_00033036,Pocillopora_meandrina_HIv1___RNAseq.g20240.t1,three_way,66.11666666666667,FUN_006640-T1,Q56P28,,,,,33.7,175.0,2.7e-23,110.2,sp|Q56P28|PRAF3_PIG PRA1 family protein 3 OS=Sus scrofa OX=9823 GN=ARL6IP5 PE=2 SV=1,,,,,,
OG_01602,1.6574062331701858,FUN_006645-T1,Peve_00029047,Pocillopora_meandrina_HIv1___RNAseq.g19947.t1,three_way,43.628166666666665,,,,,,,,,,,,,,,,,
OG_01606,2.21139560879994,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01608,2.3788814457930534,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_01612,1.4251096194652453,FUN_006692-T1,Peve_00029050,Pocillopora_meandrina_HIv1___RNAseq.g19966.t1,three_way,46.55916666666666,,,,,,,,,,,,,,,,,
OG_01615,1.631733001408236,FUN_006706-T1,Peve_00022745,Pocillopora_meandrina_HIv1___RNAseq.g19996.t1,three_way,57.7245,FUN_006706-T1,Q8VE88,,,,,36.3,411.0,8e-51,203.4,sp|Q8VE88|F1142_MOUSE Protein FAM114A2 OS=Mus musculus OX=10090 GN=Fam114a2 PE=1 SV=2,,,,,,
OG_01621,2.4523380150050262,FUN_006730-T1,Peve_00039561,Pocillopora_meandrina_HIv1___TS.g29404.t2,three_way,70.635,FUN_006730-T1,Q9CQF6,,,,,50.4,254.0,2.0000000000000002e-72,273.9,sp|Q9CQF6|ADPPT_MOUSE L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Mus musculus OX=10090 GN=Aasdhppt PE=1 SV=1,,,,,,
OG_01632,1.6118603561161735,FUN_006750-T1,Peve_00029281,Pocillopora_meandrina_HIv1___RNAseq.g20533.t1,three_way,80.3975,FUN_006750-T1,Q9H3E2,,,,,37.7,871.0,3.8e-161,570.5,sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2,,,,,,
OG_01637,1.6553910382616783,FUN_006771-T1,Peve_00027409,Pocillopora_meandrina_HIv1___RNAseq.g20026.t1,three_way,45.833333333333336,,,,,,,,,,,,,,,,,
OG_01640,1.1347462919336888,FUN_006777-T1,Peve_00012351,Pocillopora_meandrina_HIv1___TS.g29411.t1,three_way,62.50533333333333,FUN_006777-T1,Q8CFG5,CA2D3_RAT,,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],Rattus norvegicus (Rat),29.8,1024.0,4.8e-117,424.1,sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1,GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314,calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174],GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891],calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0098772,transporter activity; molecular function regulator activity
OG_01648,2.684185110415175,FUN_006802-T1,Peve_00040415,Pocillopora_meandrina_HIv1___RNAseq.g15311.t1,three_way,49.62916666666666,FUN_006802-T1,Q9UBM8,MGT4C_HUMAN,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",Homo sapiens (Human),32.2,410.0,6.4e-54,213.4,"sp|Q9UBM8|MGT4C_HUMAN Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Homo sapiens OX=9606 GN=MGAT4C PE=2 SV=2",GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0019082; GO:0046872,protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082],Golgi membrane [GO:0000139],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01649,1.4618432607274794,FUN_006803-T2,Peve_00029309,Pocillopora_meandrina_HIv1___RNAseq.g20491.t1,three_way,82.40566666666668,FUN_006803-T2,A1L1C7,PAN3_XENTR,,PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),51.1,626.0,6.2e-166,585.9,sp|A1L1C7|PAN3_XENTR PAN2-PAN3 deadenylation complex subunit pan3 OS=Xenopus tropicalis OX=8364 GN=pan3 PE=2 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0006397; GO:0008270; GO:0010606; GO:0031251,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],P-body [GO:0000932]; PAN complex [GO:0031251],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01650,1.407916941803746,FUN_006805-T1,Peve_00023740,Pocillopora_meandrina_HIv1___RNAseq.g20488.t1a,three_way,80.63166666666666,FUN_006805-T1,Q52T38,ZDH22_ARATH,,Protein S-acyltransferase 24 (EC 2.3.1.225) (Ankyrin repeat-containing S-palmitoyltransferase) (Palmitoyltransferase TIP1) (Protein TIP GROWTH DEFECTIVE 1) (AtTIP1) (Zinc finger DHHC domain-containing protein TIP1),Arabidopsis thaliana (Mouse-ear cress),32.0,222.0,5.1e-27,124.0,sp|Q52T38|ZDH22_ARATH Protein S-acyltransferase 24 OS=Arabidopsis thaliana OX=3702 GN=PAT24 PE=1 SV=1,GO:0000035; GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0009932; GO:0016417; GO:0019706; GO:0030659; GO:2000652; GO:2001006,cell tip growth [GO:0009932]; regulation of cellulose biosynthetic process [GO:2001006]; regulation of secondary cell wall biogenesis [GO:2000652],cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],acyl binding [GO:0000035]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; S-acyltransferase activity [GO:0016417],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01656,4.0680022648771,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_01659,3.099954736460933,FUN_006830-T1,Peve_00023775,Pocillopora_meandrina_HIv1___RNAseq.g20471.t1,three_way,73.49133333333333,FUN_006830-T1,Q9U637,,,,,37.9,198.0,7.3e-17,89.0,sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1,,,,,,
OG_01661,1.730471557745863,FUN_006844-T1,Peve_00023779,Pocillopora_meandrina_HIv1___RNAseq.g20468.t1,three_way,65.999,,,,,,,,,,,,,,,,,
OG_01662,1.5631003590089314,FUN_006845-T1,Peve_00023780,Pocillopora_meandrina_HIv1___RNAseq.g20467.t2,three_way,74.246,FUN_006845-T1,Q8AWB5,,,,,49.5,386.0,1.9e-105,384.4,sp|Q8AWB5|OFUT3_CHICK GDP-fucose protein O-fucosyltransferase 3 OS=Gallus gallus OX=9031 GN=FUT10 PE=2 SV=2,,,,,,
OG_01665,1.0630386424440958,FUN_006848-T1,Peve_00023783,Pocillopora_meandrina_HIv1___RNAseq.g20485.t1,three_way,69.09166666666667,,,,,,,,,,,,,,,,,
OG_01669,2.473392129371778,FUN_006856-T1,Peve_00016201,Pocillopora_meandrina_HIv1___RNAseq.g19911.t1,three_way,74.561,FUN_006856-T1,P24861,,,,,48.5,454.0,1.7e-95,351.3,sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1,,,,,,
OG_01670,1.892791592050129,FUN_006857-T1,Peve_00016203,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1b,three_way,63.460166666666666,FUN_006857-T1,B9EJ80,PDZD8_MOUSE,,PDZ domain-containing protein 8,Mus musculus (Mouse),28.5,1009.0,2.5000000000000004e-80,302.0,sp|B9EJ80|PDZD8_MOUSE PDZ domain-containing protein 8 OS=Mus musculus OX=10090 GN=Pdzd8 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008270; GO:0008289; GO:0022604; GO:0044233; GO:0051560; GO:1990456,cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604],endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; zinc ion binding [GO:0008270],GO:0005739; GO:0007010; GO:0008289; GO:0043226,mitochondrion; cytoskeleton organization; lipid binding; organelle
OG_01673,1.2014737141038938,FUN_006864-T2,Peve_00003792,Pocillopora_meandrina_HIv1___RNAseq.g19906.t1,three_way,83.79033333333334,FUN_006864-T2,P20000,ALDH2_BOVIN,,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)",Bos taurus (Bovine),68.6,510.0,5.1000000000000004e-213,741.9,"sp|P20000|ALDH2_BOVIN Aldehyde dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ALDH2 PE=1 SV=2",GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018937; GO:0046185; GO:0051287; GO:0106435; GO:1903179; GO:1905627,aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; nitroglycerin metabolic process [GO:0018937]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; carboxylesterase activity [GO:0106435]; NAD binding [GO:0051287]; phenylacetaldehyde dehydrogenase (NAD+) activity [GO:0008957],GO:0003824; GO:0005739; GO:0016491; GO:0016787; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; hydrolase activity; organelle
OG_01679,1.6953235788580372,FUN_006889-T1,Peve_00009369,Pocillopora_meandrina_HIv1___RNAseq.g19815.t1,three_way,70.95,FUN_006889-T1,P61328,FGF12_HUMAN,,Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor),Homo sapiens (Human),29.0,131.0,3.1e-16,87.0,sp|P61328|FGF12_HUMAN Fibroblast growth factor 12 OS=Homo sapiens OX=9606 GN=FGF12 PE=1 SV=1,GO:0005615; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007268; GO:0007399; GO:0007507; GO:0008083; GO:0008201; GO:0008344; GO:0010765; GO:0017080; GO:0022008; GO:0044325; GO:0045202; GO:0050905; GO:0086002; GO:0098908; GO:1902305; GO:1905150,adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202],growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005615; GO:0005634; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0050877; GO:0098772,extracellular space; nucleus; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; nervous system process; molecular function regulator activity
OG_01680,1.456130287453199,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01683,1.6525710713212047,FUN_006901-T1,Peve_00044416,Pocillopora_meandrina_HIv1___RNAseq.g19809.t1,three_way,59.586,,,,,,,,,,,,,,,,,
OG_01692,1.233187049489493,FUN_006929-T1,Peve_00044422,Pocillopora_meandrina_HIv1___RNAseq.g20101.t1,three_way,69.52066666666667,,,,,,,,,,,,,,,,,
OG_01694,1.0380560424513234,FUN_006935-T1,Peve_00036200,Pocillopora_meandrina_HIv1___RNAseq.g20119.t1,three_way,82.61133333333333,,,,,,,,,,,,,,,,,
OG_01699,1.3327535185468629,FUN_006942-T1,Peve_00014295,Pocillopora_meandrina_HIv1___RNAseq.g20148.t2,three_way,70.609,FUN_006942-T1,P23770,,,,,42.9,385.0,1.3e-66,255.4,sp|P23770|GATA2_XENLA GATA-binding factor 2 OS=Xenopus laevis OX=8355 GN=gata2 PE=2 SV=1,,,,,,
OG_01701,2.0128199250616867,FUN_006944-T1,Peve_00020225,Pocillopora_meandrina_HIv1___TS.g29510.t1,three_way,85.65633333333334,FUN_006944-T1,Q96P70,IPO9_HUMAN,,Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9),Homo sapiens (Human),60.4,916.0,2.2e-310,1066.2,sp|Q96P70|IPO9_HUMAN Importin-9 OS=Homo sapiens OX=9606 GN=IPO9 PE=1 SV=3,GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031144; GO:0031267; GO:0042393; GO:0061608; GO:0140713,proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267],GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0140104,nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; molecular carrier activity
OG_01703,2.371029514041361,FUN_006948-T1,Peve_00001502,Pocillopora_meandrina_HIv1___RNAseq.g20123.t1,three_way,82.16266666666667,FUN_006948-T1,Q9GZQ3,COMD5_HUMAN,,COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein) (HCaRG),Homo sapiens (Human),47.3,201.0,1.8e-42,174.1,sp|Q9GZQ3|COMD5_HUMAN COMM domain-containing protein 5 OS=Homo sapiens OX=9606 GN=COMMD5 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_01704,1.9435651354614003,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01708,1.1389462724278523,FUN_006981-T1,Peve_00045261,Pocillopora_meandrina_HIv1___TS.g29608.t2a,three_way,80.34333333333333,FUN_006981-T1,Q86XE3,MICU3_HUMAN,,"Calcium uptake protein 3, mitochondrial (hMICU3) (EF-hand domain-containing family member A2)",Homo sapiens (Human),35.0,203.0,1e-24,115.2,"sp|Q86XE3|MICU3_HUMAN Calcium uptake protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=MICU3 PE=1 SV=1",GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246,calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982],GO:0005739; GO:0043226; GO:0055085; GO:0098772; GO:0140299,mitochondrion; organelle; transmembrane transport; molecular function regulator activity; molecular sensor activity
OG_01709,3.2023275066319634,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01710,1.5117488751185104,FUN_006983-T1,Peve_00045259,Pocillopora_meandrina_HIv1___RNAseq.3765_t,three_way,61.745333333333335,FUN_006983-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),38.7,248.0,5.7e-40,166.0,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01713,1.7009238124340218,FUN_006988-T1,Peve_00009621,Pocillopora_meandrina_HIv1___RNAseq.g20160.t1,three_way,80.87866666666667,FUN_006988-T1,P57760,STK16_RAT,,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2),Rattus norvegicus (Rat),40.4,297.0,1.4999999999999999e-55,218.0,sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus OX=10116 GN=Stk16 PE=2 SV=2,GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0016604; GO:0045944; GO:0048471; GO:0071560; GO:0106310,cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"DNA binding; catalytic activity; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01715,1.697051668107923,FUN_006995-T1,Peve_00035637,Pocillopora_meandrina_HIv1___RNAseq.g20064.t1,three_way,61.722166666666666,,,,,,,,,,,,,,,,,
OG_01720,1.5346748906773704,FUN_007007-T1,Peve_00016932,Pocillopora_meandrina_HIv1___TS.g29917.t1,three_way,45.16033333333333,,,,,,,,,,,,,,,,,
OG_01721,2.6355489771897127,FUN_007008-T1,Peve_00044388,Pocillopora_meandrina_HIv1___TS.g27386.t2,three_way,40.379333333333335,FUN_007008-T1,Q6UW56,ARAID_HUMAN,,All-trans retinoic acid-induced differentiation factor (Apoptosis-related protein 3) (APR-3) (p18),Homo sapiens (Human),32.0,203.0,1.6e-20,101.3,sp|Q6UW56|ARAID_HUMAN All-trans retinoic acid-induced differentiation factor OS=Homo sapiens OX=9606 GN=ATRAID PE=1 SV=2,GO:0005635; GO:0005765; GO:0005886; GO:0006855; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0042177; GO:0042910; GO:0043231; GO:0045669; GO:0048471,cell differentiation [GO:0030154]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; xenobiotic transmembrane transport [GO:0006855],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005635; GO:0005886; GO:0030154; GO:0043226; GO:0055085,transporter activity; nuclear envelope; plasma membrane; cell differentiation; organelle; transmembrane transport
OG_01727,3.0475783468529327,FUN_007019-T1,Peve_00037183,Pocillopora_meandrina_HIv1___TS.g29924.t1,three_way,69.06633333333333,FUN_007019-T1,P0DPD6,ECE2_HUMAN,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Homo sapiens (Human),35.5,761.0,4e-129,463.8,sp|P0DPD6|ECE2_HUMAN Endothelin-converting enzyme 2 OS=Homo sapiens OX=9606 GN=ECE2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005886; GO:0007186; GO:0007267; GO:0008168; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168],GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; transferase activity; hydrolase activity; signaling; protein maturation; catalytic activity, acting on a protein"
OG_01728,4.387442159364254,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_01729,1.7584796745960505,FUN_007023-T2,Peve_00032897,Pocillopora_meandrina_HIv1___RNAseq.g20021.t2,three_way,56.138,,,,,,,,,,,,,,,,,
OG_01735,2.4461468783019087,FUN_007054-T1,Peve_00003799,Pocillopora_meandrina_HIv1___RNAseq.g20071.t1,three_way,78.438,FUN_007054-T1,Q01664,TFAP4_HUMAN,,Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41),Homo sapiens (Human),53.6,140.0,7.5e-27,122.5,sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837,"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; transcription regulator activity
OG_01736,1.1859334741676528,FUN_007055-T1,Peve_00003798,Pocillopora_meandrina_HIv1___RNAseq.g20072.t1,three_way,88.616,FUN_007055-T1,Q5SQX6,CYFP2_MOUSE,,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),Mus musculus (Mouse),61.2,1252.0,0.0,1540.4,sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052,apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202],small GTPase binding [GO:0031267],GO:0005634; GO:0007155; GO:0012501; GO:0043226,nucleus; cell adhesion; programmed cell death; organelle
OG_01737,1.1877314732956783,FUN_007056-T1,Peve_00003796,Pocillopora_meandrina_HIv1___RNAseq.g20073.t1,three_way,72.12466666666667,FUN_007056-T1,Q9VXB5,,,,,46.6,148.0,3.5e-27,122.9,sp|Q9VXB5|RM22_DROME Large ribosomal subunit protein uL22m OS=Drosophila melanogaster OX=7227 GN=mRpL22 PE=2 SV=2,,,,,,
OG_01738,1.0079032858643968,FUN_007057-T1,Peve_00003777,Pocillopora_meandrina_HIv1___TS.g29459.t2,three_way,64.8275,FUN_007057-T1,Q8BX17,GEMI5_MOUSE,,Gem-associated protein 5 (Gemin5),Mus musculus (Mouse),39.4,1203.0,2.2e-212,741.5,sp|Q8BX17|GEMI5_MOUSE Gem-associated protein 5 OS=Mus musculus OX=10090 GN=Gemin5 PE=1 SV=2,GO:0000340; GO:0000387; GO:0003730; GO:0005829; GO:0006412; GO:0006417; GO:0017069; GO:0030619; GO:0030621; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504,regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719],mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621],GO:0003723; GO:0005829; GO:0043226; GO:0065003,RNA binding; cytosol; organelle; protein-containing complex assembly
OG_01746,1.1036680649704695,FUN_007072-T2,Peve_00019898,Pocillopora_meandrina_HIv1___RNAseq.g20086.t1,three_way,53.24433333333334,FUN_007072-T2,B1AT66,MOT7_MOUSE,,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),Mus musculus (Mouse),24.3,202.0,2.2e-15,85.1,sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1,GO:0005368; GO:0016323,,basolateral plasma membrane [GO:0016323],taurine transmembrane transporter activity [GO:0005368],GO:0005215,transporter activity
OG_01752,1.981983640756808,FUN_007092-T1,Peve_00019879,Pocillopora_meandrina_HIv1___RNAseq.g19058.t1,three_way,57.32516666666667,FUN_007092-T1,Q8CDI6,,,,,27.6,174.0,1.1e-07,61.2,sp|Q8CDI6|CD158_MOUSE Coiled-coil domain-containing protein 158 OS=Mus musculus OX=10090 GN=Ccdc158 PE=2 SV=1,,,,,,
OG_01761,1.5272338983558975,FUN_007116-T1,Peve_00043797,Pocillopora_meandrina_HIv1___RNAseq.g18996.t1,three_way,88.80166666666666,FUN_007116-T1,Q32LE3,,,,,67.9,159.0,9e-33,141.7,sp|Q32LE3|CETN1_BOVIN Centrin-1 OS=Bos taurus OX=9913 GN=CETN1 PE=2 SV=1,,,,,,
OG_01764,1.1299859226699769,FUN_007119-T1,Peve_00043804,Pocillopora_meandrina_HIv1___RNAseq.g19000.t1,three_way,66.69666666666666,FUN_007119-T1,Q498J9,,,,,50.0,192.0,1.3000000000000002e-44,181.0,sp|Q498J9|MBLC1_XENLA Metallo-beta-lactamase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mblac1 PE=2 SV=2,,,,,,
OG_01765,1.3027677985530597,FUN_007120-T1,Peve_00043805,Pocillopora_meandrina_HIv1___RNAseq.g19001.t1,three_way,78.95066666666666,FUN_007120-T1,Q5RJZ6,,,,,54.7,117.0,1.2e-20,100.9,sp|Q5RJZ6|SCOC_RAT Short coiled-coil protein OS=Rattus norvegicus OX=10116 GN=Scoc PE=2 SV=1,,,,,,
OG_01768,1.3410827442494306,FUN_007125-T1,Peve_00012337,Pocillopora_meandrina_HIv1___RNAseq.g19008.t1a,three_way,45.29433333333333,,,,,,,,,,,,,,,,,
OG_01778,1.5982676485530858,FUN_007150-T1,Peve_00028250,Pocillopora_meandrina_HIv1___RNAseq.g19714.t1,three_way,81.34100000000001,FUN_007150-T1,Q96DB2,HDA11_HUMAN,,Histone deacetylase 11 (HD11) (EC 3.5.1.98),Homo sapiens (Human),63.6,319.0,6.7e-119,428.7,sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1,GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0040029; GO:0140297; GO:0141221,chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01782,1.3146363374118073,FUN_007155-T1,Peve_00028244,Pocillopora_meandrina_HIv1___TS.g29111.t1,three_way,72.6365,FUN_007155-T1,Q9PT84,,,,,43.9,471.0,5.1e-99,363.6,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
OG_01795,1.4210271625388178,FUN_007180-T1,Peve_00042731,Pocillopora_meandrina_HIv1___RNAseq.g19780.t1,three_way,75.47366666666666,FUN_007180-T1,P95329,,,,,40.0,475.0,2.5e-97,357.5,sp|P95329|MASY_MYXXD Malate synthase OS=Myxococcus xanthus (strain DK1622) OX=246197 GN=mls PE=3 SV=2,,,,,,
OG_01807,1.3482352463648586,FUN_007606-T1,Peve_00034276,Pocillopora_meandrina_HIv1___TS.g24525.t2,three_way,41.922,,,,,,,,,,,,,,,,,
OG_01808,1.0488452818817122,FUN_007607-T1,Peve_00034273,Pocillopora_meandrina_HIv1___RNAseq.g5809.t1,three_way,55.49466666666667,FUN_007607-T1,Q8R2S1,,,,,31.8,525.0,3.5e-63,245.0,sp|Q8R2S1|RPKL1_MOUSE Ribosomal protein S6 kinase-like 1 OS=Mus musculus OX=10090 GN=Rps6kl1 PE=1 SV=1,,,,,,
OG_01810,2.960499890361622,FUN_007645-T1,Peve_00034272,Pocillopora_meandrina_HIv1___RNAseq.g5810.t1,three_way,52.86483333333334,FUN_007645-T1,O16099,,,,,36.6,503.0,1.0000000000000001e-81,305.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_01817,1.8377562593599923,FUN_007690-T1,Peve_00012973,Pocillopora_meandrina_HIv1___RNAseq.g18009.t1b,three_way,56.254666666666665,,,,,,,,,,,,,,,,,
OG_01820,1.905112573441653,FUN_007693-T1,Peve_00026595,Pocillopora_meandrina_HIv1___RNAseq.g18006.t2,three_way,58.693666666666665,FUN_007693-T1,B0BM95,ACTMP_XENTR,,Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),38.7,261.0,1.1e-41,171.8,sp|B0BM95|ACTMP_XENTR Actin maturation protease OS=Xenopus tropicalis OX=8364 GN=actmap PE=2 SV=2,GO:0004239; GO:0005737; GO:0016485,protein processing [GO:0016485],cytoplasm [GO:0005737],initiator methionyl aminopeptidase activity [GO:0004239],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01821,1.9184966080795915,FUN_007694-T1,Peve_00026596,Pocillopora_meandrina_HIv1___RNAseq.g18005.t1,three_way,80.34066666666666,FUN_007694-T1,Q9H307,,,,,52.2,274.0,2.5e-25,117.9,sp|Q9H307|PININ_HUMAN Pinin OS=Homo sapiens OX=9606 GN=PNN PE=1 SV=5,,,,,,
OG_01822,2.0072485890485847,FUN_007695-T1,Peve_00026597,Pocillopora_meandrina_HIv1___RNAseq.g18003.t1,three_way,72.62466666666667,,,,,,,,,,,,,,,,,
OG_01823,1.0859642782925345,FUN_007696-T1,Peve_00026598,Pocillopora_meandrina_HIv1___RNAseq.g17999.t1,three_way,72.92433333333334,FUN_007696-T1,O14772,FPGT_HUMAN,,Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase),Homo sapiens (Human),42.2,588.0,1.1e-115,418.7,sp|O14772|FPGT_HUMAN Fucose-1-phosphate guanylyltransferase OS=Homo sapiens OX=9606 GN=FPGT PE=1 SV=3,GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0042350; GO:0047341,fucose metabolic process [GO:0006004]; GDP-L-fucose biosynthetic process [GO:0042350],cytoplasm [GO:0005737]; cytosol [GO:0005829],fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525],GO:0003824; GO:0005829; GO:0005975; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01828,1.1095736855767493,FUN_007708-T1,Peve_00013719,Pocillopora_meandrina_HIv1___RNAseq.g5861.t1,three_way,82.725,FUN_007708-T1,Q70CQ2,UBP34_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34),Homo sapiens (Human),42.6,3491.0,0.0,2497.2,sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263,positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01832,1.0018563556070657,FUN_007748-T1,Peve_00033175,Pocillopora_meandrina_HIv1___RNAseq.g5860.t1,three_way,75.091,FUN_007748-T1,Q5ZKL5,,,,,33.3,672.0,1.5e-98,362.1,sp|Q5ZKL5|PPCEL_CHICK Prolyl endopeptidase-like OS=Gallus gallus OX=9031 GN=PREPL PE=2 SV=1,,,,,,
OG_01837,1.95311521958236,FUN_007773-T1,Peve_00036438,Pocillopora_meandrina_HIv1___RNAseq.g5836.t1,three_way,57.734,FUN_007773-T1,Q8JFW4,,,,,39.7,378.0,5.499999999999999e-63,243.0,sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2,,,,,,
OG_01838,1.5840402592556788,FUN_007775-T1,Peve_00032268,Pocillopora_meandrina_HIv1___TS.g24628.t2,three_way,66.44866666666667,FUN_007775-T1,Q9HAV4,XPO5_HUMAN,,Exportin-5 (Exp5) (Ran-binding protein 21),Homo sapiens (Human),34.6,1233.0,3.5e-196,687.2,sp|Q9HAV4|XPO5_HUMAN Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1,GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1905172,miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565],mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,RNA binding; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_01839,2.596727139852987,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01840,2.894507471203472,FUN_007786-T1,Peve_00022059,Pocillopora_meandrina_HIv1___RNAseq.g5903.t1,three_way,66.8125,,,,,,,,,,,,,,,,,
OG_01842,1.316610048724128,FUN_007788-T1,Peve_00022036,Pocillopora_meandrina_HIv1___RNAseq.g5901.t1,three_way,61.594,FUN_007788-T1,Q9BW66,CINP_HUMAN,,Cyclin-dependent kinase 2-interacting protein (CDK2-interacting protein),Homo sapiens (Human),30.9,191.0,1.6e-17,91.3,sp|Q9BW66|CINP_HUMAN Cyclin-dependent kinase 2-interacting protein OS=Homo sapiens OX=9606 GN=CINP PE=1 SV=1,GO:0005634; GO:0006260; GO:0006281; GO:0042273; GO:0051301; GO:1990275,cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; ribosomal large subunit biogenesis [GO:0042273],nucleus [GO:0005634],preribosome binding [GO:1990275],GO:0005634; GO:0006260; GO:0006281; GO:0043226,nucleus; DNA replication; DNA repair; organelle
OG_01844,1.8610983594065111,FUN_007790-T1,Peve_00022038,Pocillopora_meandrina_HIv1___RNAseq.g5899.t1,three_way,82.86166666666666,FUN_007790-T1,Q8R1Q9,,,,,56.1,305.0,1.3000000000000001e-89,331.3,sp|Q8R1Q9|RBSK_MOUSE Ribokinase OS=Mus musculus OX=10090 GN=Rbks PE=1 SV=1,,,,,,
OG_01845,1.8422549945554272,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01848,1.7650648661484425,FUN_007798-T1,Peve_00022052,Pocillopora_meandrina_HIv1___RNAseq.g18342.t1,three_way,82.26133333333333,FUN_007798-T1,Q9UGV2,,,,,42.5,325.0,1.2e-66,255.0,sp|Q9UGV2|NDRG3_HUMAN Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2,,,,,,
OG_01851,1.1624363759296956,FUN_007801-T1,Peve_00022055,Pocillopora_meandrina_HIv1___RNAseq.g18338.t1,three_way,56.8715,,,,,,,,,,,,,,,,,
OG_01852,1.7678017708558569,FUN_007803-T2,Peve_00022056,Pocillopora_meandrina_HIv1___RNAseq.g18339.t1,three_way,75.05483333333333,FUN_007803-T2,Q96JM7,,,,,34.7,862.0,6.800000000000001e-134,479.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_01853,2.578130520786696,FUN_007804-T1,Peve_00022057,Pocillopora_meandrina_HIv1___RNAseq.g18346.t1,three_way,62.281666666666666,,,,,,,,,,,,,,,,,
OG_01862,1.0872864751730211,FUN_007821-T1,Peve_00038746,Pocillopora_meandrina_HIv1___RNAseq.g18388.t1,three_way,57.14966666666667,,,,,,,,,,,,,,,,,
OG_01864,1.0144879080679328,FUN_007824-T1,Peve_00032624,Pocillopora_meandrina_HIv1___RNAseq.g18390.t1,three_way,76.27866666666667,FUN_007824-T1,Q8CE96,,,,,41.7,458.0,4.7e-88,326.6,sp|Q8CE96|TRM6_MOUSE tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Mus musculus OX=10090 GN=Trmt6 PE=1 SV=1,,,,,,
OG_01866,2.163730751026863,FUN_007832-T1,Peve_00003986,Pocillopora_meandrina_HIv1___RNAseq.g29997.t1,three_way,76.73700000000001,FUN_007832-T1,Q7Q107,,,,,61.9,202.0,2.9e-67,256.9,sp|Q7Q107|MED6_ANOGA Mediator of RNA polymerase II transcription subunit 6 OS=Anopheles gambiae OX=7165 GN=MED6 PE=3 SV=3,,,,,,
OG_01867,1.1767730228082764,FUN_007833-T1,Peve_00003987,Pocillopora_meandrina_HIv1___RNAseq.g18399.t1,three_way,68.14616666666667,,,,,,,,,,,,,,,,,
OG_01869,3.379110884285887,FUN_007836-T1,Peve_00019311,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1a,three_way,61.774,FUN_007836-T1,E7FEV0,,,,,27.2,2195.0,1e-187,659.8,sp|E7FEV0|WDR81_DANRE WD repeat-containing protein 81 OS=Danio rerio OX=7955 GN=wdr81 PE=2 SV=1,,,,,,
OG_01870,1.5605974901179365,FUN_007837-T1,Peve_00019310,Pocillopora_meandrina_HIv1___RNAseq.g18433.t1,three_way,78.51033333333334,FUN_007837-T1,Q1L9A2,OPA3_DANRE,,Optic atrophy 3 protein homolog,Danio rerio (Zebrafish) (Brachydanio rerio),48.6,148.0,5.8e-32,138.7,sp|Q1L9A2|OPA3_DANRE Optic atrophy 3 protein homolog OS=Danio rerio OX=7955 GN=opa3 PE=3 SV=1,GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881,locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216],mitochondrion [GO:0005739],,GO:0005739; GO:0043226; GO:0050877,mitochondrion; organelle; nervous system process
OG_01877,2.117822534162986,FUN_007850-T1,Peve_00021800,Pocillopora_meandrina_HIv1___RNAseq.g18287.t1,three_way,66.41766666666666,,,,,,,,,,,,,,,,,
OG_01881,1.968067752798272,FUN_007857-T1,Peve_00024166,Pocillopora_meandrina_HIv1___RNAseq.g18294.t1,three_way,59.664,FUN_007857-T1,Q5T6L9,,,,,33.1,602.0,5.7e-82,307.0,sp|Q5T6L9|EMARD_HUMAN Endoplasmic reticulum membrane-associated RNA degradation protein OS=Homo sapiens OX=9606 GN=ERMARD PE=1 SV=1,,,,,,
OG_01888,1.7889578146675218,FUN_007869-T1,Peve_00009888,Pocillopora_meandrina_HIv1___RNAseq.g18305.t1,three_way,80.55466666666666,,,,,,,,,,,,,,,,,
OG_01889,1.7227214774357336,FUN_007871-T1,Peve_00009886,Pocillopora_meandrina_HIv1___RNAseq.g18307.t1,three_way,66.36216666666667,FUN_007871-T1,Q13613,,,,,32.8,466.0,6.600000000000003e-60,234.2,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_01894,1.1725367004448632,FUN_007892-T1,Peve_00009871,Pocillopora_meandrina_HIv1___RNAseq.g18244.t2,three_way,59.311,FUN_007892-T1,Q80UF4,SDCG8_MOUSE,,Serologically defined colon cancer antigen 8 homolog (Centrosomal colon cancer autoantigen protein) (mCCCAP),Mus musculus (Mouse),34.7,496.0,1.8e-15,86.3,sp|Q80UF4|SDCG8_MOUSE Serologically defined colon cancer antigen 8 homolog OS=Mus musculus OX=10090 GN=Sdccag8 PE=1 SV=1,GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0007098; GO:0030010; GO:0030030; GO:0031023; GO:0034451; GO:0035148; GO:0036064; GO:0097733; GO:1902017,cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148],cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733],,GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0007163; GO:0043226; GO:0048870,nucleoplasm; microtubule organizing center; cytosol; cilium; establishment or maintenance of cell polarity; organelle; cell motility
OG_01898,1.701373743074915,FUN_007909-T1,Peve_00040664,Pocillopora_meandrina_HIv1___RNAseq.g30061.t1,three_way,70.45833333333333,FUN_007909-T1,A8J4S9,TREA_APIME,,"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)",Apis mellifera (Honeybee),45.2,571.0,2e-152,540.8,sp|A8J4S9|TREA_APIME Trehalase OS=Apis mellifera OX=7460 PE=1 SV=1,GO:0004555; GO:0005993; GO:0016020,trehalose catabolic process [GO:0005993],membrane [GO:0016020],"alpha,alpha-trehalase activity [GO:0004555]",GO:0003824; GO:0005975; GO:0016787,catalytic activity; carbohydrate metabolic process; hydrolase activity
OG_01904,1.7046566989759395,FUN_007918-T1,Peve_00040674,Pocillopora_meandrina_HIv1___RNAseq.g30119.t1,three_way,52.329166666666666,FUN_007918-T1,Q9D6X6,,,,,34.3,289.0,4.4e-36,153.7,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_01908,2.3949073404468626,FUN_007922-T1,Peve_00040679,Pocillopora_meandrina_HIv1___RNAseq.g30087.t1,three_way,86.508,FUN_007922-T1,Q4V7N3,,,,,63.6,162.0,2.0999999999999998e-55,216.9,sp|Q4V7N3|STYXA_XENLA Serine/threonine/tyrosine-interacting protein A OS=Xenopus laevis OX=8355 GN=styx-a PE=2 SV=1,,,,,,
OG_01910,1.0754148702730104,FUN_007925-T1,Peve_00040685,Pocillopora_meandrina_HIv1___RNAseq.g30084.t1,three_way,71.54366666666667,,,,,,,,,,,,,,,,,
OG_01916,1.2409755583376698,FUN_007943-T1,Peve_00040696,Pocillopora_meandrina_HIv1___RNAseq.g18120.t1,three_way,83.53,FUN_007943-T1,Q9NW15,,,,,28.6,623.0,1.9e-60,235.3,sp|Q9NW15|ANO10_HUMAN Anoctamin-10 OS=Homo sapiens OX=9606 GN=ANO10 PE=1 SV=2,,,,,,
OG_01921,2.753390543953788,FUN_007951-T1,Peve_00039191,Pocillopora_meandrina_HIv1___RNAseq.g30068.t1,three_way,75.82233333333333,,,,,,,,,,,,,,,,,
OG_01927,1.7567531723424454,FUN_007964-T1,Peve_00030094,Pocillopora_meandrina_HIv1___RNAseq.g30026.t1,three_way,69.93233333333333,FUN_007964-T1,Q66HG4,,,,,48.8,281.0,1.6e-70,267.7,sp|Q66HG4|GALM_RAT Galactose mutarotase OS=Rattus norvegicus OX=10116 GN=Galm PE=1 SV=1,,,,,,
OG_01934,1.2912244227819654,FUN_007973-T1,Peve_00030074,Pocillopora_meandrina_HIv1___RNAseq.g30008.t1,three_way,60.6855,FUN_007973-T1,Q9TTK4,,,,,27.2,4160.0,0.0,1187.2,sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1,,,,,,
OG_01935,1.283296507381417,FUN_007976-T1,Peve_00040181,Pocillopora_meandrina_HIv1___RNAseq.g18173.t1,three_way,73.17483333333334,FUN_007976-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),43.1,450.0,3.8e-87,323.6,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_01938,1.6132081870119237,FUN_007980-T1,Peve_00040185,Pocillopora_meandrina_HIv1___RNAseq.g18169.t1,three_way,77.59366666666666,FUN_007980-T1,B6NXD5,BABA2_BRAFL,,BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein),Branchiostoma floridae (Florida lancelet) (Amphioxus),43.6,381.0,4.2e-92,339.7,sp|B6NXD5|BABA2_BRAFL BRISC and BRCA1-A complex member 2 OS=Branchiostoma floridae OX=7739 GN=BABAM2 PE=3 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007095; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212],BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634],polyubiquitin modification-dependent protein binding [GO:0031593],GO:0005634; GO:0006281; GO:0006325; GO:0012501; GO:0043226,nucleus; DNA repair; chromatin organization; programmed cell death; organelle
OG_01939,2.5891434353446745,FUN_007981-T1,Peve_00040186,Pocillopora_meandrina_HIv1___RNAseq.g18168.t2,three_way,61.64066666666667,FUN_007981-T1,Q8CIF6,SIDT2_MOUSE,,SID1 transmembrane family member 2,Mus musculus (Mouse),26.6,418.0,4.3999999999999995e-25,118.2,sp|Q8CIF6|SIDT2_MOUSE SID1 transmembrane family member 2 OS=Mus musculus OX=10090 GN=Sidt2 PE=1 SV=1,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_01941,3.4366115348057584,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01946,1.3273817864286217,FUN_008001-T1,Peve_00006650,Pocillopora_meandrina_HIv1___TS.g21139.t2b,three_way,61.92966666666666,FUN_008001-T1,Q8IWY9,CDAN1_HUMAN,,Codanin-1,Homo sapiens (Human),30.4,1310.0,1.6e-117,426.0,sp|Q8IWY9|CDAN1_HUMAN Codanin-1 OS=Homo sapiens OX=9606 GN=CDAN1 PE=1 SV=4,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0012505; GO:0051170,chromatin organization [GO:0006325]; import into nucleus [GO:0051170]; protein localization [GO:0008104],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005829; GO:0005886; GO:0006325; GO:0006913; GO:0043226,nucleus; cytosol; plasma membrane; chromatin organization; nucleocytoplasmic transport; organelle
OG_01947,1.2310889000261755,FUN_008003-T1,Peve_00006648,Pocillopora_meandrina_HIv1___RNAseq.g18148.t1,three_way,64.2115,FUN_008003-T1,Q9HAW4,CLSPN_HUMAN,,Claspin (hClaspin),Homo sapiens (Human),32.9,304.0,3.5e-24,114.4,sp|Q9HAW4|CLSPN_HUMAN Claspin OS=Homo sapiens OX=9606 GN=CLSPN PE=1 SV=3,GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0018105; GO:0032147; GO:0033314,activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105],Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217],GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; Golgi apparatus; DNA repair; organelle
OG_01951,1.842627607694319,FUN_008016-T1,Peve_00031315,Pocillopora_meandrina_HIv1___RNAseq.g30338.t1,three_way,69.895,FUN_008016-T1,Q6GYQ0,RGPA1_HUMAN,,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),Homo sapiens (Human),36.5,2122.0,0.0,1175.6,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; nucleus [GO:0005634],GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_01952,1.515106369622431,FUN_008018-T1,Peve_00031314,Pocillopora_meandrina_HIv1___RNAseq.g30339.t1,three_way,80.18366666666667,FUN_008018-T1,P18754,RCC1_HUMAN,,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),Homo sapiens (Human),49.0,433.0,2.4e-107,390.6,sp|P18754|RCC1_HUMAN Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0007346; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673,cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0007010; GO:0007059; GO:0042393; GO:0043226; GO:0061024; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; cytoskeleton organization; chromosome segregation; histone binding; organelle; membrane organization; molecular function regulator activity
OG_01964,1.1087155839083789,FUN_008047-T1,Peve_00045146,Pocillopora_meandrina_HIv1___RNAseq.g30362.t2,three_way,56.651333333333326,,,,,,,,,,,,,,,,,
OG_01966,2.466709964522762,FUN_008049-T1,Peve_00045150,Pocillopora_meandrina_HIv1___RNAseq.g30360.t1,three_way,52.505,,,,,,,,,,,,,,,,,
OG_01968,1.986574414180028,FUN_008058-T1,Peve_00017188,Pocillopora_meandrina_HIv1___RNAseq.g17900.t1,three_way,70.506,FUN_008058-T1,Q8AWD2,MOCS3_DANRE,,Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)],Danio rerio (Zebrafish) (Brachydanio rerio),53.7,492.0,1e-135,485.0,sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1,GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605,Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292],GO:0003824; GO:0005829; GO:0006399; GO:0016740; GO:0016874; GO:0140096; GO:0140657,"catalytic activity; cytosol; tRNA metabolic process; transferase activity; ligase activity; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01969,2.414612615670724,FUN_008060-T1,Peve_00017191,Pocillopora_meandrina_HIv1___RNAseq.g17907.t1,three_way,77.13,,,,,,,,,,,,,,,,,
OG_01970,2.159206570926826,FUN_008061-T1,Peve_00017192,Pocillopora_meandrina_HIv1___RNAseq.g17906.t1,three_way,53.46666666666666,,,,,,,,,,,,,,,,,
OG_01972,1.0234741101028146,FUN_008075-T2,Peve_00013209,Pocillopora_meandrina_HIv1___TS.g22375.t1a,three_way,80.586,FUN_008075-T2,P47990,XDH_CHICK,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Gallus gallus (Chicken),61.2,1361.0,0.0,1679.1,sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1,GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949,urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0005829; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; cytosol; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_01974,1.316797627627468,FUN_008079-T1,Peve_00041217,Pocillopora_meandrina_HIv1___RNAseq.g30082.t1,three_way,88.34400000000001,FUN_008079-T1,Q9Z2Q4,,,,,69.2,1253.0,0.0,1754.2,sp|Q9Z2Q4|METH_RAT Methionine synthase OS=Rattus norvegicus OX=10116 GN=Mtr PE=1 SV=1,,,,,,
OG_01977,2.3392108639652958,FUN_008084-T1,Peve_00041226,Pocillopora_meandrina_HIv1___RNAseq.g18089.t1,three_way,77.60133333333333,FUN_008084-T1,Q9VAI1,CIA30_DROME,,"Complex I intermediate-associated protein 30, mitochondrial (NADH:ubiquinone oxidoreductase complex assembly factor 1)",Drosophila melanogaster (Fruit fly),35.7,213.0,1.6000000000000001e-28,127.9,"sp|Q9VAI1|CIA30_DROME Complex I intermediate-associated protein 30, mitochondrial OS=Drosophila melanogaster OX=7227 GN=NdufAF1 PE=1 SV=1",GO:0001666; GO:0005739; GO:0006120; GO:0009408; GO:0032981; GO:0042594; GO:0051082; GO:0055093; GO:1990204,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to starvation [GO:0042594]",mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204],unfolded protein binding [GO:0051082],GO:0005739; GO:0006091; GO:0043226; GO:0065003,mitochondrion; generation of precursor metabolites and energy; organelle; protein-containing complex assembly
OG_01985,1.8942085262639736,FUN_008093-T1,Peve_00038989,Pocillopora_meandrina_HIv1___RNAseq.g30098.t1,three_way,63.867666666666665,FUN_008093-T1,Q8BGQ1,SPE39_MOUSE,,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),Mus musculus (Mouse),38.4,385.0,1.5e-67,258.8,sp|Q8BGQ1|SPE39_MOUSE Spermatogenesis-defective protein 39 homolog OS=Mus musculus OX=10090 GN=Vipas39 PE=1 SV=1,GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007283; GO:0008333; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0055037; GO:0099023,cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023],protein-containing complex binding [GO:0044877],GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle
OG_01987,1.0368851181537098,FUN_008095-T1,Peve_00038997,Pocillopora_meandrina_HIv1___RNAseq.g30134.t1,three_way,81.409,FUN_008095-T1,Q5E951,TBCB_BOVIN,,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),Bos taurus (Bovine),48.1,243.0,2.3000000000000002e-59,230.3,sp|Q5E951|TBCB_BOVIN Tubulin-folding cofactor B OS=Bos taurus OX=9913 GN=TBCB PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010,cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634],alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010],GO:0005634; GO:0005829; GO:0006457; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0065003,nucleus; cytosol; protein folding; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly
OG_01992,1.7195545108518748,FUN_008100-T1,Peve_00038880,Pocillopora_meandrina_HIv1___RNAseq.g30139.t1,three_way,44.18833333333333,,,,,,,,,,,,,,,,,
OG_01996,2.07794425089879,FUN_008107-T1,Peve_00019589,Pocillopora_meandrina_HIv1___RNAseq.21377_t,three_way,82.86116666666668,FUN_008107-T1,Q2PFW9,,,,,36.0,458.0,2.5000000000000002e-58,227.6,sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1,,,,,,
OG_01997,2.397562913113958,FUN_008108-T1,Peve_00019590,Pocillopora_meandrina_HIv1___RNAseq.g17896.t1,three_way,76.08733333333333,FUN_008108-T1,P31669,,,,,54.0,985.0,1.6999999999999996e-286,986.9,sp|P31669|PARP1_XENLA Poly [ADP-ribose] polymerase 1 (Fragment) OS=Xenopus laevis OX=8355 GN=parp1 PE=2 SV=1,,,,,,
OG_01998,1.017767377519315,FUN_008109-T1,Peve_00006535,Pocillopora_meandrina_HIv1___RNAseq.g17895.t1,three_way,62.32033333333333,,,,,,,,,,,,,,,,,
OG_02007,1.7465475438778548,FUN_008122-T1,Peve_00022348,Pocillopora_meandrina_HIv1___RNAseq.g17883.t1,three_way,77.1465,FUN_008122-T1,Q8R4P9,MRP7_MOUSE,,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),Mus musculus (Mouse),49.7,1236.0,0.0,1107.0,sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1,GO:0005524; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016323; GO:0016887; GO:0071716; GO:0140359,leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323],ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_02008,1.0560914069097198,FUN_008124-T1,Peve_00037845,Pocillopora_meandrina_HIv1___TS.g20865.t1c,three_way,71.69683333333333,FUN_008124-T1,Q86X10,,,,,37.7,1615.0,9.4e-255,882.1,sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1,,,,,,
OG_02013,1.2599936846008364,FUN_008186-T1,Peve_00018750,Pocillopora_meandrina_HIv1___TS.g22292.t1,three_way,69.749,FUN_008186-T1,Q91YJ5,,,,,47.6,553.0,7.4e-132,472.6,"sp|Q91YJ5|IF2M_MOUSE Translation initiation factor IF-2, mitochondrial OS=Mus musculus OX=10090 GN=Mtif2 PE=1 SV=2",,,,,,
OG_02015,2.217061458437744,FUN_008188-T1,Peve_00010859,Pocillopora_meandrina_HIv1___RNAseq.g29996.t1,three_way,81.78566666666667,FUN_008188-T1,Q99NB1,ACS2L_MOUSE,,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),62.1,612.0,1.7e-229,797.0,"sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218,acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0005739; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0055086; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_02017,1.8176413073465008,FUN_008194-T1,Peve_00022158,Pocillopora_meandrina_HIv1___RNAseq.g30170.t1,three_way,74.29066666666667,FUN_008194-T1,Q99538,LGMN_HUMAN,,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (AEP) (Protease, cysteine 1)",Homo sapiens (Human),62.9,280.0,2.7e-100,366.7,sp|Q99538|LGMN_HUMAN Legumain OS=Homo sapiens OX=9606 GN=LGMN PE=1 SV=1,GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0051604; GO:0061133; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:1900273; GO:1901185; GO:1904646; GO:2001028,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156],GO:0002376; GO:0003014; GO:0003824; GO:0005576; GO:0005764; GO:0005768; GO:0005773; GO:0006629; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0098772; GO:0140096,"immune system process; renal system process; catalytic activity; extracellular region; lysosome; endosome; vacuole; lipid metabolic process; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; nervous system process; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02024,2.012440577867028,FUN_008214-T1,Peve_00005268,Pocillopora_meandrina_HIv1___RNAseq.g30183.t1,three_way,49.18816666666667,FUN_008214-T1,A0A8J1LLF7,DICRS_XENLA,,Endoribonuclease Dicer-S (EC 3.1.26.3),Xenopus laevis (African clawed frog),28.8,2019.0,7.3e-172,607.1,sp|A0A8J1LLF7|DICRS_XENLA Endoribonuclease Dicer-S OS=Xenopus laevis OX=8355 GN=dicer1.S PE=3 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02025,1.014415058161911,FUN_008215-T1,Peve_00005269,Pocillopora_meandrina_HIv1___RNAseq.g30184.t1,three_way,71.14333333333333,FUN_008215-T1,Q8VCX6,,,,,42.6,394.0,6.2e-84,312.8,sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1,,,,,,
OG_02037,1.0694114185157977,FUN_008239-T1,Peve_00031796,Pocillopora_meandrina_HIv1___TS.g20917.t2b,three_way,81.074,FUN_008239-T1,Q6T938,FIBP_DANRE,,Acidic fibroblast growth factor intracellular-binding protein B (aFGF intracellular-binding protein B) (FGF-1 intracellular-binding protein B),Danio rerio (Zebrafish) (Brachydanio rerio),42.8,367.0,1.7e-82,307.8,sp|Q6T938|FIBP_DANRE Acidic fibroblast growth factor intracellular-binding protein B OS=Danio rerio OX=7955 GN=fibpb PE=1 SV=1,GO:0005634; GO:0007368; GO:0012505; GO:0016020; GO:0017134; GO:0060026; GO:0060271; GO:0070121,cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; Kupffer's vesicle development [GO:0070121],endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634],fibroblast growth factor binding [GO:0017134],GO:0005634; GO:0043226; GO:0044782; GO:0048856,nucleus; organelle; cilium organization; anatomical structure development
OG_02040,3.160785888577363,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_02043,3.204570464120893,FUN_008248-T1,Peve_00031792,Pocillopora_meandrina_HIv1___RNAseq.g17952.t2,three_way,55.662,FUN_008248-T1,P83618,,,,,25.9,185.0,9.7e-14,78.6,sp|P83618|RN28_PANGI Ribonuclease-like storage protein OS=Panax ginseng OX=4054 PE=1 SV=2,,,,,,
OG_02045,1.6993693309912874,FUN_008250-T1,Peve_00025019,Pocillopora_meandrina_HIv1___RNAseq.21440_t,three_way,71.38866666666667,FUN_008250-T1,Q9DCU6,,,,,44.4,216.0,2.7999999999999997e-41,170.6,sp|Q9DCU6|RM04_MOUSE Large ribosomal subunit protein uL4m OS=Mus musculus OX=10090 GN=Mrpl4 PE=1 SV=1,,,,,,
OG_02047,1.3190278045884436,FUN_008254-T2,Peve_00009135,Pocillopora_meandrina_HIv1___RNAseq.g17957.t1,three_way,62.647333333333336,FUN_008254-T2,Q9NS73,MBIP1_HUMAN,,MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein),Homo sapiens (Human),40.4,225.0,8.3e-35,149.1,sp|Q9NS73|MBIP1_HUMAN MAP3K12-binding inhibitory protein 1 OS=Homo sapiens OX=9606 GN=MBIP PE=1 SV=2,GO:0000122; GO:0004860; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0010628; GO:0042802; GO:0045995; GO:0046330; GO:0051302; GO:0051726; GO:0072686; GO:0140672,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860],GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0043226; GO:0098772,nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_02049,3.28451215151252,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02055,1.9073471876100496,FUN_008266-T1,Peve_00000650,Pocillopora_meandrina_HIv1___RNAseq.g17976.t1,three_way,56.130833333333335,FUN_008266-T1,Q64LD2,WDR25_HUMAN,,WD repeat-containing protein 25,Homo sapiens (Human),42.7,309.0,5.1e-77,290.0,sp|Q64LD2|WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens OX=9606 GN=WDR25 PE=1 SV=3,,,,,,
OG_02067,2.7868800267901284,FUN_008281-T1,Peve_00001962,Pocillopora_meandrina_HIv1___RNAseq.g17989.t1,three_way,70.79683333333334,,,,,,,,,,,,,,,,,
OG_02069,1.8443663600142988,FUN_008283-T1,Peve_00038050,Pocillopora_meandrina_HIv1___RNAseq.g17993.t1,three_way,71.20333333333333,FUN_008283-T1,Q6P158,DHX57_HUMAN,,Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57),Homo sapiens (Human),45.4,1347.0,2.2e-308,1060.1,sp|Q6P158|DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens OX=9606 GN=DHX57 PE=1 SV=2,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0008270; GO:0016887,,,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016787; GO:0016853; GO:0140098; GO:0140657,"RNA binding; catalytic activity; hydrolase activity; isomerase activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02075,1.3610627903543269,FUN_008292-T1,Peve_00034576,Pocillopora_meandrina_HIv1___RNAseq.g18017.t1,three_way,51.1595,,,,,,,,,,,,,,,,,
OG_02077,1.424933912143112,FUN_008294-T1,Peve_00012968,Pocillopora_meandrina_HIv1___RNAseq.g18015.t1,three_way,77.446,FUN_008294-T1,Q9NW38,FANCL_HUMAN,,E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL),Homo sapiens (Human),47.3,372.0,1.6e-102,374.4,sp|Q9NW38|FANCL_HUMAN E3 ubiquitin-protein ligase FANCL OS=Homo sapiens OX=9606 GN=FANCL PE=1 SV=2,GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0008270; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; nucleoplasm; cytosol; DNA repair; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_02085,1.5100252077304424,FUN_008308-T1,Peve_00015425,Pocillopora_meandrina_HIv1___TS.g24505.t2,three_way,78.96333333333334,FUN_008308-T1,Q8R2E9,ERO1B_MOUSE,,ERO1-like protein beta (ERO1-L-beta) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta),Mus musculus (Mouse),47.8,446.0,3.2e-116,420.2,sp|Q8R2E9|ERO1B_MOUSE ERO1-like protein beta OS=Mus musculus OX=10090 GN=Ero1b PE=1 SV=1,GO:0005788; GO:0005789; GO:0006888; GO:0015035; GO:0015036; GO:0016020; GO:0016972; GO:0030070; GO:0030198; GO:0034975; GO:0042593; GO:0045454; GO:0051604; GO:0071949,cell redox homeostasis [GO:0045454]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation [GO:0051604],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],disulfide oxidoreductase activity [GO:0015036]; FAD binding [GO:0071949]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972],GO:0003824; GO:0006457; GO:0016192; GO:0016491; GO:0030198; GO:0051604; GO:0140096,"catalytic activity; protein folding; vesicle-mediated transport; oxidoreductase activity; extracellular matrix organization; protein maturation; catalytic activity, acting on a protein"
OG_02090,4.213739795435699,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02091,1.333803612077831,FUN_008329-T1,Peve_00007606,Pocillopora_meandrina_HIv1___RNAseq.g5444.t1,three_way,68.1515,FUN_008329-T1,Q80TN7,NAV3_MOUSE,,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1),Mus musculus (Mouse),34.7,101.0,5e-13,78.2,sp|Q80TN7|NAV3_MOUSE Neuron navigator 3 OS=Mus musculus OX=10090 GN=Nav3 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0016887; GO:0022008,neurogenesis [GO:0022008],nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005635; GO:0016787; GO:0030154; GO:0043226,catalytic activity; nucleus; nuclear envelope; hydrolase activity; cell differentiation; organelle
OG_02092,1.9343108872965336,FUN_008331-T3,Peve_00007611,Pocillopora_meandrina_HIv1___RNAseq.g5441.t1,three_way,61.8445,FUN_008331-T3,O15040,TCPR2_HUMAN,,Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297),Homo sapiens (Human),24.6,1344.0,7.3e-81,304.3,sp|O15040|TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4,GO:0005737; GO:0006914; GO:0032527,autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527],cytoplasm [GO:0005737],,GO:0006886; GO:0006914,intracellular protein transport; autophagy
OG_02093,1.5859702030963434,FUN_008333-T1,Peve_00040480,Pocillopora_meandrina_HIv1___RNAseq.g5440.t1,three_way,84.943,FUN_008333-T1,O15160,,,,,63.2,261.0,9.3e-97,354.8,sp|O15160|RPAC1_HUMAN DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens OX=9606 GN=POLR1C PE=1 SV=1,,,,,,
OG_02095,2.101252562417047,FUN_008367-T1,Peve_00014479,Pocillopora_meandrina_HIv1___RNAseq.g5715.t1,three_way,60.782,FUN_008367-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),21.4,1717.0,2.7e-72,276.6,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02097,1.1351720762453967,FUN_008369-T1,Peve_00014482,Pocillopora_meandrina_HIv1___RNAseq.g28730.t1,three_way,91.93933333333334,FUN_008369-T1,Q969Q6,P2R3C_HUMAN,,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C),Homo sapiens (Human),78.8,443.0,1.9e-203,709.9,sp|Q969Q6|P2R3C_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma OS=Homo sapiens OX=9606 GN=PPP2R3C PE=1 SV=1,GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0015629; GO:0016604; GO:0030865; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900,B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029],actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654],metal ion binding [GO:0046872],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0043226; GO:0048856,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; organelle; anatomical structure development
OG_02098,2.062372606212012,FUN_008370-T1,Peve_00007056,Pocillopora_meandrina_HIv1___RNAseq.g5701.t1,three_way,69.50716666666666,FUN_008370-T1,F1QCP6,TAZ_DANRE,,Tafazzin (Taz) (EC 2.3.1.-),Danio rerio (Zebrafish) (Brachydanio rerio),48.6,220.0,8.700000000000001e-58,226.1,sp|F1QCP6|TAZ_DANRE Tafazzin OS=Danio rerio OX=7955 GN=tafazzin PE=2 SV=1,GO:0001947; GO:0005739; GO:0005741; GO:0005743; GO:0007007; GO:0007507; GO:0031966; GO:0035965; GO:0045823; GO:0047184,cardiolipin acyl-chain remodeling [GO:0035965]; heart development [GO:0007507]; heart looping [GO:0001947]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of heart contraction [GO:0045823],mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184],GO:0003824; GO:0005739; GO:0006629; GO:0007005; GO:0016740; GO:0043226; GO:0048856; GO:0061024,catalytic activity; mitochondrion; lipid metabolic process; mitochondrion organization; transferase activity; organelle; anatomical structure development; membrane organization
OG_02101,2.3194417100871294,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_02102,1.3529673822079302,FUN_008381-T1,Peve_00002115,Pocillopora_meandrina_HIv1___RNAseq.g18435.t2,three_way,41.09916666666667,FUN_008381-T1,Q8IW19,APLF_HUMAN,,Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1),Homo sapiens (Human),30.1,522.0,2.7e-22,109.0,sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1,GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861],3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0016787; GO:0022414; GO:0042393; GO:0043226; GO:0044183; GO:0140097; GO:0140104,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; chromatin organization; hydrolase activity; reproductive process; histone binding; organelle; protein folding chaperone; catalytic activity, acting on DNA; molecular carrier activity"
OG_02105,2.591076690068912,FUN_008388-T1,Peve_00028173,Pocillopora_meandrina_HIv1___RNAseq.g6171.t1,three_way,80.39633333333333,FUN_008388-T1,Q9Z1N4,BPNT1_RAT,,"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (3'-phosphoadenosine 5'-phosphate phosphatase) (PAP phosphatase) (Bisphosphate 3'-nucleotidase 1) (BPntase 1) (Inositol-polyphosphate 1-phosphatase) (EC 3.1.3.57) (RnPIP) (scHAL2 analogous 3)",Rattus norvegicus (Rat),51.8,305.0,1e-86,321.6,"sp|Q9Z1N4|BPNT1_RAT 3'(2'),5'-bisphosphate nucleotidase 1 OS=Rattus norvegicus OX=10116 GN=Bpnt1 PE=1 SV=1",GO:0000287; GO:0004441; GO:0008441; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],,"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_02106,1.0045598670772002,FUN_008389-T1,Peve_00028172,Pocillopora_meandrina_HIv1___RNAseq.g6172.t1,three_way,59.283,,,,,,,,,,,,,,,,,
OG_02107,1.2917205221092671,FUN_008390-T1,Peve_00028171,Pocillopora_meandrina_HIv1___RNAseq.12433_t,three_way,87.16266666666667,FUN_008390-T1,Q54BM3,,,,,41.3,300.0,1.1e-64,248.4,sp|Q54BM3|MCFG_DICDI Mitochondrial substrate carrier family protein G OS=Dictyostelium discoideum OX=44689 GN=mcfG PE=2 SV=1,,,,,,
OG_02113,1.1171300708238296,FUN_008398-T1,Peve_00043601,Pocillopora_meandrina_HIv1___RNAseq.g6180.t1,three_way,65.416,FUN_008398-T1,Q640B4,,,,,48.7,587.0,2e-144,514.2,sp|Q640B4|MUS81_XENTR Structure-specific endonuclease subunit MUS81 OS=Xenopus tropicalis OX=8364 GN=mus81 PE=2 SV=1,,,,,,
OG_02122,1.4792323814639807,FUN_008415-T1,Peve_00015094,Pocillopora_meandrina_HIv1___RNAseq.g18042.t1,three_way,72.59683333333334,FUN_008415-T1,Q9H2M9,RBGPR_HUMAN,,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),Homo sapiens (Human),37.2,1459.0,3.6999999999999996e-242,840.1,sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1,GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536],autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991],enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0023052; GO:0043226; GO:0098772,vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; signaling; organelle; molecular function regulator activity
OG_02124,2.1102470150861103,FUN_008418-T1,Peve_00009794,Pocillopora_meandrina_HIv1___RNAseq.g18045.t1,three_way,95.60633333333334,FUN_008418-T1,P53488,,,,,89.1,359.0,1.2e-192,673.7,sp|P53488|ARP2_CHICK Actin-related protein 2 OS=Gallus gallus OX=9031 GN=ACTR2 PE=2 SV=1,,,,,,
OG_02126,1.6404314246924128,FUN_008426-T1,Peve_00009790,Pocillopora_meandrina_HIv1___RNAseq.g18049.t1,three_way,71.14483333333332,FUN_008426-T1,Q5ZIF1,,,,,47.5,358.0,2.4e-87,323.9,sp|Q5ZIF1|APMAP_CHICK Adipocyte plasma membrane-associated protein OS=Gallus gallus OX=9031 GN=APMAP PE=2 SV=1,,,,,,
OG_02128,1.8285839864854656,FUN_008428-T1,Peve_00009801,Pocillopora_meandrina_HIv1___RNAseq.g18051.t1,three_way,69.97866666666667,FUN_008428-T1,Q9NQT4,EXOS5_HUMAN,,Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B),Homo sapiens (Human),41.1,202.0,7.2e-36,151.8,sp|Q9NQT4|EXOS5_HUMAN Exosome complex component RRP46 OS=Homo sapiens OX=9606 GN=EXOSC5 PE=1 SV=1,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0016075; GO:0034475; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019,defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_02133,1.8838412360888943,FUN_008438-T1,Peve_00024973,Pocillopora_meandrina_HIv1___RNAseq.g18056.t1,three_way,83.8915,FUN_008438-T1,A7SMW7,,,,,69.4,448.0,5.4e-187,655.2,"sp|A7SMW7|L2HDH_NEMVE L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g172254 PE=3 SV=1",,,,,,
OG_02157,1.3685043892502595,FUN_008489-T1,Peve_00028786,Pocillopora_meandrina_HIv1___RNAseq.g30382.t1,three_way,82.557,FUN_008489-T1,O77475,,,,,27.0,281.0,3.2000000000000003e-27,124.0,sp|O77475|CPESY_DROME Ceramide phosphoethanolamine synthase OS=Drosophila melanogaster OX=7227 GN=Cpes PE=1 SV=1,,,,,,
OG_02159,1.8701683354358616,FUN_008493-T1,Peve_00043695,Pocillopora_meandrina_HIv1___RNAseq.g6186.t1,three_way,78.713,FUN_008493-T1,B9U3F2,DISP3_CHICK,,Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1),Gallus gallus (Chicken),24.4,504.0,1.5e-19,100.1,sp|B9U3F2|DISP3_CHICK Protein dispatched homolog 3 OS=Gallus gallus OX=9031 GN=DISP3 PE=1 SV=1,GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_02163,1.8803989269926145,FUN_008499-T1,Peve_00010577,Pocillopora_meandrina_HIv1___RNAseq.g5887.t1,three_way,57.13483333333333,FUN_008499-T1,Q06194,FA8_MOUSE,,Coagulation factor VIII (Procoagulant component),Mus musculus (Mouse),39.2,153.0,3.6e-26,122.9,sp|Q06194|FA8_MOUSE Coagulation factor VIII OS=Mus musculus OX=10090 GN=F8 PE=2 SV=2,GO:0005507; GO:0005576; GO:0006953; GO:0007596; GO:0016491,acute-phase response [GO:0006953]; blood coagulation [GO:0007596],extracellular region [GO:0005576],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0006954; GO:0016491,catalytic activity; extracellular region; inflammatory response; oxidoreductase activity
OG_02166,1.2102758053972185,FUN_008515-T1,Peve_00040305,Pocillopora_meandrina_HIv1___TS.g4011.t1,three_way,81.11066666666667,FUN_008515-T1,Q5U680,,,,,52.1,261.0,4.0999999999999986e-68,259.6,sp|Q5U680|SAMC_MOUSE Mitochondrial S-adenosylmethionine carrier protein OS=Mus musculus OX=10090 GN=Slc25a26 PE=1 SV=2,,,,,,
OG_02168,1.1228680552022472,FUN_008517-T1,Peve_00042434,Pocillopora_meandrina_HIv1___TS.g3919.t1b,three_way,62.54983333333333,FUN_008517-T1,Q9ESJ4,,,,,38.8,402.0,5.6e-78,293.5,sp|Q9ESJ4|SPN90_MOUSE NCK-interacting protein with SH3 domain OS=Mus musculus OX=10090 GN=Nckipsd PE=1 SV=2,,,,,,
OG_02172,1.495913499638087,FUN_008521-T1,Peve_00023090,Pocillopora_meandrina_HIv1___RNAseq.24125_t,three_way,85.33366666666667,FUN_008521-T1,A6QL50,,,,,52.4,143.0,2.4999999999999997e-43,176.4,sp|A6QL50|FA72A_BOVIN Protein FAM72A OS=Bos taurus OX=9913 GN=FAM72A PE=1 SV=1,,,,,,
OG_02173,2.9930448402191225,FUN_008522-T1,Peve_00012217,Pocillopora_meandrina_HIv1___RNAseq.g14762.t2,three_way,80.53666666666668,FUN_008522-T1,Q9UPE1,,,,,59.4,547.0,7.599999999999999e-136,485.7,sp|Q9UPE1|SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens OX=9606 GN=SRPK3 PE=1 SV=2,,,,,,
OG_02175,1.2562195885397909,FUN_008524-T1,Peve_00027673,Pocillopora_meandrina_HIv1___RNAseq.g14752.t1,three_way,75.38833333333334,FUN_008524-T1,Q4R6K2,ZNT1_MACFA,,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),39.8,462.0,2.9e-73,277.3,sp|Q4R6K2|ZNT1_MACFA Proton-coupled zinc antiporter SLC30A1 OS=Macaca fascicularis OX=9541 GN=SLC30A1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0005886; GO:0006882; GO:0010312; GO:0016323; GO:0019855; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0062111; GO:0140826; GO:0140882,defense response to bacterium [GO:0042742]; detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005886; GO:0055085; GO:0098754; GO:0098772,transporter activity; plasma membrane; transmembrane transport; detoxification; molecular function regulator activity
OG_02179,1.2535440944589715,FUN_008530-T1,Peve_00011877,Pocillopora_meandrina_HIv1___RNAseq.g14745.t1,three_way,87.72200000000001,,,,,,,,,,,,,,,,,
OG_02185,1.3090306897774548,FUN_008538-T1,Peve_00014613,Pocillopora_meandrina_HIv1___RNAseq.g14663.t1,three_way,63.84633333333333,FUN_008538-T1,A4QND0,,,,,39.7,131.0,4.6e-20,99.0,sp|A4QND0|UBL4A_XENTR Ubiquitin-like protein 4A OS=Xenopus tropicalis OX=8364 GN=ubl4a PE=2 SV=1,,,,,,
OG_02192,1.373078881118604,FUN_008547-T1,Peve_00034512,Pocillopora_meandrina_HIv1___RNAseq.g6327.t1,three_way,36.30383333333333,,,,,,,,,,,,,,,,,
OG_02193,1.4190602317321317,FUN_008548-T1,Peve_00013780,Pocillopora_meandrina_HIv1___RNAseq.g6326.t1,three_way,74.56866666666666,FUN_008548-T1,Q6INP8,,,,,33.3,474.0,7.7e-62,240.4,sp|Q6INP8|MED1_XENLA Mediator of RNA polymerase II transcription subunit 1 OS=Xenopus laevis OX=8355 GN=med1 PE=2 SV=1,,,,,,
OG_02195,1.1224209631880528,FUN_008551-T1,Peve_00044743,Pocillopora_meandrina_HIv1___RNAseq.g68.t1,three_way,78.64366666666668,FUN_008551-T1,Q8NCE2,MTMRE_HUMAN,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 (EC 3.1.3.95) (HCV NS5A-transactivated protein 4 splice variant A-binding protein 1) (NS5ATP4ABP1) (Myotubularin-related protein 14) (Phosphatidylinositol-3-phosphate phosphatase) (hJumpy)",Homo sapiens (Human),47.7,606.0,1.2e-136,488.4,"sp|Q8NCE2|MTMRE_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 OS=Homo sapiens OX=9606 GN=MTMR14 PE=1 SV=2",GO:0001726; GO:0004438; GO:0004722; GO:0005829; GO:0006661; GO:0016236; GO:0048471; GO:0052629,macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661],cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726],"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005829; GO:0006629; GO:0006914; GO:0016787; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; autophagy; hydrolase activity; catalytic activity, acting on a protein"
OG_02197,1.4841396935877187,FUN_008561-T1,Peve_00044734,Pocillopora_meandrina_HIv1___RNAseq.g70.t1,three_way,79.849,FUN_008561-T1,Q07646,,,,,48.7,318.0,3.7e-84,313.2,sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1,,,,,,
OG_02200,2.7703561624350828,FUN_008569-T1,Peve_00044727,Pocillopora_meandrina_HIv1___RNAseq.g12789.t1,three_way,62.34433333333333,,,,,,,,,,,,,,,,,
OG_02201,1.7534640320462695,FUN_008576-T1,Peve_00044725,Pocillopora_meandrina_HIv1___RNAseq.g12787.t1,three_way,63.60733333333333,,,,,,,,,,,,,,,,,
OG_02207,2.320658039369828,FUN_008583-T1,Peve_00028408,Pocillopora_meandrina_HIv1___RNAseq.g12778.t1,three_way,81.406,FUN_008583-T1,Q5RB35,MKLN1_PONAB,,Muskelin,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.2,738.0,2.1e-273,943.0,sp|Q5RB35|MKLN1_PONAB Muskelin OS=Pongo abelii OX=9601 GN=MKLN1 PE=2 SV=1,GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],cell cortex [GO:0005938]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151],protein homodimerization activity [GO:0042803],GO:0005654; GO:0005829; GO:0007010; GO:0007155; GO:0016192,nucleoplasm; cytosol; cytoskeleton organization; cell adhesion; vesicle-mediated transport
OG_02211,1.4940750501414877,FUN_008587-T1,Peve_00028398,Pocillopora_meandrina_HIv1___RNAseq.g12773.t1,three_way,39.733,,,,,,,,,,,,,,,,,
OG_02212,1.1865156562339436,FUN_008594-T1,Peve_00002263,Pocillopora_meandrina_HIv1___RNAseq.g12762.t1,three_way,68.02633333333334,FUN_008594-T1,P02469,LAMB1_MOUSE,,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),Mus musculus (Mouse),43.3,1409.0,5.4e-246,853.2,sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3,GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046,cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637],enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0008289; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0050877,structural molecule activity; extracellular region; extracellular space; nucleus; cell adhesion; lipid binding; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; cell motility; nervous system process
OG_02219,1.085125091867016,FUN_008614-T1,Peve_00040315,Pocillopora_meandrina_HIv1___RNAseq.g6261.t1,three_way,64.44066666666667,FUN_008614-T1,O18499,,,,,34.0,374.0,6.1e-56,220.7,sp|O18499|ACT1_SACKO Actin-1 OS=Saccoglossus kowalevskii OX=10224 PE=2 SV=1,,,,,,
OG_02220,2.910745934864602,FUN_008615-T1,Peve_00015389,Pocillopora_meandrina_HIv1___RNAseq.g12744.t1,three_way,73.05916666666667,FUN_008615-T1,O35161,CELR1_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 1,Mus musculus (Mouse),33.5,2618.0,0.0,1375.5,sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3,GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007166; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475,anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell surface receptor signaling pathway [GO:0007166]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0042060; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; wound healing; anatomical structure development; cell motility; molecular transducer activity
OG_02227,3.260889434875288,FUN_008633-T1,Peve_00012386,Pocillopora_meandrina_HIv1___RNAseq.g14915.t1,three_way,74.2705,FUN_008633-T1,Q8VDT1,,,,,45.9,573.0,4.5e-140,500.0,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_02228,2.477135964251363,FUN_008634-T1,Peve_00021941,Pocillopora_meandrina_HIv1___RNAseq.g14919.t2,three_way,51.94316666666667,FUN_008634-T1,P42166,LAP2A_HUMAN,,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",Homo sapiens (Human),35.0,197.0,9.1e-16,85.9,"sp|P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0045296,,chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521],GO:0003677; GO:0005634; GO:0005635; GO:0043226,DNA binding; nucleus; nuclear envelope; organelle
OG_02233,1.575146234643792,FUN_008644-T1,Peve_00031674,Pocillopora_meandrina_HIv1___RNAseq.g10.t1,three_way,70.55633333333333,FUN_008644-T1,Q5E965,C56D2_BOVIN,,Transmembrane reductase CYB561D2 (EC 7.2.1.3) (Cytochrome b561 domain-containing protein 2),Bos taurus (Bovine),39.0,205.0,8.500000000000001e-33,142.1,sp|Q5E965|C56D2_BOVIN Transmembrane reductase CYB561D2 OS=Bos taurus OX=9913 GN=CYB561D2 PE=2 SV=1,GO:0005783; GO:0005789; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576,ascorbate homeostasis [GO:0140576],cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; vesicle [GO:0031982],heme binding [GO:0020037]; metal ion binding [GO:0046872]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575],GO:0003824; GO:0005215; GO:0005783; GO:0016491; GO:0043226,catalytic activity; transporter activity; endoplasmic reticulum; oxidoreductase activity; organelle
OG_02238,1.5721203298690103,FUN_008650-T1,Peve_00032564,Pocillopora_meandrina_HIv1___RNAseq.g16.t1,three_way,59.9695,FUN_008650-T1,Q99LJ2,,,,,46.0,502.0,4.8999999999999996e-120,433.0,sp|Q99LJ2|ABTB1_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Abtb1 PE=2 SV=1,,,,,,
OG_02240,1.581645325770071,FUN_008652-T1,Peve_00032562,Pocillopora_meandrina_HIv1___RNAseq.g18.t1,three_way,57.517,FUN_008652-T1,Q9Y3I1,,,,,31.2,478.0,3.6e-46,187.6,sp|Q9Y3I1|FBX7_HUMAN F-box only protein 7 OS=Homo sapiens OX=9606 GN=FBXO7 PE=1 SV=1,,,,,,
OG_02244,1.4805609440857117,FUN_008661-T1,Peve_00002969,Pocillopora_meandrina_HIv1___RNAseq.g14876.t1,three_way,82.85233333333333,FUN_008661-T1,P51650,SSDH_RAT,,"Succinate-semialdehyde dehydrogenase, mitochondrial (SSADH) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",Rattus norvegicus (Rat),62.6,478.0,4.1e-180,632.5,"sp|P51650|SSDH_RAT Succinate-semialdehyde dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh5a1 PE=1 SV=2",GO:0004777; GO:0005739; GO:0006105; GO:0006536; GO:0007417; GO:0009448; GO:0009450; GO:0009791; GO:0031406; GO:0042802; GO:0045202; GO:0051287; GO:0051932,"central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",mitochondrion [GO:0005739]; synapse [GO:0045202],carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0023052; GO:0043226; GO:0048856,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; signaling; organelle; anatomical structure development
OG_02249,1.4885669597824336,FUN_008668-T1,Peve_00044707,Pocillopora_meandrina_HIv1___RNAseq.g67.t1,three_way,96.41,FUN_008668-T1,Q6NZW8,,,,,86.2,130.0,1.0999999999999999e-62,240.7,sp|Q6NZW8|AR8BA_DANRE ADP-ribosylation factor-like protein 8B-A OS=Danio rerio OX=7955 GN=arl8ba PE=2 SV=1,,,,,,
OG_02257,1.054219502080504,FUN_008703-T1,Peve_00034982,Pocillopora_meandrina_HIv1___RNAseq.g25724.t1,three_way,65.04466666666667,FUN_008703-T1,Q4R684,,,,,36.8,288.0,1.1e-45,185.3,sp|Q4R684|AMZ2_MACFA Archaemetzincin-2 OS=Macaca fascicularis OX=9541 GN=AMZ2 PE=2 SV=2,,,,,,
OG_02265,1.2051160288887064,FUN_008713-T2,Peve_00025642,Pocillopora_meandrina_HIv1___RNAseq.g25652.t1,three_way,84.41833333333334,FUN_008713-T2,Q8BW96,KCC1D_MOUSE,,Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM-KI delta) (CaMKI delta) (CaM kinase ID) (CaMKI-like protein kinase) (CKLiK) (mCKLiK),Mus musculus (Mouse),68.4,329.0,5.4e-129,462.2,sp|Q8BW96|KCC1D_MOUSE Calcium/calmodulin-dependent protein kinase type 1D OS=Mus musculus OX=10090 GN=Camk1d PE=1 SV=2,GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0007399; GO:0010976; GO:0032793; GO:0043065; GO:0043066; GO:0050766; GO:0050773; GO:0060267; GO:0071622; GO:0090023; GO:0106310,inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02270,1.1692342842145709,FUN_008729-T1,Peve_00013706,Pocillopora_meandrina_HIv1___TS.g68.t1,three_way,80.84783333333333,FUN_008729-T1,Q80TR8,DCAF1_MOUSE,,DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1),Mus musculus (Mouse),47.6,1400.0,0.0,1181.8,sp|Q80TR8|DCAF1_MOUSE DDB1- and CUL4-associated factor 1 OS=Mus musculus OX=10090 GN=Dcaf1 PE=1 SV=4,GO:0000122; GO:0001650; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043161; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756,B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0006310; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0060090; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; DNA recombination; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02271,1.0897407528901022,FUN_008740-T1,Peve_00013702,Pocillopora_meandrina_HIv1___RNAseq.g12735.t1,three_way,71.64699999999999,,,,,,,,,,,,,,,,,
OG_02277,1.0525942106536306,FUN_008768-T1,Peve_00036720,Pocillopora_meandrina_HIv1___RNAseq.g12705.t1,three_way,76.76466666666667,FUN_008768-T1,Q1LXK4,,,,,38.7,1047.0,7.500000000000001e-184,646.0,sp|Q1LXK4|M10B1_DANRE Putative helicase mov-10-B.1 OS=Danio rerio OX=7955 GN=mov10b.1 PE=2 SV=2,,,,,,
OG_02284,1.136271220169728,FUN_008781-T1,Peve_00042606,Pocillopora_meandrina_HIv1___RNAseq.g12693.t1,three_way,80.42633333333333,,,,,,,,,,,,,,,,,
OG_02286,1.0515664687832136,FUN_008792-T3,Peve_00042602,Pocillopora_meandrina_HIv1___RNAseq.g12689.t1,three_way,64.93566666666666,FUN_008792-T3,P13676,,,,,41.8,728.0,1.2e-156,555.1,sp|P13676|ACPH_RAT Acylamino-acid-releasing enzyme OS=Rattus norvegicus OX=10116 GN=Apeh PE=1 SV=1,,,,,,
OG_02288,1.9210584672578968,FUN_008795-T1,Peve_00042598,Pocillopora_meandrina_HIv1___RNAseq.g12685.t1a,three_way,70.187,FUN_008795-T1,Q8IYQ7,,,,,47.4,685.0,3.8e-168,593.2,sp|Q8IYQ7|THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens OX=9606 GN=THNSL1 PE=1 SV=2,,,,,,
OG_02292,2.0324509778962354,FUN_008860-T1,Peve_00002936,Pocillopora_meandrina_HIv1___RNAseq.g30.t1,three_way,63.93383333333333,FUN_008860-T1,Q96M96,,,,,41.2,556.0,2.9e-110,401.4,"sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2",,,,,,
OG_02294,2.700858042832434,FUN_008872-T1,Peve_00000784,Pocillopora_meandrina_HIv1___RNAseq.g4010.t1,three_way,45.396166666666666,,,,,,,,,,,,,,,,,
OG_02296,2.562262935247217,FUN_008874-T1,Peve_00000786,Pocillopora_meandrina_HIv1___RNAseq.g4012.t1,three_way,67.04350000000001,,,,,,,,,,,,,,,,,
OG_02297,1.1543290860764197,FUN_008876-T1,Peve_00028551,Pocillopora_meandrina_HIv1___RNAseq.g3984.t1,three_way,72.74733333333333,FUN_008876-T1,Q9QYC7,VKGC_MOUSE,,Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase),Mus musculus (Mouse),52.3,583.0,2e-180,634.0,sp|Q9QYC7|VKGC_MOUSE Vitamin K-dependent gamma-carboxylase OS=Mus musculus OX=10090 GN=Ggcx PE=1 SV=1,GO:0005788; GO:0005789; GO:0008488; GO:0042373; GO:0046929; GO:0051604; GO:1903011; GO:2000225,negative regulation of bone development [GO:1903011]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of testosterone biosynthetic process [GO:2000225]; protein maturation [GO:0051604]; vitamin K metabolic process [GO:0042373],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],gamma-glutamyl carboxylase activity [GO:0008488],GO:0003824; GO:0016829; GO:0051604,catalytic activity; lyase activity; protein maturation
OG_02299,1.8739599216933684,FUN_008878-T1,Peve_00043353,Pocillopora_meandrina_HIv1___TS.g30034.t1,three_way,62.21333333333333,FUN_008878-T1,A7RDN6,RNLS_MOUSE,,Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) (mMAO-C),Mus musculus (Mouse),39.9,351.0,1.3e-66,255.0,sp|A7RDN6|RNLS_MOUSE Renalase OS=Mus musculus OX=10090 GN=Rnls PE=1 SV=2,GO:0003073; GO:0003214; GO:0005576; GO:0016491; GO:0016651; GO:0042414; GO:0042415; GO:0042417; GO:0055062; GO:0060047; GO:0071873,cardiac left ventricle morphogenesis [GO:0003214]; dopamine metabolic process [GO:0042417]; epinephrine metabolic process [GO:0042414]; heart contraction [GO:0060047]; norepinephrine metabolic process [GO:0042415]; phosphate ion homeostasis [GO:0055062]; regulation of systemic arterial blood pressure [GO:0003073]; response to norepinephrine [GO:0071873],extracellular region [GO:0005576],"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]",GO:0003013; GO:0003824; GO:0005576; GO:0016491,circulatory system process; catalytic activity; extracellular region; oxidoreductase activity
OG_02300,2.7442754747377798,FUN_008879-T1,Peve_00043354,Pocillopora_meandrina_HIv1___RNAseq.g14471.t1,three_way,77.52583333333332,FUN_008879-T1,O93310,,,,,39.9,642.0,2.8e-79,297.7,sp|O93310|RAD21_XENLA Double-strand-break repair protein rad21 homolog OS=Xenopus laevis OX=8355 GN=rad21 PE=1 SV=1,,,,,,
OG_02307,1.6168275560983802,FUN_008886-T1,Peve_00000787,Pocillopora_meandrina_HIv1___RNAseq.g4005.t1,three_way,34.86216666666667,,,,,,,,,,,,,,,,,
OG_02312,1.4722297106088935,FUN_008903-T1,Peve_00013993,Pocillopora_meandrina_HIv1___RNAseq.g4000.t1,three_way,73.99,FUN_008903-T1,Q9VU77,JMJD7_DROME,,Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (Jumonji domain containing protein 7),Drosophila melanogaster (Fruit fly),29.7,296.0,2.5e-29,131.3,sp|Q9VU77|JMJD7_DROME Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 OS=Drosophila melanogaster OX=7227 GN=JMJD7 PE=1 SV=1,GO:0004175; GO:0005634; GO:0005737; GO:0008198; GO:0016706; GO:0042802; GO:0048512; GO:0106155,circadian behavior [GO:0048512],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; endopeptidase activity [GO:0004175]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; peptidyl-lysine 3-dioxygenase activity [GO:0106155],GO:0003824; GO:0005634; GO:0016491; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02317,4.019386917496511,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02318,1.5398475168230756,FUN_008909-T1,Peve_00017911,Pocillopora_meandrina_HIv1___RNAseq.g3974.t1,three_way,62.283166666666666,FUN_008909-T1,Q9EQZ7,,,,,32.2,1005.0,1.6e-93,346.7,sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1,,,,,,
OG_02319,1.2205379164924977,FUN_008911-T1,Peve_00019472,Pocillopora_meandrina_HIv1___RNAseq.g3976.t1,three_way,68.34216666666667,FUN_008911-T1,O60266,ADCY3_HUMAN,,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",Homo sapiens (Human),39.5,1100.0,4.3e-204,713.4,sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3,GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322,acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0005886; GO:0005929; GO:0007018; GO:0009975; GO:0016829; GO:0022414; GO:0043226; GO:0048870; GO:0050877; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; plasma membrane; cilium; microtubule-based movement; cyclase activity; lyase activity; reproductive process; organelle; cell motility; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02325,1.0574223910712288,FUN_008917-T1,Peve_00033005,Pocillopora_meandrina_HIv1___RNAseq.g3982.t1,three_way,74.89333333333333,FUN_008917-T1,Q6V5K9,,,,,46.8,269.0,1e-59,232.6,sp|Q6V5K9|ZN474_MOUSE Zinc finger protein 474 OS=Mus musculus OX=10090 GN=Znf474 PE=2 SV=2,,,,,,
OG_02331,1.3755159122662026,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.500000000000001e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_02336,1.7668015711715883,FUN_008931-T1,Peve_00036391,Pocillopora_meandrina_HIv1___RNAseq.g14259.t1,three_way,74.031,FUN_008931-T1,Q8BSY0,ASPH_MOUSE,,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),Mus musculus (Mouse),55.5,429.0,5.6e-143,509.2,sp|Q8BSY0|ASPH_MOUSE Aspartyl/asparaginyl beta-hydroxylase OS=Mus musculus OX=10090 GN=Asph PE=1 SV=1,GO:0005737; GO:0005886; GO:0007389; GO:0008283; GO:0008285; GO:0016020; GO:0031647; GO:0032541; GO:0033017; GO:0035108; GO:0045862; GO:0046872; GO:0060021; GO:0060325; GO:0062101; GO:1901879,cell population proliferation [GO:0008283]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; positive regulation of proteolysis [GO:0045862]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; roof of mouth development [GO:0060021],cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],metal ion binding [GO:0046872]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101],GO:0003824; GO:0005886; GO:0016491; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; oxidoreductase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02337,1.287617394295274,FUN_008933-T1,Peve_00036390,Pocillopora_meandrina_HIv1___RNAseq.g14258.t1,three_way,90.02433333333333,FUN_008933-T1,A6QQY2,,,,,39.1,92.0,1.2e-09,65.5,sp|A6QQY2|KLH13_BOVIN Kelch-like protein 13 OS=Bos taurus OX=9913 GN=KLHL13 PE=2 SV=1,,,,,,
OG_02339,1.2320390607904044,FUN_008935-T1,Peve_00036395,Pocillopora_meandrina_HIv1___TS.g5740.t1,three_way,79.28566666666667,FUN_008935-T1,A0JM56,,,,,51.8,1431.0,1.4000000000000001e-186,655.6,sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2,,,,,,
OG_02344,1.3352074007419148,FUN_008945-T3,Peve_00011190,Pocillopora_meandrina_HIv1___RNAseq.g4059.t1,three_way,61.92066666666667,FUN_008945-T3,Q3T1J2,MBOA2_RAT,,Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),Rattus norvegicus (Rat),40.0,407.0,2.3e-76,287.7,sp|Q3T1J2|MBOA2_RAT Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Mboat2 PE=2 SV=2,GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047184; GO:0106262; GO:0106263,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; acyltransferase activity [GO:0016746],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_02346,1.4982816231101517,FUN_008947-T1,Peve_00011183,Pocillopora_meandrina_HIv1___RNAseq.g4057.t1,three_way,74.78516666666667,,,,,,,,,,,,,,,,,
OG_02348,1.0673326079672982,FUN_008949-T1,Peve_00011191,Pocillopora_meandrina_HIv1___RNAseq.g4054.t1,three_way,69.88833333333334,FUN_008949-T1,Q2TAA2,IAH1_HUMAN,,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),Homo sapiens (Human),38.6,233.0,6.6e-44,179.1,sp|Q2TAA2|IAH1_HUMAN Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1,GO:0010467; GO:0016042; GO:0016788; GO:0042802,gene expression [GO:0010467]; lipid catabolic process [GO:0016042],,"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]",GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_02350,1.4657796032523824,FUN_008951-T1,Peve_00008912,Pocillopora_meandrina_HIv1___RNAseq.29356_t,three_way,82.56166666666667,FUN_008951-T1,Q6IRP4,,,,,49.8,301.0,2.3e-82,307.4,sp|Q6IRP4|ABHDD_XENLA Protein ABHD13 OS=Xenopus laevis OX=8355 GN=abhd13 PE=2 SV=1,,,,,,
OG_02351,2.242312536151581,FUN_008952-T1,Peve_00037679,Pocillopora_meandrina_HIv1___RNAseq.g4051.t1,three_way,70.46833333333333,FUN_008952-T1,Q8TDM6,,,,,31.0,1363.0,9.8e-134,480.3,sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4,,,,,,
OG_02353,3.1363720876200065,FUN_008955-T1,Peve_00037682,Pocillopora_meandrina_HIv1___RNAseq.g4048.t1,three_way,75.81333333333333,FUN_008955-T1,Q149N8,,,,,35.5,1772.0,5.0000000000000005e-278,959.5,sp|Q149N8|SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens OX=9606 GN=SHPRH PE=1 SV=2,,,,,,
OG_02355,2.626228991827492,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_02359,1.962551369490244,FUN_008962-T1,Peve_00007353,Pocillopora_meandrina_HIv1___RNAseq.g3914.t1,three_way,53.4015,FUN_008962-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),31.7,489.0,3.1e-54,214.9,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02360,1.2753389672368651,FUN_008964-T1,Peve_00007334,Pocillopora_meandrina_HIv1___RNAseq.13698_t,three_way,63.264,FUN_008964-T1,Q8BKN5,,,,,34.9,1036.0,4.9e-148,526.9,sp|Q8BKN5|GCP5_MOUSE Gamma-tubulin complex component 5 OS=Mus musculus OX=10090 GN=Tubgcp5 PE=2 SV=2,,,,,,
OG_02362,1.8042961732257896,FUN_008967-T1,Peve_00007330,Pocillopora_meandrina_HIv1___RNAseq.g14273.t1,three_way,70.74066666666667,FUN_008967-T1,Q9UBI4,,,,,35.1,350.0,6.9e-45,183.0,sp|Q9UBI4|STML1_HUMAN Stomatin-like protein 1 OS=Homo sapiens OX=9606 GN=STOML1 PE=1 SV=1,,,,,,
OG_02365,1.922809717195103,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.8999999999999998e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02369,2.465666235972383,FUN_008978-T1,Peve_00017852,Pocillopora_meandrina_HIv1___RNAseq.g14265.t1,three_way,33.91433333333333,,,,,,,,,,,,,,,,,
OG_02381,2.472275960731522,FUN_008994-T1,Peve_00013183,Pocillopora_meandrina_HIv1___RNAseq.g3910.t1,three_way,75.73266666666666,FUN_008994-T1,Q5ZM65,,,,,54.3,411.0,3.8e-123,443.4,sp|Q5ZM65|PTSS1_CHICK Phosphatidylserine synthase 1 OS=Gallus gallus OX=9031 GN=PTDSS1 PE=2 SV=2,,,,,,
OG_02384,2.334299094759889,FUN_009006-T1,Peve_00029130,Pocillopora_meandrina_HIv1___RNAseq.g14283.t1,three_way,69.471,FUN_009006-T1,Q96RG2,,,,,34.2,1207.0,2.8e-153,544.7,sp|Q96RG2|PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=PASK PE=1 SV=3,,,,,,
OG_02386,1.0181391431046205,FUN_009008-T1,Peve_00031170,Pocillopora_meandrina_HIv1___RNAseq.13704_t,three_way,75.398,FUN_009008-T1,Q6SKR2,HEMK2_MOUSE,,Methyltransferase HEMK2 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Methyltransferase N6AMT1) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-),Mus musculus (Mouse),56.0,209.0,1.6000000000000006e-59,230.7,sp|Q6SKR2|HEMK2_MOUSE Methyltransferase HEMK2 OS=Mus musculus OX=10090 GN=Hemk2 PE=1 SV=1,GO:0003676; GO:0005634; GO:0008276; GO:0009404; GO:0018364; GO:0018872; GO:0030307; GO:0030791; GO:0032259; GO:0032991; GO:0036009; GO:0045814; GO:0045815; GO:0140984; GO:1904047,"arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]; transcription initiation-coupled chromatin remodeling [GO:0045815]",nucleus [GO:0005634]; protein-containing complex [GO:0032991],arsenite methyltransferase activity [GO:0030791]; histone H4K12 methyltransferase activity [GO:0140984]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005634; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02388,1.2913944265039574,FUN_009010-T1,Peve_00031167,Pocillopora_meandrina_HIv1___RNAseq.g14287.t1,three_way,69.723,FUN_009010-T1,Q505B7,ARCH_MOUSE,,Protein archease (Protein ZBTB8OS),Mus musculus (Mouse),67.9,78.0,3.7e-24,112.5,sp|Q505B7|ARCH_MOUSE Protein archease OS=Mus musculus OX=10090 GN=Zbtb8os PE=1 SV=2,GO:0006388; GO:0046872; GO:0072669,"tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",tRNA-splicing ligase complex [GO:0072669],metal ion binding [GO:0046872],GO:0006399,tRNA metabolic process
OG_02392,1.3706394523069645,FUN_009019-T1,Peve_00021058,Pocillopora_meandrina_HIv1___RNAseq.g14304.t1,three_way,74.17666666666666,FUN_009019-T1,O14649,KCNK3_HUMAN,,Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1),Homo sapiens (Human),36.5,208.0,5.5e-32,139.8,sp|O14649|KCNK3_HUMAN Potassium channel subfamily K member 3 OS=Homo sapiens OX=9606 GN=KCNK3 PE=1 SV=1,GO:0003029; GO:0005216; GO:0005252; GO:0005267; GO:0005272; GO:0005886; GO:0006813; GO:0007268; GO:0009410; GO:0015271; GO:0022841; GO:0034220; GO:0044548; GO:0045202; GO:0046872; GO:0046982; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071468; GO:0071805; GO:0090102; GO:0099605,cellular response to acidic pH [GO:0071468]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [GO:0003029]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential firing rate [GO:0099605]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410],plasma membrane [GO:0005886]; synapse [GO:0045202],metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982]; S100 protein binding [GO:0044548]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0055085,transporter activity; plasma membrane; signaling; anatomical structure development; transmembrane transport
OG_02393,1.7552420915544726,FUN_009021-T1,Peve_00044339,Pocillopora_meandrina_HIv1___RNAseq.g3922.t1,three_way,71.4215,,,,,,,,,,,,,,,,,
OG_02401,1.1308256571970752,FUN_009042-T1,Peve_00033723,Pocillopora_meandrina_HIv1___RNAseq.g14377.t1,three_way,63.53966666666667,FUN_009042-T1,O95551,TYDP2_HUMAN,,Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase),Homo sapiens (Human),39.8,334.0,1.1999999999999999e-61,238.4,sp|O95551|TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens OX=9606 GN=TDP2 PE=1 SV=1,GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260,cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666],aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0016787; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140098; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; hydrolase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity"
OG_02402,2.847509430247634,FUN_009043-T1,Peve_00033724,Pocillopora_meandrina_HIv1___RNAseq.g14380.t1,three_way,66.07533333333333,FUN_009043-T1,Q6P3K3,FBX9_DANRE,,F-box only protein 9,Danio rerio (Zebrafish) (Brachydanio rerio),39.8,437.0,1.3e-81,305.1,sp|Q6P3K3|FBX9_DANRE F-box only protein 9 OS=Danio rerio OX=7955 GN=fbxo9 PE=2 SV=1,GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006,protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005],,GO:0030163,protein catabolic process
OG_02404,1.6412883489527097,FUN_009053-T1,Peve_00032043,Pocillopora_meandrina_HIv1___RNAseq.g14499.t1,three_way,60.631166666666665,FUN_009053-T1,Q68FD7,FNIP1_MOUSE,,Folliculin-interacting protein 1,Mus musculus (Mouse),29.9,1162.0,7.4e-115,416.8,sp|Q68FD7|FNIP1_MOUSE Folliculin-interacting protein 1 OS=Mus musculus OX=10090 GN=Fnip1 PE=1 SV=1,GO:0000122; GO:0001783; GO:0002327; GO:0002904; GO:0005737; GO:0005765; GO:0005829; GO:0008047; GO:0008285; GO:0009267; GO:0019899; GO:0031334; GO:0031929; GO:0032007; GO:0032008; GO:0042030; GO:0051087; GO:1904263; GO:1905672; GO:2000973,B cell apoptotic process [GO:0001783]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of pro-B cell differentiation [GO:2000973]; TOR signaling [GO:0031929],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765],ATPase inhibitor activity [GO:0042030]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0098772,immune system process; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; molecular function regulator activity
OG_02405,1.9019076580094727,FUN_009054-T1,Peve_00032030,Pocillopora_meandrina_HIv1___RNAseq.g14498.t1,three_way,59.42516666666667,FUN_009054-T1,Q9WVK8,CP46A_MOUSE,,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),Mus musculus (Mouse),32.7,493.0,1.3000000000000001e-67,258.8,sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1,GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044,cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02408,1.3522281547391874,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02409,1.6687802091709547,FUN_009268-T1,Peve_00032035,Pocillopora_meandrina_HIv1___RNAseq.g3994.t1,three_way,78.74633333333333,FUN_009268-T1,Q4R516,ELOV5_MACFA,,Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.5,231.0,4.8e-25,116.3,sp|Q4R516|ELOV5_MACFA Very long chain fatty acid elongase 5 OS=Macaca fascicularis OX=9541 GN=ELOVL5 PE=2 SV=1,GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0043025; GO:0097447,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_02411,2.0856250366455185,FUN_009270-T1,Peve_00032038,Pocillopora_meandrina_HIv1___RNAseq.g3996.t1,three_way,56.53483333333333,,,,,,,,,,,,,,,,,
OG_02412,1.2961434079826248,FUN_009271-T1,Peve_00032040,Pocillopora_meandrina_HIv1___RNAseq.g14262.t1,three_way,73.62033333333333,FUN_009271-T1,Q56585,,,,,50.5,99.0,4.8e-22,105.5,sp|Q56585|BOLA_VIBAL DNA-binding transcriptional regulator BolA OS=Vibrio alginolyticus OX=663 GN=bolA PE=3 SV=1,,,,,,
OG_02415,1.8013601262275707,FUN_009296-T1,Peve_00041170,Pocillopora_meandrina_HIv1___RNAseq.g14453.t3,three_way,46.81766666666667,,,,,,,,,,,,,,,,,
OG_02416,1.712776481447303,FUN_009298-T1,Peve_00041169,Pocillopora_meandrina_HIv1___RNAseq.g14449.t1,three_way,55.967,,,,,,,,,,,,,,,,,
OG_02417,2.478038294224449,FUN_009301-T1,Peve_00025384,Pocillopora_meandrina_HIv1___RNAseq.g14448.t1,three_way,83.23466666666667,FUN_009301-T1,Q867C9,,,,,59.6,757.0,8.799999999999999e-268,924.5,"sp|Q867C9|PFKAM_HORSE ATP-dependent 6-phosphofructokinase, muscle type OS=Equus caballus OX=9796 GN=PFKM PE=2 SV=3",,,,,,
OG_02424,2.411533932083792,FUN_009349-T1,Peve_00038081,Pocillopora_meandrina_HIv1___RNAseq.g14427.t2,three_way,67.24183333333333,,,,,,,,,,,,,,,,,
OG_02428,1.225678300723028,FUN_009369-T1,Peve_00011042,Pocillopora_meandrina_HIv1___RNAseq.g14409.t1,three_way,62.123666666666665,FUN_009369-T1,A8KBE0,,,,,31.3,823.0,3.5e-86,321.2,sp|A8KBE0|OXR1_XENTR Oxidation resistance protein 1 OS=Xenopus tropicalis OX=8364 GN=oxr1 PE=2 SV=2,,,,,,
OG_02430,2.2566855619705435,FUN_009383-T1,Peve_00026822,Pocillopora_meandrina_HIv1___RNAseq.g14536.t2,three_way,52.69433333333333,FUN_009383-T1,O57382,,,,,33.2,238.0,1.9e-27,125.9,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_02432,1.80426497479302,FUN_009438-T1,Peve_00031029,Pocillopora_meandrina_HIv1___RNAseq.g25068.t1,three_way,73.89733333333334,,,,,,,,,,,,,,,,,
OG_02435,1.536365769013352,FUN_009441-T1,Peve_00031034,Pocillopora_meandrina_HIv1___RNAseq.g25070.t1,three_way,55.70133333333333,,,,,,,,,,,,,,,,,
OG_02436,1.7622173620167434,FUN_009442-T1,Peve_00031035,Pocillopora_meandrina_HIv1___RNAseq.g25071.t1,three_way,65.98966666666666,FUN_009442-T1,Q9UMS0,,,,,65.8,193.0,2.4e-71,270.4,"sp|Q9UMS0|NFU1_HUMAN NFU1 iron-sulfur cluster scaffold homolog, mitochondrial OS=Homo sapiens OX=9606 GN=NFU1 PE=1 SV=2",,,,,,
OG_02437,1.5922572710957543,FUN_009450-T1,Peve_00009284,Pocillopora_meandrina_HIv1___RNAseq.g25115.t1,three_way,64.19466666666666,FUN_009450-T1,Q9DBW0,CP4V2_MOUSE,,Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),Mus musculus (Mouse),47.4,508.0,6.2e-131,469.2,sp|Q9DBW0|CP4V2_MOUSE Cytochrome P450 4V2 OS=Mus musculus OX=10090 GN=Cyp4v2 PE=1 SV=1,GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033,fatty acid omega-oxidation [GO:0010430],endoplasmic reticulum membrane [GO:0005789],heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02439,2.4144976866144923,FUN_009459-T2,Peve_00010355,Pocillopora_meandrina_HIv1___RNAseq.g25133.t1,three_way,61.281333333333336,FUN_009459-T2,Q24JV9,,,,,58.1,105.0,3.1999999999999997e-31,139.0,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02443,1.6978197342996566,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_02448,1.535933473728854,FUN_009519-T1,Peve_00014186,Pocillopora_meandrina_HIv1___RNAseq.g24501.t1,three_way,81.64666666666666,FUN_009519-T1,Q02874,H2AY_RAT,,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),Rattus norvegicus (Rat),55.9,381.0,1.7e-101,370.9,sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5,GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841,"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734],ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],GO:0000228; GO:0003677; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0065003; GO:0098772,nuclear chromosome; DNA binding; structural molecule activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; molecular function regulator activity
OG_02452,2.098252415581034,FUN_009530-T1,Peve_00009552,Pocillopora_meandrina_HIv1___RNAseq.g24495.t1,three_way,46.4995,FUN_009530-T1,Q460N3,PAR15_HUMAN,,Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15),Homo sapiens (Human),27.4,201.0,6.3e-14,80.9,sp|Q460N3|PAR15_HUMAN Protein mono-ADP-ribosyltransferase PARP15 OS=Homo sapiens OX=9606 GN=PARP15 PE=1 SV=2,GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0016779; GO:0070212; GO:0070403; GO:0140806; GO:0140807; GO:1990404,negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein poly-ADP-ribosylation [GO:0070212],cytoplasm [GO:0005737]; nucleus [GO:0005634],NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02455,1.5373224494037845,FUN_009533-T1,Peve_00009554,Pocillopora_meandrina_HIv1___RNAseq.g24492.t1,three_way,81.537,FUN_009533-T1,Q27958,DPOLB_BOVIN,,DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18),Bos taurus (Bovine),65.8,336.0,2.1999999999999998e-121,436.8,sp|Q27958|DPOLB_BOVIN DNA polymerase beta OS=Bos taurus OX=9913 GN=POLB PE=2 SV=3,GO:0003677; GO:0003887; GO:0005634; GO:0005737; GO:0006261; GO:0006284; GO:0006303; GO:0006974; GO:0016829; GO:0046872; GO:0051575; GO:0140078,base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303],cytoplasm [GO:0005737]; nucleus [GO:0005634],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_02464,1.0824292334600534,FUN_009655-T1,Peve_00003554,Pocillopora_meandrina_HIv1___RNAseq.g24582.t1,three_way,64.32866666666666,,,,,,,,,,,,,,,,,
OG_02468,1.7397900249875429,FUN_009667-T1,Peve_00009664,Pocillopora_meandrina_HIv1___RNAseq.g24575.t1,three_way,87.4595,,,,,,,,,,,,,,,,,
OG_02479,1.4327403971367445,FUN_009767-T1,Peve_00002100,Pocillopora_meandrina_HIv1___RNAseq.g24564.t1,three_way,61.841,,,,,,,,,,,,,,,,,
OG_02481,1.174516241095084,FUN_009771-T1,Peve_00002097,Pocillopora_meandrina_HIv1___RNAseq.g24559.t1,three_way,79.394,FUN_009771-T1,Q9WVK7,HCDH_RAT,,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)",Rattus norvegicus (Rat),65.4,286.0,9.4e-104,378.3,"sp|Q9WVK7|HCDH_RAT Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Hadh PE=2 SV=1",GO:0003857; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0007283; GO:0009410; GO:0009725; GO:0014823; GO:0030154; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162,cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403],GO:0003824; GO:0005654; GO:0005739; GO:0006629; GO:0016491; GO:0022414; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; lipid metabolic process; oxidoreductase activity; reproductive process; cell differentiation; organelle
OG_02482,1.6687270609448015,FUN_009776-T1,Peve_00002105,Pocillopora_meandrina_HIv1___TS.g12502.t1,three_way,70.31866666666666,FUN_009776-T1,Q9JID6,,,,,50.2,665.0,5.3e-189,662.5,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02483,2.6043258091288903,FUN_009777-T1,Peve_00002096,Pocillopora_meandrina_HIv1___RNAseq.g24558.t1,three_way,79.21533333333333,FUN_009777-T1,Q9JID6,,,,,48.5,699.0,9.999999999999999e-193,674.9,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02484,3.999692573986305,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02485,1.2505833430962978,FUN_009817-T1,Peve_00020547,Pocillopora_meandrina_HIv1___RNAseq.g24553.t1,three_way,74.48683333333334,FUN_009817-T1,Q3UQI9,,,,,37.9,771.0,2.3e-118,427.9,sp|Q3UQI9|MINY4_MOUSE Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Mus musculus OX=10090 GN=Mindy4 PE=1 SV=1,,,,,,
OG_02494,1.0556320866018922,FUN_009828-T1,Peve_00042906,Pocillopora_meandrina_HIv1___TS.g12483.t2,three_way,70.49633333333334,FUN_009828-T1,Q58D00,,,,,50.3,344.0,1e-50,202.2,sp|Q58D00|FBXW2_BOVIN F-box/WD repeat-containing protein 2 OS=Bos taurus OX=9913 GN=FBXW2 PE=2 SV=1,,,,,,
OG_02501,2.4068551257517043,FUN_009856-T1,Peve_00009092,Pocillopora_meandrina_HIv1___RNAseq.g24507.t1,three_way,69.30833333333334,,,,,,,,,,,,,,,,,
OG_02505,2.993072700334029,FUN_009961-T1,Peve_00036464,Pocillopora_meandrina_HIv1___RNAseq.g24242.t1,three_way,77.88566666666667,FUN_009961-T1,Q90ZC7,KCMA1_XENLA,,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (xSlo)",Xenopus laevis (African clawed frog),45.5,1111.0,7.3e-262,905.2,sp|Q90ZC7|KCMA1_XENLA Calcium-activated potassium channel subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kcnma1 PE=2 SV=1,GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805,potassium ion transmembrane transport [GO:0071805],monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_02507,2.6464542325267737,FUN_010019-T1,Peve_00036456,Pocillopora_meandrina_HIv1___TS.g12195.t1a,three_way,70.6275,FUN_010019-T1,Q7Z5K2,WAPL_HUMAN,,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),Homo sapiens (Human),38.7,545.0,3.8e-92,340.9,sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP-dependent protein-DNA unloader activity [GO:0140083],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromosome segregation; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02512,1.322200238686893,FUN_010555-T1,Peve_00032733,Pocillopora_meandrina_HIv1___RNAseq.g21411.t1,three_way,87.566,FUN_010555-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),25.4,508.0,1.8e-30,137.1,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_02521,2.373650822089714,FUN_010586-T1,Peve_00032749,Pocillopora_meandrina_HIv1___RNAseq.g21514.t1,three_way,59.089333333333336,FUN_010586-T1,Q28EM3,PARI_XENTR,,PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),24.7,636.0,5.9000000000000005e-30,134.0,sp|Q28EM3|PARI_XENTR PCNA-interacting partner OS=Xenopus tropicalis OX=8364 GN=parpbp PE=2 SV=2,GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:2000042,DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0006281; GO:0043226,DNA binding; nucleus; DNA repair; organelle
OG_02522,1.8169705025504523,FUN_010588-T1,Peve_00032700,Pocillopora_meandrina_HIv1___RNAseq.g21512.t1,three_way,83.79533333333333,FUN_010588-T1,Q6INX4,,,,,58.8,434.0,3.0000000000000003e-161,569.7,sp|Q6INX4|ENOF1_XENLA Mitochondrial enolase superfamily member 1 OS=Xenopus laevis OX=8355 GN=enosf1 PE=2 SV=1,,,,,,
OG_02527,2.6378358041003502,FUN_010601-T1,Peve_00032713,Pocillopora_meandrina_HIv1___RNAseq.g21495.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_02539,1.334465332946235,FUN_010622-T1,Peve_00010090,Pocillopora_meandrina_HIv1___RNAseq.g20925.t1,three_way,73.781,,,,,,,,,,,,,,,,,
OG_02543,1.7062914648123475,FUN_010626-T1,Peve_00004474,Pocillopora_meandrina_HIv1___RNAseq.g21298.t1,three_way,89.19266666666667,FUN_010626-T1,Q91YL3,,,,,66.8,400.0,5.5e-149,528.9,sp|Q91YL3|UCKL1_MOUSE Uridine-cytidine kinase-like 1 OS=Mus musculus OX=10090 GN=Uckl1 PE=1 SV=1,,,,,,
OG_02545,1.030851494491506,FUN_010630-T1,Peve_00004479,Pocillopora_meandrina_HIv1___RNAseq.g21302.t1,three_way,47.447833333333335,,,,,,,,,,,,,,,,,
OG_02546,1.5152969037821842,FUN_010633-T1,Peve_00004481,Pocillopora_meandrina_HIv1___RNAseq.g21305.t1,three_way,37.91866666666667,FUN_010633-T1,Q6P0J3,SP8_DANRE,,Transcription factor Sp8,Danio rerio (Zebrafish) (Brachydanio rerio),48.8,84.0,4.1e-15,84.7,sp|Q6P0J3|SP8_DANRE Transcription factor Sp8 OS=Danio rerio OX=7955 GN=sp8b PE=2 SV=1,GO:0000978; GO:0000981; GO:0003690; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_02548,1.4935082303889549,FUN_010635-T1,Peve_00009633,Pocillopora_meandrina_HIv1___RNAseq.g21307.t2,three_way,60.11416666666666,FUN_010635-T1,P07996,TSP1_HUMAN,,Thrombospondin-1 (Glycoprotein G),Homo sapiens (Human),59.6,525.0,5.4e-56,221.5,sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002020; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0004866; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006915; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032693; GO:0032695; GO:0032720; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0038060; GO:0040037; GO:0042327; GO:0042803; GO:0043032; GO:0043066; GO:0043236; GO:0043394; GO:0043410; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431],GO:0002376; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0008289; GO:0012501; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0098772,immune system process; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; lipid binding; programmed cell death; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; cell motility; membrane organization; molecular function regulator activity
OG_02549,1.3065138383356056,FUN_010637-T1,Peve_00009635,Pocillopora_meandrina_HIv1___RNAseq.g21308.t1,three_way,68.79866666666666,FUN_010637-T1,P0CB87,,,,,40.6,64.0,2.4e-07,56.2,sp|P0CB87|NDUS5_PONAB NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 OS=Pongo abelii OX=9601 GN=NDUFS5 PE=3 SV=1,,,,,,
OG_02550,3.882375517489032,FUN_010638-T1,Peve_00009636,Pocillopora_meandrina_HIv1___RNAseq.g21309.t1,three_way,85.60366666666667,FUN_010638-T1,P79733,RIR2_DANRE,,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),Danio rerio (Zebrafish) (Brachydanio rerio),79.4,335.0,5.3e-151,535.4,sp|P79733|RIR2_DANRE Ribonucleoside-diphosphate reductase subunit M2 OS=Danio rerio OX=7955 GN=rrm2 PE=1 SV=1,GO:0004748; GO:0005829; GO:0009263; GO:0046872,deoxyribonucleotide biosynthetic process [GO:0009263],cytosol [GO:0005829],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02555,1.0139370547257611,FUN_010644-T1,Peve_00031456,Pocillopora_meandrina_HIv1___RNAseq.g21330.t1,three_way,73.147,FUN_010644-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),47.9,317.0,2.7999999999999997e-68,260.4,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_02557,1.7416481981038667,FUN_010654-T1,Peve_00031468,Pocillopora_meandrina_HIv1___RNAseq.g21322.t1,three_way,49.04883333333333,FUN_010654-T1,Q5FWF5,ESCO1_HUMAN,,N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1),Homo sapiens (Human),47.1,240.0,5.2e-58,227.3,sp|Q5FWF5|ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3,GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733,mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062],chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; protein-lysine-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02559,1.4712616049498397,FUN_010656-T2,Peve_00031470,Pocillopora_meandrina_HIv1___RNAseq.g21320.t1,three_way,60.860166666666665,FUN_010656-T2,Q5ZKG3,DNA2_CHICK,,DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)],Gallus gallus (Chicken),36.6,831.0,2.4999999999999998e-139,498.4,sp|Q5ZKG3|DNA2_CHICK DNA replication ATP-dependent helicase/nuclease DNA2 OS=Gallus gallus OX=9031 GN=DNA2 PE=2 SV=2,GO:0000076; GO:0000729; GO:0003677; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0043137; GO:0043139; GO:0045740; GO:0046872; GO:0051539; GO:0071932,"base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA replication [GO:0006264]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006260; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; DNA replication; DNA repair; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02560,1.837011892049378,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_02563,1.6099361951725664,FUN_010662-T1,Peve_00031441,Pocillopora_meandrina_HIv1___RNAseq.g21360.t1,three_way,72.268,FUN_010662-T1,Q8BZT9,LACC1_MOUSE,,Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28),Mus musculus (Mouse),42.9,266.0,7.3e-54,213.0,sp|Q8BZT9|LACC1_MOUSE Purine nucleoside phosphorylase LACC1 OS=Mus musculus OX=10090 GN=Lacc1 PE=1 SV=1,GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005634; GO:0005737; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046872; GO:0047975; GO:0050727; GO:0070431; GO:1900542,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777],adenosine deaminase activity [GO:0004000]; guanosine phosphorylase activity [GO:0047975]; metal ion binding [GO:0046872]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061],GO:0002376; GO:0003824; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0016740; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; nucleus; peroxisome; endoplasmic reticulum; inflammatory response; transferase activity; hydrolase activity; organelle; defense response to other organism
OG_02567,1.003332095775586,FUN_010667-T1,Peve_00031447,Pocillopora_meandrina_HIv1___TS.g26107.t1,three_way,77.829,FUN_010667-T1,O04287,,,,,57.0,93.0,1.9e-26,119.8,sp|O04287|FKB12_VICFA Peptidyl-prolyl cis-trans isomerase FKBP12 OS=Vicia faba OX=3906 GN=FKBP12 PE=1 SV=1,,,,,,
OG_02568,2.3457865081907388,FUN_010668-T1,Peve_00031448,Pocillopora_meandrina_HIv1___RNAseq.g21354.t1,three_way,71.776,FUN_010668-T1,Q6GLL2,ABH6A_XENLA,,Monoacylglycerol lipase abhd6-A (EC 3.1.1.23) (Abhydrolase domain-containing protein 6-A),Xenopus laevis (African clawed frog),39.1,289.0,3.3e-56,220.3,sp|Q6GLL2|ABH6A_XENLA Monoacylglycerol lipase abhd6-A OS=Xenopus laevis OX=8355 GN=abhd6-a PE=2 SV=1,GO:0005765; GO:0016020; GO:0031902; GO:0031966; GO:0032281; GO:0046464; GO:0047372; GO:0052651; GO:2001311,acylglycerol catabolic process [GO:0046464]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651],AMPA glutamate receptor complex [GO:0032281]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966],monoacylglycerol lipase activity [GO:0047372],GO:0003824; GO:0006629; GO:0016787; GO:1901135,catalytic activity; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_02576,1.0006041337674882,FUN_010682-T1,Peve_00044787,Pocillopora_meandrina_HIv1___TS.g26094.t1,three_way,77.71233333333333,FUN_010682-T1,Q9CQN6,,,,,50.5,109.0,3.1999999999999998e-24,112.5,sp|Q9CQN6|TM14C_MOUSE Transmembrane protein 14C OS=Mus musculus OX=10090 GN=Tmem14c PE=1 SV=1,,,,,,
OG_02580,1.2507469310240034,FUN_010696-T1,Peve_00040382,Pocillopora_meandrina_HIv1___RNAseq.g6938.t1,three_way,55.94833333333333,FUN_010696-T1,F4JTS8,NOV_ARATH,,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),Arabidopsis thaliana (Mouse-ear cress),26.4,2000.0,7.3e-152,541.2,sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1,GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364,auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],nucleus [GO:0005634],,GO:0005634; GO:0022414; GO:0043226; GO:0048856,nucleus; reproductive process; organelle; anatomical structure development
OG_02581,1.1175097295021816,FUN_010697-T1,Peve_00012866,Pocillopora_meandrina_HIv1___RNAseq.g21335.t1,three_way,68.102,FUN_010697-T1,P27808,MGAT1_MOUSE,,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",Mus musculus (Mouse),57.1,333.0,8.599999999999999e-115,415.2,"sp|P27808|MGAT1_MOUSE Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=Mgat1 PE=1 SV=1",GO:0000139; GO:0001701; GO:0003827; GO:0006049; GO:0008375; GO:0018279; GO:0030145; GO:0048471,in utero embryonic development [GO:0001701]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049],Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0048856; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02584,3.001528378025048,FUN_010703-T1,Peve_00022609,Pocillopora_meandrina_HIv1___TS.g25727.t1,three_way,70.271,,,,,,,,,,,,,,,,,
OG_02592,1.505211388896262,FUN_010712-T1,Peve_00022571,Pocillopora_meandrina_HIv1___RNAseq.g20959.t1,three_way,69.79433333333333,FUN_010712-T1,Q96NA8,,,,,31.0,200.0,1.8e-14,81.6,sp|Q96NA8|TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TSNARE1 PE=1 SV=2,,,,,,
OG_02594,1.535647528428947,FUN_010714-T1,Peve_00022559,Pocillopora_meandrina_HIv1___RNAseq.g20957.t1,three_way,53.61783333333334,FUN_010714-T1,Q8WV22,NSE1_HUMAN,,Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27),Homo sapiens (Human),34.5,258.0,3.2e-35,150.2,sp|Q8WV22|NSE1_HUMAN Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens OX=9606 GN=NSMCE1 PE=1 SV=5,GO:0000724; GO:0000775; GO:0000781; GO:0004842; GO:0005634; GO:0005654; GO:0006974; GO:0008270; GO:0016925; GO:0030915; GO:0032204; GO:0043231; GO:0046983; GO:0061630; GO:0097431; GO:0140588,chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]",protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02596,1.5921472380329913,FUN_010717-T1,Peve_00022590,Pocillopora_meandrina_HIv1___RNAseq.g20954.t1,three_way,77.32616666666667,FUN_010717-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),57.2,530.0,1.7e-168,594.0,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_02599,4.979101442297512,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_02600,1.9540633762244115,FUN_010726-T1,Peve_00038971,Pocillopora_meandrina_HIv1___RNAseq.g20947.t1,three_way,72.91166666666666,FUN_010726-T1,Q17QM4,EPT1_BOVIN,,Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI),Bos taurus (Bovine),44.5,380.0,3.2999999999999996e-90,333.6,sp|Q17QM4|EPT1_BOVIN Ethanolaminephosphotransferase 1 OS=Bos taurus OX=9913 GN=SELENOI PE=2 SV=3,GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872,ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; organelle
OG_02612,1.5202104963005416,FUN_010746-T1,Peve_00038410,Pocillopora_meandrina_HIv1___RNAseq.g20932.t1,three_way,83.767,FUN_010746-T1,Q96QK8,,,,,62.9,70.0,3.9e-19,95.1,sp|Q96QK8|SIM14_HUMAN Small integral membrane protein 14 OS=Homo sapiens OX=9606 GN=SMIM14 PE=1 SV=1,,,,,,
OG_02614,1.5664508648397837,FUN_010753-T1,Peve_00004503,Pocillopora_meandrina_HIv1___RNAseq.g21292.t1,three_way,87.76683333333334,FUN_010753-T1,Q9NV56,,,,,61.1,90.0,1.4e-26,120.9,sp|Q9NV56|MRGBP_HUMAN MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1,,,,,,
OG_02616,1.6017809111817392,FUN_010755-T1,Peve_00008039,Pocillopora_meandrina_HIv1___RNAseq.g20929.t1,three_way,67.73883333333333,FUN_010755-T1,A7RM45,,,,,60.1,552.0,4.8e-161,569.3,sp|A7RM45|LMBD1_NEMVE Probable lysosomal cobalamin transporter OS=Nematostella vectensis OX=45351 GN=v1g160387 PE=3 SV=1,,,,,,
OG_02617,1.944283245691307,FUN_010756-T1,Peve_00008040,Pocillopora_meandrina_HIv1___RNAseq.g20928.t1,three_way,75.21683333333334,FUN_010756-T1,P33610,,,,,53.5,460.0,2e-140,500.7,sp|P33610|PRI2_MOUSE DNA primase large subunit OS=Mus musculus OX=10090 GN=Prim2 PE=1 SV=1,,,,,,
OG_02625,2.253937476800378,FUN_010775-T1,Peve_00004492,Pocillopora_meandrina_HIv1___RNAseq.g21202.t1,three_way,84.75166666666667,FUN_010775-T1,Q15560,TCEA2_HUMAN,,Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l),Homo sapiens (Human),48.7,306.0,6.9e-69,262.3,sp|Q15560|TCEA2_HUMAN Transcription elongation factor A protein 2 OS=Homo sapiens OX=9606 GN=TCEA2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006354; GO:0006357; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0036064,DNA-templated transcription elongation [GO:0006354]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; organelle
OG_02635,1.1715482572621951,FUN_010802-T1,Peve_00007033,Pocillopora_meandrina_HIv1___TS.g25986.t1,three_way,47.278,FUN_010802-T1,Q8NDA2,,,,,20.6,880.0,4.9e-29,131.7,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_02638,1.8719785018573352,FUN_010805-T1,Peve_00006505,Pocillopora_meandrina_HIv1___RNAseq.g26670.t1,three_way,61.43866666666667,FUN_010805-T1,P31228,OXDD_BOVIN,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Bos taurus (Bovine),26.8,406.0,3.7999999999999995e-24,114.0,sp|P31228|OXDD_BOVIN D-aspartate oxidase OS=Bos taurus OX=9913 GN=DDO PE=1 SV=3,GO:0005737; GO:0005782; GO:0005829; GO:0008445; GO:0019478; GO:0047821; GO:0050877; GO:0071949,D-amino acid catabolic process [GO:0019478]; nervous system process [GO:0050877],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005829; GO:0006520; GO:0016491; GO:0050877,catalytic activity; cytosol; amino acid metabolic process; oxidoreductase activity; nervous system process
OG_02639,2.062455659720698,FUN_010807-T1,Peve_00006506,Pocillopora_meandrina_HIv1___RNAseq.g20902.t1,three_way,83.408,FUN_010807-T1,Q9QXG4,ACSA_MOUSE,,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),65.8,679.0,2.1999999999999999e-280,966.1,"sp|Q9QXG4|ACSA_MOUSE Acetyl-coenzyme A synthetase, cytoplasmic OS=Mus musculus OX=10090 GN=Acss2 PE=1 SV=2",GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0006629; GO:0007616; GO:0050218,acetyl-CoA biosynthetic process [GO:0006085]; lipid metabolic process [GO:0006629]; long-term memory [GO:0007616],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0050877; GO:0055086; GO:0060090; GO:0140110; GO:0140657,catalytic activity; nucleus; cytosol; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nervous system process; nucleobase-containing small molecule metabolic process; molecular adaptor activity; transcription regulator activity; ATP-dependent activity
OG_02642,2.722902393715104,FUN_010810-T1,Peve_00006510,Pocillopora_meandrina_HIv1___RNAseq.g20905.t1,three_way,54.041,FUN_010810-T1,Q49LS8,,,,,31.2,420.0,1e-51,207.2,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_02644,1.3202950837453,FUN_010814-T1,Peve_00006521,Pocillopora_meandrina_HIv1___RNAseq.g20908.t1,three_way,94.45533333333331,FUN_010814-T1,Q96BR1,SGK3_HUMAN,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Homo sapiens (Human),64.1,485.0,1e-175,617.8,sp|Q96BR1|SGK3_HUMAN Serine/threonine-protein kinase Sgk3 OS=Homo sapiens OX=9606 GN=SGK3 PE=1 SV=1,GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090],cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080],GO:0003824; GO:0005768; GO:0005829; GO:0006355; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; cytosol; regulation of DNA-templated transcription; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02645,3.000200624132769,FUN_010818-T1,Peve_00006523,Pocillopora_meandrina_HIv1___RNAseq.g20909.t1,three_way,90.38933333333334,FUN_010818-T1,Q8R4V0,SGK3_RAT,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Rattus norvegicus (Rat),62.1,451.0,9.6e-163,574.7,sp|Q8R4V0|SGK3_RAT Serine/threonine-protein kinase Sgk3 OS=Rattus norvegicus OX=10116 GN=Sgk3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005769; GO:0015459; GO:0031410; GO:0035091; GO:0035556; GO:0055037; GO:0060090; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240],cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; endosome; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02648,1.1939569699806272,FUN_010830-T1,Peve_00017535,Pocillopora_meandrina_HIv1___RNAseq.g20913.t1,three_way,81.01133333333334,FUN_010830-T1,Q9NXB0,MKS1_HUMAN,,Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein),Homo sapiens (Human),42.4,557.0,5.1e-126,453.0,sp|Q9NXB0|MKS1_HUMAN Tectonic-like complex member MKS1 OS=Homo sapiens OX=9606 GN=MKS1 PE=1 SV=2,GO:0001843; GO:0003271; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1905515; GO:1990403; GO:2000095,"branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]",centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856,nucleoplasm; nucleolus; microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development
OG_02652,1.8673131964912923,FUN_010835-T1,Peve_00030776,Pocillopora_meandrina_HIv1___RNAseq.g20920.t1,three_way,69.44516666666667,FUN_010835-T1,Q8BFW9,,,,,39.7,574.0,5.3e-110,399.8,"sp|Q8BFW9|GTR12_MOUSE Solute carrier family 2, facilitated glucose transporter member 12 OS=Mus musculus OX=10090 GN=Slc2a12 PE=2 SV=1",,,,,,
OG_02657,1.411851482966462,FUN_010840-T3,Peve_00014596,Pocillopora_meandrina_HIv1___RNAseq.g21008.t1,three_way,71.34866666666667,FUN_010840-T3,Q05B79,DHX36_BOVIN,,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),Bos taurus (Bovine),49.9,1010.0,5.3e-265,915.6,sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1,GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02662,1.9502194579141747,FUN_010878-T1,Peve_00009759,Pocillopora_meandrina_HIv1___TS.128_t,three_way,78.95733333333334,FUN_010878-T1,Q86WA6,BPHL_HUMAN,,Serine hydrolase BPHL (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA) (L-homocysteine-thiolactonase BPHL) (Valacyclovir hydrolase) (VACVase) (Valacyclovirase),Homo sapiens (Human),57.3,253.0,1.5e-85,317.4,sp|Q86WA6|BPHL_HUMAN Serine hydrolase BPHL OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1,GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0017171; GO:0047658; GO:0050667,amino acid metabolic process [GO:0006520]; homocysteine metabolic process [GO:0050667]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],alpha-amino-acid esterase activity [GO:0047658]; serine hydrolase activity [GO:0017171],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016787; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle
OG_02663,1.6328538439665383,FUN_010879-T1,Peve_00035832,Pocillopora_meandrina_HIv1___RNAseq.g21030.t1,three_way,86.78866666666667,FUN_010879-T1,Q2KJI3,CYRIB_BOVIN,,CYFIP-related Rac1 interactor B (Protein FAM49B),Bos taurus (Bovine),65.7,327.0,8.4e-116,418.3,sp|Q2KJI3|CYRIB_BOVIN CYFIP-related Rac1 interactor B OS=Bos taurus OX=9913 GN=CYRIB PE=2 SV=1,GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568,cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140],cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739],"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]",GO:0005739; GO:0005929; GO:0043226,mitochondrion; cilium; organelle
OG_02671,2.034961994462048,FUN_010896-T1,Peve_00044943,Pocillopora_meandrina_HIv1___RNAseq.g20992.t1,three_way,75.72,FUN_010896-T1,Q10075,PCS_SCHPO,,Glutathione gamma-glutamylcysteinyltransferase (EC 2.3.2.15) (Phytochelatin synthase),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),44.3,235.0,1.8e-53,211.1,sp|Q10075|PCS_SCHPO Glutathione gamma-glutamylcysteinyltransferase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC3H1.10 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0010273; GO:0016756; GO:0046870; GO:0046938; GO:0071276; GO:0098849,cellular detoxification of cadmium ion [GO:0098849]; cellular response to cadmium ion [GO:0071276]; detoxification of copper ion [GO:0010273]; phytochelatin biosynthetic process [GO:0046938],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cadmium ion binding [GO:0046870]; glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0098754,catalytic activity; nucleus; cytosol; transferase activity; organelle; detoxification
OG_02672,1.1640138941502205,FUN_010897-T1,Peve_00044944,Pocillopora_meandrina_HIv1___RNAseq.91_t,three_way,74.07666666666667,FUN_010897-T1,D3ZAT9,,,,,38.3,227.0,9.3e-45,181.8,sp|D3ZAT9|FAXC_RAT Failed axon connections homolog OS=Rattus norvegicus OX=10116 GN=Faxc PE=3 SV=1,,,,,,
OG_02679,2.262449883230637,FUN_010929-T1,Peve_00005959,Pocillopora_meandrina_HIv1___RNAseq.g20983.t1,three_way,77.19966666666666,FUN_010929-T1,Q29RS4,IN80E_BOVIN,,INO80 complex subunit E (Coiled-coil domain-containing protein 95),Bos taurus (Bovine),70.3,64.0,1.3e-16,88.6,sp|Q29RS4|IN80E_BOVIN INO80 complex subunit E OS=Bos taurus OX=9913 GN=INO80E PE=2 SV=1,GO:0006281; GO:0006310; GO:0006338; GO:0031011,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],Ino80 complex [GO:0031011],,GO:0006281; GO:0006310; GO:0006325,DNA repair; DNA recombination; chromatin organization
OG_02680,1.4179426843641678,FUN_010930-T1,Peve_00005960,Pocillopora_meandrina_HIv1___RNAseq.g20982.t1a,three_way,40.99766666666667,,,,,,,,,,,,,,,,,
OG_02686,1.6099710398978424,FUN_010946-T1,Peve_00040400,Pocillopora_meandrina_HIv1___RNAseq.g21809.t1,three_way,75.744,FUN_010946-T1,Q9Y6J8,STYL1_HUMAN,,Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Inactive dual specificity protein phosphatase MK-STYX) (Map kinase phosphatase-like protein MK-STYX),Homo sapiens (Human),38.3,324.0,1.4999999999999999e-55,218.0,sp|Q9Y6J8|STYL1_HUMAN Serine/threonine/tyrosine-interacting-like protein 1 OS=Homo sapiens OX=9606 GN=STYXL1 PE=1 SV=1,GO:0001691; GO:0005739; GO:0005759; GO:0010976; GO:0019212; GO:0019903; GO:0035556; GO:0062030; GO:2001242; GO:2001244,intracellular signal transduction [GO:0035556]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],phosphatase inhibitor activity [GO:0019212]; protein phosphatase binding [GO:0019903]; pseudophosphatase activity [GO:0001691],GO:0005739; GO:0043226; GO:0098772,mitochondrion; organelle; molecular function regulator activity
OG_02687,1.818681706092169,FUN_010947-T1,Peve_00040399,Pocillopora_meandrina_HIv1___RNAseq.g21805.t1,three_way,64.768,,,,,,,,,,,,,,,,,
OG_02690,2.396656398354806,FUN_010950-T1,Peve_00040405,Pocillopora_meandrina_HIv1___RNAseq.g21821.t1,three_way,69.54883333333333,FUN_010950-T1,Q7TN88,,,,,38.0,403.0,5.7e-77,292.4,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_02694,1.9144788881038863,FUN_010957-T1,Peve_00035899,Pocillopora_meandrina_HIv1___RNAseq.g21825.t1,three_way,53.990833333333335,,,,,,,,,,,,,,,,,
OG_02696,1.2798407198519972,FUN_010960-T1,Peve_00007918,Pocillopora_meandrina_HIv1___RNAseq.g21827.t1,three_way,80.13816666666666,FUN_010960-T1,Q5F259,AN13B_MOUSE,,Ankyrin repeat domain-containing protein 13B,Mus musculus (Mouse),45.7,532.0,1.2e-126,455.3,sp|Q5F259|AN13B_MOUSE Ankyrin repeat domain-containing protein 13B OS=Mus musculus OX=10090 GN=Ankrd13b PE=2 SV=1,GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0048471; GO:0140036,negative regulation of receptor internalization [GO:0002091],cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ubiquitin-modified protein reader activity [GO:0140036],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0060090,endosome; plasma membrane; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_02707,2.065365764776788,FUN_010984-T1,Peve_00013386,Pocillopora_meandrina_HIv1___RNAseq.g22009.t1,three_way,79.6975,FUN_010984-T1,Q7Z3V4,UBE3B_HUMAN,,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),Homo sapiens (Human),50.4,1075.0,3.1e-310,1065.8,sp|Q7Z3V4|UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens OX=9606 GN=UBE3B PE=1 SV=3,GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098978; GO:0150052,protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02709,2.2538183240364247,FUN_010986-T1,Peve_00013392,Pocillopora_meandrina_HIv1___RNAseq.g22007.t2,three_way,74.76766666666667,FUN_010986-T1,Q96LW2,,,,,38.4,315.0,3.4e-61,237.3,sp|Q96LW2|KS6R_HUMAN Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=3,,,,,,
OG_02712,1.6886311641603966,FUN_010990-T1,Peve_00013396,Pocillopora_meandrina_HIv1___TS.g29847.t1,three_way,54.55116666666667,FUN_010990-T1,Q6J4K2,NCLX_HUMAN,,"Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Homo sapiens (Human),39.1,539.0,1.6e-99,365.2,sp|Q6J4K2|NCLX_HUMAN Mitochondrial sodium/calcium exchanger protein OS=Homo sapiens OX=9606 GN=SLC8B1 PE=1 SV=2,GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0015368; GO:0016020; GO:0030061; GO:0031966; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256,calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; intracellular calcium ion homeostasis [GO:0006874]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; monoatomic ion transport [GO:0006811]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256],membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_02714,1.1544660073186674,FUN_010997-T1,Peve_00013403,Pocillopora_meandrina_HIv1___RNAseq.g22025.t1,three_way,73.773,FUN_010997-T1,P78330,SERB_HUMAN,,Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase),Homo sapiens (Human),57.1,219.0,8.8e-70,265.0,sp|P78330|SERB_HUMAN Phosphoserine phosphatase OS=Homo sapiens OX=9606 GN=PSPH PE=1 SV=2,GO:0000287; GO:0001701; GO:0005737; GO:0005829; GO:0006563; GO:0006564; GO:0009612; GO:0031667; GO:0033574; GO:0036424; GO:0042802; GO:0042803,in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574],cytoplasm [GO:0005737]; cytosol [GO:0005829],identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; anatomical structure development
OG_02716,1.5897316061066256,FUN_010999-T1,Peve_00013407,Pocillopora_meandrina_HIv1___RNAseq.g22023.t1,three_way,83.44866666666667,FUN_010999-T1,A4IF93,,,,,42.4,582.0,1.5999999999999999e-127,458.0,sp|A4IF93|TBCC1_BOVIN TBCC domain-containing protein 1 OS=Bos taurus OX=9913 GN=TBCCD1 PE=2 SV=1,,,,,,
OG_02718,3.0895319360785645,FUN_011001-T1,Peve_00013415,Pocillopora_meandrina_HIv1___RNAseq.g22019.t1,three_way,62.246,FUN_011001-T1,A8WFU8,KIF22_DANRE,,Kinesin-like protein KIF22,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,632.0,3.4e-120,433.7,sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1,GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592,axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003677; GO:0003774; GO:0003824; GO:0005634; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140657,DNA binding; cytoskeletal motor activity; catalytic activity; nucleus; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; anatomical structure development; ATP-dependent activity
OG_02719,1.255206619297633,FUN_011046-T1,Peve_00013440,Pocillopora_meandrina_HIv1___RNAseq.g21485.t2,three_way,75.79966666666667,FUN_011046-T1,Q567Y6,,,,,48.7,187.0,3.3999999999999995e-53,209.9,sp|Q567Y6|IFT22_DANRE Intraflagellar transport protein 22 homolog OS=Danio rerio OX=7955 GN=ift22 PE=2 SV=1,,,,,,
OG_02720,2.259250133585838,FUN_011048-T1,Peve_00013435,Pocillopora_meandrina_HIv1___RNAseq.g21483.t1,three_way,68.41766666666666,FUN_011048-T1,Q5PQT2,MTMR3_RAT,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)",Rattus norvegicus (Rat),37.4,1193.0,2.4e-206,720.7,"sp|Q5PQT2|MTMR3_RAT Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Rattus norvegicus OX=10116 GN=Mtmr3 PE=1 SV=1",GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016020; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785,cellular response to glucose starvation [GO:0042149]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],"molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0060090; GO:0061024; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; hydrolase activity; molecular adaptor activity; membrane organization; catalytic activity, acting on a protein"
OG_02721,1.7315617455111307,FUN_011049-T1,Peve_00013424,Pocillopora_meandrina_HIv1___TS.g26228.t1,three_way,60.9865,,,,,,,,,,,,,,,,,
OG_02724,1.4743844681403988,FUN_011059-T1,Peve_00009502,Pocillopora_meandrina_HIv1___RNAseq.g22348.t1,three_way,91.228,FUN_011059-T1,P63271,,,,,62.7,110.0,6.599999999999997e-41,167.9,sp|P63271|SPT4A_MOUSE Transcription elongation factor SPT4-A OS=Mus musculus OX=10090 GN=Supt4h1a PE=2 SV=1,,,,,,
OG_02728,2.209038317556033,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_02731,1.7695558768364357,FUN_011259-T1,Peve_00032917,Pocillopora_meandrina_HIv1___RNAseq.g20815.t1,three_way,43.78766666666667,,,,,,,,,,,,,,,,,
OG_02738,1.0185457941554226,FUN_011279-T1,Peve_00030533,Pocillopora_meandrina_HIv1___RNAseq.g16628.t1,three_way,79.54599999999999,FUN_011279-T1,Q96FV9,THOC1_HUMAN,,THO complex subunit 1 (Nuclear matrix protein p84) (p84N5) (hTREX84),Homo sapiens (Human),57.0,530.0,2.1999999999999998e-166,587.0,sp|Q96FV9|THOC1_HUMAN THO complex subunit 1 OS=Homo sapiens OX=9606 GN=THOC1 PE=1 SV=1,GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607,apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006913; GO:0012501; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; organelle
OG_02744,3.816674654825496,FUN_011308-T1,Peve_00024988,Pocillopora_meandrina_HIv1___RNAseq.g22351.t1,three_way,73.087,FUN_011308-T1,Q8L7W2,,,,,39.7,214.0,6.0999999999999996e-43,176.0,sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2,,,,,,
OG_02748,2.7784465116482377,FUN_011416-T1,Peve_00033619,Pocillopora_meandrina_HIv1___TS.g27041.t2,three_way,80.652,FUN_011416-T1,Q14165,MLEC_HUMAN,,Malectin,Homo sapiens (Human),54.3,245.0,9.6e-67,255.0,sp|Q14165|MLEC_HUMAN Malectin OS=Homo sapiens OX=9606 GN=MLEC PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0008250; GO:0016020; GO:0019899; GO:0030246; GO:0035579,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899],GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_02751,1.2546289653466238,FUN_011680-T1,Peve_00027006,Pocillopora_meandrina_HIv1___TS.g16787.t2,three_way,51.315666666666665,FUN_011680-T1,Q58DQ5,RT09_BOVIN,,"Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt)",Bos taurus (Bovine),38.9,211.0,8.200000000000001e-32,139.8,sp|Q58DQ5|RT09_BOVIN Small ribosomal subunit protein uS9m OS=Bos taurus OX=9913 GN=MRPS9 PE=1 SV=3,GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412,translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198,RNA binding; structural molecule activity
OG_02752,1.315160023054386,FUN_011681-T1,Peve_00027007,Pocillopora_meandrina_HIv1___RNAseq.g23914.t1,three_way,78.4315,FUN_011681-T1,Q13492,,,,,59.6,349.0,2e-112,407.5,sp|Q13492|PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2,,,,,,
OG_02754,1.483849068791441,FUN_011684-T1,Peve_00027010,Pocillopora_meandrina_HIv1___RNAseq.g23917.t1b,three_way,67.25733333333334,FUN_011684-T1,Q9KX40,,,,,31.0,187.0,4.1e-13,78.2,sp|Q9KX40|ESTB_BURGA Esterase EstB OS=Burkholderia gladioli OX=28095 GN=estB PE=1 SV=1,,,,,,
OG_02756,1.1471022384944225,FUN_011693-T1,Peve_00027018,Pocillopora_meandrina_HIv1___RNAseq.g23907.t1,three_way,70.913,FUN_011693-T1,Q96A49,SYAP1_HUMAN,,Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA),Homo sapiens (Human),41.0,346.0,6.2e-48,193.0,sp|Q96A49|SYAP1_HUMAN Synapse-associated protein 1 OS=Homo sapiens OX=9606 GN=SYAP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009898; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045202; GO:0045211; GO:0045600; GO:0048172; GO:0048471; GO:0070062; GO:0071364; GO:0071902; GO:1990314,cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],,GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0030154; GO:0043226,nucleus; nucleoplasm; Golgi apparatus; cytosol; cell differentiation; organelle
OG_02764,1.3798317612831268,FUN_011702-T1,Peve_00025136,Pocillopora_meandrina_HIv1___RNAseq.g23824.t1,three_way,84.61633333333333,FUN_011702-T1,P59235,,,,,43.8,379.0,2.3e-90,334.0,sp|P59235|NUP43_MOUSE Nucleoporin Nup43 OS=Mus musculus OX=10090 GN=Nup43 PE=1 SV=2,,,,,,
OG_02766,1.2235805720706174,FUN_011704-T1,Peve_00025152,Pocillopora_meandrina_HIv1___RNAseq.g23821.t1,three_way,60.856,,,,,,,,,,,,,,,,,
OG_02770,1.507629640935339,FUN_011709-T1,Peve_00025138,Pocillopora_meandrina_HIv1___RNAseq.g23817.t1,three_way,57.62166666666666,,,,,,,,,,,,,,,,,
OG_02771,1.2575953363406869,FUN_011710-T1,Peve_00025140,Pocillopora_meandrina_HIv1___RNAseq.g23816.t1,three_way,86.54816666666667,FUN_011710-T1,Q9JJ31,CUL5_RAT,,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),Rattus norvegicus (Rat),71.6,784.0,0.0,1121.3,sp|Q9JJ31|CUL5_RAT Cullin-5 OS=Rattus norvegicus OX=10116 GN=Cul5 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005000; GO:0005634; GO:0016567; GO:0019005; GO:0021799; GO:0021942; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038026; GO:0043161; GO:0051480; GO:0070979; GO:0090734; GO:0160072; GO:2001222,cerebral cortex radially oriented cell migration [GO:0021799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; reelin-mediated signaling pathway [GO:0038026]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; vasopressin receptor activity [GO:0005000],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0048870; GO:0060089; GO:0060090; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; cell motility; molecular transducer activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02776,1.9877012353999477,FUN_011724-T1,Peve_00039706,Pocillopora_meandrina_HIv1___RNAseq.g23851.t1,three_way,75.24866666666667,FUN_011724-T1,Q6ZV70,,,,,39.1,238.0,1.7999999999999998e-35,151.0,sp|Q6ZV70|LANC3_HUMAN LanC-like protein 3 OS=Homo sapiens OX=9606 GN=LANCL3 PE=1 SV=2,,,,,,
OG_02782,1.7597732331437648,FUN_011733-T1,Peve_00001121,Pocillopora_meandrina_HIv1___RNAseq.g23840.t2,three_way,53.03233333333333,FUN_011733-T1,Q6ZPR6,,,,,30.4,1491.0,1.3e-160,569.3,sp|Q6ZPR6|IBTK_MOUSE Inhibitor of Bruton tyrosine kinase OS=Mus musculus OX=10090 GN=Ibtk PE=1 SV=3,,,,,,
OG_02785,1.042149473740649,FUN_011740-T1,Peve_00034096,Pocillopora_meandrina_HIv1___RNAseq.g23881.t1,three_way,76.12266666666666,,,,,,,,,,,,,,,,,
OG_02789,1.881742130987244,FUN_011745-T1,Peve_00034105,Pocillopora_meandrina_HIv1___RNAseq.g23887.t1,three_way,65.875,FUN_011745-T1,P49406,,,,,41.1,168.0,1.7e-21,104.8,sp|P49406|RM19_HUMAN Large ribosomal subunit protein bL19m OS=Homo sapiens OX=9606 GN=MRPL19 PE=1 SV=2,,,,,,
OG_02792,1.6471634849750931,FUN_011749-T1,Peve_00034098,Pocillopora_meandrina_HIv1___RNAseq.g23883.t1,three_way,76.81333333333333,FUN_011749-T1,P48279,,,,,25.2,222.0,9.8e-07,55.5,sp|P48279|YCF39_CYAPA Photosystem II assembly factor Ycf39 OS=Cyanophora paradoxa OX=2762 GN=ycf39 PE=3 SV=1,,,,,,
OG_02795,1.5956324665083006,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_02798,1.4172936824164986,FUN_011765-T1,Peve_00035074,Pocillopora_meandrina_HIv1___RNAseq.g23800.t1,three_way,86.81066666666666,FUN_011765-T1,P43246,MSH2_HUMAN,,DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2),Homo sapiens (Human),59.3,934.0,0.0,1095.9,sp|P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1,GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008047; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0140664,B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204],"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; guanine/thymine mispair binding [GO:0032137]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006091; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; generation of precursor metabolites and energy; DNA repair; DNA recombination; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_02816,1.7390757814214624,FUN_011803-T1,Peve_00028441,Pocillopora_meandrina_HIv1___RNAseq.g23250.t1,three_way,44.53766666666667,,,,,,,,,,,,,,,,,
OG_02820,1.225483067766027,FUN_011808-T1,Peve_00020938,Pocillopora_meandrina_HIv1___RNAseq.g23246.t1,three_way,76.82233333333333,,,,,,,,,,,,,,,,,
OG_02824,1.0039177408094515,FUN_011814-T1,Peve_00020927,Pocillopora_meandrina_HIv1___RNAseq.g23235.t1,three_way,75.693,FUN_011814-T1,Q71B07,,,,,48.0,710.0,7.700000000000002e-180,632.1,sp|Q71B07|D19L3_MOUSE Protein C-mannosyl-transferase DPY19L3 OS=Mus musculus OX=10090 GN=Dpy19l3 PE=1 SV=2,,,,,,
OG_02831,1.838048011508453,FUN_011846-T1,Peve_00034370,Pocillopora_meandrina_HIv1___RNAseq.g23376.t1,three_way,70.376,,,,,,,,,,,,,,,,,
OG_02835,1.9790528481897525,FUN_011853-T1,Peve_00034403,Pocillopora_meandrina_HIv1___RNAseq.g23381.t1,three_way,67.724,FUN_011853-T1,Q3ZBE6,,,,,37.9,443.0,1.8e-72,274.6,sp|Q3ZBE6|TM135_BOVIN Transmembrane protein 135 OS=Bos taurus OX=9913 GN=TMEM135 PE=2 SV=1,,,,,,
OG_02837,1.541278723733395,FUN_011861-T1,Peve_00006759,Pocillopora_meandrina_HIv1___TS.g16269.t1,three_way,62.36083333333333,,,,,,,,,,,,,,,,,
OG_02841,1.126295267472379,FUN_011865-T1,Peve_00006754,Pocillopora_meandrina_HIv1___RNAseq.g23392.t1,three_way,81.326,FUN_011865-T1,Q921W4,,,,,48.3,321.0,2.4e-73,277.3,sp|Q921W4|QORL1_MOUSE Quinone oxidoreductase-like protein 1 OS=Mus musculus OX=10090 GN=Cryzl1 PE=1 SV=1,,,,,,
OG_02842,1.1663104146716397,FUN_011866-T1,Peve_00014172,Pocillopora_meandrina_HIv1___RNAseq.g23393.t1,three_way,82.23866666666666,FUN_011866-T1,Q5U3Y5,,,,,57.9,159.0,2.9999999999999997e-47,189.5,sp|Q5U3Y5|SFT2A_RAT Vesicle transport protein SFT2A OS=Rattus norvegicus OX=10116 GN=Sft2d1 PE=2 SV=1,,,,,,
OG_02843,1.0105261939822687,FUN_011867-T1,Peve_00005279,Pocillopora_meandrina_HIv1___RNAseq.g26657.t1,three_way,72.6535,,,,,,,,,,,,,,,,,
OG_02853,3.9386769389605454,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_02857,1.2568771150997675,FUN_011899-T1,Peve_00010113,Pocillopora_meandrina_HIv1___RNAseq.g23787.t1,three_way,67.8275,FUN_011899-T1,Q5R9B8,DCAF6_PONAB,,DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,843.0,7.8e-144,512.7,sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2,GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_02864,1.0910089093717554,FUN_011911-T1,Peve_00039386,Pocillopora_meandrina_HIv1___RNAseq.g23361.t1,three_way,83.54433333333334,FUN_011911-T1,Q96VG1,,,,,50.9,57.0,7.7e-12,70.9,sp|Q96VG1|YBAI_SCHPO Uncharacterized protein C119.18 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC119.18 PE=3 SV=1,,,,,,
OG_02865,1.1581672615981176,FUN_011912-T1,Peve_00020699,Pocillopora_meandrina_HIv1___RNAseq.g23360.t1,three_way,69.96266666666666,FUN_011912-T1,Q92562,FIG4_HUMAN,,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16)",Homo sapiens (Human),45.8,1014.0,7.2e-216,752.3,sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1,GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037,locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037],"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005768; GO:0005811; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; lipid droplet; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02869,1.4181564642473672,FUN_011919-T1,Peve_00010933,Pocillopora_meandrina_HIv1___RNAseq.g23318.t1,three_way,75.38133333333333,FUN_011919-T1,A4FUI1,,,,,53.3,135.0,1.1e-35,151.0,sp|A4FUI1|MIX23_BOVIN Protein MIX23 OS=Bos taurus OX=9913 GN=MIX23 PE=2 SV=1,,,,,,
OG_02872,1.1244724036126008,FUN_011922-T1,Peve_00002208,Pocillopora_meandrina_HIv1___TS.g16203.t1,three_way,84.6935,FUN_011922-T1,Q9C102,GLT1_SCHPO,,Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),51.7,2161.0,0.0,2202.6,sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1,GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054,ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054],cytosol [GO:0005829]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle
OG_02878,1.472856933360985,FUN_011928-T1,Peve_00039387,Pocillopora_meandrina_HIv1___RNAseq.g23329.t1,three_way,69.43666666666667,FUN_011928-T1,Q5E9H9,ABHDA_BOVIN,,"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)",Bos taurus (Bovine),44.6,251.0,9.7e-64,245.0,"sp|Q5E9H9|ABHDA_BOVIN Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Bos taurus OX=9913 GN=ABHD10 PE=2 SV=1",GO:0002084; GO:0004553; GO:0005739; GO:0008474; GO:0102390,protein depalmitoylation [GO:0002084],mitochondrion [GO:0005739],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474]",GO:0003824; GO:0005739; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02890,1.5138801222615264,FUN_011945-T1,Peve_00016921,Pocillopora_meandrina_HIv1___RNAseq.g9189.t2,three_way,87.27733333333333,FUN_011945-T1,Q9YH18,,,,,42.9,324.0,4.7e-59,229.6,sp|Q9YH18|QKI_CHICK KH domain-containing RNA-binding protein QKI OS=Gallus gallus OX=9031 GN=QKI PE=2 SV=2,,,,,,
OG_02902,1.88633054628378,FUN_011961-T1,Peve_00032575,Pocillopora_meandrina_HIv1___RNAseq.g12963.t1,three_way,70.89166666666667,FUN_011961-T1,Q5ZID0,,,,,42.0,300.0,3.1e-64,246.9,sp|Q5ZID0|NMRL1_CHICK NmrA-like family domain-containing protein 1 OS=Gallus gallus OX=9031 GN=NMRAL1 PE=2 SV=1,,,,,,
OG_02903,1.9390000952354705,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02911,1.0296948242148434,FUN_011990-T1,Peve_00000527,Pocillopora_meandrina_HIv1___RNAseq.g23707.t1,three_way,59.033,FUN_011990-T1,Q9CXC3,,,,,40.8,245.0,1.6000000000000002e-44,181.8,sp|Q9CXC3|MGME1_MOUSE Mitochondrial genome maintenance exonuclease 1 OS=Mus musculus OX=10090 GN=Mgme1 PE=2 SV=1,,,,,,
OG_02912,2.978681066313741,FUN_011991-T1,Peve_00000528,Pocillopora_meandrina_HIv1___RNAseq.g23706.t1,three_way,78.50233333333333,FUN_011991-T1,P11620,,,,,48.9,174.0,5.2e-39,162.5,sp|P11620|YPT1_SCHPO GTP-binding protein ypt1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ypt1 PE=1 SV=2,,,,,,
OG_02921,1.044754649256084,FUN_012004-T1,Peve_00016377,Pocillopora_meandrina_HIv1___RNAseq.g24027.t1,three_way,69.86833333333334,FUN_012004-T1,Q1L864,JGN1B_DANRE,,Protein jagunal homolog 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),34.8,187.0,7.4e-23,108.6,sp|Q1L864|JGN1B_DANRE Protein jagunal homolog 1-B OS=Danio rerio OX=7955 GN=jagn1b PE=3 SV=1,GO:0002446; GO:0005783; GO:0005789; GO:0007029; GO:0015031; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:1990266,defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0002376; GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048870,immune system process; endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; cell motility
OG_02922,2.046428043774265,FUN_012008-T1,Peve_00016374,Pocillopora_meandrina_HIv1___RNAseq.g24029.t1,three_way,89.249,FUN_012008-T1,Q17QU4,RB39B_BOVIN,,Ras-related protein Rab-39B (EC 3.6.5.2),Bos taurus (Bovine),54.0,187.0,9.1e-56,218.4,sp|Q17QU4|RB39B_BOVIN Ras-related protein Rab-39B OS=Bos taurus OX=9913 GN=RAB39B PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0032482; GO:0043005; GO:0050808,autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192],cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],GO:0003824; GO:0003924; GO:0005794; GO:0005886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0034330; GO:0043226; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; plasma membrane; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell junction organization; organelle; molecular function regulator activity
OG_02941,2.548763000775815,FUN_012050-T2,Peve_00004087,Pocillopora_meandrina_HIv1___RNAseq.g23649.t1,three_way,70.43433333333333,,,,,,,,,,,,,,,,,
OG_02959,2.3688678729019577,FUN_012105-T1,Peve_00000984,Pocillopora_meandrina_HIv1___RNAseq.9341_t,three_way,72.279,,,,,,,,,,,,,,,,,
OG_02966,2.422022341641472,FUN_012120-T1,Peve_00035447,Pocillopora_meandrina_HIv1___TS.g16803.t2,three_way,75.527,FUN_012120-T1,Q8VIH3,S28A3_RAT,,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3),Rattus norvegicus (Rat),47.3,499.0,1.3e-119,431.8,sp|Q8VIH3|S28A3_RAT Solute carrier family 28 member 3 OS=Rattus norvegicus OX=10116 GN=Slc28a3 PE=2 SV=1,GO:0001895; GO:0005886; GO:0015213; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642,nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; retina homeostasis [GO:0001895]; uridine transmembrane transport [GO:0015862],brush border membrane [GO:0031526]; plasma membrane [GO:0005886],purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenosine-specific:sodium symporter activity [GO:0015389]; uridine transmembrane transporter activity [GO:0015213],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_02968,3.632689968483573,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_02969,1.9901142003366885,FUN_012132-T1,Peve_00035465,Pocillopora_meandrina_HIv1___RNAseq.g23782.t1,three_way,56.359,FUN_012132-T1,Q07113,MPRI_MOUSE,,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),Mus musculus (Mouse),30.7,2462.0,7.5e-280,966.1,sp|Q07113|MPRI_MOUSE Cation-independent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=Igf2r PE=1 SV=1,GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005802; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:1904772; GO:1905394,animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023],GO:0005615; GO:0005634; GO:0005768; GO:0008289; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060089,extracellular space; nucleus; endosome; lipid binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity
OG_02971,1.4559124694089558,FUN_012134-T1,Peve_00035463,Pocillopora_meandrina_HIv1___RNAseq.g23780.t2,three_way,75.01566666666668,FUN_012134-T1,Q32L92,CNN3_BOVIN,,"Calponin-3 (Calponin, acidic isoform)",Bos taurus (Bovine),36.9,130.0,1.5e-15,84.0,sp|Q32L92|CNN3_BOVIN Calponin-3 OS=Bos taurus OX=9913 GN=CNN3 PE=2 SV=1,GO:0005516; GO:0007015; GO:0008017; GO:0015629; GO:0031032; GO:0051015,actin filament organization [GO:0007015]; actomyosin structure organization [GO:0031032],actin cytoskeleton [GO:0015629],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02978,1.7099254622374442,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_02980,1.4744255748877242,FUN_012150-T1,Peve_00035454,Pocillopora_meandrina_HIv1___RNAseq.9397_t,three_way,84.231,FUN_012150-T1,Q00796,DHSO_HUMAN,,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",Homo sapiens (Human),58.6,263.0,1.2e-85,317.8,sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0008270; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; sorbitol catabolic process [GO:0006062]; xylitol catabolic process [GO:0051160]; xylitol metabolic process [GO:0051164],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],"(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase (NAD+) activity [GO:0050255]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005829; GO:0005929; GO:0005975; GO:0007018; GO:0016491; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; extracellular space; cytosol; cilium; carbohydrate metabolic process; microtubule-based movement; oxidoreductase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_02981,1.286263822127217,FUN_012151-T1,Peve_00035456,Pocillopora_meandrina_HIv1___RNAseq.g23773.t1,three_way,68.10066666666667,FUN_012151-T1,Q91W96,,,,,33.8,769.0,1.4999999999999999e-92,342.4,sp|Q91W96|APC4_MOUSE Anaphase-promoting complex subunit 4 OS=Mus musculus OX=10090 GN=Anapc4 PE=1 SV=1,,,,,,
OG_02982,3.075951921381261,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_02985,2.4127759763226613,FUN_012155-T1,Peve_00040791,Pocillopora_meandrina_HIv1___RNAseq.g23435.t1,three_way,55.4285,FUN_012155-T1,E7FA21,,,,,24.2,854.0,6.6e-38,161.0,sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1,,,,,,
OG_02986,1.0045253987819611,FUN_012156-T1,Peve_00040786,Pocillopora_meandrina_HIv1___RNAseq.g23443.t3,three_way,55.64566666666666,FUN_012156-T1,Q2PFX0,,,,,47.5,524.0,3.500000000000001e-118,426.8,sp|Q2PFX0|ATE1_MACFA Arginyl-tRNA--protein transferase 1 OS=Macaca fascicularis OX=9541 GN=ATE1 PE=2 SV=1,,,,,,
OG_02987,1.7077330779775113,FUN_012159-T1,Peve_00040785,Pocillopora_meandrina_HIv1___RNAseq.g23444.t1,three_way,81.69933333333333,FUN_012159-T1,Q6DGJ3,,,,,64.5,93.0,6e-25,114.8,sp|Q6DGJ3|TIM13_DANRE Mitochondrial import inner membrane translocase subunit Tim13 OS=Danio rerio OX=7955 GN=timm13 PE=3 SV=1,,,,,,
OG_02993,1.698939284036724,FUN_012169-T1,Peve_00008636,Pocillopora_meandrina_HIv1___RNAseq.g23452.t1,three_way,71.68166666666667,,,,,,,,,,,,,,,,,
OG_02997,1.2529371986070743,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03000,1.051485954333577,FUN_012179-T1,Peve_00001104,Pocillopora_meandrina_HIv1___RNAseq.g23863.t1,three_way,61.80133333333333,FUN_012179-T1,Q61503,5NTD_MOUSE,,5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73),Mus musculus (Mouse),44.1,535.0,7.7e-125,449.1,sp|Q61503|5NTD_MOUSE 5'-nucleotidase OS=Mus musculus OX=10090 GN=Nt5e PE=1 SV=2,GO:0000166; GO:0002953; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008253; GO:0008270; GO:0009897; GO:0016020; GO:0033198; GO:0042802; GO:0046032; GO:0046034; GO:0046086; GO:0050340; GO:0050483; GO:0050484; GO:0050728; GO:0055074; GO:0140928,adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; nucleotide binding [GO:0000166]; thymidylate 5'-phosphatase activity [GO:0050340]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0007155; GO:0016787; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; plasma membrane; cell adhesion; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03001,1.6041926584913704,FUN_012180-T1,Peve_00020513,Pocillopora_meandrina_HIv1___RNAseq.g23512.t1,three_way,61.40383333333333,FUN_012180-T1,J9HGJ1,,,,,34.1,88.0,9.7e-08,59.3,sp|J9HGJ1|LTRIN_AEDAE Lymphotoxin beta receptor inhibitor OS=Aedes aegypti OX=7159 GN=AaeL_AAEL017253 PE=1 SV=1,,,,,,
OG_03004,1.878775169162868,FUN_012192-T1,Peve_00013741,Pocillopora_meandrina_HIv1___RNAseq.g23419.t1,three_way,64.87933333333334,FUN_012192-T1,Q9NFP5,,,,,41.6,101.0,5.9e-11,68.2,sp|Q9NFP5|SH3BG_DROME SH3 domain-binding glutamic acid-rich protein homolog OS=Drosophila melanogaster OX=7227 GN=Sh3beta PE=1 SV=2,,,,,,
OG_03005,1.7132215641730668,FUN_012193-T1,Peve_00013740,Pocillopora_meandrina_HIv1___RNAseq.g23420.t1,three_way,60.66016666666667,FUN_012193-T1,Q91VW3,,,,,44.8,87.0,1.9e-17,89.7,sp|Q91VW3|SH3L3_MOUSE SH3 domain-binding glutamic acid-rich-like protein 3 OS=Mus musculus OX=10090 GN=Sh3bgrl3 PE=1 SV=1,,,,,,
OG_03006,2.594321651108916,FUN_012194-T1,Peve_00013739,Pocillopora_meandrina_HIv1___RNAseq.g23421.t2,three_way,77.17933333333333,FUN_012194-T1,Q6NYU7,,,,,59.0,249.0,1.1e-77,291.2,sp|Q6NYU7|UPP_DANRE Uracil phosphoribosyltransferase homolog OS=Danio rerio OX=7955 GN=uprt PE=2 SV=1,,,,,,
OG_03009,1.8429782125175849,FUN_012218-T1,Peve_00005373,Pocillopora_meandrina_HIv1___TS.g16318.t1,three_way,65.238,FUN_012218-T1,Q008S8,,,,,35.3,405.0,6.800000000000001e-58,226.5,sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2,,,,,,
OG_03017,1.3589761768006248,FUN_012237-T1,Peve_00020565,Pocillopora_meandrina_HIv1___TS.g16409.t1,three_way,77.12433333333334,FUN_012237-T1,P52649,,,,,48.8,562.0,8.6e-150,531.9,sp|P52649|CY24B_PIG NADPH oxidase 2 OS=Sus scrofa OX=9823 GN=CYBB PE=2 SV=3,,,,,,
OG_03019,2.44025668604786,FUN_012239-T1,Peve_00020584,Pocillopora_meandrina_HIv1___TS.g16406.t3,three_way,55.63166666666667,FUN_012239-T1,Q8BGT0,OSTM1_MOUSE,,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit) (Grey-lethal protein),Mus musculus (Mouse),27.2,239.0,1.4e-20,101.7,sp|Q8BGT0|OSTM1_MOUSE Osteopetrosis-associated transmembrane protein 1 OS=Mus musculus OX=10090 GN=Ostm1 PE=1 SV=1,GO:0005765; GO:0005829; GO:0030316; GO:0030321; GO:0034707,osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765],,GO:0005829; GO:0030154,cytosol; cell differentiation
OG_03020,1.07888563949144,FUN_012240-T1,Peve_00020563,Pocillopora_meandrina_HIv1___TS.g16404.t1,three_way,71.79433333333333,FUN_012240-T1,Q7XJJ7,,,,,38.9,525.0,8.899999999999999e-92,339.3,sp|Q7XJJ7|FAAH_ARATH Fatty acid amide hydrolase OS=Arabidopsis thaliana OX=3702 GN=FAAH PE=1 SV=1,,,,,,
OG_03024,2.118814401091322,FUN_012250-T1,Peve_00020519,Pocillopora_meandrina_HIv1___RNAseq.g23517.t1,three_way,75.335,FUN_012250-T1,Q5T5C0,STXB5_HUMAN,,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),Homo sapiens (Human),38.5,1156.0,1.5999999999999999e-208,728.0,sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807],acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0005829; GO:0005886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03028,1.730841604523685,FUN_012254-T1,Peve_00036363,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1a,three_way,48.51266666666667,FUN_012254-T1,Q6NV72,,,,,22.0,641.0,1.3e-16,89.7,sp|Q6NV72|WDCP_MOUSE WD repeat and coiled-coil-containing protein OS=Mus musculus OX=10090 GN=Wdcp PE=2 SV=2,,,,,,
OG_03029,1.3979102620100203,FUN_012257-T2,Peve_00036357,Pocillopora_meandrina_HIv1___TS.g16433.t1,three_way,75.69800000000001,FUN_012257-T2,Q795M8,,,,,37.6,93.0,5.2e-06,54.3,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_03038,1.7462469317269995,FUN_012276-T1,Peve_00014709,Pocillopora_meandrina_HIv1___RNAseq.g23566.t1,three_way,68.43366666666667,FUN_012276-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,32.3,541.0,6.1e-52,208.0,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03040,1.4034238130478425,FUN_012279-T1,Peve_00014710,Pocillopora_meandrina_HIv1___RNAseq.g23569.t1,three_way,80.28833333333333,FUN_012279-T1,Q8BHB4,,,,,63.4,938.0,2.5e-138,494.6,sp|Q8BHB4|WDR3_MOUSE WD repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Wdr3 PE=1 SV=1,,,,,,
OG_03047,1.194654058064316,FUN_012293-T1,Peve_00036366,Pocillopora_meandrina_HIv1___RNAseq.g23562.t1,three_way,84.339,FUN_012293-T1,Q96JB1,,,,,26.2,4649.0,0.0,1572.4,sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2,,,,,,
OG_03048,2.1509148861776777,FUN_012295-T1,Peve_00036365,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1b,three_way,72.36266666666667,FUN_012295-T1,D3ZGS3,OCRL_RAT,,"Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86)",Rattus norvegicus (Rat),48.5,616.0,3.2e-174,613.6,sp|D3ZGS3|OCRL_RAT Inositol polyphosphate 5-phosphatase OCRL OS=Rattus norvegicus OX=10116 GN=Ocrl PE=1 SV=1,GO:0001701; GO:0001750; GO:0004439; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005905; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031267; GO:0031901; GO:0034485; GO:0043005; GO:0046856; GO:0052658; GO:0052659; GO:0052745; GO:0060271,cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],"GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0098772,catalytic activity; nucleus; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_03049,1.583129112031843,FUN_012296-T1,Peve_00002353,Pocillopora_meandrina_HIv1___RNAseq.g23873.t1,three_way,63.77733333333334,FUN_012296-T1,Q4R3G4,,,,,23.3,1242.0,3.8999999999999995e-46,189.1,sp|Q4R3G4|RNF17_MACFA RING finger protein 17 OS=Macaca fascicularis OX=9541 GN=RNF17 PE=2 SV=2,,,,,,
OG_03052,2.535560522096384,FUN_012299-T1,Peve_00038613,Pocillopora_meandrina_HIv1___RNAseq.g23767.t1,three_way,72.542,,,,,,,,,,,,,,,,,
OG_03060,1.374451439948894,FUN_012324-T1,Peve_00022884,Pocillopora_meandrina_HIv1___RNAseq.g23750.t1,three_way,74.87566666666666,,,,,,,,,,,,,,,,,
OG_03061,3.674972992621701,FUN_012325-T1,Peve_00022885,Pocillopora_meandrina_HIv1___RNAseq.g23751.t1,three_way,82.00566666666667,FUN_012325-T1,Q8R3S2,TSN33_MOUSE,,Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane),Mus musculus (Mouse),45.7,258.0,7.699999999999999e-56,218.8,sp|Q8R3S2|TSN33_MOUSE Tetraspanin-33 OS=Mus musculus OX=10090 GN=Tspan33 PE=1 SV=1,GO:0005737; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197,pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197],enzyme binding [GO:0019899],GO:0051604; GO:0065003; GO:0072659,protein maturation; protein-containing complex assembly; protein localization to plasma membrane
OG_03076,1.9899053902961688,FUN_012348-T1,Peve_00029070,Pocillopora_meandrina_HIv1___RNAseq.g24069.t1,three_way,66.19800000000001,FUN_012348-T1,P0C8E4,M3K7_RAT,,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25),Rattus norvegicus (Rat),36.2,796.0,1.6e-112,408.7,sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus OX=10116 GN=Map3k7 PE=1 SV=1,GO:0000165; GO:0000287; GO:0001223; GO:0001525; GO:0001649; GO:0001666; GO:0001841; GO:0002726; GO:0004674; GO:0004707; GO:0004708; GO:0004709; GO:0005114; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010508; GO:0010629; GO:0014069; GO:0016239; GO:0030971; GO:0031625; GO:0032743; GO:0034142; GO:0035173; GO:0038066; GO:0038172; GO:0038173; GO:0042742; GO:0042802; GO:0043123; GO:0043276; GO:0043410; GO:0043507; GO:0045787; GO:0045793; GO:0046330; GO:0051403; GO:0060348; GO:0060546; GO:0070498; GO:0071356; GO:0071456; GO:0071560; GO:0097110; GO:0097190; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:1901224; GO:1902443; GO:1904385; GO:1904707; GO:1904754; GO:1990450; GO:1990776; GO:2000377; GO:2000378; GO:2001234,angiogenesis [GO:0001525]; anoikis [GO:0043276]; apoptotic signaling pathway [GO:0097190]; bone development [GO:0060348]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; defense response to bacterium [GO:0042742]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression [GO:0010629]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179],ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; inflammatory response; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03078,1.581142788512103,FUN_012350-T1,Peve_00042525,Pocillopora_meandrina_HIv1___RNAseq.g23281.t1,three_way,96.66666666666669,FUN_012350-T1,Q5ZI57,,,,,72.2,180.0,6.499999999999999e-75,281.6,sp|Q5ZI57|TPPC3_CHICK Trafficking protein particle complex subunit 3 OS=Gallus gallus OX=9031 GN=TRAPPC3 PE=2 SV=1,,,,,,
OG_03084,2.858252006126901,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03085,2.7033488598224324,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_03098,1.1973511028274544,FUN_012385-T1,Peve_00030647,Pocillopora_meandrina_HIv1___RNAseq.g23346.t1,three_way,76.08833333333334,FUN_012385-T1,Q99ND9,,,,,51.5,231.0,8.2e-43,175.3,sp|Q99ND9|RWDD1_RAT RWD domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Rwdd1 PE=2 SV=1,,,,,,
OG_03101,1.7244759249565835,FUN_012388-T1,Peve_00029782,Pocillopora_meandrina_HIv1___RNAseq.g23654.t1,three_way,67.31333333333333,,,,,,,,,,,,,,,,,
OG_03114,1.3092275845575414,FUN_012419-T1,Peve_00026917,Pocillopora_meandrina_HIv1___TS.g16564.t1,three_way,78.13533333333334,FUN_012419-T1,Q8HXQ3,,,,,68.6,153.0,6.3999999999999995e-55,214.9,sp|Q8HXQ3|SODC_HYLLA Superoxide dismutase [Cu-Zn] OS=Hylobates lar OX=9580 GN=SOD1 PE=2 SV=3,,,,,,
OG_03117,2.056743357055223,FUN_012465-T1,Peve_00000724,Pocillopora_meandrina_HIv1___RNAseq.g24004.t1,three_way,90.188,FUN_012465-T1,P63030,,,,,73.1,78.0,2.8999999999999997e-29,129.0,sp|P63030|MPC1_MOUSE Mitochondrial pyruvate carrier 1 OS=Mus musculus OX=10090 GN=Mpc1 PE=1 SV=1,,,,,,
OG_03118,2.1185273826136712,FUN_012466-T1,Peve_00034217,Pocillopora_meandrina_HIv1___RNAseq.g24003.t1,three_way,65.63133333333333,FUN_012466-T1,P46029,,,,,41.7,672.0,1.1e-136,488.8,sp|P46029|S15A2_RABIT Solute carrier family 15 member 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC15A2 PE=1 SV=1,,,,,,
OG_03120,2.303136226360128,FUN_012469-T1,Peve_00007945,Pocillopora_meandrina_HIv1___RNAseq.g27161.t1,three_way,62.98266666666667,FUN_012469-T1,Q9XTR8,,,,,29.8,302.0,2.6e-34,147.9,sp|Q9XTR8|LIP1_CAEEL Lipase ZK262.3 OS=Caenorhabditis elegans OX=6239 GN=txt-8 PE=1 SV=1,,,,,,
OG_03123,1.2708270564509243,FUN_012477-T1,Peve_00004006,Pocillopora_meandrina_HIv1___RNAseq.g23991.t1,three_way,62.38933333333333,,,,,,,,,,,,,,,,,
OG_03126,1.9327594241759989,FUN_012482-T1,Peve_00004001,Pocillopora_meandrina_HIv1___RNAseq.g23996.t2,three_way,49.154,FUN_012482-T1,O15287,FANCG_HUMAN,,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),26.7,243.0,4.6e-08,61.6,sp|O15287|FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens OX=9606 GN=FANCG PE=1 SV=1,GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0016607; GO:0036297; GO:0043240,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684],GO:0003677; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0007005; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleoplasm; mitochondrion; cytosol; DNA repair; mitochondrion organization; reproductive process; organelle; anatomical structure development
OG_03135,1.5427034203135754,FUN_012514-T1,Peve_00035872,Pocillopora_meandrina_HIv1___RNAseq.g23968.t1,three_way,64.965,FUN_012514-T1,Q9WVS6,,,,,40.9,286.0,8.3e-64,245.4,sp|Q9WVS6|PRKN_MOUSE E3 ubiquitin-protein ligase parkin OS=Mus musculus OX=10090 GN=Prkn PE=1 SV=1,,,,,,
OG_03137,1.4448661996329757,FUN_012518-T1,Peve_00022370,Pocillopora_meandrina_HIv1___RNAseq.g23957.t1,three_way,84.53366666666666,FUN_012518-T1,Q8CHX6,MBTP2_MOUSE,,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P),Mus musculus (Mouse),40.6,508.0,4.7e-104,379.8,sp|Q8CHX6|MBTP2_MOUSE Membrane-bound transcription factor site-2 protease OS=Mus musculus OX=10090 GN=Mbtps2 PE=2 SV=1,GO:0000139; GO:0004222; GO:0005737; GO:0005789; GO:0007095; GO:0008203; GO:0031293; GO:0034976; GO:0045542; GO:0045944; GO:0046872; GO:0051604; GO:0070977; GO:0140537,bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein maturation [GO:0051604]; response to endoplasmic reticulum stress [GO:0034976],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; transcription regulator activator activity [GO:0140537],GO:0003824; GO:0006355; GO:0006629; GO:0016787; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03139,1.0698739241074893,FUN_012521-T1,Peve_00029780,Pocillopora_meandrina_HIv1___RNAseq.g23961.t1,three_way,79.82916666666667,FUN_012521-T1,Q3SZ90,RL13A_BOVIN,,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),Bos taurus (Bovine),63.1,195.0,5.899999999999999e-68,259.6,sp|Q3SZ90|RL13A_BOVIN Large ribosomal subunit protein uL13 OS=Bos taurus OX=9913 GN=RPL13A PE=2 SV=3,GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194,cellular response to type II interferon [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002376; GO:0003723; GO:0005198; GO:0005840; GO:0043226; GO:0048870,immune system process; RNA binding; structural molecule activity; ribosome; organelle; cell motility
OG_03148,1.2714014613037614,FUN_012534-T1,Peve_00034224,Pocillopora_meandrina_HIv1___RNAseq.g23953.t1,three_way,94.06183333333334,FUN_012534-T1,Q148M7,,,,,70.2,121.0,2e-40,166.4,sp|Q148M7|TAF13_BOVIN Transcription initiation factor TFIID subunit 13 OS=Bos taurus OX=9913 GN=TAF13 PE=2 SV=1,,,,,,
OG_03150,1.0120360198147849,FUN_012536-T1,Peve_00034222,Pocillopora_meandrina_HIv1___RNAseq.g23951.t1,three_way,83.14166666666667,FUN_012536-T1,Q5RES3,,,,,52.9,87.0,3.9e-17,88.6,sp|Q5RES3|LYRM2_PONAB LYR motif-containing protein 2 OS=Pongo abelii OX=9601 GN=LYRM2 PE=3 SV=1,,,,,,
OG_03158,2.6431501683180434,FUN_012554-T1,Peve_00030421,Pocillopora_meandrina_HIv1___RNAseq.g23587.t2,three_way,58.8805,,,,,,,,,,,,,,,,,
OG_03161,3.1409336358365256,FUN_012557-T1,Peve_00030425,Pocillopora_meandrina_HIv1___TS.g16464.t1,three_way,86.991,FUN_012557-T1,Q8IZN3,ZDH14_HUMAN,,Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14),Homo sapiens (Human),65.3,303.0,6.5e-121,435.6,sp|Q8IZN3|ZDH14_HUMAN Palmitoyltransferase ZDHHC14 OS=Homo sapiens OX=9606 GN=ZDHHC14 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0003824; GO:0005783; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03162,1.1897253534801429,FUN_012560-T1,Peve_00016376,Pocillopora_meandrina_HIv1___RNAseq.g23583.t2,three_way,80.59633333333333,FUN_012560-T1,O19072,,,,,62.7,316.0,7.9e-115,415.2,"sp|O19072|OTC_PIG Ornithine transcarbamylase, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=OTC PE=2 SV=1",,,,,,
OG_03166,1.7581742450666025,FUN_012588-T1,Peve_00038785,Pocillopora_meandrina_HIv1___TS.g2635.t1,three_way,81.07383333333334,FUN_012588-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,30.8,568.0,2.3e-54,216.1,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03168,2.2393992247345285,FUN_012590-T1,Peve_00038782,Pocillopora_meandrina_HIv1___RNAseq.g13637.t1,three_way,72.70233333333334,FUN_012590-T1,Q53FA7,QORX_HUMAN,,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),Homo sapiens (Human),53.7,322.0,9.4e-97,355.1,sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2,GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402,NADP metabolic process [GO:0006739],cytosol [GO:0005829],NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038],GO:0003824; GO:0005829; GO:0016491; GO:0055086,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03170,1.2589500007087036,FUN_012592-T1,Peve_00038776,Pocillopora_meandrina_HIv1___RNAseq.g13634.t1,three_way,58.254333333333335,,,,,,,,,,,,,,,,,
OG_03172,1.378655139343311,FUN_012595-T1,Peve_00042401,Pocillopora_meandrina_HIv1___TS.g2626.t1,three_way,93.69466666666666,FUN_012595-T1,Q8BWD8,,,,,81.7,367.0,3.4e-181,636.0,sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus OX=10090 GN=Cdk19 PE=2 SV=1,,,,,,
OG_03176,1.5839099992590844,FUN_012611-T1,Peve_00040819,Pocillopora_meandrina_HIv1___RNAseq.g13692.t1,three_way,81.25366666666666,FUN_012611-T1,Q64674,,,,,68.6,283.0,1.6e-115,417.2,sp|Q64674|SPEE_MOUSE Spermidine synthase OS=Mus musculus OX=10090 GN=Srm PE=1 SV=1,,,,,,
OG_03180,1.389550985869321,FUN_012628-T1,Peve_00040111,Pocillopora_meandrina_HIv1___RNAseq.g13728.t1,three_way,73.136,FUN_012628-T1,Q5BKR2,SL9B2_MOUSE,,Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Mus musculus (Mouse),50.6,451.0,9.2e-114,412.1,sp|Q5BKR2|SL9B2_MOUSE Sodium/hydrogen exchanger 9B2 OS=Mus musculus OX=10090 GN=Slc9b2 PE=1 SV=2,GO:0005765; GO:0005886; GO:0010008; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0046872; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; lithium ion transport [GO:0010351]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; metal ion binding [GO:0046872]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_03181,2.8988711525100705,FUN_012630-T1,Peve_00040109,Pocillopora_meandrina_HIv1___RNAseq.g22915.t2,three_way,37.121,,,,,,,,,,,,,,,,,
OG_03183,1.4846080559439163,FUN_012638-T1,Peve_00036816,Pocillopora_meandrina_HIv1___RNAseq.g22910.t1,three_way,71.77066666666667,FUN_012638-T1,Q6P1A2,MBOA5_HUMAN,,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),Homo sapiens (Human),39.7,448.0,2e-91,337.8,sp|Q6P1A2|MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens OX=9606 GN=LPCAT3 PE=1 SV=1,GO:0003841; GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047144; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1903573; GO:1905885,chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617],GO:0003824; GO:0006575; GO:0006629; GO:0016740; GO:0061024; GO:0065003,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity; membrane organization; protein-containing complex assembly
OG_03190,1.1929745040734092,FUN_012662-T1,Peve_00020495,Pocillopora_meandrina_HIv1___RNAseq.g22891.t1,three_way,60.961666666666666,FUN_012662-T1,Q8BZ20,,,,,32.8,649.0,2e-78,295.0,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_03196,1.44433769364174,FUN_012675-T1,Peve_00025241,Pocillopora_meandrina_HIv1___RNAseq.g22881.t1,three_way,86.62966666666667,FUN_012675-T1,Q9UNL2,,,,,60.6,180.0,9.9e-55,214.5,sp|Q9UNL2|SSRG_HUMAN Translocon-associated protein subunit gamma OS=Homo sapiens OX=9606 GN=SSR3 PE=1 SV=1,,,,,,
OG_03198,1.4626664708495165,FUN_012677-T1,Peve_00042301,Pocillopora_meandrina_HIv1___RNAseq.g22878.t1,three_way,73.87016666666666,FUN_012677-T1,Q9C0J8,WDR33_HUMAN,,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa),Homo sapiens (Human),74.4,406.0,2.2e-161,571.2,sp|Q9C0J8|WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2,GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0007283; GO:0031124,mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283],collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0016071; GO:0022414; GO:0043226,RNA binding; nucleus; nucleoplasm; DNA repair; mRNA metabolic process; reproductive process; organelle
OG_03199,1.4272950316266255,FUN_012684-T1,Peve_00042302,Pocillopora_meandrina_HIv1___RNAseq.g22874.t1,three_way,80.24466666666666,FUN_012684-T1,P52209,6PGD_HUMAN,,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)",Homo sapiens (Human),76.5,481.0,1.5999999999999998e-221,770.0,"sp|P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3",GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0050661; GO:0070062,"D-gluconate metabolic process [GO:0019521]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]",cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03203,1.8494598282452872,FUN_012689-T1,Peve_00016816,Pocillopora_meandrina_HIv1___RNAseq.g22864.t1,three_way,78.05083333333333,FUN_012689-T1,Q9YHY6,,,,,42.0,1454.0,3.1999999999999995e-300,1033.1,sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1,,,,,,
OG_03207,1.4670387060147525,FUN_012699-T1,Peve_00016830,Pocillopora_meandrina_HIv1___RNAseq.g22854.t1,three_way,70.60966666666667,FUN_012699-T1,O94923,GLCE_HUMAN,,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),Homo sapiens (Human),44.1,612.0,9.099999999999999e-137,488.8,sp|O94923|GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3,GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0060391,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",GO:0003824; GO:0005794; GO:0009101; GO:0016853; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; isomerase activity; organelle; carbohydrate derivative metabolic process
OG_03208,2.78006636139274,FUN_012700-T1,Peve_00016832,Pocillopora_meandrina_HIv1___RNAseq.g12826.t1,three_way,67.51966666666667,FUN_012700-T1,Q12794,,,,,39.9,353.0,2.5000000000000002e-73,278.1,sp|Q12794|HYAL1_HUMAN Hyaluronidase-1 OS=Homo sapiens OX=9606 GN=HYAL1 PE=1 SV=2,,,,,,
OG_03211,1.3370796190402543,FUN_012707-T1,Peve_00004150,Pocillopora_meandrina_HIv1___RNAseq.g12831.t1,three_way,67.89066666666668,FUN_012707-T1,A7YY53,ADPRM_BOVIN,,Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase),Bos taurus (Bovine),41.1,333.0,1.1e-70,268.5,sp|A7YY53|ADPRM_BOVIN Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Bos taurus OX=9913 GN=ADPRM PE=2 SV=2,GO:0008663; GO:0030145; GO:0047631; GO:0047734,,,"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03224,1.3729511411395532,FUN_012764-T2,Peve_00006134,Pocillopora_meandrina_HIv1___TS.g16045.t1,three_way,49.54133333333333,FUN_012764-T2,Q5RFG8,UBE3D_PONAB,,E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,359.0,8.100000000000001e-28,126.3,sp|Q5RFG8|UBE3D_PONAB E3 ubiquitin-protein ligase E3D OS=Pongo abelii OX=9601 GN=UBE3D PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0051865; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03233,1.091909134124463,FUN_012778-T1,Peve_00017055,Pocillopora_meandrina_HIv1___RNAseq.g12882.t1,three_way,73.01033333333334,FUN_012778-T1,A7RL75,,,,,52.5,179.0,4e-40,166.4,sp|A7RL75|TTC36_NEMVE Tetratricopeptide repeat protein 36 homolog OS=Nematostella vectensis OX=45351 GN=ttc36 PE=3 SV=1,,,,,,
OG_03234,1.3411581839036522,FUN_012779-T1,Peve_00017054,Pocillopora_meandrina_HIv1___RNAseq.g12883.t1,three_way,75.45166666666667,FUN_012779-T1,Q9WVK0,ATRAP_MOUSE,,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),Mus musculus (Mouse),46.3,121.0,1.7000000000000002e-22,107.5,sp|Q9WVK0|ATRAP_MOUSE Type-1 angiotensin II receptor-associated protein OS=Mus musculus OX=10090 GN=Agtrap PE=1 SV=2,GO:0000139; GO:0001666; GO:0004945; GO:0005789; GO:0005886; GO:0005938; GO:0008217; GO:0030659,regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],angiotensin type II receptor activity [GO:0004945],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03235,1.7783293612482254,FUN_012784-T1,Peve_00018305,Pocillopora_meandrina_HIv1___TS.g1875.t1,three_way,84.45266666666667,FUN_012784-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),47.9,816.0,1.4e-205,718.4,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_03237,1.011193549217704,FUN_012787-T1,Peve_00023538,Pocillopora_meandrina_HIv1___TS.g1877.t1,three_way,62.16516666666666,FUN_012787-T1,Q920Q2,REV1_MOUSE,,DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase),Mus musculus (Mouse),33.0,1286.0,1.2e-152,542.3,sp|Q920Q2|REV1_MOUSE DNA repair protein REV1 OS=Mus musculus OX=10090 GN=Rev1 PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0009411; GO:0017125; GO:0042276; GO:0046872,error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_03248,1.1432267722932994,FUN_012927-T1,Peve_00000417,Pocillopora_meandrina_HIv1___RNAseq.g12969.t1,three_way,70.33383333333335,FUN_012927-T1,P08510,,,,,55.7,397.0,3.6e-99,363.6,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_03252,2.6623758530763517,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_03255,1.8766972457696096,FUN_013023-T1,Peve_00032574,Pocillopora_meandrina_HIv1___RNAseq.g12958.t1,three_way,85.64083333333333,,,,,,,,,,,,,,,,,
OG_03259,1.344780420715112,FUN_013077-T2,Peve_00027399,Pocillopora_meandrina_HIv1___RNAseq.g13103.t1,three_way,65.751,,,,,,,,,,,,,,,,,
OG_03261,1.4397020033937804,FUN_013085-T1,Peve_00027392,Pocillopora_meandrina_HIv1___RNAseq.g13092.t2,three_way,58.874,FUN_013085-T1,Q8IZH2,XRN1_HUMAN,,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),45.9,1541.0,0.0,1238.8,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; plasma membrane; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03270,1.7758278677478732,FUN_013139-T1,Peve_00042385,Pocillopora_meandrina_HIv1___RNAseq.g23012.t1,three_way,50.720333333333336,FUN_013139-T1,Q63341,MMP12_RAT,,Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12),Rattus norvegicus (Rat),36.7,267.0,1.2e-34,148.7,sp|Q63341|MMP12_RAT Macrophage metalloelastase OS=Rattus norvegicus OX=10116 GN=Mmp12 PE=2 SV=1,GO:0000122; GO:0001046; GO:0001666; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0009410; GO:0010628; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050679; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1901163; GO:1904905,"bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; wound healing, spreading of epidermal cells [GO:0035313]",cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005615; GO:0005634; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030163; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096; GO:1901135,"DNA binding; catalytic activity; extracellular space; nucleus; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03273,2.3944964663470656,FUN_013146-T1,Peve_00024360,Pocillopora_meandrina_HIv1___RNAseq.g13823.t1,three_way,75.41933333333333,FUN_013146-T1,Q5U247,,,,,34.6,673.0,1e-96,355.9,sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1,,,,,,
OG_03285,1.3654845106920992,FUN_013323-T1,Peve_00027397,Pocillopora_meandrina_HIv1___RNAseq.g941.t1,three_way,74.55333333333333,FUN_013323-T1,Q9D2I5,ARMC9_MOUSE,,LisH domain-containing protein ARMC9,Mus musculus (Mouse),50.8,675.0,6.9e-166,585.9,sp|Q9D2I5|ARMC9_MOUSE LisH domain-containing protein ARMC9 OS=Mus musculus OX=10090 GN=Armc9 PE=1 SV=1,GO:0005737; GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0043226; GO:0044782,microtubule organizing center; cilium; organelle; cilium organization
OG_03289,1.378254071708533,FUN_013330-T1,Peve_00022425,Pocillopora_meandrina_HIv1___RNAseq.g12990.t1a,three_way,66.249,FUN_013330-T1,P42893,,,,,37.2,686.0,2.6000000000000003e-133,477.6,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03294,1.5414380871158735,FUN_013359-T1,Peve_00001202,Pocillopora_meandrina_HIv1___TS.g2338.t1,three_way,77.81466666666667,,,,,,,,,,,,,,,,,
OG_03296,1.0429148458035775,FUN_013363-T1,Peve_00001194,Pocillopora_meandrina_HIv1___RNAseq.g13339.t1,three_way,64.70333333333333,FUN_013363-T1,P61007,,,,,60.4,169.0,2.2e-55,216.9,sp|P61007|RAB8A_CANLF Ras-related protein Rab-8A OS=Canis lupus familiaris OX=9615 GN=RAB8A PE=1 SV=1,,,,,,
OG_03298,1.4326803210295027,FUN_013365-T1,Peve_00001191,Pocillopora_meandrina_HIv1___RNAseq.g13342.t1,three_way,66.11066666666666,FUN_013365-T1,Q8IS64,,,,,46.9,685.0,1.8e-185,651.0,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03299,2.798172556762321,FUN_013366-T1,Peve_00001190,Pocillopora_meandrina_HIv1___RNAseq.g13343.t1,three_way,74.01916666666666,FUN_013366-T1,Q28IJ3,,,,,50.0,80.0,6.2e-13,74.7,sp|Q28IJ3|PXL2B_XENTR Prostamide/prostaglandin F synthase OS=Xenopus tropicalis OX=8364 GN=prxl2b PE=2 SV=1,,,,,,
OG_03300,1.173149473100011,FUN_013368-T1,Peve_00001209,Pocillopora_meandrina_HIv1___RNAseq.g13344.t1,three_way,89.73183333333333,FUN_013368-T1,Q96C19,,,,,64.6,161.0,5.9e-50,198.7,sp|Q96C19|EFHD2_HUMAN EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1,,,,,,
OG_03311,2.307241409372858,FUN_013389-T1,Peve_00031288,Pocillopora_meandrina_HIv1___TS.g15861.t1,three_way,67.08366666666667,,,,,,,,,,,,,,,,,
OG_03314,1.3551954968366224,FUN_013392-T1,Peve_00028094,Pocillopora_meandrina_HIv1___RNAseq.g22974.t2,three_way,67.61166666666666,,,,,,,,,,,,,,,,,
OG_03320,1.60773769482541,FUN_013399-T1,Peve_00028082,Pocillopora_meandrina_HIv1___RNAseq.g22938.t1,three_way,78.69366666666667,FUN_013399-T1,Q7T3H7,,,,,49.5,194.0,3.4e-48,193.0,sp|Q7T3H7|MED18_DANRE Mediator of RNA polymerase II transcription subunit 18 OS=Danio rerio OX=7955 GN=med18 PE=2 SV=1,,,,,,
OG_03332,3.4254324204059983,FUN_013545-T1,Peve_00038572,Pocillopora_meandrina_HIv1___RNAseq.g22955.t1a,three_way,83.74533333333333,FUN_013545-T1,Q99570,PI3R4_HUMAN,,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Homo sapiens (Human),51.6,1405.0,0.0,1382.1,sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3,GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043231; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310,autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241],"autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0005773; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; vacuole; microtubule organizing center; cytosol; cytoskeleton; cilium; lipid metabolic process; intracellular protein transport; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03334,1.4255490106135926,FUN_013555-T1,Peve_00024216,Pocillopora_meandrina_HIv1___RNAseq.g22959.t1,three_way,90.33133333333332,FUN_013555-T1,Q9YHT2,,,,,83.1,249.0,8.500000000000001e-126,451.4,"sp|Q9YHT2|SDHB_CHICK Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Gallus gallus OX=9031 GN=SDHB PE=1 SV=1",,,,,,
OG_03337,2.4585036598764707,FUN_013559-T1,Peve_00036543,Pocillopora_meandrina_HIv1___RNAseq.g22968.t1,three_way,88.23,FUN_013559-T1,P47756,CAPZB_HUMAN,,F-actin-capping protein subunit beta (CapZ beta),Homo sapiens (Human),80.8,271.0,1.9999999999999999e-128,459.9,sp|P47756|CAPZB_HUMAN F-actin-capping protein subunit beta OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=5,GO:0003779; GO:0005829; GO:0005856; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0014069; GO:0015629; GO:0016020; GO:0022604; GO:0030017; GO:0030027; GO:0030032; GO:0030863; GO:0045296; GO:0051016; GO:0070062; GO:0071203; GO:0098685; GO:0098686; GO:0120212,actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; regulation of cell morphogenesis [GO:0022604],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; sarcomere [GO:0030017]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm head-tail coupling apparatus [GO:0120212]; WASH complex [GO:0071203],actin binding [GO:0003779]; cadherin binding [GO:0045296],GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_03340,2.1788899814180094,FUN_013570-T1,Peve_00018159,Pocillopora_meandrina_HIv1___RNAseq.g13476.t1,three_way,85.26566666666666,FUN_013570-T1,Q9CPV0,TM107_MOUSE,,Transmembrane protein 107,Mus musculus (Mouse),52.7,129.0,1.4e-32,140.6,sp|Q9CPV0|TM107_MOUSE Transmembrane protein 107 OS=Mus musculus OX=10090 GN=Tmem107 PE=1 SV=1,GO:0003127; GO:0007368; GO:0010468; GO:0016020; GO:0021532; GO:0035869; GO:0036038; GO:0042733; GO:0044782; GO:0060021; GO:0060271; GO:0097094; GO:1904491; GO:1905515,cilium assembly [GO:0060271]; cilium organization [GO:0044782]; craniofacial suture morphogenesis [GO:0097094]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021],ciliary transition zone [GO:0035869]; membrane [GO:0016020]; MKS complex [GO:0036038],,GO:0044782; GO:0048856,cilium organization; anatomical structure development
OG_03346,2.1306894580594187,FUN_013582-T1,Peve_00018189,Pocillopora_meandrina_HIv1___RNAseq.g13504.t1,three_way,62.93,,,,,,,,,,,,,,,,,
OG_03347,1.7572669964648022,FUN_013583-T1,Peve_00018188,Pocillopora_meandrina_HIv1___RNAseq.g13503.t1,three_way,63.407,FUN_013583-T1,Q5RDQ4,,,,,41.8,91.0,2e-11,70.9,sp|Q5RDQ4|CH033_PONAB UPF0488 protein C8orf33 homolog OS=Pongo abelii OX=9601 PE=2 SV=1,,,,,,
OG_03348,1.917757204590959,FUN_013584-T1,Peve_00018186,Pocillopora_meandrina_HIv1___RNAseq.g13502.t1,three_way,72.53633333333333,,,,,,,,,,,,,,,,,
OG_03349,2.991805442293635,FUN_013585-T1,Peve_00018185,Pocillopora_meandrina_HIv1___RNAseq.g13501.t1,three_way,78.13466666666666,FUN_013585-T1,O35454,CLCN6_MOUSE,,H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6),Mus musculus (Mouse),54.1,857.0,1.0999999999999999e-249,864.4,sp|O35454|CLCN6_MOUSE H(+)/Cl(-) exchange transporter 6 OS=Mus musculus OX=10090 GN=Clcn6 PE=1 SV=1,GO:0005247; GO:0005524; GO:0006821; GO:0015297; GO:0031902,chloride transport [GO:0006821],late endosome membrane [GO:0031902],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247],GO:0005215,transporter activity
OG_03350,1.3621973885457603,FUN_013586-T1,Peve_00018184,Pocillopora_meandrina_HIv1___TS.g2494.t1,three_way,61.21066666666667,,,,,,,,,,,,,,,,,
OG_03351,1.6605838884013973,FUN_013587-T1,Peve_00018181,Pocillopora_meandrina_HIv1___RNAseq.g13494.t1,three_way,61.905,FUN_013587-T1,A1A5V9,,,,,27.1,303.0,1.1000000000000001e-27,125.6,sp|A1A5V9|ELP5_DANRE Elongator complex protein 5 OS=Danio rerio OX=7955 GN=elp5 PE=2 SV=1,,,,,,
OG_03355,1.1152284351004504,FUN_013591-T1,Peve_00018178,Pocillopora_meandrina_HIv1___RNAseq.g13491.t1,three_way,67.64033333333333,FUN_013591-T1,Q9Y2Q3,GSTK1_HUMAN,,Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13),Homo sapiens (Human),55.1,216.0,6.900000000000003e-66,251.9,sp|Q9Y2Q3|GSTK1_HUMAN Glutathione S-transferase kappa 1 OS=Homo sapiens OX=9606 GN=GSTK1 PE=1 SV=3,GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006749; GO:0016020; GO:0030855; GO:0070062,epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0016740; GO:0030154; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; cell differentiation; organelle
OG_03357,2.047183245336149,FUN_013594-T1,Peve_00029572,Pocillopora_meandrina_HIv1___RNAseq.g6546.t1,three_way,67.05166666666666,,,,,,,,,,,,,,,,,
OG_03358,1.0898067935461984,FUN_013595-T1,Peve_00034270,Pocillopora_meandrina_HIv1___RNAseq.g13485.t1,three_way,69.64366666666666,FUN_013595-T1,P21728,DRD1_HUMAN,,D(1A) dopamine receptor (Dopamine D1 receptor),Homo sapiens (Human),25.8,368.0,3.4e-16,87.4,sp|P21728|DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD1 PE=1 SV=1,GO:0001588; GO:0001659; GO:0001661; GO:0001662; GO:0001965; GO:0001975; GO:0004930; GO:0004952; GO:0005634; GO:0005789; GO:0005886; GO:0005929; GO:0006606; GO:0007187; GO:0007189; GO:0007191; GO:0007212; GO:0007416; GO:0007613; GO:0007617; GO:0007625; GO:0007628; GO:0008542; GO:0009410; GO:0014002; GO:0015872; GO:0019226; GO:0019228; GO:0021542; GO:0021756; GO:0021853; GO:0030335; GO:0030432; GO:0032795; GO:0035106; GO:0035240; GO:0035249; GO:0042053; GO:0042311; GO:0042417; GO:0042711; GO:0042734; GO:0043197; GO:0043268; GO:0043410; GO:0045211; GO:0046323; GO:0046959; GO:0046960; GO:0048148; GO:0051281; GO:0051584; GO:0051968; GO:0060134; GO:0060158; GO:0060170; GO:0060291; GO:0060292; GO:0071870; GO:0071880; GO:0097648; GO:0097730; GO:0098978; GO:0098982; GO:0099010; GO:0099171; GO:1990763; GO:2001224,"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; cellular response to catecholamine stimulus [GO:0071870]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; D-glucose import [GO:0046323]; dentate gyrus development [GO:0021542]; dopamine metabolic process [GO:0042417]; dopamine transport [GO:0015872]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; grooming behavior [GO:0007625]; habituation [GO:0046959]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; modification of postsynaptic structure [GO:0099010]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein import into nucleus [GO:0006606]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; response to amphetamine [GO:0001975]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]",ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; G protein-coupled receptor complex [GO:0097648]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],"arrestin family protein binding [GO:1990763]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; heterotrimeric G-protein binding [GO:0032795]",GO:0003012; GO:0003013; GO:0005634; GO:0005886; GO:0005929; GO:0006886; GO:0006913; GO:0022414; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0060089,muscle system process; circulatory system process; nucleus; plasma membrane; cilium; intracellular protein transport; nucleocytoplasmic transport; reproductive process; signaling; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular transducer activity
OG_03362,1.4168236491384365,FUN_013601-T1,Peve_00018166,Pocillopora_meandrina_HIv1___RNAseq.g13480.t1,three_way,70.76016666666666,,,,,,,,,,,,,,,,,
OG_03374,1.7653898129746164,FUN_013620-T1,Peve_00014987,Pocillopora_meandrina_HIv1___RNAseq.g13541.t1,three_way,88.12266666666667,FUN_013620-T1,B9GCH9,UREA_ORYSJ,,Urease (EC 3.5.1.5) (Urea amidohydrolase),Oryza sativa subsp. japonica (Rice),62.3,862.0,3.4e-307,1055.4,sp|B9GCH9|UREA_ORYSJ Urease OS=Oryza sativa subsp. japonica OX=39947 GN=Os12g0234800 PE=3 SV=2,GO:0009039; GO:0016151; GO:0035550; GO:0043419,urea catabolic process [GO:0043419],urease complex [GO:0035550],nickel cation binding [GO:0016151]; urease activity [GO:0009039],GO:0003824; GO:0016787; GO:0071941,catalytic activity; hydrolase activity; nitrogen cycle metabolic process
OG_03377,1.8802416639088428,FUN_013623-T1,Peve_00014994,Pocillopora_meandrina_HIv1___RNAseq.g13544.t1,three_way,69.24266666666666,FUN_013623-T1,A9GP79,,,,,32.0,256.0,1.0999999999999998e-24,115.5,sp|A9GP79|URED_SORC5 Urease accessory protein UreD OS=Sorangium cellulosum (strain So ce56) OX=448385 GN=ureD PE=3 SV=2,,,,,,
OG_03379,1.0776726409536346,FUN_013627-T1,Peve_00018598,Pocillopora_meandrina_HIv1___RNAseq.g13548.t1,three_way,66.10166666666667,,,,,,,,,,,,,,,,,
OG_03382,1.3305333636368386,FUN_013634-T1,Peve_00039087,Pocillopora_meandrina_HIv1___RNAseq.g13560.t1,three_way,39.31766666666667,,,,,,,,,,,,,,,,,
OG_03393,1.165091246347569,FUN_014123-T2,Peve_00030269,Pocillopora_meandrina_HIv1___RNAseq.g15590.t1,three_way,84.48033333333333,FUN_014123-T2,O73787,,,,,51.1,915.0,1.6999999999999999e-251,870.5,sp|O73787|GCP3_XENLA Gamma-tubulin complex component 3 homolog OS=Xenopus laevis OX=8355 GN=tubgcp3 PE=1 SV=1,,,,,,
OG_03394,1.1875615563792998,FUN_014166-T1,Peve_00026508,Pocillopora_meandrina_HIv1___RNAseq.g7362.t1,three_way,57.504,FUN_014166-T1,Q9H2K2,,,,,28.4,211.0,3.9e-08,62.0,sp|Q9H2K2|TNKS2_HUMAN Poly [ADP-ribose] polymerase tankyrase-2 OS=Homo sapiens OX=9606 GN=TNKS2 PE=1 SV=1,,,,,,
OG_03406,2.5793151389946565,FUN_014449-T1,Peve_00009606,Pocillopora_meandrina_HIv1___RNAseq.1985_t,three_way,77.316,FUN_014449-T1,Q54BU4,ABCB1_DICDI,,ABC transporter B family member 1 (ABC transporter ABCB.1),Dictyostelium discoideum (Social amoeba),51.9,620.0,1.3e-162,575.1,sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1,GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359,chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085],membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626],GO:0003824; GO:0005215; GO:0016787; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_03409,2.2433115892761903,FUN_014456-T1,Peve_00009600,Pocillopora_meandrina_HIv1___RNAseq.g22824.t1,three_way,65.45816666666667,FUN_014456-T1,O35551,RABE1_MOUSE,,Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha),Mus musculus (Mouse),33.5,367.0,7.700000000000001e-38,160.6,sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2,GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:1903441,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037],growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; cytosol; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_03423,1.411934838752739,FUN_014477-T1,Peve_00037306,Pocillopora_meandrina_HIv1___RNAseq.g22817.t1,three_way,73.20533333333333,FUN_014477-T1,Q9NZ71,,,,,43.0,1046.0,9.9e-235,815.1,sp|Q9NZ71|RTEL1_HUMAN Regulator of telomere elongation helicase 1 OS=Homo sapiens OX=9606 GN=RTEL1 PE=1 SV=2,,,,,,
OG_03425,1.5499086736476289,FUN_014480-T1,Peve_00037298,Pocillopora_meandrina_HIv1___RNAseq.g22815.t1,three_way,78.496,FUN_014480-T1,Q6AZJ9,,,,,63.9,83.0,3e-28,125.9,sp|Q6AZJ9|RS21_XENLA Small ribosomal subunit protein eS21 OS=Xenopus laevis OX=8355 GN=rps21 PE=1 SV=1,,,,,,
OG_03432,1.2841497715910477,FUN_014489-T1,Peve_00033868,Pocillopora_meandrina_HIv1___RNAseq.g22519.t1,three_way,84.413,FUN_014489-T1,A0JNN3,,,,,71.8,110.0,7.6e-23,108.2,sp|A0JNN3|MED31_BOVIN Mediator of RNA polymerase II transcription subunit 31 OS=Bos taurus OX=9913 GN=MED31 PE=2 SV=1,,,,,,
OG_03435,1.4545300739169822,FUN_014492-T1,Peve_00024063,Pocillopora_meandrina_HIv1___RNAseq.g22516.t1,three_way,57.00866666666666,FUN_014492-T1,Q9DB28,,,,,38.6,145.0,4.2e-26,119.4,sp|Q9DB28|POP5_MOUSE Ribonuclease P/MRP protein subunit POP5 OS=Mus musculus OX=10090 GN=Pop5 PE=1 SV=1,,,,,,
OG_03438,1.3546399855307767,FUN_014497-T1,Peve_00037310,Pocillopora_meandrina_HIv1___RNAseq.1964_t,three_way,81.125,FUN_014497-T1,Q5R8D0,,,,,65.0,343.0,1.3e-132,474.2,sp|Q5R8D0|GALE_PONAB UDP-glucose 4-epimerase OS=Pongo abelii OX=9601 GN=GALE PE=2 SV=1,,,,,,
OG_03440,1.9240169456590863,FUN_014499-T1,Peve_00013881,Pocillopora_meandrina_HIv1___TS.g27403.t1,three_way,65.235,FUN_014499-T1,Q6DE37,GXLT2_XENLA,,Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4),Xenopus laevis (African clawed frog),52.9,280.0,3.6000000000000004e-86,320.1,sp|Q6DE37|GXLT2_XENLA Glucoside xylosyltransferase 2 OS=Xenopus laevis OX=8355 GN=gxylt2 PE=2 SV=1,GO:0016020; GO:0016266; GO:0035252; GO:0140563,O-glycan processing [GO:0016266],membrane [GO:0016020],"UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_03442,1.08228645118109,FUN_014502-T1,Peve_00025868,Pocillopora_meandrina_HIv1___RNAseq.g22637.t1,three_way,80.94816666666667,FUN_014502-T1,Q9DG67,,,,,56.6,657.0,2.3e-210,733.4,sp|Q9DG67|RA54B_CHICK DNA repair and recombination protein RAD54B OS=Gallus gallus OX=9031 GN=RAD54B PE=2 SV=1,,,,,,
OG_03444,1.510319351929863,FUN_014506-T1,Peve_00015332,Pocillopora_meandrina_HIv1___RNAseq.g22634.t1,three_way,64.51866666666666,FUN_014506-T1,Q5XHG1,NSMA3_XENLA,,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),Xenopus laevis (African clawed frog),32.9,828.0,6.3e-106,386.7,sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2,GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383],metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290],GO:0003824; GO:0005635; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nuclear envelope; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_03446,1.4984255579691357,FUN_014510-T1,Peve_00024077,Pocillopora_meandrina_HIv1___RNAseq.g22630.t1,three_way,76.287,FUN_014510-T1,Q8CG45,ARK72_RAT,,Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase),Rattus norvegicus (Rat),52.2,322.0,1.1e-94,348.2,sp|Q8CG45|ARK72_RAT Aflatoxin B1 aldehyde reductase member 2 OS=Rattus norvegicus OX=10116 GN=Akr7a2 PE=1 SV=2,GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598,daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635],"aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]",GO:0003824; GO:0005635; GO:0005739; GO:0006629; GO:0016491; GO:0016787; GO:0043226; GO:1901135,catalytic activity; nuclear envelope; mitochondrion; lipid metabolic process; oxidoreductase activity; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_03447,3.7823344232987823,FUN_014512-T1,Peve_00032000,Pocillopora_meandrina_HIv1___TS.g27391.t1,three_way,41.315000000000005,,,,,,,,,,,,,,,,,
OG_03452,2.5449661783776425,FUN_014527-T1,Peve_00044379,Pocillopora_meandrina_HIv1___RNAseq.g22617.t1,three_way,81.44616666666667,FUN_014527-T1,O15297,PPM1D_HUMAN,,Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1),Homo sapiens (Human),51.3,277.0,1.2e-79,298.5,sp|O15297|PPM1D_HUMAN Protein phosphatase 1D OS=Homo sapiens OX=9606 GN=PPM1D PE=1 SV=1,GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260; GO:1902531,"cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of intracellular signal transduction [GO:1902531]; regulation of transcription initiation by RNA polymerase II [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]",cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03454,1.4638880529480374,FUN_014529-T1,Peve_00044375,Pocillopora_meandrina_HIv1___RNAseq.g22615.t1,three_way,84.25116666666666,FUN_014529-T1,P61267,,,,,57.3,267.0,9.1e-74,278.5,sp|P61267|STX1B_BOVIN Syntaxin-1B OS=Bos taurus OX=9913 GN=STX1B PE=1 SV=1,,,,,,
OG_03455,1.4829015434160668,FUN_014530-T1,Peve_00044383,Pocillopora_meandrina_HIv1___RNAseq.g22614.t1,three_way,89.24866666666667,FUN_014530-T1,P52301,,,,,86.3,211.0,6.7e-106,384.8,sp|P52301|RAN_XENLA GTP-binding nuclear protein Ran OS=Xenopus laevis OX=8355 GN=ran PE=1 SV=2,,,,,,
OG_03457,1.486734922221538,FUN_014533-T1,Peve_00040829,Pocillopora_meandrina_HIv1___RNAseq.g22609.t1,three_way,87.76966666666667,FUN_014533-T1,Q9UBR1,BUP1_HUMAN,,Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase),Homo sapiens (Human),71.8,379.0,2.1e-163,576.6,sp|Q9UBR1|BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens OX=9606 GN=UPB1 PE=1 SV=1,GO:0001701; GO:0001889; GO:0003837; GO:0005829; GO:0006248; GO:0006249; GO:0033396; GO:0042803; GO:0046050; GO:0046079; GO:0046135; GO:0051260; GO:0051289; GO:0070062,beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050],cytosol [GO:0005829]; extracellular exosome [GO:0070062],beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0043226; GO:0048856; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_03459,1.6685443183986146,FUN_014536-T1,Peve_00040838,Pocillopora_meandrina_HIv1___RNAseq.g22607.t1,three_way,36.9925,,,,,,,,,,,,,,,,,
OG_03461,1.2478791658729838,FUN_014542-T1,Peve_00035999,Pocillopora_meandrina_HIv1___RNAseq.g22596.t1,three_way,85.815,FUN_014542-T1,Q7T0U5,,,,,67.7,158.0,2.2999999999999998e-55,216.5,sp|Q7T0U5|ARC3B_XENLA Actin-related protein 2/3 complex subunit 3-B OS=Xenopus laevis OX=8355 GN=arpc3-b PE=2 SV=1,,,,,,
OG_03462,1.9482502006853804,FUN_014543-T1,Peve_00035998,Pocillopora_meandrina_HIv1___RNAseq.g22595.t1,three_way,76.62,FUN_014543-T1,Q7K556,TTD14_DROME,,TRPL translocation defect protein 14,Drosophila melanogaster (Fruit fly),53.4,294.0,5.800000000000001e-89,328.9,sp|Q7K556|TTD14_DROME TRPL translocation defect protein 14 OS=Drosophila melanogaster OX=7227 GN=Ttd14 PE=1 SV=1,GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300,photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],cytosol [GO:0005829],GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0008289,cytosol; lipid binding
OG_03473,2.4599619556654853,FUN_014561-T1,Peve_00023543,Pocillopora_meandrina_HIv1___RNAseq.g22703.t1,three_way,65.42583333333333,FUN_014561-T1,Q96S52,PIGS_HUMAN,,GPI-anchor transamidase component PIGS (Phosphatidylinositol-glycan biosynthesis class S protein),Homo sapiens (Human),36.6,508.0,2.9e-81,304.3,sp|Q96S52|PIGS_HUMAN GPI-anchor transamidase component PIGS OS=Homo sapiens OX=9606 GN=PIGS PE=1 SV=3,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0042765; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],,GO:0006629; GO:0051604; GO:1901135,lipid metabolic process; protein maturation; carbohydrate derivative metabolic process
OG_03474,1.124018143798685,FUN_014562-T1,Peve_00023544,Pocillopora_meandrina_HIv1___TS.g27467.t2,three_way,54.1165,FUN_014562-T1,Q14BV6,,,,,46.6,298.0,2.8999999999999997e-75,283.5,sp|Q14BV6|YDJC_MOUSE Carbohydrate deacetylase OS=Mus musculus OX=10090 GN=Ydjc PE=2 SV=2,,,,,,
OG_03478,1.8338191315323569,FUN_014572-T1,Peve_00027631,Pocillopora_meandrina_HIv1___RNAseq.1861_t,three_way,78.95566666666666,FUN_014572-T1,Q6DDL7,,,,,50.4,282.0,2.600000000000001e-71,270.4,sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1,,,,,,
OG_03481,1.145728504375464,FUN_014575-T1,Peve_00037170,Pocillopora_meandrina_HIv1___RNAseq.g22712.t1,three_way,86.77133333333333,FUN_014575-T1,Q0IIF2,,,,,60.7,300.0,5.3e-94,345.9,sp|Q0IIF2|EI2BA_BOVIN Translation initiation factor eIF2B subunit alpha OS=Bos taurus OX=9913 GN=EIF2B1 PE=2 SV=1,,,,,,
OG_03484,1.144584711456614,FUN_014586-T1,Peve_00001489,Pocillopora_meandrina_HIv1___RNAseq.g22723.t1,three_way,55.93383333333333,FUN_014586-T1,Q7T2Z5,UNC5C_CHICK,,Netrin receptor UNC5C (Protein unc-5 homolog 3) (cUNC-5H3) (Protein unc-5 homolog C),Gallus gallus (Chicken),42.2,102.0,3.3e-18,96.3,sp|Q7T2Z5|UNC5C_CHICK Netrin receptor UNC5C OS=Gallus gallus OX=9031 GN=UNC5C PE=2 SV=1,GO:0005042; GO:0005886; GO:0007411; GO:0009986; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0045202; GO:1990791,axon guidance [GO:0007411]; dorsal root ganglion development [GO:1990791],cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202],netrin receptor activity [GO:0005042],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_03485,1.1939739293289513,FUN_014587-T1,Peve_00011851,Pocillopora_meandrina_HIv1___RNAseq.g22725.t1,three_way,61.32233333333333,FUN_014587-T1,Q6DRD9,ABHDB_DANRE,,sn-1-specific diacylglycerol lipase ABHD11 (EC 3.1.1.116) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog),Danio rerio (Zebrafish) (Brachydanio rerio),42.0,274.0,1.3000000000000002e-57,224.9,sp|Q6DRD9|ABHDB_DANRE sn-1-specific diacylglycerol lipase ABHD11 OS=Danio rerio OX=7955 GN=abhd11 PE=2 SV=1,GO:0005739; GO:0005759; GO:0006629; GO:0016298; GO:0045252; GO:0052689,lipid metabolic process [GO:0006629],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252],carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298],GO:0003824; GO:0005739; GO:0006629; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; hydrolase activity; organelle
OG_03486,1.3069568744733122,FUN_014589-T1,Peve_00011858,Pocillopora_meandrina_HIv1___TS.g27493.t1,three_way,81.65599999999999,FUN_014589-T1,O43147,,,,,45.5,1038.0,4.3e-227,789.6,sp|O43147|SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens OX=9606 GN=SGSM2 PE=1 SV=4,,,,,,
OG_03492,2.9366191354589537,FUN_014601-T1,Peve_00034546,Pocillopora_meandrina_HIv1___RNAseq.g22743.t1,three_way,50.54366666666667,,,,,,,,,,,,,,,,,
OG_03493,1.071206010035605,FUN_014602-T1,Peve_00028207,Pocillopora_meandrina_HIv1___RNAseq.g22747.t1,three_way,77.274,FUN_014602-T1,Q9CXS4,CENPV_MOUSE,,Centromere protein V (CENP-V) (Proline-rich protein 6),Mus musculus (Mouse),58.8,131.0,2.4e-45,183.0,sp|Q9CXS4|CENPV_MOUSE Centromere protein V OS=Mus musculus OX=10090 GN=Cenpv PE=1 SV=2,GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301,ameboidal-type cell migration [GO:0001667]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233],carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0016829; GO:0043226; GO:0048870; GO:0065003,catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; chromatin organization; lyase activity; organelle; cell motility; protein-containing complex assembly
OG_03495,1.6732408112943766,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_03496,1.782047494548436,FUN_014605-T1,Peve_00001902,Pocillopora_meandrina_HIv1___RNAseq.g22752.t1,three_way,91.59133333333334,FUN_014605-T1,Q14254,FLOT2_HUMAN,,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),Homo sapiens (Human),58.5,417.0,1.6999999999999998e-105,384.4,sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2,GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043123; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982],protease binding [GO:0002020],GO:0005768; GO:0005886; GO:0007018; GO:0007155; GO:0031410; GO:0043226; GO:0048856; GO:0072659,endosome; plasma membrane; microtubule-based movement; cell adhesion; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane
OG_03499,2.2566482287128244,FUN_014608-T1,Peve_00002424,Pocillopora_meandrina_HIv1___RNAseq.g22764.t1,three_way,78.122,FUN_014608-T1,Q8SX37,CDIPT_DROME,,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (CDIPT) (EC 2.7.8.11) (Phosphatidylinositol synthase),Drosophila melanogaster (Fruit fly),44.0,84.0,1.2e-09,65.1,sp|Q8SX37|CDIPT_DROME CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Drosophila melanogaster OX=7227 GN=Pis PE=1 SV=1,GO:0003881; GO:0005794; GO:0006661; GO:0007602; GO:0016324; GO:0016328; GO:0046872; GO:0071711,basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602],apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328],CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0030198; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; extracellular matrix organization; organelle
OG_03500,4.385460423047356,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_03501,1.3375536256903573,FUN_014611-T1,Peve_00027568,Pocillopora_meandrina_HIv1___TS.g27528.t1,three_way,54.368,,,,,,,,,,,,,,,,,
OG_03502,1.3787627509713822,FUN_014612-T1,Peve_00027569,Pocillopora_meandrina_HIv1___RNAseq.g22760.t1,three_way,63.5955,FUN_014612-T1,A2CEI4,,,,,30.4,756.0,3.1e-94,347.8,sp|A2CEI4|NUP88_DANRE Nucleoporin 88 OS=Danio rerio OX=7955 GN=nup88 PE=1 SV=1,,,,,,
OG_03505,1.4205951386857192,FUN_014615-T1,Peve_00001904,Pocillopora_meandrina_HIv1___RNAseq.1913_t,three_way,90.09,FUN_014615-T1,Q15370,ELOB_HUMAN,,Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2),Homo sapiens (Human),66.3,104.0,5.9e-34,144.8,sp|Q15370|ELOB_HUMAN Elongin-B OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1,GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449; GO:0140958,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; target-directed miRNA degradation [GO:0140958]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891],transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625],GO:0005654; GO:0005829; GO:0065003,nucleoplasm; cytosol; protein-containing complex assembly
OG_03506,1.714292612074582,FUN_014616-T1,Peve_00001903,Pocillopora_meandrina_HIv1___RNAseq.g22756.t1,three_way,96.60133333333332,FUN_014616-T1,Q6IP91,,,,,90.6,309.0,1.3e-168,593.6,sp|Q6IP91|PP4C_XENLA Serine/threonine-protein phosphatase 4 catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp4c PE=2 SV=1,,,,,,
OG_03509,1.6251092622883383,FUN_014619-T1,Peve_00002405,Pocillopora_meandrina_HIv1___RNAseq.g22775.t1,three_way,73.92766666666667,,,,,,,,,,,,,,,,,
OG_03510,1.2422142314522122,FUN_014621-T1,Peve_00002408,Pocillopora_meandrina_HIv1___RNAseq.g22778.t1,three_way,70.79983333333334,FUN_014621-T1,A4QNN3,UBP30_XENTR,,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),39.8,450.0,2.7e-74,280.8,sp|A4QNN3|UBP30_XENTR Ubiquitin carboxyl-terminal hydrolase 30 OS=Xenopus tropicalis OX=8364 GN=usp30 PE=2 SV=1,GO:0000422; GO:0004197; GO:0004843; GO:0005739; GO:0005741; GO:0006508; GO:0008053; GO:0016579; GO:0035871; GO:0044313,autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005739; GO:0006914; GO:0007005; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; autophagy; mitochondrion organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03514,3.0378403518981463,FUN_014625-T1,Peve_00002412,Pocillopora_meandrina_HIv1___TS.g27550.t1,three_way,56.03566666666666,,,,,,,,,,,,,,,,,
OG_03515,2.5584772091326564,FUN_014626-T1,Peve_00002414,Pocillopora_meandrina_HIv1___RNAseq.g22784.t1,three_way,94.20133333333334,FUN_014626-T1,Q3MHR3,,,,,94.4,89.0,2.3e-44,179.5,"sp|Q3MHR3|DYL2_BOVIN Dynein light chain 2, cytoplasmic OS=Bos taurus OX=9913 GN=DYNLL2 PE=3 SV=1",,,,,,
OG_03517,3.2416051344826573,FUN_014630-T1,Peve_00002417,Pocillopora_meandrina_HIv1___RNAseq.g22787.t1,three_way,63.39333333333334,FUN_014630-T1,Q5R5S1,,,,,31.7,612.0,1.1999999999999999e-75,285.8,sp|Q5R5S1|FBX21_PONAB F-box only protein 21 OS=Pongo abelii OX=9601 GN=FBXO21 PE=2 SV=1,,,,,,
OG_03520,1.4586024224831695,FUN_014633-T1,Peve_00002421,Pocillopora_meandrina_HIv1___RNAseq.g22790.t1,three_way,53.859,,,,,,,,,,,,,,,,,
OG_03522,1.4933105010674164,FUN_014637-T1,Peve_00002423,Pocillopora_meandrina_HIv1___RNAseq.g22792.t1,three_way,83.999,FUN_014637-T1,P15651,,,,,74.8,377.0,4.1e-165,582.4,"sp|P15651|ACADS_RAT Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acads PE=1 SV=2",,,,,,
OG_03530,1.0647795425441855,FUN_014645-T1,Peve_00002388,Pocillopora_meandrina_HIv1___TS.g27454.t2,three_way,69.99833333333333,FUN_014645-T1,A3KGZ2,,,,,56.8,333.0,1.0999999999999998e-105,384.8,sp|A3KGZ2|OGFD2_DANRE 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 OS=Danio rerio OX=7955 GN=ogfod2 PE=2 SV=1,,,,,,
OG_03538,2.041364980055505,FUN_014657-T1,Peve_00014510,Pocillopora_meandrina_HIv1___RNAseq.g22581.t2,three_way,74.71600000000001,FUN_014657-T1,Q9NUQ2,PLCE_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),Homo sapiens (Human),45.6,261.0,1.9e-63,244.2,sp|Q9NUQ2|PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3,GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016024; GO:0016746; GO:0036149,acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746],GO:0003824; GO:0005635; GO:0005730; GO:0005739; GO:0005783; GO:0006629; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nuclear envelope; nucleolus; mitochondrion; endoplasmic reticulum; lipid metabolic process; transferase activity; cell differentiation; organelle
OG_03546,2.8757965840316126,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_03551,2.296953925138242,FUN_014683-T2,Peve_00033420,Pocillopora_meandrina_HIv1___RNAseq.g22591.t1,three_way,70.162,FUN_014683-T2,Q9Y3E5,PTH2_HUMAN,,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",Homo sapiens (Human),59.4,160.0,4.000000000000001e-45,182.6,"sp|Q9Y3E5|PTH2_HUMAN Peptidyl-tRNA hydrolase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PTRH2 PE=1 SV=1",GO:0004045; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0010629; GO:0016020; GO:2000210; GO:2000811,apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],peptidyl-tRNA hydrolase activity [GO:0004045],GO:0003824; GO:0005739; GO:0005829; GO:0012501; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; mitochondrion; cytosol; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03560,1.0875758318025237,FUN_014707-T1,Peve_00021214,Pocillopora_meandrina_HIv1___RNAseq.g22533.t1,three_way,80.39150000000001,FUN_014707-T1,P50897,PPT1_HUMAN,,Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.2) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1),Homo sapiens (Human),64.8,273.0,4.1e-106,386.0,sp|P50897|PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0006897; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030672; GO:0031579; GO:0034164; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0052816; GO:0070062; GO:0099523; GO:0120146,adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; endocytosis [GO:0006897]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; sulfatide binding [GO:0120146],GO:0003824; GO:0005576; GO:0005634; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0006629; GO:0006790; GO:0008289; GO:0016192; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0061024; GO:0140096,"catalytic activity; extracellular region; nucleus; lysosome; vacuole; Golgi apparatus; cytosol; lipid metabolic process; sulfur compound metabolic process; lipid binding; vesicle-mediated transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; membrane organization; catalytic activity, acting on a protein"
OG_03563,2.286170286454415,FUN_014712-T1,Peve_00028586,Pocillopora_meandrina_HIv1___RNAseq.g22528.t1,three_way,51.81133333333333,,,,,,,,,,,,,,,,,
OG_03564,1.965811107807902,FUN_014713-T1,Peve_00028587,Pocillopora_meandrina_HIv1___RNAseq.g22527.t1,three_way,84.00266666666667,FUN_014713-T1,Q96DM3,,,,,53.3,647.0,7.699999999999999e-198,691.8,sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2,,,,,,
OG_03566,1.7689903043589734,FUN_014715-T1,Peve_00023482,Pocillopora_meandrina_HIv1___RNAseq.g22525.t1,three_way,70.94933333333333,FUN_014715-T1,Q5RA75,,,,,35.2,1159.0,4.4e-158,560.5,sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1,,,,,,
OG_03568,1.0148036164892822,FUN_014718-T1,Peve_00006840,Pocillopora_meandrina_HIv1___RNAseq.g22503.t1,three_way,67.64766666666667,FUN_014718-T1,Q5PP32,,,,,34.4,340.0,6.1e-35,149.8,sp|Q5PP32|WTR25_ARATH WAT1-related protein At3g45870 OS=Arabidopsis thaliana OX=3702 GN=At3g45870 PE=2 SV=1,,,,,,
OG_03569,1.071508045033055,FUN_014720-T1,Peve_00006843,Pocillopora_meandrina_HIv1___RNAseq.g22498.t1,three_way,63.56933333333333,FUN_014720-T1,Q9VCR7,,,,,26.0,204.0,1.7e-07,58.5,sp|Q9VCR7|CTNS_DROME Cystinosin OS=Drosophila melanogaster OX=7227 GN=Ctns PE=1 SV=2,,,,,,
OG_03573,1.4402316052690498,FUN_014727-T1,Peve_00009517,Pocillopora_meandrina_HIv1___RNAseq.g22492.t1,three_way,75.87566666666666,FUN_014727-T1,A9KJR7,,,,,25.7,222.0,8.7e-11,68.9,sp|A9KJR7|UREF_LACP7 Urease accessory protein UreF OS=Lachnoclostridium phytofermentans (strain ATCC 700394 / DSM 18823 / ISDg) OX=357809 GN=ureF PE=3 SV=1,,,,,,
OG_03577,1.152271583105316,FUN_014731-T1,Peve_00010437,Pocillopora_meandrina_HIv1___TS.g27252.t1,three_way,82.48166666666667,FUN_014731-T1,Q7SXP2,,,,,58.6,526.0,3.0999999999999996e-189,662.9,sp|Q7SXP2|ULA1_DANRE NEDD8-activating enzyme E1 regulatory subunit OS=Danio rerio OX=7955 GN=nae1 PE=2 SV=2,,,,,,
OG_03582,2.788169600683859,FUN_014737-T1,Peve_00010440,Pocillopora_meandrina_HIv1___RNAseq.g22480.t1c,three_way,64.17166666666667,FUN_014737-T1,Q6PAY6,,,,,40.4,421.0,2.1e-80,301.2,sp|Q6PAY6|HYPDH_XENLA Hydroxyproline dehydrogenase OS=Xenopus laevis OX=8355 GN=prodh2 PE=2 SV=1,,,,,,
OG_03584,1.25438884865111,FUN_014740-T1,Peve_00027516,Pocillopora_meandrina_HIv1___RNAseq.g22474.t1,three_way,83.22066666666666,FUN_014740-T1,Q2XWK0,,,,,45.2,334.0,1.8e-73,277.7,sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1,,,,,,
OG_03586,2.2496942668915207,FUN_014742-T1,Peve_00036169,Pocillopora_meandrina_HIv1___RNAseq.g22472.t1,three_way,71.57566666666666,FUN_014742-T1,Q502L2,PGAM5_DANRE,,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,233.0,2.1e-67,257.3,"sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2",GO:0004722; GO:0005739; GO:0005741; GO:0012501; GO:0090141,positive regulation of mitochondrial fission [GO:0090141]; programmed cell death [GO:0012501],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0012501; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03595,1.8074689548886784,FUN_014754-T1,Peve_00039160,Pocillopora_meandrina_HIv1___RNAseq.g22445.t1,three_way,85.86266666666667,FUN_014754-T1,Q8TCT6,SPPL3_HUMAN,,Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4),Homo sapiens (Human),58.8,386.0,5.9e-118,425.6,sp|Q8TCT6|SPPL3_HUMAN Signal peptide peptidase-like 3 OS=Homo sapiens OX=9606 GN=SPPL3 PE=1 SV=2,GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0033116; GO:0033619; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0098553; GO:0098554,membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003824; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"immune system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_03596,2.1475731924678634,FUN_014755-T1,Peve_00039152,Pocillopora_meandrina_HIv1___RNAseq.g22443.t1,three_way,62.79233333333333,FUN_014755-T1,Q9CQK1,,,,,36.1,144.0,2.5e-17,90.1,sp|Q9CQK1|ZNHI3_MOUSE Zinc finger HIT domain-containing protein 3 OS=Mus musculus OX=10090 GN=Znhit3 PE=1 SV=1,,,,,,
OG_03597,1.987739283724284,FUN_014756-T1,Peve_00039153,Pocillopora_meandrina_HIv1___RNAseq.g22442.t1,three_way,67.01416666666667,FUN_014756-T1,Q07066,,,,,38.9,180.0,1.1e-35,151.4,sp|Q07066|PXMP2_RAT Peroxisomal membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Pxmp2 PE=1 SV=2,,,,,,
OG_03600,1.2706753195422529,FUN_014764-T1,Peve_00000342,Pocillopora_meandrina_HIv1___RNAseq.g22434.t1,three_way,79.31733333333334,FUN_014764-T1,P70645,,,,,53.3,465.0,1.3e-151,537.7,sp|P70645|BLMH_RAT Bleomycin hydrolase OS=Rattus norvegicus OX=10116 GN=Blmh PE=1 SV=1,,,,,,
OG_03602,1.3988515816925091,FUN_014769-T1,Peve_00000348,Pocillopora_meandrina_HIv1___RNAseq.g22568.t1,three_way,57.41133333333333,,,,,,,,,,,,,,,,,
OG_03603,2.164489911287554,FUN_014770-T1,Peve_00014608,Pocillopora_meandrina_HIv1___RNAseq.g22567.t1,three_way,76.14166666666667,FUN_014770-T1,A2BFP5,,,,,43.0,900.0,7.000000000000001e-186,652.5,sp|A2BFP5|S12A9_DANRE Solute carrier family 12 member 9 OS=Danio rerio OX=7955 GN=slc12a9 PE=3 SV=1,,,,,,
OG_03604,1.3979676524308378,FUN_014771-T1,Peve_00014607,Pocillopora_meandrina_HIv1___RNAseq.g22566.t1,three_way,79.51866666666668,FUN_014771-T1,Q8K370,,,,,57.8,1018.0,0.0,1177.2,sp|Q8K370|ACD10_MOUSE Acyl-CoA dehydrogenase family member 10 OS=Mus musculus OX=10090 GN=Acad10 PE=1 SV=1,,,,,,
OG_03612,1.3490863459548692,FUN_014793-T1,Peve_00015736,Pocillopora_meandrina_HIv1___RNAseq.g22428.t1,three_way,75.05016666666667,FUN_014793-T1,A1L2H9,RFA2B_XENLA,,Replication protein A 32 kDa subunit-B (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34),Xenopus laevis (African clawed frog),44.4,295.0,3.9999999999999997e-56,219.9,sp|A1L2H9|RFA2B_XENLA Replication protein A 32 kDa subunit-B OS=Xenopus laevis OX=8355 GN=rpa2-b PE=2 SV=1,GO:0000076; GO:0000723; GO:0000724; GO:0000781; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0016605; GO:0034502; GO:0035861; GO:0042162; GO:2000001,base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; telomere maintenance [GO:0000723],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0032200; GO:0043226,DNA binding; nucleus; DNA replication; DNA repair; DNA recombination; telomere organization; organelle
OG_03614,2.307931121599616,FUN_014796-T1,Peve_00026742,Pocillopora_meandrina_HIv1___RNAseq.g22420.t1,three_way,83.09333333333333,FUN_014796-T1,Q8CFG5,CA2D3_RAT,,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],Rattus norvegicus (Rat),26.6,632.0,1.9e-50,203.0,sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1,GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314,calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174],GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891],calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0098772,transporter activity; molecular function regulator activity
OG_03623,2.022042032700422,FUN_014810-T1,Peve_00022206,Pocillopora_meandrina_HIv1___RNAseq.g22405.t1,three_way,74.15333333333334,FUN_014810-T1,Q9NXZ2,,,,,46.8,577.0,2.1e-146,521.2,sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2,,,,,,
OG_03631,3.3965643712984317,FUN_014848-T1,Peve_00038810,Pocillopora_meandrina_HIv1___RNAseq.g22383.t1,three_way,69.762,FUN_014848-T1,Q9SJM7,URH1_ARATH,,Uridine nucleosidase 1 (EC 3.2.2.3) (Adenosine nucleosidase) (EC 3.2.2.7) (Inosine nucleosidase) (EC 3.2.2.2) (Nucleoside hydrolase 1) (Uridine ribohydrolase 1) (Xanthosine nucleosidase) (EC 3.2.2.-),Arabidopsis thaliana (Mouse-ear cress),34.5,287.0,1.8e-32,141.4,sp|Q9SJM7|URH1_ARATH Uridine nucleosidase 1 OS=Arabidopsis thaliana OX=3702 GN=URH1 PE=1 SV=2,GO:0005829; GO:0006152; GO:0006218; GO:0042802; GO:0042803; GO:0045437; GO:0046982; GO:0047622; GO:0047724; GO:0072585,purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218],cytosol [GO:0005829],adenosine nucleosidase activity [GO:0047622]; identical protein binding [GO:0042802]; inosine nucleosidase activity [GO:0047724]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585],GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03633,1.762227893527172,FUN_014852-T1,Peve_00038812,Pocillopora_meandrina_HIv1___RNAseq.g22380.t1b,three_way,70.72466666666666,FUN_014852-T1,Q9BW91,NUDT9_HUMAN,,"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)",Homo sapiens (Human),52.1,317.0,2.1e-89,330.5,"sp|Q9BW91|NUDT9_HUMAN ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1",GO:0005739; GO:0005759; GO:0005829; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0047631; GO:0055086; GO:0070062,ADP catabolic process [GO:0046032]; nucleobase-containing small molecule metabolic process [GO:0055086],cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965],ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03636,1.051041615284916,FUN_014856-T1,Peve_00024574,Pocillopora_meandrina_HIv1___RNAseq.g22372.t1,three_way,92.46416666666669,FUN_014856-T1,A7SXK3,TMED_NEMVE,,Transmembrane emp24 domain-containing protein,Nematostella vectensis (Starlet sea anemone),81.3,203.0,3.6e-90,332.4,sp|A7SXK3|TMED_NEMVE Transmembrane emp24 domain-containing protein OS=Nematostella vectensis OX=45351 GN=v1g194562 PE=3 SV=1,GO:0005783; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0030659,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],,GO:0005783; GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226,endoplasmic reticulum; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03639,2.9549856575049027,FUN_014861-T1,Peve_00016000,Pocillopora_meandrina_HIv1___RNAseq.g22368.t1,three_way,62.06,FUN_014861-T1,Q69ZM6,STK36_MOUSE,,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Mus musculus (Mouse),25.5,1026.0,5.9e-57,224.6,sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3,GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310,axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005856; GO:0006355; GO:0007010; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0140096,"catalytic activity; extracellular region; nucleus; cytosol; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; catalytic activity, acting on a protein"
OG_03643,2.456774355585897,FUN_014871-T1,Peve_00012980,Pocillopora_meandrina_HIv1___RNAseq.g21043.t2a,three_way,72.989,FUN_014871-T1,Q05B54,,,,,27.7,213.0,3.2e-12,73.6,sp|Q05B54|TM134_BOVIN Transmembrane protein 134 OS=Bos taurus OX=9913 GN=TMEM134 PE=2 SV=2,,,,,,
OG_03645,1.489954189586988,FUN_014876-T1,Peve_00013646,Pocillopora_meandrina_HIv1___RNAseq.g21045.t1,three_way,76.93633333333334,FUN_014876-T1,P22061,PIMT_HUMAN,,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),Homo sapiens (Human),60.5,223.0,5.6e-76,285.4,sp|P22061|PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens OX=9606 GN=PCMT1 PE=1 SV=4,GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0030091; GO:0045296; GO:0070062; GO:1903561,protein methylation [GO:0006479]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561],cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03646,1.5881596816824648,FUN_014877-T1,Peve_00013644,Pocillopora_meandrina_HIv1___RNAseq.g21046.t1,three_way,63.173,,,,,,,,,,,,,,,,,
OG_03650,1.461830047366098,FUN_014882-T1,Peve_00013645,Pocillopora_meandrina_HIv1___RNAseq.g21054.t1,three_way,56.43533333333333,FUN_014882-T1,Q5SSG4,GA2L2_MOUSE,,GAS2-like protein 2 (Growth arrest-specific protein 2-like 2),Mus musculus (Mouse),35.9,473.0,1.6999999999999998e-53,213.0,sp|Q5SSG4|GA2L2_MOUSE GAS2-like protein 2 OS=Mus musculus OX=10090 GN=Gas2l2 PE=1 SV=1,GO:0001578; GO:0001725; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825,microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017],GO:0005815; GO:0005886; GO:0007010; GO:0008092; GO:0060090,microtubule organizing center; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; molecular adaptor activity
OG_03651,2.606769574328886,FUN_014883-T1,Peve_00032212,Pocillopora_meandrina_HIv1___RNAseq.g21057.t1,three_way,86.76933333333334,FUN_014883-T1,A1L0Y5,,,,,78.5,288.0,2.8e-130,466.5,sp|A1L0Y5|SEP2B_XENTR Septin-2B OS=Xenopus tropicalis OX=8364 GN=sept2-B PE=2 SV=1,,,,,,
OG_03657,1.3135565933055031,FUN_014893-T1,Peve_00003548,Pocillopora_meandrina_HIv1___RNAseq.g21106.t1,three_way,54.15466666666666,,,,,,,,,,,,,,,,,
OG_03658,4.163855700238367,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.3999999999999975e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_03659,1.7066242526082736,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_03666,1.087960110218132,FUN_014905-T1,Peve_00003537,Pocillopora_meandrina_HIv1___RNAseq.g21071.t1,three_way,89.49799999999999,FUN_014905-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),46.7,210.0,4.3e-39,163.7,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_03667,1.1656063208061458,FUN_014907-T1,Peve_00003536,Pocillopora_meandrina_HIv1___RNAseq.g21072.t1,three_way,37.61533333333333,,,,,,,,,,,,,,,,,
OG_03671,3.0622287694001256,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_03678,2.071362682946136,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_03682,2.41257614570357,FUN_014941-T2,Peve_00037149,Pocillopora_meandrina_HIv1___RNAseq.g21098.t1,three_way,78.08300000000001,FUN_014941-T2,O43435,TBX1_HUMAN,,T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein),Homo sapiens (Human),74.4,203.0,2.7e-85,317.4,sp|O43435|TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens OX=9606 GN=TBX1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035019; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_03683,2.9530775980486963,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_03684,1.6263078015124384,FUN_014944-T1,Peve_00037147,Pocillopora_meandrina_HIv1___RNAseq.g21100.t1,three_way,64.583,,,,,,,,,,,,,,,,,
OG_03685,1.298224557141667,FUN_014945-T1,Peve_00037135,Pocillopora_meandrina_HIv1___RNAseq.g21101.t1,three_way,68.88033333333333,FUN_014945-T1,Q6WBX8,RAD9B_HUMAN,,Cell cycle checkpoint control protein RAD9B (DNA repair exonuclease rad9 homolog B) (hRAD9B),Homo sapiens (Human),43.9,287.0,2.2e-65,251.5,sp|Q6WBX8|RAD9B_HUMAN Cell cycle checkpoint control protein RAD9B OS=Homo sapiens OX=9606 GN=RAD9B PE=1 SV=2,GO:0000076; GO:0005634; GO:0005654; GO:0006281; GO:0030896; GO:0031573; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573],checkpoint clamp complex [GO:0030896]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_03686,2.1223740873430006,FUN_014948-T1,Peve_00024855,Pocillopora_meandrina_HIv1___RNAseq.g21115.t1,three_way,80.74033333333334,FUN_014948-T1,Q04336,,,,,46.8,939.0,1.3999999999999998e-250,867.5,sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1,,,,,,
OG_03687,1.6637682724807912,FUN_014949-T1,Peve_00006235,Pocillopora_meandrina_HIv1___RNAseq.g21116.t1,three_way,79.29216666666667,FUN_014949-T1,Q9Y6J0,,,,,36.0,1819.0,9e-282,972.2,sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1,,,,,,
OG_03688,1.7238642861542062,FUN_014950-T1,Peve_00006243,Pocillopora_meandrina_HIv1___RNAseq.g21117.t1,three_way,81.29683333333332,FUN_014950-T1,O60671,,,,,66.7,90.0,1.7e-26,119.8,sp|O60671|RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens OX=9606 GN=RAD1 PE=1 SV=1,,,,,,
OG_03690,2.406703556459033,FUN_014952-T1,Peve_00006246,Pocillopora_meandrina_HIv1___RNAseq.g21119.t1,three_way,65.61866666666666,,,,,,,,,,,,,,,,,
OG_03691,2.264971112989591,FUN_014954-T1,Peve_00006248,Pocillopora_meandrina_HIv1___RNAseq.g21121.t1,three_way,69.067,,,,,,,,,,,,,,,,,
OG_03698,1.7259609401224678,FUN_014969-T1,Peve_00006263,Pocillopora_meandrina_HIv1___RNAseq.g21132.t2,three_way,67.03883333333333,FUN_014969-T1,B2RXZ1,PNDC1_MOUSE,,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1),Mus musculus (Mouse),35.4,463.0,4.3e-65,250.4,sp|B2RXZ1|PNDC1_MOUSE Poly(A)-specific ribonuclease PNLDC1 OS=Mus musculus OX=10090 GN=Pnldc1 PE=1 SV=1,GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872,"blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005783; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; endoplasmic reticulum; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_03699,1.48445308041795,FUN_014970-T1,Peve_00006264,Pocillopora_meandrina_HIv1___RNAseq.g21133.t1,three_way,54.491166666666665,FUN_014970-T1,P18887,XRCC1_HUMAN,,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),Homo sapiens (Human),42.3,123.0,4.6e-20,100.9,sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3,GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599,base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]",3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_03702,1.6118494669011272,FUN_014974-T1,Peve_00006267,Pocillopora_meandrina_HIv1___TS.g25888.t1,three_way,80.358,,,,,,,,,,,,,,,,,
OG_03703,1.695403530126735,FUN_014975-T1,Peve_00024846,Pocillopora_meandrina_HIv1___RNAseq.g21114.t1,three_way,68.426,FUN_014975-T1,Q6DGR4,,,,,47.2,343.0,1.5e-86,321.2,sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1,,,,,,
OG_03707,2.981097103535426,FUN_014980-T3,Peve_00024829,Pocillopora_meandrina_HIv1___RNAseq.g21142.t1,three_way,72.68066666666667,FUN_014980-T3,P51577,,,,,52.3,392.0,5.2000000000000004e-110,399.4,sp|P51577|P2RX4_RAT P2X purinoceptor 4 OS=Rattus norvegicus OX=10116 GN=P2rx4 PE=1 SV=1,,,,,,
OG_03709,2.243287407421182,FUN_014983-T1,Peve_00039940,Pocillopora_meandrina_HIv1___RNAseq.g21145.t1,three_way,62.897,,,,,,,,,,,,,,,,,
OG_03710,1.595349270510724,FUN_014984-T1,Peve_00039939,Pocillopora_meandrina_HIv1___RNAseq.g21146.t1,three_way,63.29966666666667,FUN_014984-T1,Q29RU9,SOX_BOVIN,,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),Bos taurus (Bovine),43.6,397.0,5.7e-87,322.8,sp|Q29RU9|SOX_BOVIN Peroxisomal sarcosine oxidase OS=Bos taurus OX=9913 GN=PIPOX PE=2 SV=2,GO:0005777; GO:0008115; GO:0033514; GO:0050031; GO:0050660,L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514],peroxisome [GO:0005777],flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115],GO:0003824; GO:0005777; GO:0006520; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03711,1.2593218012473684,FUN_014985-T1,Peve_00039936,Pocillopora_meandrina_HIv1___RNAseq.g21148.t1,three_way,95.19833333333334,FUN_014985-T1,Q61025,IFT20_MOUSE,,Intraflagellar transport protein 20 homolog (mIFT20),Mus musculus (Mouse),82.0,100.0,1.4e-37,156.8,sp|Q61025|IFT20_MOUSE Intraflagellar transport protein 20 homolog OS=Mus musculus OX=10090 GN=Ift20 PE=1 SV=1,GO:0001669; GO:0001736; GO:0001750; GO:0001822; GO:0002046; GO:0002177; GO:0005737; GO:0005794; GO:0005801; GO:0005813; GO:0005814; GO:0005902; GO:0005929; GO:0007224; GO:0007283; GO:0008542; GO:0022008; GO:0030992; GO:0031267; GO:0031410; GO:0031514; GO:0032391; GO:0032420; GO:0034067; GO:0035720; GO:0035845; GO:0036064; GO:0036372; GO:0042073; GO:0043005; GO:0044292; GO:0045198; GO:0045724; GO:0051642; GO:0055007; GO:0060122; GO:0060271; GO:0060828; GO:0061351; GO:0061512; GO:0071806; GO:0072659; GO:0090102; GO:0097546; GO:1902017; GO:1902636; GO:2000583; GO:2000785,cardiac muscle cell differentiation [GO:0055007]; centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; opsin transport [GO:0036372]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; protein transmembrane transport [GO:0071806]; regulation of autophagosome assembly [GO:2000785]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cilium assembly [GO:1902017]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; visual learning [GO:0008542],acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; kinociliary basal body [GO:1902636]; manchette [GO:0002177]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420],opsin binding [GO:0002046]; small GTPase binding [GO:0031267],GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0007163; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0055085; GO:0072659,Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; establishment or maintenance of cell polarity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; nervous system process; transmembrane transport; protein localization to plasma membrane
OG_03712,1.749264465742653,FUN_014986-T1,Peve_00039934,Pocillopora_meandrina_HIv1___RNAseq.g21149.t1,three_way,93.70633333333332,FUN_014986-T1,Q9H3F6,BACD3_HUMAN,,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),Homo sapiens (Human),66.9,278.0,1.7e-101,370.5,sp|Q9H3F6|BACD3_HUMAN BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 OS=Homo sapiens OX=9606 GN=KCTD10 PE=1 SV=1,GO:0005112; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; Notch binding [GO:0005112],GO:0005654; GO:0005829; GO:0005886; GO:0030163; GO:0065003,nucleoplasm; cytosol; plasma membrane; protein catabolic process; protein-containing complex assembly
OG_03713,2.0014140190395424,FUN_014987-T1,Peve_00039946,Pocillopora_meandrina_HIv1___RNAseq.g21150.t1,three_way,82.91666666666667,FUN_014987-T1,O14874,,,,,55.7,368.0,1.4e-109,397.9,sp|O14874|BCKD_HUMAN Branched-chain alpha-ketoacid dehydrogenase kinase OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2,,,,,,
OG_03717,1.367698511191075,FUN_014992-T1,Peve_00032856,Pocillopora_meandrina_HIv1___RNAseq.g21155.t1,three_way,77.725,FUN_014992-T1,O15254,ACOX3_HUMAN,,Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase),Homo sapiens (Human),52.3,692.0,5.3e-205,715.7,sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2,GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0071949,fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402],GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0008289; GO:0016491; GO:0043226,catalytic activity; peroxisome; cytosol; lipid metabolic process; lipid binding; oxidoreductase activity; organelle
OG_03718,1.5994604290264278,FUN_014993-T1,Peve_00031667,Pocillopora_meandrina_HIv1___RNAseq.g21156.t1,three_way,73.09666666666666,FUN_014993-T1,P51659,DHB4_HUMAN,,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",Homo sapiens (Human),53.7,751.0,2e-231,803.5,sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3,GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0006636; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042759; GO:0042803; GO:0044594; GO:0060009; GO:0106386; GO:1901570,alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],"(3R)-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0006790; GO:0016491; GO:0016829; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086,catalytic activity; peroxisome; cytosol; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; lyase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03719,1.8574320286229389,FUN_014995-T1,Peve_00010955,Pocillopora_meandrina_HIv1___RNAseq.g21158.t1,three_way,83.375,FUN_014995-T1,Q23979,MY61F_DROME,,Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C),Drosophila melanogaster (Fruit fly),55.3,1014.0,0.0,1112.4,sp|Q23979|MY61F_DROME Unconventional myosin IC OS=Drosophila melanogaster OX=7227 GN=Myo61F PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030048; GO:0032528; GO:0042742; GO:0048803; GO:0051015,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; endocytosis [GO:0006897]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; reproductive process; organelle; anatomical structure development; ATP-dependent activity
OG_03724,1.6890756083986251,FUN_015009-T1,Peve_00034685,Pocillopora_meandrina_HIv1___RNAseq.g21245.t1,three_way,73.11366666666666,,,,,,,,,,,,,,,,,
OG_03737,2.3116809001366985,FUN_015038-T1,Peve_00024408,Pocillopora_meandrina_HIv1___RNAseq.g21253.t1,three_way,68.02199999999999,FUN_015038-T1,P11023,RAB3A_BOVIN,,Ras-related protein Rab-3A (EC 3.6.5.2) (SMG P25A),Bos taurus (Bovine),45.0,171.0,1.1e-41,171.4,sp|P11023|RAB3A_BOVIN Ras-related protein Rab-3A OS=Bos taurus OX=9913 GN=RAB3A PE=1 SV=3,GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0009791; GO:0015031; GO:0016020; GO:0016079; GO:0016188; GO:0017157; GO:0030324; GO:0030424; GO:0030672; GO:0031489; GO:0031630; GO:0048786; GO:0048790; GO:0050975; GO:0051602; GO:0060478; GO:0098793; GO:0098794,acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; lung development [GO:0030324]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; post-embryonic development [GO:0009791]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188],axon [GO:0030424]; cytosol [GO:0005829]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],GO:0003016; GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,respiratory system process; catalytic activity; GTPase activity; lysosome; endosome; vacuole; cytosol; plasma membrane; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03748,1.493129479828534,FUN_015056-T1,Peve_00001169,Pocillopora_meandrina_HIv1___RNAseq.g21272.t1,three_way,93.25166666666668,FUN_015056-T1,Q9QZ88,VPS29_MOUSE,,Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29),Mus musculus (Mouse),81.9,182.0,5.8e-87,321.6,sp|Q9QZ88|VPS29_MOUSE Vacuolar protein sorting-associated protein 29 OS=Mus musculus OX=10090 GN=Vps29 PE=1 SV=1,GO:0005829; GO:0006896; GO:0010008; GO:0015031; GO:0030904; GO:0030906; GO:0032456; GO:0042147; GO:0046872,"endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]","cytosol [GO:0005829]; endosome membrane [GO:0010008]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]",metal ion binding [GO:0046872],GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_03751,1.2079038945095193,FUN_015059-T1,Peve_00015744,Pocillopora_meandrina_HIv1___TS.g26027.t1b,three_way,56.31366666666667,,,,,,,,,,,,,,,,,
OG_03752,1.9307353853654576,FUN_015061-T1,Peve_00015752,Pocillopora_meandrina_HIv1___RNAseq.g21278.t1,three_way,60.377,FUN_015061-T1,Q9UH36,,,,,47.6,187.0,2.4e-42,174.1,sp|Q9UH36|SRR1L_HUMAN SRR1-like protein OS=Homo sapiens OX=9606 GN=SRRD PE=1 SV=1,,,,,,
OG_03753,1.9801976224529048,FUN_015062-T1,Peve_00015751,Pocillopora_meandrina_HIv1___RNAseq.g21279.t1,three_way,81.46366666666667,FUN_015062-T1,Q9H773,DCTP1_HUMAN,,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),Homo sapiens (Human),58.9,141.0,2.9e-39,162.9,sp|Q9H773|DCTP1_HUMAN dCTP pyrophosphatase 1 OS=Homo sapiens OX=9606 GN=DCTPP1 PE=1 SV=1,GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840,dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03756,1.2965583786779824,FUN_015065-T1,Peve_00022386,Pocillopora_meandrina_HIv1___RNAseq.g21282.t1,three_way,90.77866666666668,FUN_015065-T1,Q8K3J1,NDUS8_MOUSE,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit)",Mus musculus (Mouse),83.6,177.0,7.5e-59,228.4,"sp|Q8K3J1|NDUS8_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs8 PE=1 SV=1",GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0045271; GO:0046872; GO:0051539,"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]",GO:0005215; GO:0005739; GO:0006091; GO:0043226; GO:0055086; GO:0065003; GO:1901135,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_03765,2.2193747259719228,FUN_015090-T1,Peve_00010706,Pocillopora_meandrina_HIv1___RNAseq.g21186.t1,three_way,63.61833333333333,FUN_015090-T1,Q8HZ69,,,,,41.6,505.0,3.8e-115,416.8,sp|Q8HZ69|FMO2_GORGO Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Gorilla gorilla gorilla OX=9595 GN=FMO2 PE=3 SV=3,,,,,,
OG_03766,1.9417348415193487,FUN_015091-T1,Peve_00010707,Pocillopora_meandrina_HIv1___RNAseq.g21185.t1,three_way,59.72,,,,,,,,,,,,,,,,,
OG_03767,1.6244980238380973,FUN_015095-T1,Peve_00043821,Pocillopora_meandrina_HIv1___RNAseq.g22283.t1,three_way,81.09083333333334,FUN_015095-T1,Q8IZ69,TRM2A_HUMAN,,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-),Homo sapiens (Human),40.3,618.0,9.4e-120,432.6,sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2,GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259,methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033],cytosol [GO:0005829],"C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",GO:0003723; GO:0003824; GO:0005829; GO:0006399; GO:0016071; GO:0016740; GO:0140098,"RNA binding; catalytic activity; cytosol; tRNA metabolic process; mRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_03769,1.3331850386750352,FUN_015098-T1,Peve_00009747,Pocillopora_meandrina_HIv1___RNAseq.g22143.t1,three_way,73.82233333333333,FUN_015098-T1,Q8R2J9,RA51C_CRIGR,,DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),53.1,352.0,1e-99,365.2,sp|Q8R2J9|RA51C_CRIGR DNA repair protein RAD51 homolog 3 OS=Cricetulus griseus OX=10029 GN=RAD51C PE=2 SV=1,GO:0000400; GO:0000707; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0048471; GO:0140664,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0065003; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; DNA repair; DNA recombination; hydrolase activity; reproductive process; telomere organization; organelle; protein-containing complex assembly; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03771,2.116202084183993,FUN_015100-T1,Peve_00027023,Pocillopora_meandrina_HIv1___RNAseq.g22141.t1,three_way,83.81099999999999,FUN_015100-T1,Q5U3N5,,,,,51.7,238.0,6.2e-63,242.3,sp|Q5U3N5|PPTC7_DANRE Protein phosphatase PTC7 homolog OS=Danio rerio OX=7955 GN=pptc7 PE=2 SV=1,,,,,,
OG_03772,2.7892158629720467,FUN_015101-T1,Peve_00027022,Pocillopora_meandrina_HIv1___RNAseq.g22124.t1,three_way,62.69583333333333,FUN_015101-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),37.0,683.0,1.8e-109,398.3,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03775,1.4992721947458898,FUN_015104-T1,Peve_00036871,Pocillopora_meandrina_HIv1___RNAseq.g22119.t3,three_way,78.71466666666666,FUN_015104-T1,Q5ZKJ5,,,,,31.5,496.0,7.6e-55,216.5,sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1,,,,,,
OG_03777,2.510608142728521,FUN_015107-T1,Peve_00036875,Pocillopora_meandrina_HIv1___TS.g26879.t1,three_way,68.18,FUN_015107-T1,Q86YT5,S13A5_HUMAN,,Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5),Homo sapiens (Human),45.1,618.0,1.4e-138,495.0,sp|Q86YT5|S13A5_HUMAN Na(+)/citrate cotransporter OS=Homo sapiens OX=9606 GN=SLC13A5 PE=1 SV=1,GO:0005343; GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015729; GO:0015741; GO:0015742; GO:0015744; GO:0015746; GO:0017153; GO:0042802; GO:0055085; GO:0071285,alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744]; transmembrane transport [GO:0055085],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141],GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0055085,transporter activity; nucleoplasm; cytosol; plasma membrane; transmembrane transport
OG_03780,1.9108878771833504,FUN_015110-T1,Peve_00024794,Pocillopora_meandrina_HIv1___RNAseq.g7729.t1,three_way,38.797,FUN_015110-T1,P82596,,,,,31.1,135.0,1e-08,65.5,sp|P82596|PLC_HALLA Perlucin OS=Haliotis laevigata OX=36097 PE=1 SV=3,,,,,,
OG_03781,1.5857843549145578,FUN_015136-T1,Peve_00001089,Pocillopora_meandrina_HIv1___RNAseq.g21740.t1,three_way,78.34933333333333,FUN_015136-T1,A1L2R7,,,,,47.0,230.0,7.499999999999999e-53,208.8,sp|A1L2R7|TACAN_XENLA Transmembrane protein 120A OS=Xenopus laevis OX=8355 GN=tmem120a.L PE=2 SV=1,,,,,,
OG_03784,1.283865530266495,FUN_015140-T1,Peve_00001082,Pocillopora_meandrina_HIv1___RNAseq.g21745.t1,three_way,84.37516666666667,FUN_015140-T1,Q9U6B8,,,,,57.0,193.0,1.6e-51,204.1,sp|Q9U6B8|ORAI1_DROME Calcium release-activated calcium channel protein 1 OS=Drosophila melanogaster OX=7227 GN=Orai PE=1 SV=1,,,,,,
OG_03790,1.4444543656947475,FUN_015155-T1,Peve_00001868,Pocillopora_meandrina_HIv1___RNAseq.g21762.t1,three_way,71.99633333333334,FUN_015155-T1,B6NK32,,,,,57.8,64.0,4.8e-15,81.6,sp|B6NK32|LYRM9_BRAFL LYR motif-containing protein 9 OS=Branchiostoma floridae OX=7739 GN=LYRM9 PE=3 SV=1,,,,,,
OG_03792,3.5052315210767997,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_03793,2.605903658486372,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_03795,1.738494130258704,FUN_015167-T1,Peve_00014588,Pocillopora_meandrina_HIv1___RNAseq.g21772.t1,three_way,74.31233333333333,,,,,,,,,,,,,,,,,
OG_03799,1.122112368983709,FUN_015179-T1,Peve_00001854,Pocillopora_meandrina_HIv1___RNAseq.g21786.t1,three_way,59.745333333333335,,,,,,,,,,,,,,,,,
OG_03801,1.9734784527277751,FUN_015184-T1,Peve_00023889,Pocillopora_meandrina_HIv1___RNAseq.g22343.t1,three_way,40.410833333333336,FUN_015184-T1,P34331,PLK1_CAEEL,,Serine/threonine-protein kinase plk-1 (EC 2.7.11.21) (Polo-like kinase 1),Caenorhabditis elegans,29.1,292.0,1.2e-19,100.1,sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans OX=6239 GN=plk-1 PE=1 SV=4,GO:0000776; GO:0000793; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007077; GO:0007098; GO:0007147; GO:0030496; GO:0040038; GO:0045132; GO:0051233; GO:0051726; GO:0106310; GO:0110039,centrosome cycle [GO:0007098]; female meiosis II [GO:0007147]; meiotic chromosome segregation [GO:0045132]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of cell cycle [GO:0051726],centrosome [GO:0005813]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0061024; GO:0140013; GO:0140096,"cytokinesis; catalytic activity; nucleus; chromosome; microtubule organizing center; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; membrane organization; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03802,1.052397939723486,FUN_015186-T1,Peve_00019714,Pocillopora_meandrina_HIv1___RNAseq.g22308.t1,three_way,66.40933333333334,,,,,,,,,,,,,,,,,
OG_03803,1.2352728060490363,FUN_015187-T1,Peve_00013021,Pocillopora_meandrina_HIv1___RNAseq.g22307.t1,three_way,65.45766666666667,FUN_015187-T1,O88845,AKA10_MOUSE,,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",Mus musculus (Mouse),33.2,596.0,9.3e-79,296.2,"sp|O88845|AKA10_MOUSE A-kinase anchor protein 10, mitochondrial OS=Mus musculus OX=10090 GN=Akap10 PE=1 SV=3",GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018,protein localization [GO:0008104],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],protein kinase A binding [GO:0051018],GO:0005739; GO:0005829; GO:0005886; GO:0043226,mitochondrion; cytosol; plasma membrane; organelle
OG_03806,1.0009624546987823,FUN_015193-T1,Peve_00013020,Pocillopora_meandrina_HIv1___RNAseq.g22296.t1,three_way,76.85266666666666,FUN_015193-T1,Q6PCX9,TRI37_MOUSE,,E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37),Mus musculus (Mouse),79.4,447.0,4.6e-210,733.0,sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1,GO:0000122; GO:0003682; GO:0003713; GO:0005164; GO:0005694; GO:0005737; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862,"aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]",aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778],chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005694; GO:0005829; GO:0006325; GO:0006355; GO:0006886; GO:0007031; GO:0016740; GO:0043226; GO:0055085; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; chromosome; cytosol; chromatin organization; regulation of DNA-templated transcription; intracellular protein transport; peroxisome organization; transferase activity; organelle; transmembrane transport; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03815,1.315951011678086,FUN_015226-T1,Peve_00016437,Pocillopora_meandrina_HIv1___RNAseq.g22183.t1,three_way,58.229,FUN_015226-T1,Q9R008,,,,,41.3,407.0,1.5e-74,281.6,sp|Q9R008|KIME_MOUSE Mevalonate kinase OS=Mus musculus OX=10090 GN=Mvk PE=1 SV=1,,,,,,
OG_03819,1.4348783235967668,FUN_015230-T1,Peve_00025468,Pocillopora_meandrina_HIv1___RNAseq.g22179.t1,three_way,80.00733333333334,FUN_015230-T1,A7RFA1,,,,,61.3,357.0,4.800000000000001e-130,465.7,sp|A7RFA1|PTER_NEMVE Phosphotriesterase-related protein OS=Nematostella vectensis OX=45351 GN=v1g177083 PE=3 SV=1,,,,,,
OG_03820,1.0144586571758771,FUN_015231-T1,Peve_00016438,Pocillopora_meandrina_HIv1___RNAseq.g22178.t1,three_way,73.793,FUN_015231-T1,Q9CWQ2,,,,,39.3,135.0,2.2e-23,110.2,sp|Q9CWQ2|ZSWM7_MOUSE Zinc finger SWIM domain-containing protein 7 OS=Mus musculus OX=10090 GN=Zswim7 PE=2 SV=1,,,,,,
OG_03822,1.138196593764764,FUN_015236-T2,Peve_00003466,Pocillopora_meandrina_HIv1___TS.g26934.t1,three_way,62.57566666666666,FUN_015236-T2,Q91X60,ACHA2_MOUSE,,Neuronal acetylcholine receptor subunit alpha-2,Mus musculus (Mouse),38.2,325.0,4.2999999999999997e-61,237.3,sp|Q91X60|ACHA2_MOUSE Neuronal acetylcholine receptor subunit alpha-2 OS=Mus musculus OX=10090 GN=Chrna2 PE=2 SV=1,GO:0005654; GO:0005892; GO:0015464; GO:0022848; GO:0034703; GO:0045171; GO:0045211; GO:0048167; GO:0050997; GO:0071316; GO:0071944; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,cellular response to nicotine [GO:0071316]; modulation of inhibitory postsynaptic potential [GO:0098828]; regulation of synaptic plasticity [GO:0048167]; response to acetylcholine [GO:1905144],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0060089,transporter activity; nucleoplasm; molecular transducer activity
OG_03824,1.6668314796212864,FUN_015239-T1,Peve_00003462,Pocillopora_meandrina_HIv1___RNAseq.g22171.t1,three_way,77.89233333333334,FUN_015239-T1,Q8CAM5,,,,,52.4,254.0,7.7e-72,271.9,sp|Q8CAM5|RAB36_MOUSE Ras-related protein Rab-36 OS=Mus musculus OX=10090 GN=Rab36 PE=1 SV=1,,,,,,
OG_03828,1.4708814549985003,FUN_015258-T1,Peve_00014298,Pocillopora_meandrina_HIv1___RNAseq.g22209.t1,three_way,46.362,FUN_015258-T1,Q8BHE0,,,,,37.9,145.0,7e-15,83.2,sp|Q8BHE0|PRR11_MOUSE Proline-rich protein 11 OS=Mus musculus OX=10090 GN=Prr11 PE=2 SV=1,,,,,,
OG_03829,1.6758220337983094,FUN_015262-T1,Peve_00044772,Pocillopora_meandrina_HIv1___RNAseq.g22284.t1,three_way,66.1165,FUN_015262-T1,Q91XW8,FKBP6_MOUSE,,Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36),Mus musculus (Mouse),38.3,298.0,7e-52,206.5,sp|Q91XW8|FKBP6_MOUSE Inactive peptidyl-prolyl cis-trans isomerase FKBP6 OS=Mus musculus OX=10090 GN=Fkbp6 PE=1 SV=1,GO:0000795; GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0015630; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0045070; GO:0045171; GO:0051321; GO:0051879; GO:0141196,cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795],Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802],GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0006457; GO:0022414; GO:0030154; GO:0031047; GO:0043226,nucleoplasm; cytosol; cytoskeleton; chromatin organization; protein folding; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_03830,1.8117268922062568,FUN_015263-T1,Peve_00044771,Pocillopora_meandrina_HIv1___RNAseq.g22216.t1,three_way,70.697,FUN_015263-T1,Q9CQM5,,,,,45.2,115.0,2.1e-22,106.7,sp|Q9CQM5|TXD17_MOUSE Thioredoxin domain-containing protein 17 OS=Mus musculus OX=10090 GN=Txndc17 PE=1 SV=1,,,,,,
OG_03833,1.3858896066707642,FUN_015275-T1,Peve_00014300,Pocillopora_meandrina_HIv1___RNAseq.g22211.t1,three_way,69.08766666666666,FUN_015275-T1,B5X5N3,SKA2_SALSA,,SKA complex subunit 2 (Protein FAM33A) (Spindle and kinetochore-associated protein 2),Salmo salar (Atlantic salmon),29.1,234.0,9.7e-15,82.0,sp|B5X5N3|SKA2_SALSA SKA complex subunit 2 OS=Salmo salar OX=8030 GN=ska2 PE=2 SV=1,GO:0000070; GO:0000940; GO:0005737; GO:0005876; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072687,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876],microtubule binding [GO:0008017],GO:0007059; GO:0008092; GO:0043226,chromosome segregation; cytoskeletal protein binding; organelle
OG_03834,1.3965359546278255,FUN_015291-T1,Peve_00022865,Pocillopora_meandrina_HIv1___RNAseq.g22113.t1,three_way,61.755,FUN_015291-T1,O75771,RA51D_HUMAN,,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),Homo sapiens (Human),40.4,319.0,2.5e-56,220.7,sp|O75771|RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens OX=9606 GN=RAD51D PE=1 SV=1,GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005815; GO:0006281; GO:0007131; GO:0008094; GO:0016887; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726; GO:0140664,DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0008092; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; cytoskeletal protein binding; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03836,1.4557375826078065,FUN_015293-T1,Peve_00022868,Pocillopora_meandrina_HIv1___RNAseq.g22111.t2,three_way,70.97083333333333,FUN_015293-T1,Q08D69,,,,,31.1,892.0,3.4999999999999997e-113,411.0,sp|Q08D69|MED16_XENTR Mediator of RNA polymerase II transcription subunit 16 OS=Xenopus tropicalis OX=8364 GN=med16 PE=2 SV=1,,,,,,
OG_03843,1.5752680891826758,FUN_015308-T1,Peve_00024022,Pocillopora_meandrina_HIv1___RNAseq.g21734.t1,three_way,74.93433333333334,FUN_015308-T1,Q9WU01,KHDR2_MOUSE,,"KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (mSLM-1)",Mus musculus (Mouse),53.1,226.0,9.8e-56,218.8,"sp|Q9WU01|KHDR2_MOUSE KH domain-containing, RNA-binding, signal transduction-associated protein 2 OS=Mus musculus OX=10090 GN=Khdrbs2 PE=1 SV=1",GO:0005634; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]",nucleus [GO:0005634],poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_03858,1.3053604083261692,FUN_015352-T1,Peve_00017515,Pocillopora_meandrina_HIv1___RNAseq.g21698.t1,three_way,68.03,FUN_015352-T1,P07098,LIPF_HUMAN,,Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3),Homo sapiens (Human),53.2,370.0,9.900000000000001e-111,401.7,sp|P07098|LIPF_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens OX=9606 GN=LIPF PE=1 SV=1,GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006641; GO:0008289; GO:0016042; GO:0016615; GO:0043231,lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005576; GO:0005739; GO:0006629; GO:0008289; GO:0016491; GO:0016787; GO:0043226,catalytic activity; extracellular region; mitochondrion; lipid metabolic process; lipid binding; oxidoreductase activity; hydrolase activity; organelle
OG_03874,2.151261151618105,FUN_015405-T1,Peve_00000200,Pocillopora_meandrina_HIv1___RNAseq.g21681.t1,three_way,86.47533333333334,FUN_015405-T1,Q26619,,,,,47.3,383.0,1.5e-89,331.3,sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_03878,1.657989659960884,FUN_015411-T1,Peve_00026943,Pocillopora_meandrina_HIv1___RNAseq.g21674.t1,three_way,92.28733333333334,FUN_015411-T1,Q7ZVM1,WASC5_DANRE,,WASH complex subunit 5 (WASH complex subunit strumpellin),Danio rerio (Zebrafish) (Brachydanio rerio),67.2,1161.0,0.0,1580.8,sp|Q7ZVM1|WASC5_DANRE WASH complex subunit 5 OS=Danio rerio OX=7955 GN=washc5 PE=2 SV=1,GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0048738; GO:0051125; GO:0060047; GO:0071203; GO:0140285; GO:1905304,actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; cardiac muscle tissue development [GO:0048738]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of cardiac myofibril assembly [GO:1905304],early endosome [GO:0005769]; endosome [GO:0005768]; WASH complex [GO:0071203],,GO:0003013; GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0065003,circulatory system process; endosome; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_03884,1.1494984501882388,FUN_015429-T1,Peve_00033649,Pocillopora_meandrina_HIv1___RNAseq.g22262.t1,three_way,84.209,FUN_015429-T1,Q5ZI89,,,,,48.9,1121.0,0.0,1077.0,sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1,,,,,,
OG_03890,1.630642434329591,FUN_015443-T1,Peve_00013024,Pocillopora_meandrina_HIv1___RNAseq.g22268.t1,three_way,73.08466666666666,FUN_015443-T1,A7S4N4,,,,,57.8,455.0,6.6e-129,462.2,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_03891,1.1559671180109714,FUN_015445-T1,Peve_00013658,Pocillopora_meandrina_HIv1___TS.g26948.t2,three_way,62.11333333333334,FUN_015445-T1,O75140,DEPD5_HUMAN,,GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5),Homo sapiens (Human),33.7,1699.0,4.9e-238,826.6,sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2,GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0005764; GO:0005773; GO:0005829; GO:0043226; GO:0098772,lysosome; vacuole; cytosol; organelle; molecular function regulator activity
OG_03896,2.0739941366585306,FUN_015474-T1,Peve_00009512,Pocillopora_meandrina_HIv1___TS.g26531.t2,three_way,73.673,FUN_015474-T1,Q14CX7,NAA25_HUMAN,,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",Homo sapiens (Human),36.3,980.0,6.4000000000000005e-161,569.7,"sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416],acetyltransferase activator activity [GO:0010698],GO:0005794; GO:0005829; GO:0007010; GO:0043226; GO:0098772,Golgi apparatus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_03903,2.652856179923885,FUN_015977-T1,Peve_00032728,Pocillopora_meandrina_HIv1___RNAseq.g21409.t1,three_way,72.505,,,,,,,,,,,,,,,,,
OG_03908,1.4782925446074695,FUN_015984-T1,Peve_00024010,Pocillopora_meandrina_HIv1___RNAseq.g21402.t1,three_way,68.71833333333333,FUN_015984-T1,Q9WTL7,LYPA2_MOUSE,,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) (mLyso II) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),Mus musculus (Mouse),52.0,229.0,5.7e-64,245.7,sp|Q9WTL7|LYPA2_MOUSE Acyl-protein thioesterase 2 OS=Mus musculus OX=10090 GN=Lypla2 PE=1 SV=1,GO:0002084; GO:0004622; GO:0005654; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0008474; GO:0046464; GO:1905344,acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleoplasm [GO:0005654],lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; nucleoplasm; cytosol; lipid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03911,3.996624167884371,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_03913,1.493177395040937,FUN_015994-T1,Peve_00023995,Pocillopora_meandrina_HIv1___RNAseq.g21381.t1,three_way,89.52166666666666,FUN_015994-T1,Q9ULC3,RAB23_HUMAN,,Ras-related protein Rab-23 (EC 3.6.5.2),Homo sapiens (Human),67.2,232.0,1.1e-80,301.2,sp|Q9ULC3|RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1,GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0036064; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094,autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308],autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005773; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0055086; GO:1901135,catalytic activity; GTPase activity; vacuole; microtubule organizing center; cytosol; plasma membrane; cilium; intracellular protein transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03916,1.578795207612751,FUN_016002-T1,Peve_00004542,Pocillopora_meandrina_HIv1___RNAseq.g21371.t1,three_way,80.09833333333333,FUN_016002-T1,Q9D7A8,,,,,43.2,273.0,7.999999999999999e-53,208.8,sp|Q9D7A8|ARMC1_MOUSE Armadillo repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Armc1 PE=1 SV=1,,,,,,
OG_03923,1.444100647981282,FUN_016033-T1,Peve_00011813,Pocillopora_meandrina_HIv1___RNAseq.g21653.t1,three_way,71.436,FUN_016033-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),38.0,839.0,6.400000000000001e-158,559.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_03926,3.5725135092967704,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_03931,1.9928759731178185,FUN_016047-T2,Peve_00011791,Pocillopora_meandrina_HIv1___RNAseq.g21637.t1,three_way,75.40733333333333,FUN_016047-T2,O43272,PROD_HUMAN,,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)",Homo sapiens (Human),49.1,556.0,4.5e-144,513.1,"sp|O43272|PROD_HUMAN Proline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=4",GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0019470; GO:0043231; GO:0071949; GO:1903376,4-hydroxyproline catabolic process [GO:0019470]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376],intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_03932,1.8825058526638383,FUN_016048-T1,Peve_00011790,Pocillopora_meandrina_HIv1___RNAseq.g26043.t1,three_way,52.87083333333334,,,,,,,,,,,,,,,,,
OG_03933,1.806799039895569,FUN_016049-T1,Peve_00011814,Pocillopora_meandrina_HIv1___RNAseq.g21636.t1,three_way,52.112,,,,,,,,,,,,,,,,,
OG_03944,1.3892257431673265,FUN_016081-T1,Peve_00021927,Pocillopora_meandrina_HIv1___RNAseq.g21612.t1,three_way,72.43566666666666,,,,,,,,,,,,,,,,,
OG_03945,1.4178110199279503,FUN_016082-T1,Peve_00021929,Pocillopora_meandrina_HIv1___RNAseq.g21611.t1,three_way,89.665,FUN_016082-T1,Q8CCB4,,,,,60.6,830.0,1.8000000000000002e-273,943.3,sp|Q8CCB4|VPS53_MOUSE Vacuolar protein sorting-associated protein 53 homolog OS=Mus musculus OX=10090 GN=Vps53 PE=1 SV=1,,,,,,
OG_03946,1.677498491212838,FUN_016083-T1,Peve_00021930,Pocillopora_meandrina_HIv1___RNAseq.g21608.t1,three_way,63.108,FUN_016083-T1,Q503L9,NXN_DANRE,,Nucleoredoxin (EC 1.8.1.8),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,413.0,5.8e-95,349.4,sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1,GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359,cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005829; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03949,2.890568878543252,FUN_016088-T1,Peve_00010756,Pocillopora_meandrina_HIv1___RNAseq.g21605.t1,three_way,64.84400000000001,FUN_016088-T1,A6NFN9,,,,,31.8,466.0,7.399999999999999e-56,220.3,sp|A6NFN9|ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens OX=9606 GN=ANKUB1 PE=2 SV=3,,,,,,
OG_03956,1.5744353197429817,FUN_016101-T1,Peve_00010770,Pocillopora_meandrina_HIv1___RNAseq.g21591.t1,three_way,72.2,FUN_016101-T1,Q9W704,,,,,35.9,234.0,6.9e-30,132.5,sp|Q9W704|RIPA_XENLA RPA-interacting protein A OS=Xenopus laevis OX=8355 GN=rpain-a PE=1 SV=1,,,,,,
OG_03962,1.2915472857937242,FUN_016111-T1,Peve_00013359,Pocillopora_meandrina_HIv1___RNAseq.g21553.t2,three_way,68.24533333333333,FUN_016111-T1,Q8WXX7,,,,,35.2,162.0,1.2e-07,60.5,sp|Q8WXX7|AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1,,,,,,
OG_03966,1.8368592934006875,FUN_016115-T1,Peve_00013352,Pocillopora_meandrina_HIv1___RNAseq.g21556.t1,three_way,63.22466666666667,FUN_016115-T1,Q9H9H4,VP37B_HUMAN,,Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B),Homo sapiens (Human),36.6,82.0,2.4e-06,53.1,sp|Q9H9H4|VP37B_HUMAN Vacuolar protein sorting-associated protein 37B OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1,GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148; GO:1903774,macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306],GO:0005768; GO:0005886; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03969,1.2723585729200466,FUN_016123-T1,Peve_00013454,Pocillopora_meandrina_HIv1___RNAseq.g21533.t1,three_way,88.006,FUN_016123-T1,Q9YHZ6,,,,,47.3,566.0,1.3e-150,534.6,sp|Q9YHZ6|CDC45_XENLA Cell division control protein 45 homolog OS=Xenopus laevis OX=8355 GN=cdc45 PE=1 SV=2,,,,,,
OG_03976,2.60288554651432,FUN_016130-T1,Peve_00022572,Pocillopora_meandrina_HIv1___RNAseq.g21959.t1,three_way,68.79966666666667,FUN_016130-T1,A3KCL7,OXDD_PIG,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Sus scrofa (Pig),40.6,342.0,3.8e-63,243.4,sp|A3KCL7|OXDD_PIG D-aspartate oxidase OS=Sus scrofa OX=9823 GN=DDO PE=1 SV=2,GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006531; GO:0007320; GO:0007625; GO:0008445; GO:0010646; GO:0019478; GO:0042445; GO:0047821; GO:0050877; GO:0071949,aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]; nervous system process [GO:0050877]; regulation of cell communication [GO:0010646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; peroxisome; cytosol; amino acid metabolic process; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_03977,1.2645247267581654,FUN_016131-T1,Peve_00022577,Pocillopora_meandrina_HIv1___RNAseq.g22028.t1,three_way,72.21333333333334,FUN_016131-T1,Q2KIY5,,,,,49.0,531.0,7e-144,512.3,sp|Q2KIY5|PLBL2_BOVIN Putative phospholipase B-like 2 OS=Bos taurus OX=9913 GN=PLBD2 PE=2 SV=1,,,,,,
OG_03979,1.0652221212958135,FUN_016137-T1,Peve_00022581,Pocillopora_meandrina_HIv1___RNAseq.g22030.t1,three_way,83.41883333333334,FUN_016137-T1,Q810B6,ANFY1_MOUSE,,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),Mus musculus (Mouse),49.1,1329.0,3.3e-253,876.7,sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2,GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981,"endocytosis [GO:0006897]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; retromer complex [GO:0030904],phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005829; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03982,2.6199205828062038,FUN_016141-T1,Peve_00013437,Pocillopora_meandrina_HIv1___TS.g26796.t1c,three_way,79.88266666666667,FUN_016141-T1,O14578,,,,,35.7,1950.0,1.8999999999999999e-239,831.6,sp|O14578|CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens OX=9606 GN=CIT PE=1 SV=2,,,,,,
OG_03983,1.4335569481810149,FUN_016148-T1,Peve_00013425,Pocillopora_meandrina_HIv1___RNAseq.g22092.t1,three_way,82.95133333333334,FUN_016148-T1,P79987,HIRA_CHICK,,Protein HIRA (cHIRA) (TUP1-like enhancer of split protein 1),Gallus gallus (Chicken),44.1,1049.0,7.2e-216,752.3,sp|P79987|HIRA_CHICK Protein HIRA OS=Gallus gallus OX=9031 GN=HIRA PE=1 SV=2,GO:0000417; GO:0000785; GO:0005634; GO:0006338; GO:0006351; GO:0006355,chromatin remodeling [GO:0006338]; DNA-templated transcription [GO:0006351]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; HIR complex [GO:0000417]; nucleus [GO:0005634],,GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0043226,nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; organelle
OG_03985,1.796481024302267,FUN_016150-T1,Peve_00013422,Pocillopora_meandrina_HIv1___RNAseq.g22094.t1,three_way,87.48066666666666,,,,,,,,,,,,,,,,,
OG_03988,2.942806297338521,FUN_016154-T1,Peve_00004478,Pocillopora_meandrina_HIv1___RNAseq.g21231.t1,three_way,69.62266666666667,,,,,,,,,,,,,,,,,
OG_03989,1.2399815490517556,FUN_016156-T1,Peve_00022567,Pocillopora_meandrina_HIv1___RNAseq.g21232.t1,three_way,67.495,FUN_016156-T1,Q6GQN8,MECR_DANRE,,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase)",Danio rerio (Zebrafish) (Brachydanio rerio),47.7,130.0,7.1e-31,134.8,"sp|Q6GQN8|MECR_DANRE Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Danio rerio OX=7955 GN=mecr PE=2 SV=2",GO:0005739; GO:0006631; GO:0006633; GO:0141148,fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],mitochondrion [GO:0005739],enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_03991,2.992818342747925,FUN_016163-T1,Peve_00022617,Pocillopora_meandrina_HIv1___RNAseq.g21016.t1,three_way,65.033,FUN_016163-T1,Q9ULI0,ATD2B_HUMAN,,ATPase family AAA domain-containing protein 2B,Homo sapiens (Human),42.8,1254.0,1.0999999999999999e-249,865.1,sp|Q9ULI0|ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=4,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0070577,nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; chromatin organization; hydrolase activity; histone binding; organelle; protein-containing complex assembly
OG_03996,1.182194743471496,FUN_016280-T2,Peve_00003392,Pocillopora_meandrina_HIv1___RNAseq.g403.t1,three_way,76.21483333333333,FUN_016280-T2,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),42.5,742.0,6.9e-166,585.9,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04016,1.3226172736969448,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,361.0,7e-47,191.0,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04016,1.3226172736969448,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),47.1,70.0,3e-13,79.3,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04026,1.953490968851884,FUN_016333-T1,Peve_00044546,Pocillopora_meandrina_HIv1___TS.g23374.t1,three_way,71.42983333333333,FUN_016333-T1,P35869,AHR_HUMAN,,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),Homo sapiens (Human),40.4,381.0,7.4e-62,240.4,sp|P35869|AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens OX=9606 GN=AHR PE=1 SV=2,GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837,"apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_04030,1.3927870830318947,FUN_016338-T1,Peve_00044573,Pocillopora_meandrina_HIv1___RNAseq.g9726.t1,three_way,78.57166666666667,FUN_016338-T1,Q6NWF4,,,,,59.3,177.0,7.1e-61,235.0,sp|Q6NWF4|VPS25_DANRE Vacuolar protein-sorting-associated protein 25 OS=Danio rerio OX=7955 GN=vps25 PE=2 SV=2,,,,,,
OG_04031,2.057771455868623,FUN_016339-T1,Peve_00044575,Pocillopora_meandrina_HIv1___RNAseq.g9729.t1,three_way,89.3255,FUN_016339-T1,Q9CQ19,MYL9_MOUSE,,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)",Mus musculus (Mouse),73.4,169.0,2.000000000000001e-65,250.0,sp|Q9CQ19|MYL9_MOUSE Myosin regulatory light polypeptide 9 OS=Mus musculus OX=10090 GN=Myl9 PE=1 SV=3,GO:0001725; GO:0005200; GO:0005509; GO:0005938; GO:0016460; GO:0030018; GO:0032036; GO:0043149,stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0007010; GO:0008092,structural molecule activity; cytoskeleton organization; cytoskeletal protein binding
OG_04034,2.149448646836956,FUN_016342-T1,Peve_00044580,Pocillopora_meandrina_HIv1___RNAseq.g9725.t1,three_way,65.89516666666667,FUN_016342-T1,Q9USQ7,,,,,38.4,578.0,3.8e-99,364.0,sp|Q9USQ7|DPH6_SCHPO Diphthine--ammonia ligase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=mug71 PE=1 SV=1,,,,,,
OG_04035,1.4668274817551106,FUN_016343-T1,Peve_00044581,Pocillopora_meandrina_HIv1___RNAseq.g9724.t1,three_way,79.218,FUN_016343-T1,Q28DS0,,,,,49.7,342.0,5.4e-94,345.9,sp|Q28DS0|SAE1_XENTR SUMO-activating enzyme subunit 1 OS=Xenopus tropicalis OX=8364 GN=sae1 PE=2 SV=1,,,,,,
OG_04036,1.5141897416132328,FUN_016344-T1,Peve_00004330,Pocillopora_meandrina_HIv1___RNAseq.g9849.t1,three_way,55.79433333333333,FUN_016344-T1,Q28GL6,,,,,30.6,281.0,2.7e-14,80.9,sp|Q28GL6|S7A6O_XENTR Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Xenopus tropicalis OX=8364 GN=slc7a6os PE=2 SV=1,,,,,,
OG_04038,1.5117478204822214,FUN_016346-T2,Peve_00004339,Pocillopora_meandrina_HIv1___TS.g23215.t1,three_way,85.454,FUN_016346-T2,Q6NW96,SP9_DANRE,,Transcription factor Sp9,Danio rerio (Zebrafish) (Brachydanio rerio),39.6,341.0,1.2999999999999998e-43,178.7,sp|Q6NW96|SP9_DANRE Transcription factor Sp9 OS=Danio rerio OX=7955 GN=sp9 PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04040,1.569735416685547,FUN_016349-T1,Peve_00004360,Pocillopora_meandrina_HIv1___RNAseq.g9678.t1,three_way,89.957,FUN_016349-T1,Q7ZU42,,,,,75.0,388.0,1.4e-166,587.4,sp|Q7ZU42|OLA1_DANRE Obg-like ATPase 1 OS=Danio rerio OX=7955 GN=ola1 PE=2 SV=1,,,,,,
OG_04045,1.0625999809959132,FUN_016357-T1,Peve_00004337,Pocillopora_meandrina_HIv1___RNAseq.g9673.t1,three_way,68.83566666666667,FUN_016357-T1,Q8NBP0,,,,,36.6,470.0,3.1e-84,314.3,sp|Q8NBP0|TTC13_HUMAN Tetratricopeptide repeat protein 13 OS=Homo sapiens OX=9606 GN=TTC13 PE=1 SV=3,,,,,,
OG_04048,1.1463939823021512,FUN_016362-T1,Peve_00004341,Pocillopora_meandrina_HIv1___RNAseq.g9604.t1,three_way,75.83800000000001,FUN_016362-T1,Q9D1Q6,ERP44_MOUSE,,Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4),Mus musculus (Mouse),47.8,427.0,4.6e-111,402.9,sp|Q9D1Q6|ERP44_MOUSE Endoplasmic reticulum resident protein 44 OS=Mus musculus OX=10090 GN=Erp44 PE=1 SV=1,GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976,glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793],protein disulfide isomerase activity [GO:0003756],GO:0003824; GO:0006457; GO:0016853; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; protein folding; isomerase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04051,1.1651490971033789,FUN_016370-T1,Peve_00022928,Pocillopora_meandrina_HIv1___RNAseq.g20804.t1,three_way,58.012,FUN_016370-T1,Q9CQM0,,,,,36.2,207.0,3e-34,146.7,sp|Q9CQM0|NICN1_MOUSE Nicolin-1 OS=Mus musculus OX=10090 GN=Nicn1 PE=1 SV=1,,,,,,
OG_04062,2.6820224455017043,FUN_016382-T1,Peve_00022906,Pocillopora_meandrina_HIv1___RNAseq.g9735.t1,three_way,83.83333333333333,FUN_016382-T1,Q3MHX1,,,,,50.0,200.0,4.0000000000000005e-49,196.1,sp|Q3MHX1|COMD7_BOVIN COMM domain-containing protein 7 OS=Bos taurus OX=9913 GN=COMMD7 PE=2 SV=1,,,,,,
OG_04065,1.5141111876437576,FUN_016386-T1,Peve_00030460,Pocillopora_meandrina_HIv1___RNAseq.g15065.t1,three_way,69.083,FUN_016386-T1,Q9UBD5,ORC3_HUMAN,,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),Homo sapiens (Human),40.6,729.0,7.2e-149,529.3,sp|Q9UBD5|ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens OX=9606 GN=ORC3 PE=1 SV=1,GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005634; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006270; GO:0006275; GO:0014009; GO:0016604; GO:0031261; GO:0061351,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; organelle
OG_04075,3.374515507035504,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_04077,2.14597469977534,FUN_016402-T1,Peve_00028063,Pocillopora_meandrina_HIv1___RNAseq.g9780.t1,three_way,62.028666666666666,FUN_016402-T1,Q9Y2I7,FYV1_HUMAN,,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1),Homo sapiens (Human),31.1,2630.0,2.5e-294,1014.2,sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3,GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]",cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506],"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005829; GO:0006629; GO:0016192; GO:0016740; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0140096,"immune system process; catalytic activity; cytosol; lipid metabolic process; vesicle-mediated transport; transferase activity; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_04078,1.6733313670917735,FUN_016408-T1,Peve_00018205,Pocillopora_meandrina_HIv1___TS.g23317.t1,three_way,74.89666666666666,FUN_016408-T1,Q98TY9,,,,,63.8,469.0,2.1e-170,600.1,sp|Q98TY9|AKT1_XENLA RAC-alpha serine/threonine-protein kinase OS=Xenopus laevis OX=8355 GN=akt1 PE=2 SV=1,,,,,,
OG_04079,1.913730630886448,FUN_016409-T1,Peve_00018211,Pocillopora_meandrina_HIv1___TS.g23318.t2,three_way,80.886,FUN_016409-T1,Q5RBS1,NDUF5_PONAB,,"Arginine-hydroxylase NDUFAF5, mitochondrial (EC 1.-.-.-) (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5) (EC 2.1.1.-)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),62.6,294.0,3.2e-107,389.8,"sp|Q5RBS1|NDUF5_PONAB Arginine-hydroxylase NDUFAF5, mitochondrial OS=Pongo abelii OX=9601 GN=NDUFAF5 PE=2 SV=1",GO:0004497; GO:0005739; GO:0008757; GO:0032259; GO:0032981; GO:0099617,methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981],matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrion [GO:0005739],monooxygenase activity [GO:0004497]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005739; GO:0016491; GO:0016740; GO:0043226; GO:0065003,catalytic activity; mitochondrion; oxidoreductase activity; transferase activity; organelle; protein-containing complex assembly
OG_04080,1.2929177333309043,FUN_016410-T1,Peve_00018210,Pocillopora_meandrina_HIv1___RNAseq.g9784.t1,three_way,70.55316666666667,,,,,,,,,,,,,,,,,
OG_04085,1.479695509320642,FUN_016421-T1,Peve_00023006,Pocillopora_meandrina_HIv1___RNAseq.g9803.t1,three_way,72.968,FUN_016421-T1,Q9P2G1,AKIB1_HUMAN,,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),Homo sapiens (Human),50.3,746.0,6.800000000000001e-211,735.7,sp|Q9P2G1|AKIB1_HUMAN Ankyrin repeat and IBR domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKIB1 PE=1 SV=3,GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04086,1.901391195872243,FUN_016422-T1,Peve_00004363,Pocillopora_meandrina_HIv1___RNAseq.g9804.t1,three_way,88.40866666666666,FUN_016422-T1,P62490,,,,,67.1,207.0,2e-70,266.9,sp|P62490|RB11A_CANLF Ras-related protein Rab-11A OS=Canis lupus familiaris OX=9615 GN=RAB11A PE=2 SV=3,,,,,,
OG_04088,1.0494650124593563,FUN_016425-T1,Peve_00004359,Pocillopora_meandrina_HIv1___TS.g23342.t4,three_way,52.22683333333333,,,,,,,,,,,,,,,,,
OG_04090,1.739658112929512,FUN_016429-T1,Peve_00004354,Pocillopora_meandrina_HIv1___RNAseq.g9810.t1,three_way,71.03866666666667,FUN_016429-T1,Q642M9,,,,,44.1,331.0,4.8e-79,296.2,"sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2",,,,,,
OG_04099,2.140699204776431,FUN_016445-T1,Peve_00032930,Pocillopora_meandrina_HIv1___RNAseq.g9836.t1,three_way,92.40566666666666,FUN_016445-T1,Q5NVP8,,,,,67.9,112.0,1e-36,154.1,sp|Q5NVP8|LIN52_PONAB Protein lin-52 homolog OS=Pongo abelii OX=9601 GN=LIN52 PE=3 SV=1,,,,,,
OG_04103,1.771459194733204,FUN_016454-T1,Peve_00040139,Pocillopora_meandrina_HIv1___RNAseq.g98.t1,three_way,77.08683333333333,FUN_016454-T1,Q6DJM7,CDK14_XENLA,,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14),Xenopus laevis (African clawed frog),56.3,421.0,1.8e-121,437.6,sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis OX=8355 GN=cdk14 PE=2 SV=1,GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04105,2.06671081404435,FUN_016469-T1,Peve_00015303,Pocillopora_meandrina_HIv1___RNAseq.g100.t1,three_way,99.05466666666666,FUN_016469-T1,Q17QC5,AP2S1_BOVIN,,AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin),Bos taurus (Bovine),92.3,142.0,1.4e-69,263.5,sp|Q17QC5|AP2S1_BOVIN AP-2 complex subunit sigma OS=Bos taurus OX=9913 GN=AP2S1 PE=2 SV=1,GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231],clathrin adaptor activity [GO:0035615],GO:0006886; GO:0016192; GO:0043226; GO:0060090,intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity
OG_04106,1.6350800402021426,FUN_016470-T1,Peve_00015304,Pocillopora_meandrina_HIv1___RNAseq.g101.t1,three_way,67.28366666666666,FUN_016470-T1,Q6P4F7,RHGBA_HUMAN,,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),Homo sapiens (Human),37.3,260.0,1.6999999999999996e-31,139.0,sp|Q6P4F7|RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens OX=9606 GN=ARHGAP11A PE=1 SV=2,GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056,positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleus [GO:0005634],GTPase activator activity [GO:0005096],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_04108,1.24707628207947,FUN_016473-T1,Peve_00015306,Pocillopora_meandrina_HIv1___RNAseq.g145.t1,three_way,60.1465,FUN_016473-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),81.0,58.0,5e-21,102.8,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04109,2.1889691530511106,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04113,1.7295004270663312,FUN_016489-T1,Peve_00001327,Pocillopora_meandrina_HIv1___RNAseq.g9629.t1,three_way,83.481,FUN_016489-T1,Q8R5L3,,,,,52.2,596.0,7.399999999999999e-171,602.1,sp|Q8R5L3|VPS39_MOUSE Vam6/Vps39-like protein OS=Mus musculus OX=10090 GN=Vps39 PE=1 SV=1,,,,,,
OG_04114,1.1619107903844623,FUN_016490-T1,Peve_00001326,Pocillopora_meandrina_HIv1___RNAseq.g9508.t1,three_way,62.83783333333333,FUN_016490-T1,Q505F5,,,,,40.5,333.0,1.1e-45,186.0,sp|Q505F5|LRC47_MOUSE Leucine-rich repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Lrrc47 PE=1 SV=1,,,,,,
OG_04115,1.3383852557161662,FUN_016491-T1,Peve_00024202,Pocillopora_meandrina_HIv1___RNAseq.g9195.t1,three_way,72.09166666666667,FUN_016491-T1,P31006,,,,,54.1,185.0,5.899999999999999e-53,208.8,sp|P31006|KGUA_PIG Guanylate kinase OS=Sus scrofa OX=9823 GN=GUK1 PE=1 SV=2,,,,,,
OG_04117,2.4581850939356364,FUN_016493-T1,Peve_00042754,Pocillopora_meandrina_HIv1___RNAseq.g178.t1,three_way,75.77766666666666,FUN_016493-T1,P54357,,,,,44.8,145.0,1.8e-29,130.6,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_04118,1.072456535083228,FUN_016494-T1,Peve_00042755,Pocillopora_meandrina_HIv1___TS.g6942.t1,three_way,83.782,FUN_016494-T1,Q9UT00,,,,,22.7,519.0,8.7e-20,100.9,sp|Q9UT00|YKH3_SCHPO Uncharacterized protein PYUK71.03c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAPYUK71.03c PE=1 SV=1,,,,,,
OG_04129,3.8828479123326702,FUN_016578-T1,Peve_00002516,Pocillopora_meandrina_HIv1___RNAseq.g9694.t1,three_way,71.17683333333333,FUN_016578-T1,Q8K4Q6,NEIL1_MOUSE,,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1),Mus musculus (Mouse),49.5,307.0,1.9000000000000002e-80,301.2,sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3,GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016829; GO:0019104; GO:0140078,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04130,2.4168674076933105,FUN_016580-T1,Peve_00002515,Pocillopora_meandrina_HIv1___RNAseq.g9696.t1,three_way,53.467,,,,,,,,,,,,,,,,,
OG_04133,2.1034578930150425,FUN_016587-T1,Peve_00000800,Pocillopora_meandrina_HIv1___RNAseq.g2974.t1,three_way,65.638,FUN_016587-T1,Q92900,RENT1_HUMAN,,Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1),Homo sapiens (Human),38.4,440.0,3.5999999999999997e-69,265.8,sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2,GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006913; GO:0016071; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; nucleocytoplasmic transport; mRNA metabolic process; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04134,1.4049908104733062,FUN_016588-T1,Peve_00000798,Pocillopora_meandrina_HIv1___RNAseq.g2973.t1,three_way,71.725,,,,,,,,,,,,,,,,,
OG_04137,1.605239321522229,FUN_016591-T1,Peve_00005997,Pocillopora_meandrina_HIv1___RNAseq.g474.t1,three_way,70.59733333333334,FUN_016591-T1,Q4KLE6,,,,,47.7,241.0,2.5999999999999998e-61,236.9,sp|Q4KLE6|NT1AB_XENLA N-terminal Xaa-Pro-Lys N-methyltransferase 1-B OS=Xenopus laevis OX=8355 GN=ntmt1-b PE=2 SV=1,,,,,,
OG_04144,1.1329279998250803,FUN_016605-T1,Peve_00044543,Pocillopora_meandrina_HIv1___RNAseq.g9626.t1,three_way,81.345,FUN_016605-T1,Q7SXP8,,,,,52.2,295.0,1.4e-88,327.8,sp|Q7SXP8|GMPAB_DANRE Mannose-1-phosphate guanylyltransferase regulatory subunit alpha-B OS=Danio rerio OX=7955 GN=gmppab PE=2 SV=1,,,,,,
OG_04146,2.227158673555115,FUN_016608-T1,Peve_00010249,Pocillopora_meandrina_HIv1___RNAseq.g9623.t1b,three_way,79.465,FUN_016608-T1,P58465,,,,,63.3,270.0,1.5e-89,330.9,sp|P58465|CTDSL_MOUSE CTD small phosphatase-like protein OS=Mus musculus OX=10090 GN=Ctdspl PE=2 SV=3,,,,,,
OG_04157,1.0318140907455842,FUN_016625-T1,Peve_00020325,Pocillopora_meandrina_HIv1___RNAseq.g148.t1,three_way,74.75966666666666,FUN_016625-T1,A0A8V1ABE9,DSD1_CHICK,,D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase),Gallus gallus (Chicken),46.1,310.0,9e-77,288.5,sp|A0A8V1ABE9|DSD1_CHICK D-serine dehydratase OS=Gallus gallus OX=9031 GN=DSD PE=1 SV=1,GO:0005737; GO:0008270; GO:0008721; GO:0030170; GO:0030425; GO:0036088,D-serine catabolic process [GO:0036088],cytoplasm [GO:0005737]; dendrite [GO:0030425],D-serine ammonia-lyase activity [GO:0008721]; pyridoxal phosphate binding [GO:0030170]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0016829,catalytic activity; amino acid metabolic process; lyase activity
OG_04163,1.085403658680523,FUN_016642-T1,Peve_00042750,Pocillopora_meandrina_HIv1___RNAseq.g209.t1,three_way,69.53533333333333,FUN_016642-T1,Q5ZHV5,JMJD4_CHICK,,2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4),Gallus gallus (Chicken),54.8,325.0,8.5e-110,398.7,sp|Q5ZHV5|JMJD4_CHICK 2-oxoglutarate and iron-dependent oxygenase JMJD4 OS=Gallus gallus OX=9031 GN=JMJD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0043565; GO:0045905; GO:0046872; GO:0106156,positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; peptidyl-lysine 4-dioxygenase activity [GO:0106156]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_04167,2.484597199384411,FUN_016648-T1,Peve_00042742,Pocillopora_meandrina_HIv1___RNAseq.g197.t1,three_way,86.58166666666666,FUN_016648-T1,A8QCE4,,,,,45.3,64.0,6.8e-15,83.6,sp|A8QCE4|LST2_BRUMA Lateral signaling target protein 2 homolog OS=Brugia malayi OX=6279 GN=Bm5439 PE=3 SV=1,,,,,,
OG_04170,4.051838570783794,FUN_016651-T1,Peve_00042780,Pocillopora_meandrina_HIv1___TS.g6961.t1,three_way,81.653,FUN_016651-T1,Q6TMK4,POXA_DICDI,,Peroxinectin A (EC 1.11.1.7),Dictyostelium discoideum (Social amoeba),34.7,521.0,3.3e-86,322.0,sp|Q6TMK4|POXA_DICDI Peroxinectin A OS=Dictyostelium discoideum OX=44689 GN=poxA PE=1 SV=1,GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,immune system process; catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_04171,1.3173311171418065,FUN_016652-T1,Peve_00042777,Pocillopora_meandrina_HIv1___RNAseq.22127_t,three_way,89.431,FUN_016652-T1,Q2KIA2,TR112_BOVIN,,Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog),Bos taurus (Bovine),61.8,123.0,2.2e-37,156.4,sp|Q2KIA2|TR112_BOVIN Multifunctional methyltransferase subunit TRM112-like protein OS=Bos taurus OX=9913 GN=TRMT112 PE=2 SV=1,GO:0000470; GO:0005634; GO:0005654; GO:0005737; GO:0018364; GO:0030490; GO:0031167; GO:0043528; GO:0045815; GO:0046982; GO:0048471; GO:0070476; GO:0141106; GO:2000234,maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA (m2G10) methyltransferase complex [GO:0043528],protein heterodimerization activity [GO:0046982]; tRNA methyltransferase activator activity [GO:0141106],GO:0005634; GO:0005654; GO:0006325; GO:0043226; GO:0098772,nucleus; nucleoplasm; chromatin organization; organelle; molecular function regulator activity
OG_04175,1.8285934977656897,FUN_016660-T2,Peve_00032318,Pocillopora_meandrina_HIv1___RNAseq.g10087.t1,three_way,86.16333333333333,FUN_016660-T2,Q92047,,,,,58.3,223.0,3.4000000000000004e-74,279.6,sp|Q92047|PIMT_DANRE Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Danio rerio OX=7955 GN=pcmt PE=2 SV=3,,,,,,
OG_04178,1.021969401653256,FUN_016668-T1,Peve_00002514,Pocillopora_meandrina_HIv1___RNAseq.g9697.t1,three_way,79.70833333333333,FUN_016668-T1,A0JNI5,CLASR_BOVIN,,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Bos taurus (Bovine),51.1,309.0,1.2e-50,202.6,sp|A0JNI5|CLASR_BOVIN CLK4-associating serine/arginine rich protein OS=Bos taurus OX=9913 GN=CLASRP PE=2 SV=1,GO:0005634; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226,nucleus; mRNA metabolic process; organelle
OG_04179,1.848957137984078,FUN_016671-T1,Peve_00034246,Pocillopora_meandrina_HIv1___TS.g7272.t1b,three_way,52.63633333333333,FUN_016671-T1,Q28C74,,,,,26.6,992.0,1.1e-15,87.4,"sp|Q28C74|LPPRC_XENTR Leucine-rich PPR motif-containing protein, mitochondrial OS=Xenopus tropicalis OX=8364 GN=lrpprc PE=2 SV=1",,,,,,
OG_04180,1.175887260127447,FUN_016676-T1,Peve_00013936,Pocillopora_meandrina_HIv1___RNAseq.g504.t1,three_way,57.66266666666667,FUN_016676-T1,Q96L42,,,,,50.7,213.0,2.8999999999999996e-55,218.8,sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2,,,,,,
OG_04185,1.608517744047379,FUN_016705-T1,Peve_00004831,Pocillopora_meandrina_HIv1___RNAseq.g281.t1,three_way,77.65433333333333,FUN_016705-T1,Q9SB50,,,,,48.3,292.0,1.1e-71,271.6,sp|Q9SB50|AP4M_ARATH AP-4 complex subunit mu OS=Arabidopsis thaliana OX=3702 GN=AP4M PE=2 SV=1,,,,,,
OG_04186,2.3371701682137456,FUN_016706-T1,Peve_00034244,Pocillopora_meandrina_HIv1___RNAseq.g282.t2,three_way,70.44399999999999,FUN_016706-T1,Q8VDM6,HNRL1_MOUSE,,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Mus musculus (Mouse),50.9,399.0,8.3e-112,406.4,sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904,,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],enzyme binding [GO:0019899]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0043226,RNA binding; nucleus; nucleoplasm; organelle
OG_04190,1.5724653323973208,FUN_016711-T1,Peve_00024193,Pocillopora_meandrina_HIv1___RNAseq.g274.t1,three_way,81.8285,FUN_016711-T1,Q9BGI1,,,,,59.1,171.0,2e-55,216.9,"sp|Q9BGI1|PRDX5_BOVIN Peroxiredoxin-5, mitochondrial OS=Bos taurus OX=9913 GN=PRDX5 PE=2 SV=2",,,,,,
OG_04195,3.9117761455145663,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04197,2.0935736768205677,FUN_016724-T1,Peve_00014678,Pocillopora_meandrina_HIv1___RNAseq.g232.t1,three_way,75.45816666666667,,,,,,,,,,,,,,,,,
OG_04204,1.4021190618092854,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04205,2.7135254058380216,FUN_016777-T1,Peve_00032303,Pocillopora_meandrina_HIv1___RNAseq.g10047.t1,three_way,85.97500000000001,FUN_016777-T1,Q86SR1,GLT10_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),Homo sapiens (Human),41.8,584.0,1.1e-123,445.3,sp|Q86SR1|GLT10_HUMAN Polypeptide N-acetylgalactosaminyltransferase 10 OS=Homo sapiens OX=9606 GN=GALNT10 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04209,1.2040768579462635,FUN_016791-T1,Peve_00032297,Pocillopora_meandrina_HIv1___RNAseq.g10045.t1,three_way,78.91866666666667,FUN_016791-T1,Q65X23,,,,,26.7,292.0,1.5e-14,83.6,sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica OX=39947 GN=WNK2 PE=2 SV=1,,,,,,
OG_04211,1.9296219461016209,FUN_016798-T1,Peve_00023973,Pocillopora_meandrina_HIv1___RNAseq.g242.t1,three_way,87.46816666666666,FUN_016798-T1,Q9Y2E4,,,,,56.7,1558.0,0.0,1701.0,sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2,,,,,,
OG_04213,2.216698291702294,FUN_016850-T1,Peve_00018595,Pocillopora_meandrina_HIv1___RNAseq.g15658.t1,three_way,64.21766666666667,,,,,,,,,,,,,,,,,
OG_04217,2.1763068797956,FUN_016964-T1,Peve_00025247,Pocillopora_meandrina_HIv1___RNAseq.g9909.t1,three_way,65.26533333333333,FUN_016964-T1,P24540,,,,,60.2,98.0,9.2e-26,117.5,sp|P24540|ACYP1_PIG Acylphosphatase-1 OS=Sus scrofa OX=9823 GN=ACYP1 PE=1 SV=2,,,,,,
OG_04218,1.7450527350103104,FUN_016968-T1,Peve_00025295,Pocillopora_meandrina_HIv1___RNAseq.g9906.t1,three_way,69.24583333333334,FUN_016968-T1,O13046,,,,,38.1,1161.0,8.099999999999999e-200,699.1,sp|O13046|WDHD1_XENLA WD repeat and HMG-box DNA-binding protein 1 OS=Xenopus laevis OX=8355 GN=wdhd1 PE=1 SV=1,,,,,,
OG_04227,1.5019133061343484,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_04230,2.245468180093035,FUN_017693-T1,Peve_00030752,Pocillopora_meandrina_HIv1___RNAseq.g23495.t1,three_way,47.43216666666667,,,,,,,,,,,,,,,,,
OG_04232,1.6552740930495653,FUN_017709-T1,Peve_00022746,Pocillopora_meandrina_HIv1___RNAseq.g19535.t1,three_way,68.68633333333334,FUN_017709-T1,Q12931,TRAP1_HUMAN,,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (Heat shock protein family C member 5) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",Homo sapiens (Human),50.5,661.0,7.799999999999998e-177,622.1,"sp|Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3",GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0140662; GO:1901856; GO:1903427; GO:1903751,chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0140657,RNA binding; catalytic activity; nucleoplasm; mitochondrion; protein folding; hydrolase activity; organelle; protein folding chaperone; ATP-dependent activity
OG_04235,3.778951372137842,FUN_017756-T1,Peve_00030017,Pocillopora_meandrina_HIv1___RNAseq.g15152.t1,three_way,86.29766666666667,FUN_017756-T1,Q3ZBG9,,,,,63.9,233.0,3.8e-92,339.3,sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1,,,,,,
OG_04243,2.3468441148956884,FUN_017765-T1,Peve_00003282,Pocillopora_meandrina_HIv1___RNAseq.g446.t1,three_way,79.75516666666667,FUN_017765-T1,Q5RD44,B3A2_PONAB,,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Solute carrier family 4 member 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),43.1,1043.0,1.9e-207,724.5,sp|Q5RD44|B3A2_PONAB Anion exchange protein 2 OS=Pongo abelii OX=9601 GN=SLC4A2 PE=2 SV=2,GO:0016323; GO:0016324; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0140900; GO:2000565,"negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323],chloride:bicarbonate antiporter activity [GO:0140900],GO:0005215; GO:0030154,transporter activity; cell differentiation
OG_04249,2.049058034104056,FUN_017777-T1,Peve_00006865,Pocillopora_meandrina_HIv1___RNAseq.g9511.t1,three_way,83.44666666666667,FUN_017777-T1,Q6IMK3,,,,,38.7,168.0,6.9e-33,142.1,sp|Q6IMK3|DJC27_DANRE DnaJ homolog subfamily C member 27 OS=Danio rerio OX=7955 GN=dnajc27 PE=2 SV=1,,,,,,
OG_04254,1.273287321234821,FUN_017784-T1,Peve_00040540,Pocillopora_meandrina_HIv1___RNAseq.g9518.t1,three_way,64.44666666666666,FUN_017784-T1,P29351,,,,,35.2,105.0,2.7e-10,67.0,sp|P29351|PTN6_MOUSE Tyrosine-protein phosphatase non-receptor type 6 OS=Mus musculus OX=10090 GN=Ptpn6 PE=1 SV=2,,,,,,
OG_04255,1.1870194095554911,FUN_017786-T1,Peve_00040532,Pocillopora_meandrina_HIv1___RNAseq.g9521.t1,three_way,78.56866666666667,FUN_017786-T1,A0A455ZMR3,,,,,31.7,322.0,3.7999999999999996e-35,150.2,sp|A0A455ZMR3|PPZD_METMF 2-oxoglutarate-Fe(II) type oxidoreductase ppzD OS=Metarhizium majus (strain ARSEF 297) OX=1276143 GN=ppzD PE=1 SV=1,,,,,,
OG_04265,2.496636486380076,FUN_017815-T1,Peve_00006859,Pocillopora_meandrina_HIv1___RNAseq.g9541.t1,three_way,67.37566666666666,FUN_017815-T1,P22727,WNT6_MOUSE,,Protein Wnt-6,Mus musculus (Mouse),41.3,366.0,3e-82,307.0,sp|P22727|WNT6_MOUSE Protein Wnt-6 OS=Mus musculus OX=10090 GN=Wnt6 PE=1 SV=2,GO:0001658; GO:0005102; GO:0005576; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0031012; GO:0042475; GO:0045893; GO:0060684; GO:0070172; GO:0072079; GO:0072080,animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0006355; GO:0023052; GO:0030312; GO:0031012; GO:0048856,extracellular region; regulation of DNA-templated transcription; signaling; external encapsulating structure; extracellular matrix; anatomical structure development
OG_04266,1.9071547441037409,FUN_017816-T1,Peve_00006857,Pocillopora_meandrina_HIv1___RNAseq.g9540.t1,three_way,72.20233333333334,FUN_017816-T1,Q2LMP1,WNT3A_CHICK,,Protein Wnt-3a,Gallus gallus (Chicken),41.7,314.0,2.3000000000000002e-71,270.8,sp|Q2LMP1|WNT3A_CHICK Protein Wnt-3a OS=Gallus gallus OX=9031 GN=WNT3A PE=1 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0005640; GO:0005783; GO:0005829; GO:0005886; GO:0009953; GO:0010628; GO:0010831; GO:0030182; GO:0030509; GO:0035108; GO:0040036; GO:0042472; GO:0045165; GO:0045663; GO:0045743; GO:0045944; GO:0048263; GO:0050679; GO:0060070; GO:0060173; GO:0060828; GO:0061303; GO:0090263,BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cornea development in camera-type eye [GO:0061303]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_04275,2.0240067923178584,FUN_017834-T1,Peve_00009484,Pocillopora_meandrina_HIv1___RNAseq.g9635.t1,three_way,60.010333333333335,FUN_017834-T1,Q9H3U7,,,,,30.4,214.0,7e-14,80.9,sp|Q9H3U7|SMOC2_HUMAN SPARC-related modular calcium-binding protein 2 OS=Homo sapiens OX=9606 GN=SMOC2 PE=1 SV=2,,,,,,
OG_04276,1.8509102102546413,FUN_017835-T1,Peve_00027711,Pocillopora_meandrina_HIv1___RNAseq.g9593.t1,three_way,65.258,FUN_017835-T1,E1C1L6,ENTP5_CHICK,,Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5),Gallus gallus (Chicken),47.1,380.0,1.0000000000000001e-88,328.6,sp|E1C1L6|ENTP5_CHICK Ectonucleoside triphosphate diphosphohydrolase 5 OS=Gallus gallus OX=9031 GN=ENTPD5 PE=3 SV=1,GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003,'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0005576; GO:0005783; GO:0006457; GO:0009101; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; extracellular region; endoplasmic reticulum; protein folding; glycoprotein biosynthetic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04279,1.2243451856033716,FUN_017840-T1,Peve_00011468,Pocillopora_meandrina_HIv1___RNAseq.g9633.t1,three_way,76.64583333333333,FUN_017840-T1,F4JYJ3,,,,,35.1,225.0,6.599999999999997e-29,129.8,sp|F4JYJ3|SFH11_ARATH Phosphatidylinositol/phosphatidylcholine transfer protein SFH11 OS=Arabidopsis thaliana OX=3702 GN=SFH11 PE=3 SV=1,,,,,,
OG_04281,1.8456447621676928,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_04283,1.4455433570975822,FUN_017846-T1,Peve_00018628,Pocillopora_meandrina_HIv1___RNAseq.g9585.t1,three_way,60.34483333333333,,,,,,,,,,,,,,,,,
OG_04285,3.3883975055242708,FUN_017848-T2,Peve_00013267,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1a,three_way,68.80566666666667,FUN_017848-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),37.0,873.0,6.1e-166,586.3,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04287,1.2228828157196974,FUN_017850-T1,Peve_00019991,Pocillopora_meandrina_HIv1___RNAseq.g9582.t1,three_way,53.20133333333334,FUN_017850-T1,C5FWH1,,,,,34.9,146.0,8.9e-14,79.7,sp|C5FWH1|LIS1_ARTOC Nuclear distribution protein PAC1 OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=PAC1 PE=3 SV=1,,,,,,
OG_04288,2.159375550894691,FUN_017851-T1,Peve_00019990,Pocillopora_meandrina_HIv1___RNAseq.g9581.t1,three_way,70.00766666666667,FUN_017851-T1,Q9CXL1,,,,,54.8,155.0,8.7e-44,177.9,sp|Q9CXL1|TM50A_MOUSE Transmembrane protein 50A OS=Mus musculus OX=10090 GN=Tmem50a PE=1 SV=1,,,,,,
OG_04296,1.3050291025873555,FUN_017862-T1,Peve_00016055,Pocillopora_meandrina_HIv1___RNAseq.g9571.t1,three_way,53.224,,,,,,,,,,,,,,,,,
OG_04297,1.3345984926757568,FUN_017864-T1,Peve_00018760,Pocillopora_meandrina_HIv1___RNAseq.g9560.t1,three_way,71.19116666666666,FUN_017864-T1,Q9VM21,,,,,27.0,629.0,9.8e-54,213.4,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04300,1.1876142128344471,FUN_017869-T1,Peve_00023912,Pocillopora_meandrina_HIv1___RNAseq.g9555.t1,three_way,85.59933333333333,FUN_017869-T1,P80205,OTX1_MOUSE,,Homeobox protein OTX1 (Orthodenticle homolog 1),Mus musculus (Mouse),69.2,91.0,2.4e-26,120.6,sp|P80205|OTX1_MOUSE Homeobox protein OTX1 OS=Mus musculus OX=10090 GN=Otx1 PE=2 SV=1,GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030900; GO:0030901; GO:0042472; GO:0048852,anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; forebrain development [GO:0030900]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04306,1.5648463826945749,FUN_017891-T1,Peve_00019165,Pocillopora_meandrina_HIv1___TS.g23200.t2,three_way,53.3605,,,,,,,,,,,,,,,,,
OG_04318,1.5147471305950186,FUN_017918-T1,Peve_00013068,Pocillopora_meandrina_HIv1___RNAseq.g326.t1,three_way,47.547,,,,,,,,,,,,,,,,,
OG_04319,2.355534877226072,FUN_017919-T1,Peve_00005940,Pocillopora_meandrina_HIv1___RNAseq.g312.t1,three_way,45.6825,FUN_017919-T1,O88488,PTPRQ_RAT,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Rattus norvegicus (Rat),26.4,1078.0,1.7e-50,203.8,sp|O88488|PTPRQ_RAT Phosphatidylinositol phosphatase PTPRQ OS=Rattus norvegicus OX=10116 GN=Ptprq PE=1 SV=1,GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_04325,1.6336506320191777,FUN_017927-T2,Peve_00001600,Pocillopora_meandrina_HIv1___TS.g7049.t1,three_way,73.92666666666668,FUN_017927-T2,A0A8V0ZB02,TM63B_CHICK,,Mechanosensitive cation channel TMEM63B (Transmembrane protein 63B),Gallus gallus (Chicken),39.6,700.0,1.6e-133,478.4,sp|A0A8V0ZB02|TM63B_CHICK Mechanosensitive cation channel TMEM63B OS=Gallus gallus OX=9031 GN=TMEM63B PE=3 SV=1,GO:0005227; GO:0005765; GO:0005886; GO:0007605; GO:0015629; GO:0017128; GO:0031901; GO:0036335; GO:0042756; GO:0120019; GO:0140135; GO:0140338; GO:0160069; GO:1990760,drinking behavior [GO:0042756]; intestinal stem cell homeostasis [GO:0036335]; sensory perception of sound [GO:0007605]; surfactant secretion [GO:0160069],actin cytoskeleton [GO:0015629]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],calcium-activated cation channel activity [GO:0005227]; mechanosensitive monoatomic cation channel activity [GO:0140135]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; phosphatidylcholine transfer activity [GO:0120019]; phospholipid scramblase activity [GO:0017128]; sphingomyelin transfer activity [GO:0140338],GO:0005215; GO:0005856; GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772; GO:0140299,transporter activity; cytoskeleton; plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity; molecular sensor activity
OG_04335,4.072243807734813,FUN_017947-T1,Peve_00000380,Pocillopora_meandrina_HIv1___RNAseq.g25233.t1,three_way,66.458,FUN_017947-T1,F1M0Z1,TRIO_RAT,,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),Rattus norvegicus (Rat),44.3,314.0,2.1999999999999998e-69,265.8,sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4,GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310,axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04336,4.607611348228055,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_04337,1.779541847858718,FUN_017950-T1,Peve_00000377,Pocillopora_meandrina_HIv1___RNAseq.g25230.t1,three_way,61.35916666666667,FUN_017950-T1,Q8T689,,,,,26.9,583.0,8.299999999999999e-46,188.0,sp|Q8T689|ABCG4_DICDI ABC transporter G family member 4 OS=Dictyostelium discoideum OX=44689 GN=abcG4 PE=3 SV=1,,,,,,
OG_04340,2.1526916602194244,FUN_017955-T1,Peve_00000384,Pocillopora_meandrina_HIv1___RNAseq.g25234.t1,three_way,69.41033333333334,FUN_017955-T1,Q6GLK6,,,,,52.1,530.0,4.1e-155,549.7,"sp|Q6GLK6|ACSF3_XENLA Malonate--CoA ligase ACSF3, mitochondrial OS=Xenopus laevis OX=8355 GN=acsf3 PE=2 SV=1",,,,,,
OG_04346,1.3128544830609508,FUN_017970-T1,Peve_00000395,Pocillopora_meandrina_HIv1___TS.g25528.t2,three_way,63.346833333333336,FUN_017970-T1,Q9VM21,,,,,33.0,624.0,2.1999999999999997e-53,212.2,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04348,1.0421352904353236,FUN_017974-T1,Peve_00027236,Pocillopora_meandrina_HIv1___RNAseq.g25289.t1,three_way,57.09133333333333,,,,,,,,,,,,,,,,,
OG_04354,1.086621492180111,FUN_018004-T1,Peve_00015727,Pocillopora_meandrina_HIv1___RNAseq.g25251.t1,three_way,57.72966666666667,FUN_018004-T1,Q9JI78,NGLY1_MOUSE,,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),Mus musculus (Mouse),41.8,509.0,2.6e-100,367.5,sp|Q9JI78|NGLY1_MOUSE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Mus musculus OX=10090 GN=Ngly1 PE=1 SV=2,GO:0000224; GO:0005634; GO:0005737; GO:0006516; GO:0046872; GO:0062023,glycoprotein catabolic process [GO:0006516],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nucleus [GO:0005634],metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224],GO:0003824; GO:0005634; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; nucleus; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_04361,1.3214042730311757,FUN_018012-T1,Peve_00000401,Pocillopora_meandrina_HIv1___RNAseq.g25253.t1,three_way,51.12533333333333,,,,,,,,,,,,,,,,,
OG_04366,1.1164303994574518,FUN_018019-T1,Peve_00026634,Pocillopora_meandrina_HIv1___RNAseq.29613_t,three_way,80.27433333333333,FUN_018019-T1,Q9I3S3,,,,,66.9,314.0,3.5000000000000005e-125,449.5,sp|Q9I3S3|GBUA_PSEAE Guanidinobutyrase OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=gbuA PE=1 SV=1,,,,,,
OG_04368,1.1224760649580856,FUN_018026-T1,Peve_00005737,Pocillopora_meandrina_HIv1___RNAseq.g25300.t1,three_way,69.16366666666667,FUN_018026-T1,Q9Z0W3,,,,,33.6,1163.0,8.8e-181,636.0,sp|Q9Z0W3|NU160_MOUSE Nuclear pore complex protein Nup160 OS=Mus musculus OX=10090 GN=Nup160 PE=1 SV=2,,,,,,
OG_04378,1.9077298116652328,FUN_018044-T1,Peve_00021778,Pocillopora_meandrina_HIv1___RNAseq.g25351.t1,three_way,82.307,FUN_018044-T1,Q3ZCH9,,,,,61.7,248.0,2.0000000000000001e-88,327.0,sp|Q3ZCH9|HDHD2_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Bos taurus OX=9913 GN=HDHD2 PE=2 SV=1,,,,,,
OG_04379,1.2033837728502457,FUN_018045-T1,Peve_00021776,Pocillopora_meandrina_HIv1___RNAseq.g25350.t1,three_way,76.90433333333333,FUN_018045-T1,Q99741,CDC6_HUMAN,,Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6),Homo sapiens (Human),42.7,571.0,9.5e-109,395.6,sp|Q99741|CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens OX=9606 GN=CDC6 PE=1 SV=1,GO:0000076; GO:0000079; GO:0000166; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0016887; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:0120283; GO:1904117; GO:1904385,cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; protein serine/threonine kinase binding [GO:0120283],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226,DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle
OG_04381,2.296606250147577,FUN_018086-T1,Peve_00021774,Pocillopora_meandrina_HIv1___RNAseq.g25348.t1,three_way,67.76233333333333,FUN_018086-T1,A0JM23,,,,,37.7,1131.0,2.1e-142,508.4,sp|A0JM23|NPHP3_XENTR Nephrocystin-3 OS=Xenopus tropicalis OX=8364 GN=nphp3 PE=2 SV=2,,,,,,
OG_04383,1.6220595146554184,FUN_018089-T1,Peve_00034409,Pocillopora_meandrina_HIv1___RNAseq.g25344.t1,three_way,74.77966666666667,FUN_018089-T1,A6QQX9,TM163_BOVIN,,Transmembrane protein 163,Bos taurus (Bovine),35.8,215.0,2.7e-29,130.6,sp|A6QQX9|TM163_BOVIN Transmembrane protein 163 OS=Bos taurus OX=9913 GN=TMEM163 PE=2 SV=1,GO:0005765; GO:0005886; GO:0008270; GO:0030672; GO:0031901; GO:0031902; GO:0042552; GO:0140882,myelination [GO:0042552]; zinc export across plasma membrane [GO:0140882],early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0005886; GO:0055085,plasma membrane; transmembrane transport
OG_04384,1.2763778552579996,FUN_018090-T1,Peve_00017613,Pocillopora_meandrina_HIv1___RNAseq.g25343.t1,three_way,84.46766666666666,FUN_018090-T1,Q64521,GPDM_MOUSE,,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (Protein TISP38)",Mus musculus (Mouse),62.2,717.0,1.6999999999999998e-259,896.7,"sp|Q64521|GPDM_MOUSE Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Gpd2 PE=1 SV=2",GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0019563; GO:0035264; GO:0043010,camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368],GO:0003824; GO:0005739; GO:0005975; GO:0016491; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04385,1.697256404308593,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_04395,1.3881743162275109,FUN_018398-T1,Peve_00032288,Pocillopora_meandrina_HIv1___TS.g23627.t2,three_way,73.27966666666667,FUN_018398-T1,P70168,IMB1_MOUSE,,Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG),Mus musculus (Mouse),64.6,878.0,0.0,1105.5,sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2,GO:0005654; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0010494; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0040001; GO:0042564; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307,astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267],GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0007010; GO:0007018; GO:0043226; GO:0140104,nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; microtubule-based movement; organelle; molecular carrier activity
OG_04396,1.4726125099700824,FUN_018401-T1,Peve_00031702,Pocillopora_meandrina_HIv1___RNAseq.g10160.t1,three_way,68.175,FUN_018401-T1,Q6DIM3,TBD_XENTR,,Tubulin delta chain (Delta-tubulin),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),31.4,255.0,1.5e-26,122.5,sp|Q6DIM3|TBD_XENTR Tubulin delta chain OS=Xenopus tropicalis OX=8364 GN=tubd1 PE=2 SV=1,GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007017; GO:0030030; GO:0045880,cell projection organization [GO:0030030]; microtubule-based process [GO:0007017]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005634; GO:0005929; GO:0043226,structural molecule activity; nucleus; cilium; organelle
OG_04397,2.306388105721985,FUN_018402-T1,Peve_00033494,Pocillopora_meandrina_HIv1___RNAseq.16819_t,three_way,58.857,FUN_018402-T1,Q8BVT6,,,,,27.0,429.0,2.6e-26,122.1,sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1,,,,,,
OG_04398,2.7517398312796306,FUN_018403-T1,Peve_00033495,Pocillopora_meandrina_HIv1___RNAseq.g10162.t1,three_way,77.55466666666666,FUN_018403-T1,Q28811,,,,,61.2,485.0,7.3000000000000005e-180,631.7,sp|Q28811|PHR_POTTR Deoxyribodipyrimidine photo-lyase OS=Potorous tridactylus OX=9310 GN=PHR PE=2 SV=1,,,,,,
OG_04402,1.2484057460791815,FUN_018414-T1,Peve_00031694,Pocillopora_meandrina_HIv1___TS.g23697.t1,three_way,70.86200000000001,FUN_018414-T1,Q5ZID6,5NT3A_CHICK,,Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I),Gallus gallus (Chicken),38.2,325.0,3.8000000000000003e-57,223.4,sp|Q5ZID6|5NT3A_CHICK Cytosolic 5'-nucleotidase 3A OS=Gallus gallus OX=9031 GN=NT5C3A PE=1 SV=3,GO:0000166; GO:0000287; GO:0005737; GO:0005783; GO:0005829; GO:0006248; GO:0008253; GO:0016604; GO:0016740,CMP catabolic process [GO:0006248],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604],5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740],GO:0003824; GO:0005783; GO:0005829; GO:0016740; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; endoplasmic reticulum; cytosol; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04403,1.8874011154252976,FUN_018416-T1,Peve_00031691,Pocillopora_meandrina_HIv1___RNAseq.g10170.t1,three_way,54.97866666666667,FUN_018416-T1,Q49A88,CCD14_HUMAN,,Coiled-coil domain-containing protein 14,Homo sapiens (Human),29.7,229.0,3.1e-18,95.5,sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539,protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630],,GO:0005815; GO:0005856; GO:0005929; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton; cilium; organelle; anatomical structure development
OG_04409,1.396693509819141,FUN_018428-T1,Peve_00007315,Pocillopora_meandrina_HIv1___TS.g23705.t3,three_way,65.60566666666666,FUN_018428-T1,P97321,SEPR_MOUSE,,"Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]",Mus musculus (Mouse),35.3,787.0,7.4e-134,479.6,sp|P97321|SEPR_MOUSE Prolyl endopeptidase FAP OS=Mus musculus OX=10090 GN=Fap PE=1 SV=1,GO:0001525; GO:0002020; GO:0004252; GO:0005178; GO:0005615; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0051726; GO:0060244; GO:0070161; GO:0097325; GO:1900119; GO:1902362; GO:1903054; GO:1905368,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710],anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; extracellular space [GO:0005615]; lamellipodium membrane [GO:0031258]; peptidase complex [GO:1905368]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005615; GO:0005886; GO:0007155; GO:0012501; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; extracellular space; plasma membrane; cell adhesion; programmed cell death; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_04410,1.732756836625899,FUN_018429-T1,Peve_00007316,Pocillopora_meandrina_HIv1___RNAseq.g10178.t1,three_way,79.36266666666667,FUN_018429-T1,P20664,,,,,57.6,399.0,1.9e-133,477.2,sp|P20664|PRI1_MOUSE DNA primase small subunit OS=Mus musculus OX=10090 GN=Prim1 PE=1 SV=1,,,,,,
OG_04412,1.3967477583835652,FUN_018519-T1,Peve_00007317,Pocillopora_meandrina_HIv1___TS.g23707.t1,three_way,53.989333333333335,FUN_018519-T1,Q0Z7W6,TMX1_BOVIN,,Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1),Bos taurus (Bovine),40.5,195.0,6.0999999999999996e-43,176.0,sp|Q0Z7W6|TMX1_BOVIN Thioredoxin-related transmembrane protein 1 OS=Bos taurus OX=9913 GN=TMX1 PE=2 SV=1,GO:0003756; GO:0004857; GO:0005576; GO:0005789; GO:0010868; GO:0012505; GO:0015035; GO:0015036; GO:0031966; GO:0034976; GO:0044233; GO:0051924; GO:0090331; GO:1904294,negative regulation of platelet aggregation [GO:0090331]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of ERAD pathway [GO:1904294]; regulation of calcium ion transport [GO:0051924]; response to endoplasmic reticulum stress [GO:0034976],endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966],disulfide oxidoreductase activity [GO:0015036]; enzyme inhibitor activity [GO:0004857]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005576; GO:0016491; GO:0016853; GO:0098772; GO:0140096,"catalytic activity; extracellular region; oxidoreductase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04418,1.9440362301989704,FUN_018526-T1,Peve_00039209,Pocillopora_meandrina_HIv1___TS.g23531.t1,three_way,63.84433333333334,,,,,,,,,,,,,,,,,
OG_04422,2.3530680584414543,FUN_018531-T1,Peve_00039201,Pocillopora_meandrina_HIv1___RNAseq.g9981.t1,three_way,73.98216666666667,FUN_018531-T1,Q9H9S5,FKRP_HUMAN,,Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase),Homo sapiens (Human),44.4,522.0,2.4e-120,434.1,sp|Q9H9S5|FKRP_HUMAN Ribitol 5-phosphate transferase FKRP OS=Homo sapiens OX=9606 GN=FKRP PE=1 SV=1,GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723,adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403],cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723],"dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003012; GO:0003016; GO:0003824; GO:0005615; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0006575; GO:0006629; GO:0006954; GO:0009101; GO:0016740; GO:0030154; GO:0030198; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0051604; GO:0055086; GO:0065003; GO:1901135,muscle system process; respiratory system process; catalytic activity; extracellular space; nucleoplasm; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; inflammatory response; glycoprotein biosynthetic process; transferase activity; cell differentiation; extracellular matrix organization; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; protein maturation; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_04423,3.2967837524235937,FUN_018532-T1,Peve_00039214,Pocillopora_meandrina_HIv1___RNAseq.g9982.t1,three_way,57.187333333333335,,,,,,,,,,,,,,,,,
OG_04427,2.002908764786508,FUN_018550-T1,Peve_00032304,Pocillopora_meandrina_HIv1___RNAseq.g10049.t1,three_way,68.13333333333334,FUN_018550-T1,Q5BLD8,,,,,33.1,166.0,2.1e-17,90.9,sp|Q5BLD8|MT21A_DANRE Protein N-lysine methyltransferase METTL21A OS=Danio rerio OX=7955 GN=mettl21a PE=2 SV=1,,,,,,
OG_04434,2.296569532489323,FUN_018790-T1,Peve_00013151,Pocillopora_meandrina_HIv1___RNAseq.g14712.t1,three_way,68.35233333333333,,,,,,,,,,,,,,,,,
OG_04439,4.745736570501418,FUN_018835-T2,Peve_00035787,Pocillopora_meandrina_HIv1___RNAseq.g9856.t1,three_way,77.22033333333333,FUN_018835-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),37.1,4337.0,0.0,2654.0,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_04443,1.491052961552088,FUN_018864-T3,Peve_00035796,Pocillopora_meandrina_HIv1___RNAseq.g371.t1,three_way,60.120666666666665,FUN_018864-T3,G3V928,LRP1_RAT,,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],Rattus norvegicus (Rat),36.6,3344.0,4.5e-259,897.9,sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1,GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005815; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010951; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032374; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104],apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235],alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003013; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089,immune system process; circulatory system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity
OG_04456,1.608571464402747,FUN_019139-T1,Peve_00032879,Pocillopora_meandrina_HIv1___RNAseq.g25379.t1,three_way,83.4905,FUN_019139-T1,P37287,PIGA_HUMAN,,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A),Homo sapiens (Human),64.6,424.0,6.1e-154,545.4,sp|P37287|PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens OX=9606 GN=PIGA PE=1 SV=1,GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0016020; GO:0017176; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; membrane [GO:0016020],phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194],GO:0003824; GO:0006629; GO:0016740; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_04459,1.502059012195212,FUN_019331-T1,Peve_00032903,Pocillopora_meandrina_HIv1___RNAseq.g20800.t1,three_way,84.01033333333334,FUN_019331-T1,O18373,,,,,64.6,305.0,4.3999999999999996e-116,419.1,"sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1",,,,,,
OG_04465,1.435065275875406,FUN_019382-T1,Peve_00031766,Pocillopora_meandrina_HIv1___RNAseq.g23704.t1,three_way,75.74716666666667,,,,,,,,,,,,,,,,,
OG_04474,1.380319596796635,FUN_020855-T1,Peve_00032916,Pocillopora_meandrina_HIv1___RNAseq.g20813.t1,three_way,66.00766666666667,,,,,,,,,,,,,,,,,
OG_04479,1.4276955721153513,FUN_021449-T1,Peve_00025992,Pocillopora_meandrina_HIv1___RNAseq.g2971.t1,three_way,68.957,FUN_021449-T1,Q13416,ORC2_HUMAN,,Origin recognition complex subunit 2,Homo sapiens (Human),43.0,505.0,6.2e-99,362.8,sp|Q13416|ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens OX=9606 GN=ORC2 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000792; GO:0000808; GO:0000939; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0005813; GO:0006270; GO:0016020,DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; organelle
OG_04486,1.236042498295043,FUN_021479-T1,Peve_00013215,Pocillopora_meandrina_HIv1___RNAseq.g9419.t1,three_way,44.461333333333336,,,,,,,,,,,,,,,,,
OG_04489,1.7668370952588517,FUN_021612-T1,Peve_00021567,Pocillopora_meandrina_HIv1___RNAseq.g4223.t1,three_way,65.06666666666666,FUN_021612-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),35.3,439.0,6.1e-64,246.5,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04492,1.1146085810707094,FUN_021923-T1,Peve_00016339,Pocillopora_meandrina_HIv1___RNAseq.g2916.t1a,three_way,59.88366666666666,FUN_021923-T1,Q9CPS6,,,,,43.3,67.0,9.4e-10,64.3,sp|Q9CPS6|HINT3_MOUSE Adenosine 5'-monophosphoramidase HINT3 OS=Mus musculus OX=10090 GN=Hint3 PE=1 SV=1,,,,,,
OG_04496,3.0446050794845627,FUN_021928-T1,Peve_00023935,Pocillopora_meandrina_HIv1___RNAseq.g2913.t1,three_way,79.017,FUN_021928-T1,O81884,,,,,44.3,316.0,7.099999999999999e-70,265.8,sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1,,,,,,
OG_04498,1.873723522747744,FUN_021934-T1,Peve_00023932,Pocillopora_meandrina_HIv1___RNAseq.g2962.t1,three_way,57.409666666666666,,,,,,,,,,,,,,,,,
OG_04501,1.249461114082307,FUN_021939-T1,Peve_00022544,Pocillopora_meandrina_HIv1___RNAseq.g12977.t2,three_way,61.04866666666667,FUN_021939-T1,Q5M888,,,,,43.1,404.0,8.3e-83,308.9,sp|Q5M888|CG025_RAT UPF0415 protein C7orf25 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1,,,,,,
OG_04503,2.450807850286371,FUN_022013-T1,Peve_00042673,Pocillopora_meandrina_HIv1___RNAseq.g3139.t1,three_way,74.30833333333334,FUN_022013-T1,Q05360,,,,,43.6,676.0,1.9e-149,531.2,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_04509,1.3399334947673502,FUN_022038-T1,Peve_00016622,Pocillopora_meandrina_HIv1___RNAseq.g9268.t1,three_way,65.09233333333333,FUN_022038-T1,Q568B7,,,,,53.4,425.0,7.300000000000001e-125,448.7,sp|Q568B7|QTMAN_DANRE tRNA-queuosine alpha-mannosyltransferase OS=Danio rerio OX=7955 GN=gtdc1 PE=2 SV=2,,,,,,
OG_04512,1.1755424694331271,FUN_022044-T1,Peve_00007834,Pocillopora_meandrina_HIv1___RNAseq.g9290.t1,three_way,72.45516666666667,FUN_022044-T1,Q5T2R2,DPS1_HUMAN,,All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),Homo sapiens (Human),57.9,323.0,3e-102,373.6,sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1,GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142,isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142],all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04513,1.7703411199024683,FUN_022046-T1,Peve_00007833,Pocillopora_meandrina_HIv1___RNAseq.g9288.t1,three_way,85.22166666666666,FUN_022046-T1,Q8WVP7,LMBR1_HUMAN,,Limb region 1 protein homolog (Differentiation-related gene 14 protein),Homo sapiens (Human),51.5,464.0,4.4000000000000006e-118,426.4,sp|Q8WVP7|LMBR1_HUMAN Limb region 1 protein homolog OS=Homo sapiens OX=9606 GN=LMBR1 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007165; GO:0042733,embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165],plasma membrane [GO:0005886],transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_04517,1.2381056860858497,FUN_022051-T1,Peve_00014023,Pocillopora_meandrina_HIv1___RNAseq.g4603.t1,three_way,64.20333333333333,,,,,,,,,,,,,,,,,
OG_04524,1.0207284029203365,FUN_022059-T1,Peve_00014932,Pocillopora_meandrina_HIv1___RNAseq.g4610.t1,three_way,48.778,FUN_022059-T1,Q9NVV4,PAPD1_HUMAN,,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",Homo sapiens (Human),35.3,292.0,4.3e-40,167.9,"sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817,histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140053,RNA binding; catalytic activity; nucleoplasm; mitochondrion; mRNA metabolic process; transferase activity; organelle; mitochondrial gene expression
OG_04529,1.2511617367469725,FUN_022073-T1,Peve_00012101,Pocillopora_meandrina_HIv1___RNAseq.g4581.t1,three_way,60.477,FUN_022073-T1,P58557,,,,,36.4,162.0,2.6e-19,97.1,sp|P58557|YBEY_HUMAN Endoribonuclease YbeY OS=Homo sapiens OX=9606 GN=YBEY PE=1 SV=2,,,,,,
OG_04531,2.520167204873951,FUN_022075-T1,Peve_00038290,Pocillopora_meandrina_HIv1___RNAseq.g9321.t1,three_way,59.58166666666667,,,,,,,,,,,,,,,,,
OG_04536,2.399697132256926,FUN_022092-T1,Peve_00038684,Pocillopora_meandrina_HIv1___RNAseq.g4111.t1,three_way,48.881,,,,,,,,,,,,,,,,,
OG_04547,1.1836384585672035,FUN_022170-T1,Peve_00036602,Pocillopora_meandrina_HIv1___RNAseq.g4779.t1,three_way,50.17433333333334,FUN_022170-T1,B8UU78,,,,,90.7,1117.0,0.0,1992.2,sp|B8UU78|ELP_ACRMI EGF and laminin G domain-containing protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04559,2.1393460070731747,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_04567,1.709699578954912,FUN_022210-T1,Peve_00008600,Pocillopora_meandrina_HIv1___RNAseq.g4765.t1,three_way,84.062,FUN_022210-T1,Q8HYI9,,,,,45.7,138.0,1.9e-30,133.7,sp|Q8HYI9|PFD5_BOVIN Prefoldin subunit 5 OS=Bos taurus OX=9913 GN=PFDN5 PE=2 SV=1,,,,,,
OG_04581,1.4157192793093505,FUN_022244-T1,Peve_00037427,Pocillopora_meandrina_HIv1___RNAseq.g4759.t1,three_way,49.892,,,,,,,,,,,,,,,,,
OG_04583,1.0114217546688684,FUN_022248-T1,Peve_00021274,Pocillopora_meandrina_HIv1___RNAseq.g4731.t1,three_way,77.724,FUN_022248-T1,P50171,,,,,54.1,259.0,1.3e-68,261.2,sp|P50171|DHB8_MOUSE (3R)-3-hydroxyacyl-CoA dehydrogenase OS=Mus musculus OX=10090 GN=Hsd17b8 PE=1 SV=2,,,,,,
OG_04584,1.8194779022256409,FUN_022249-T1,Peve_00021283,Pocillopora_meandrina_HIv1___RNAseq.g4723.t1,three_way,79.9,FUN_022249-T1,Q1ECX4,TLK2_DANRE,,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2),Danio rerio (Zebrafish) (Brachydanio rerio),51.9,697.0,1.7e-174,614.4,sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310,chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556],cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton; chromosome segregation; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04589,1.1943914533982924,FUN_022261-T1,Peve_00043989,Pocillopora_meandrina_HIv1___RNAseq.g4717.t1,three_way,64.07733333333333,,,,,,,,,,,,,,,,,
OG_04594,1.162299703103004,FUN_022278-T1,Peve_00022094,Pocillopora_meandrina_HIv1___RNAseq.g4704.t1,three_way,78.5305,FUN_022278-T1,Q08CH6,CATIP_DANRE,,Ciliogenesis-associated TTC17-interacting protein,Danio rerio (Zebrafish) (Brachydanio rerio),43.1,341.0,9.5e-73,275.4,sp|Q08CH6|CATIP_DANRE Ciliogenesis-associated TTC17-interacting protein OS=Danio rerio OX=7955 GN=catip PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371,actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,nucleus; cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_04595,1.2793054993879656,FUN_022279-T1,Peve_00022093,Pocillopora_meandrina_HIv1___RNAseq.g4703.t2,three_way,75.602,FUN_022279-T1,Q7ZWS1,DUS3L_XENLA,,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Xenopus laevis (African clawed frog),54.4,634.0,7.399999999999997e-190,665.2,sp|Q7ZWS1|DUS3L_XENLA tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Xenopus laevis OX=8355 GN=dus3l PE=2 SV=1,GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414,mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0006399; GO:0016071; GO:0016491; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; mRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_04596,2.4119754931061936,FUN_022280-T1,Peve_00022092,Pocillopora_meandrina_HIv1___RNAseq.g4702.t1,three_way,79.605,FUN_022280-T1,Q0V9W6,,,,,40.9,423.0,5.6e-88,326.2,sp|Q0V9W6|BTBD6_XENTR BTB/POZ domain-containing protein 6 OS=Xenopus tropicalis OX=8364 GN=btbd6 PE=2 SV=2,,,,,,
OG_04600,2.4885200615424705,FUN_022285-T1,Peve_00003591,Pocillopora_meandrina_HIv1___RNAseq.g4696.t1,three_way,62.73716666666667,FUN_022285-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),69.0,58.0,3.8e-17,90.1,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04604,1.927726752073635,FUN_022293-T1,Peve_00003688,Pocillopora_meandrina_HIv1___RNAseq.g4691.t1,three_way,65.73366666666666,,,,,,,,,,,,,,,,,
OG_04607,1.4056274595504288,FUN_022297-T1,Peve_00021643,Pocillopora_meandrina_HIv1___RNAseq.g4620.t1,three_way,54.49733333333333,FUN_022297-T1,Q6AXX1,,,,,37.6,178.0,1.2e-23,112.1,sp|Q6AXX1|SLNL1_RAT Schlafen-like protein 1 OS=Rattus norvegicus OX=10116 GN=Slfnl1 PE=2 SV=1,,,,,,
OG_04609,2.1175349502181597,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_04611,1.1172897683202243,FUN_022308-T1,Peve_00021683,Pocillopora_meandrina_HIv1___RNAseq.g4624.t1,three_way,85.60266666666666,FUN_022308-T1,Q3TZZ7,ESYT2_MOUSE,,Extended synaptotagmin-2 (E-Syt2),Mus musculus (Mouse),35.6,793.0,2.9e-132,474.2,sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1,GO:0005509; GO:0005789; GO:0005829; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0008289; GO:0016192,cytosol; lipid binding; vesicle-mediated transport
OG_04635,2.635047251325921,FUN_022357-T1,Peve_00021682,Pocillopora_meandrina_HIv1___RNAseq.g4585.t1,three_way,74.13533333333334,FUN_022357-T1,P55011,S12A2_HUMAN,,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1),Homo sapiens (Human),45.9,1014.0,4e-238,826.2,sp|P55011|S12A2_HUMAN Solute carrier family 12 member 2 OS=Homo sapiens OX=9606 GN=SLC12A2 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869,ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion transport [GO:0006811]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519]; chloride:monoatomic cation symporter activity [GO:0015377]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; protein-folding chaperone binding [GO:0051087]; sodium:potassium:chloride symporter activity [GO:0008511],GO:0002376; GO:0003013; GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0048870; GO:0055085,immune system process; circulatory system process; transporter activity; plasma membrane; signaling; organelle; cell motility; transmembrane transport
OG_04637,2.131981817207366,FUN_022363-T1,Peve_00021993,Pocillopora_meandrina_HIv1___RNAseq.g4594.t1,three_way,86.07533333333333,FUN_022363-T1,Q7Z5J8,,,,,48.0,1367.0,3.1e-212,740.7,sp|Q7Z5J8|ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens OX=9606 GN=ANKAR PE=1 SV=3,,,,,,
OG_04639,1.91146606274603,FUN_022365-T1,Peve_00021988,Pocillopora_meandrina_HIv1___TS.g22011.t1,three_way,64.79716666666667,FUN_022365-T1,A2RRU4,SCAP_RAT,,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),Rattus norvegicus (Rat),35.1,1375.0,2.4999999999999998e-147,525.0,sp|A2RRU4|SCAP_RAT Sterol regulatory element-binding protein cleavage-activating protein OS=Rattus norvegicus OX=10116 GN=Scap PE=2 SV=1,GO:0000139; GO:0001666; GO:0005789; GO:0006629; GO:0006955; GO:0008203; GO:0012507; GO:0019217; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0032991; GO:0033552; GO:0042304; GO:0044877; GO:0045540; GO:0045542; GO:0090110,cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; lipid metabolic process [GO:0006629]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin B3 [GO:0033552]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; SREBP-SCAP complex [GO:0032936],protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934],GO:0002376; GO:0006629; GO:0008289,immune system process; lipid metabolic process; lipid binding
OG_04641,1.0323273267035602,FUN_022367-T1,Peve_00013238,Pocillopora_meandrina_HIv1___TS.g19588.t1,three_way,84.17866666666667,FUN_022367-T1,P53603,,,,,60.6,543.0,4.5e-188,659.1,sp|P53603|FTCD_PIG Formimidoyltransferase-cyclodeaminase OS=Sus scrofa OX=9823 GN=FTCD PE=1 SV=1,,,,,,
OG_04642,2.1499015697297588,FUN_022368-T1,Peve_00013237,Pocillopora_meandrina_HIv1___RNAseq.g9293.t2,three_way,55.12766666666666,FUN_022368-T1,B2GV47,,,,,31.2,523.0,1.9000000000000001e-66,255.8,sp|B2GV47|RADX_RAT RPA-related protein RADX OS=Rattus norvegicus OX=10116 GN=Radx PE=2 SV=1,,,,,,
OG_04643,1.5136220889057956,FUN_022369-T1,Peve_00013236,Pocillopora_meandrina_HIv1___RNAseq.g9295.t1,three_way,77.29733333333333,FUN_022369-T1,Q8NCL4,GALT6_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6),Homo sapiens (Human),52.4,450.0,6.6e-132,472.6,sp|Q8NCL4|GALT6_HUMAN Polypeptide N-acetylgalactosaminyltransferase 6 OS=Homo sapiens OX=9606 GN=GALNT6 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0048471,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04646,1.494395375031762,FUN_022378-T1,Peve_00013226,Pocillopora_meandrina_HIv1___RNAseq.g9303.t1,three_way,49.90833333333334,,,,,,,,,,,,,,,,,
OG_04650,1.5160386278923212,FUN_022383-T1,Peve_00013221,Pocillopora_meandrina_HIv1___RNAseq.g9308.t1,three_way,67.081,FUN_022383-T1,P20009,DLL_DROME,,Homeotic protein distal-less (Protein brista),Drosophila melanogaster (Fruit fly),47.1,174.0,6.900000000000001e-28,125.9,sp|P20009|DLL_DROME Homeotic protein distal-less OS=Drosophila melanogaster OX=7227 GN=Dll PE=2 SV=3,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0030154; GO:0035114; GO:0035215; GO:0045893; GO:0048264; GO:0048728,"analia development [GO:0007487]; antennal development [GO:0007469]; cell differentiation [GO:0030154]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04652,2.059005849424167,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.4999999999999995e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04657,1.3612211687056663,FUN_022397-T1,Peve_00037595,Pocillopora_meandrina_HIv1___RNAseq.g9319.t1a,three_way,71.057,,,,,,,,,,,,,,,,,
OG_04662,1.756459672525282,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04669,1.556638539391039,FUN_022425-T1,Peve_00037613,Pocillopora_meandrina_HIv1___RNAseq.g4349.t1,three_way,66.758,,,,,,,,,,,,,,,,,
OG_04688,1.088876601171152,FUN_022479-T1,Peve_00002930,Pocillopora_meandrina_HIv1___RNAseq.g4300.t2,three_way,75.41633333333333,FUN_022479-T1,P52624,UPP1_MOUSE,,Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3),Mus musculus (Mouse),50.2,285.0,6.900000000000001e-78,292.4,sp|P52624|UPP1_MOUSE Uridine phosphorylase 1 OS=Mus musculus OX=10090 GN=Upp1 PE=1 SV=2,GO:0004850; GO:0005654; GO:0005829; GO:0006218; GO:0006220; GO:0006248; GO:0006249; GO:0009032; GO:0042149; GO:0042802; GO:0044206; GO:0046050; GO:0046074; GO:0046079; GO:0046108; GO:0047847,cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108],cytosol [GO:0005829]; nucleoplasm [GO:0005654],deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04690,1.602494941049163,FUN_022481-T1,Peve_00002920,Pocillopora_meandrina_HIv1___RNAseq.g4298.t1,three_way,71.46483333333333,FUN_022481-T1,Q99MZ8,LASP1_RAT,,LIM and SH3 domain protein 1 (LASP-1),Rattus norvegicus (Rat),56.1,264.0,1.0999999999999999e-53,211.5,sp|Q99MZ8|LASP1_RAT LIM and SH3 domain protein 1 OS=Rattus norvegicus OX=10116 GN=Lasp1 PE=1 SV=1,GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0046872; GO:0051015; GO:0098794,monoatomic ion transport [GO:0006811],cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794],actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075],GO:0005215; GO:0005856; GO:0008092; GO:0043226,transporter activity; cytoskeleton; cytoskeletal protein binding; organelle
OG_04691,2.5220783250379264,FUN_022482-T1,Peve_00002923,Pocillopora_meandrina_HIv1___RNAseq.g4296.t1,three_way,79.319,FUN_022482-T1,O14929,HAT1_HUMAN,,Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1),Homo sapiens (Human),48.1,401.0,2.5e-106,387.1,sp|O14929|HAT1_HUMAN Histone acetyltransferase type B catalytic subunit OS=Homo sapiens OX=9606 GN=HAT1 PE=1 SV=2,GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006334; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043997; GO:0051276,chromosome organization [GO:0051276]; internal protein amino acid acetylation [GO:0006475]; nucleosome assembly [GO:0006334]; subtelomeric heterochromatin formation [GO:0031509],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; chromatin organization; transferase activity; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_04692,1.6558569021733078,FUN_022484-T1,Peve_00002924,Pocillopora_meandrina_HIv1___RNAseq.g4295.t1,three_way,86.47083333333333,FUN_022484-T1,Q8VID6,PDE11_RAT,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Rattus norvegicus (Rat),47.6,930.0,9.3e-242,838.2,"sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1",GO:0004115; GO:0004118; GO:0005829; GO:0010754; GO:0019933; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162,cAMP-mediated signaling [GO:0019933]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754],cytosol [GO:0005829]; perikaryon [GO:0043204],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787,catalytic activity; cytosol; hydrolase activity
OG_04694,1.1796939597475562,FUN_022486-T1,Peve_00002926,Pocillopora_meandrina_HIv1___RNAseq.g4292.t1,three_way,75.504,FUN_022486-T1,P15882,CHIN_HUMAN,,N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2),Homo sapiens (Human),55.8,457.0,7e-142,505.4,sp|P15882|CHIN_HUMAN N-chimaerin OS=Homo sapiens OX=9606 GN=CHN1 PE=1 SV=3,GO:0005096; GO:0005829; GO:0008045; GO:0008270; GO:0046875; GO:0048013; GO:0050770; GO:0051056,ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829],ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_04697,1.400543561819536,FUN_022494-T1,Peve_00043030,Pocillopora_meandrina_HIv1___TS.18734_t,three_way,69.23266666666666,,,,,,,,,,,,,,,,,
OG_04699,2.052781898247792,FUN_022499-T1,Peve_00033031,Pocillopora_meandrina_HIv1___RNAseq.g4275.t1,three_way,69.74766666666667,FUN_022499-T1,A4IH82,,,,,29.7,290.0,3.3e-22,107.8,sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1,,,,,,
OG_04706,1.353132695858562,FUN_022507-T1,Peve_00002459,Pocillopora_meandrina_HIv1___RNAseq.g4261.t1,three_way,67.73566666666666,FUN_022507-T1,F1QDI9,,,,,65.5,640.0,6.4e-248,858.6,sp|F1QDI9|MCM9_DANRE DNA helicase MCM9 OS=Danio rerio OX=7955 GN=mcm9 PE=3 SV=2,,,,,,
OG_04708,1.9699341755520137,FUN_022512-T3,Peve_00029626,Pocillopora_meandrina_HIv1___RNAseq.g4258.t2,three_way,80.24166666666667,FUN_022512-T3,P49282,NRAM2_MOUSE,,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),Mus musculus (Mouse),65.1,504.0,1.1e-179,631.3,sp|P49282|NRAM2_MOUSE Natural resistance-associated macrophage protein 2 OS=Mus musculus OX=10090 GN=Slc11a2 PE=1 SV=2,GO:0005375; GO:0005381; GO:0005384; GO:0005634; GO:0005741; GO:0005765; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006826; GO:0007611; GO:0009986; GO:0010039; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015295; GO:0016324; GO:0031526; GO:0031901; GO:0031902; GO:0033212; GO:0045178; GO:0046870; GO:0048471; GO:0048813; GO:0048821; GO:0051649; GO:0055037; GO:0055038; GO:0060586; GO:0070574; GO:0070826; GO:1902600; GO:1903561,cadmium ion transmembrane transport [GO:0070574]; cobalt ion transport [GO:0006824]; dendrite morphogenesis [GO:0048813]; erythrocyte development [GO:0048821]; establishment of localization in cell [GO:0051649]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transport [GO:0006826]; learning or memory [GO:0007611]; multicellular organismal-level iron ion homeostasis [GO:0060586]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to iron ion [GO:0010039],apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; proton transmembrane transporter activity [GO:0015078]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0005634; GO:0005768; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleus; endosome; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_04714,1.023713207196192,FUN_022525-T1,Peve_00020800,Pocillopora_meandrina_HIv1___RNAseq.g4522.t1,three_way,52.60116666666667,,,,,,,,,,,,,,,,,
OG_04717,1.802640861926894,FUN_022539-T2,Peve_00025372,Pocillopora_meandrina_HIv1___RNAseq.g4147.t1,three_way,68.20566666666667,,,,,,,,,,,,,,,,,
OG_04722,3.384038757005185,FUN_022580-T1,Peve_00020261,Pocillopora_meandrina_HIv1___RNAseq.g4432.t1,three_way,74.89066666666666,FUN_022580-T1,Q5F3W2,,,,,42.0,205.0,8.4e-46,185.3,sp|Q5F3W2|INSI2_CHICK Insulin-induced gene 2 protein OS=Gallus gallus OX=9031 GN=INSIG2 PE=2 SV=2,,,,,,
OG_04723,1.7305078756493435,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_04731,2.1605217236718586,FUN_022599-T1,Peve_00012273,Pocillopora_meandrina_HIv1___RNAseq.g4424.t2,three_way,83.4855,FUN_022599-T1,F1LZW6,S2513_RAT,,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Solute carrier family 25 member 13)",Rattus norvegicus (Rat),51.9,671.0,7.100000000000001e-186,652.1,"sp|F1LZW6|S2513_RAT Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Rattus norvegicus OX=10116 GN=Slc25a13 PE=3 SV=4",GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006754; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592,aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",GO:0005215; GO:0005739; GO:0005975; GO:0006091; GO:0043226; GO:0055085; GO:0055086; GO:1901135,transporter activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04732,1.3271445097760115,FUN_022601-T1,Peve_00012225,Pocillopora_meandrina_HIv1___RNAseq.g4422.t1,three_way,65.245,FUN_022601-T1,Q498E7,SMAL1_XENLA,,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (Sucrose nonfermenting protein 2-like 1),Xenopus laevis (African clawed frog),56.2,571.0,1.2e-174,615.1,sp|Q498E7|SMAL1_XENLA SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Xenopus laevis OX=8355 GN=smarcal1 PE=2 SV=1,GO:0004386; GO:0005524; GO:0005634; GO:0006281; GO:0006357; GO:0016787; GO:0031297; GO:0036310; GO:0043596,DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297],nuclear replication fork [GO:0043596]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_04737,6.006968449558631,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04739,1.467280914875816,FUN_022615-T1,Peve_00012268,Pocillopora_meandrina_HIv1___RNAseq.g4395.t1,three_way,62.804,FUN_022615-T1,P79691,SHH_CARAU,,Sonic hedgehog protein (SHHA) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein A N-product (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein N-product) (ShhN)],Carassius auratus (Goldfish),44.2,398.0,9.4e-82,305.4,sp|P79691|SHH_CARAU Sonic hedgehog protein OS=Carassius auratus OX=7957 GN=shha PE=3 SV=3,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0007389; GO:0008233; GO:0009888; GO:0010468; GO:0016539; GO:0016540; GO:0030182; GO:0035295; GO:0042127; GO:0045880; GO:0048468; GO:0048513; GO:0048709; GO:0050793; GO:0097264; GO:0140853,animal organ development [GO:0048513]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; pattern specification process [GO:0007389]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of cell population proliferation [GO:0042127]; regulation of developmental process [GO:0050793]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888]; tube development [GO:0035295],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04743,1.3631794890112678,FUN_022622-T1,Peve_00012274,Pocillopora_meandrina_HIv1___RNAseq.g4388.t1,three_way,79.17566666666667,FUN_022622-T1,Q58EB4,,,,,64.5,242.0,7.4e-80,298.5,"sp|Q58EB4|HIBCH_DANRE 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Danio rerio OX=7955 GN=hibch PE=2 SV=1",,,,,,
OG_04745,1.1398216854451897,FUN_022626-T1,Peve_00012279,Pocillopora_meandrina_HIv1___RNAseq.g4386.t1,three_way,75.93066666666667,FUN_022626-T1,Q5U3U0,,,,,52.9,291.0,3.4e-89,329.7,sp|Q5U3U0|PHYD1_DANRE Phytanoyl-CoA dioxygenase domain-containing protein 1 OS=Danio rerio OX=7955 GN=phyhd1 PE=2 SV=1,,,,,,
OG_04749,1.4503950890765591,FUN_022632-T1,Peve_00012223,Pocillopora_meandrina_HIv1___RNAseq.g2906.t1,three_way,91.81466666666668,FUN_022632-T1,Q2NKW0,BL1S1_BOVIN,,Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (Protein acetyltransferase BLOC1S1) (EC 2.3.1.-),Bos taurus (Bovine),61.9,118.0,2.7000000000000004e-32,139.4,sp|Q2NKW0|BL1S1_BOVIN Biogenesis of lysosome-related organelles complex 1 subunit 1 OS=Bos taurus OX=9913 GN=BLOC1S1 PE=2 SV=1,GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0048490; GO:0061733; GO:0099078; GO:1904115,aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394],axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759],protein-lysine-acetyltransferase activity [GO:0061733],GO:0003824; GO:0005829; GO:0006091; GO:0007018; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; cytosol; generation of precursor metabolites and energy; microtubule-based movement; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_04754,3.275524227578967,FUN_022639-T1,Peve_00022141,Pocillopora_meandrina_HIv1___RNAseq.g9366.t2,three_way,68.227,FUN_022639-T1,Q9H330,,,,,37.4,854.0,4.4999999999999997e-129,463.8,sp|Q9H330|TM245_HUMAN Transmembrane protein 245 OS=Homo sapiens OX=9606 GN=TMEM245 PE=1 SV=3,,,,,,
OG_04755,2.5253555935635874,FUN_022640-T1,Peve_00022140,Pocillopora_meandrina_HIv1___RNAseq.g9367.t1,three_way,76.032,FUN_022640-T1,P49356,FNTB_HUMAN,,Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta),Homo sapiens (Human),54.6,388.0,6.6e-122,438.7,sp|P49356|FNTB_HUMAN Protein farnesyltransferase subunit beta OS=Homo sapiens OX=9606 GN=FNTB PE=1 SV=1,GO:0004660; GO:0005829; GO:0005875; GO:0005965; GO:0006629; GO:0008270; GO:0008284; GO:0010698; GO:0018343; GO:0019899; GO:0042277; GO:0045787; GO:0060632,lipid metabolic process [GO:0006629]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; protein farnesylation [GO:0018343]; regulation of microtubule-based movement [GO:0060632],cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965],acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; peptide binding [GO:0042277]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04756,1.2926302478234089,FUN_022642-T1,Peve_00044337,Pocillopora_meandrina_HIv1___RNAseq.g9369.t1,three_way,57.92616666666667,FUN_022642-T1,Q14517,,,,,26.9,334.0,2.4e-19,100.1,sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2,,,,,,
OG_04758,2.673926590474668,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_04760,1.7594000046032658,FUN_022656-T1,Peve_00019498,Pocillopora_meandrina_HIv1___RNAseq.g21258.t1,three_way,47.02216666666666,,,,,,,,,,,,,,,,,
OG_04761,1.0544149744418128,FUN_022659-T1,Peve_00020231,Pocillopora_meandrina_HIv1___RNAseq.g3028.t1,three_way,39.47416666666667,,,,,,,,,,,,,,,,,
OG_04762,1.308872168330114,FUN_022662-T1,Peve_00027940,Pocillopora_meandrina_HIv1___RNAseq.g3157.t1b,three_way,84.34933333333333,FUN_022662-T1,Q5ZLC8,,,,,47.4,137.0,1.4e-25,120.2,sp|Q5ZLC8|ANR52_CHICK Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Gallus gallus OX=9031 GN=ANKRD52 PE=2 SV=1,,,,,,
OG_04769,1.5305020781071046,FUN_022671-T1,Peve_00010104,Pocillopora_meandrina_HIv1___RNAseq.g4534.t1,three_way,94.68966666666668,FUN_022671-T1,Q00535,CDK5_HUMAN,,Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit),Homo sapiens (Human),84.4,237.0,2.1e-121,436.4,sp|Q00535|CDK5_HUMAN Cyclin-dependent kinase 5 OS=Homo sapiens OX=9606 GN=CDK5 PE=1 SV=3,GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016533; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030036; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032801; GO:0035249; GO:0035418; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098793; GO:0099533; GO:0106310; GO:1901987; GO:1903076; GO:1903234; GO:1903421; GO:1904646,"actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903234]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]",axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533],acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016740; GO:0023052; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; transferase activity; signaling; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04776,2.1423311005562664,FUN_022682-T1,Peve_00018005,Pocillopora_meandrina_HIv1___RNAseq.g4839.t1,three_way,89.59733333333334,FUN_022682-T1,Q9WUD8,,,,,67.6,176.0,4.5e-68,258.8,sp|Q9WUD8|FAIM1_MOUSE Fas apoptotic inhibitory molecule 1 OS=Mus musculus OX=10090 GN=Faim PE=1 SV=1,,,,,,
OG_04780,1.0272790949339785,FUN_022689-T1,Peve_00045106,Pocillopora_meandrina_HIv1___RNAseq.g4835.t1,three_way,78.04266666666666,FUN_022689-T1,Q8NKE2,,,,,44.2,278.0,4.999999999999999e-62,239.6,"sp|Q8NKE2|AOX_CRYNH Alternative oxidase, mitochondrial OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=AOX1 PE=3 SV=2",,,,,,
OG_04785,2.2298603672167907,FUN_022697-T1,Peve_00045103,Pocillopora_meandrina_HIv1___RNAseq.g4828.t1,three_way,67.73633333333333,FUN_022697-T1,Q9XJ54,,,,,53.3,120.0,8.5e-26,117.9,sp|Q9XJ54|NTF2_ORYSJ Nuclear transport factor 2 OS=Oryza sativa subsp. japonica OX=39947 GN=NTF2 PE=2 SV=1,,,,,,
OG_04791,1.6379719891244564,FUN_022707-T1,Peve_00006887,Pocillopora_meandrina_HIv1___RNAseq.g4819.t1a,three_way,61.56366666666667,FUN_022707-T1,O60294,TYW4_HUMAN,,tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase),Homo sapiens (Human),32.6,242.0,5.8e-26,119.4,sp|O60294|TYW4_HUMAN tRNA wybutosine-synthesizing protein 4 OS=Homo sapiens OX=9606 GN=LCMT2 PE=1 SV=3,GO:0005737; GO:0006400; GO:0008175; GO:0030488; GO:0031591,tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],tRNA methyltransferase activity [GO:0008175],GO:0003824; GO:0006399; GO:0016740; GO:0140098; GO:1901135,"catalytic activity; tRNA metabolic process; transferase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04794,1.825721708895978,FUN_022710-T1,Peve_00006885,Pocillopora_meandrina_HIv1___RNAseq.g4817.t1,three_way,81.13166666666666,FUN_022710-T1,Q3T904,ATG9A_BOVIN,,Autophagy-related protein 9A (APG9-like 1) (Autophagy protein 9),Bos taurus (Bovine),54.5,462.0,1.2e-152,541.6,sp|Q3T904|ATG9A_BOVIN Autophagy-related protein 9A OS=Bos taurus OX=9913 GN=ATG9A PE=2 SV=1,GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000423; GO:0005739; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0017128; GO:0031902; GO:0031966; GO:0034045; GO:0034497; GO:0034727; GO:0055038; GO:0060349; GO:0061709; GO:0097300,autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802],phospholipid scramblase activity [GO:0017128],GO:0005215; GO:0005739; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226,transporter activity; mitochondrion; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle
OG_04795,2.2312151684647064,FUN_022711-T1,Peve_00006886,Pocillopora_meandrina_HIv1___TS.g22231.t1,three_way,42.857,,,,,,,,,,,,,,,,,
OG_04796,1.7307309963105004,FUN_022715-T1,Peve_00016563,Pocillopora_meandrina_HIv1___RNAseq.g3160.t1,three_way,74.70833333333333,FUN_022715-T1,O88794,,,,,52.1,234.0,1.4e-65,251.1,sp|O88794|PNPO_RAT Pyridoxine-5'-phosphate oxidase OS=Rattus norvegicus OX=10116 GN=Pnpo PE=1 SV=1,,,,,,
OG_04807,1.8631779858206023,FUN_022766-T1,Peve_00014657,Pocillopora_meandrina_HIv1___RNAseq.g4730.t1,three_way,58.63033333333333,,,,,,,,,,,,,,,,,
OG_04808,2.097913103856238,FUN_022767-T1,Peve_00014658,Pocillopora_meandrina_HIv1___RNAseq.g4729.t1,three_way,73.63166666666666,FUN_022767-T1,Q7ZX22,WDR24_XENLA,,GATOR2 complex protein WDR24 (EC 2.3.2.27),Xenopus laevis (African clawed frog),38.4,799.0,4.6e-160,566.6,sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1,GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263,autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; cytosol; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_04809,1.079334846908454,FUN_022771-T1,Peve_00043386,Pocillopora_meandrina_HIv1___RNAseq.g4766.t1,three_way,62.87,FUN_022771-T1,P49442,,,,,39.7,393.0,1.5e-66,255.0,sp|P49442|INPP_MOUSE Inositol polyphosphate 1-phosphatase OS=Mus musculus OX=10090 GN=Inpp1 PE=1 SV=2,,,,,,
OG_04810,1.1422840561770755,FUN_022772-T1,Peve_00043388,Pocillopora_meandrina_HIv1___RNAseq.g4767.t1,three_way,97.277,FUN_022772-T1,P23258,TBG1_HUMAN,,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),Homo sapiens (Human),81.6,451.0,5.9e-221,768.1,sp|P23258|TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2,GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0000931; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005881; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0043005; GO:0045177; GO:0055037; GO:0097730; GO:0140490; GO:1990498,cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052],apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819],GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule nucleator activity [GO:0140490]; structural constituent of cytoskeleton [GO:0005200],GO:0000228; GO:0000278; GO:0005198; GO:0005634; GO:0005694; GO:0005768; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0007059; GO:0022414; GO:0031410; GO:0043226,nuclear chromosome; mitotic cell cycle; structural molecule activity; nucleus; chromosome; endosome; microtubule organizing center; cytosol; cilium; cytoskeleton organization; chromosome segregation; reproductive process; cytoplasmic vesicle; organelle
OG_04818,2.3204667063193978,FUN_022804-T1,Peve_00024731,Pocillopora_meandrina_HIv1___RNAseq.g3480.t1,three_way,66.91633333333334,FUN_022804-T1,Q9NQZ5,STAR7_HUMAN,,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",Homo sapiens (Human),44.1,247.0,7.6000000000000005e-59,229.2,"sp|Q9NQZ5|STAR7_HUMAN StAR-related lipid transfer protein 7, mitochondrial OS=Homo sapiens OX=9606 GN=STARD7 PE=1 SV=2",GO:0001773; GO:0005576; GO:0005739; GO:0005741; GO:0006744; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120013; GO:0120197; GO:0140104,establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092]; ubiquinone biosynthetic process [GO:0006744],extracellular region [GO:0005576]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; molecular carrier activity [GO:0140104],GO:0002376; GO:0003016; GO:0005215; GO:0005576; GO:0005739; GO:0006954; GO:0007018; GO:0008289; GO:0043226; GO:0048856; GO:0140104,immune system process; respiratory system process; transporter activity; extracellular region; mitochondrion; inflammatory response; microtubule-based movement; lipid binding; organelle; anatomical structure development; molecular carrier activity
OG_04819,2.4752174055798646,FUN_022805-T1,Peve_00018106,Pocillopora_meandrina_HIv1___RNAseq.g3479.t1,three_way,60.698,,,,,,,,,,,,,,,,,
OG_04821,1.2492893610085134,FUN_022810-T1,Peve_00031624,Pocillopora_meandrina_HIv1___RNAseq.g3470.t1,three_way,49.74966666666666,,,,,,,,,,,,,,,,,
OG_04831,1.255543108474248,FUN_022825-T1,Peve_00028904,Pocillopora_meandrina_HIv1___RNAseq.g3433.t1,three_way,66.04366666666667,FUN_022825-T1,O43156,TTI1_HUMAN,,TELO2-interacting protein 1 homolog (Protein SMG10),Homo sapiens (Human),33.4,1144.0,2.5e-172,607.8,sp|O43156|TTI1_HUMAN TELO2-interacting protein 1 homolog OS=Homo sapiens OX=9606 GN=TTI1 PE=1 SV=3,GO:0005634; GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_04832,1.0460151594939249,FUN_022826-T1,Peve_00028899,Pocillopora_meandrina_HIv1___RNAseq.g3432.t1,three_way,71.25966666666666,FUN_022826-T1,Q7Z6M1,RABEK_HUMAN,,Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40),Homo sapiens (Human),46.3,218.0,1.1e-57,225.3,sp|Q7Z6M1|RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens OX=9606 GN=RABEPK PE=1 SV=1,GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588; GO:0043231,receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904],cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133],,GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_04833,1.7494682386408162,FUN_022827-T1,Peve_00028898,Pocillopora_meandrina_HIv1___RNAseq.g3431.t1,three_way,84.11833333333334,FUN_022827-T1,Q0IJ33,,,,,54.4,362.0,6.2e-117,422.2,sp|Q0IJ33|TM129_XENTR E3 ubiquitin-protein ligase TM129 OS=Xenopus tropicalis OX=8364 GN=tmem129 PE=2 SV=1,,,,,,
OG_04835,1.6221435138207227,FUN_022833-T1,Peve_00028896,Pocillopora_meandrina_HIv1___RNAseq.g3429.t1,three_way,83.13033333333334,FUN_022833-T1,Q969Q5,RAB24_HUMAN,,Ras-related protein Rab-24 (EC 3.6.5.2),Homo sapiens (Human),69.6,171.0,4.8e-66,252.3,sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1,GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0048471; GO:0140013,attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772; GO:0140013,catalytic activity; GTPase activity; mitochondrion; endosome; vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity; meiotic nuclear division
OG_04836,1.8358091452788097,FUN_022834-T1,Peve_00028894,Pocillopora_meandrina_HIv1___RNAseq.g3426.t1,three_way,70.747,FUN_022834-T1,P57775,,,,,34.0,391.0,1.3e-56,221.9,sp|P57775|FBXW4_HUMAN F-box/WD repeat-containing protein 4 OS=Homo sapiens OX=9606 GN=FBXW4 PE=1 SV=1,,,,,,
OG_04846,1.9005220877770923,FUN_022856-T1,Peve_00004026,Pocillopora_meandrina_HIv1___RNAseq.g3389.t1,three_way,83.74,FUN_022856-T1,A2TLM1,,,,,67.5,194.0,8.9e-66,251.5,sp|A2TLM1|RPIA_PIG Ribose-5-phosphate isomerase OS=Sus scrofa OX=9823 GN=RPIA PE=2 SV=1,,,,,,
OG_04849,2.0471941570110994,FUN_022861-T1,Peve_00025611,Pocillopora_meandrina_HIv1___RNAseq.g3605.t1,three_way,79.88833333333334,FUN_022861-T1,O55003,BNIP3_MOUSE,,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,Mus musculus (Mouse),33.5,188.0,1.5e-15,84.3,sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1,GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144,apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0006914; GO:0007005; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0061024,nucleus; nuclear envelope; nucleoplasm; mitochondrion; autophagy; mitochondrion organization; programmed cell death; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; membrane organization
OG_04850,1.091057380522186,FUN_022862-T1,Peve_00025610,Pocillopora_meandrina_HIv1___RNAseq.g3606.t1,three_way,84.90033333333334,FUN_022862-T1,Q5EA43,SFXN2_BOVIN,,Sideroflexin-2,Bos taurus (Bovine),60.2,314.0,9.8e-106,384.8,sp|Q5EA43|SFXN2_BOVIN Sideroflexin-2 OS=Bos taurus OX=9913 GN=SFXN2 PE=2 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0015075; GO:0022857; GO:0140300; GO:1990542,mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_04851,1.9777448752447493,FUN_022863-T1,Peve_00025604,Pocillopora_meandrina_HIv1___RNAseq.g3607.t1,three_way,83.18433333333333,FUN_022863-T1,Q5F450,PAN2_CHICK,,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2),Gallus gallus (Chicken),51.1,1129.0,0.0,1086.6,sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1,GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04852,1.0422702538509625,FUN_022864-T1,Peve_00025619,Pocillopora_meandrina_HIv1___TS.g9783.t1,three_way,69.89,FUN_022864-T1,Q9BSG0,,,,,43.6,165.0,7.2e-38,158.7,sp|Q9BSG0|PADC1_HUMAN Protease-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PRADC1 PE=1 SV=1,,,,,,
OG_04854,1.3779753057250517,FUN_022868-T1,Peve_00012303,Pocillopora_meandrina_HIv1___RNAseq.g3613.t1,three_way,73.38633333333333,FUN_022868-T1,Q804R0,LBX2_DANRE,,Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2),Danio rerio (Zebrafish) (Brachydanio rerio),46.3,177.0,4.2e-30,132.9,sp|Q804R0|LBX2_DANRE Transcription factor LBX2 OS=Danio rerio OX=7955 GN=lbx2 PE=1 SV=1,GO:0000578; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:0048920; GO:0048922; GO:0055001; GO:0060828; GO:1904105; GO:1990837; GO:2000052,embryonic axis specification [GO:0000578]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; posterior lateral line neuromast deposition [GO:0048922]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04859,1.2714776051114027,FUN_022876-T1,Peve_00012294,Pocillopora_meandrina_HIv1___RNAseq.g3619.t2,three_way,78.97766666666666,FUN_022876-T1,Q5SNQ7,,,,,44.6,489.0,1.9999999999999999e-115,417.9,sp|Q5SNQ7|SRAC1_DANRE Protein SERAC1 OS=Danio rerio OX=7955 GN=serac1 PE=3 SV=1,,,,,,
OG_04860,1.5282006076266788,FUN_022877-T1,Peve_00012293,Pocillopora_meandrina_HIv1___RNAseq.g3620.t1,three_way,78.91933333333333,FUN_022877-T1,Q9BRF8,CPPED_HUMAN,,Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1),Homo sapiens (Human),48.3,294.0,1.3e-80,301.2,sp|Q9BRF8|CPPED_HUMAN Serine/threonine-protein phosphatase CPPED1 OS=Homo sapiens OX=9606 GN=CPPED1 PE=1 SV=3,GO:0004722; GO:0005576; GO:0005829; GO:0005886; GO:0035578; GO:0046872,,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005576; GO:0005829; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular region; cytosol; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_04861,1.3763552177056468,FUN_022878-T1,Peve_00012292,Pocillopora_meandrina_HIv1___RNAseq.g3621.t1,three_way,69.06,,,,,,,,,,,,,,,,,
OG_04864,1.7642181798331045,FUN_022888-T1,Peve_00001730,Pocillopora_meandrina_HIv1___RNAseq.g3687.t1,three_way,82.29666666666667,FUN_022888-T1,Q8TCE6,,,,,48.3,263.0,1.1e-72,275.0,sp|Q8TCE6|DEN10_HUMAN DENN domain-containing protein 10 OS=Homo sapiens OX=9606 GN=DENND10 PE=1 SV=1,,,,,,
OG_04865,1.1673993437650805,FUN_022890-T1,Peve_00001724,Pocillopora_meandrina_HIv1___RNAseq.g3688.t1,three_way,77.9365,FUN_022890-T1,Q14147,DHX34_HUMAN,,Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34),Homo sapiens (Human),53.8,1013.0,2.4e-288,993.0,sp|Q14147|DHX34_HUMAN Probable ATP-dependent RNA helicase DHX34 OS=Homo sapiens OX=9606 GN=DHX34 PE=1 SV=2,GO:0000956; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016020; GO:0016887; GO:0042327; GO:0044877; GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of phosphorylation [GO:0042327]",membrane [GO:0016020],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0016071; GO:0016787; GO:0016853; GO:0140098; GO:0140657,"RNA binding; catalytic activity; mRNA metabolic process; hydrolase activity; isomerase activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04868,2.789925580212135,FUN_022895-T1,Peve_00001718,Pocillopora_meandrina_HIv1___RNAseq.g3694.t1,three_way,68.29366666666667,FUN_022895-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),39.7,715.0,1.4e-142,508.4,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04871,1.899638637367648,FUN_022899-T1,Peve_00001716,Pocillopora_meandrina_HIv1___RNAseq.g3699.t1,three_way,85.126,FUN_022899-T1,Q99LZ3,,,,,53.1,179.0,8.599999999999999e-49,194.9,sp|Q99LZ3|SLD5_MOUSE DNA replication complex GINS protein SLD5 OS=Mus musculus OX=10090 GN=Gins4 PE=1 SV=1,,,,,,
OG_04873,1.2148400657418057,FUN_022902-T1,Peve_00001843,Pocillopora_meandrina_HIv1___RNAseq.g3701.t1,three_way,79.475,FUN_022902-T1,Q2KIG5,THAS_BOVIN,,Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),Bos taurus (Bovine),36.2,116.0,1.9e-13,78.6,sp|Q2KIG5|THAS_BOVIN Thromboxane-A synthase OS=Bos taurus OX=9913 GN=TBXAS1 PE=2 SV=1,GO:0001516; GO:0004497; GO:0004796; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0036134; GO:0106256,icosanoid metabolic process [GO:0006690]; prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum membrane [GO:0005789],"12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]",GO:0003824; GO:0006629; GO:0016491; GO:0016829; GO:0016853,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity
OG_04874,2.4177322870309164,FUN_022903-T1,Peve_00001842,Pocillopora_meandrina_HIv1___RNAseq.g3702.t1,three_way,81.031,FUN_022903-T1,Q6ZQN7,SO4C1_HUMAN,,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),Homo sapiens (Human),35.1,615.0,6.1e-111,403.3,sp|Q6ZQN7|SO4C1_HUMAN Solute carrier organic anion transporter family member 4C1 OS=Homo sapiens OX=9606 GN=SLCO4C1 PE=1 SV=1,GO:0005886; GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062,cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347],GO:0005215; GO:0005886; GO:0022414; GO:0030154; GO:0043226,transporter activity; plasma membrane; reproductive process; cell differentiation; organelle
OG_04875,1.1745091942096628,FUN_022906-T1,Peve_00001841,Pocillopora_meandrina_HIv1___RNAseq.g3703.t1,three_way,76.03683333333333,,,,,,,,,,,,,,,,,
OG_04876,1.4211560640010794,FUN_022907-T1,Peve_00001835,Pocillopora_meandrina_HIv1___RNAseq.g3704.t2,three_way,64.9645,FUN_022907-T1,Q5TFE4,,,,,37.9,390.0,1.9e-70,268.1,sp|Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NT5DC1 PE=1 SV=1,,,,,,
OG_04884,1.3449666307308663,FUN_022918-T1,Peve_00001740,Pocillopora_meandrina_HIv1___RNAseq.g3714.t1,three_way,73.348,FUN_022918-T1,O94903,,,,,58.6,239.0,4.2e-77,289.3,sp|O94903|PLPHP_HUMAN Pyridoxal phosphate homeostasis protein OS=Homo sapiens OX=9606 GN=PLPBP PE=1 SV=1,,,,,,
OG_04885,1.2967626063691688,FUN_022922-T1,Peve_00008665,Pocillopora_meandrina_HIv1___RNAseq.g3726.t1,three_way,68.77866666666667,FUN_022922-T1,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),33.6,661.0,3e-82,307.8,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_04894,1.2209285160389067,FUN_022938-T1,Peve_00026754,Pocillopora_meandrina_HIv1___RNAseq.g3738.t1,three_way,80.67833333333333,FUN_022938-T1,Q9HAN9,NMNA1_HUMAN,,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide-nucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1),Homo sapiens (Human),53.8,251.0,1.9e-71,270.4,sp|Q9HAN9|NMNA1_HUMAN Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Homo sapiens OX=9606 GN=NMNAT1 PE=1 SV=1,GO:0000309; GO:0000785; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:0043410; GO:0043524; GO:0045892; GO:0140768; GO:1902511; GO:1990535; GO:1990966,ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection maintenance [GO:1990535]; nucleotide biosynthetic process [GO:0009165]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611],chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:1901135,catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; carbohydrate derivative metabolic process
OG_04895,2.1360857153301467,FUN_022939-T1,Peve_00026755,Pocillopora_meandrina_HIv1___RNAseq.g3742.t1,three_way,61.73183333333333,FUN_022939-T1,A8WG21,,,,,39.9,153.0,2.9e-19,97.1,sp|A8WG21|SNXAB_DANRE Sorting nexin-10B OS=Danio rerio OX=7955 GN=snx10b PE=2 SV=1,,,,,,
OG_04896,1.7558362001039485,FUN_022940-T1,Peve_00001686,Pocillopora_meandrina_HIv1___RNAseq.g3744.t1,three_way,83.253,FUN_022940-T1,Q9JJX8,,,,,59.5,375.0,1.900000000000001e-130,467.2,sp|Q9JJX8|ST32B_MOUSE Serine/threonine-protein kinase 32B OS=Mus musculus OX=10090 GN=Stk32b PE=2 SV=2,,,,,,
OG_04897,1.810889180352899,FUN_022941-T1,Peve_00001690,Pocillopora_meandrina_HIv1___RNAseq.g3745.t1,three_way,72.69833333333334,FUN_022941-T1,Q9HDY1,,,,,24.5,575.0,2.9e-24,115.2,sp|Q9HDY1|ASE1_SCHPO Anaphase spindle elongation protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ase1 PE=1 SV=1,,,,,,
OG_04900,1.9248493288085025,FUN_022945-T1,Peve_00015105,Pocillopora_meandrina_HIv1___RNAseq.g3748.t1,three_way,90.02333333333334,FUN_022945-T1,E7FDB3,,,,,59.2,76.0,2e-20,100.9,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_04902,1.4965749882747157,FUN_022948-T1,Peve_00005141,Pocillopora_meandrina_HIv1___RNAseq.g3749.t1b,three_way,55.449,FUN_022948-T1,O16374,GALT1_CAEEL,,"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)",Caenorhabditis elegans,26.7,303.0,1.7e-26,121.7,"sp|O16374|GALT1_CAEEL Beta-1,4-galactosyltransferase galt-1 OS=Caenorhabditis elegans OX=6239 GN=galt-1 PE=1 SV=4",GO:0003831; GO:0005737; GO:0006491; GO:0016757; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872; GO:0070085,glycosylation [GO:0070085]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125],cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; intracellular organelle [GO:0043229],"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]",GO:0003824; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_04903,2.951060753806525,FUN_022949-T1,Peve_00005144,Pocillopora_meandrina_HIv1___TS.g9923.t1,three_way,70.34633333333333,FUN_022949-T1,Q9JIP0,TRPV5_RAT,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transporter 2) (CaT2) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Rattus norvegicus (Rat),27.3,598.0,1.4999999999999998e-43,179.5,sp|Q9JIP0|TRPV5_RAT Transient receptor potential cation channel subfamily V member 5 OS=Rattus norvegicus OX=10116 GN=Trpv5 PE=1 SV=1,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_04905,1.086128016830241,FUN_022951-T1,Peve_00001408,Pocillopora_meandrina_HIv1___TS.g9408.t1,three_way,68.699,,,,,,,,,,,,,,,,,
OG_04914,1.22094912793524,FUN_022968-T1,Peve_00011901,Pocillopora_meandrina_HIv1___RNAseq.g3762.t1,three_way,74.65283333333333,FUN_022968-T1,Q14185,,,,,47.2,1635.0,0.0,1488.4,sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2,,,,,,
OG_04916,1.5035702711483456,FUN_022970-T1,Peve_00011906,Pocillopora_meandrina_HIv1___RNAseq.17380_t,three_way,66.845,FUN_022970-T1,Q9QYC0,ADDA_MOUSE,,Alpha-adducin (Erythrocyte adducin subunit alpha),Mus musculus (Mouse),34.7,395.0,3.5e-58,227.6,sp|Q9QYC0|ADDA_MOUSE Alpha-adducin OS=Mus musculus OX=10090 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0003779; GO:0005200; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006884; GO:0016020; GO:0016604; GO:0020027; GO:0030218; GO:0035264; GO:0045202; GO:0048873; GO:0071277; GO:1903142; GO:1903393,cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04919,2.149482071447489,FUN_022976-T1,Peve_00011912,Pocillopora_meandrina_HIv1___RNAseq.g3755.t1,three_way,63.82566666666666,,,,,,,,,,,,,,,,,
OG_04920,1.755016826822587,FUN_022978-T1,Peve_00027960,Pocillopora_meandrina_HIv1___RNAseq.g3754.t1,three_way,71.34933333333333,FUN_022978-T1,Q28FF3,,,,,41.1,436.0,3.3e-92,340.5,sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2,,,,,,
OG_04931,1.7529880198395584,FUN_022998-T1,Peve_00006898,Pocillopora_meandrina_HIv1___RNAseq.g3792.t1,three_way,50.482,,,,,,,,,,,,,,,,,
OG_04936,1.0053227178395632,FUN_023007-T1,Peve_00009984,Pocillopora_meandrina_HIv1___RNAseq.g3820.t1,three_way,51.1705,,,,,,,,,,,,,,,,,
OG_04942,1.2932971316516588,FUN_023017-T1,Peve_00010018,Pocillopora_meandrina_HIv1___RNAseq.g3833.t1,three_way,60.31033333333333,FUN_023017-T1,Q1PSW8,LIN41_MOUSE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Mus musculus (Mouse),21.1,313.0,9.5e-09,63.2,sp|Q1PSW8|LIN41_MOUSE E3 ubiquitin-protein ligase TRIM71 OS=Mus musculus OX=10090 GN=Trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04944,1.5151044838562344,FUN_023023-T1,Peve_00010022,Pocillopora_meandrina_HIv1___RNAseq.g3837.t1,three_way,74.59233333333333,FUN_023023-T1,Q91175,,,,,31.2,333.0,6e-37,156.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04950,1.0156063487384177,FUN_023040-T1,Peve_00008504,Pocillopora_meandrina_HIv1___RNAseq.g3859.t1,three_way,86.40083333333334,FUN_023040-T1,Q28479,IDH3B_MACFA,,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.6,337.0,1.3e-112,407.9,"sp|Q28479|IDH3B_MACFA Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=IDH3B PE=2 SV=2",GO:0000287; GO:0005739; GO:0006099; GO:0006102; GO:0016616; GO:0051287,isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],"magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_04951,1.0312776498311569,FUN_023041-T1,Peve_00008505,Pocillopora_meandrina_HIv1___RNAseq.g3860.t1,three_way,73.58200000000001,FUN_023041-T1,P40692,MLH1_HUMAN,,DNA mismatch repair protein Mlh1 (MutL protein homolog 1),Homo sapiens (Human),53.6,813.0,1.3e-236,820.8,sp|P40692|MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens OX=9606 GN=MLH1 PE=1 SV=1,GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664,double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283],chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0007059; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA repair; DNA recombination; chromosome segregation; mRNA metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_04953,1.867973280230993,FUN_023043-T1,Peve_00008509,Pocillopora_meandrina_HIv1___RNAseq.g3862.t1,three_way,69.66266666666667,FUN_023043-T1,Q6DCF2,,,,,35.5,991.0,7.2e-163,576.2,sp|Q6DCF2|MMS19_XENLA MMS19 nucleotide excision repair protein homolog OS=Xenopus laevis OX=8355 GN=mms19 PE=2 SV=1,,,,,,
OG_04957,1.2616227068204071,FUN_023047-T1,Peve_00008514,Pocillopora_meandrina_HIv1___RNAseq.g3871.t1,three_way,45.82666666666667,FUN_023047-T1,Q6NUJ5,PWP2B_HUMAN,,PWWP domain-containing protein 2B,Homo sapiens (Human),48.9,92.0,3.3e-17,91.7,sp|Q6NUJ5|PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens OX=9606 GN=PWWP2B PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0032968; GO:0120161; GO:0120325,chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161],nucleoplasm [GO:0005654]; nucleus [GO:0005634],NuRD complex binding [GO:0120325],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_04960,1.9568389094716807,FUN_023051-T1,Peve_00008518,Pocillopora_meandrina_HIv1___TS.g10046.t1,three_way,59.464666666666666,FUN_023051-T1,Q99ME2,,,,,28.8,1022.0,2.5e-109,398.7,sp|Q99ME2|WDR6_MOUSE tRNA (34-2'-O)-methyltransferase regulator WDR6 OS=Mus musculus OX=10090 GN=Wdr6 PE=1 SV=1,,,,,,
OG_04962,2.2034860527768623,FUN_023054-T2,Peve_00008519,Pocillopora_meandrina_HIv1___RNAseq.g3877.t1,three_way,70.94933333333334,FUN_023054-T2,Q9BPW9,DHRS9_HUMAN,,Dehydrogenase/reductase SDR family member 9 (EC 1.1.1.209) (EC 1.1.1.53) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),Homo sapiens (Human),45.9,305.0,1.2e-66,255.0,sp|Q9BPW9|DHRS9_HUMAN Dehydrogenase/reductase SDR family member 9 OS=Homo sapiens OX=9606 GN=DHRS9 PE=1 SV=1,GO:0004022; GO:0004745; GO:0005789; GO:0008202; GO:0008209; GO:0016491; GO:0016854; GO:0030855; GO:0042448; GO:0042572; GO:0042904; GO:0043231; GO:0047023; GO:0047035; GO:0047044,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"alcohol dehydrogenase (NAD+) activity [GO:0004022]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; oxidoreductase activity [GO:0016491]; racemase and epimerase activity [GO:0016854]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",GO:0003824; GO:0006629; GO:0016491; GO:0016853; GO:0030154; GO:0043226,catalytic activity; lipid metabolic process; oxidoreductase activity; isomerase activity; cell differentiation; organelle
OG_04965,2.411933974583968,FUN_023064-T1,Peve_00024668,Pocillopora_meandrina_HIv1___RNAseq.g3883.t1,three_way,87.05566666666667,FUN_023064-T1,P43249,,,,,62.2,566.0,1.8e-203,710.3,sp|P43249|GRK5_BOVIN G protein-coupled receptor kinase 5 OS=Bos taurus OX=9913 GN=GRK5 PE=1 SV=1,,,,,,
OG_04966,1.0848325312619818,FUN_023066-T1,Peve_00024667,Pocillopora_meandrina_HIv1___RNAseq.g3884.t2,three_way,87.49933333333333,FUN_023066-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),46.5,2103.0,0.0,1895.2,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_04973,1.2194944687005496,FUN_023080-T1,Peve_00038940,Pocillopora_meandrina_HIv1___RNAseq.g1655.t1,three_way,72.83166666666666,FUN_023080-T1,Q28EX9,UBCP1_XENTR,,Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),65.9,232.0,9e-83,308.1,sp|Q28EX9|UBCP1_XENTR Ubiquitin-like domain-containing CTD phosphatase 1 OS=Xenopus tropicalis OX=8364 GN=ublcp1 PE=2 SV=1,GO:0004722; GO:0005634; GO:0046872; GO:0090364,regulation of proteasome assembly [GO:0090364],nucleus [GO:0005634],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_04992,1.6072069932158328,FUN_023122-T1,Peve_00021098,Pocillopora_meandrina_HIv1___RNAseq.g1689.t1,three_way,60.922666666666665,FUN_023122-T1,Q9VY86,,,,,61.6,151.0,2.1e-52,206.8,sp|Q9VY86|TM2D2_DROME TM2 domain-containing protein amaretto OS=Drosophila melanogaster OX=7227 GN=amrt PE=2 SV=3,,,,,,
OG_04995,1.542427561799082,FUN_023127-T1,Peve_00011778,Pocillopora_meandrina_HIv1___RNAseq.g1757.t1,three_way,70.8965,FUN_023127-T1,P42859,,,,,34.8,3196.0,0.0,1587.0,sp|P42859|HD_MOUSE Huntingtin OS=Mus musculus OX=10090 GN=Htt PE=1 SV=2,,,,,,
OG_04998,1.2764615935796528,FUN_023133-T1,Peve_00008525,Pocillopora_meandrina_HIv1___RNAseq.g1754.t1,three_way,68.886,FUN_023133-T1,Q9EPZ8,,,,,36.0,663.0,6.6e-106,386.3,sp|Q9EPZ8|RN103_RAT E3 ubiquitin-protein ligase RNF103 OS=Rattus norvegicus OX=10116 GN=Rnf103 PE=2 SV=1,,,,,,
OG_04999,5.540335334848202,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05000,2.867955182032705,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_05004,1.19872483450025,FUN_023140-T1,Peve_00042480,Pocillopora_meandrina_HIv1___RNAseq.g1748.t1,three_way,90.46233333333332,FUN_023140-T1,Q9YGD2,,,,,79.1,292.0,6.5e-136,485.0,"sp|Q9YGD2|SUCA_COLLI Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (Fragment) OS=Columba livia OX=8932 GN=SUCLG1 PE=1 SV=1",,,,,,
OG_05009,1.8470373697351896,FUN_023160-T2,Peve_00018797,Pocillopora_meandrina_HIv1___RNAseq.g641.t1,three_way,62.85266666666667,,,,,,,,,,,,,,,,,
OG_05014,1.8236572046224444,FUN_023173-T1,Peve_00009976,Pocillopora_meandrina_HIv1___TS.g25350.t1,three_way,83.18433333333333,FUN_023173-T1,O93309,SMC3_XENLA,,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3),Xenopus laevis (African clawed frog),50.2,630.0,2.6e-150,533.9,sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2,GO:0000775; GO:0000785; GO:0003690; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0007064; GO:0016887; GO:0030892; GO:0030893; GO:0051301; GO:0051321,cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0022414; GO:0043226,DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; reproductive process; organelle
OG_05015,1.8558827060249328,FUN_023177-T1,Peve_00009975,Pocillopora_meandrina_HIv1___RNAseq.g656.t1,three_way,61.85766666666667,FUN_023177-T1,Q9LJR3,SPA3_ARATH,,Protein SPA1-RELATED 3,Arabidopsis thaliana (Mouse-ear cress),24.5,143.0,4.2e-06,53.9,sp|Q9LJR3|SPA3_ARATH Protein SPA1-RELATED 3 OS=Arabidopsis thaliana OX=3702 GN=SPA3 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005634; GO:0009585; GO:0009640; GO:0042802,"photomorphogenesis [GO:0009640]; red, far-red light phototransduction [GO:0009585]",nucleus [GO:0005634],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05016,1.306777773000387,FUN_023178-T1,Peve_00009977,Pocillopora_meandrina_HIv1___RNAseq.g659.t2,three_way,55.161,FUN_023178-T1,Q8WY21,SORC1_HUMAN,,VPS10 domain-containing receptor SorCS1 (hSorCS),Homo sapiens (Human),28.4,989.0,4.4e-95,351.3,sp|Q8WY21|SORC1_HUMAN VPS10 domain-containing receptor SorCS1 OS=Homo sapiens OX=9606 GN=SORCS1 PE=1 SV=3,GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020,neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892],Golgi apparatus [GO:0005794]; membrane [GO:0016020],neuropeptide receptor activity [GO:0008188],GO:0005794; GO:0016192; GO:0043226; GO:0060089,Golgi apparatus; vesicle-mediated transport; organelle; molecular transducer activity
OG_05017,1.9282151284940616,FUN_023180-T1,Peve_00009979,Pocillopora_meandrina_HIv1___RNAseq.g661.t1,three_way,65.57166666666666,FUN_023180-T1,Q2NL37,BCCIP_BOVIN,,BRCA2 and CDKN1A-interacting protein,Bos taurus (Bovine),30.5,272.0,2.3000000000000002e-30,134.4,sp|Q2NL37|BCCIP_BOVIN BRCA2 and CDKN1A-interacting protein OS=Bos taurus OX=9913 GN=BCCIP PE=2 SV=1,GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0006281; GO:0007052; GO:0034453; GO:0090307; GO:0097431,DNA repair [GO:0006281]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634],,GO:0005634; GO:0005815; GO:0006281; GO:0007010; GO:0043226,nucleus; microtubule organizing center; DNA repair; cytoskeleton organization; organelle
OG_05018,2.9871113072003275,FUN_023181-T1,Peve_00009980,Pocillopora_meandrina_HIv1___RNAseq.g662.t1,three_way,72.565,FUN_023181-T1,Q8R0X2,,,,,46.7,225.0,3.5999999999999986e-55,216.5,sp|Q8R0X2|CACL1_MOUSE CDK2-associated and cullin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cacul1 PE=2 SV=1,,,,,,
OG_05024,1.2367323297083208,FUN_023187-T1,Peve_00009989,Pocillopora_meandrina_HIv1___RNAseq.g669.t1,three_way,73.152,FUN_023187-T1,F1Q8J0,RNPC3_DANRE,,RNA-binding region-containing protein 3 (RNA-binding protein 40),Danio rerio (Zebrafish) (Brachydanio rerio),44.0,489.0,1.1999999999999999e-75,285.4,sp|F1Q8J0|RNPC3_DANRE RNA-binding region-containing protein 3 OS=Danio rerio OX=7955 GN=rnpc3 PE=2 SV=1,GO:0000398; GO:0001889; GO:0005689; GO:0030626; GO:0031016; GO:0048565; GO:0097157,"digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]",U12-type spliceosomal complex [GO:0005689],pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626],GO:0003723; GO:0016071; GO:0048856,RNA binding; mRNA metabolic process; anatomical structure development
OG_05030,1.5912316066893404,FUN_023202-T1,Peve_00010001,Pocillopora_meandrina_HIv1___RNAseq.g680.t1,three_way,51.176,FUN_023202-T1,Q9Z0R0,,,,,46.0,339.0,2e-82,308.5,sp|Q9Z0R0|HASP_MOUSE Serine/threonine-protein kinase haspin OS=Mus musculus OX=10090 GN=Haspin PE=1 SV=3,,,,,,
OG_05033,1.5323495629943944,FUN_023213-T1,Peve_00010009,Pocillopora_meandrina_HIv1___RNAseq.g689.t1,three_way,68.199,FUN_023213-T1,Q8IUR5,,,,,44.5,456.0,6e-86,320.9,sp|Q8IUR5|TMTC1_HUMAN Protein O-mannosyl-transferase TMTC1 OS=Homo sapiens OX=9606 GN=TMTC1 PE=1 SV=3,,,,,,
OG_05035,2.7503122795061974,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_05042,1.1593399118829402,FUN_023226-T1,Peve_00029805,Pocillopora_meandrina_HIv1___TS.g25414.t1,three_way,82.15833333333333,FUN_023226-T1,A1A4R8,,,,,53.7,294.0,1e-84,315.8,sp|A1A4R8|CDC23_BOVIN Cell division cycle protein 23 homolog OS=Bos taurus OX=9913 GN=CDC23 PE=2 SV=1,,,,,,
OG_05044,1.0270191359040586,FUN_023228-T1,Peve_00029803,Pocillopora_meandrina_HIv1___RNAseq.g718.t1,three_way,84.18599999999999,FUN_023228-T1,Q5U4F6,DC2I2_MOUSE,,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),Mus musculus (Mouse),45.9,492.0,1.2e-121,438.3,sp|Q5U4F6|DC2I2_MOUSE Cytoplasmic dynein 2 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync2i2 PE=1 SV=3,GO:0005730; GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0016604; GO:0030175; GO:0031965; GO:0035721; GO:0036064; GO:0045503; GO:0060271,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],dynein light chain binding [GO:0045503],GO:0005730; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0043226; GO:0044782,nucleolus; microtubule organizing center; cytosol; cilium; microtubule-based movement; organelle; cilium organization
OG_05047,1.5171613903119614,FUN_023236-T1,Peve_00029852,Pocillopora_meandrina_HIv1___TS.g16967.t1,three_way,66.868,FUN_023236-T1,Q8AW42,,,,,44.2,353.0,1.7e-70,268.1,sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1,,,,,,
OG_05052,1.3223156838695531,FUN_023248-T1,Peve_00019246,Pocillopora_meandrina_HIv1___RNAseq.g17397.t1,three_way,77.48166666666667,FUN_023248-T1,Q5ZIZ2,SMYD5_CHICK,,Protein-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.-) (SET and MYND domain-containing protein 5) ([histone H3]-lysine20 N-trimethyltransferase SMYD5) (EC 2.1.1.372) ([histone H4]-lysine36 N-trimethyltransferase SMYD5) (EC 2.1.1.359),Gallus gallus (Chicken),55.4,381.0,2.800000000000001e-118,426.8,sp|Q5ZIZ2|SMYD5_CHICK Protein-lysine N-trimethyltransferase SMYD5 OS=Gallus gallus OX=9031 GN=SMYD5 PE=2 SV=1,GO:0005737; GO:0008270; GO:0016279; GO:0032259; GO:0042799; GO:0045814; GO:0140943; GO:0140955; GO:1900249; GO:2000035; GO:2000736,"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of cytoplasmic translational elongation [GO:1900249]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]",cytoplasm [GO:0005737],histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 trimethyltransferase activity [GO:0140943]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270],GO:0003824; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_05053,3.835448567840358,FUN_023249-T1,Peve_00019252,Pocillopora_meandrina_HIv1___TS.g16979.t2,three_way,58.003,,,,,,,,,,,,,,,,,
OG_05058,1.0121670228998996,FUN_023255-T1,Peve_00019259,Pocillopora_meandrina_HIv1___RNAseq.g571.t1,three_way,52.29533333333333,,,,,,,,,,,,,,,,,
OG_05061,1.4704333234397056,FUN_023258-T1,Peve_00019265,Pocillopora_meandrina_HIv1___RNAseq.g29203.t1,three_way,59.568333333333335,FUN_023258-T1,Q057J1,,,,,53.5,71.0,4.5e-13,75.9,sp|Q057J1|RL27_BUCCC Large ribosomal subunit protein bL27 OS=Buchnera aphidicola subsp. Cinara cedri (strain Cc) OX=372461 GN=rpmA PE=3 SV=1,,,,,,
OG_05062,1.5031564905655117,FUN_023259-T1,Peve_00019266,Pocillopora_meandrina_HIv1___RNAseq.g574.t1,three_way,69.79666666666667,,,,,,,,,,,,,,,,,
OG_05063,1.906894831953628,FUN_023260-T1,Peve_00019268,Pocillopora_meandrina_HIv1___RNAseq.g578.t1,three_way,89.18833333333333,FUN_023260-T1,Q9W676,,,,,61.8,382.0,2.4e-114,413.7,sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1,,,,,,
OG_05064,2.054299265499509,FUN_023262-T2,Peve_00019267,Pocillopora_meandrina_HIv1___RNAseq.g576.t2,three_way,62.084,FUN_023262-T2,A4IG62,SUV3_DANRE,,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",Danio rerio (Zebrafish) (Brachydanio rerio),45.3,583.0,4.8e-149,530.0,"sp|A4IG62|SUV3_DANRE ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Danio rerio OX=7955 GN=supv3l1 PE=2 SV=1",GO:0000958; GO:0000962; GO:0000965; GO:0001889; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0007005; GO:0016887; GO:0030307; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:2000827,DNA recombination [GO:0006310]; liver development [GO:0001889]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401],mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006310; GO:0007005; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140053; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; DNA recombination; mitochondrion organization; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; anatomical structure development; mitochondrial gene expression; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05066,1.3577850859386502,FUN_023269-T1,Peve_00019482,Pocillopora_meandrina_HIv1___TS.g17377.t1a,three_way,74.93916666666667,FUN_023269-T1,Q9PVF8,CTNA1_DANRE,,Catenin alpha-1 (Alpha E-catenin),Danio rerio (Zebrafish) (Brachydanio rerio),23.7,628.0,5.3e-38,162.2,sp|Q9PVF8|CTNA1_DANRE Catenin alpha-1 OS=Danio rerio OX=7955 GN=ctnna1 PE=1 SV=1,GO:0001894; GO:0005198; GO:0005634; GO:0005902; GO:0005911; GO:0005912; GO:0005938; GO:0008013; GO:0015629; GO:0016342; GO:0016477; GO:0034334; GO:0043009; GO:0045296; GO:0051015; GO:0098609,adherens junction maintenance [GO:0034334]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; tissue homeostasis [GO:0001894],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; microvillus [GO:0005902]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0034330; GO:0043226; GO:0048856; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development; cell motility
OG_05069,2.752396040029337,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05072,2.545898296184132,FUN_023298-T1,Peve_00041305,Pocillopora_meandrina_HIv1___RNAseq.g17780.t1,three_way,76.65966666666667,FUN_023298-T1,Q5XIH9,HPDL_RAT,,4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) (EC 1.13.11.46) (Glyoxalase domain-containing protein 1),Rattus norvegicus (Rat),32.8,390.0,1.4e-48,195.3,sp|Q5XIH9|HPDL_RAT 4-hydroxyphenylpyruvate dioxygenase-like protein OS=Rattus norvegicus OX=10116 GN=Hpdl PE=2 SV=1,GO:0003868; GO:0005739; GO:0009072; GO:0046872; GO:0050585,aromatic amino acid metabolic process [GO:0009072],mitochondrion [GO:0005739],4-hydroxymandelate synthase activity [GO:0050585]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_05074,1.8924449312794889,FUN_023300-T1,Peve_00041309,Pocillopora_meandrina_HIv1___RNAseq.g17778.t1,three_way,86.52966666666667,FUN_023300-T1,Q3ZCF5,,,,,75.7,276.0,3.2e-128,459.5,"sp|Q3ZCF5|OAT_BOVIN Ornithine aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=OAT PE=2 SV=1",,,,,,
OG_05075,2.66054237553839,FUN_023301-T1,Peve_00041311,Pocillopora_meandrina_HIv1___RNAseq.g17777.t1,three_way,77.84916666666666,FUN_023301-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),31.5,371.0,1.6000000000000001e-38,162.5,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_05078,2.21176761813984,FUN_023307-T1,Peve_00041315,Pocillopora_meandrina_HIv1___RNAseq.g17774.t1,three_way,62.178,FUN_023307-T1,Q9QXT1,,,,,36.0,86.0,3.4e-10,67.4,sp|Q9QXT1|DAPP1_MOUSE Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Mus musculus OX=10090 GN=Dapp1 PE=1 SV=1,,,,,,
OG_05079,1.8137432661833213,FUN_023308-T1,Peve_00041319,Pocillopora_meandrina_HIv1___RNAseq.g17773.t1,three_way,65.986,FUN_023308-T1,Q80YG3,,,,,38.9,378.0,3.6e-73,276.9,sp|Q80YG3|KLDC1_MOUSE Kelch domain-containing protein 1 OS=Mus musculus OX=10090 GN=Klhdc1 PE=2 SV=1,,,,,,
OG_05082,1.037738373940718,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05090,1.830607838772699,FUN_023334-T1,Peve_00001906,Pocillopora_meandrina_HIv1___RNAseq.g17417.t1,three_way,76.06566666666667,FUN_023334-T1,Q9HB40,,,,,53.6,379.0,2.3e-114,413.7,sp|Q9HB40|RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,,,,,,
OG_05091,1.5389598443986228,FUN_023336-T1,Peve_00001907,Pocillopora_meandrina_HIv1___RNAseq.g17418.t1,three_way,88.16199999999999,FUN_023336-T1,Q9NX55,HYPK_HUMAN,,Huntingtin-interacting protein K (Huntingtin yeast partner K),Homo sapiens (Human),59.6,104.0,1.5e-23,110.2,sp|Q9NX55|HYPK_HUMAN Huntingtin-interacting protein K OS=Homo sapiens OX=9606 GN=HYPK PE=1 SV=3,GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0044183; GO:0050821,negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],protein folding chaperone [GO:0044183],GO:0005634; GO:0005654; GO:0005856; GO:0043226; GO:0044183,nucleus; nucleoplasm; cytoskeleton; organelle; protein folding chaperone
OG_05092,1.83764244257664,FUN_023338-T1,Peve_00001905,Pocillopora_meandrina_HIv1___RNAseq.g17419.t1,three_way,63.309333333333335,FUN_023338-T1,Q9HB40,,,,,47.1,408.0,6.6e-100,365.9,sp|Q9HB40|RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,,,,,,
OG_05096,1.135958170020837,FUN_023343-T1,Peve_00023293,Pocillopora_meandrina_HIv1___RNAseq.g17424.t1,three_way,72.48533333333333,FUN_023343-T1,Q05AM5,,,,,45.9,854.0,2.9e-210,733.4,sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1,,,,,,
OG_05103,1.8811870708321776,FUN_023358-T2,Peve_00005335,Pocillopora_meandrina_HIv1___TS.g17018.t1,three_way,80.87916666666666,FUN_023358-T2,Q96A58,RERG_HUMAN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Homo sapiens (Human),36.9,160.0,2.8000000000000002e-28,127.1,sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; plasma membrane; hydrolase activity; organelle; molecular function regulator activity
OG_05104,1.3527048687768637,FUN_023360-T1,Peve_00005336,Pocillopora_meandrina_HIv1___TS.g17019.t1,three_way,64.49333333333334,FUN_023360-T1,Q0VCJ7,RERG_BOVIN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Bos taurus (Bovine),38.9,193.0,1.5999999999999999e-29,131.3,sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005829; GO:0005886; GO:0008285; GO:0009725; GO:0019003; GO:0030308,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; molecular function regulator activity
OG_05105,1.3215766363613652,FUN_023363-T1,Peve_00005341,Pocillopora_meandrina_HIv1___RNAseq.g17541.t1,three_way,60.940666666666665,FUN_023363-T1,Q24207,BOULE_DROME,,Protein boule,Drosophila melanogaster (Fruit fly),35.0,163.0,3.5e-13,76.6,sp|Q24207|BOULE_DROME Protein boule OS=Drosophila melanogaster OX=7227 GN=bol PE=1 SV=1,GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935,3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204],mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],GO:0003723; GO:0005634; GO:0022414; GO:0030154; GO:0043226; GO:0045182,RNA binding; nucleus; reproductive process; cell differentiation; organelle; translation regulator activity
OG_05109,1.6349948595281707,FUN_023368-T1,Peve_00005353,Pocillopora_meandrina_HIv1___RNAseq.g17535.t1,three_way,80.16333333333333,FUN_023368-T1,Q12981,,,,,45.7,219.0,9.3e-42,171.8,sp|Q12981|SEC20_HUMAN Vesicle transport protein SEC20 OS=Homo sapiens OX=9606 GN=BNIP1 PE=1 SV=3,,,,,,
OG_05110,3.380289178410729,FUN_023369-T2,Peve_00005354,Pocillopora_meandrina_HIv1___TS.g17121.t2,three_way,69.55983333333333,FUN_023369-T2,O96028,NSD2_HUMAN,,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein),Homo sapiens (Human),41.5,1229.0,2.6e-223,777.3,sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1,GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006355; GO:0008270; GO:0032259; GO:0042799; GO:0043565; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:0140938; GO:0140954; GO:0140955; GO:2001032,atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05116,1.0534516150144848,FUN_023376-T1,Peve_00005364,Pocillopora_meandrina_HIv1___RNAseq.g17526.t1,three_way,65.55333333333333,FUN_023376-T1,Q54PR9,CF60_DICDI,,Counting factor 60,Dictyostelium discoideum (Social amoeba),31.2,404.0,3.9e-42,174.1,sp|Q54PR9|CF60_DICDI Counting factor 60 OS=Dictyostelium discoideum OX=44689 GN=cf60 PE=1 SV=1,GO:0005576; GO:0016791; GO:0031158,negative regulation of aggregate size involved in sorocarp development [GO:0031158],extracellular region [GO:0005576],phosphatase activity [GO:0016791],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_05119,2.294512913715377,FUN_023381-T1,Peve_00030697,Pocillopora_meandrina_HIv1___RNAseq.g17515.t1,three_way,64.44500000000001,FUN_023381-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.7,428.0,4.3e-52,207.2,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05130,2.7520247555908552,FUN_023398-T1,Peve_00004631,Pocillopora_meandrina_HIv1___RNAseq.g17445.t1,three_way,65.884,FUN_023398-T1,Q9BW72,,,,,47.9,71.0,1.4e-12,74.3,"sp|Q9BW72|HIG2A_HUMAN HIG1 domain family member 2A, mitochondrial OS=Homo sapiens OX=9606 GN=HIGD2A PE=1 SV=1",,,,,,
OG_05134,1.4253424210830157,FUN_023405-T1,Peve_00016099,Pocillopora_meandrina_HIv1___RNAseq.g17555.t1,three_way,68.52166666666666,,,,,,,,,,,,,,,,,
OG_05138,1.6295346041150227,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_05140,2.3564425704828995,FUN_023416-T1,Peve_00017406,Pocillopora_meandrina_HIv1___RNAseq.g17587.t2,three_way,86.484,FUN_023416-T1,Q9UHX1,,,,,45.5,569.0,4.5e-115,416.8,sp|Q9UHX1|PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=1,,,,,,
OG_05143,1.0187880632733075,FUN_023419-T2,Peve_00019272,Pocillopora_meandrina_HIv1___RNAseq.g580.t1,three_way,70.67533333333334,FUN_023419-T2,Q8N9I5,FADS6_HUMAN,,Fatty acid desaturase 6 (EC 1.14.19.-),Homo sapiens (Human),45.8,330.0,2.4e-77,290.8,sp|Q8N9I5|FADS6_HUMAN Fatty acid desaturase 6 OS=Homo sapiens OX=9606 GN=FADS6 PE=1 SV=2,GO:0006629; GO:0006633; GO:0016020; GO:0016717,fatty acid biosynthetic process [GO:0006633]; lipid metabolic process [GO:0006629],membrane [GO:0016020],"oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_05147,2.095548003367559,FUN_023426-T1,Peve_00019216,Pocillopora_meandrina_HIv1___RNAseq.g584.t1,three_way,75.90066666666667,FUN_023426-T1,Q6P4Q7,CNNM4_HUMAN,,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),Homo sapiens (Human),52.5,537.0,1.7e-155,550.8,sp|Q6P4Q7|CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens OX=9606 GN=CNNM4 PE=1 SV=3,GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016323; GO:0030003; GO:0032991; GO:0070166,enamel mineralization [GO:0070166]; intracellular monoatomic cation homeostasis [GO:0030003]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; visual perception [GO:0007601],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081],GO:0005215; GO:0005886; GO:0048856; GO:0050877,transporter activity; plasma membrane; anatomical structure development; nervous system process
OG_05155,2.121270165453868,FUN_023442-T1,Peve_00019240,Pocillopora_meandrina_HIv1___RNAseq.g17640.t2,three_way,86.21766666666667,FUN_023442-T1,I6LDA6,,,,,61.0,520.0,2.4e-183,643.3,"sp|I6LDA6|GPMI_ONCVO 2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Onchocerca volvulus OX=6282 GN=ipgm-1 PE=1 SV=1",,,,,,
OG_05157,1.111845910274296,FUN_023446-T1,Peve_00019244,Pocillopora_meandrina_HIv1___RNAseq.g17636.t1,three_way,73.13333333333333,FUN_023446-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),32.2,457.0,5.9999999999999996e-55,216.9,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05159,1.2557298526272649,FUN_023449-T1,Peve_00037222,Pocillopora_meandrina_HIv1___RNAseq.g17631.t2,three_way,40.68716666666667,,,,,,,,,,,,,,,,,
OG_05160,1.832131109319714,FUN_023450-T1,Peve_00037237,Pocillopora_meandrina_HIv1___RNAseq.g17630.t1,three_way,87.68333333333334,FUN_023450-T1,Q9JI08,,,,,42.9,254.0,5.1999999999999996e-46,186.0,sp|Q9JI08|BIN3_MOUSE Bridging integrator 3 OS=Mus musculus OX=10090 GN=Bin3 PE=1 SV=1,,,,,,
OG_05167,1.117584364463901,FUN_023494-T1,Peve_00017462,Pocillopora_meandrina_HIv1___RNAseq.g542.t1,three_way,88.889,FUN_023494-T1,P51157,RAB28_HUMAN,,Ras-related protein Rab-28 (EC 3.6.5.2),Homo sapiens (Human),59.4,224.0,2.6e-73,276.6,sp|P51157|RAB28_HUMAN Ras-related protein Rab-28 OS=Homo sapiens OX=9606 GN=RAB28 PE=1 SV=2,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0012505; GO:0019003; GO:0035253; GO:0036064,intracellular protein transport [GO:0006886],ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0006886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; intracellular protein transport; hydrolase activity; molecular function regulator activity
OG_05170,1.35870439412746,FUN_023498-T1,Peve_00017458,Pocillopora_meandrina_HIv1___RNAseq.g538.t1,three_way,71.93366666666667,FUN_023498-T1,Q9DAM9,FANK1_MOUSE,,Fibronectin type 3 and ankyrin repeat domains 1 protein (Germ cell-specific gene 1 protein) (GSG1),Mus musculus (Mouse),40.9,149.0,1.5999999999999999e-24,115.2,sp|Q9DAM9|FANK1_MOUSE Fibronectin type 3 and ankyrin repeat domains 1 protein OS=Mus musculus OX=10090 GN=Fank1 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005929; GO:0036064; GO:0045893; GO:0051091; GO:0097546,positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893],chromatin [GO:0000785]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0006355; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; regulation of DNA-templated transcription; organelle
OG_05173,1.8404482482839368,FUN_023501-T1,Peve_00017454,Pocillopora_meandrina_HIv1___RNAseq.g534.t1,three_way,56.98533333333334,,,,,,,,,,,,,,,,,
OG_05175,1.994653960295134,FUN_023503-T1,Peve_00017430,Pocillopora_meandrina_HIv1___RNAseq.g531.t2,three_way,72.32416666666667,FUN_023503-T1,Q3UUG6,TBC24_MOUSE,,TBC1 domain family member 24,Mus musculus (Mouse),28.8,539.0,1.3e-52,209.1,sp|Q3UUG6|TBC24_MOUSE TBC1 domain family member 24 OS=Mus musculus OX=10090 GN=Tbc1d24 PE=1 SV=2,GO:0005096; GO:0005886; GO:0016358; GO:0030659; GO:0031175; GO:0031594; GO:0034599; GO:0043195; GO:0048488; GO:0050775; GO:0061564; GO:1900408; GO:2000463; GO:2001224,axon development [GO:0061564]; cellular response to oxidative stress [GO:0034599]; dendrite development [GO:0016358]; negative regulation of cellular response to oxidative stress [GO:1900408]; neuron projection development [GO:0031175]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron migration [GO:2001224]; synaptic vesicle endocytosis [GO:0048488],cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195],GTPase activator activity [GO:0005096],GO:0005886; GO:0016192; GO:0048856; GO:0098772,plasma membrane; vesicle-mediated transport; anatomical structure development; molecular function regulator activity
OG_05181,1.2005334378585553,FUN_023522-T1,Peve_00009063,Pocillopora_meandrina_HIv1___RNAseq.g3599.t1,three_way,72.77533333333334,FUN_023522-T1,Q8BH74,,,,,43.7,948.0,3.4e-215,750.0,sp|Q8BH74|NU107_MOUSE Nuclear pore complex protein Nup107 OS=Mus musculus OX=10090 GN=Nup107 PE=1 SV=1,,,,,,
OG_05184,1.0326552776091458,FUN_023550-T1,Peve_00041532,Pocillopora_meandrina_HIv1___RNAseq.g11206.t1a,three_way,67.22466666666666,FUN_023550-T1,Q5SSH8,NEUFC_MOUSE,,Neuferricin (Cytochrome b5 domain-containing protein 2),Mus musculus (Mouse),43.9,223.0,2.5000000000000002e-58,227.3,sp|Q5SSH8|NEUFC_MOUSE Neuferricin OS=Mus musculus OX=10090 GN=Cyb5d2 PE=1 SV=1,GO:0005576; GO:0020037; GO:0030182; GO:0045666,neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666],extracellular region [GO:0005576],heme binding [GO:0020037],GO:0005576; GO:0030154,extracellular region; cell differentiation
OG_05185,1.0982045705248504,FUN_023551-T1,Peve_00009052,Pocillopora_meandrina_HIv1___RNAseq.g3556.t1,three_way,81.81566666666666,FUN_023551-T1,Q4R4Q3,,,,,32.7,297.0,1.1e-40,168.7,sp|Q4R4Q3|NDRG1_MACFA Protein NDRG1 OS=Macaca fascicularis OX=9541 GN=Ndrg1 PE=2 SV=1,,,,,,
OG_05187,1.2053879099632543,FUN_023553-T1,Peve_00009074,Pocillopora_meandrina_HIv1___RNAseq.g3589.t1,three_way,89.21216666666666,FUN_023553-T1,Q8NE35,CPEB3_HUMAN,,Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3),Homo sapiens (Human),70.5,369.0,1.6e-146,521.2,sp|Q8NE35|CPEB3_HUMAN Cytoplasmic polyadenylation element-binding protein 3 OS=Homo sapiens OX=9606 GN=CPEB3 PE=1 SV=2,GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030425; GO:0030496; GO:0035613; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0045727; GO:0048167; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0071230; GO:0097440; GO:1900153; GO:1900248; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]",apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],"mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]",GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0045182; GO:0050877,RNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; translation regulator activity; nervous system process
OG_05188,2.277971992871074,FUN_023554-T1,Peve_00024945,Pocillopora_meandrina_HIv1___RNAseq.g3590.t1,three_way,88.87966666666667,FUN_023554-T1,Q6GM44,,,,,63.3,275.0,7.8e-104,378.3,sp|Q6GM44|MARH5_XENLA E3 ubiquitin-protein ligase MARCHF5 OS=Xenopus laevis OX=8355 GN=marchf5 PE=2 SV=1,,,,,,
OG_05189,1.9130261375877184,FUN_023555-T1,Peve_00009058,Pocillopora_meandrina_HIv1___RNAseq.g3555.t1,three_way,64.18966666666667,FUN_023555-T1,Q9UIF7,MUTYH_HUMAN,,Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH),Homo sapiens (Human),47.7,472.0,1.2e-110,401.7,sp|Q9UIF7|MUTYH_HUMAN Adenine DNA glycosylase OS=Homo sapiens OX=9606 GN=MUTYH PE=1 SV=1,GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546,base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_05191,1.2654161642205188,FUN_023557-T1,Peve_00037255,Pocillopora_meandrina_HIv1___RNAseq.g520.t1,three_way,63.37466666666667,FUN_023557-T1,Q5TEA3,,,,,35.3,1191.0,5.8e-204,713.0,sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1,,,,,,
OG_05200,1.853422428884268,FUN_023581-T1,Peve_00035146,Pocillopora_meandrina_HIv1___RNAseq.g3529.t1,three_way,51.781333333333336,,,,,,,,,,,,,,,,,
OG_05202,1.5724025752470043,FUN_023586-T1,Peve_00039436,Pocillopora_meandrina_HIv1___RNAseq.g3307.t1,three_way,72.94,,,,,,,,,,,,,,,,,
OG_05203,1.3370072792451415,FUN_023587-T1,Peve_00012774,Pocillopora_meandrina_HIv1___RNAseq.g17843.t1,three_way,73.40833333333333,FUN_023587-T1,Q6DIF4,WDR1_XENTR,,WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),50.6,607.0,1.3e-172,607.8,sp|Q6DIF4|WDR1_XENTR WD repeat-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=wdr1 PE=2 SV=1,GO:0003779; GO:0005634; GO:0005737; GO:0005884; GO:0005886; GO:0030043; GO:0051015,actin filament fragmentation [GO:0030043],actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; actin filament binding [GO:0051015],GO:0005634; GO:0005886; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeletal protein binding; organelle
OG_05205,1.1486212279504682,FUN_023589-T1,Peve_00028962,Pocillopora_meandrina_HIv1___RNAseq.g17840.t1,three_way,69.53,FUN_023589-T1,Q1ZZH1,,,,,37.3,823.0,6.8e-149,529.6,sp|Q1ZZH1|GRM3_MACFA Metabotropic glutamate receptor 3 OS=Macaca fascicularis OX=9541 GN=GRM3 PE=2 SV=1,,,,,,
OG_05208,4.387189014932848,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05215,3.232394742992491,FUN_023623-T1,Peve_00010900,Pocillopora_meandrina_HIv1___RNAseq.g3525.t1,three_way,73.34016666666666,FUN_023623-T1,Q90W58,,,,,46.8,308.0,4.4e-68,260.0,sp|Q90W58|DUS1B_XENLA Dual specificity protein phosphatase 1-B OS=Xenopus laevis OX=8355 GN=dusp1-b PE=2 SV=1,,,,,,
OG_05220,3.1834937457419548,FUN_023632-T1,Peve_00017477,Pocillopora_meandrina_HIv1___RNAseq.g527.t1,three_way,59.04733333333333,,,,,,,,,,,,,,,,,
OG_05229,3.4263408502589767,FUN_023642-T1,Peve_00027826,Pocillopora_meandrina_HIv1___RNAseq.g17815.t1,three_way,79.919,FUN_023642-T1,P06798,,,,,55.1,107.0,5.1e-20,99.8,sp|P06798|HXA4_MOUSE Homeobox protein Hox-A4 OS=Mus musculus OX=10090 GN=Hoxa4 PE=2 SV=4,,,,,,
OG_05230,1.0947336918765993,FUN_023643-T1,Peve_00027825,Pocillopora_meandrina_HIv1___RNAseq.g17818.t1,three_way,90.502,FUN_023643-T1,Q9DAA6,EXOS1_MOUSE,,Exosome complex component CSL4 (Exosome component 1),Mus musculus (Mouse),64.6,147.0,2.7000000000000004e-44,179.9,sp|Q9DAA6|EXOS1_MOUSE Exosome complex component CSL4 OS=Mus musculus OX=10090 GN=Exosc1 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0101019,RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleus; nucleolus; cytosol; organelle
OG_05232,2.684201667229641,FUN_023647-T1,Peve_00027823,Pocillopora_meandrina_HIv1___RNAseq.23947_t,three_way,76.041,FUN_023647-T1,Q6PCJ9,,,,,50.9,287.0,2.7e-78,293.5,sp|Q6PCJ9|PPT2A_XENLA Lysosomal thioesterase PPT2-A OS=Xenopus laevis OX=8355 GN=ppt2-a PE=2 SV=1,,,,,,
OG_05242,1.6812308861712435,FUN_023683-T2,Peve_00014143,Pocillopora_meandrina_HIv1___RNAseq.g17734.t1,three_way,51.321,,,,,,,,,,,,,,,,,
OG_05244,1.060634255525338,FUN_023689-T1,Peve_00014149,Pocillopora_meandrina_HIv1___RNAseq.g17728.t1,three_way,68.89233333333334,FUN_023689-T1,F6S215,,,,,25.8,979.0,3.2e-75,285.0,sp|F6S215|AP5B1_XENTR AP-5 complex subunit beta-1 OS=Xenopus tropicalis OX=8364 GN=ap5b1 PE=3 SV=1,,,,,,
OG_05247,2.204266274105748,FUN_023693-T1,Peve_00014155,Pocillopora_meandrina_HIv1___RNAseq.g17720.t1,three_way,64.13166666666666,FUN_023693-T1,Q5YCC5,,,,,29.7,660.0,6.2e-79,297.0,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_05248,1.0415270700572543,FUN_023694-T1,Peve_00017435,Pocillopora_meandrina_HIv1___RNAseq.g17612.t1,three_way,85.42266666666667,FUN_023694-T1,Q28G26,P4K2B_XENTR,,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),61.3,434.0,4.4e-152,539.3,sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1,GO:0000139; GO:0004430; GO:0005524; GO:0005789; GO:0005829; GO:0005886; GO:0031901; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity
OG_05254,2.757641309919421,FUN_023702-T1,Peve_00017411,Pocillopora_meandrina_HIv1___RNAseq.g17589.t1,three_way,69.48033333333333,FUN_023702-T1,Q3KP44,ANR55_HUMAN,,Ankyrin repeat domain-containing protein 55,Homo sapiens (Human),25.1,259.0,1.5e-16,89.0,sp|Q3KP44|ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens OX=9606 GN=ANKRD55 PE=1 SV=3,,,,,,
OG_05255,1.600082435627664,FUN_023758-T1,Peve_00044463,Pocillopora_meandrina_HIv1___RNAseq.g3496.t2,three_way,86.88133333333333,FUN_023758-T1,Q3T0Z7,,,,,59.3,226.0,2.7e-76,286.6,sp|Q3T0Z7|DHPR_BOVIN Dihydropteridine reductase OS=Bos taurus OX=9913 GN=QDPR PE=2 SV=1,,,,,,
OG_05268,3.0930688515120712,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_05269,1.3725361873343431,FUN_023922-T1,Peve_00017665,Pocillopora_meandrina_HIv1___TS.g28130.t1a,three_way,66.8095,FUN_023922-T1,Q3UMC0,AFG2A_MOUSE,,ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5),Mus musculus (Mouse),47.8,856.0,3.2e-207,723.4,sp|Q3UMC0|AFG2A_MOUSE ATPase family gene 2 protein homolog A OS=Mus musculus OX=10090 GN=Afg2a PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275,brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; mitochondrion; cytosol; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_05274,2.890902553716652,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_05278,1.4397944209349065,FUN_023936-T1,Peve_00023219,Pocillopora_meandrina_HIv1___RNAseq.g18856.t1,three_way,83.582,,,,,,,,,,,,,,,,,
OG_05281,1.4053991818154958,FUN_023943-T2,Peve_00023222,Pocillopora_meandrina_HIv1___RNAseq.g18860.t1,three_way,70.39283333333333,FUN_023943-T2,Q9JHI7,EXOS9_MOUSE,,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),Mus musculus (Mouse),48.0,452.0,3.4e-104,380.2,sp|Q9JHI7|EXOS9_MOUSE Exosome complex component RRP45 OS=Mus musculus OX=10090 GN=Exosc9 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0030307; GO:0035925; GO:0045944; GO:0061629; GO:0071028; GO:0071035; GO:0101019,nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000228; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006355; GO:0016071; GO:0043226,nuclear chromosome; RNA binding; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_05283,1.803504691003288,FUN_023945-T1,Peve_00010787,Pocillopora_meandrina_HIv1___RNAseq.g18863.t1,three_way,91.15233333333332,FUN_023945-T1,Q6NYV5,SP30L_DANRE,,Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like),Danio rerio (Zebrafish) (Brachydanio rerio),62.1,174.0,1.5e-54,213.8,sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1,GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273,heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005730; GO:0006355; GO:0008289; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleolus; regulation of DNA-templated transcription; lipid binding; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05288,1.274182688833044,FUN_023952-T1,Peve_00017998,Pocillopora_meandrina_HIv1___RNAseq.g18523.t1,three_way,45.82333333333333,,,,,,,,,,,,,,,,,
OG_05290,1.7408963969625544,FUN_023956-T1,Peve_00017997,Pocillopora_meandrina_HIv1___RNAseq.g18522.t1,three_way,84.48,FUN_023956-T1,O60271,,,,,49.1,642.0,1.4e-149,531.2,sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,,,,,,
OG_05292,1.6090218055414902,FUN_023959-T1,Peve_00017995,Pocillopora_meandrina_HIv1___RNAseq.g18520.t1,three_way,96.22633333333332,FUN_023959-T1,Q5XGI0,PRPS2_XENTR,,Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.8,318.0,5.6e-146,518.5,sp|Q5XGI0|PRPS2_XENTR Ribose-phosphate pyrophosphokinase 2 OS=Xenopus tropicalis OX=8364 GN=prps2 PE=2 SV=1,GO:0000287; GO:0004749; GO:0005524; GO:0006015; GO:0009156; GO:0009165; GO:0016301; GO:0042803,5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156],,ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749],GO:0003824; GO:0016740; GO:0055086; GO:1901135,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05299,1.1517589151435317,FUN_023969-T1,Peve_00043982,Pocillopora_meandrina_HIv1___RNAseq.g18532.t2,three_way,60.025333333333336,FUN_023969-T1,Q5FVB0,,,,,34.9,401.0,1.6e-51,205.3,sp|Q5FVB0|ATX10_XENTR Ataxin-10 OS=Xenopus tropicalis OX=8364 GN=atxn10 PE=2 SV=1,,,,,,
OG_05301,1.9615667053739985,FUN_023971-T1,Peve_00025477,Pocillopora_meandrina_HIv1___RNAseq.g18534.t1,three_way,57.55416666666667,FUN_023971-T1,P15384,,,,,33.7,395.0,9.300000000000001e-57,222.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_05304,2.358221773538839,FUN_023976-T1,Peve_00020879,Pocillopora_meandrina_HIv1___RNAseq.g19436.t1,three_way,62.5495,FUN_023976-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),37.6,93.0,1.4e-08,65.1,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05305,1.4740335570973937,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_05306,1.0118171091457646,FUN_023979-T1,Peve_00020872,Pocillopora_meandrina_HIv1___RNAseq.g19434.t1,three_way,54.052166666666665,,,,,,,,,,,,,,,,,
OG_05308,1.6485436486195788,FUN_023982-T1,Peve_00020888,Pocillopora_meandrina_HIv1___RNAseq.g19411.t1,three_way,76.62366666666667,FUN_023982-T1,Q8N264,RHG24_HUMAN,,Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP),Homo sapiens (Human),47.5,341.0,3.3e-91,337.0,sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2,GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:1900028,"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]",adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],GTPase activator activity [GO:0005096],GO:0005856; GO:0030154; GO:0043226; GO:0048870; GO:0098772,cytoskeleton; cell differentiation; organelle; cell motility; molecular function regulator activity
OG_05315,1.100100823649696,FUN_024000-T1,Peve_00034190,Pocillopora_meandrina_HIv1___RNAseq.g19352.t1,three_way,67.46066666666667,FUN_024000-T1,Q5E9U6,,,,,44.0,368.0,1.3e-87,324.7,sp|Q5E9U6|WNT16_BOVIN Protein Wnt-16 OS=Bos taurus OX=9913 GN=WNT16 PE=2 SV=1,,,,,,
OG_05321,1.4054231008310945,FUN_024010-T1,Peve_00042605,Pocillopora_meandrina_HIv1___RNAseq.g7352.t1,three_way,64.49566666666666,,,,,,,,,,,,,,,,,
OG_05332,1.9256272388923736,FUN_024041-T2,Peve_00020339,Pocillopora_meandrina_HIv1___RNAseq.g19271.t1,three_way,87.892,FUN_024041-T2,P11024,NNTM_BOVIN,,"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",Bos taurus (Bovine),63.4,1036.0,0.0,1258.0,"sp|P11024|NNTM_BOVIN NAD(P) transhydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=NNT PE=1 SV=3",GO:0005743; GO:0006740; GO:0008750; GO:0016491; GO:0050661; GO:0072593,NADPH regeneration [GO:0006740]; reactive oxygen species metabolic process [GO:0072593],mitochondrial inner membrane [GO:0005743],NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; proton-translocating NAD(P)+ transhydrogenase activity [GO:0008750],GO:0003824; GO:0005215; GO:0006091; GO:0016491; GO:0055086,catalytic activity; transporter activity; generation of precursor metabolites and energy; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_05335,1.9585451666224043,FUN_024047-T1,Peve_00020347,Pocillopora_meandrina_HIv1___RNAseq.g19265.t1,three_way,76.87566666666666,FUN_024047-T1,Q99MB5,,,,,60.5,124.0,1.3000000000000002e-44,180.6,sp|Q99MB5|LMO3_RAT LIM domain only protein 3 OS=Rattus norvegicus OX=10116 GN=Lmo3 PE=2 SV=2,,,,,,
OG_05337,2.0941677040585307,FUN_024053-T1,Peve_00000160,Pocillopora_meandrina_HIv1___RNAseq.g19257.t2,three_way,68.68216666666666,FUN_024053-T1,Q8CIQ7,DOCK3_MOUSE,,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),Mus musculus (Mouse),42.0,1682.0,0.0,1276.5,sp|Q8CIQ7|DOCK3_MOUSE Dedicator of cytokinesis protein 3 OS=Mus musculus OX=10090 GN=Dock3 PE=1 SV=1,GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0017124,small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_05342,1.8064944767692075,FUN_024071-T1,Peve_00014630,Pocillopora_meandrina_HIv1___RNAseq.23622_t,three_way,47.72133333333333,,,,,,,,,,,,,,,,,
OG_05348,3.736564233162345,FUN_024111-T1,Peve_00000186,Pocillopora_meandrina_HIv1___RNAseq.g19189.t1,three_way,75.39166666666667,FUN_024111-T1,O00408,PDE2A_HUMAN,,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",Homo sapiens (Human),45.4,868.0,9.700000000000001e-196,685.3,"sp|O00408|PDE2A_HUMAN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Homo sapiens OX=9606 GN=PDE2A PE=1 SV=1",GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:0106072; GO:1904613,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; ventricular septum development [GO:0003281]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]",GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:1901135,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05350,2.389961126441198,FUN_024113-T1,Peve_00000184,Pocillopora_meandrina_HIv1___RNAseq.g19187.t1,three_way,78.90166666666667,FUN_024113-T1,Q9UI95,MD2L2_HUMAN,,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7),Homo sapiens (Human),55.6,160.0,4.5e-44,179.1,sp|Q9UI95|MD2L2_HUMAN Mitotic spindle assembly checkpoint protein MAD2B OS=Homo sapiens OX=9606 GN=MAD2L2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0001558; GO:0002208; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0006302; GO:0007015; GO:0007094; GO:0008432; GO:0010719; GO:0010944; GO:0016035; GO:0033138; GO:0035861; GO:0042177; GO:0042276; GO:0042772; GO:0043247; GO:0045830; GO:0045893; GO:0051301; GO:0061629; GO:0090090; GO:1904667; GO:2000042; GO:2000048; GO:2001034,"actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]",chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035],JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006355; GO:0032200; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; nucleoplasm; chromosome; DNA repair; regulation of DNA-templated transcription; telomere organization; organelle; molecular adaptor activity; transcription regulator activity
OG_05354,1.668786713134842,FUN_024126-T1,Peve_00000142,Pocillopora_meandrina_HIv1___RNAseq.g19899.t1,three_way,63.01416666666667,FUN_024126-T1,A6QQL0,S15A4_BOVIN,,Solute carrier family 15 member 4 (Peptide/histidine transporter 1),Bos taurus (Bovine),30.3,545.0,1.1999999999999999e-54,216.1,sp|A6QQL0|S15A4_BOVIN Solute carrier family 15 member 4 OS=Bos taurus OX=9913 GN=SLC15A4 PE=2 SV=2,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_05355,1.0213216920307202,FUN_024127-T1,Peve_00000138,Pocillopora_meandrina_HIv1___RNAseq.g19898.t1,three_way,68.97566666666667,FUN_024127-T1,Q8N5I4,DHRSX_HUMAN,,Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase),Homo sapiens (Human),44.9,321.0,1.2000000000000001e-74,281.6,sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2,GO:0005576; GO:0005811; GO:0010508; GO:0019408; GO:0160196; GO:0160197,dolichol biosynthetic process [GO:0019408]; positive regulation of autophagy [GO:0010508],extracellular region [GO:0005576]; lipid droplet [GO:0005811],dolichal reductase [NAD(P)+] activity [GO:0160197]; polyprenol dehydrogenase activity [GO:0160196],GO:0003824; GO:0005576; GO:0005811; GO:0016491; GO:0043226,catalytic activity; extracellular region; lipid droplet; oxidoreductase activity; organelle
OG_05356,1.4377582419464867,FUN_024129-T1,Peve_00005110,Pocillopora_meandrina_HIv1___RNAseq.g19897.t1,three_way,72.21683333333333,FUN_024129-T1,F1MDL2,,,,,35.2,899.0,1.6e-142,508.4,sp|F1MDL2|INTU_BOVIN Protein inturned OS=Bos taurus OX=9913 GN=INTU PE=3 SV=2,,,,,,
OG_05361,1.7510450613692856,FUN_024136-T1,Peve_00020658,Pocillopora_meandrina_HIv1___RNAseq.g19872.t1,three_way,70.992,FUN_024136-T1,A7SNN5,PLK4_NEMVE,,Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4),Nematostella vectensis (Starlet sea anemone),55.1,1013.0,1.3999999999999998e-280,967.2,sp|A7SNN5|PLK4_NEMVE Serine/threonine-protein kinase PLK4 OS=Nematostella vectensis OX=45351 GN=v1g246408 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0106310,,centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05376,1.5936921620263766,FUN_024192-T1,Peve_00018693,Pocillopora_meandrina_HIv1___RNAseq.g18883.t1,three_way,75.952,FUN_024192-T1,Q921D9,GRHL1_MOUSE,,Grainyhead-like protein 1 homolog (Transcription factor CP2-like 2) (Transcription factor LBP-32),Mus musculus (Mouse),33.3,93.0,6.4e-10,65.5,sp|Q921D9|GRHL1_MOUSE Grainyhead-like protein 1 homolog OS=Mus musculus OX=10090 GN=Grhl1 PE=1 SV=1,GO:0000976; GO:0000978; GO:0001228; GO:0002934; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0008544; GO:0031490; GO:0042803; GO:0043565; GO:0045616; GO:0045944; GO:0061436; GO:0140297,desmosome organization [GO:0002934]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of keratinocyte differentiation [GO:0045616],nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_05378,1.287600498826737,FUN_024195-T1,Peve_00018698,Pocillopora_meandrina_HIv1___RNAseq.g18880.t1,three_way,77.08933333333333,FUN_024195-T1,Q96NL6,SCLT1_HUMAN,,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),Homo sapiens (Human),27.6,613.0,2.3999999999999998e-54,215.3,sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539,cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080],GO:0005815; GO:0005829; GO:0005856; GO:0043226; GO:0044782; GO:0061024; GO:0098772,microtubule organizing center; cytosol; cytoskeleton; organelle; cilium organization; membrane organization; molecular function regulator activity
OG_05382,2.078296809758102,FUN_024199-T1,Peve_00031882,Pocillopora_meandrina_HIv1___RNAseq.g18898.t1,three_way,95.62316666666666,FUN_024199-T1,A5WWB0,,,,,75.2,375.0,3.8e-162,572.4,sp|A5WWB0|UBP46_DANRE Ubiquitin carboxyl-terminal hydrolase 46 OS=Danio rerio OX=7955 GN=usp46 PE=3 SV=2,,,,,,
OG_05390,1.2444214855705615,FUN_024216-T1,Peve_00031907,Pocillopora_meandrina_HIv1___RNAseq.g18909.t1,three_way,78.90966666666667,FUN_024216-T1,Q5F452,MTMR8_CHICK,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 (EC 3.1.3.95) (Myotubularin-related protein 8) (Phosphatidylinositol-3-phosphate phosphatase)",Gallus gallus (Chicken),55.8,543.0,1.6e-188,661.0,"sp|Q5F452|MTMR8_CHICK Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 OS=Gallus gallus OX=9031 GN=MTMR8 PE=2 SV=1",GO:0004438; GO:0005635; GO:0005737; GO:0046856; GO:0052629; GO:0106018,phosphatidylinositol dephosphorylation [GO:0046856],cytoplasm [GO:0005737]; nuclear envelope [GO:0005635],"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]",GO:0003824; GO:0005635; GO:0006629; GO:0016787,catalytic activity; nuclear envelope; lipid metabolic process; hydrolase activity
OG_05395,5.559741859242816,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05396,1.0025061047857462,FUN_024223-T1,Peve_00031888,Pocillopora_meandrina_HIv1___RNAseq.g18916.t1,three_way,89.404,FUN_024223-T1,P49596,,,,,62.5,309.0,1.6e-113,410.6,sp|P49596|PP2C2_CAEEL Probable protein phosphatase 2C T23F11.1 OS=Caenorhabditis elegans OX=6239 GN=ppm-2 PE=3 SV=2,,,,,,
OG_05399,1.2659860096206836,FUN_024328-T1,Peve_00016318,Pocillopora_meandrina_HIv1___RNAseq.g18924.t1,three_way,71.84100000000001,FUN_024328-T1,Q21565,,,,,49.4,419.0,7.6e-111,402.5,sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2,,,,,,
OG_05400,3.887460833916514,FUN_024330-T1,Peve_00016319,Pocillopora_meandrina_HIv1___RNAseq.g18926.t1,three_way,76.277,FUN_024330-T1,O89023,TPP1_MOUSE,,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),Mus musculus (Mouse),50.2,562.0,2.3e-155,550.4,sp|O89023|TPP1_MOUSE Tripeptidyl-peptidase 1 OS=Mus musculus OX=10090 GN=Tpp1 PE=1 SV=2,GO:0004175; GO:0004252; GO:0005739; GO:0005764; GO:0005794; GO:0006508; GO:0007040; GO:0007399; GO:0008233; GO:0008236; GO:0008240; GO:0030855; GO:0035727; GO:0042470; GO:0043171; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070198; GO:0120146; GO:1905146,"bone resorption [GO:0045453]; epithelial cell differentiation [GO:0030855]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]",Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; recycling endosome [GO:0055037],endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007040; GO:0008289; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; mitochondrion; lysosome; endosome; vacuole; Golgi apparatus; lysosome organization; lipid binding; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05403,2.36200514850698,FUN_024334-T1,Peve_00016307,Pocillopora_meandrina_HIv1___RNAseq.g18941.t1,three_way,70.359,FUN_024334-T1,Q99MK9,,,,,38.3,313.0,2e-57,224.9,sp|Q99MK9|RASF1_MOUSE Ras association domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rassf1 PE=1 SV=1,,,,,,
OG_05404,1.9902386476534053,FUN_024335-T1,Peve_00016306,Pocillopora_meandrina_HIv1___TS.g28328.t1c,three_way,80.27,FUN_024335-T1,O75896,TUSC2_HUMAN,,Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2),Homo sapiens (Human),55.6,72.0,2.7e-17,89.4,sp|O75896|TUSC2_HUMAN Tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=TUSC2 PE=1 SV=3,GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0070945; GO:2000377,cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377],mitochondrion [GO:0005739],,GO:0002376; GO:0005739; GO:0006954; GO:0016192; GO:0030154; GO:0043226; GO:0098542,immune system process; mitochondrion; inflammatory response; vesicle-mediated transport; cell differentiation; organelle; defense response to other organism
OG_05407,1.5155496489558848,FUN_024339-T1,Peve_00016804,Pocillopora_meandrina_HIv1___RNAseq.g18936.t1,three_way,66.383,FUN_024339-T1,Q96H96,COQ2_HUMAN,,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",Homo sapiens (Human),66.2,305.0,3.4e-116,419.9,"sp|Q96H96|COQ2_HUMAN 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ2 PE=1 SV=2",GO:0004659; GO:0005739; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0031314,glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; transferase activity; organelle
OG_05415,1.1363780379336126,FUN_024353-T1,Peve_00024188,Pocillopora_meandrina_HIv1___RNAseq.g18689.t1,three_way,83.83233333333334,FUN_024353-T1,A6NFE3,,,,,36.8,117.0,2.2e-15,83.2,sp|A6NFE3|EFC10_HUMAN EF-hand calcium-binding domain-containing protein 10 OS=Homo sapiens OX=9606 GN=EFCAB10 PE=1 SV=2,,,,,,
OG_05422,1.0247004020606765,FUN_024367-T1,Peve_00003572,Pocillopora_meandrina_HIv1___RNAseq.g18652.t1,three_way,79.83883333333333,FUN_024367-T1,Q8BM85,,,,,51.3,905.0,2.2e-245,850.1,sp|Q8BM85|TBCK_MOUSE TBC domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Tbck PE=1 SV=2,,,,,,
OG_05426,1.5123521261741018,FUN_024371-T1,Peve_00003576,Pocillopora_meandrina_HIv1___RNAseq.g19086.t1,three_way,85.09433333333334,FUN_024371-T1,Q80UU9,PGRC2_MOUSE,,Membrane-associated progesterone receptor component 2,Mus musculus (Mouse),61.1,131.0,5.5e-37,155.6,sp|Q80UU9|PGRC2_MOUSE Membrane-associated progesterone receptor component 2 OS=Mus musculus OX=10090 GN=Pgrmc2 PE=1 SV=2,GO:0005496; GO:0005576; GO:0005635; GO:0005783; GO:0015232; GO:0015886; GO:0016020; GO:0020037; GO:0045202; GO:0060612; GO:0098978,adipose tissue development [GO:0060612]; heme transport [GO:0015886],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; synapse [GO:0045202],heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496],GO:0005215; GO:0005576; GO:0005635; GO:0005783; GO:0008289; GO:0043226; GO:0048856,transporter activity; extracellular region; nuclear envelope; endoplasmic reticulum; lipid binding; organelle; anatomical structure development
OG_05436,2.8073122630051786,FUN_024389-T1,Peve_00018044,Pocillopora_meandrina_HIv1___RNAseq.g18620.t1,three_way,74.58266666666667,FUN_024389-T1,O70433,,,,,39.0,269.0,1.3e-68,262.3,sp|O70433|FHL2_MOUSE Four and a half LIM domains protein 2 OS=Mus musculus OX=10090 GN=Fhl2 PE=1 SV=1,,,,,,
OG_05437,2.8551162902202267,FUN_024390-T2,Peve_00018042,Pocillopora_meandrina_HIv1___RNAseq.g18621.t1,three_way,74.62266666666667,FUN_024390-T2,Q80VL3,,,,,50.8,413.0,3e-126,454.1,sp|Q80VL3|PRIC3_MOUSE Prickle planar cell polarity protein 3 OS=Mus musculus OX=10090 GN=Prickle3 PE=1 SV=1,,,,,,
OG_05443,2.882713487151818,FUN_024398-T2,Peve_00021812,Pocillopora_meandrina_HIv1___RNAseq.g18631.t1,three_way,82.838,FUN_024398-T2,Q66GS9,CP135_HUMAN,,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),Homo sapiens (Human),37.8,566.0,6.9e-91,337.4,sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],GO:0005815; GO:0005829; GO:0008092; GO:0043226,microtubule organizing center; cytosol; cytoskeletal protein binding; organelle
OG_05444,1.540708038797167,FUN_024399-T1,Peve_00021813,Pocillopora_meandrina_HIv1___RNAseq.g18632.t1,three_way,82.354,FUN_024399-T1,Q9QZN3,,,,,52.8,267.0,1.5e-81,304.3,sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2,,,,,,
OG_05446,2.9737561957387624,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05455,1.164928927078559,FUN_024413-T1,Peve_00029254,Pocillopora_meandrina_HIv1___TS.g28094.t1,three_way,72.38216666666666,FUN_024413-T1,Q08874,MITF_MOUSE,,Microphthalmia-associated transcription factor,Mus musculus (Mouse),41.5,366.0,1.1e-46,189.1,sp|Q08874|MITF_MOUSE Microphthalmia-associated transcription factor OS=Mus musculus OX=10090 GN=Mitf PE=1 SV=4,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0006357; GO:0010468; GO:0010628; GO:0016055; GO:0030154; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0043473; GO:0043565; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:1902362; GO:2000144,bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_05462,1.944668527169736,FUN_024445-T1,Peve_00025478,Pocillopora_meandrina_HIv1___RNAseq.g18708.t1,three_way,87.55799999999999,FUN_024445-T1,Q14643,,,,,59.9,2841.0,0.0,3137.1,"sp|Q14643|ITPR1_HUMAN Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",,,,,,
OG_05473,2.872720899676292,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2000000000000002e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_05475,1.490565375051608,FUN_024460-T1,Peve_00032923,Pocillopora_meandrina_HIv1___RNAseq.g14859.t1,three_way,88.63699999999999,FUN_024460-T1,Q2M389,WASC4_HUMAN,,WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP),Homo sapiens (Human),64.5,920.0,0.0,1206.8,sp|Q2M389|WASC4_HUMAN WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=2,GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0050890; GO:0050905; GO:0061635; GO:0071203; GO:0140591; GO:0140894,cognition [GO:0050890]; endolysosomal toll-like receptor signaling pathway [GO:0140894]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; neuromuscular process [GO:0050905]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein complex stability [GO:0061635],early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203],,GO:0002376; GO:0005654; GO:0005768; GO:0006913; GO:0016192; GO:0031410; GO:0043226; GO:0050877,immune system process; nucleoplasm; endosome; nucleocytoplasmic transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process
OG_05476,1.6480760633132887,FUN_024466-T1,Peve_00026420,Pocillopora_meandrina_HIv1___RNAseq.g18562.t1,three_way,72.03833333333334,FUN_024466-T1,J7GQ11,,,,,35.2,495.0,1e-70,270.0,sp|J7GQ11|TYRDC_LEVBR L-tyrosine decarboxylase OS=Levilactobacillus brevis OX=1580 GN=tdc PE=1 SV=1,,,,,,
OG_05479,1.5465470434757438,FUN_024473-T1,Peve_00002830,Pocillopora_meandrina_HIv1___RNAseq.g18567.t1,three_way,52.34666666666666,FUN_024473-T1,P97460,NPAS2_MOUSE,,Neuronal PAS domain-containing protein 2 (Neuronal PAS2),Mus musculus (Mouse),34.6,413.0,1.1999999999999999e-46,190.7,sp|P97460|NPAS2_MOUSE Neuronal PAS domain-containing protein 2 OS=Mus musculus OX=10090 GN=Npas2 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006974; GO:0007623; GO:0009410; GO:0032922; GO:0042745; GO:0042752; GO:0045475; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:2000987,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; DNA damage response [GO:0006974]; locomotor rhythm [GO:0045475]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05498,2.977320417687675,FUN_024557-T1,Peve_00039513,Pocillopora_meandrina_HIv1___RNAseq.g18656.t1,three_way,51.671,,,,,,,,,,,,,,,,,
OG_05505,1.7448151923467283,FUN_024577-T1,Peve_00007643,Pocillopora_meandrina_HIv1___TS.g28491.t1,three_way,74.36816666666667,FUN_024577-T1,Q2LD37,BLTP1_HUMAN,,Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein),Homo sapiens (Human),29.4,5271.0,0.0,1751.9,sp|Q2LD37|BLTP1_HUMAN Bridge-like lipid transfer protein family member 1 OS=Homo sapiens OX=9606 GN=BLTP1 PE=1 SV=2,GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006909; GO:0016020; GO:0016197; GO:0030856; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],phosphatidylethanolamine transfer activity [GO:1904121],GO:0005215; GO:0005634; GO:0005886; GO:0016192; GO:0043226; GO:0061024,transporter activity; nucleus; plasma membrane; vesicle-mediated transport; organelle; membrane organization
OG_05509,1.307661241518972,FUN_024592-T1,Peve_00037916,Pocillopora_meandrina_HIv1___RNAseq.g19122.t1,three_way,65.791,FUN_024592-T1,Q2KIK0,,,,,38.3,397.0,1.2e-68,261.9,sp|Q2KIK0|SGT1_BOVIN Protein SGT1 homolog OS=Bos taurus OX=9913 GN=SUGT1 PE=2 SV=1,,,,,,
OG_05514,2.066964924846917,FUN_024614-T1,Peve_00041134,Pocillopora_meandrina_HIv1___RNAseq.g19147.t1,three_way,72.74433333333333,FUN_024614-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),96.7,1114.0,0.0,2249.2,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_05518,2.336894041826104,FUN_024618-T1,Peve_00027329,Pocillopora_meandrina_HIv1___RNAseq.g19153.t1,three_way,82.87033333333333,FUN_024618-T1,Q9VJ79,PDE11_DROME,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11) (PDE11)",Drosophila melanogaster (Fruit fly),51.3,915.0,3.4e-254,879.4,"sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4",GO:0004115; GO:0005829; GO:0019933; GO:0046058; GO:0046068; GO:0046872; GO:0047555,cAMP metabolic process [GO:0046058]; cAMP-mediated signaling [GO:0019933]; cGMP metabolic process [GO:0046068],cytosol [GO:0005829],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05522,2.541733886443597,FUN_024625-T1,Peve_00012720,Pocillopora_meandrina_HIv1___TS.g28341.t1,three_way,37.063,,,,,,,,,,,,,,,,,
OG_05524,2.008138680482303,FUN_024632-T1,Peve_00012707,Pocillopora_meandrina_HIv1___RNAseq.g18962.t1,three_way,81.95866666666667,FUN_024632-T1,P07742,,,,,75.2,793.0,0.0,1231.5,sp|P07742|RIR1_MOUSE Ribonucleoside-diphosphate reductase large subunit OS=Mus musculus OX=10090 GN=Rrm1 PE=1 SV=2,,,,,,
OG_05533,2.045794226857414,FUN_024719-T1,Peve_00012704,Pocillopora_meandrina_HIv1___RNAseq.g18947.t1,three_way,64.05266666666667,FUN_024719-T1,A7MBB3,,,,,31.4,175.0,8.8e-10,65.9,sp|A7MBB3|T150B_BOVIN Modulator of macroautophagy TMEM150B OS=Bos taurus OX=9913 GN=TMEM150B PE=2 SV=1,,,,,,
OG_05535,1.3973778943780022,FUN_024724-T1,Peve_00012714,Pocillopora_meandrina_HIv1___RNAseq.g18835.t1,three_way,82.242,FUN_024724-T1,Q9EPW0,INP4A_MOUSE,,"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Inositol polyphosphate 4-phosphatase-1) (4-Ptase-1) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)",Mus musculus (Mouse),37.1,911.0,3.5e-154,547.4,sp|Q9EPW0|INP4A_MOUSE Inositol polyphosphate-4-phosphatase type I A OS=Mus musculus OX=10090 GN=Inpp4a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0006798; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0052828; GO:0055038; GO:0098978; GO:0099072,polyphosphate catabolic process [GO:0006798]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038],"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]",GO:0003824; GO:0005634; GO:0005886; GO:0016787; GO:0043226,catalytic activity; nucleus; plasma membrane; hydrolase activity; organelle
OG_05537,1.901991609195649,FUN_024726-T1,Peve_00029154,Pocillopora_meandrina_HIv1___RNAseq.g18837.t1,three_way,72.15833333333333,FUN_024726-T1,A0A1J6KGJ9,,,,,30.6,563.0,1e-55,219.5,sp|A0A1J6KGJ9|JAR4_NICAT Jasmonoyl--L-amino acid synthetase JAR4 OS=Nicotiana attenuata OX=49451 GN=JAR4 PE=1 SV=1,,,,,,
OG_05540,1.926399773633504,FUN_024742-T1,Peve_00005934,Pocillopora_meandrina_HIv1___TS.g28230.t1,three_way,61.432,FUN_024742-T1,Q865W2,,,,,26.7,217.0,2e-10,69.3,sp|Q865W2|TRI50_PIG E3 ubiquitin-protein ligase TRIM50 OS=Sus scrofa OX=9823 GN=TRIM50 PE=2 SV=1,,,,,,
OG_05546,1.1073133619916598,FUN_024753-T1,Peve_00041145,Pocillopora_meandrina_HIv1___RNAseq.g18834.t1,three_way,70.904,,,,,,,,,,,,,,,,,
OG_05547,3.270760974393612,FUN_024754-T1,Peve_00041144,Pocillopora_meandrina_HIv1___RNAseq.g18833.t1,three_way,62.28083333333333,FUN_024754-T1,Q9NXR5,,,,,41.9,93.0,3.5e-12,73.9,sp|Q9NXR5|ANR10_HUMAN Ankyrin repeat domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ANKRD10 PE=1 SV=2,,,,,,
OG_05548,3.1615097158915844,FUN_024755-T1,Peve_00041143,Pocillopora_meandrina_HIv1___RNAseq.2312_t,three_way,71.259,FUN_024755-T1,P22304,IDS_HUMAN,,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],Homo sapiens (Human),52.4,510.0,3.2e-146,520.0,sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1,GO:0004423; GO:0005509; GO:0005737; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202,dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200],cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05551,2.768596415050043,FUN_024758-T1,Peve_00027326,Pocillopora_meandrina_HIv1___RNAseq.g18826.t1,three_way,87.74933333333333,,,,,,,,,,,,,,,,,
OG_05554,1.9261354928190324,FUN_024762-T1,Peve_00020489,Pocillopora_meandrina_HIv1___RNAseq.g18822.t1,three_way,75.65866666666666,FUN_024762-T1,Q5U3V7,,,,,46.3,341.0,4.3e-72,273.1,sp|Q5U3V7|S2543_DANRE Solute carrier family 25 member 43 OS=Danio rerio OX=7955 GN=slc25a43 PE=2 SV=1,,,,,,
OG_05557,3.366312439744709,FUN_024775-T1,Peve_00033053,Pocillopora_meandrina_HIv1___RNAseq.g18815.t1,three_way,70.15433333333333,FUN_024775-T1,Q92629,,,,,40.8,265.0,5.6999999999999996e-49,196.1,sp|Q92629|SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCD PE=1 SV=2,,,,,,
OG_05558,1.1257116688700453,FUN_024776-T1,Peve_00036224,Pocillopora_meandrina_HIv1___RNAseq.g18814.t1,three_way,89.42866666666667,FUN_024776-T1,Q8BTV1,TUSC3_MOUSE,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33) (Tumor suppressor candidate 3),Mus musculus (Mouse),65.9,299.0,8.100000000000001e-124,444.9,sp|Q8BTV1|TUSC3_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 OS=Mus musculus OX=10090 GN=Tusc3 PE=1 SV=1,GO:0005739; GO:0008250; GO:0015693; GO:0018279; GO:0050890; GO:0062062,cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279],mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250],oligosaccharyltransferase complex binding [GO:0062062],GO:0005739; GO:0009101; GO:0043226; GO:0050877; GO:1901135,mitochondrion; glycoprotein biosynthetic process; organelle; nervous system process; carbohydrate derivative metabolic process
OG_05562,1.853652224697616,FUN_024781-T1,Peve_00015076,Pocillopora_meandrina_HIv1___TS.g28189.t2,three_way,75.94966666666666,FUN_024781-T1,Q5F3U9,,,,,42.0,1148.0,3.5999999999999997e-242,840.1,sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3,,,,,,
OG_05563,1.2279573670639126,FUN_024783-T1,Peve_00007043,Pocillopora_meandrina_HIv1___TS.g28188.t1,three_way,49.95166666666667,FUN_024783-T1,Q3U481,MFS12_MOUSE,,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),Mus musculus (Mouse),32.5,206.0,9e-19,96.7,sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1,GO:0005764; GO:0005765; GO:0005770; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; cytoplasmic vesicle; organelle; transmembrane transport
OG_05576,1.2306389617348867,FUN_024871-T1,Peve_00016134,Pocillopora_meandrina_HIv1___RNAseq.g18750.t1,three_way,55.18966666666667,FUN_024871-T1,P39022,,,,,68.3,161.0,3.8e-60,233.8,sp|P39022|RAD52_CHICK DNA repair protein RAD52 homolog OS=Gallus gallus OX=9031 GN=RAD52 PE=2 SV=1,,,,,,
OG_05582,2.5051684985748,FUN_024906-T1,Peve_00038387,Pocillopora_meandrina_HIv1___RNAseq.g19419.t1,three_way,66.53216666666667,FUN_024906-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),24.3,382.0,1.2000000000000001e-30,135.6,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05587,1.3261685792057458,FUN_024944-T1,Peve_00038384,Pocillopora_meandrina_HIv1___RNAseq.g19542.t1,three_way,72.11733333333333,FUN_024944-T1,A1L1R5,,,,,38.1,636.0,9.2e-106,386.0,sp|A1L1R5|PTPC1_DANRE Protein tyrosine phosphatase domain-containing protein 1 OS=Danio rerio OX=7955 GN=ptpdc1 PE=2 SV=1,,,,,,
OG_05588,1.4630896175771586,FUN_025031-T1,Peve_00004654,Pocillopora_meandrina_HIv1___TS.g28790.t2,three_way,69.56233333333333,FUN_025031-T1,Q6R1L1,,,,,55.9,195.0,5.1999999999999996e-46,186.4,sp|Q6R1L1|TAF7_CRIGR Transcription initiation factor TFIID subunit 7 OS=Cricetulus griseus OX=10029 GN=TAF7 PE=1 SV=1,,,,,,
OG_05589,1.692843594707163,FUN_025035-T1,Peve_00038379,Pocillopora_meandrina_HIv1___RNAseq.g19423.t1,three_way,84.7295,FUN_025035-T1,Q6DCE3,ZNT9_XENLA,,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",Xenopus laevis (African clawed frog),48.4,517.0,2.8e-121,437.2,"sp|Q6DCE3|ZNT9_XENLA Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Xenopus laevis OX=8355 GN=slc30a9 PE=2 SV=1",GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966,intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005783; GO:0031410; GO:0043226,transporter activity; nucleus; endoplasmic reticulum; cytoplasmic vesicle; organelle
OG_05595,2.704709971296012,FUN_025109-T1,Peve_00038375,Pocillopora_meandrina_HIv1___RNAseq.g19429.t1,three_way,81.03466666666667,FUN_025109-T1,P23935,,,,,54.4,114.0,4.2e-27,122.1,sp|P23935|NDUA5_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Bos taurus OX=9913 GN=NDUFA5 PE=1 SV=3,,,,,,
OG_05608,1.8981366246435205,FUN_025291-T1,Peve_00040962,Pocillopora_meandrina_HIv1___RNAseq.g13475.t1,three_way,54.800666666666665,,,,,,,,,,,,,,,,,
OG_05609,1.976781410742504,FUN_025294-T1,Peve_00040955,Pocillopora_meandrina_HIv1___RNAseq.g13469.t1,three_way,53.38583333333333,,,,,,,,,,,,,,,,,
OG_05612,1.3959232025844666,FUN_025297-T1,Peve_00040951,Pocillopora_meandrina_HIv1___TS.g2463.t1,three_way,68.94166666666666,,,,,,,,,,,,,,,,,
OG_05619,2.502845226110435,FUN_025309-T1,Peve_00027055,Pocillopora_meandrina_HIv1___RNAseq.g13452.t2,three_way,92.745,FUN_025309-T1,Q9XT54,,,,,80.8,146.0,2e-66,253.1,"sp|Q9XT54|PDE6D_CANLF Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta OS=Canis lupus familiaris OX=9615 GN=PDE6D PE=2 SV=1",,,,,,
OG_05620,1.545249458448024,FUN_025310-T1,Peve_00027063,Pocillopora_meandrina_HIv1___RNAseq.g13451.t1,three_way,53.777,,,,,,,,,,,,,,,,,
OG_05624,1.181690849076798,FUN_025318-T1,Peve_00027086,Pocillopora_meandrina_HIv1___RNAseq.14712_t,three_way,59.059000000000005,,,,,,,,,,,,,,,,,
OG_05631,2.384026965520362,FUN_025328-T1,Peve_00027062,Pocillopora_meandrina_HIv1___RNAseq.g13406.t1,three_way,70.02683333333333,FUN_025328-T1,Q9H3D4,,,,,34.9,272.0,1.1999999999999999e-35,152.5,sp|Q9H3D4|P63_HUMAN Tumor protein 63 OS=Homo sapiens OX=9606 GN=TP63 PE=1 SV=1,,,,,,
OG_05638,2.054599802230463,FUN_025342-T1,Peve_00027052,Pocillopora_meandrina_HIv1___RNAseq.g13380.t1,three_way,69.806,FUN_025342-T1,Q7RYI0,,,,,42.1,57.0,4.4e-06,52.4,sp|Q7RYI0|MIC10_NEUCR MICOS complex subunit mic10 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mic10 PE=3 SV=1,,,,,,
OG_05640,2.9839893545995926,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_05643,1.384210575096135,FUN_025361-T1,Peve_00040526,Pocillopora_meandrina_HIv1___RNAseq.14643_t,three_way,74.309,FUN_025361-T1,P10160,,,,,69.3,153.0,2.4e-57,223.0,sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2,,,,,,
OG_05644,1.122987892996977,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_05648,2.3947977922474046,FUN_025368-T1,Peve_00040520,Pocillopora_meandrina_HIv1___RNAseq.g13331.t1,three_way,95.874,FUN_025368-T1,Q6PH57,,,,,91.4,339.0,2.9e-140,499.6,sp|Q6PH57|GBB1_DANRE Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1,,,,,,
OG_05650,1.6750809282953294,FUN_025373-T1,Peve_00040523,Pocillopora_meandrina_HIv1___RNAseq.g13328.t1,three_way,60.128166666666665,FUN_025373-T1,A1L0Y2,,,,,39.5,1520.0,7.3e-307,1055.0,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_05652,1.8252213640891948,FUN_025393-T1,Peve_00031004,Pocillopora_meandrina_HIv1___RNAseq.g13303.t1,three_way,60.83166666666666,FUN_025393-T1,Q9NH13,,,,,29.0,352.0,1.2e-32,142.9,sp|Q9NH13|RP43_RIFPA Exoskeleton protein RP43 OS=Riftia pachyptila OX=6426 PE=1 SV=1,,,,,,
OG_05655,1.302285705338471,FUN_025410-T1,Peve_00017348,Pocillopora_meandrina_HIv1___RNAseq.14602_t,three_way,53.36533333333333,,,,,,,,,,,,,,,,,
OG_05658,1.3102502798493998,FUN_025425-T1,Peve_00030588,Pocillopora_meandrina_HIv1___RNAseq.g13315.t1,three_way,80.68633333333334,,,,,,,,,,,,,,,,,
OG_05661,1.3571259224647754,FUN_025430-T2,Peve_00030583,Pocillopora_meandrina_HIv1___RNAseq.g13324.t1,three_way,80.823,FUN_025430-T2,Q3ZBV2,DD19A_BOVIN,,ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A),Bos taurus (Bovine),64.6,418.0,8.7e-162,571.6,sp|Q3ZBV2|DD19A_BOVIN ATP-dependent RNA helicase DDX19A OS=Bos taurus OX=9913 GN=DDX19A PE=2 SV=1,GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016887; GO:0016973,poly(A)+ mRNA export from nucleus [GO:0016973],cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006913; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleocytoplasmic transport; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05666,2.063717854342604,FUN_025441-T1,Peve_00029478,Pocillopora_meandrina_HIv1___RNAseq.g13294.t1,three_way,72.48916666666666,FUN_025441-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),45.7,361.0,2.8e-94,349.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_05669,3.274177709015833,FUN_025459-T1,Peve_00005466,Pocillopora_meandrina_HIv1___RNAseq.g13245.t1,three_way,94.06666666666666,FUN_025459-T1,Q2KJ93,CDC42_BOVIN,,Cell division control protein 42 homolog (EC 3.6.5.2),Bos taurus (Bovine),90.6,191.0,9e-99,360.9,sp|Q2KJ93|CDC42_BOVIN Cell division control protein 42 homolog OS=Bos taurus OX=9913 GN=CDC42 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0006911; GO:0007015; GO:0007165; GO:0007264; GO:0016020; GO:0019901; GO:0030010; GO:0030425; GO:0030496; GO:0031258; GO:0032467; GO:0034329; GO:0045198; GO:0048549; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:1900026,"actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of pinocytosis [GO:0048549]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0007163; GO:0016192; GO:0016787; GO:0030154; GO:0034330; GO:0043226; GO:0061024; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; hydrolase activity; cell differentiation; cell junction organization; organelle; membrane organization; molecular function regulator activity
OG_05675,1.0050065043391023,FUN_025505-T1,Peve_00040925,Pocillopora_meandrina_HIv1___RNAseq.g13216.t1,three_way,38.21266666666666,,,,,,,,,,,,,,,,,
OG_05678,2.0145582537048043,FUN_025511-T1,Peve_00002249,Pocillopora_meandrina_HIv1___RNAseq.g13212.t1,three_way,56.655,FUN_025511-T1,Q8TCQ1,MARH1_HUMAN,,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),Homo sapiens (Human),28.2,206.0,7.7e-14,79.7,sp|Q8TCQ1|MARH1_HUMAN E3 ubiquitin-protein ligase MARCHF1 OS=Homo sapiens OX=9606 GN=MARCHF1 PE=1 SV=1,GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630,antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05679,2.277217839279882,FUN_025516-T1,Peve_00002247,Pocillopora_meandrina_HIv1___RNAseq.g13210.t1,three_way,89.46916666666667,,,,,,,,,,,,,,,,,
OG_05681,1.7292333954352312,FUN_025518-T1,Peve_00031512,Pocillopora_meandrina_HIv1___RNAseq.g13207.t1,three_way,87.27499999999999,FUN_025518-T1,O95140,,,,,51.6,744.0,3.3999999999999997e-205,716.5,sp|O95140|MFN2_HUMAN Mitofusin-2 OS=Homo sapiens OX=9606 GN=MFN2 PE=1 SV=3,,,,,,
OG_05683,2.528271659452926,FUN_025520-T1,Peve_00024301,Pocillopora_meandrina_HIv1___RNAseq.g13205.t1,three_way,68.23033333333333,,,,,,,,,,,,,,,,,
OG_05684,1.5734521811356106,FUN_025527-T1,Peve_00009002,Pocillopora_meandrina_HIv1___RNAseq.g23047.t1,three_way,85.454,FUN_025527-T1,Q9D2N4,DTNA_MOUSE,,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin),Mus musculus (Mouse),46.0,554.0,2.5e-117,424.1,sp|Q9D2N4|DTNA_MOUSE Dystrobrevin alpha OS=Mus musculus OX=10090 GN=Dtna PE=1 SV=2,GO:0005737; GO:0008270; GO:0016014; GO:0032991; GO:0042383; GO:0045202,,cytoplasm [GO:0005737]; dystrobrevin complex [GO:0016014]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005886,plasma membrane
OG_05685,1.9937706075312964,FUN_025530-T1,Peve_00009476,Pocillopora_meandrina_HIv1___TS.g2807.t1,three_way,91.53566666666669,FUN_025530-T1,Q5U395,,,,,73.8,244.0,2.7000000000000002e-104,379.8,sp|Q5U395|CNEPA_DANRE CTD nuclear envelope phosphatase 1A OS=Danio rerio OX=7955 GN=ctdnep1a PE=2 SV=1,,,,,,
OG_05691,2.8236149446488583,FUN_025542-T1,Peve_00032958,Pocillopora_meandrina_HIv1___RNAseq.g13798.t1,three_way,69.249,,,,,,,,,,,,,,,,,
OG_05721,1.4855982971776227,FUN_025629-T1,Peve_00032155,Pocillopora_meandrina_HIv1___TS.g16003.t1,three_way,70.9745,FUN_025629-T1,A2AP18,,,,,46.6,736.0,4.500000000000001e-186,652.9,"sp|A2AP18|PLCH2_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Mus musculus OX=10090 GN=Plch2 PE=1 SV=2",,,,,,
OG_05723,2.14340007816696,FUN_025642-T1,Peve_00039651,Pocillopora_meandrina_HIv1___RNAseq.g23097.t1,three_way,81.889,FUN_025642-T1,Q5I598,MTHR_BOVIN,,Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53),Bos taurus (Bovine),63.3,602.0,5.7e-238,825.1,sp|Q5I598|MTHR_BOVIN Methylenetetrahydrofolate reductase (NADPH) OS=Bos taurus OX=9913 GN=MTHFR PE=2 SV=1,GO:0004489; GO:0009086; GO:0035999; GO:0071949; GO:0106313,methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999],,FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_05728,1.4196291879182552,FUN_025651-T1,Peve_00002530,Pocillopora_meandrina_HIv1___RNAseq.g23086.t1,three_way,78.245,FUN_025651-T1,Q9Z1L0,PK3CB_RAT,,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)",Rattus norvegicus (Rat),46.3,1059.0,4.4e-264,912.5,"sp|Q9Z1L0|PK3CB_RAT Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Rattus norvegicus OX=10116 GN=Pik3cb PE=2 SV=1",GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671,angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]","1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0006914; GO:0007155; GO:0016192; GO:0016740; GO:0043226; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; autophagy; cell adhesion; vesicle-mediated transport; transferase activity; organelle; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_05731,3.710105923438173,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_05732,2.4986442997415708,FUN_025658-T1,Peve_00042175,Pocillopora_meandrina_HIv1___RNAseq.g23074.t1,three_way,65.081,FUN_025658-T1,Q8C033,ARHGA_MOUSE,,Rho guanine nucleotide exchange factor 10,Mus musculus (Mouse),34.0,920.0,1.1e-133,479.9,sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2,GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0035025; GO:0051298; GO:0051496; GO:0090307,centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496],centrosome [GO:0005813],guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894],GO:0005815; GO:0007010; GO:0008092; GO:0098772,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; molecular function regulator activity
OG_05734,2.4295812515250623,FUN_025660-T1,Peve_00042171,Pocillopora_meandrina_HIv1___RNAseq.g23068.t1,three_way,78.61866666666667,FUN_025660-T1,B0DOB4,NPHP4_XENLA,,Nephrocystin-4,Xenopus laevis (African clawed frog),41.9,1048.0,1.8e-222,774.2,sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1,GO:0005737; GO:0035869; GO:0036064; GO:0090090; GO:0097546; GO:0097730; GO:1904491,negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to ciliary transition zone [GO:1904491],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05739,1.250940293629487,FUN_025666-T1,Peve_00042166,Pocillopora_meandrina_HIv1___RNAseq.g23061.t1,three_way,80.65366666666667,FUN_025666-T1,Q5E9Q4,NECP2_BOVIN,,Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2),Bos taurus (Bovine),48.3,269.0,4.7e-66,252.7,sp|Q5E9Q4|NECP2_BOVIN Adaptin ear-binding coat-associated protein 2 OS=Bos taurus OX=9913 GN=NECAP2 PE=2 SV=1,GO:0005886; GO:0006897; GO:0015031; GO:0016192; GO:0030125,endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],clathrin vesicle coat [GO:0030125]; plasma membrane [GO:0005886],,GO:0005886; GO:0016192,plasma membrane; vesicle-mediated transport
OG_05740,1.1523985466383415,FUN_025667-T2,Peve_00042165,Pocillopora_meandrina_HIv1___RNAseq.g23060.t1,three_way,41.132,,,,,,,,,,,,,,,,,
OG_05753,2.6217502398110724,FUN_025686-T1,Peve_00022755,Pocillopora_meandrina_HIv1___RNAseq.g13112.t1,three_way,71.20066666666666,FUN_025686-T1,O76075,,,,,35.7,328.0,1.5999999999999999e-55,218.0,sp|O76075|DFFB_HUMAN DNA fragmentation factor subunit beta OS=Homo sapiens OX=9606 GN=DFFB PE=1 SV=1,,,,,,
OG_05754,1.0090439450156046,FUN_025689-T1,Peve_00005582,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2a,three_way,81.69233333333334,FUN_025689-T1,P58058,,,,,53.0,389.0,1.3999999999999999e-112,407.9,sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2,,,,,,
OG_05757,4.008276280697878,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_05761,2.815033525393365,FUN_025702-T1,Peve_00004694,Pocillopora_meandrina_HIv1___RNAseq.g13827.t1,three_way,44.88766666666667,FUN_025702-T1,Q08D19,,,,,43.6,110.0,8.7e-14,80.1,sp|Q08D19|GOLI4_XENTR Golgi integral membrane protein 4 OS=Xenopus tropicalis OX=8364 GN=golim4 PE=2 SV=2,,,,,,
OG_05765,3.24787086538497,FUN_025723-T1,Peve_00001126,Pocillopora_meandrina_HIv1___RNAseq.g10454.t2,three_way,89.69200000000001,FUN_025723-T1,Q14566,MCM6_HUMAN,,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),Homo sapiens (Human),70.7,808.0,0.0,1134.0,sp|Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 OS=Homo sapiens OX=9606 GN=MCM6 PE=1 SV=1,GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-templated DNA replication initiation [GO:0030174],"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_05766,1.5439229463520454,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_05767,2.192575641421457,FUN_025725-T1,Peve_00001159,Pocillopora_meandrina_HIv1___RNAseq.g10457.t1,three_way,72.23316666666668,FUN_025725-T1,Q9NZI7,UBIP1_HUMAN,,Upstream-binding protein 1 (Transcription factor LBP-1),Homo sapiens (Human),36.7,586.0,8.2e-89,329.3,sp|Q9NZI7|UBIP1_HUMAN Upstream-binding protein 1 OS=Homo sapiens OX=9606 GN=UBP1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05769,2.5536418522381155,FUN_025728-T1,Peve_00024169,Pocillopora_meandrina_HIv1___RNAseq.g10438.t1,three_way,70.458,FUN_025728-T1,Q8WZA2,RPGF4_HUMAN,,Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII),Homo sapiens (Human),49.9,351.0,4.2e-105,382.9,sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1,GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0050796; GO:0098686; GO:0098693,adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle cycle [GO:0098693],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0002376; GO:0005829; GO:0005886; GO:0016192; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; vesicle-mediated transport; molecular adaptor activity; molecular function regulator activity
OG_05772,1.4614305416120126,FUN_025734-T1,Peve_00013274,Pocillopora_meandrina_HIv1___TS.g13847.t1,three_way,69.05016666666667,FUN_025734-T1,Q68DK7,MSL1_HUMAN,,Male-specific lethal 1 homolog (MSL-1) (Male-specific lethal 1-like 1) (MSL1-like 1) (Male-specific lethal-1 homolog 1),Homo sapiens (Human),39.4,127.0,1.1e-14,82.8,sp|Q68DK7|MSL1_HUMAN Male-specific lethal 1 homolog OS=Homo sapiens OX=9606 GN=MSL1 PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0016607; GO:0030674; GO:0045893; GO:0072487,chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893],MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],protein-macromolecule adaptor activity [GO:0030674],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0060090,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_05773,1.172568032827587,FUN_025736-T1,Peve_00013270,Pocillopora_meandrina_HIv1___RNAseq.g10430.t1,three_way,64.86883333333334,,,,,,,,,,,,,,,,,
OG_05775,1.5731430550303338,FUN_025738-T1,Peve_00008539,Pocillopora_meandrina_HIv1___RNAseq.g30315.t1,three_way,59.97833333333333,,,,,,,,,,,,,,,,,
OG_05776,3.351532914472699,FUN_025745-T1,Peve_00008538,Pocillopora_meandrina_HIv1___TS.g13844.t2,three_way,50.434333333333335,FUN_025745-T1,Q86XL3,ANKL2_HUMAN,,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),Homo sapiens (Human),28.6,889.0,7.4e-84,313.5,sp|Q86XL3|ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKLE2 PE=1 SV=4,GO:0004860; GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721,cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; regulation of catalytic activity [GO:0050790],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],protein kinase inhibitor activity [GO:0004860]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],GO:0005783; GO:0043226; GO:0048856; GO:0061024; GO:0098772,endoplasmic reticulum; organelle; anatomical structure development; membrane organization; molecular function regulator activity
OG_05779,3.0073910992831325,FUN_025750-T1,Peve_00007726,Pocillopora_meandrina_HIv1___RNAseq.g10411.t1,three_way,86.325,FUN_025750-T1,O57656,,,,,52.3,392.0,2.1999999999999998e-107,390.6,"sp|O57656|GPDA_TAKRU Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic OS=Takifugu rubripes OX=31033 GN=gpd1 PE=3 SV=1",,,,,,
OG_05780,2.9013367012750435,FUN_025751-T1,Peve_00007731,Pocillopora_meandrina_HIv1___RNAseq.g10407.t1,three_way,81.0305,FUN_025751-T1,A2A935,PRD16_MOUSE,,Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1),Mus musculus (Mouse),24.8,298.0,1.1e-20,103.2,sp|A2A935|PRD16_MOUSE Histone-lysine N-methyltransferase PRDM16 OS=Mus musculus OX=10090 GN=Prdm16 PE=1 SV=1,GO:0000122; GO:0001228; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0008270; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0032259; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162; GO:0140947; GO:0140948,brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05783,2.863828921604884,FUN_025757-T1,Peve_00029936,Pocillopora_meandrina_HIv1___RNAseq.g10418.t1,three_way,73.75783333333334,FUN_025757-T1,Q5R4D6,LEO1_PONAB,,RNA polymerase-associated protein LEO1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.6,256.0,2.5000000000000002e-89,330.9,sp|Q5R4D6|LEO1_PONAB RNA polymerase-associated protein LEO1 OS=Pongo abelii OX=9601 GN=LEO1 PE=2 SV=1,GO:0001711; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0031124; GO:0032968; GO:0045638; GO:1990269,endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593],RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],GO:0006355; GO:0016071,regulation of DNA-templated transcription; mRNA metabolic process
OG_05786,1.0595252203210728,FUN_025762-T1,Peve_00041464,Pocillopora_meandrina_HIv1___RNAseq.g10422.t1,three_way,66.92333333333333,FUN_025762-T1,Q6PFM4,,,,,42.4,361.0,1.3999999999999999e-61,238.4,sp|Q6PFM4|LNPB_DANRE Endoplasmic reticulum junction formation protein lunapark-B OS=Danio rerio OX=7955 GN=lnpkb PE=2 SV=2,,,,,,
OG_05793,1.224142844985063,FUN_025774-T1,Peve_00016582,Pocillopora_meandrina_HIv1___RNAseq.g10364.t1,three_way,67.209,FUN_025774-T1,Q66IB8,,,,,55.5,119.0,2.600000000000001e-33,142.9,sp|Q66IB8|CB076_DANRE UPF0538 protein C2orf76 homolog OS=Danio rerio OX=7955 GN=zgc:101851 PE=2 SV=1,,,,,,
OG_05803,1.1989041817819155,FUN_025793-T1,Peve_00021012,Pocillopora_meandrina_HIv1___RNAseq.g10402.t1,three_way,55.269666666666666,FUN_025793-T1,Q6R3M4,POLI_MOUSE,,DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B),Mus musculus (Mouse),40.9,541.0,1.2e-94,349.0,sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_05805,1.4529887956270302,FUN_025800-T1,Peve_00017926,Pocillopora_meandrina_HIv1___RNAseq.g10386.t2,three_way,84.613,FUN_025800-T1,Q8VDT1,,,,,52.0,666.0,8.599999999999999e-189,661.8,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_05808,2.9806585010749944,FUN_025806-T1,Peve_00017932,Pocillopora_meandrina_HIv1___RNAseq.g10347.t1,three_way,73.36699999999999,FUN_025806-T1,Q95245,,,,,44.4,169.0,4.999999999999999e-32,139.0,sp|Q95245|CY561_PIG Transmembrane ascorbate-dependent reductase CYB561 OS=Sus scrofa OX=9823 GN=CYB561 PE=2 SV=1,,,,,,
OG_05810,1.5082534178894274,FUN_025810-T1,Peve_00002517,Pocillopora_meandrina_HIv1___RNAseq.g9333.t1,three_way,83.25233333333333,FUN_025810-T1,Q9Y6W3,CAN7_HUMAN,,Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH),Homo sapiens (Human),52.7,522.0,7.499999999999999e-143,508.8,sp|Q9Y6W3|CAN7_HUMAN Calpain-7 OS=Homo sapiens OX=9606 GN=CAPN7 PE=1 SV=1,GO:0004175; GO:0004197; GO:0004198; GO:0005634; GO:0005813; GO:0005829; GO:0006508; GO:0010634; GO:0070062; GO:0090541; GO:0097264,positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05815,1.7659288768839414,FUN_025821-T1,Peve_00036285,Pocillopora_meandrina_HIv1___RNAseq.g9341.t1,three_way,70.9975,FUN_025821-T1,Q9TUI4,,,,,51.1,924.0,2.8e-231,803.5,sp|Q9TUI4|KCNH2_PIG Voltage-gated inwardly rectifying potassium channel KCNH2 OS=Sus scrofa OX=9823 GN=KCNH2 PE=2 SV=2,,,,,,
OG_05818,1.0892583489373544,FUN_025825-T2,Peve_00036287,Pocillopora_meandrina_HIv1___RNAseq.g9345.t1,three_way,78.706,FUN_025825-T2,P54513,,,,,32.3,195.0,9.9e-15,83.6,sp|P54513|YQHO_BACSU Uncharacterized protein YqhO OS=Bacillus subtilis (strain 168) OX=224308 GN=yqhO PE=3 SV=1,,,,,,
OG_05821,1.5723771675316338,FUN_025836-T1,Peve_00028304,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1b,three_way,67.41033333333334,FUN_025836-T1,Q9DBC0,SELO_MOUSE,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Mus musculus (Mouse),46.7,642.0,4.0999999999999995e-148,526.6,"sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4",GO:0005524; GO:0005694; GO:0005739; GO:0046872; GO:0070733,,chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_05822,1.5198274513030816,FUN_025838-T1,Peve_00028309,Pocillopora_meandrina_HIv1___RNAseq.g10332.t1,three_way,68.98100000000001,FUN_025838-T1,Q14957,NMDE3_HUMAN,,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",Homo sapiens (Human),25.0,472.0,4.799999999999997e-41,171.4,"sp|Q14957|NMDE3_HUMAN Glutamate receptor ionotropic, NMDA 2C OS=Homo sapiens OX=9606 GN=GRIN2C PE=1 SV=3",GO:0004972; GO:0005261; GO:0005789; GO:0005886; GO:0007215; GO:0007420; GO:0009611; GO:0017146; GO:0033058; GO:0035235; GO:0035249; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904062; GO:1904315; GO:2000463,"brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; synaptic transmission, glutamatergic [GO:0035249]",endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_05824,2.19996940150408,FUN_025841-T1,Peve_00028314,Pocillopora_meandrina_HIv1___RNAseq.g10337.t1,three_way,68.842,FUN_025841-T1,Q921L8,GLT11_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),Mus musculus (Mouse),52.4,553.0,7.5e-165,582.0,sp|Q921L8|GLT11_MOUSE Polypeptide N-acetylgalactosaminyltransferase 11 OS=Mus musculus OX=10090 GN=Galnt11 PE=1 SV=1,GO:0000139; GO:0004653; GO:0005112; GO:0007220; GO:0007368; GO:0008593; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0016740; GO:0044782; GO:0140096,"catalytic activity; transferase activity; cilium organization; catalytic activity, acting on a protein"
OG_05825,1.584168907741381,FUN_025842-T1,Peve_00028315,Pocillopora_meandrina_HIv1___TS.g13751.t1,three_way,74.87866666666667,FUN_025842-T1,Q91WG5,AAKG2_MOUSE,,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2),Mus musculus (Mouse),61.1,314.0,5.6e-108,392.9,sp|Q91WG5|AAKG2_MOUSE 5'-AMP-activated protein kinase subunit gamma-2 OS=Mus musculus OX=10090 GN=Prkag2 PE=1 SV=2,GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0008607; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0043531,cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588],ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887],GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05826,1.1685776413966158,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_05836,1.4147737688239976,FUN_025881-T1,Peve_00018905,Pocillopora_meandrina_HIv1___RNAseq.g10520.t1,three_way,82.03883333333333,FUN_025881-T1,Q3ZBT6,TRA2B_BOVIN,,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",Bos taurus (Bovine),59.6,141.0,7.8e-43,175.6,sp|Q3ZBT6|TRA2B_BOVIN Transformer-2 protein homolog beta OS=Bos taurus OX=9913 GN=TRA2B PE=2 SV=1,GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0043484; GO:0048026,"mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]",nucleus [GO:0005634]; spliceosomal complex [GO:0005681],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_05845,2.334493108705521,FUN_025914-T1,Peve_00010173,Pocillopora_meandrina_HIv1___TS.g13966.t1,three_way,69.57366666666667,,,,,,,,,,,,,,,,,
OG_05850,1.0692529098931935,FUN_025923-T1,Peve_00018907,Pocillopora_meandrina_HIv1___TS.g13940.t2,three_way,74.94983333333333,FUN_025923-T1,A1A5K2,CLA1B_XENLA,,CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP),Xenopus laevis (African clawed frog),42.2,756.0,1.2e-134,482.3,sp|A1A5K2|CLA1B_XENLA CLIP-associating protein 1-B OS=Xenopus laevis OX=8355 GN=clasp1b PE=1 SV=1,GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307; GO:1902903,cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903],basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876],kinetochore binding [GO:0043515]; microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0007010; GO:0008092; GO:0043226,Golgi apparatus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05851,1.188277018674912,FUN_025924-T1,Peve_00027741,Pocillopora_meandrina_HIv1___RNAseq.g10523.t1,three_way,81.66433333333333,FUN_025924-T1,Q80TV8,CLAP1_MOUSE,,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1),Mus musculus (Mouse),41.3,726.0,1.1e-131,472.2,sp|Q80TV8|CLAP1_MOUSE CLIP-associating protein 1 OS=Mus musculus OX=10090 GN=Clasp1 PE=1 SV=2,GO:0000776; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0005938; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0016477; GO:0030010; GO:0031023; GO:0034453; GO:0051294; GO:0051301,cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of spindle orientation [GO:0051294]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; negative regulation of microtubule depolymerization [GO:0007026],cell cortex [GO:0005938]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0043226; GO:0048870,Golgi apparatus; microtubule organizing center; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle; cell motility
OG_05853,1.1266907405756472,FUN_025926-T1,Peve_00027735,Pocillopora_meandrina_HIv1___RNAseq.g10525.t1,three_way,70.25033333333333,FUN_025926-T1,Q28I29,,,,,39.1,179.0,4.3e-28,125.9,sp|Q28I29|DTWD1_XENTR tRNA-uridine aminocarboxypropyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=dtwd1 PE=2 SV=1,,,,,,
OG_05856,1.5022946112981548,FUN_025935-T1,Peve_00027752,Pocillopora_meandrina_HIv1___RNAseq.g13629.t2,three_way,63.209,FUN_025935-T1,Q4PZA2,ECE1_MOUSE,,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),Mus musculus (Mouse),35.1,701.0,2.4e-126,454.5,sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1,GO:0001921; GO:0004222; GO:0005768; GO:0005794; GO:0007411; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010814; GO:0010815; GO:0010816; GO:0016486; GO:0031175; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0097492; GO:1902287,axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],cell surface [GO:0009986]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Weibel-Palade body [GO:0033093],metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; endosome; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05861,1.3864855159403495,FUN_025968-T1,Peve_00015812,Pocillopora_meandrina_HIv1___RNAseq.g10513.t1,three_way,76.54333333333334,FUN_025968-T1,Q8IZ52,CHSS2_HUMAN,,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),Homo sapiens (Human),31.2,794.0,3.2e-100,367.9,sp|Q8IZ52|CHSS2_HUMAN Chondroitin sulfate synthase 2 OS=Homo sapiens OX=9606 GN=CHPF PE=1 SV=2,GO:0000139; GO:0005759; GO:0005829; GO:0032580; GO:0046872; GO:0047238; GO:0050510; GO:0050650,chondroitin sulfate proteoglycan biosynthetic process [GO:0050650],cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial matrix [GO:0005759],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005829; GO:0009101; GO:0016740; GO:1901135,catalytic activity; cytosol; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_05864,2.184577951252642,FUN_025971-T1,Peve_00002910,Pocillopora_meandrina_HIv1___RNAseq.g10510.t1,three_way,71.926,FUN_025971-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),34.1,229.0,9.900000000000001e-28,125.2,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05866,2.7296806298182754,FUN_025975-T1,Peve_00002326,Pocillopora_meandrina_HIv1___RNAseq.g10507.t1,three_way,57.90466666666666,,,,,,,,,,,,,,,,,
OG_05867,2.35054133376319,FUN_025976-T1,Peve_00002325,Pocillopora_meandrina_HIv1___RNAseq.g10506.t1,three_way,64.18716666666667,FUN_025976-T1,Q13873,BMPR2_HUMAN,,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),Homo sapiens (Human),38.1,494.0,1.9e-88,328.2,sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2,GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782,anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235],"activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024]",GO:0003013; GO:0003824; GO:0005615; GO:0005654; GO:0005886; GO:0006355; GO:0009101; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140096; GO:1901135,"circulatory system process; catalytic activity; extracellular space; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; glycoprotein biosynthetic process; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05868,1.4195956381452528,FUN_025977-T1,Peve_00002324,Pocillopora_meandrina_HIv1___RNAseq.g10505.t1,three_way,91.186,FUN_025977-T1,P43450,,,,,76.2,294.0,7.8e-134,478.0,sp|P43450|CDK2_CARAU Cyclin-dependent kinase 2 OS=Carassius auratus OX=7957 GN=cdk2 PE=1 SV=1,,,,,,
OG_05870,1.7703036977325122,FUN_025985-T1,Peve_00002331,Pocillopora_meandrina_HIv1___RNAseq.g10502.t1,three_way,56.960166666666666,,,,,,,,,,,,,,,,,
OG_05872,2.74288230918736,FUN_026014-T1,Peve_00004062,Pocillopora_meandrina_HIv1___RNAseq.g10490.t1,three_way,68.83616666666667,FUN_026014-T1,Q61122,,,,,30.6,317.0,1.0999999999999998e-24,116.3,sp|Q61122|NAB1_MOUSE NGFI-A-binding protein 1 OS=Mus musculus OX=10090 GN=Nab1 PE=1 SV=2,,,,,,
OG_05884,1.5709873082246986,FUN_026037-T1,Peve_00025183,Pocillopora_meandrina_HIv1___RNAseq.g10550.t1,three_way,71.07133333333333,FUN_026037-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),45.3,278.0,2.3e-66,253.8,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_05885,1.1279610218771776,FUN_026038-T1,Peve_00022188,Pocillopora_meandrina_HIv1___RNAseq.g10551.t1,three_way,73.833,FUN_026038-T1,A0JMH2,,,,,40.4,292.0,2.700000000000001e-59,230.3,sp|A0JMH2|CB069_DANRE Mitochondrial protein C2orf69 homolog OS=Danio rerio OX=7955 GN=zgc:153521 PE=2 SV=1,,,,,,
OG_05886,1.759279267867268,FUN_026049-T1,Peve_00022189,Pocillopora_meandrina_HIv1___TS.g13972.t1,three_way,66.42933333333333,FUN_026049-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),35.0,537.0,5.4e-80,300.1,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05899,2.544338531546384,FUN_026076-T1,Peve_00002022,Pocillopora_meandrina_HIv1___RNAseq.g10561.t1,three_way,58.79216666666667,FUN_026076-T1,Q9NVE5,,,,,35.0,1254.0,1.6e-196,688.3,sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3,,,,,,
OG_05900,1.2296909270909646,FUN_026078-T1,Peve_00016849,Pocillopora_meandrina_HIv1___RNAseq.g10560.t1,three_way,71.18333333333334,FUN_026078-T1,Q9D1Z3,ACKMT_MOUSE,,ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (mFam173b),Mus musculus (Mouse),53.5,187.0,2.9e-50,199.9,sp|Q9D1Z3|ACKMT_MOUSE ATP synthase subunit C lysine N-methyltransferase OS=Mus musculus OX=10090 GN=Atpsckmt PE=1 SV=1,GO:0005739; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706,"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]",mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739],protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05904,1.485728128442278,FUN_026090-T1,Peve_00004127,Pocillopora_meandrina_HIv1___TS.g13992.t1,three_way,76.80466666666666,FUN_026090-T1,Q08D64,ABCB6_XENTR,,ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),55.9,755.0,4.0999999999999995e-234,812.8,sp|Q08D64|ABCB6_XENTR ATP-binding cassette sub-family B member 6 OS=Xenopus tropicalis OX=8364 GN=abcb6 PE=2 SV=1,GO:0000139; GO:0005524; GO:0005739; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0006878; GO:0015439; GO:0016887; GO:0031901; GO:0031902; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0046906; GO:0070062; GO:0098849; GO:0140359; GO:1903232,cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; intracellular copper ion homeostasis [GO:0006878]; melanosome assembly [GO:1903232]; porphyrin-containing compound metabolic process [GO:0006778]; tetrapyrrole metabolic process [GO:0033013],early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; tetrapyrrole binding [GO:0046906],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0098754; GO:0140657,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; plasma membrane; hydrolase activity; organelle; transmembrane transport; detoxification; ATP-dependent activity
OG_05905,1.1180881742417104,FUN_026091-T1,Peve_00017829,Pocillopora_meandrina_HIv1___RNAseq.g10573.t1,three_way,33.376,,,,,,,,,,,,,,,,,
OG_05910,1.2847582010230787,FUN_026101-T1,Peve_00013338,Pocillopora_meandrina_HIv1___RNAseq.g10579.t1,three_way,87.09166666666667,FUN_026101-T1,Q96JG6,,,,,51.6,965.0,9.3e-269,927.9,sp|Q96JG6|VPS50_HUMAN Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3,,,,,,
OG_05913,1.345514340901563,FUN_026104-T1,Peve_00044188,Pocillopora_meandrina_HIv1___RNAseq.g10324.t1,three_way,89.33133333333333,FUN_026104-T1,P15690,,,,,68.5,695.0,7.7e-284,977.6,"sp|P15690|NDUS1_BOVIN NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS1 PE=1 SV=1",,,,,,
OG_05918,1.6890080789008874,FUN_026113-T1,Peve_00013996,Pocillopora_meandrina_HIv1___RNAseq.g10315.t1,three_way,80.111,FUN_026113-T1,Q642F4,,,,,39.4,307.0,4.7e-54,213.0,sp|Q642F4|SC22A_RAT Vesicle-trafficking protein SEC22a OS=Rattus norvegicus OX=10116 GN=Sec22a PE=2 SV=1,,,,,,
OG_05926,2.460314265784671,FUN_026150-T1,Peve_00020731,Pocillopora_meandrina_HIv1___RNAseq.g3216.t1,three_way,83.78333333333333,FUN_026150-T1,Q9UJ83,HACL1_HUMAN,,2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),Homo sapiens (Human),60.0,578.0,2.3e-206,719.9,sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106359; GO:0106376; GO:1903512,fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005654; GO:0005777; GO:0005829; GO:0006629; GO:0016829; GO:0043226,catalytic activity; nucleoplasm; peroxisome; cytosol; lipid metabolic process; lyase activity; organelle
OG_05928,1.4745741130458518,FUN_026154-T1,Peve_00000925,Pocillopora_meandrina_HIv1___RNAseq.g3213.t1,three_way,86.743,FUN_026154-T1,O60921,HUS1_HUMAN,,Checkpoint protein HUS1 (hHUS1),Homo sapiens (Human),53.2,282.0,1.7e-82,307.4,sp|O60921|HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens OX=9606 GN=HUS1 PE=1 SV=1,GO:0000077; GO:0000723; GO:0000724; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; telomere maintenance [GO:0000723],checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006310; GO:0022414; GO:0032200; GO:0043226; GO:0048856,nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; DNA recombination; reproductive process; telomere organization; organelle; anatomical structure development
OG_05933,2.621673784595316,FUN_026161-T1,Peve_00006892,Pocillopora_meandrina_HIv1___RNAseq.g3202.t1,three_way,65.80033333333333,FUN_026161-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),33.2,564.0,2.7999999999999997e-82,307.8,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05934,1.3957770568756522,FUN_026162-T1,Peve_00006896,Pocillopora_meandrina_HIv1___RNAseq.g3201.t1,three_way,64.434,FUN_026162-T1,Q5RAP8,,,,,35.1,211.0,1.4000000000000002e-23,111.3,sp|Q5RAP8|TSN31_PONAB Tetraspanin-31 OS=Pongo abelii OX=9601 GN=TSPAN31 PE=2 SV=1,,,,,,
OG_05935,1.6865527909224096,FUN_026165-T1,Peve_00008133,Pocillopora_meandrina_HIv1___RNAseq.g3173.t1,three_way,63.327666666666666,FUN_026165-T1,Q5NU32,AOFA_HORSE,,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),Equus caballus (Horse),37.2,468.0,2.9e-77,290.8,sp|Q5NU32|AOFA_HORSE Amine oxidase [flavin-containing] A OS=Equus caballus OX=9796 GN=MAOA PE=2 SV=1,GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0050660; GO:0097621,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_05938,1.9643307034344164,FUN_026173-T1,Peve_00039168,Pocillopora_meandrina_HIv1___RNAseq.g3177.t1,three_way,35.60133333333333,FUN_026173-T1,P24668,MPRD_MOUSE,,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),Mus musculus (Mouse),51.8,56.0,7e-07,56.2,sp|P24668|MPRD_MOUSE Cation-dependent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=M6pr PE=1 SV=1,GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394,intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471],protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394],GO:0005768; GO:0005794; GO:0006886; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; cytoplasmic vesicle; organelle
OG_05942,2.2171409986692625,FUN_026179-T1,Peve_00012698,Pocillopora_meandrina_HIv1___RNAseq.g3034.t1,three_way,82.133,FUN_026179-T1,O02695,,,,,58.0,440.0,8.500000000000001e-133,476.1,sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1,,,,,,
OG_05945,1.829541115746217,FUN_026188-T1,Peve_00007220,Pocillopora_meandrina_HIv1___RNAseq.g9603.t1,three_way,49.890166666666666,,,,,,,,,,,,,,,,,
OG_05947,1.9576076861316432,FUN_026194-T1,Peve_00016690,Pocillopora_meandrina_HIv1___TS.g18158.t1,three_way,54.12983333333333,,,,,,,,,,,,,,,,,
OG_05954,1.2741129989082045,FUN_026297-T1,Peve_00030617,Pocillopora_meandrina_HIv1___TS.g18167.t1,three_way,62.13683333333333,FUN_026297-T1,Q28824,MYLK_BOVIN,,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",Bos taurus (Bovine),43.7,332.0,4e-75,284.3,"sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1",GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872,tonic smooth muscle contraction [GO:0014820],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725],actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687],GO:0003012; GO:0003824; GO:0008092; GO:0016740; GO:0140096,"muscle system process; catalytic activity; cytoskeletal protein binding; transferase activity; catalytic activity, acting on a protein"
OG_05961,1.2151956745857926,FUN_026308-T1,Peve_00023863,Pocillopora_meandrina_HIv1___RNAseq.g3063.t1,three_way,52.47083333333333,,,,,,,,,,,,,,,,,
OG_05963,1.0403966582831932,FUN_026310-T1,Peve_00036855,Pocillopora_meandrina_HIv1___RNAseq.g3065.t1,three_way,55.12266666666667,FUN_026310-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),26.6,549.0,1.2e-49,199.9,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_05972,1.4688207088289884,FUN_026388-T1,Peve_00032419,Pocillopora_meandrina_HIv1___RNAseq.g2952.t1,three_way,95.50233333333334,FUN_026388-T1,Q9D1K2,,,,,70.7,116.0,7.8e-43,174.5,sp|Q9D1K2|VATF_MOUSE V-type proton ATPase subunit F OS=Mus musculus OX=10090 GN=Atp6v1f PE=1 SV=2,,,,,,
OG_05973,1.9736480095526927,FUN_026389-T1,Peve_00032417,Pocillopora_meandrina_HIv1___RNAseq.g2951.t1,three_way,65.594,FUN_026389-T1,Q54UT2,DGK_DICDI,,Deoxyguanosine kinase (dGK) (EC 2.7.1.113) (DddGK),Dictyostelium discoideum (Social amoeba),46.5,217.0,9e-51,202.2,sp|Q54UT2|DGK_DICDI Deoxyguanosine kinase OS=Dictyostelium discoideum OX=44689 GN=dgk PE=1 SV=2,GO:0004138; GO:0005524; GO:0005737; GO:0005739; GO:0006120; GO:0006180; GO:0045271,"deoxyguanosine salvage [GO:0006180]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],ATP binding [GO:0005524]; deoxyguanosine kinase activity [GO:0004138],GO:0003824; GO:0005739; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05976,1.3007055597865325,FUN_026399-T1,Peve_00028956,Pocillopora_meandrina_HIv1___TS.g18054.t2,three_way,70.44033333333333,FUN_026399-T1,P02720,,,,,49.0,206.0,3.5e-53,209.9,sp|P02720|PPCT_BOVIN Phosphatidylcholine transfer protein OS=Bos taurus OX=9913 GN=PCTP PE=1 SV=1,,,,,,
OG_05977,1.9630077633575385,FUN_026406-T1,Peve_00000795,Pocillopora_meandrina_HIv1___RNAseq.g2938.t1,three_way,71.30283333333334,,,,,,,,,,,,,,,,,
OG_05979,1.1561844835770927,FUN_026410-T1,Peve_00000792,Pocillopora_meandrina_HIv1___TS.g18090.t2,three_way,66.82866666666666,,,,,,,,,,,,,,,,,
OG_05982,1.295303331580638,FUN_026413-T1,Peve_00006097,Pocillopora_meandrina_HIv1___RNAseq.g2986.t1,three_way,57.643,,,,,,,,,,,,,,,,,
OG_05985,1.3186041799641222,FUN_026471-T1,Peve_00030192,Pocillopora_meandrina_HIv1___RNAseq.g4186.t1,three_way,66.35833333333333,FUN_026471-T1,F4JZ24,,,,,31.6,177.0,5e-17,90.5,sp|F4JZ24|P4H10_ARATH Probable prolyl 4-hydroxylase 10 OS=Arabidopsis thaliana OX=3702 GN=P4H10 PE=3 SV=1,,,,,,
OG_05987,1.6730956745704098,FUN_026473-T1,Peve_00002338,Pocillopora_meandrina_HIv1___RNAseq.g4184.t1,three_way,47.833,,,,,,,,,,,,,,,,,
OG_05988,3.5202360866733176,FUN_026474-T1,Peve_00002337,Pocillopora_meandrina_HIv1___RNAseq.g4183.t1,three_way,68.71333333333334,FUN_026474-T1,P35244,RFA3_HUMAN,,Replication protein A 14 kDa subunit (RP-A p14) (Replication factor A protein 3) (RF-A protein 3),Homo sapiens (Human),38.3,107.0,2.6e-13,76.3,sp|P35244|RFA3_HUMAN Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1,GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007346; GO:0035861; GO:0042127,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; regulation of cell population proliferation [GO:0042127]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723],DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006310; GO:0032200,DNA binding; nucleoplasm; DNA replication; DNA repair; DNA recombination; telomere organization
OG_05989,1.3032958902414236,FUN_026475-T1,Peve_00002335,Pocillopora_meandrina_HIv1___RNAseq.g4182.t1,three_way,75.23366666666666,FUN_026475-T1,Q802U2,MIOS_DANRE,,GATOR2 complex protein MIOS,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,443.0,7.2e-107,389.0,sp|Q802U2|MIOS_DANRE GATOR2 complex protein MIOS OS=Danio rerio OX=7955 GN=mios PE=2 SV=1,GO:0005737; GO:0005765; GO:0008270; GO:0031669; GO:0034198; GO:0060047; GO:0060841; GO:0061700; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; heart contraction [GO:0060047]; positive regulation of TORC1 signaling [GO:1904263]; venous blood vessel development [GO:0060841],cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_05990,1.5584120388107734,FUN_026477-T1,Peve_00002334,Pocillopora_meandrina_HIv1___RNAseq.g4181.t1,three_way,66.879,,,,,,,,,,,,,,,,,
OG_05992,1.6382583025408084,FUN_026481-T1,Peve_00002333,Pocillopora_meandrina_HIv1___RNAseq.g4177.t1,three_way,82.02083333333333,FUN_026481-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.3,414.0,6.6e-58,226.5,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05993,1.348732617195689,FUN_026482-T1,Peve_00002332,Pocillopora_meandrina_HIv1___RNAseq.g4176.t1,three_way,69.22866666666667,FUN_026482-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),30.8,402.0,2.2999999999999998e-55,218.0,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05995,1.3979728915115712,FUN_026484-T1,Peve_00022075,Pocillopora_meandrina_HIv1___RNAseq.g4174.t1,three_way,66.93066666666667,FUN_026484-T1,Q8N5B7,CERS5_HUMAN,,Ceramide synthase 5 (CerS5) (LAG1 longevity assurance homolog 5) (Sphingoid base N-palmitoyltransferase CERS5) (EC 2.3.1.291) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24),Homo sapiens (Human),41.5,347.0,8.999999999999999e-71,268.9,sp|Q8N5B7|CERS5_HUMAN Ceramide synthase 5 OS=Homo sapiens OX=9606 GN=CERS5 PE=1 SV=1,GO:0003677; GO:0005789; GO:0014003; GO:0030148; GO:0046513; GO:0050291,ceramide biosynthetic process [GO:0046513]; oligodendrocyte development [GO:0014003]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum membrane [GO:0005789],DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291],GO:0003677; GO:0003824; GO:0006629; GO:0016740; GO:0048856,DNA binding; catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_05996,1.7391922939586395,FUN_026485-T1,Peve_00030055,Pocillopora_meandrina_HIv1___RNAseq.g4173.t1,three_way,93.52966666666669,FUN_026485-T1,Q9CZQ9,,,,,78.2,335.0,3.5e-154,545.8,sp|Q9CZQ9|BBS5_MOUSE BBSome complex member BBS5 OS=Mus musculus OX=10090 GN=Bbs5 PE=1 SV=1,,,,,,
OG_05997,1.7202189181680994,FUN_026486-T1,Peve_00037221,Pocillopora_meandrina_HIv1___RNAseq.g4172.t1,three_way,92.45966666666668,FUN_026486-T1,Q8N138,ORML3_HUMAN,,ORM1-like protein 3,Homo sapiens (Human),59.0,144.0,3.2e-46,186.0,sp|Q8N138|ORML3_HUMAN ORM1-like protein 3 OS=Homo sapiens OX=9606 GN=ORMDL3 PE=1 SV=1,GO:0002903; GO:0005783; GO:0005789; GO:0005886; GO:0006672; GO:0006686; GO:0006940; GO:0010508; GO:0017059; GO:0030148; GO:0030667; GO:0035579; GO:0042552; GO:0061744; GO:0090156; GO:1900060; GO:1900182,ceramide metabolic process [GO:0006672]; intracellular sphingolipid homeostasis [GO:0090156]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine palmitoyltransferase complex [GO:0017059]; specific granule membrane [GO:0035579],,GO:0005783; GO:0005886; GO:0006629; GO:0043226,endoplasmic reticulum; plasma membrane; lipid metabolic process; organelle
OG_05999,1.5420182069584532,FUN_026488-T1,Peve_00030554,Pocillopora_meandrina_HIv1___RNAseq.g4190.t1,three_way,72.27866666666667,,,,,,,,,,,,,,,,,
OG_06003,1.0579255676387358,FUN_026492-T1,Peve_00032990,Pocillopora_meandrina_HIv1___RNAseq.g4194.t1,three_way,63.86033333333334,,,,,,,,,,,,,,,,,
OG_06009,1.7183369281405652,FUN_026529-T1,Peve_00021569,Pocillopora_meandrina_HIv1___RNAseq.g4217.t1,three_way,74.87133333333334,FUN_026529-T1,Q9JIT1,,,,,47.4,369.0,1.4000000000000001e-89,331.3,sp|Q9JIT1|RNF32_MOUSE RING finger protein 32 OS=Mus musculus OX=10090 GN=Rnf32 PE=1 SV=1,,,,,,
OG_06010,1.0233664775359934,FUN_026532-T1,Peve_00021566,Pocillopora_meandrina_HIv1___RNAseq.g4216.t1,three_way,63.30566666666667,,,,,,,,,,,,,,,,,
OG_06012,1.115379943955417,FUN_026539-T1,Peve_00002363,Pocillopora_meandrina_HIv1___RNAseq.g4243.t1,three_way,67.683,,,,,,,,,,,,,,,,,
OG_06019,1.5330802383566453,FUN_026547-T1,Peve_00002361,Pocillopora_meandrina_HIv1___RNAseq.g4233.t1,three_way,71.54266666666666,,,,,,,,,,,,,,,,,
OG_06029,1.1834418197892511,FUN_026590-T1,Peve_00043908,Pocillopora_meandrina_HIv1___RNAseq.g4497.t1,three_way,58.6655,FUN_026590-T1,A4D1E9,GTPBA_HUMAN,,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),Homo sapiens (Human),46.9,286.0,1.5e-65,252.3,sp|A4D1E9|GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254,ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005694; GO:0005730; GO:0005739; GO:0016787; GO:0042254; GO:0043226,RNA binding; catalytic activity; GTPase activity; chromosome; nucleolus; mitochondrion; hydrolase activity; ribosome biogenesis; organelle
OG_06030,1.40361096501535,FUN_026591-T1,Peve_00035407,Pocillopora_meandrina_HIv1___RNAseq.g4496.t1,three_way,59.29,,,,,,,,,,,,,,,,,
OG_06032,1.7328631749668566,FUN_026617-T1,Peve_00043915,Pocillopora_meandrina_HIv1___RNAseq.g4482.t1,three_way,86.23883333333333,FUN_026617-T1,A0A8I5ZNK2,OXSR1_RAT,,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),Rattus norvegicus (Rat),54.0,522.0,8.8e-151,535.0,sp|A0A8I5ZNK2|OXSR1_RAT Serine/threonine-protein kinase OSR1 OS=Rattus norvegicus OX=10116 GN=Oxsr1 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006884; GO:0006979; GO:0007165; GO:0007231; GO:0009410; GO:0010820; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0070294; GO:0071474; GO:0071476; GO:1901380; GO:1990869,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; osmosensory signaling pathway [GO:0007231]; positive regulation of T cell chemotaxis [GO:0010820]; renal sodium ion absorption [GO:0070294]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674],GO:0003014; GO:0003824; GO:0005829; GO:0016740; GO:0140096,"renal system process; catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_06033,3.0724795724619782,FUN_026619-T1,Peve_00043889,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1a,three_way,66.35766666666667,FUN_026619-T1,Q8BHC4,,,,,46.8,222.0,1.7e-51,204.1,sp|Q8BHC4|DCAKD_MOUSE Dephospho-CoA kinase domain-containing protein OS=Mus musculus OX=10090 GN=Dcakd PE=1 SV=1,,,,,,
OG_06034,1.9078861391346629,FUN_026626-T1,Peve_00030694,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1b,three_way,49.834833333333336,FUN_026626-T1,P23785,GRN_RAT,,Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)],Rattus norvegicus (Rat),31.6,510.0,1.8999999999999998e-62,243.0,sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3,GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673,astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488]; trophectodermal cell proliferation [GO:0001834],cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0007040; GO:0016192; GO:0022414; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048018; GO:0048856; GO:0098772,immune system process; extracellular region; extracellular space; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; lysosome organization; vesicle-mediated transport; reproductive process; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06044,1.4371955254470927,FUN_026709-T1,Peve_00018525,Pocillopora_meandrina_HIv1___RNAseq.g9380.t1,three_way,64.574,,,,,,,,,,,,,,,,,
OG_06056,1.4094758477264266,FUN_026739-T2,Peve_00021666,Pocillopora_meandrina_HIv1___RNAseq.g9411.t1,three_way,70.781,FUN_026739-T2,P42232,STA5B_MOUSE,,Signal transducer and activator of transcription 5B,Mus musculus (Mouse),32.8,729.0,1e-96,356.3,sp|P42232|STA5B_MOUSE Signal transducer and activator of transcription 5B OS=Mus musculus OX=10090 GN=Stat5b PE=1 SV=1,GO:0000278; GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001787; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008283; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030098; GO:0030155; GO:0030183; GO:0030218; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0033028; GO:0033033; GO:0033077; GO:0035259; GO:0038162; GO:0040014; GO:0040018; GO:0042104; GO:0042267; GO:0042448; GO:0042492; GO:0042803; GO:0043029; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0050798; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531,activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; lymphocyte differentiation [GO:0030098]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000278; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0006629; GO:0006790; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140110,mitotic cell cycle; immune system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; lipid metabolic process; sulfur compound metabolic process; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; defense response to other organism; transcription regulator activity
OG_06060,1.5468733992642585,FUN_026826-T1,Peve_00021661,Pocillopora_meandrina_HIv1___RNAseq.g2905.t1,three_way,81.5875,FUN_026826-T1,Q6PHS6,,,,,41.4,950.0,6.9e-205,715.7,sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1,,,,,,
OG_06068,2.646919436028909,FUN_026916-T1,Peve_00014703,Pocillopora_meandrina_HIv1___RNAseq.g11017.t1,three_way,54.9965,,,,,,,,,,,,,,,,,
OG_06069,1.6699424358906974,FUN_026917-T1,Peve_00013239,Pocillopora_meandrina_HIv1___RNAseq.g9415.t2,three_way,55.821,FUN_026917-T1,A2VD33,,,,,42.9,825.0,2.5e-193,677.2,sp|A2VD33|MOCOS_DANRE Molybdenum cofactor sulfurase OS=Danio rerio OX=7955 GN=mocos PE=2 SV=2,,,,,,
OG_06072,2.0458880462005475,FUN_026981-T1,Peve_00013217,Pocillopora_meandrina_HIv1___RNAseq.g9421.t1,three_way,51.642,,,,,,,,,,,,,,,,,
OG_06078,1.4937889976151366,FUN_026989-T1,Peve_00012936,Pocillopora_meandrina_HIv1___RNAseq.g10353.t1,three_way,77.742,FUN_026989-T1,Q6UW02,,,,,30.3,472.0,2.6e-70,267.7,sp|Q6UW02|CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens OX=9606 GN=CYP20A1 PE=1 SV=1,,,,,,
OG_06087,1.0381804679056037,FUN_027086-T1,Peve_00012245,Pocillopora_meandrina_HIv1___TS.g17920.t1,three_way,91.32083333333333,FUN_027086-T1,Q14562,DHX8_HUMAN,,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),Homo sapiens (Human),75.5,1179.0,0.0,1576.2,sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008186; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]",GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06090,1.3064087665380388,FUN_027128-T1,Peve_00039620,Pocillopora_meandrina_HIv1___TS.g10360.t2,three_way,69.8775,FUN_027128-T1,O60244,MED14_HUMAN,,Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150),Homo sapiens (Human),36.0,1532.0,7.500000000000001e-225,782.7,sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847,positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_06092,1.9893265924246832,FUN_027218-T1,Peve_00018289,Pocillopora_meandrina_HIv1___RNAseq.g15249.t1,three_way,69.15166666666667,FUN_027218-T1,Q8IW92,,,,,43.8,665.0,4.3e-148,526.6,sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1,,,,,,
OG_06096,1.4659923004695736,FUN_027270-T1,Peve_00018292,Pocillopora_meandrina_HIv1___TS.g10917.t1,three_way,87.52583333333334,FUN_027270-T1,Q80W99,CTSR3_MOUSE,,Cation channel sperm-associated protein 3 (CatSper3),Mus musculus (Mouse),34.5,383.0,1.4e-53,211.8,sp|Q80W99|CTSR3_MOUSE Cation channel sperm-associated protein 3 OS=Mus musculus OX=10090 GN=Catsper3 PE=1 SV=2,GO:0001669; GO:0005245; GO:0005783; GO:0006814; GO:0030317; GO:0031514; GO:0036128; GO:0048240; GO:0051649,establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240],acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514],voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005783; GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endoplasmic reticulum; cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06098,2.5107697373555258,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06099,1.6044544045871345,FUN_027735-T1,Peve_00036492,Pocillopora_meandrina_HIv1___RNAseq.g13904.t1,three_way,70.82816666666666,FUN_027735-T1,O94888,UBXN7_HUMAN,,UBX domain-containing protein 7,Homo sapiens (Human),41.6,500.0,1e-93,345.5,sp|O94888|UBXN7_HUMAN UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_06111,1.0420789639929915,FUN_027817-T1,Peve_00042678,Pocillopora_meandrina_HIv1___TS.g22877.t1b,three_way,64.28866666666667,,,,,,,,,,,,,,,,,
OG_06114,2.1702446641852227,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_06115,2.6172404169403007,FUN_027832-T1,Peve_00020550,Pocillopora_meandrina_HIv1___TS.g11651.t1a,three_way,84.66816666666666,FUN_027832-T1,Q6NRH1,,,,,58.3,408.0,3.2e-139,496.5,sp|Q6NRH1|DCAF8_XENLA DDB1- and CUL4-associated factor 8 OS=Xenopus laevis OX=8355 GN=dcaf8 PE=2 SV=1,,,,,,
OG_06120,2.0354709779636986,FUN_027852-T2,Peve_00031657,Pocillopora_meandrina_HIv1___TS.g11671.t1,three_way,59.174166666666665,,,,,,,,,,,,,,,,,
OG_06125,1.893970402560358,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_06126,1.004032502363159,FUN_027923-T1,Peve_00020108,Pocillopora_meandrina_HIv1___RNAseq.g13880.t1,three_way,62.48633333333333,FUN_027923-T1,Q2KHV4,,,,,42.6,298.0,1.4999999999999999e-61,238.0,"sp|Q2KHV4|PARL_BOVIN Presenilin-associated rhomboid-like protein, mitochondrial OS=Bos taurus OX=9913 GN=PARL PE=2 SV=1",,,,,,
OG_06136,1.7237851810391256,FUN_027947-T1,Peve_00034209,Pocillopora_meandrina_HIv1___RNAseq.g14034.t1,three_way,76.312,,,,,,,,,,,,,,,,,
OG_06144,1.776083233029324,FUN_027971-T1,Peve_00031357,Pocillopora_meandrina_HIv1___RNAseq.g14053.t1,three_way,64.43966666666667,FUN_027971-T1,Q7PCJ9,,,,,47.6,168.0,1.4e-37,157.5,sp|Q7PCJ9|SAT2_PIG Thialysine N-epsilon-acetyltransferase OS=Sus scrofa OX=9823 GN=SAT2 PE=2 SV=1,,,,,,
OG_06147,1.5846915480132036,FUN_027977-T1,Peve_00031366,Pocillopora_meandrina_HIv1___RNAseq.g14058.t1,three_way,74.97666666666666,FUN_027977-T1,Q9Z2F6,,,,,44.0,175.0,4.2000000000000005e-33,143.7,sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2,,,,,,
OG_06151,1.6726372387279462,FUN_027983-T1,Peve_00033313,Pocillopora_meandrina_HIv1___RNAseq.g14010.t1,three_way,75.17066666666666,FUN_027983-T1,O53901,,,,,27.8,320.0,8.5e-29,129.4,sp|O53901|PKS5_MYCTU Mycocerosic acid synthase-like polyketide synthase OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=pks5 PE=1 SV=2,,,,,,
OG_06154,3.920202734350775,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_06160,1.363702106931284,FUN_028005-T1,Peve_00032127,Pocillopora_meandrina_HIv1___RNAseq.g14075.t1,three_way,71.60433333333333,FUN_028005-T1,Q28678,ICLN_RABIT,,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))",Oryctolagus cuniculus (Rabbit),42.4,236.0,4.4999999999999996e-35,149.4,sp|Q28678|ICLN_RABIT Methylosome subunit pICln OS=Oryctolagus cuniculus OX=9986 GN=CLNS1A PE=2 SV=2,GO:0000387; GO:0005634; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0045292,"cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; mRNA cis splicing, via spliceosome [GO:0045292]; spliceosomal snRNP assembly [GO:0000387]",cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681],,GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0016071; GO:0043226; GO:0065003,nucleus; cytosol; cytoskeleton; plasma membrane; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06162,1.7864364797279615,FUN_028008-T1,Peve_00008115,Pocillopora_meandrina_HIv1___RNAseq.g14077.t1,three_way,56.86366666666667,FUN_028008-T1,D8VNS7,,,,,46.8,231.0,2.2e-52,208.8,sp|D8VNS7|FCNV1_CERRY Ryncolin-1 OS=Cerberus rynchops OX=46267 PE=1 SV=1,,,,,,
OG_06163,1.355982711063292,FUN_028014-T1,Peve_00008114,Pocillopora_meandrina_HIv1___RNAseq.g14103.t1,three_way,86.13066666666667,FUN_028014-T1,Q66HG5,,,,,64.5,639.0,2e-238,826.6,sp|Q66HG5|TM9S2_RAT Transmembrane 9 superfamily member 2 OS=Rattus norvegicus OX=10116 GN=Tm9sf2 PE=2 SV=1,,,,,,
OG_06166,2.3839228747717014,FUN_028019-T1,Peve_00036500,Pocillopora_meandrina_HIv1___RNAseq.g13910.t1,three_way,60.98683333333333,FUN_028019-T1,Q6DCD5,TMTC2_XENLA,,Protein O-mannosyl-transferase tmtc2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),Xenopus laevis (African clawed frog),36.7,581.0,5.800000000000001e-86,320.5,sp|Q6DCD5|TMTC2_XENLA Protein O-mannosyl-transferase tmtc2 OS=Xenopus laevis OX=8355 GN=tmtc2 PE=2 SV=1,GO:0000030; GO:0004169; GO:0005789; GO:0035269,protein O-linked mannosylation [GO:0035269],endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06167,1.4871916432858503,FUN_028020-T1,Peve_00036501,Pocillopora_meandrina_HIv1___RNAseq.g13911.t1,three_way,68.68566666666666,FUN_028020-T1,Q6NME7,TEN1_ARATH,,CST complex subunit TEN1 (Protein MERISTEM DISORGANIZATION 1) (Protein telomeric pathways with STN1 homolog),Arabidopsis thaliana (Mouse-ear cress),30.5,95.0,2.1e-06,53.5,sp|Q6NME7|TEN1_ARATH CST complex subunit TEN1 OS=Arabidopsis thaliana OX=3702 GN=TEN1 PE=1 SV=1,GO:0000723; GO:0000781; GO:0003697; GO:0009408; GO:0010521; GO:0019827; GO:0044183; GO:0048367; GO:1990879,response to heat [GO:0009408]; shoot system development [GO:0048367]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723],"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]",protein folding chaperone [GO:0044183]; single-stranded DNA binding [GO:0003697]; telomerase inhibitor activity [GO:0010521],GO:0003677; GO:0032200; GO:0044183; GO:0048856; GO:0098772,DNA binding; telomere organization; protein folding chaperone; anatomical structure development; molecular function regulator activity
OG_06175,1.0132987747305793,FUN_028032-T1,Peve_00020106,Pocillopora_meandrina_HIv1___RNAseq.g13935.t1,three_way,50.176,,,,,,,,,,,,,,,,,
OG_06177,1.292011081113591,FUN_028040-T1,Peve_00020094,Pocillopora_meandrina_HIv1___RNAseq.g13938.t1,three_way,66.845,,,,,,,,,,,,,,,,,
OG_06179,1.776376568331398,FUN_028042-T1,Peve_00020097,Pocillopora_meandrina_HIv1___RNAseq.g15391.t1,three_way,65.06816666666667,FUN_028042-T1,Q568J8,,,,,41.3,104.0,2.5e-07,55.8,sp|Q568J8|TM256_DANRE Transmembrane protein 256 OS=Danio rerio OX=7955 GN=tmem256 PE=3 SV=1,,,,,,
OG_06181,2.5051502266609096,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_06182,1.751196712706833,FUN_028092-T1,Peve_00031646,Pocillopora_meandrina_HIv1___RNAseq.g16567.t1,three_way,76.8695,FUN_028092-T1,Q5F364,MRP1_CHICK,,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),Gallus gallus (Chicken),53.1,1353.0,0.0,1347.0,sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1,GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729,cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],basolateral plasma membrane [GO:0016323],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634],GO:0003824; GO:0005215; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_06195,1.5598100504079313,FUN_028120-T1,Peve_00033839,Pocillopora_meandrina_HIv1___TS.g10588.t1b,three_way,59.40266666666667,,,,,,,,,,,,,,,,,
OG_06198,3.063970004511689,FUN_028130-T1,Peve_00004260,Pocillopora_meandrina_HIv1___RNAseq.g15556.t1,three_way,59.60266666666666,FUN_028130-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.8,276.0,4.9e-14,81.6,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06203,3.069003149854039,FUN_028139-T1,Peve_00025714,Pocillopora_meandrina_HIv1___RNAseq.g16451.t1,three_way,81.30433333333333,FUN_028139-T1,A1L3P4,SL9A6_MOUSE,,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Sodium/hydrogen exchanger) (Solute carrier family 9 member 6),Mus musculus (Mouse),55.7,587.0,3.3e-153,543.5,sp|A1L3P4|SL9A6_MOUSE Sodium/hydrogen exchanger 6 OS=Mus musculus OX=10090 GN=Slc9a6 PE=1 SV=1,GO:0005739; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0015385; GO:0015386; GO:0030010; GO:0030425; GO:0031410; GO:0031547; GO:0031901; GO:0031902; GO:0043679; GO:0044308; GO:0045202; GO:0048675; GO:0048812; GO:0050808; GO:0051386; GO:0051453; GO:0055037; GO:0055038; GO:0060996; GO:0097484; GO:0098685; GO:0098978; GO:0099072; GO:1902600,axon extension [GO:0048675]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; dendrite extension [GO:0097484]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; neuron projection morphogenesis [GO:0048812]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; synapse organization [GO:0050808],axon terminus [GO:0043679]; axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; establishment or maintenance of cell polarity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; transmembrane transport
OG_06204,1.0039321410415922,FUN_028140-T1,Peve_00037731,Pocillopora_meandrina_HIv1___RNAseq.g16455.t1,three_way,89.77433333333333,,,,,,,,,,,,,,,,,
OG_06205,1.9057455494812947,FUN_028141-T1,Peve_00037718,Pocillopora_meandrina_HIv1___RNAseq.g16456.t1,three_way,57.817,,,,,,,,,,,,,,,,,
OG_06206,1.183421327845723,FUN_028142-T1,Peve_00037719,Pocillopora_meandrina_HIv1___RNAseq.g16428.t1,three_way,69.77866666666667,FUN_028142-T1,Q53RE8,,,,,50.8,65.0,6.8e-11,68.9,sp|Q53RE8|ANR39_HUMAN Ankyrin repeat domain-containing protein 39 OS=Homo sapiens OX=9606 GN=ANKRD39 PE=1 SV=1,,,,,,
OG_06208,1.154829653329287,FUN_028145-T1,Peve_00037725,Pocillopora_meandrina_HIv1___RNAseq.g16425.t1,three_way,84.72733333333333,FUN_028145-T1,A0JPE9,,,,,53.0,513.0,8.6e-160,565.1,sp|A0JPE9|GLPK5_DANRE Glycerol kinase 5 OS=Danio rerio OX=7955 GN=gk5 PE=2 SV=2,,,,,,
OG_06223,1.2883405753785273,FUN_028167-T1,Peve_00029326,Pocillopora_meandrina_HIv1___RNAseq.g16473.t1,three_way,78.41499999999999,FUN_028167-T1,Q8VDI9,,,,,56.0,563.0,3.4e-184,646.4,"sp|Q8VDI9|ALG9_MOUSE Alpha-1,2-mannosyltransferase ALG9 OS=Mus musculus OX=10090 GN=Alg9 PE=2 SV=1",,,,,,
OG_06225,2.259187208000648,FUN_028170-T1,Peve_00044582,Pocillopora_meandrina_HIv1___RNAseq.g16470.t1,three_way,67.04516666666666,,,,,,,,,,,,,,,,,
OG_06232,1.300585776699226,FUN_028185-T1,Peve_00001293,Pocillopora_meandrina_HIv1___TS.g11524.t1,three_way,76.6565,FUN_028185-T1,Q86YW9,MD12L_HUMAN,,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),Homo sapiens (Human),39.9,1865.0,0.0,1122.5,sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2,GO:0003713; GO:0008013; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592],beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],GO:0006355; GO:0060090; GO:0140110,regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_06241,1.6972175710694068,FUN_028229-T1,Peve_00015265,Pocillopora_meandrina_HIv1___TS.g10556.t1,three_way,86.2135,FUN_028229-T1,Q9H172,ABCG4_HUMAN,,ATP-binding cassette sub-family G member 4 (EC 7.6.2.-),Homo sapiens (Human),58.5,602.0,8.9e-191,668.3,sp|Q9H172|ABCG4_HUMAN ATP-binding cassette sub-family G member 4 OS=Homo sapiens OX=9606 GN=ABCG4 PE=1 SV=2,GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830,cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; transmembrane transport [GO:0055085],cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005886; GO:0006355; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06246,2.4566702233360758,FUN_028241-T1,Peve_00019542,Pocillopora_meandrina_HIv1___RNAseq.g15522.t1,three_way,71.78316666666666,FUN_028241-T1,Q155Q3,DIXC1_HUMAN,,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Homo sapiens (Human),41.1,725.0,4.900000000000001e-71,270.8,sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2,GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978,canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725],actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904],GO:0005829; GO:0008092; GO:0034330; GO:0048870,cytosol; cytoskeletal protein binding; cell junction organization; cell motility
OG_06256,1.7667280670552503,FUN_028272-T1,Peve_00005744,Pocillopora_meandrina_HIv1___RNAseq.g15508.t1,three_way,60.34533333333333,,,,,,,,,,,,,,,,,
OG_06261,1.1497355535068796,FUN_028279-T1,Peve_00003674,Pocillopora_meandrina_HIv1___RNAseq.g15496.t1,three_way,60.25483333333333,FUN_028279-T1,Q1L8I0,,,,,35.2,687.0,2.8e-90,334.7,sp|Q1L8I0|PUS7L_DANRE Pseudouridylate synthase PUS7L OS=Danio rerio OX=7955 GN=pus7l PE=2 SV=1,,,,,,
OG_06262,1.1554691980600875,FUN_028287-T1,Peve_00003672,Pocillopora_meandrina_HIv1___RNAseq.g15495.t1,three_way,73.47366666666667,FUN_028287-T1,Q8K1K9,HINFP_MOUSE,,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),Mus musculus (Mouse),50.1,413.0,4.2e-106,386.7,sp|Q8K1K9|HINFP_MOUSE Histone H4 transcription factor OS=Mus musculus OX=10090 GN=Hinfp PE=2 SV=3,GO:0000077; GO:0000082; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893,cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355],Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; transcription regulator activity
OG_06266,1.3449515676124209,FUN_028293-T1,Peve_00000716,Pocillopora_meandrina_HIv1___TS.g10567.t1,three_way,55.41733333333333,FUN_028293-T1,G5EBF1,SAX3_CAEEL,,Protein sax-3 (Sensory axon guidance 3),Caenorhabditis elegans,24.9,887.0,4.3e-42,175.6,sp|G5EBF1|SAX3_CAEEL Protein sax-3 OS=Caenorhabditis elegans OX=6239 GN=sax-3 PE=2 SV=1,GO:0001764; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0030424; GO:0033563; GO:0035385; GO:0097374; GO:0098609; GO:1905489,axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374],axon [GO:0030424]; cytosol [GO:0005829]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046],GO:0005829; GO:0005886; GO:0007155; GO:0048870; GO:0060089,cytosol; plasma membrane; cell adhesion; cell motility; molecular transducer activity
OG_06277,1.2563923276944045,FUN_028316-T1,Peve_00040892,Pocillopora_meandrina_HIv1___RNAseq.g16390.t1,three_way,51.38133333333333,FUN_028316-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),41.5,325.0,2.4e-68,261.9,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06280,1.238083572780739,FUN_028449-T1,Peve_00031080,Pocillopora_meandrina_HIv1___TS.g11207.t1,three_way,39.0405,FUN_028449-T1,Q62718,NTRI_RAT,,Neurotrimin (GP65),Rattus norvegicus (Rat),31.4,204.0,2.4e-18,95.9,sp|Q62718|NTRI_RAT Neurotrimin OS=Rattus norvegicus OX=10116 GN=Ntm PE=1 SV=1,GO:0005615; GO:0007155; GO:0009986; GO:0010976; GO:0010977; GO:0021549; GO:0030424; GO:0032355; GO:0042802; GO:0048471; GO:0048787; GO:0060076; GO:0060253; GO:0071392; GO:0098552; GO:0098686; GO:0098839; GO:1900149,cell adhesion [GO:0007155]; cellular response to estradiol stimulus [GO:0071392]; cerebellum development [GO:0021549]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron projection development [GO:0010977]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Schwann cell migration [GO:1900149]; response to estradiol [GO:0032355],axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; side of membrane [GO:0098552],identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0048856,extracellular space; cell adhesion; anatomical structure development
OG_06283,2.6356118777453243,FUN_028468-T1,Peve_00036785,Pocillopora_meandrina_HIv1___RNAseq.g16127.t1,three_way,61.769666666666666,FUN_028468-T1,Q17LW0,,,,,35.2,577.0,2.8e-92,340.9,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06284,2.6806731485835247,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06286,1.2086780149051684,FUN_028473-T1,Peve_00023657,Pocillopora_meandrina_HIv1___RNAseq.g16117.t1,three_way,88.432,FUN_028473-T1,O60573,IF4E2_HUMAN,,Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3),Homo sapiens (Human),76.0,179.0,2.2e-80,300.4,sp|O60573|IF4E2_HUMAN Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1,GO:0000339; GO:0000340; GO:0000932; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016281; GO:0017148; GO:0031625; GO:0035278; GO:0045947; GO:0060339; GO:0072344; GO:0098808,miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; rescue of stalled ribosome [GO:0072344]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; P-body [GO:0000932],"mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]",GO:0003723; GO:0005829; GO:0031047; GO:0043226,RNA binding; cytosol; regulatory ncRNA-mediated gene silencing; organelle
OG_06288,1.8084058605180768,FUN_028482-T1,Peve_00039731,Pocillopora_meandrina_HIv1___RNAseq.11963_t,three_way,70.764,FUN_028482-T1,Q9NYR8,,,,,45.3,287.0,1.1000000000000001e-60,235.0,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_06293,1.1020113883023024,FUN_028491-T1,Peve_00015137,Pocillopora_meandrina_HIv1___RNAseq.g20858.t1,three_way,70.98166666666667,FUN_028491-T1,Q6P4R8,NFRKB_HUMAN,,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G),Homo sapiens (Human),75.4,167.0,3.6999999999999996e-68,260.4,sp|Q6P4R8|NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein OS=Homo sapiens OX=9606 GN=NFRKB PE=1 SV=2,GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; protease binding [GO:0002020],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_06295,1.8609222970508217,FUN_028495-T1,Peve_00019600,Pocillopora_meandrina_HIv1___RNAseq.g16122.t1,three_way,80.23233333333333,FUN_028495-T1,Q9CQ92,FIS1_MOUSE,,Mitochondrial fission 1 protein (FIS1 homolog) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11),Mus musculus (Mouse),46.9,147.0,1.1e-32,141.0,sp|Q9CQ92|FIS1_MOUSE Mitochondrial fission 1 protein OS=Mus musculus OX=10090 GN=Fis1 PE=1 SV=1,GO:0000266; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0006626; GO:0006915; GO:0007005; GO:0016559; GO:0032991; GO:0042802; GO:1903579; GO:2000192; GO:2001244,apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of fatty acid transport [GO:2000192]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein targeting to mitochondrion [GO:0006626],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802],GO:0005739; GO:0005777; GO:0007005; GO:0012501; GO:0043226,mitochondrion; peroxisome; mitochondrion organization; programmed cell death; organelle
OG_06310,2.472388660144479,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06316,1.3882239852944314,FUN_028658-T1,Peve_00027144,Pocillopora_meandrina_HIv1___TS.g27058.t1,three_way,39.778333333333336,,,,,,,,,,,,,,,,,
OG_06318,1.691995691690929,FUN_028794-T1,Peve_00000751,Pocillopora_meandrina_HIv1___RNAseq.g20732.t1,three_way,77.11333333333333,FUN_028794-T1,Q9W352,,,,,39.9,313.0,1.9e-21,104.8,sp|Q9W352|CXXC1_DROME CXXC-type zinc finger protein 1 OS=Drosophila melanogaster OX=7227 GN=Cfp1 PE=1 SV=1,,,,,,
OG_06319,2.117100688524907,FUN_028795-T1,Peve_00000745,Pocillopora_meandrina_HIv1___RNAseq.g20731.t1,three_way,70.815,FUN_028795-T1,P52756,RBM5_HUMAN,,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),Homo sapiens (Human),39.6,768.0,1.8e-75,285.8,sp|P52756|RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0006915; GO:0008270; GO:0008285; GO:0043065; GO:0043231,"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0012501; GO:0016071; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; programmed cell death; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06325,2.3327547018737853,FUN_028843-T1,Peve_00024571,Pocillopora_meandrina_HIv1___RNAseq.g20712.t1,three_way,79.26683333333334,FUN_028843-T1,Q32M08,DUS4L_MOUSE,,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.90) (tRNA-dihydrouridine synthase 4-like),Mus musculus (Mouse),60.2,299.0,5e-110,399.1,sp|Q32M08|DUS4L_MOUSE tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Mus musculus OX=10090 GN=Dus4l PE=2 SV=1,GO:0002943; GO:0050660; GO:0102266; GO:0102267,tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; tRNA-dihydrouridine20a synthase activity [GO:0102266]; tRNA-dihydrouridine20b synthase activity [GO:0102267],GO:0003824; GO:0006399; GO:0016491; GO:0140098,"catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_06327,1.1395205573227225,FUN_028847-T1,Peve_00044608,Pocillopora_meandrina_HIv1___RNAseq.g12800.t1,three_way,69.94233333333334,,,,,,,,,,,,,,,,,
OG_06338,1.370649707010028,FUN_028897-T1,Peve_00027290,Pocillopora_meandrina_HIv1___RNAseq.g25674.t1,three_way,93.493,FUN_028897-T1,A8WIP6,CDK20_DANRE,,Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20),Danio rerio (Zebrafish) (Brachydanio rerio),79.6,334.0,1.2e-152,540.8,sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio OX=7955 GN=cdk20 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271],cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_06340,1.4311844006040193,FUN_028905-T1,Peve_00042688,Pocillopora_meandrina_HIv1___RNAseq.g25682.t1,three_way,65.59266666666667,,,,,,,,,,,,,,,,,
OG_06348,1.3720662703563022,FUN_028918-T1,Peve_00028028,Pocillopora_meandrina_HIv1___TS.g9367.t1,three_way,84.30666666666667,FUN_028918-T1,A7RX26,HUTI_NEMVE,,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),Nematostella vectensis (Starlet sea anemone),71.0,317.0,6.6e-131,468.4,sp|A7RX26|HUTI_NEMVE Probable imidazolonepropionase OS=Nematostella vectensis OX=45351 GN=amdhd1 PE=3 SV=1,GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872],GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_06354,1.7377789083491124,FUN_028947-T1,Peve_00026866,Pocillopora_meandrina_HIv1___RNAseq.g25582.t1,three_way,71.633,FUN_028947-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),39.5,390.0,6.4e-67,256.1,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_06357,1.4104019627389046,FUN_028953-T1,Peve_00025108,Pocillopora_meandrina_HIv1___RNAseq.g25579.t1,three_way,77.653,FUN_028953-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),43.3,395.0,4.900000000000001e-71,270.0,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06360,1.7705237829375429,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_06361,1.7104321205426678,FUN_028965-T1,Peve_00020162,Pocillopora_meandrina_HIv1___RNAseq.g25571.t1,three_way,72.39466666666667,FUN_028965-T1,Q9Y2M2,SSUH2_HUMAN,,Protein SSUH2 homolog (Protein ssu-2 homolog),Homo sapiens (Human),38.1,357.0,7.200000000000001e-44,179.5,sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0031072; GO:0042476; GO:0051082,odontogenesis [GO:0042476],cytoplasm [GO:0005737]; nucleus [GO:0005634],heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082],GO:0005634; GO:0043226,nucleus; organelle
OG_06362,1.5593705021006066,FUN_028966-T1,Peve_00020164,Pocillopora_meandrina_HIv1___RNAseq.g25572.t1,three_way,56.937333333333335,,,,,,,,,,,,,,,,,
OG_06367,1.8034947384040565,FUN_028971-T1,Peve_00006112,Pocillopora_meandrina_HIv1___RNAseq.g25601.t1,three_way,69.34566666666667,FUN_028971-T1,Q80TM9,NISCH_MOUSE,,Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor I-1-like protein) (Imidazoline-1 receptor) (I1R),Mus musculus (Mouse),25.1,343.0,6e-15,85.5,sp|Q80TM9|NISCH_MOUSE Nischarin OS=Mus musculus OX=10090 GN=Nisch PE=1 SV=2,GO:0005178; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0045171; GO:0055037,actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601],cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091],GO:0005654; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008289; GO:0012501; GO:0031410; GO:0043226,nucleoplasm; endosome; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; lipid binding; programmed cell death; cytoplasmic vesicle; organelle
OG_06369,1.4337938389484062,FUN_028973-T1,Peve_00031293,Pocillopora_meandrina_HIv1___RNAseq.g25606.t1,three_way,43.651833333333336,,,,,,,,,,,,,,,,,
OG_06373,2.9764637655129422,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06375,1.4890835516190342,FUN_028980-T1,Peve_00015446,Pocillopora_meandrina_HIv1___RNAseq.g25620.t1,three_way,72.642,FUN_028980-T1,Q9UHQ4,BAP29_HUMAN,,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),Homo sapiens (Human),47.0,168.0,9.6e-32,138.7,sp|Q9UHQ4|BAP29_HUMAN B-cell receptor-associated protein 29 OS=Homo sapiens OX=9606 GN=BCAP29 PE=1 SV=2,GO:0001649; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0070973,apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,GO:0006886; GO:0012501; GO:0016192; GO:0030154,intracellular protein transport; programmed cell death; vesicle-mediated transport; cell differentiation
OG_06385,1.4783083731965367,FUN_029018-T1,Peve_00028035,Pocillopora_meandrina_HIv1___TS.g9259.t2,three_way,56.882666666666665,FUN_029018-T1,Q6IC98,GRAM4_HUMAN,,GRAM domain-containing protein 4 (Death-inducing protein),Homo sapiens (Human),33.6,429.0,2.2e-54,215.3,sp|Q6IC98|GRAM4_HUMAN GRAM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GRAMD4 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006915; GO:0031966; GO:0034164; GO:0043065,apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of apoptotic process [GO:0043065],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],,GO:0005739; GO:0012501; GO:0043226,mitochondrion; programmed cell death; organelle
OG_06404,1.234436471026943,FUN_029078-T1,Peve_00042919,Pocillopora_meandrina_HIv1___RNAseq.g25462.t1,three_way,70.93966666666667,FUN_029078-T1,Q5RCU3,NAPEP_PONAB,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),50.0,346.0,7.099999999999999e-105,382.1,sp|Q5RCU3|NAPEP_PONAB N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Pongo abelii OX=9601 GN=NAPEPLD PE=2 SV=1,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0031901; GO:0048874; GO:0050729; GO:0070290; GO:0070291; GO:0070292; GO:0090336,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; temperature homeostasis [GO:0001659],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06406,1.1529842764356448,FUN_029080-T1,Peve_00012860,Pocillopora_meandrina_HIv1___RNAseq.g25461.t1,three_way,67.50433333333334,FUN_029080-T1,Q6IQ20,NAPEP_HUMAN,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Homo sapiens (Human),54.1,344.0,7.000000000000003e-110,398.7,sp|Q6IQ20|NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens OX=9606 GN=NAPEPLD PE=1 SV=2,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0030868; GO:0031901; GO:0032052; GO:0035900; GO:0042622; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0098686; GO:1903999,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; smooth endoplasmic reticulum membrane [GO:0030868],bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06409,1.4699587907948075,FUN_029091-T1,Peve_00033472,Pocillopora_meandrina_HIv1___RNAseq.g25753.t1,three_way,63.12366666666667,FUN_029091-T1,Q8R4U0,STAB2_MOUSE,,"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2]",Mus musculus (Mouse),35.9,2141.0,2.6e-153,545.8,sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1,GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0050830,cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044],GO:0005829; GO:0007155; GO:0016192; GO:0038024; GO:1901135,cytosol; cell adhesion; vesicle-mediated transport; cargo receptor activity; carbohydrate derivative metabolic process
OG_06420,1.0447766400494725,FUN_029108-T1,Peve_00017655,Pocillopora_meandrina_HIv1___RNAseq.g25465.t1,three_way,91.391,FUN_029108-T1,Q3SZ71,MPPB_BOVIN,,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP),Bos taurus (Bovine),69.1,469.0,1.3000000000000006e-186,654.1,sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06421,2.946953939926505,FUN_029110-T1,Peve_00004670,Pocillopora_meandrina_HIv1___RNAseq.g25754.t1,three_way,87.27333333333334,FUN_029110-T1,Q99LW6,,,,,52.4,143.0,9.8e-29,127.9,sp|Q99LW6|YAF2_MOUSE YY1-associated factor 2 OS=Mus musculus OX=10090 GN=Yaf2 PE=1 SV=1,,,,,,
OG_06422,1.7711775173490945,FUN_029111-T1,Peve_00004671,Pocillopora_meandrina_HIv1___TS.g9201.t1,three_way,50.54466666666666,FUN_029111-T1,Q9NS91,RAD18_HUMAN,,E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18),Homo sapiens (Human),32.9,523.0,3.6999999999999998e-56,221.1,sp|Q9NS91|RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens OX=9606 GN=RAD18 PE=1 SV=2,GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0008270; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0044877; GO:0051865; GO:0051984; GO:0061630; GO:0097505,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06424,1.2890479244289628,FUN_029113-T1,Peve_00013129,Pocillopora_meandrina_HIv1___RNAseq.g25757.t1,three_way,79.15533333333333,FUN_029113-T1,A7RK30,,,,,66.5,364.0,2.7e-136,486.5,sp|A7RK30|QORL2_NEMVE Quinone oxidoreductase-like protein 2 homolog OS=Nematostella vectensis OX=45351 GN=v1g238856 PE=3 SV=1,,,,,,
OG_06427,1.6028099332651402,FUN_029117-T1,Peve_00013133,Pocillopora_meandrina_HIv1___RNAseq.g25773.t1,three_way,89.271,FUN_029117-T1,Q6NYH1,IF122_DANRE,,Intraflagellar transport protein 122 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),70.9,1191.0,0.0,1824.3,sp|Q6NYH1|IF122_DANRE Intraflagellar transport protein 122 homolog OS=Danio rerio OX=7955 GN=ift122 PE=2 SV=1,GO:0001823; GO:0005737; GO:0005929; GO:0007507; GO:0008589; GO:0008594; GO:0030991; GO:0032402; GO:0035721; GO:0036064; GO:0036372; GO:0042073; GO:0045494; GO:0045879; GO:0048593; GO:0060271; GO:0061512; GO:0097730; GO:1905515,camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; melanosome transport [GO:0032402]; mesonephros development [GO:0001823]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; opsin transport [GO:0036372]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_06438,2.036034801173561,FUN_029139-T1,Peve_00041022,Pocillopora_meandrina_HIv1___TS.g9187.t2,three_way,76.01066666666667,FUN_029139-T1,Q9H1D0,TRPV6_HUMAN,,Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2),Homo sapiens (Human),27.6,566.0,5.5e-48,194.1,sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592],calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06442,1.448376719813378,FUN_029149-T1,Peve_00000508,Pocillopora_meandrina_HIv1___RNAseq.g25732.t1,three_way,83.18866666666666,FUN_029149-T1,Q62717,,,,,54.3,1182.0,0.0,1248.0,sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1,,,,,,
OG_06448,1.8253139095687765,FUN_029167-T1,Peve_00000513,Pocillopora_meandrina_HIv1___RNAseq.g25650.t1,three_way,55.28533333333333,,,,,,,,,,,,,,,,,
OG_06451,1.14950843680368,FUN_029171-T1,Peve_00042456,Pocillopora_meandrina_HIv1___RNAseq.g25478.t1,three_way,65.962,FUN_029171-T1,Q9UHD2,TBK1_HUMAN,,Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1),Homo sapiens (Human),42.0,628.0,2.1000000000000002e-125,451.4,sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1,GO:0002218; GO:0002753; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010508; GO:0010629; GO:0016236; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1902554; GO:1904262; GO:1904263; GO:1904417; GO:1904515,activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0002376; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006914; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; autophagy; inflammatory response; transferase activity; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_06453,1.692881066854191,FUN_029174-T1,Peve_00015171,Pocillopora_meandrina_HIv1___TS.g8934.t1,three_way,64.79366666666667,FUN_029174-T1,Q62277,SYPH_MOUSE,,Synaptophysin (BM89 antigen) (Major synaptic vesicle protein p38),Mus musculus (Mouse),30.8,240.0,2.2000000000000004e-28,127.5,sp|Q62277|SYPH_MOUSE Synaptophysin OS=Mus musculus OX=10090 GN=Syp PE=1 SV=2,GO:0006897; GO:0007268; GO:0008021; GO:0010807; GO:0015485; GO:0016020; GO:0017075; GO:0030672; GO:0031594; GO:0042169; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044306; GO:0045202; GO:0048169; GO:0048172; GO:0048471; GO:0048786; GO:0050804; GO:0060076; GO:0060203; GO:0098685; GO:0098793; GO:2000474,chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; modulation of chemical synaptic transmission [GO:0050804]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807],clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; excitatory synapse [GO:0060076]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195],cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; syntaxin-1 binding [GO:0017075],GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226,lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle
OG_06455,1.2986048088725175,FUN_029177-T1,Peve_00031203,Pocillopora_meandrina_HIv1___TS.g8937.t1,three_way,73.50366666666666,FUN_029177-T1,Q9DC53,,,,,63.0,519.0,6.399999999999999e-190,665.2,sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3,,,,,,
OG_06459,1.2869804030312533,FUN_029188-T1,Peve_00031212,Pocillopora_meandrina_HIv1___RNAseq.g25507.t1,three_way,58.37133333333333,FUN_029188-T1,P70677,,,,,38.7,261.0,3.4999999999999996e-43,177.2,sp|P70677|CASP3_MOUSE Caspase-3 OS=Mus musculus OX=10090 GN=Casp3 PE=1 SV=1,,,,,,
OG_06461,1.874298301800537,FUN_029192-T1,Peve_00028753,Pocillopora_meandrina_HIv1___RNAseq.g25516.t1,three_way,63.91766666666667,,,,,,,,,,,,,,,,,
OG_06464,2.904557202137799,FUN_029195-T1,Peve_00025427,Pocillopora_meandrina_HIv1___RNAseq.g25521.t1,three_way,69.22866666666667,,,,,,,,,,,,,,,,,
OG_06465,1.4972111692184924,FUN_029196-T1,Peve_00004309,Pocillopora_meandrina_HIv1___RNAseq.g25522.t1,three_way,39.9695,FUN_029196-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),29.6,213.0,2.1e-13,79.3,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_06466,1.592098410225683,FUN_029197-T1,Peve_00004308,Pocillopora_meandrina_HIv1___RNAseq.g25524.t1,three_way,73.50966666666666,FUN_029197-T1,P0AGF8,,,,,30.2,235.0,9.5e-21,102.1,sp|P0AGF8|TDCB_ECO57 L-threonine dehydratase catabolic TdcB OS=Escherichia coli O157:H7 OX=83334 GN=tdcB PE=3 SV=1,,,,,,
OG_06467,1.169883425229588,FUN_029198-T1,Peve_00004307,Pocillopora_meandrina_HIv1___RNAseq.g25525.t1,three_way,50.453833333333336,,,,,,,,,,,,,,,,,
OG_06469,2.1252298822360816,FUN_029208-T1,Peve_00013633,Pocillopora_meandrina_HIv1___RNAseq.g25538.t1,three_way,48.8415,,,,,,,,,,,,,,,,,
OG_06472,2.029073121715762,FUN_029234-T1,Peve_00045061,Pocillopora_meandrina_HIv1___RNAseq.g25553.t1,three_way,64.42733333333334,FUN_029234-T1,O15427,MOT4_HUMAN,,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),Homo sapiens (Human),27.4,398.0,5.9999999999999996e-40,166.8,sp|O15427|MOT4_HUMAN Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,GO:0003723; GO:0005886; GO:0008028; GO:0015650; GO:0015718; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035873; GO:0035879; GO:0042867; GO:0050833; GO:1901475,lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],lactate:proton symporter activity [GO:0015650]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; RNA binding [GO:0003723],GO:0003723; GO:0005215; GO:0005886; GO:0055085,RNA binding; transporter activity; plasma membrane; transmembrane transport
OG_06474,2.6641804192228684,FUN_029241-T1,Peve_00013753,Pocillopora_meandrina_HIv1___RNAseq.g25410.t1,three_way,73.27116666666666,FUN_029241-T1,Q9D8P7,,,,,39.5,119.0,5.8e-17,88.6,sp|Q9D8P7|TF3C6_MOUSE General transcription factor 3C polypeptide 6 OS=Mus musculus OX=10090 GN=Gtf3c6 PE=2 SV=1,,,,,,
OG_06478,2.259006572632368,FUN_029246-T1,Peve_00013747,Pocillopora_meandrina_HIv1___RNAseq.g25404.t1,three_way,78.42166666666667,FUN_029246-T1,Q9Y2I9,TBC30_HUMAN,,TBC1 domain family member 30,Homo sapiens (Human),49.0,569.0,8.899999999999999e-139,496.1,sp|Q9Y2I9|TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens OX=9606 GN=TBC1D30 PE=1 SV=2,GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0016604; GO:0031267; GO:0036064; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; plasma membrane; cilium; organelle; molecular function regulator activity
OG_06479,1.3968397279319131,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06481,1.0073187922414897,FUN_029252-T1,Peve_00024381,Pocillopora_meandrina_HIv1___RNAseq.g15018.t1,three_way,65.63983333333334,FUN_029252-T1,Q3UGP8,,,,,44.5,465.0,1.6999999999999998e-92,341.3,"sp|Q3UGP8|AG10B_MOUSE Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase OS=Mus musculus OX=10090 GN=Alg10b PE=1 SV=1",,,,,,
OG_06489,1.951141994796779,FUN_029264-T1,Peve_00030745,Pocillopora_meandrina_HIv1___RNAseq.g15034.t1,three_way,71.40766666666667,,,,,,,,,,,,,,,,,
OG_06494,2.2778271381027504,FUN_029275-T1,Peve_00030743,Pocillopora_meandrina_HIv1___RNAseq.g15044.t1,three_way,76.801,FUN_029275-T1,Q9SLX0,,,,,29.3,188.0,5.7e-16,86.7,sp|Q9SLX0|IMA1B_ORYSJ Importin subunit alpha-1b OS=Oryza sativa subsp. japonica OX=39947 GN=Os05g0155601 PE=1 SV=2,,,,,,
OG_06496,1.452936213745661,FUN_029277-T1,Peve_00030739,Pocillopora_meandrina_HIv1___RNAseq.g25413.t1,three_way,84.80083333333334,FUN_029277-T1,Q16829,DUS7_HUMAN,,Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2),Homo sapiens (Human),44.7,358.0,9e-73,275.4,sp|Q16829|DUS7_HUMAN Dual specificity protein phosphatase 7 OS=Homo sapiens OX=9606 GN=DUSP7 PE=1 SV=4,GO:0000165; GO:0004722; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008138; GO:0008330; GO:0017017; GO:0033550; GO:0035335; GO:0043407; GO:0070371; GO:0070373,ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_06509,1.153173026259168,FUN_029306-T2,Peve_00040799,Pocillopora_meandrina_HIv1___RNAseq.g12583.t1,three_way,74.93816666666666,FUN_029306-T2,O55164,MPDZ_RAT,,Multiple PDZ domain protein (Multi-PDZ domain protein 1),Rattus norvegicus (Rat),35.8,2259.0,2.8000000000000002e-304,1047.0,sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1,GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192,cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202],,GO:0005886; GO:0006886; GO:0007155; GO:0031410; GO:0034330; GO:0043226; GO:0048856,plasma membrane; intracellular protein transport; cell adhesion; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development
OG_06513,2.3673739448027047,FUN_029310-T1,Peve_00038264,Pocillopora_meandrina_HIv1___RNAseq.g12579.t1,three_way,89.39833333333333,FUN_029310-T1,O00139,KIF2A_HUMAN,,Kinesin-like protein KIF2A (Kinesin-2) (hK2),Homo sapiens (Human),53.7,709.0,1.3e-187,657.9,sp|O00139|KIF2A_HUMAN Kinesin-like protein KIF2A OS=Homo sapiens OX=9606 GN=KIF2A PE=1 SV=3,GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0036064; GO:0051301; GO:0072686; GO:0090307; GO:0120103,cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleoplasm; nucleolus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_06522,4.188560633879146,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_06526,2.2982223621197035,FUN_029345-T1,Peve_00023375,Pocillopora_meandrina_HIv1___RNAseq.g17294.t1,three_way,65.33866666666667,FUN_029345-T1,Q6PB03,PLD3_XENLA,,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3),Xenopus laevis (African clawed frog),48.3,445.0,6.4e-117,422.5,sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1,GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015,immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202],single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145],GO:0002376; GO:0003824; GO:0006954; GO:0016787; GO:0030154; GO:0140097,"immune system process; catalytic activity; inflammatory response; hydrolase activity; cell differentiation; catalytic activity, acting on DNA"
OG_06528,1.914800710428025,FUN_029357-T1,Peve_00023328,Pocillopora_meandrina_HIv1___RNAseq.g17291.t1,three_way,87.65433333333334,FUN_029357-T1,Q9UIJ7,KAD3_HUMAN,,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",Homo sapiens (Human),57.9,209.0,2.1e-67,256.9,"sp|Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016874; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899,ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; ligase activity [GO:0016874]; nucleoside triphosphate adenylate kinase activity [GO:0046899],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06533,2.122708079346874,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,55.2,87.0,8.5e-18,94.4,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06533,2.122708079346874,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,56.2,48.0,2e-06,56.6,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06536,1.6938432473234373,FUN_029396-T1,Peve_00044520,Pocillopora_meandrina_HIv1___RNAseq.g17138.t1,three_way,63.98033333333333,FUN_029396-T1,Q7SZC5,,,,,32.8,673.0,7.2e-84,313.2,sp|Q7SZC5|NDC1_DANRE Nucleoporin NDC1 OS=Danio rerio OX=7955 GN=ndc1 PE=2 SV=1,,,,,,
OG_06538,2.516657907558324,FUN_029400-T1,Peve_00044529,Pocillopora_meandrina_HIv1___RNAseq.g17141.t1,three_way,71.86333333333333,FUN_029400-T1,Q7T3H9,,,,,41.9,265.0,5.600000000000001e-59,229.2,sp|Q7T3H9|HYI_DANRE Putative hydroxypyruvate isomerase OS=Danio rerio OX=7955 GN=hyi PE=2 SV=2,,,,,,
OG_06539,1.3830420032775674,FUN_029401-T1,Peve_00044530,Pocillopora_meandrina_HIv1___RNAseq.g17142.t1,three_way,73.958,,,,,,,,,,,,,,,,,
OG_06540,1.8696985542954605,FUN_029404-T2,Peve_00044518,Pocillopora_meandrina_HIv1___RNAseq.g17143.t1,three_way,73.2395,FUN_029404-T2,Q5ZLX5,,,,,66.9,136.0,1.8e-50,200.7,sp|Q5ZLX5|ZRAB2_CHICK Zinc finger Ran-binding domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ZRANB2 PE=2 SV=1,,,,,,
OG_06541,1.952972880630659,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_06542,1.207024937376358,FUN_029410-T1,Peve_00004978,Pocillopora_meandrina_HIv1___RNAseq.g19537.t1,three_way,82.68033333333334,FUN_029410-T1,Q3T0P6,PGK1_BOVIN,,Phosphoglycerate kinase 1 (EC 2.7.11.1) (EC 2.7.2.3),Bos taurus (Bovine),69.6,411.0,1.9e-162,573.5,sp|Q3T0P6|PGK1_BOVIN Phosphoglycerate kinase 1 OS=Bos taurus OX=9913 GN=PGK1 PE=2 SV=3,GO:0004618; GO:0004674; GO:0005524; GO:0005615; GO:0005759; GO:0005829; GO:0006094; GO:0006096; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0044325; GO:0045121; GO:0046872; GO:0047134; GO:0061621; GO:0071456; GO:0106310; GO:0160218,canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0160218]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639],cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; mitochondrial matrix [GO:0005759],ADP binding [GO:0043531]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoglycerate kinase activity [GO:0004618]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005615; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0016740; GO:0030154; GO:0051604; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; extracellular space; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; transferase activity; cell differentiation; protein maturation; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06549,1.3581493663490367,FUN_029421-T1,Peve_00005727,Pocillopora_meandrina_HIv1___RNAseq.g17180.t1,three_way,63.6955,,,,,,,,,,,,,,,,,
OG_06550,1.244950117188138,FUN_029422-T1,Peve_00005721,Pocillopora_meandrina_HIv1___RNAseq.g17177.t2,three_way,42.010666666666665,,,,,,,,,,,,,,,,,
OG_06555,1.2306295821611213,FUN_029434-T1,Peve_00039460,Pocillopora_meandrina_HIv1___RNAseq.g17170.t1,three_way,82.005,FUN_029434-T1,Q2TA24,VATO_BOVIN,,V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c''),Bos taurus (Bovine),62.9,197.0,5.8e-62,238.8,sp|Q2TA24|VATO_BOVIN V-type proton ATPase 21 kDa proteolipid subunit c'' OS=Bos taurus OX=9913 GN=ATP6V0B PE=1 SV=1,GO:0000220; GO:0005768; GO:0016020; GO:0030665; GO:0045851; GO:0046961; GO:1902600,pH reduction [GO:0045851]; proton transmembrane transport [GO:1902600],"clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; endosome; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06557,2.2869719702562468,FUN_029439-T1,Peve_00028189,Pocillopora_meandrina_HIv1___RNAseq.g17153.t1,three_way,82.17283333333333,FUN_029439-T1,Q91X83,,,,,67.5,381.0,1.1e-154,547.7,sp|Q91X83|METK1_MOUSE S-adenosylmethionine synthase isoform type-1 OS=Mus musculus OX=10090 GN=Mat1a PE=1 SV=1,,,,,,
OG_06562,1.0667799104634403,FUN_029451-T1,Peve_00018719,Pocillopora_meandrina_HIv1___RNAseq.g17159.t1,three_way,61.97333333333333,FUN_029451-T1,Q61469,,,,,38.3,256.0,1.1e-40,168.7,sp|Q61469|PLPP1_MOUSE Phospholipid phosphatase 1 OS=Mus musculus OX=10090 GN=Plpp1 PE=1 SV=1,,,,,,
OG_06574,1.3594349069419085,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_06578,1.3738582725475392,FUN_029525-T1,Peve_00010677,Pocillopora_meandrina_HIv1___RNAseq.g17107.t1,three_way,53.90266666666667,FUN_029525-T1,A8Y5U1,,,,,35.4,285.0,9.9e-41,168.7,sp|A8Y5U1|RIMC1_DANRE RAB7A-interacting MON1-CCZ1 complex subunit 1 OS=Danio rerio OX=7955 GN=rimoc1 PE=2 SV=1,,,,,,
OG_06581,1.1641750930895818,FUN_029538-T1,Peve_00012818,Pocillopora_meandrina_HIv1___RNAseq.g2589.t1,three_way,73.36083333333333,,,,,,,,,,,,,,,,,
OG_06584,2.1372412129014613,FUN_029556-T1,Peve_00023360,Pocillopora_meandrina_HIv1___TS.g3028.t1,three_way,49.354,,,,,,,,,,,,,,,,,
OG_06588,2.1821023560267885,FUN_029570-T1,Peve_00018824,Pocillopora_meandrina_HIv1___RNAseq.g17256.t1,three_way,51.34166666666667,,,,,,,,,,,,,,,,,
OG_06595,1.03681355506907,FUN_029644-T1,Peve_00038767,Pocillopora_meandrina_HIv1___RNAseq.g17207.t1,three_way,82.503,FUN_029644-T1,Q92113,,,,,43.0,498.0,3.1000000000000003e-119,430.3,"sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_06600,1.7544056477145709,FUN_029706-T1,Peve_00018722,Pocillopora_meandrina_HIv1___RNAseq.g17309.t1,three_way,68.622,FUN_029706-T1,P27792,,,,,53.7,95.0,1.1e-19,97.8,sp|P27792|LYL1_MOUSE Protein lyl-1 OS=Mus musculus OX=10090 GN=Lyl1 PE=2 SV=2,,,,,,
OG_06605,1.156159270122664,FUN_029753-T1,Peve_00031236,Pocillopora_meandrina_HIv1___RNAseq.g17314.t1,three_way,79.57516666666666,FUN_029753-T1,Q5U2Z0,,,,,57.1,205.0,1.3999999999999998e-29,131.7,sp|Q5U2Z0|ZN367_RAT Zinc finger protein 367 OS=Rattus norvegicus OX=10116 GN=Znf367 PE=2 SV=1,,,,,,
OG_06610,1.300480194285104,FUN_029760-T1,Peve_00019501,Pocillopora_meandrina_HIv1___RNAseq.g17234.t1,three_way,80.53166666666667,FUN_029760-T1,Q8NBS3,,,,,44.5,815.0,1.7000000000000001e-178,627.9,sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3,,,,,,
OG_06616,1.1541931239331369,FUN_029772-T1,Peve_00013611,Pocillopora_meandrina_HIv1___RNAseq.g17328.t1a,three_way,49.64566666666666,FUN_029772-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),21.8,458.0,5e-18,94.7,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06621,2.1939385422470328,FUN_029882-T1,Peve_00024289,Pocillopora_meandrina_HIv1___RNAseq.g17341.t1,three_way,72.087,FUN_029882-T1,Q9BT73,,,,,34.5,119.0,2.2e-13,76.6,sp|Q9BT73|PSMG3_HUMAN Proteasome assembly chaperone 3 OS=Homo sapiens OX=9606 GN=PSMG3 PE=1 SV=1,,,,,,
OG_06634,1.0723789596508664,FUN_030182-T1,Peve_00004650,Pocillopora_meandrina_HIv1___RNAseq.g17358.t1,three_way,61.07183333333333,FUN_030182-T1,Q6ZNA5,,,,,30.9,330.0,1.2e-40,169.1,sp|Q6ZNA5|FRRS1_HUMAN Ferric-chelate reductase 1 OS=Homo sapiens OX=9606 GN=FRRS1 PE=1 SV=2,,,,,,
OG_06639,1.918055107047991,FUN_030196-T1,Peve_00004645,Pocillopora_meandrina_HIv1___RNAseq.g17363.t1,three_way,66.36449999999999,FUN_030196-T1,Q8BH88,,,,,31.6,554.0,1.5e-64,248.8,sp|Q8BH88|DEP1B_MOUSE DEP domain-containing protein 1B OS=Mus musculus OX=10090 GN=Depdc1b PE=2 SV=1,,,,,,
OG_06643,2.1046095664818223,FUN_030655-T1,Peve_00043685,Pocillopora_meandrina_HIv1___RNAseq.g30310.t1,three_way,62.553666666666665,FUN_030655-T1,Q80T85,DCAF5_MOUSE,,DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22),Mus musculus (Mouse),49.2,445.0,8.699999999999999e-107,389.4,sp|Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated factor 5 OS=Mus musculus OX=10090 GN=Dcaf5 PE=1 SV=2,GO:0005739; GO:0016567; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_06647,1.142130965756536,FUN_030663-T1,Peve_00043681,Pocillopora_meandrina_HIv1___RNAseq.g30304.t1,three_way,83.89,FUN_030663-T1,P20650,PPM1A_RAT,,Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA),Rattus norvegicus (Rat),54.7,369.0,2.6e-114,413.7,sp|P20650|PPM1A_RAT Protein phosphatase 1A OS=Rattus norvegicus OX=10116 GN=Ppm1a PE=1 SV=1,GO:0000287; GO:0004721; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0006611; GO:0016020; GO:0030145; GO:0030512; GO:0030514; GO:0033192; GO:0043005; GO:0043122; GO:0043124; GO:0044325; GO:0045893; GO:0046827; GO:0070412; GO:0071560; GO:0090263; GO:1901223,cellular response to transforming growth factor beta stimulus [GO:0071560]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634],calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06650,1.3648773010290725,FUN_030671-T1,Peve_00028182,Pocillopora_meandrina_HIv1___RNAseq.g30313.t1,three_way,75.83566666666667,FUN_030671-T1,Q9Y6R9,CCD61_HUMAN,,Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog),Homo sapiens (Human),47.6,296.0,1.5e-58,228.8,sp|Q9Y6R9|CCD61_HUMAN Centrosomal protein CCDC61 OS=Homo sapiens OX=9606 GN=CCDC61 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005815; GO:0008017; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103,cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding
OG_06651,1.4433740710964442,FUN_030672-T1,Peve_00028178,Pocillopora_meandrina_HIv1___RNAseq.g30294.t1,three_way,67.33333333333333,FUN_030672-T1,P55345,ANM2_HUMAN,,Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2),Homo sapiens (Human),46.5,409.0,6.200000000000001e-106,386.0,sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1,GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:0140592; GO:0140938; GO:2000134,chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06652,1.5758587154373704,FUN_030673-T1,Peve_00028169,Pocillopora_meandrina_HIv1___RNAseq.g30328.t1,three_way,63.029,FUN_030673-T1,Q28C69,,,,,49.0,239.0,3.9e-60,233.0,sp|Q28C69|ENOPH_XENTR Enolase-phosphatase E1 OS=Xenopus tropicalis OX=8364 GN=enoph1 PE=2 SV=1,,,,,,
OG_06660,2.202736283411053,FUN_030876-T1,Peve_00043621,Pocillopora_meandrina_HIv1___RNAseq.g30292.t1,three_way,68.59583333333333,FUN_030876-T1,Q96F63,,,,,38.8,289.0,4.3e-33,143.3,sp|Q96F63|CCD97_HUMAN Coiled-coil domain-containing protein 97 OS=Homo sapiens OX=9606 GN=CCDC97 PE=1 SV=1,,,,,,
OG_06661,1.29053163692417,FUN_030880-T1,Peve_00043612,Pocillopora_meandrina_HIv1___RNAseq.g30296.t1,three_way,70.443,,,,,,,,,,,,,,,,,
OG_06668,1.2021891495764423,FUN_031067-T1,Peve_00028134,Pocillopora_meandrina_HIv1___RNAseq.g30320.t1,three_way,70.354,FUN_031067-T1,O89043,,,,,41.5,619.0,1.5e-126,454.9,sp|O89043|DPOA2_RAT DNA polymerase alpha subunit B OS=Rattus norvegicus OX=10116 GN=Pola2 PE=1 SV=2,,,,,,
OG_06669,2.541493829750361,FUN_031068-T1,Peve_00028133,Pocillopora_meandrina_HIv1___RNAseq.g30321.t1,three_way,84.0175,FUN_031068-T1,P05094,,,,,65.8,876.0,0.0,1176.4,sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3,,,,,,
OG_06670,1.7149951786750637,FUN_031070-T1,Peve_00025081,Pocillopora_meandrina_HIv1___RNAseq.g6195.t1,three_way,68.65666666666667,FUN_031070-T1,Q93VC9,,,,,40.9,320.0,1.6e-60,234.6,sp|Q93VC9|CATB2_ARATH Cathepsin B-like protease 2 OS=Arabidopsis thaliana OX=3702 GN=CATHB2 PE=2 SV=1,,,,,,
OG_06672,1.5361094140452796,FUN_031075-T1,Peve_00028138,Pocillopora_meandrina_HIv1___RNAseq.g30319.t1,three_way,66.64233333333333,FUN_031075-T1,P56965,DDAH1_BOVIN,,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)",Bos taurus (Bovine),46.1,269.0,2e-57,224.2,"sp|P56965|DDAH1_BOVIN N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 OS=Bos taurus OX=9913 GN=DDAH1 PE=1 SV=3",GO:0000052; GO:0006525; GO:0006809; GO:0008270; GO:0016403; GO:0016597; GO:0017014; GO:0045429,arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014],,amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_06678,2.0161357255736467,FUN_031081-T1,Peve_00031208,Pocillopora_meandrina_HIv1___RNAseq.g25502.t1,three_way,48.558,,,,,,,,,,,,,,,,,
OG_06679,1.660187220284325,FUN_031085-T1,Peve_00025083,Pocillopora_meandrina_HIv1___RNAseq.g5957.t1,three_way,74.02966666666667,FUN_031085-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),51.6,580.0,2.8e-175,616.7,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06680,3.1329405238318344,FUN_031176-T1,Peve_00016087,Pocillopora_meandrina_HIv1___TS.g23938.t1b,three_way,56.30883333333333,,,,,,,,,,,,,,,,,
OG_06681,1.141324050411158,FUN_031184-T1,Peve_00016090,Pocillopora_meandrina_HIv1___RNAseq.g5221.t1,three_way,48.904,,,,,,,,,,,,,,,,,
OG_06685,3.431219667530583,FUN_031206-T1,Peve_00041864,Pocillopora_meandrina_HIv1___RNAseq.g5212.t1,three_way,67.21766666666666,,,,,,,,,,,,,,,,,
OG_06686,1.2690585705040318,FUN_031212-T1,Peve_00041872,Pocillopora_meandrina_HIv1___RNAseq.g5200.t1,three_way,90.47633333333332,FUN_031212-T1,P36954,RPB9_HUMAN,,DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),Homo sapiens (Human),79.2,125.0,3.3e-55,216.1,sp|P36954|RPB9_HUMAN DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1,GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270,maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06690,1.7313238078942454,FUN_031234-T1,Peve_00040979,Pocillopora_meandrina_HIv1___RNAseq.g22662.t1,three_way,68.60033333333334,FUN_031234-T1,Q9ULQ1,,,,,45.7,750.0,3.3e-152,540.4,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06693,1.6686570141911523,FUN_031241-T1,Peve_00043067,Pocillopora_meandrina_HIv1___RNAseq.g5192.t1,three_way,56.55766666666667,,,,,,,,,,,,,,,,,
OG_06697,1.3570665958562111,FUN_031252-T1,Peve_00015905,Pocillopora_meandrina_HIv1___RNAseq.g5183.t1,three_way,69.73966666666666,FUN_031252-T1,O15033,AREL1_HUMAN,,Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1),Homo sapiens (Human),45.2,814.0,7.6e-194,679.1,sp|O15033|AREL1_HUMAN Apoptosis-resistant E3 ubiquitin protein ligase 1 OS=Homo sapiens OX=9606 GN=AREL1 PE=1 SV=3,GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; cytosol; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_06698,1.2584227970182285,FUN_031263-T1,Peve_00001470,Pocillopora_meandrina_HIv1___RNAseq.g5187.t1,three_way,67.0335,,,,,,,,,,,,,,,,,
OG_06702,2.5451721631911552,FUN_031269-T1,Peve_00036737,Pocillopora_meandrina_HIv1___TS.g23896.t1,three_way,69.62383333333334,FUN_031269-T1,Q3T906,GNPTA_HUMAN,,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],Homo sapiens (Human),39.7,1334.0,1e-257,891.7,sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1,GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835,carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],GO:0003824; GO:0005794; GO:0005975; GO:0007040; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; carbohydrate metabolic process; lysosome organization; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06706,1.3769128834471056,FUN_031286-T1,Peve_00036747,Pocillopora_meandrina_HIv1___RNAseq.g5173.t1,three_way,73.2735,FUN_031286-T1,Q8CHB8,TTLL5_MOUSE,,Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5),Mus musculus (Mouse),44.1,870.0,1.4999999999999998e-189,665.2,sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3,GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; ligase activity; reproductive process; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_06714,1.3647165851953194,FUN_031307-T1,Peve_00026514,Pocillopora_meandrina_HIv1___TS.g23874.t1,three_way,75.132,FUN_031307-T1,Q9CWG8,NDUF7_MOUSE,,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)",Mus musculus (Mouse),50.9,407.0,7.8e-106,385.6,"sp|Q9CWG8|NDUF7_MOUSE Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Mus musculus OX=10090 GN=Ndufaf7 PE=1 SV=4",GO:0005739; GO:0019899; GO:0019918; GO:0032981; GO:0035243,"mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]",mitochondrion [GO:0005739],enzyme binding [GO:0019899]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_06723,1.0882242119349133,FUN_031489-T1,Peve_00026539,Pocillopora_meandrina_HIv1___RNAseq.g5078.t1,three_way,87.43599999999999,FUN_031489-T1,O82018,,,,,70.5,146.0,1.3e-29,131.0,sp|O82018|CALM_MOUSC Calmodulin OS=Mougeotia scalaris OX=13158 PE=2 SV=3,,,,,,
OG_06728,1.1484044356310694,FUN_031501-T1,Peve_00044288,Pocillopora_meandrina_HIv1___RNAseq.g5104.t1,three_way,66.48166666666667,FUN_031501-T1,O58320,,,,,47.3,292.0,1.0000000000000001e-60,235.3,sp|O58320|GYAR_PYRHO Glyoxylate reductase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=gyaR PE=1 SV=2,,,,,,
OG_06729,1.4033611823076344,FUN_031505-T1,Peve_00004810,Pocillopora_meandrina_HIv1___TS.g23831.t2,three_way,48.518166666666666,FUN_031505-T1,Q6L4L4,SIZ1_ORYSJ,,E3 SUMO-protein ligase SIZ1 (EC 2.3.2.-) (E3 SUMO-protein transferase SIZ1),Oryza sativa subsp. japonica (Rice),33.0,109.0,6e-10,66.6,sp|Q6L4L4|SIZ1_ORYSJ E3 SUMO-protein ligase SIZ1 OS=Oryza sativa subsp. japonica OX=39947 GN=SIZ1 PE=1 SV=1,GO:0000785; GO:0005634; GO:0008270; GO:0016925; GO:0061665,protein sumoylation [GO:0016925],chromatin [GO:0000785]; nucleus [GO:0005634],SUMO ligase activity [GO:0061665]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06730,2.0744583640988976,FUN_031507-T1,Peve_00004813,Pocillopora_meandrina_HIv1___RNAseq.g5114.t1,three_way,62.814,FUN_031507-T1,H3ZPL1,,,,,29.4,394.0,3.1e-48,194.1,sp|H3ZPL1|ARAT1_THELN Aromatic-amino-acid aminotransferase 1 OS=Thermococcus litoralis (strain ATCC 51850 / DSM 5473 / JCM 8560 / NS-C) OX=523849 GN=OCC_04335 PE=1 SV=1,,,,,,
OG_06734,1.853161385961248,FUN_031518-T1,Peve_00045248,Pocillopora_meandrina_HIv1___RNAseq.g5120.t1,three_way,47.7075,FUN_031518-T1,D0PRN3,,,,,27.2,463.0,3.3000000000000003e-34,148.3,sp|D0PRN3|NRX3A_CHICK Neurexin-3 OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06735,1.0437346307414173,FUN_031519-T1,Peve_00045247,Pocillopora_meandrina_HIv1___RNAseq.g5126.t1,three_way,70.90833333333333,,,,,,,,,,,,,,,,,
OG_06739,1.0675037839073676,FUN_031526-T1,Peve_00022762,Pocillopora_meandrina_HIv1___RNAseq.g5133.t1,three_way,69.272,FUN_031526-T1,Q99N57,RAF1_MOUSE,,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),Mus musculus (Mouse),31.8,283.0,3.3e-28,127.9,sp|Q99N57|RAF1_MOUSE RAF proto-oncogene serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Raf1 PE=1 SV=2,GO:0000165; GO:0001678; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0008270; GO:0008285; GO:0008286; GO:0008625; GO:0010856; GO:0014044; GO:0030154; GO:0030878; GO:0031143; GO:0031267; GO:0031333; GO:0035019; GO:0035556; GO:0035773; GO:0035994; GO:0038133; GO:0042552; GO:0042802; GO:0043410; GO:0044342; GO:0045104; GO:0045944; GO:0048009; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:0106310; GO:1902042,cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular glucose homeostasis [GO:0001678]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; Schwann cell development [GO:0014044]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; type B pancreatic cell proliferation [GO:0044342],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],adenylate cyclase activator activity [GO:0010856]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; transferase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06750,1.83253807301842,FUN_031559-T1,Peve_00032865,Pocillopora_meandrina_HIv1___RNAseq.g5076.t1,three_way,48.826166666666666,FUN_031559-T1,Q8WXE1,ATRIP_HUMAN,,ATR-interacting protein (ATM and Rad3-related-interacting protein),Homo sapiens (Human),30.7,153.0,1.1e-07,60.8,sp|Q8WXE1|ATRIP_HUMAN ATR-interacting protein OS=Homo sapiens OX=9606 GN=ATRIP PE=1 SV=1,GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779],ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_06751,2.391953809419736,FUN_031560-T1,Peve_00032864,Pocillopora_meandrina_HIv1___TS.g23795.t1,three_way,47.11333333333334,FUN_031560-T1,B1H349,,,,,42.6,68.0,1.3e-06,57.4,sp|B1H349|SOX6_XENTR Transcription factor Sox-6 OS=Xenopus tropicalis OX=8364 GN=sox6 PE=2 SV=1,,,,,,
OG_06752,1.3642823263245518,FUN_031561-T1,Peve_00025442,Pocillopora_meandrina_HIv1___RNAseq.g5074.t2,three_way,66.97466666666666,FUN_031561-T1,Q8TCS8,PNPT1_HUMAN,,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)",Homo sapiens (Human),44.5,366.0,1e-83,312.0,"sp|Q8TCS8|PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2",GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0005840; GO:0006397; GO:0006401; GO:0006402; GO:0007005; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042802; GO:0043457; GO:0045025; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772,cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion organization [GO:0007005]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; rRNA import into mitochondrion [GO:0035928],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosome [GO:0005840],3'-5'-RNA exonuclease activity [GO:0000175]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0005840; GO:0007005; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0065003; GO:0140053; GO:0140098,"RNA binding; catalytic activity; mitochondrion; cytosol; ribosome; mitochondrion organization; mRNA metabolic process; transferase activity; hydrolase activity; organelle; anatomical structure development; transmembrane transport; protein-containing complex assembly; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_06758,1.5456203960334676,FUN_031589-T1,Peve_00021514,Pocillopora_meandrina_HIv1___RNAseq.g5069.t1,three_way,86.82000000000001,FUN_031589-T1,Q561L1,,,,,61.0,438.0,3.8e-161,569.3,sp|Q561L1|PUA1A_XENLA Adenylosuccinate synthetase isozyme 1 A OS=Xenopus laevis OX=8355 GN=adss1-a PE=2 SV=1,,,,,,
OG_06761,1.3400958844742217,FUN_031592-T1,Peve_00012523,Pocillopora_meandrina_HIv1___RNAseq.g5060.t1,three_way,68.10383333333334,FUN_031592-T1,P41823,,,,,25.5,165.0,2.3e-09,64.3,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_06762,1.3325297240930636,FUN_031593-T1,Peve_00012522,Pocillopora_meandrina_HIv1___RNAseq.g5059.t1,three_way,61.513,,,,,,,,,,,,,,,,,
OG_06766,1.6022768434497354,FUN_031605-T1,Peve_00012514,Pocillopora_meandrina_HIv1___RNAseq.g5989.t1,three_way,84.85766666666667,FUN_031605-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),62.1,493.0,2.2999999999999998e-192,673.3,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06769,1.336277505339725,FUN_031627-T1,Peve_00019757,Pocillopora_meandrina_HIv1___RNAseq.g5964.t1,three_way,88.16233333333334,,,,,,,,,,,,,,,,,
OG_06771,2.199723713606774,FUN_031635-T1,Peve_00032682,Pocillopora_meandrina_HIv1___RNAseq.g5688.t1,three_way,60.882666666666665,FUN_031635-T1,Q9DBY8,NVL_MOUSE,,Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein),Mus musculus (Mouse),44.8,562.0,1.9e-102,374.8,sp|Q9DBY8|NVL_MOUSE Nuclear valosin-containing protein-like OS=Mus musculus OX=10090 GN=Nvl PE=1 SV=1,GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0032206; GO:0042254; GO:0042273; GO:1904749; GO:1905323; GO:1990275,positive regulation of protein binding [GO:0032092]; positive regulation of telomere maintenance [GO:0032206]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323],nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0042254; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; ribosome biogenesis; organelle; protein-containing complex assembly
OG_06774,1.1395103697021958,FUN_031639-T1,Peve_00032679,Pocillopora_meandrina_HIv1___TS.g24410.t3b,three_way,82.65466666666667,FUN_031639-T1,Q6NWD4,TIM50_DANRE,,Mitochondrial import inner membrane translocase subunit TIM50,Danio rerio (Zebrafish) (Brachydanio rerio),50.0,268.0,1.1e-68,261.9,sp|Q6NWD4|TIM50_DANRE Mitochondrial import inner membrane translocase subunit TIM50 OS=Danio rerio OX=7955 GN=timm50 PE=2 SV=2,GO:0004722; GO:0004725; GO:0005743; GO:0005744; GO:0006470; GO:0006915; GO:0007006; GO:0030150,apoptotic process [GO:0006915]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150],mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007005; GO:0012501; GO:0016787; GO:0055085; GO:0061024; GO:0140096,"catalytic activity; mitochondrion organization; programmed cell death; hydrolase activity; transmembrane transport; membrane organization; catalytic activity, acting on a protein"
OG_06777,1.7024611602170967,FUN_031643-T1,Peve_00043580,Pocillopora_meandrina_HIv1___RNAseq.g5686.t1,three_way,83.8815,FUN_031643-T1,Q14738,2A5D_HUMAN,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),Homo sapiens (Human),65.9,548.0,3.3e-205,716.1,sp|Q14738|2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Homo sapiens OX=9606 GN=PPP2R5D PE=1 SV=1,GO:0000159; GO:0005634; GO:0005654; GO:0005829; GO:0007165; GO:0007399; GO:0019888; GO:0051177; GO:0072542,meiotic sister chromatid cohesion [GO:0051177]; nervous system development [GO:0007399]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159],protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0048856; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; anatomical structure development; molecular function regulator activity
OG_06778,2.701026002783323,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_06779,2.7781691840025453,FUN_031646-T1,Peve_00043571,Pocillopora_meandrina_HIv1___RNAseq.g5683.t1,three_way,65.723,FUN_031646-T1,A6H7B1,,,,,54.9,144.0,2.7e-34,146.4,sp|A6H7B1|TOM20_BOVIN Mitochondrial import receptor subunit TOM20 homolog OS=Bos taurus OX=9913 GN=TOMM20 PE=2 SV=1,,,,,,
OG_06782,1.1564575731149738,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06783,1.919690418915011,FUN_031650-T1,Peve_00043578,Pocillopora_meandrina_HIv1___TS.g24400.t2b,three_way,70.58166666666666,FUN_031650-T1,Q5R5D8,BODG_PONAB,,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.3,380.0,3e-73,277.3,sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1,GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329,carnitine biosynthetic process [GO:0045329],mitochondrion [GO:0005739],gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_06784,1.46103991147744,FUN_031651-T1,Peve_00017754,Pocillopora_meandrina_HIv1___RNAseq.g5677.t1,three_way,75.48266666666667,FUN_031651-T1,Q9NQX3,GEPH_HUMAN,,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],Homo sapiens (Human),46.9,721.0,2.5e-174,614.4,sp|Q9NQX3|GEPH_HUMAN Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1,GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007416; GO:0007529; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0030425; GO:0030674; GO:0032324; GO:0042802; GO:0043197; GO:0043546; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098982; GO:0099091; GO:0099572; GO:0099645,establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synapse assembly [GO:0007416],"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060]",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0016491; GO:0016740; GO:0034330; GO:0043226; GO:0060090,catalytic activity; cytosol; cytoskeleton; plasma membrane; oxidoreductase activity; transferase activity; cell junction organization; organelle; molecular adaptor activity
OG_06787,1.4319592245764046,FUN_031665-T2,Peve_00015111,Pocillopora_meandrina_HIv1___RNAseq.g5666.t1,three_way,79.292,FUN_031665-T2,Q86TV6,TTC7B_HUMAN,,Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1),Homo sapiens (Human),41.4,751.0,1.1e-137,492.3,sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3,GO:0005829; GO:0005886; GO:0046854; GO:0072659,phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659],cytosol [GO:0005829]; plasma membrane [GO:0005886],,GO:0005829; GO:0005886; GO:0006629; GO:0072659,cytosol; plasma membrane; lipid metabolic process; protein localization to plasma membrane
OG_06792,1.703746762374858,FUN_031678-T1,Peve_00012833,Pocillopora_meandrina_HIv1___RNAseq.g5745.t1,three_way,69.84783333333333,FUN_031678-T1,Q5R4I2,RNF8_PONAB,,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),29.4,446.0,2.1e-21,105.5,sp|Q5R4I2|RNF8_PONAB E3 ubiquitin-protein ligase RNF8 OS=Pongo abelii OX=9601 GN=RNF8 PE=2 SV=1,GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06794,2.105735808472501,FUN_031681-T1,Peve_00012830,Pocillopora_meandrina_HIv1___RNAseq.g5749.t1,three_way,56.66333333333333,,,,,,,,,,,,,,,,,
OG_06796,1.7690464403860495,FUN_031684-T1,Peve_00013836,Pocillopora_meandrina_HIv1___RNAseq.g5778.t1,three_way,57.97633333333333,,,,,,,,,,,,,,,,,
OG_06803,1.308354512617382,FUN_031698-T1,Peve_00008191,Pocillopora_meandrina_HIv1___TS.g24481.t1b,three_way,82.58383333333333,FUN_031698-T1,Q5BIN6,,,,,50.0,164.0,1.1e-39,164.5,sp|Q5BIN6|CNIH1_BOVIN Protein cornichon homolog 1 OS=Bos taurus OX=9913 GN=CNIH1 PE=2 SV=1,,,,,,
OG_06805,2.503160688551848,FUN_031703-T1,Peve_00018219,Pocillopora_meandrina_HIv1___RNAseq.g5760.t1,three_way,62.979,FUN_031703-T1,Q9H1A4,APC1_HUMAN,,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),Homo sapiens (Human),31.9,1180.0,1.5000000000000001e-145,518.8,sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],molecular adaptor activity [GO:0060090],GO:0005654; GO:0005829; GO:0030163; GO:0060090,nucleoplasm; cytosol; protein catabolic process; molecular adaptor activity
OG_06809,1.4793687016425232,FUN_031708-T1,Peve_00002669,Pocillopora_meandrina_HIv1___RNAseq.g5756.t1,three_way,77.23333333333333,FUN_031708-T1,P26642,,,,,62.6,436.0,1.7000000000000001e-134,480.7,sp|P26642|EF1GA_XENLA Elongation factor 1-gamma-A OS=Xenopus laevis OX=8355 GN=eef1g-a PE=1 SV=1,,,,,,
OG_06811,1.5756731824247243,FUN_031711-T1,Peve_00002662,Pocillopora_meandrina_HIv1___RNAseq.g5753.t1a,three_way,72.13733333333333,FUN_031711-T1,Q5RGU1,COQ8A_DANRE,,"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)",Danio rerio (Zebrafish) (Brachydanio rerio),57.9,494.0,3.7e-159,563.1,"sp|Q5RGU1|COQ8A_DANRE Atypical kinase COQ8A, mitochondrial OS=Danio rerio OX=7955 GN=coq8a PE=2 SV=2",GO:0004672; GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031966; GO:0043531,phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744],mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06817,2.1201072726177768,FUN_031723-T1,Peve_00040627,Pocillopora_meandrina_HIv1___RNAseq.g5482.t1,three_way,60.10466666666667,FUN_031723-T1,Q8BH86,,,,,37.3,510.0,3.3e-76,287.3,"sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1",,,,,,
OG_06823,1.0507515131990874,FUN_031733-T1,Peve_00029893,Pocillopora_meandrina_HIv1___RNAseq.g5510.t1,three_way,68.32266666666666,FUN_031733-T1,Q3UDE2,,,,,24.0,492.0,1.4000000000000002e-23,113.2,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_06835,2.0570165946754533,FUN_031753-T1,Peve_00023213,Pocillopora_meandrina_HIv1___RNAseq.g5536.t1,three_way,55.97633333333333,,,,,,,,,,,,,,,,,
OG_06836,2.7148062452958905,FUN_031754-T1,Peve_00023210,Pocillopora_meandrina_HIv1___RNAseq.g5542.t1,three_way,70.37316666666666,FUN_031754-T1,Q8R9T6,,,,,32.9,246.0,1.1e-20,104.0,sp|Q8R9T6|PKN1_CALS4 Probable serine/threonine-protein kinase Sps1 OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=sps1 PE=3 SV=1,,,,,,
OG_06849,1.6100937423756514,FUN_031790-T1,Peve_00019330,Pocillopora_meandrina_HIv1___TS.g24291.t1,three_way,72.05833333333334,,,,,,,,,,,,,,,,,
OG_06851,2.656226004902096,FUN_031800-T1,Peve_00019322,Pocillopora_meandrina_HIv1___RNAseq.g5573.t1,three_way,74.092,FUN_031800-T1,Q99986,VRK1_HUMAN,,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),Homo sapiens (Human),53.3,336.0,1.4000000000000001e-101,371.3,sp|Q99986|VRK1_HUMAN Serine/threonine-protein kinase VRK1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006468; GO:0006974; GO:0007077; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0046777; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222,Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; mitotic nuclear membrane disassembly [GO:0007077]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165],Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; transferase activity; histone binding; organelle; membrane organization; catalytic activity, acting on a protein"
OG_06853,2.465420157877724,FUN_031802-T1,Peve_00030270,Pocillopora_meandrina_HIv1___RNAseq.g5589.t1,three_way,72.05866666666667,FUN_031802-T1,Q0V9J5,,,,,66.4,107.0,1.6999999999999999e-35,150.6,sp|Q0V9J5|EIF1A_XENTR Probable RNA-binding protein EIF1AD OS=Xenopus tropicalis OX=8364 GN=eif1ad PE=2 SV=1,,,,,,
OG_06864,2.358429863827113,FUN_031860-T1,Peve_00011073,Pocillopora_meandrina_HIv1___RNAseq.g5631.t4,three_way,80.47416666666668,FUN_031860-T1,Q86UA1,,,,,44.6,579.0,9.1e-144,512.3,sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3,,,,,,
OG_06866,1.2202141001015017,FUN_031862-T1,Peve_00011064,Pocillopora_meandrina_HIv1___RNAseq.g5635.t1,three_way,61.84783333333333,,,,,,,,,,,,,,,,,
OG_06871,1.0368571766604189,FUN_031874-T1,Peve_00012650,Pocillopora_meandrina_HIv1___RNAseq.g5445.t1b,three_way,69.66433333333333,FUN_031874-T1,A5D6U8,ACP7_DANRE,,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,414.0,1.5e-144,514.2,sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1,GO:0003993; GO:0005576; GO:0046872,,extracellular region [GO:0005576],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_06873,1.219601191634173,FUN_031876-T1,Peve_00012647,Pocillopora_meandrina_HIv1___RNAseq.g5446.t1,three_way,98.995,FUN_031876-T1,P63099,CANB1_BOVIN,,Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1),Bos taurus (Bovine),88.2,170.0,7.999999999999999e-83,307.8,sp|P63099|CANB1_BOVIN Calcineurin subunit B type 1 OS=Bos taurus OX=9913 GN=PPP3R1 PE=1 SV=2,GO:0005509; GO:0005829; GO:0005955; GO:0008597; GO:0019902; GO:0033173; GO:0042383,calcineurin-NFAT signaling cascade [GO:0033173],calcineurin complex [GO:0005955]; cytosol [GO:0005829]; sarcolemma [GO:0042383],calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_06874,2.790807609141508,FUN_031877-T1,Peve_00012644,Pocillopora_meandrina_HIv1___RNAseq.g5447.t1,three_way,82.98033333333333,FUN_031877-T1,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),40.7,685.0,5.4e-154,546.2,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_06875,1.4988604889666013,FUN_031878-T1,Peve_00031835,Pocillopora_meandrina_HIv1___TS.g24761.t1,three_way,73.57633333333334,FUN_031878-T1,Q05973,,,,,36.1,1564.0,1.8000000000000003e-248,861.3,sp|Q05973|SCN1_HETBL Sodium channel protein 1 brain OS=Heterololigo bleekeri OX=1423826 PE=2 SV=1,,,,,,
OG_06876,1.5153878079144063,FUN_031888-T1,Peve_00031832,Pocillopora_meandrina_HIv1___RNAseq.g6051.t1,three_way,66.68083333333333,FUN_031888-T1,P23913,,,,,45.3,417.0,4.9e-103,376.7,sp|P23913|LBR_CHICK Delta(14)-sterol reductase LBR OS=Gallus gallus OX=9031 GN=LBR PE=1 SV=1,,,,,,
OG_06882,2.095073593805351,FUN_031903-T1,Peve_00037702,Pocillopora_meandrina_HIv1___RNAseq.g30040.t1,three_way,82.041,FUN_031903-T1,Q7ZXY0,,,,,73.9,506.0,4.6e-220,765.4,sp|Q7ZXY0|INO1A_XENLA Inositol-3-phosphate synthase 1-A OS=Xenopus laevis OX=8355 GN=isyna1-a PE=2 SV=1,,,,,,
OG_06883,1.0851152670407995,FUN_031904-T1,Peve_00037700,Pocillopora_meandrina_HIv1___RNAseq.g30041.t1,three_way,62.568666666666665,,,,,,,,,,,,,,,,,
OG_06885,1.5053560290922716,FUN_031908-T1,Peve_00037696,Pocillopora_meandrina_HIv1___RNAseq.g30045.t1,three_way,57.48116666666667,FUN_031908-T1,Q9Z2E9,,,,,45.7,221.0,1.5e-52,209.1,sp|Q9Z2E9|BSCL2_MOUSE Seipin OS=Mus musculus OX=10090 GN=Bscl2 PE=1 SV=2,,,,,,
OG_06887,1.9284384769448943,FUN_031921-T1,Peve_00040661,Pocillopora_meandrina_HIv1___RNAseq.g30046.t1,three_way,57.22266666666666,FUN_031921-T1,Q3LU38,,,,,36.1,183.0,3.9e-15,83.6,sp|Q3LU38|PROP1_ALOBE Homeobox protein prophet of Pit-1 OS=Alouatta belzebul OX=30590 GN=PROP1 PE=3 SV=1,,,,,,
OG_06888,1.1442004211237569,FUN_031925-T1,Peve_00004245,Pocillopora_meandrina_HIv1___TS.g21220.t1,three_way,43.71983333333333,,,,,,,,,,,,,,,,,
OG_06889,2.5014856137495984,FUN_031927-T1,Peve_00004242,Pocillopora_meandrina_HIv1___RNAseq.g18295.t1,three_way,59.02133333333333,FUN_031927-T1,Q9C907,,,,,36.2,257.0,4.8e-40,166.4,sp|Q9C907|GDPD5_ARATH Glycerophosphodiester phosphodiesterase GDPD5 OS=Arabidopsis thaliana OX=3702 GN=GDPD5 PE=2 SV=1,,,,,,
OG_06892,1.349549754356535,FUN_031931-T1,Peve_00004235,Pocillopora_meandrina_HIv1___RNAseq.g18238.t1,three_way,59.82666666666667,FUN_031931-T1,Q498L0,,,,,51.9,104.0,1.7000000000000002e-22,110.2,sp|Q498L0|C170B_XENLA Centrosomal protein of 170 kDa protein B OS=Xenopus laevis OX=8355 GN=cep170b PE=2 SV=1,,,,,,
OG_06901,1.56934141628925,FUN_031944-T1,Peve_00031843,Pocillopora_meandrina_HIv1___RNAseq.g18204.t2,three_way,92.98266666666666,FUN_031944-T1,Q7ZT47,PSF1_XENLA,,DNA replication complex GINS protein PSF1 (GINS complex subunit 1),Xenopus laevis (African clawed frog),59.0,195.0,4.900000000000001e-65,248.8,sp|Q7ZT47|PSF1_XENLA DNA replication complex GINS protein PSF1 OS=Xenopus laevis OX=8355 GN=gins1 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902983,DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_06902,1.520855940746344,FUN_031945-T1,Peve_00031844,Pocillopora_meandrina_HIv1___RNAseq.g6066.t1,three_way,66.55733333333333,FUN_031945-T1,Q08C93,ABD12_DANRE,,Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-),Danio rerio (Zebrafish) (Brachydanio rerio),41.7,326.0,3.9999999999999997e-63,243.4,sp|Q08C93|ABD12_DANRE Lysophosphatidylserine lipase ABHD12 OS=Danio rerio OX=7955 GN=abhd12 PE=2 SV=1,GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016020; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651,acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],lysophospholipase activity [GO:0004622]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],GO:0003824; GO:0006575; GO:0006629; GO:0016787; GO:0048856,catalytic activity; modified amino acid metabolic process; lipid metabolic process; hydrolase activity; anatomical structure development
OG_06903,1.700264361747677,FUN_031949-T1,Peve_00031822,Pocillopora_meandrina_HIv1___RNAseq.g6063.t2,three_way,64.09533333333334,FUN_031949-T1,P81439,,,,,40.1,187.0,5.8e-32,141.7,sp|P81439|EQSTC_ACTEQ Equistatin OS=Actinia equina OX=6106 PE=1 SV=2,,,,,,
OG_06917,1.071054158960241,FUN_031981-T1,Peve_00028816,Pocillopora_meandrina_HIv1___RNAseq.g30256.t2,three_way,80.43633333333334,FUN_031981-T1,A7RZW4,DPP3_NEMVE,,Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III),Nematostella vectensis (Starlet sea anemone),69.4,731.0,1.7e-302,1039.6,sp|A7RZW4|DPP3_NEMVE Dipeptidyl peptidase 3 OS=Nematostella vectensis OX=45351 GN=dpp3 PE=3 SV=1,GO:0004177; GO:0005737; GO:0006508; GO:0008235; GO:0008239; GO:0046872,proteolysis [GO:0006508],cytoplasm [GO:0005737],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_06919,2.0904302164748616,FUN_031983-T1,Peve_00028814,Pocillopora_meandrina_HIv1___RNAseq.g30258.t1,three_way,74.83933333333334,FUN_031983-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),55.7,298.0,1e-85,318.2,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_06922,1.236553939027916,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_06923,1.129933126311282,FUN_032013-T1,Peve_00028828,Pocillopora_meandrina_HIv1___RNAseq.g30268.t1,three_way,59.529,FUN_032013-T1,Q49LS6,,,,,25.3,359.0,1.5e-12,76.3,sp|Q49LS6|XKR9_TETNG XK-related protein 9 OS=Tetraodon nigroviridis OX=99883 GN=xkr9 PE=2 SV=1,,,,,,
OG_06928,2.1059956357377767,FUN_032018-T1,Peve_00041130,Pocillopora_meandrina_HIv1___RNAseq.g30276.t1,three_way,85.556,,,,,,,,,,,,,,,,,
OG_06929,1.3867122095558326,FUN_032019-T1,Peve_00041125,Pocillopora_meandrina_HIv1___TS.g22573.t1,three_way,74.76366666666667,FUN_032019-T1,Q55E31,RB32B_DICDI,,Ras-related protein Rab-32B,Dictyostelium discoideum (Social amoeba),61.0,182.0,6.3999999999999996e-62,238.8,sp|Q55E31|RB32B_DICDI Ras-related protein Rab-32B OS=Dictyostelium discoideum OX=44689 GN=rab32B PE=3 SV=1,GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0031982; GO:0032438,intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192],endomembrane system [GO:0012505]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0006886; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle
OG_06930,1.523751859257711,FUN_032021-T1,Peve_00041120,Pocillopora_meandrina_HIv1___RNAseq.g25906.t1,three_way,45.036,,,,,,,,,,,,,,,,,
OG_06939,1.6624633369140251,FUN_032048-T1,Peve_00013563,Pocillopora_meandrina_HIv1___RNAseq.g5934.t1,three_way,88.20733333333334,FUN_032048-T1,Q9XTL9,,,,,70.2,831.0,0.0,1236.1,sp|Q9XTL9|PYG_DROME Glycogen phosphorylase OS=Drosophila melanogaster OX=7227 GN=Glyp PE=2 SV=2,,,,,,
OG_06942,2.796859599396925,FUN_032052-T1,Peve_00012445,Pocillopora_meandrina_HIv1___RNAseq.g6026.t1,three_way,72.548,FUN_032052-T1,Q96NT5,,,,,28.5,445.0,2.6e-38,161.4,sp|Q96NT5|PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens OX=9606 GN=SLC46A1 PE=1 SV=1,,,,,,
OG_06943,1.4565762609258348,FUN_032053-T1,Peve_00012451,Pocillopora_meandrina_HIv1___RNAseq.g6027.t1,three_way,65.46633333333334,FUN_032053-T1,Q68DK2,ZFY26_HUMAN,,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),Homo sapiens (Human),31.7,1223.0,2.8e-168,595.9,sp|Q68DK2|ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ZFYVE26 PE=1 SV=4,GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037,autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],GO:0000910; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0006281; GO:0006310; GO:0007040; GO:0008289; GO:0031410; GO:0043226,cytokinesis; lysosome; endosome; vacuole; microtubule organizing center; DNA repair; DNA recombination; lysosome organization; lipid binding; cytoplasmic vesicle; organelle
OG_06948,2.2550342361809177,FUN_032061-T2,Peve_00040453,Pocillopora_meandrina_HIv1___RNAseq.g6047.t1,three_way,65.65933333333334,FUN_032061-T2,P39428,TRAF1_MOUSE,,TNF receptor-associated factor 1,Mus musculus (Mouse),31.4,264.0,1.1000000000000001e-27,125.9,sp|P39428|TRAF1_MOUSE TNF receptor-associated factor 1 OS=Mus musculus OX=10090 GN=Traf1 PE=1 SV=2,GO:0005164; GO:0005737; GO:0006915; GO:0007165; GO:0008270; GO:0031625; GO:0031996; GO:0042802; GO:2001236,apoptotic process [GO:0006915]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; signal transduction [GO:0007165],cytoplasm [GO:0005737],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0012501,programmed cell death
OG_06950,2.5363285529051365,FUN_032063-T1,Peve_00024739,Pocillopora_meandrina_HIv1___RNAseq.g6045.t1,three_way,41.4025,,,,,,,,,,,,,,,,,
OG_06955,1.2298171133446476,FUN_032074-T1,Peve_00018829,Pocillopora_meandrina_HIv1___RNAseq.g6016.t1,three_way,67.94316666666667,FUN_032074-T1,P78504,JAG1_HUMAN,,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),Homo sapiens (Human),41.2,204.0,9.5e-42,174.5,sp|P78504|JAG1_HUMAN Protein jagged-1 OS=Homo sapiens OX=9606 GN=JAG1 PE=1 SV=3,GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737,angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198],GO:0002376; GO:0005198; GO:0005576; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0048018; GO:0048856; GO:0060090; GO:0098772,immune system process; structural molecule activity; extracellular region; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_06958,1.7380477256438525,FUN_032087-T1,Peve_00026034,Pocillopora_meandrina_HIv1___RNAseq.g5298.t1,three_way,38.37983333333334,,,,,,,,,,,,,,,,,
OG_06966,2.520588591094249,FUN_032098-T1,Peve_00035667,Pocillopora_meandrina_HIv1___RNAseq.g5302.t1,three_way,77.37366666666667,FUN_032098-T1,Q9Y256,FACE2_HUMAN,,CAAX prenyl protease 2 (EC 3.4.26.1) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1),Homo sapiens (Human),47.3,292.0,1.5e-65,251.1,sp|Q9Y256|FACE2_HUMAN CAAX prenyl protease 2 OS=Homo sapiens OX=9606 GN=RCE1 PE=1 SV=1,GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005886; GO:0008238; GO:0016020; GO:0018342; GO:0071586,CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; cytosol; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_06967,2.0374066561552606,FUN_032099-T1,Peve_00035662,Pocillopora_meandrina_HIv1___RNAseq.g5303.t1,three_way,74.34366666666666,FUN_032099-T1,P98192,GNPAT_MOUSE,,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),Mus musculus (Mouse),36.0,659.0,1.3e-94,349.0,sp|P98192|GNPAT_MOUSE Dihydroxyacetone phosphate acyltransferase OS=Mus musculus OX=10090 GN=Gnpat PE=1 SV=1,GO:0003824; GO:0005777; GO:0005778; GO:0005782; GO:0006650; GO:0007416; GO:0008611; GO:0016287; GO:0021587; GO:0030054; GO:0030913; GO:0042552; GO:0061024,cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; synapse assembly [GO:0007416],cell junction [GO:0030054]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287],GO:0003824; GO:0005777; GO:0006629; GO:0016740; GO:0034330; GO:0043226; GO:0061024,catalytic activity; peroxisome; lipid metabolic process; transferase activity; cell junction organization; organelle; membrane organization
OG_06968,1.2504898121897272,FUN_032101-T1,Peve_00018056,Pocillopora_meandrina_HIv1___RNAseq.g5996.t1b,three_way,72.21733333333333,FUN_032101-T1,Q05B60,,,,,39.9,213.0,8.999999999999997e-41,168.7,sp|Q05B60|NUD14_BOVIN Uridine diphosphate glucose pyrophosphatase NUDT14 OS=Bos taurus OX=9913 GN=NUDT14 PE=2 SV=1,,,,,,
OG_06970,1.3039256085709774,FUN_032103-T1,Peve_00011281,Pocillopora_meandrina_HIv1___RNAseq.g5999.t1,three_way,81.78566666666667,,,,,,,,,,,,,,,,,
OG_06973,3.294017818451085,FUN_032108-T1,Peve_00030224,Pocillopora_meandrina_HIv1___RNAseq.g5393.t1,three_way,58.33233333333333,FUN_032108-T1,Q8IWX5,SGPP2_HUMAN,,Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2),Homo sapiens (Human),34.5,403.0,2.3e-56,221.1,sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006670; GO:0030149; GO:0042392; GO:0046839; GO:0061469; GO:0070780,phospholipid dephosphorylation [GO:0046839]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_06974,1.8482493923904544,FUN_032109-T1,Peve_00030225,Pocillopora_meandrina_HIv1___RNAseq.g5392.t1,three_way,77.26299999999999,FUN_032109-T1,F1RAX8,,,,,55.6,444.0,2.5e-134,480.3,"sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1",,,,,,
OG_06975,1.973026278658976,FUN_032110-T1,Peve_00030226,Pocillopora_meandrina_HIv1___RNAseq.g5391.t1,three_way,85.20466666666667,FUN_032110-T1,Q8K4M5,COMD1_MOUSE,,COMM domain-containing protein 1 (Protein Murr1),Mus musculus (Mouse),46.2,182.0,1.9e-40,167.2,sp|Q8K4M5|COMD1_MOUSE COMM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Commd1 PE=1 SV=2,GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006878; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0031648; GO:0032088; GO:0032434; GO:0034383; GO:0034394; GO:0042632; GO:0042803; GO:0043325; GO:0048227; GO:0050750; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:0097006; GO:1902072; GO:1902306; GO:1904109; GO:1905751; GO:2000009; GO:2000010,cholesterol homeostasis [GO:0042632]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; intracellular copper ion homeostasis [GO:0006878]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of cholesterol import [GO:1904109]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein transport [GO:0015031]; regulation of plasma lipoprotein particle levels [GO:0097006]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037],"copper ion binding [GO:0005507]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]",GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0006281; GO:0006355; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772,nucleus; nucleoplasm; endosome; cytosol; DNA repair; regulation of DNA-templated transcription; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_06979,1.4238133112615308,FUN_032115-T1,Peve_00030231,Pocillopora_meandrina_HIv1___RNAseq.g5383.t1,three_way,75.76333333333334,,,,,,,,,,,,,,,,,
OG_06980,1.5246718051283557,FUN_032117-T1,Peve_00030232,Pocillopora_meandrina_HIv1___TS.g24094.t1,three_way,95.08266666666668,FUN_032117-T1,Q80U96,XPO1_RAT,,Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog),Rattus norvegicus (Rat),78.0,1074.0,0.0,1682.5,sp|Q80U96|XPO1_RAT Exportin-1 OS=Rattus norvegicus OX=10116 GN=Xpo1 PE=1 SV=1,GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0071401; GO:0140297; GO:1902075; GO:1990904,cellular response to salt [GO:1902075]; cellular response to triglyceride [GO:0071401]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254],annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DNA-binding transcription factor binding [GO:0140297]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0042254; GO:0043226; GO:0140104,RNA binding; nucleus; nucleolus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; ribosome biogenesis; organelle; molecular carrier activity
OG_06987,1.6277897303863045,FUN_032128-T1,Peve_00040717,Pocillopora_meandrina_HIv1___RNAseq.g5363.t1,three_way,49.11266666666667,,,,,,,,,,,,,,,,,
OG_06989,1.370012770836419,FUN_032130-T1,Peve_00040711,Pocillopora_meandrina_HIv1___RNAseq.g5361.t1,three_way,79.16666666666667,FUN_032130-T1,Q6PBM1,GLRX5_DANRE,,"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)",Danio rerio (Zebrafish) (Brachydanio rerio),68.1,113.0,4e-43,175.6,"sp|Q6PBM1|GLRX5_DANRE Glutaredoxin-related protein 5, mitochondrial OS=Danio rerio OX=7955 GN=glrx5 PE=2 SV=1",GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0030097; GO:0046872; GO:0051537,hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]",GO:0005739; GO:0043226; GO:0048856,mitochondrion; organelle; anatomical structure development
OG_06991,1.8578246356040304,FUN_032133-T1,Peve_00029139,Pocillopora_meandrina_HIv1___RNAseq.g5353.t1,three_way,78.61566666666667,FUN_032133-T1,Q9ULQ1,,,,,28.8,552.0,2.7000000000000004e-44,181.8,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06993,4.0145580229445965,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_06995,2.0421571364846898,FUN_032143-T1,Peve_00007909,Pocillopora_meandrina_HIv1___RNAseq.g5346.t1,three_way,75.438,FUN_032143-T1,Q9H0R1,AP5M1_HUMAN,,AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein),Homo sapiens (Human),34.8,515.0,1.2e-78,295.4,sp|Q9H0R1|AP5M1_HUMAN AP-5 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP5M1 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599,endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06996,2.370060880806645,FUN_032145-T1,Peve_00007916,Pocillopora_meandrina_HIv1___TS.g24057.t1,three_way,48.8235,,,,,,,,,,,,,,,,,
OG_07002,1.8138125318446567,FUN_032154-T1,Peve_00003238,Pocillopora_meandrina_HIv1___RNAseq.g5326.t1,three_way,41.39083333333333,,,,,,,,,,,,,,,,,
OG_07003,2.360875214199433,FUN_032155-T1,Peve_00003240,Pocillopora_meandrina_HIv1___RNAseq.g5324.t1,three_way,81.494,FUN_032155-T1,Q80U44,,,,,40.9,88.0,2.1e-14,80.9,sp|Q80U44|ZFY16_MOUSE Zinc finger FYVE domain-containing protein 16 OS=Mus musculus OX=10090 GN=Zfyve16 PE=1 SV=2,,,,,,
OG_07004,2.8833312924637924,FUN_032156-T1,Peve_00003241,Pocillopora_meandrina_HIv1___RNAseq.g5323.t1,three_way,54.30733333333333,,,,,,,,,,,,,,,,,
OG_07005,1.8896672381764872,FUN_032157-T1,Peve_00003243,Pocillopora_meandrina_HIv1___RNAseq.11552_t,three_way,70.325,,,,,,,,,,,,,,,,,
OG_07007,2.720331423248879,FUN_032160-T1,Peve_00005389,Pocillopora_meandrina_HIv1___RNAseq.g5308.t1,three_way,84.28083333333333,FUN_032160-T1,Q9BX10,GTPB2_HUMAN,,GTP-binding protein 2,Homo sapiens (Human),61.1,535.0,2.7e-191,669.8,sp|Q9BX10|GTPB2_HUMAN GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GTPBP2 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0070966; GO:0072344; GO:1904678,"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]",extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0016071; GO:0016787,RNA binding; catalytic activity; GTPase activity; extracellular region; mRNA metabolic process; hydrolase activity
OG_07009,1.7447992855880612,FUN_032162-T1,Peve_00038631,Pocillopora_meandrina_HIv1___RNAseq.g5313.t1,three_way,99.18466666666669,FUN_032162-T1,Q6GQL2,PP1B_XENLA,,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16),Xenopus laevis (African clawed frog),94.5,325.0,3.300000000000001e-186,652.1,sp|Q6GQL2|PP1B_XENLA Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp1cb PE=2 SV=1,GO:0004722; GO:0005634; GO:0005737; GO:0005977; GO:0030155; GO:0032922; GO:0042752; GO:0046872; GO:0050115; GO:0051301; GO:0072357,cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005975; GO:0006091; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; carbohydrate metabolic process; generation of precursor metabolites and energy; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07012,1.702613884575824,FUN_032165-T1,Peve_00013928,Pocillopora_meandrina_HIv1___RNAseq.g5318.t1,three_way,78.37766666666666,FUN_032165-T1,Q2JVA4,GLMU_SYNJA,,Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)],Synechococcus sp. (strain JA-3-3Ab) (Cyanobacteria bacterium Yellowstone A-Prime),39.7,136.0,1.7e-18,94.0,sp|Q2JVA4|GLMU_SYNJA Bifunctional protein GlmU OS=Synechococcus sp. (strain JA-3-3Ab) OX=321327 GN=glmU PE=3 SV=1,GO:0000287; GO:0000902; GO:0003977; GO:0005737; GO:0006048; GO:0008360; GO:0009245; GO:0009252; GO:0016020; GO:0019134; GO:0031470; GO:0043886; GO:0071555,cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; lipid A biosynthetic process [GO:0009245]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],carboxysome [GO:0031470]; cytoplasm [GO:0005737]; membrane [GO:0016020],glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; structural constituent of carboxysome shell [GO:0043886]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977],GO:0003824; GO:0005198; GO:0006629; GO:0016740; GO:0043226; GO:0055086; GO:0071554; GO:1901135,catalytic activity; structural molecule activity; lipid metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; cell wall organization or biogenesis; carbohydrate derivative metabolic process
OG_07014,1.6996148255630803,FUN_032167-T1,Peve_00012811,Pocillopora_meandrina_HIv1___RNAseq.g5306.t1,three_way,90.62433333333334,FUN_032167-T1,P18074,ERCC2_HUMAN,,General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 5.6.2.3) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA 5'-3' helicase XPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),Homo sapiens (Human),72.6,731.0,0.0,1078.9,sp|P18074|ERCC2_HUMAN General transcription and DNA repair factor IIH helicase subunit XPD OS=Homo sapiens OX=9606 GN=ERCC2 PE=1 SV=1,GO:0000439; GO:0000462; GO:0001666; GO:0001701; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0005737; GO:0005819; GO:0005829; GO:0006283; GO:0006289; GO:0006357; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0007059; GO:0008340; GO:0009650; GO:0009791; GO:0016887; GO:0021510; GO:0030198; GO:0030282; GO:0030674; GO:0032289; GO:0035264; GO:0035315; GO:0040016; GO:0043139; GO:0043249; GO:0045951; GO:0046872; GO:0048009; GO:0048568; GO:0048820; GO:0051539; GO:0060218; GO:0070516; GO:0071425; GO:0071817; GO:0072332; GO:1901990,"apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; determination of adult lifespan [GO:0008340]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; positive regulation of mitotic recombination [GO:0045951]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]",CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006351; GO:0006355; GO:0007059; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; chromosome segregation; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07015,1.98073441875144,FUN_032191-T1,Peve_00020048,Pocillopora_meandrina_HIv1___RNAseq.g24664.t1,three_way,75.42333333333333,FUN_032191-T1,Q0V9A9,,,,,59.2,284.0,1.1e-90,334.7,sp|Q0V9A9|LACB2_XENTR Endoribonuclease LACTB2 OS=Xenopus tropicalis OX=8364 GN=lactb2 PE=2 SV=1,,,,,,
OG_07017,1.3297354081014008,FUN_032193-T1,Peve_00020046,Pocillopora_meandrina_HIv1___RNAseq.g24666.t1,three_way,76.88433333333333,FUN_032193-T1,Q6P0I8,,,,,41.4,268.0,5.9e-56,219.2,sp|Q6P0I8|EXOS6_DANRE Exosome complex component MTR3 OS=Danio rerio OX=7955 GN=exosc6 PE=2 SV=2,,,,,,
OG_07018,1.862089317415956,FUN_032194-T1,Peve_00017482,Pocillopora_meandrina_HIv1___RNAseq.g24398.t1,three_way,85.27199999999999,FUN_032194-T1,P48506,GSH1_HUMAN,,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),Homo sapiens (Human),62.3,628.0,4.5e-227,788.9,sp|P48506|GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens OX=9606 GN=GCLC PE=1 SV=2,GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237,blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006355; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874; GO:0043226; GO:0061024,circulatory system process; catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; regulation of DNA-templated transcription; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity; organelle; membrane organization
OG_07023,1.5345900545268485,FUN_032204-T1,Peve_00013799,Pocillopora_meandrina_HIv1___RNAseq.g24269.t1,three_way,60.29666666666667,FUN_032204-T1,Q9UBU6,,,,,33.3,201.0,1.1e-22,109.0,sp|Q9UBU6|FA8A1_HUMAN Protein FAM8A1 OS=Homo sapiens OX=9606 GN=FAM8A1 PE=1 SV=1,,,,,,
OG_07025,1.748518517800555,FUN_032217-T1,Peve_00015500,Pocillopora_meandrina_HIv1___RNAseq.g24278.t1,three_way,88.01366666666667,,,,,,,,,,,,,,,,,
OG_07027,1.673300939095122,FUN_032219-T1,Peve_00015512,Pocillopora_meandrina_HIv1___RNAseq.g24280.t1,three_way,65.81,FUN_032219-T1,A3KP40,,,,,24.7,461.0,2.2e-09,65.5,sp|A3KP40|CH034_DANRE Uncharacterized protein C8orf34 homolog OS=Danio rerio OX=7955 GN=zgc:162928 PE=2 SV=1,,,,,,
OG_07028,2.5110207953657064,FUN_032220-T1,Peve_00015518,Pocillopora_meandrina_HIv1___RNAseq.g24281.t1,three_way,76.94216666666667,FUN_032220-T1,P08461,,,,,60.7,443.0,2.7e-132,473.8,"sp|P08461|ODP2_RAT Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Rattus norvegicus OX=10116 GN=Dlat PE=1 SV=3",,,,,,
OG_07029,1.07345825429849,FUN_032221-T1,Peve_00015532,Pocillopora_meandrina_HIv1___RNAseq.g24282.t1,three_way,58.141666666666666,FUN_032221-T1,Q9W6I0,,,,,46.7,169.0,1e-40,168.7,sp|Q9W6I0|UQCC1_XENLA Ubiquinol-cytochrome-c reductase complex assembly factor 1 OS=Xenopus laevis OX=8355 GN=uqcc1 PE=2 SV=1,,,,,,
OG_07030,1.3317497643319216,FUN_032222-T1,Peve_00015538,Pocillopora_meandrina_HIv1___RNAseq.g24283.t1,three_way,63.73566666666667,FUN_032222-T1,Q8BVA5,LDAH_MOUSE,,Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) (mLDAH),Mus musculus (Mouse),39.9,288.0,2.1e-50,201.1,sp|Q8BVA5|LDAH_MOUSE Lipid droplet-associated hydrolase OS=Mus musculus OX=10090 GN=Ldah PE=1 SV=1,GO:0004771; GO:0005783; GO:0005811; GO:0019915; GO:0035356; GO:0042632; GO:0090077; GO:0160077,cholesterol homeostasis [GO:0042632]; foam cell differentiation [GO:0090077]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],sterol ester esterase activity [GO:0004771],GO:0003824; GO:0005783; GO:0005811; GO:0016787; GO:0030154; GO:0043226,catalytic activity; endoplasmic reticulum; lipid droplet; hydrolase activity; cell differentiation; organelle
OG_07035,1.1878399709310177,FUN_032229-T1,Peve_00027503,Pocillopora_meandrina_HIv1___RNAseq.g24831.t1,three_way,71.70400000000001,FUN_032229-T1,Q66GV0,,,,,49.1,175.0,1.7e-41,170.6,sp|Q66GV0|MPV17_XENLA Mitochondrial inner membrane protein Mpv17 OS=Xenopus laevis OX=8355 GN=mpv17 PE=2 SV=2,,,,,,
OG_07042,1.6006950859512503,FUN_032241-T1,Peve_00023301,Pocillopora_meandrina_HIv1___TS.g12785.t1,three_way,77.97733333333333,FUN_032241-T1,Q9JLT4,TRXR2_MOUSE,,"Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) (Thioredoxin reductase TR3)",Mus musculus (Mouse),64.1,493.0,1.2e-193,677.6,"sp|Q9JLT4|TRXR2_MOUSE Thioredoxin reductase 2, mitochondrial OS=Mus musculus OX=10090 GN=Txnrd2 PE=1 SV=4",GO:0000305; GO:0004791; GO:0005739; GO:0007507; GO:0030097; GO:0042803; GO:0045454; GO:0050660,cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005739; GO:0016209; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; antioxidant activity; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07051,2.549927578595114,FUN_032271-T1,Peve_00030007,Pocillopora_meandrina_HIv1___RNAseq.g24973.t1,three_way,77.01566666666666,FUN_032271-T1,A5PJJ7,,,,,49.8,301.0,1.8999999999999998e-82,307.8,sp|A5PJJ7|S16C6_BOVIN Short-chain dehydrogenase/reductase family 16C member 6 OS=Bos taurus OX=9913 GN=SDR16C6 PE=2 SV=1,,,,,,
OG_07052,3.161448385488857,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_07053,1.4439896233278475,FUN_032276-T1,Peve_00011761,Pocillopora_meandrina_HIv1___RNAseq.g24976.t1,three_way,83.19833333333334,FUN_032276-T1,Q8QZZ8,RAB38_MOUSE,,Ras-related protein Rab-38 (EC 3.6.5.2),Mus musculus (Mouse),70.5,129.0,3.4e-52,205.7,sp|Q8QZZ8|RAB38_MOUSE Ras-related protein Rab-38 OS=Mus musculus OX=10090 GN=Rab38 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005886; GO:0007005; GO:0015031; GO:0016192; GO:0030670; GO:0030742; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247,endosome to melanosome transport [GO:0035646]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell body [GO:0044297]; early endosome [GO:0005769]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007005; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; mitochondrion; lysosome; endosome; vacuole; plasma membrane; mitochondrion organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07055,1.8371528946021063,FUN_032278-T1,Peve_00011758,Pocillopora_meandrina_HIv1___RNAseq.g24978.t1,three_way,81.38966666666667,FUN_032278-T1,Q8N584,,,,,40.9,587.0,4.1e-121,436.8,sp|Q8N584|TT39C_HUMAN Tetratricopeptide repeat protein 39C OS=Homo sapiens OX=9606 GN=TTC39C PE=1 SV=2,,,,,,
OG_07056,1.775496071846072,FUN_032281-T1,Peve_00015549,Pocillopora_meandrina_HIv1___RNAseq.g24293.t1,three_way,73.47583333333333,FUN_032281-T1,P13264,GLSK_RAT,,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]",Rattus norvegicus (Rat),52.4,517.0,1.8000000000000002e-158,560.8,"sp|P13264|GLSK_RAT Glutaminase kidney isoform, mitochondrial OS=Rattus norvegicus OX=10116 GN=Gls PE=1 SV=2",GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0045202; GO:0051289; GO:0090461,chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; intracellular glutamate homeostasis [GO:0090461]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202],glutaminase activity [GO:0004359],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016787; GO:0023052; GO:0043226; GO:0050877; GO:0065003,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; hydrolase activity; signaling; organelle; nervous system process; protein-containing complex assembly
OG_07059,1.5630218104593867,FUN_032285-T1,Peve_00015515,Pocillopora_meandrina_HIv1___RNAseq.g3787.t1,three_way,65.661,FUN_032285-T1,P26186,,,,,39.3,168.0,1.8e-27,124.0,sp|P26186|MGMT_CRIGR Methylated-DNA--protein-cysteine methyltransferase OS=Cricetulus griseus OX=10029 GN=MGMT PE=2 SV=1,,,,,,
OG_07063,2.026908262481291,FUN_032289-T1,Peve_00015510,Pocillopora_meandrina_HIv1___TS.g12261.t1,three_way,71.52666666666667,FUN_032289-T1,Q54SR7,FKBP2_DICDI,,FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase),Dictyostelium discoideum (Social amoeba),50.8,132.0,2.3000000000000002e-30,133.7,sp|Q54SR7|FKBP2_DICDI FK506-binding protein 2 OS=Dictyostelium discoideum OX=44689 GN=fkbp2 PE=3 SV=1,GO:0003755; GO:0005783; GO:0061077,chaperone-mediated protein folding [GO:0061077],endoplasmic reticulum [GO:0005783],peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0005783; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_07066,3.2735213864888486,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_07071,1.760764838154398,FUN_032307-T1,Peve_00001538,Pocillopora_meandrina_HIv1___RNAseq.g24762.t2,three_way,70.71366666666667,FUN_032307-T1,Q3U0J8,,,,,48.1,480.0,9.9e-126,452.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_07073,1.1581707461112645,FUN_032309-T1,Peve_00009101,Pocillopora_meandrina_HIv1___RNAseq.g24764.t1,three_way,78.17133333333334,FUN_032309-T1,A7RZS0,BL1S2_NEMVE,,Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2),Nematostella vectensis (Starlet sea anemone),53.8,104.0,2.7e-21,103.2,sp|A7RZS0|BL1S2_NEMVE Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Nematostella vectensis OX=45351 GN=bloc1s2 PE=3 SV=1,GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078,endosomal transport [GO:0016197]; lysosome localization [GO:0032418],BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765],gamma-tubulin binding [GO:0043015],GO:0005815; GO:0008092; GO:0016192,microtubule organizing center; cytoskeletal protein binding; vesicle-mediated transport
OG_07075,1.921921231098061,FUN_032312-T1,Peve_00002566,Pocillopora_meandrina_HIv1___RNAseq.g24785.t1,three_way,58.21183333333333,,,,,,,,,,,,,,,,,
OG_07079,1.788514981568974,FUN_032317-T1,Peve_00031925,Pocillopora_meandrina_HIv1___RNAseq.g24788.t1,three_way,48.4895,FUN_032317-T1,Q3ULM6,,,,,29.3,300.0,2.1e-30,135.6,sp|Q3ULM6|USPL1_MOUSE SUMO-specific isopeptidase USPL1 OS=Mus musculus OX=10090 GN=Uspl1 PE=2 SV=2,,,,,,
OG_07087,1.0639404256578344,FUN_032344-T1,Peve_00021401,Pocillopora_meandrina_HIv1___RNAseq.g29796.t1,three_way,74.12733333333334,FUN_032344-T1,Q9H3R1,,,,,40.3,749.0,4.3000000000000005e-161,570.1,sp|Q9H3R1|NDST4_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Homo sapiens OX=9606 GN=NDST4 PE=1 SV=1,,,,,,
OG_07088,2.7293432962758577,FUN_032345-T1,Peve_00021405,Pocillopora_meandrina_HIv1___RNAseq.g29797.t2,three_way,70.41966666666667,FUN_032345-T1,Q9V3L1,NDST_DROME,,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],Drosophila melanogaster (Fruit fly),46.3,901.0,9.6e-236,818.1,sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1,GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140,"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016],GO:0003824; GO:0005783; GO:0005794; GO:0006790; GO:0009101; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; hydrolase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_07093,2.0075533532708127,FUN_032350-T1,Peve_00012758,Pocillopora_meandrina_HIv1___RNAseq.g29802.t1,three_way,54.929,FUN_032350-T1,Q5BJT4,TXD15_RAT,,Thioredoxin domain-containing protein 15,Rattus norvegicus (Rat),40.4,198.0,3.1999999999999997e-29,130.6,sp|Q5BJT4|TXD15_RAT Thioredoxin domain-containing protein 15 OS=Rattus norvegicus OX=10116 GN=Txndc15 PE=2 SV=1,GO:0005929; GO:0045880; GO:0060170; GO:0060271,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226; GO:0044782,cilium; organelle; cilium organization
OG_07098,1.947419181174424,FUN_032356-T1,Peve_00001943,Pocillopora_meandrina_HIv1___RNAseq.g29814.t1,three_way,72.94966666666667,FUN_032356-T1,O95876,FRITZ_HUMAN,,WD repeat-containing and planar cell polarity effector protein fritz homolog (hFRTZ) (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein),Homo sapiens (Human),42.2,720.0,3.6e-153,543.5,sp|O95876|FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens OX=9606 GN=WDPCP PE=1 SV=2,GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0035091; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114,auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; podocyte cell migration [GO:0090521]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587],axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886],phosphatidylinositol binding [GO:0035091],GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008289; GO:0043226; GO:0044782; GO:0048856; GO:0048870,plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; lipid binding; organelle; cilium organization; anatomical structure development; cell motility
OG_07102,3.052659913077939,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
OG_07103,3.915373971427013,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07107,1.294373918412435,FUN_032377-T1,Peve_00041775,Pocillopora_meandrina_HIv1___RNAseq.g24363.t1,three_way,75.99600000000001,FUN_032377-T1,Q3SX30,,,,,27.7,285.0,4.5e-20,100.1,sp|Q3SX30|PSMF1_BOVIN Proteasome inhibitor PI31 subunit OS=Bos taurus OX=9913 GN=PSMF1 PE=2 SV=2,,,,,,
OG_07108,1.5692499645730782,FUN_032378-T1,Peve_00041776,Pocillopora_meandrina_HIv1___RNAseq.7604_t,three_way,89.479,FUN_032378-T1,Q5R7J8,TP4A1_PONAB,,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),64.7,167.0,1.4000000000000001e-59,230.7,sp|Q5R7J8|TP4A1_PONAB Protein tyrosine phosphatase type IVA 1 OS=Pongo abelii OX=9601 GN=PTP4A1 PE=2 SV=1,GO:0004725; GO:0005634; GO:0005769; GO:0005783; GO:0005819; GO:0005886,,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07110,1.4172583002124013,FUN_032381-T1,Peve_00041787,Pocillopora_meandrina_HIv1___RNAseq.g24369.t2,three_way,58.79066666666667,FUN_032381-T1,Q0VGT4,ZGRF1_MOUSE,,5'-3' DNA helicase ZGRF1 (EC 5.6.2.3) (GRF-type zinc finger domain-containing protein 1),Mus musculus (Mouse),49.1,846.0,3.2e-210,734.2,sp|Q0VGT4|ZGRF1_MOUSE 5'-3' DNA helicase ZGRF1 OS=Mus musculus OX=10090 GN=Zgrf1 PE=1 SV=2,GO:0000725; GO:0005524; GO:0005634; GO:0008270; GO:0016787; GO:0043139,recombinational repair [GO:0000725],nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07111,1.065773895385112,FUN_032384-T1,Peve_00041789,Pocillopora_meandrina_HIv1___RNAseq.g24371.t1,three_way,71.52466666666666,FUN_032384-T1,Q92113,,,,,35.0,472.0,2.7e-81,304.3,"sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_07113,1.0617317394892551,FUN_032386-T1,Peve_00032594,Pocillopora_meandrina_HIv1___RNAseq.g29750.t1,three_way,46.69566666666667,FUN_032386-T1,Q5ZI22,NUP42_CHICK,,Nucleoporin NUP42 (Nucleoporin-like protein 2),Gallus gallus (Chicken),28.6,259.0,9.2e-15,82.8,sp|Q5ZI22|NUP42_CHICK Nucleoporin NUP42 OS=Gallus gallus OX=9031 GN=NUP42 PE=2 SV=1,GO:0005049; GO:0005643; GO:0008270; GO:0015031; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; protein transport [GO:0015031],nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],nuclear export signal receptor activity [GO:0005049]; zinc ion binding [GO:0008270],GO:0140104,molecular carrier activity
OG_07116,2.0596751716155457,FUN_032392-T1,Peve_00023247,Pocillopora_meandrina_HIv1___RNAseq.g29740.t1,three_way,68.81316666666666,FUN_032392-T1,Q641M3,,,,,38.8,134.0,3.6e-23,109.4,sp|Q641M3|TMM18_DANRE Transmembrane protein 18 OS=Danio rerio OX=7955 GN=tmem18 PE=2 SV=1,,,,,,
OG_07117,1.8654519971063257,FUN_032394-T1,Peve_00018856,Pocillopora_meandrina_HIv1___RNAseq.g29832.t1,three_way,75.89816666666667,FUN_032394-T1,P40123,CAP2_HUMAN,,Adenylyl cyclase-associated protein 2 (CAP 2),Homo sapiens (Human),40.3,467.0,2.3e-79,297.7,sp|P40123|CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens OX=9606 GN=CAP2 PE=1 SV=1,GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0099140,actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; presynaptic actin cytoskeleton organization [GO:0099140]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802],GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0043226,plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle
OG_07123,1.501928015634962,FUN_032422-T1,Peve_00009161,Pocillopora_meandrina_HIv1___RNAseq.g21126.t1,three_way,56.91133333333333,,,,,,,,,,,,,,,,,
OG_07124,2.173386241734413,FUN_032423-T1,Peve_00009162,Pocillopora_meandrina_HIv1___RNAseq.g29841.t1,three_way,74.066,FUN_032423-T1,Q8N3Y7,RDHE2_HUMAN,,Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5),Homo sapiens (Human),43.0,284.0,2.1e-62,240.7,sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297,"keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]",chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005811; GO:0006325; GO:0006355; GO:0006629; GO:0016491; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; lipid droplet; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; oxidoreductase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_07125,1.6707218007654827,FUN_032425-T1,Peve_00007852,Pocillopora_meandrina_HIv1___RNAseq.g29732.t1,three_way,72.82133333333334,FUN_032425-T1,Q90YB1,,,,,48.1,909.0,1.2000000000000002e-246,854.4,sp|Q90YB1|DNLI4_CHICK DNA ligase 4 OS=Gallus gallus OX=9031 GN=LIG4 PE=2 SV=2,,,,,,
OG_07132,2.7391039837804816,FUN_032433-T1,Peve_00038721,Pocillopora_meandrina_HIv1___RNAseq.g20796.t1b,three_way,50.24216666666667,FUN_032433-T1,Q12789,TF3C1_HUMAN,,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),Homo sapiens (Human),25.0,1605.0,2.7e-101,372.9,sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904,5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0006399; GO:0043226; GO:0140223,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; tRNA metabolic process; organelle; general transcription initiation factor activity
OG_07138,2.1376854983624445,FUN_032464-T1,Peve_00009180,Pocillopora_meandrina_HIv1___TS.g12111.t1,three_way,65.44783333333334,FUN_032464-T1,E1BB03,ZRAB3_BOVIN,,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],Bos taurus (Bovine),45.5,521.0,7.4999999999999995e-115,416.0,sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3,GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0031297; GO:0036310; GO:0043596; GO:0070530,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411],nuclear replication fork [GO:0043596],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006281; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07144,3.2602997449231705,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_07145,1.3530413010996811,FUN_032477-T1,Peve_00041760,Pocillopora_meandrina_HIv1___RNAseq.g24343.t1,three_way,81.312,FUN_032477-T1,Q6DGE9,UN45B_DANRE,,Protein unc-45 homolog B (Unc-45B) (UNC45-related protein),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,929.0,1.9e-165,584.7,sp|Q6DGE9|UN45B_DANRE Protein unc-45 homolog B OS=Danio rerio OX=7955 GN=unc45b PE=1 SV=2,GO:0002088; GO:0005737; GO:0007519; GO:0030018; GO:0030239; GO:0031672; GO:0048471; GO:0048738; GO:0051879; GO:0055001; GO:0055002; GO:0060538; GO:0061077,cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle cell development [GO:0055001]; myofibril assembly [GO:0030239]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]; striated muscle cell development [GO:0055002],A band [GO:0031672]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018],Hsp90 protein binding [GO:0051879],GO:0007010; GO:0048856,cytoskeleton organization; anatomical structure development
OG_07154,2.1409256786998583,FUN_032533-T1,Peve_00000693,Pocillopora_meandrina_HIv1___RNAseq.g24729.t1,three_way,83.166,FUN_032533-T1,Q55CD9,,,,,47.7,413.0,1.2e-101,371.7,sp|Q55CD9|NDH_DICDI Probable NADH dehydrogenase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0270104 PE=3 SV=2,,,,,,
OG_07159,2.006375688580788,FUN_032569-T1,Peve_00000700,Pocillopora_meandrina_HIv1___RNAseq.g24716.t1a,three_way,75.09,FUN_032569-T1,Q5FWL4,EST2A_XENLA,,Extended synaptotagmin-2-A (E-Syt2-A),Xenopus laevis (African clawed frog),28.4,855.0,1.4000000000000001e-89,332.4,sp|Q5FWL4|EST2A_XENLA Extended synaptotagmin-2-A OS=Xenopus laevis OX=8355 GN=esyt2-a PE=2 SV=1,GO:0005509; GO:0005544; GO:0005789; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0008289; GO:0016192,lipid binding; vesicle-mediated transport
OG_07160,2.0128048570570023,FUN_032571-T1,Peve_00000701,Pocillopora_meandrina_HIv1___RNAseq.g24714.t1,three_way,68.33,FUN_032571-T1,O95497,VNN1_HUMAN,,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1),Homo sapiens (Human),45.2,496.0,7.1e-112,406.0,sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens OX=9606 GN=VNN1 PE=1 SV=2,GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015938; GO:0015939; GO:0016020; GO:0017159; GO:0033089; GO:0035577; GO:0045087; GO:0098552; GO:0098609; GO:1902177,acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; coenzyme A catabolic process [GO:0015938]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979],azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],pantetheine hydrolase activity [GO:0017159],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0006575; GO:0006790; GO:0006954; GO:0007155; GO:0016787; GO:0055086; GO:0098542,immune system process; catalytic activity; extracellular region; plasma membrane; modified amino acid metabolic process; sulfur compound metabolic process; inflammatory response; cell adhesion; hydrolase activity; nucleobase-containing small molecule metabolic process; defense response to other organism
OG_07161,2.4801217298120712,FUN_032573-T1,Peve_00020057,Pocillopora_meandrina_HIv1___RNAseq.g24657.t1,three_way,46.22766666666666,FUN_032573-T1,Q90876,,,,,34.0,153.0,5.600000000000001e-23,109.4,sp|Q90876|IRF1_CHICK Interferon regulatory factor 1 OS=Gallus gallus OX=9031 GN=IRF1 PE=2 SV=1,,,,,,
OG_07162,2.175985104311646,FUN_032574-T1,Peve_00020059,Pocillopora_meandrina_HIv1___RNAseq.g24656.t1,three_way,65.90716666666667,FUN_032574-T1,P23906,,,,,51.3,117.0,2.3999999999999999e-35,150.6,sp|P23906|IRF2_MOUSE Interferon regulatory factor 2 OS=Mus musculus OX=10090 GN=Irf2 PE=1 SV=1,,,,,,
OG_07165,1.8302664792625825,FUN_032583-T1,Peve_00026847,Pocillopora_meandrina_HIv1___RNAseq.g24648.t1,three_way,42.123333333333335,,,,,,,,,,,,,,,,,
OG_07166,2.52702774202225,FUN_032584-T1,Peve_00024132,Pocillopora_meandrina_HIv1___TS.g12593.t1,three_way,79.44666666666666,FUN_032584-T1,A3KPN8,,,,,50.9,456.0,4.1e-137,489.6,sp|A3KPN8|TTC38_DANRE Tetratricopeptide repeat protein 38 OS=Danio rerio OX=7955 GN=ttc38 PE=3 SV=1,,,,,,
OG_07167,2.2698265058262432,FUN_032602-T1,Peve_00001527,Pocillopora_meandrina_HIv1___RNAseq.g24628.t1,three_way,85.47983333333333,FUN_032602-T1,Q9Y2J2,E41L3_HUMAN,,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",Homo sapiens (Human),51.7,348.0,4e-95,349.7,sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens OX=9606 GN=EPB41L3 PE=1 SV=2,GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005929; GO:0006915; GO:0008360; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0036064; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659; GO:0098696; GO:0098794; GO:0098978; GO:0106006,actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0008092; GO:0012501; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659,structural molecule activity; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; cytoskeletal protein binding; programmed cell death; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_07168,1.172047188070776,FUN_032603-T1,Peve_00001522,Pocillopora_meandrina_HIv1___RNAseq.g24627.t1,three_way,61.717666666666666,FUN_032603-T1,Q8NFZ3,,,,,34.2,588.0,2.8e-77,291.2,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_07179,2.065324614273496,FUN_032632-T1,Peve_00033689,Pocillopora_meandrina_HIv1___RNAseq.g24117.t1,three_way,60.99433333333333,FUN_032632-T1,Q5ZIJ9,,,,,45.3,1029.0,1.5e-112,409.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07190,1.3243801345712358,FUN_032683-T1,Peve_00015966,Pocillopora_meandrina_HIv1___RNAseq.g24105.t1,three_way,78.53933333333333,FUN_032683-T1,P38060,HMGCL_MOUSE,,"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)",Mus musculus (Mouse),71.4,105.0,2.3e-38,159.5,"sp|P38060|HMGCL_MOUSE Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Mus musculus OX=10090 GN=Hmgcl PE=1 SV=2",GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005743; GO:0005759; GO:0005777; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951,ketone body biosynthetic process [GO:0046951]; mitochondrion organization [GO:0007005],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005739; GO:0005777; GO:0006091; GO:0006629; GO:0007005; GO:0016829; GO:0043226,catalytic activity; structural molecule activity; mitochondrion; peroxisome; generation of precursor metabolites and energy; lipid metabolic process; mitochondrion organization; lyase activity; organelle
OG_07194,1.0752535834726016,FUN_032692-T1,Peve_00017799,Pocillopora_meandrina_HIv1___RNAseq.g5050.t1,three_way,78.03866666666667,FUN_032692-T1,Q8IWA6,,,,,28.3,173.0,2.3e-08,62.8,sp|Q8IWA6|CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens OX=9606 GN=CCDC60 PE=1 SV=2,,,,,,
OG_07199,1.0124963922196282,FUN_032708-T1,Peve_00029922,Pocillopora_meandrina_HIv1___RNAseq.g29872.t1,three_way,49.76916666666667,,,,,,,,,,,,,,,,,
OG_07203,3.048440742923107,FUN_032738-T1,Peve_00029918,Pocillopora_meandrina_HIv1___RNAseq.g29876.t1,three_way,86.90433333333334,FUN_032738-T1,P49739,,,,,65.5,823.0,6e-285,981.5,sp|P49739|MCM3M_XENLA Maternal DNA replication licensing factor mcm3 OS=Xenopus laevis OX=8355 GN=mmcm3 PE=1 SV=2,,,,,,
OG_07211,2.0533153347130284,FUN_032755-T1,Peve_00023820,Pocillopora_meandrina_HIv1___RNAseq.g29864.t1,three_way,82.49766666666667,FUN_032755-T1,Q62825,,,,,43.2,750.0,3.3e-160,567.0,sp|Q62825|EXOC3_RAT Exocyst complex component 3 OS=Rattus norvegicus OX=10116 GN=Exoc3 PE=1 SV=1,,,,,,
OG_07213,1.158839380342272,FUN_032772-T1,Peve_00017712,Pocillopora_meandrina_HIv1___RNAseq.g29730.t1,three_way,60.71333333333333,,,,,,,,,,,,,,,,,
OG_07218,2.5074546024245525,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07221,2.056491150935785,FUN_032814-T1,Peve_00014511,Pocillopora_meandrina_HIv1___RNAseq.g29708.t1,three_way,72.67099999999999,FUN_032814-T1,A7SCH8,KYNU_NEMVE,,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),Nematostella vectensis (Starlet sea anemone),58.9,472.0,1.2e-166,587.8,sp|A7SCH8|KYNU_NEMVE Kynureninase OS=Nematostella vectensis OX=45351 GN=kynu PE=3 SV=1,GO:0005737; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034354; GO:0043420; GO:0097053,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process to kynurenine [GO:0019441]; quinolinate biosynthetic process [GO:0019805],cytoplasm [GO:0005737],kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016787; GO:0055086,catalytic activity; amino acid metabolic process; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_07222,1.1881719789685192,FUN_032815-T1,Peve_00014570,Pocillopora_meandrina_HIv1___RNAseq.g29707.t1,three_way,69.17233333333334,FUN_032815-T1,Q5HYM0,ZC12B_HUMAN,,Probable ribonuclease ZC3H12B (EC 3.1.-.-) (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B),Homo sapiens (Human),59.1,220.0,8.099999999999997e-69,263.1,sp|Q5HYM0|ZC12B_HUMAN Probable ribonuclease ZC3H12B OS=Homo sapiens OX=9606 GN=ZC3H12B PE=1 SV=3,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_07238,2.075324329673388,FUN_032958-T1,Peve_00014537,Pocillopora_meandrina_HIv1___RNAseq.g24985.t1,three_way,92.142,FUN_032958-T1,Q16204,CCDC6_HUMAN,,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),Homo sapiens (Human),66.4,369.0,7.5e-39,162.9,sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802,,cytoskeleton [GO:0005856]; cytosol [GO:0005829],identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005829; GO:0005856; GO:0043226,structural molecule activity; cytosol; cytoskeleton; organelle
OG_07239,1.4610976962855449,FUN_032960-T1,Peve_00015577,Pocillopora_meandrina_HIv1___RNAseq.g24902.t1,three_way,69.48333333333333,FUN_032960-T1,P07099,HYEP_HUMAN,,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH),Homo sapiens (Human),46.5,428.0,8.2e-106,385.6,sp|P07099|HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens OX=9606 GN=EPHX1 PE=1 SV=1,GO:0004301; GO:0005789; GO:0006805; GO:0008142; GO:0009636; GO:0019369; GO:0033961; GO:0097176; GO:0120253,arachidonate metabolic process [GO:0019369]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142],GO:0003824; GO:0006629; GO:0008289; GO:0016787,catalytic activity; lipid metabolic process; lipid binding; hydrolase activity
OG_07241,1.9913650817425943,FUN_032971-T1,Peve_00017817,Pocillopora_meandrina_HIv1___RNAseq.g29687.t1,three_way,75.51633333333334,FUN_032971-T1,Q8IX29,,,,,52.3,214.0,1.3e-58,228.4,sp|Q8IX29|FBX16_HUMAN F-box only protein 16 OS=Homo sapiens OX=9606 GN=FBXO16 PE=1 SV=1,,,,,,
OG_07248,1.1436768190048694,FUN_032987-T2,Peve_00014549,Pocillopora_meandrina_HIv1___RNAseq.g24997.t1,three_way,40.58166666666667,,,,,,,,,,,,,,,,,
OG_07251,2.731853982712808,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_07258,2.528768821145901,FUN_033035-T1,Peve_00017503,Pocillopora_meandrina_HIv1___RNAseq.g24452.t1,three_way,61.70483333333333,,,,,,,,,,,,,,,,,
OG_07262,1.9657149272716152,FUN_033039-T1,Peve_00017500,Pocillopora_meandrina_HIv1___RNAseq.g24445.t1,three_way,64.32033333333334,FUN_033039-T1,O94766,,,,,45.2,303.0,1.9e-65,251.1,sp|O94766|B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,,,,,,
OG_07266,2.9156950325227675,FUN_033114-T1,Peve_00019518,Pocillopora_meandrina_HIv1___RNAseq.g24261.t1,three_way,54.964666666666666,FUN_033114-T1,Q1EG27,MYO3B_MOUSE,,Myosin-IIIb (EC 2.7.11.1),Mus musculus (Mouse),33.6,769.0,3.6e-116,421.4,sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2,GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310,auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0005829; GO:0008092; GO:0016740; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytosol; cytoskeletal protein binding; transferase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07268,1.3316837573983191,FUN_033119-T1,Peve_00013204,Pocillopora_meandrina_HIv1___TS.g25013.t2,three_way,69.678,FUN_033119-T1,Q9R1R2,TRIM3_MOUSE,,Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1),Mus musculus (Mouse),23.2,482.0,3.9e-23,111.7,sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1,GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0061351; GO:0061630; GO:0070534,neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein K63-linked ubiquitination [GO:0070534]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07271,1.287672204249647,FUN_033127-T1,Peve_00043508,Pocillopora_meandrina_HIv1___RNAseq.g29764.t1,three_way,64.51100000000001,FUN_033127-T1,P0C152,MKS3_RAT,,Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67),Rattus norvegicus (Rat),39.0,1006.0,3.6e-183,643.7,sp|P0C152|MKS3_RAT Meckelin OS=Rattus norvegicus OX=10116 GN=Tmem67 PE=1 SV=1,GO:0001822; GO:0005789; GO:0005813; GO:0005930; GO:0007368; GO:0007507; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035845; GO:0035869; GO:0036038; GO:0036503; GO:0048754; GO:0051082; GO:0051787; GO:0060170; GO:0060271; GO:0060322; GO:0060441; GO:1902857; GO:1904294,branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERAD pathway [GO:0036503]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038],filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082],GO:0005815; GO:0008092; GO:0030163; GO:0044782; GO:0048856,microtubule organizing center; cytoskeletal protein binding; protein catabolic process; cilium organization; anatomical structure development
OG_07272,1.1514610130979417,FUN_033210-T1,Peve_00043517,Pocillopora_meandrina_HIv1___RNAseq.g29763.t1,three_way,93.34833333333331,FUN_033210-T1,P63328,PP2BA_MOUSE,,Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform),Mus musculus (Mouse),80.6,407.0,2.1e-201,703.0,sp|P63328|PP2BA_MOUSE Protein phosphatase 3 catalytic subunit alpha OS=Mus musculus OX=10090 GN=Ppp3ca PE=1 SV=1,GO:0000082; GO:0004721; GO:0004723; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0019722; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042104; GO:0042383; GO:0043197; GO:0045669; GO:0045672; GO:0045807; GO:0045944; GO:0046872; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070886; GO:0090193; GO:0097205; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903244; GO:1905205; GO:1905665; GO:1905949,calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018],ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983],GO:0003012; GO:0003014; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"muscle system process; renal system process; catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07281,2.1414258529211696,FUN_033488-T1,Peve_00033737,Pocillopora_meandrina_HIv1___RNAseq.g12099.t1,three_way,71.806,FUN_033488-T1,Q60848,HELLS_MOUSE,,Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein),Mus musculus (Mouse),50.1,807.0,3.8e-200,699.9,sp|Q60848|HELLS_MOUSE Lymphocyte-specific helicase OS=Mus musculus OX=10090 GN=Hells PE=1 SV=2,GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0141119; GO:1990830; GO:2001243,apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655],"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0002376; GO:0003824; GO:0005634; GO:0006325; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,immune system process; catalytic activity; nucleus; chromatin organization; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_07282,1.2029898496628812,FUN_033509-T1,Peve_00009172,Pocillopora_meandrina_HIv1___RNAseq.g24179.t1,three_way,62.28966666666666,FUN_033509-T1,P14942,GSTA4_RAT,,Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk),Rattus norvegicus (Rat),30.8,211.0,1.5e-17,91.3,sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2,GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0071285,cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; mitochondrion [GO:0005739],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643],GO:0003824; GO:0005739; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle
OG_07291,1.061316032320834,FUN_033672-T1,Peve_00037093,Pocillopora_meandrina_HIv1___RNAseq.g25923.t1,three_way,75.25266666666667,FUN_033672-T1,O05218,,,,,36.4,549.0,6.5e-89,329.7,sp|O05218|YWRD_BACSU Glutathione hydrolase-like YwrD proenzyme OS=Bacillus subtilis (strain 168) OX=224308 GN=ywrD PE=1 SV=1,,,,,,
OG_07293,1.8915453123405808,FUN_033675-T1,Peve_00006808,Pocillopora_meandrina_HIv1___TS.g8603.t2,three_way,61.733,FUN_033675-T1,Q8R1N4,,,,,33.3,360.0,2.1e-53,211.1,sp|Q8R1N4|NUDC3_MOUSE NudC domain-containing protein 3 OS=Mus musculus OX=10090 GN=Nudcd3 PE=1 SV=3,,,,,,
OG_07297,1.7338221053234713,FUN_033681-T1,Peve_00042855,Pocillopora_meandrina_HIv1___RNAseq.g25845.t3,three_way,71.65066666666667,FUN_033681-T1,Q80TT2,BAIP3_MOUSE,,BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3) (Baiap3),Mus musculus (Mouse),32.6,1060.0,1.9e-154,548.5,sp|Q80TT2|BAIP3_MOUSE BAI1-associated protein 3 OS=Mus musculus OX=10090 GN=Baiap3 PE=1 SV=4,GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0050795; GO:0050804; GO:0055038; GO:0098793; GO:0098982; GO:1905413; GO:1990502,"dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of behavior [GO:0050795]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0008289; GO:0016192,cytosol; plasma membrane; lipid binding; vesicle-mediated transport
OG_07298,1.200802569588627,FUN_033683-T1,Peve_00042857,Pocillopora_meandrina_HIv1___RNAseq.g25846.t1,three_way,70.0405,FUN_033683-T1,Q6ZUK4,,,,,26.1,387.0,2.9e-23,111.3,sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1,,,,,,
OG_07308,1.0906287679335285,FUN_033694-T1,Peve_00042849,Pocillopora_meandrina_HIv1___RNAseq.g25879.t1,three_way,83.94766666666666,FUN_033694-T1,A8E4L1,,,,,55.4,65.0,5.1e-16,84.7,sp|A8E4L1|COX19_BOVIN Cytochrome c oxidase assembly protein COX19 OS=Bos taurus OX=9913 GN=COX19 PE=3 SV=1,,,,,,
OG_07311,2.423318654296271,FUN_033700-T1,Peve_00027581,Pocillopora_meandrina_HIv1___RNAseq.g28769.t1,three_way,83.841,FUN_033700-T1,Q2HZX7,FUZZY_XENTR,,Protein fuzzy homolog (Xfy),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),47.5,417.0,1.0999999999999999e-107,391.7,sp|Q2HZX7|FUZZY_XENTR Protein fuzzy homolog OS=Xenopus tropicalis OX=8364 GN=fuz PE=1 SV=1,GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0042995; GO:0048704; GO:0060271,cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],,GO:0005856; GO:0016192; GO:0043226; GO:0044782,cytoskeleton; vesicle-mediated transport; organelle; cilium organization
OG_07315,1.187981677805508,FUN_033707-T1,Peve_00042846,Pocillopora_meandrina_HIv1___TS.g18650.t1,three_way,55.01383333333333,FUN_033707-T1,Q6S5C2,GNPTG_MOUSE,,N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (M6PR domain-containing protein 1) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma),Mus musculus (Mouse),40.2,276.0,7.9e-49,196.1,sp|Q6S5C2|GNPTG_MOUSE N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Mus musculus OX=10090 GN=Gnptg PE=1 SV=1,GO:0005576; GO:0005794; GO:0042803; GO:0046835,carbohydrate phosphorylation [GO:0046835],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005794; GO:0005975; GO:0043226,extracellular region; Golgi apparatus; carbohydrate metabolic process; organelle
OG_07317,1.389113649401643,FUN_033710-T1,Peve_00014635,Pocillopora_meandrina_HIv1___RNAseq.g25890.t1,three_way,79.785,FUN_033710-T1,P53369,8ODP_RAT,,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",Rattus norvegicus (Rat),61.4,153.0,6.1e-53,208.4,sp|P53369|8ODP_RAT Oxidized purine nucleoside triphosphate hydrolase OS=Rattus norvegicus OX=10116 GN=Nudt1 PE=1 SV=1,GO:0001669; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0006152; GO:0008413; GO:0008584; GO:0008828; GO:0016818; GO:0030515; GO:0031965; GO:0035539; GO:0042262; GO:0046686; GO:0046872; GO:0047693; GO:0106377; GO:0106378; GO:0106431; GO:0106433,DNA protection [GO:0042262]; male gonad development [GO:0008584]; purine nucleoside catabolic process [GO:0006152]; response to cadmium ion [GO:0046686],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634],"2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP diphosphatase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; N6-methyl-(d)ATP hydrolase activity [GO:0106431]; O6-methyl-dGTP hydrolase activity [GO:0106433]; snoRNA binding [GO:0030515]",GO:0003723; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:1901135,RNA binding; catalytic activity; extracellular space; nucleus; mitochondrion; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07319,1.415171702749323,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),34.7,404.0,4.399999999999997e-47,191.8,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07319,1.415171702749323,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),36.6,243.0,1.1e-37,160.6,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07326,1.3686889202138752,FUN_033720-T1,Peve_00027572,Pocillopora_meandrina_HIv1___RNAseq.g25888.t1,three_way,75.48283333333333,FUN_033720-T1,Q8VDL4,ADPGK_MOUSE,,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147),Mus musculus (Mouse),32.2,428.0,2.5e-49,198.0,sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2,GO:0005576; GO:0006006; GO:0006096; GO:0043843; GO:0046872,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],extracellular region [GO:0005576],ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07327,1.2043645342495992,FUN_033721-T1,Peve_00027574,Pocillopora_meandrina_HIv1___RNAseq.g23690.t2,three_way,54.64266666666667,FUN_033721-T1,Q9CWB7,,,,,60.0,85.0,4.5999999999999995e-24,112.1,sp|Q9CWB7|YD286_MOUSE Glutaredoxin-like protein C5orf63 homolog OS=Mus musculus OX=10090 PE=1 SV=1,,,,,,
OG_07329,2.035275003837504,FUN_033730-T1,Peve_00027615,Pocillopora_meandrina_HIv1___RNAseq.g28784.t1,three_way,68.86500000000001,FUN_033730-T1,Q96RR1,PEO1_HUMAN,,"Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)",Homo sapiens (Human),40.6,611.0,5.2e-118,426.8,sp|Q96RR1|PEO1_HUMAN Twinkle mtDNA helicase OS=Homo sapiens OX=9606 GN=TWNK PE=1 SV=1,GO:0000262; GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006261; GO:0006264; GO:0006390; GO:0008289; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139,DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214],mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006351; GO:0008289; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA-templated transcription; lipid binding; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07341,2.2361203422931832,FUN_033746-T1,Peve_00004930,Pocillopora_meandrina_HIv1___RNAseq.g16445.t1,three_way,68.84733333333334,,,,,,,,,,,,,,,,,
OG_07347,2.2942777961556824,FUN_033754-T1,Peve_00004912,Pocillopora_meandrina_HIv1___TS.g8539.t2,three_way,70.884,FUN_033754-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),48.5,371.0,5.8e-94,345.9,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07350,2.2689099362850764,FUN_033757-T1,Peve_00004916,Pocillopora_meandrina_HIv1___RNAseq.g28746.t2,three_way,69.06666666666666,FUN_033757-T1,Q8IYG6,LRC56_HUMAN,,Leucine-rich repeat-containing protein 56,Homo sapiens (Human),35.6,413.0,1.5000000000000001e-30,136.0,sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1,GO:0005929; GO:0030030,cell projection organization [GO:0030030],cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_07354,1.7123380948452285,FUN_033762-T1,Peve_00009249,Pocillopora_meandrina_HIv1___TS.g8524.t1,three_way,86.10033333333332,FUN_033762-T1,Q9VFC8,GYS_DROME,,Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase),Drosophila melanogaster (Fruit fly),60.9,627.0,8e-232,804.7,sp|Q9VFC8|GYS_DROME Glycogen [starch] synthase OS=Drosophila melanogaster OX=7227 GN=Glys PE=1 SV=2,GO:0004373; GO:0005737; GO:0005776; GO:0005829; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0071329,cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; response to sucrose [GO:0009744],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829],"alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity [GO:0004373]",GO:0003824; GO:0005773; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0031410; GO:0043226,catalytic activity; vacuole; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; cytoplasmic vesicle; organelle
OG_07358,1.6091680501458767,FUN_033769-T1,Peve_00006493,Pocillopora_meandrina_HIv1___RNAseq.g26662.t1,three_way,67.60866666666666,FUN_033769-T1,Q6B9X6,VWKA_DICDI,,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Dictyostelium discoideum (Social amoeba),35.0,137.0,1.1e-14,82.4,sp|Q6B9X6|VWKA_DICDI Alpha-protein kinase vwkA OS=Dictyostelium discoideum OX=44689 GN=vwkA PE=1 SV=1,GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310,contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005773; GO:0005829; GO:0007010; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"cytokinesis; catalytic activity; vacuole; cytosol; cytoskeleton organization; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07362,2.3196609097606227,FUN_033774-T1,Peve_00005278,Pocillopora_meandrina_HIv1___RNAseq.g26656.t1,three_way,62.04566666666667,,,,,,,,,,,,,,,,,
OG_07365,1.0718102575062591,FUN_033777-T1,Peve_00005283,Pocillopora_meandrina_HIv1___RNAseq.g26653.t1,three_way,63.86333333333334,FUN_033777-T1,P35790,CHKA_HUMAN,,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),Homo sapiens (Human),42.2,372.0,1.8e-79,297.7,sp|P35790|CHKA_HUMAN Choline kinase alpha OS=Homo sapiens OX=9606 GN=CHKA PE=1 SV=3,GO:0004103; GO:0004104; GO:0004305; GO:0004713; GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0006657; GO:0006869; GO:0042149; GO:0042803; GO:1905691,CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811],ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07372,2.616628697781513,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,43.9,214.0,1.7e-40,169.9,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07372,2.616628697781513,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,30.4,171.0,0.00058,48.5,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07374,1.1113878525120922,FUN_033796-T1,Peve_00029689,Pocillopora_meandrina_HIv1___RNAseq.g26321.t1,three_way,45.691,,,,,,,,,,,,,,,,,
OG_07375,1.4279045452262011,FUN_033797-T1,Peve_00029703,Pocillopora_meandrina_HIv1___RNAseq.g26319.t1,three_way,67.2325,FUN_033797-T1,O95071,,,,,39.0,318.0,1.5e-52,211.1,sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,,,,,,
OG_07378,1.005829450712891,FUN_033800-T1,Peve_00007584,Pocillopora_meandrina_HIv1___RNAseq.g26322.t1,three_way,43.99316666666667,,,,,,,,,,,,,,,,,
OG_07386,1.12248727308797,FUN_033813-T1,Peve_00028719,Pocillopora_meandrina_HIv1___RNAseq.g26346.t1,three_way,86.456,FUN_033813-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,533.0,2.9e-60,235.0,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07391,1.5547921897727632,FUN_033820-T1,Peve_00028743,Pocillopora_meandrina_HIv1___RNAseq.g26352.t1,three_way,71.83,FUN_033820-T1,Q80VW5,WHRN_MOUSE,,Whirlin,Mus musculus (Mouse),32.1,324.0,3.8000000000000004e-36,154.5,sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005829; GO:0005884; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043005; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; cytosol; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_07395,2.5596033566233425,FUN_033834-T1,Peve_00028775,Pocillopora_meandrina_HIv1___RNAseq.g26359.t1,three_way,52.308,FUN_033834-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),32.0,328.0,2e-52,208.8,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_07397,1.0839659025990604,FUN_033836-T1,Peve_00013463,Pocillopora_meandrina_HIv1___RNAseq.g26363.t1,three_way,68.35566666666666,FUN_033836-T1,Q8H1F7,,,,,35.8,288.0,1.3e-35,151.8,sp|Q8H1F7|IPK_ARATH Isopentenyl phosphate kinase OS=Arabidopsis thaliana OX=3702 GN=IPK PE=1 SV=1,,,,,,
OG_07402,1.4100873844327937,FUN_033843-T1,Peve_00013534,Pocillopora_meandrina_HIv1___RNAseq.g26141.t1,three_way,90.93266666666668,FUN_033843-T1,Q6P6Z0,,,,,68.4,1095.0,0.0,1486.5,sp|Q6P6Z0|DDB1_XENLA DNA damage-binding protein 1 OS=Xenopus laevis OX=8355 GN=ddb1 PE=2 SV=1,,,,,,
OG_07403,1.8881127557802249,FUN_033845-T1,Peve_00039879,Pocillopora_meandrina_HIv1___RNAseq.g26135.t1,three_way,74.83,FUN_033845-T1,P50430,,,,,43.8,525.0,6.2e-118,426.0,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_07405,1.0177836976850247,FUN_033856-T2,Peve_00043300,Pocillopora_meandrina_HIv1___TS.g8205.t2,three_way,77.4,FUN_033856-T2,Q96KP4,CNDP2_HUMAN,,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),Homo sapiens (Human),65.4,474.0,6.799999999999999e-188,658.3,sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573,proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07406,1.875441983743346,FUN_033859-T1,Peve_00043297,Pocillopora_meandrina_HIv1___RNAseq.g28418.t1,three_way,86.258,FUN_033859-T1,Q3MHW9,,,,,57.1,303.0,4.4000000000000003e-100,365.9,sp|Q3MHW9|NB5R1_BOVIN NADH-cytochrome b5 reductase 1 OS=Bos taurus OX=9913 GN=CYB5R1 PE=2 SV=1,,,,,,
OG_07407,1.3612720218357182,FUN_033860-T1,Peve_00043298,Pocillopora_meandrina_HIv1___RNAseq.20855_t,three_way,71.87700000000001,,,,,,,,,,,,,,,,,
OG_07408,4.375018062509505,FUN_033861-T1,Peve_00043296,Pocillopora_meandrina_HIv1___RNAseq.g28415.t1,three_way,63.10766666666667,FUN_033861-T1,Q95JR6,,,,,28.8,295.0,3.5e-27,124.8,sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1,,,,,,
OG_07421,1.656396651142219,FUN_033883-T1,Peve_00043307,Pocillopora_meandrina_HIv1___RNAseq.g28394.t1,three_way,75.87733333333333,FUN_033883-T1,P28739,,,,,55.2,377.0,4.1e-107,390.6,sp|P28739|KLPA_EMENI Kinesin-like protein klpA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=klpA PE=2 SV=3,,,,,,
OG_07422,1.893754537389184,FUN_033884-T1,Peve_00043305,Pocillopora_meandrina_HIv1___RNAseq.g28393.t1,three_way,52.554,,,,,,,,,,,,,,,,,
OG_07428,1.272151775852428,FUN_033913-T1,Peve_00032110,Pocillopora_meandrina_HIv1___RNAseq.g28372.t2,three_way,56.92033333333333,FUN_033913-T1,Q5R4A6,,,,,31.1,344.0,9.1e-40,166.8,sp|Q5R4A6|AMZ2_PONAB Archaemetzincin-2 OS=Pongo abelii OX=9601 GN=AMZ2 PE=2 SV=1,,,,,,
OG_07429,1.094825145858995,FUN_033915-T1,Peve_00022636,Pocillopora_meandrina_HIv1___RNAseq.g26598.t1,three_way,74.89316666666667,FUN_033915-T1,E7EY42,PTSS2_DANRE,,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,366.0,2.1e-146,520.4,sp|E7EY42|PTSS2_DANRE Phosphatidylserine synthase 2 OS=Danio rerio OX=7955 GN=ptdss2 PE=3 SV=1,GO:0005789; GO:0006659; GO:0106245,phosphatidylserine biosynthetic process [GO:0006659],endoplasmic reticulum membrane [GO:0005789],L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_07432,1.1519473963566025,FUN_033920-T1,Peve_00022629,Pocillopora_meandrina_HIv1___RNAseq.g26595.t1,three_way,69.64033333333333,,,,,,,,,,,,,,,,,
OG_07433,1.2745749726464564,FUN_033921-T1,Peve_00022625,Pocillopora_meandrina_HIv1___RNAseq.g26594.t1,three_way,72.53766666666667,FUN_033921-T1,Q8IUH5,ZDH17_HUMAN,,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17),Homo sapiens (Human),50.0,564.0,7.8e-130,465.7,sp|Q8IUH5|ZDH17_HUMAN Palmitoyltransferase ZDHHC17 OS=Homo sapiens OX=9606 GN=ZDHHC17 PE=1 SV=2,GO:0000139; GO:0005102; GO:0005794; GO:0007409; GO:0016409; GO:0018345; GO:0019705; GO:0019706; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043067; GO:0043123; GO:0043231; GO:0051386; GO:0070372; GO:0098978; GO:0098987; GO:0140240; GO:0140439; GO:0150051,"axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of modification of synapse structure, modulating synaptic transmission [GO:0098987]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of programmed cell death [GO:0043067]",cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; perforant pathway to dendrate granule cell synapse [GO:0140240]; postsynaptic Golgi apparatus [GO:0150051]; presynaptic membrane [GO:0042734],identical protein binding [GO:0042802]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07440,1.1439752961749976,FUN_033932-T1,Peve_00020979,Pocillopora_meandrina_HIv1___RNAseq.g26584.t1,three_way,60.418,,,,,,,,,,,,,,,,,
OG_07445,1.1826851050611686,FUN_033937-T1,Peve_00020988,Pocillopora_meandrina_HIv1___RNAseq.g26578.t1,three_way,78.66766666666666,FUN_033937-T1,A7SK27,,,,,56.0,350.0,1.4e-113,411.0,sp|A7SK27|EKI_NEMVE Probable ethanolamine kinase OS=Nematostella vectensis OX=45351 GN=etnk PE=3 SV=1,,,,,,
OG_07449,3.5995131779457465,FUN_033943-T1,Peve_00020995,Pocillopora_meandrina_HIv1___RNAseq.g26573.t1,three_way,65.91733333333333,FUN_033943-T1,Q8WVB3,,,,,40.2,460.0,1.3e-86,322.0,sp|Q8WVB3|HEXD_HUMAN Hexosaminidase D OS=Homo sapiens OX=9606 GN=HEXD PE=1 SV=3,,,,,,
OG_07453,1.4239569620866706,FUN_033948-T2,Peve_00039785,Pocillopora_meandrina_HIv1___RNAseq.g26569.t1,three_way,56.28533333333333,,,,,,,,,,,,,,,,,
OG_07457,1.618798189584654,FUN_033958-T1,Peve_00022633,Pocillopora_meandrina_HIv1___RNAseq.g26600.t1,three_way,70.71616666666667,FUN_033958-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),32.6,972.0,1.4e-144,516.2,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_07464,3.108554144455237,FUN_033968-T1,Peve_00015220,Pocillopora_meandrina_HIv1___RNAseq.g28549.t1,three_way,90.424,FUN_033968-T1,Q9Y2H1,ST38L_HUMAN,,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),Homo sapiens (Human),71.3,442.0,1.3e-188,660.6,sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3,GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07467,1.862953605740044,FUN_033971-T3,Peve_00015223,Pocillopora_meandrina_HIv1___RNAseq.g26370.t1,three_way,66.31200000000001,FUN_033971-T3,Q5E9H2,,,,,39.4,419.0,1.4e-85,318.5,sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1,,,,,,
OG_07469,2.097599059166813,FUN_033979-T1,Peve_00004846,Pocillopora_meandrina_HIv1___RNAseq.g26111.t1,three_way,80.1855,FUN_033979-T1,O70247,,,,,40.7,570.0,5.3000000000000004e-111,403.3,sp|O70247|SC5A6_RAT Sodium-dependent multivitamin transporter OS=Rattus norvegicus OX=10116 GN=Slc5a6 PE=1 SV=1,,,,,,
OG_07476,1.72388483690556,FUN_033998-T2,Peve_00000499,Pocillopora_meandrina_HIv1___RNAseq.g26093.t2,three_way,69.55316666666667,FUN_033998-T2,Q8CDK2,,,,,49.7,734.0,1.8e-192,674.9,sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1,,,,,,
OG_07477,1.0481818883593832,FUN_033999-T1,Peve_00044495,Pocillopora_meandrina_HIv1___RNAseq.g9828.t1,three_way,84.30799999999999,FUN_033999-T1,Q9F234,,,,,29.2,854.0,2.3e-86,322.0,sp|Q9F234|AGL2_BACTQ Alpha-glucosidase 2 OS=Bacillus thermoamyloliquefaciens OX=1425 PE=3 SV=1,,,,,,
OG_07483,1.6143876864195958,FUN_034008-T1,Peve_00033154,Pocillopora_meandrina_HIv1___RNAseq.g26086.t1,three_way,63.45133333333334,FUN_034008-T1,P46023,,,,,46.7,347.0,3.7e-84,314.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_07484,1.3735981180549737,FUN_034010-T1,Peve_00030670,Pocillopora_meandrina_HIv1___RNAseq.g26085.t1,three_way,72.63733333333333,FUN_034010-T1,Q9Y2V2,CHSP1_HUMAN,,Calcium-regulated heat-stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),Homo sapiens (Human),55.4,130.0,8.4e-31,134.8,sp|Q9Y2V2|CHSP1_HUMAN Calcium-regulated heat-stable protein 1 OS=Homo sapiens OX=9606 GN=CARHSP1 PE=1 SV=2,GO:0000177; GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0019902; GO:0035556; GO:0043186; GO:0043488,intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902],GO:0003723; GO:0005829; GO:0043226,RNA binding; cytosol; organelle
OG_07488,1.5919517527986378,FUN_034015-T1,Peve_00007012,Pocillopora_meandrina_HIv1___RNAseq.g26080.t1,three_way,77.31,FUN_034015-T1,A5PK16,CCNF_BOVIN,,Cyclin-F,Bos taurus (Bovine),40.1,619.0,3.5e-119,430.6,sp|A5PK16|CCNF_BOVIN Cyclin-F OS=Bos taurus OX=9913 GN=CCNF PE=2 SV=1,GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005814; GO:0005815; GO:0010826; GO:0016538; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301; GO:0051726,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],centriole [GO:0005814]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],GO:0005634; GO:0005815; GO:0030163; GO:0043226; GO:0098772,nucleus; microtubule organizing center; protein catabolic process; organelle; molecular function regulator activity
OG_07491,2.3870689570559915,FUN_034018-T1,Peve_00024700,Pocillopora_meandrina_HIv1___RNAseq.g26076.t1,three_way,64.037,FUN_034018-T1,Q9Z2E3,,,,,35.4,401.0,2.3e-51,206.5,sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus OX=10090 GN=Ern2 PE=2 SV=2,,,,,,
OG_07496,1.0669519671316057,FUN_034028-T1,Peve_00043490,Pocillopora_meandrina_HIv1___RNAseq.g16571.t1,three_way,51.52466666666667,,,,,,,,,,,,,,,,,
OG_07500,3.0240013620856447,FUN_034039-T1,Peve_00023160,Pocillopora_meandrina_HIv1___RNAseq.17737_t,three_way,94.59466666666668,FUN_034039-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),80.3,188.0,1.6999999999999999e-84,313.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_07507,2.262441666498066,FUN_034049-T1,Peve_00022955,Pocillopora_meandrina_HIv1___RNAseq.g26034.t2,three_way,61.748,FUN_034049-T1,Q9JIH2,NUP50_MOUSE,,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),Mus musculus (Mouse),30.3,478.0,2.7e-38,161.0,sp|Q9JIH2|NUP50_MOUSE Nuclear pore complex protein Nup50 OS=Mus musculus OX=10090 GN=Nup50 PE=1 SV=3,GO:0001841; GO:0005635; GO:0005643; GO:0005654; GO:0006913; GO:0015031; GO:0031965; GO:0051028; GO:1990904,mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],,GO:0005635; GO:0005654; GO:0006913,nuclear envelope; nucleoplasm; nucleocytoplasmic transport
OG_07508,1.9245138080880853,FUN_034050-T2,Peve_00022956,Pocillopora_meandrina_HIv1___TS.g18783.t1,three_way,73.61983333333333,FUN_034050-T2,Q22516,CHD3_CAEEL,,Chromodomain-helicase-DNA-binding protein 3 homolog (CHD-3) (EC 3.6.4.-),Caenorhabditis elegans,46.0,63.0,6.7e-12,73.6,sp|Q22516|CHD3_CAEEL Chromodomain-helicase-DNA-binding protein 3 homolog OS=Caenorhabditis elegans OX=6239 GN=chd-3 PE=2 SV=2,GO:0000118; GO:0000785; GO:0001709; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0006338; GO:0008270; GO:0016581; GO:0016887; GO:0040027; GO:0042393; GO:0046580; GO:0140658,cell fate determination [GO:0001709]; chromatin remodeling [GO:0006338]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of vulval development [GO:0040027],chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; NuRD complex [GO:0016581],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0042393; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; histone binding; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07509,1.3433078930897524,FUN_034051-T1,Peve_00009941,Pocillopora_meandrina_HIv1___RNAseq.g26031.t1,three_way,79.378,FUN_034051-T1,O93257,XRCC6_CHICK,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70),Gallus gallus (Chicken),46.8,583.0,2.6e-147,523.9,sp|O93257|XRCC6_CHICK X-ray repair cross-complementing protein 5 OS=Gallus gallus OX=9031 GN=XRCC6 PE=2 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003723; GO:0005524; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564; GO:0045892; GO:0051575; GO:0070419; GO:0071480; GO:1990904,cellular response to gamma radiation [GO:0071480]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; telomere maintenance [GO:0000723],chromosome [GO:0005694]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016829; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; chromosome; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; lyase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07510,1.1639900630922526,FUN_034052-T1,Peve_00009942,Pocillopora_meandrina_HIv1___RNAseq.g26030.t1,three_way,36.97683333333333,,,,,,,,,,,,,,,,,
OG_07512,1.5142493400538477,FUN_034055-T1,Peve_00015322,Pocillopora_meandrina_HIv1___RNAseq.g26028.t2,three_way,81.44633333333333,FUN_034055-T1,O08873,MADD_RAT,,MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP),Rattus norvegicus (Rat),38.5,1719.0,1.8e-285,984.2,sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1,GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236,anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0007018; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; microtubule-based movement; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07516,1.5307416058640648,FUN_034084-T1,Peve_00037080,Pocillopora_meandrina_HIv1___RNAseq.g26054.t2,three_way,74.45100000000001,FUN_034084-T1,P07607,,,,,71.9,299.0,1.900000000000001e-130,466.8,sp|P07607|TYSY_MOUSE Thymidylate synthase OS=Mus musculus OX=10090 GN=Tyms PE=1 SV=1,,,,,,
OG_07519,3.653074036161203,FUN_034088-T1,Peve_00037071,Pocillopora_meandrina_HIv1___RNAseq.g26059.t1,three_way,77.17566666666667,FUN_034088-T1,Q4V920,PACN1_DANRE,,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,449.0,4.1e-70,266.9,sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; synapse [GO:0045202],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; membrane organization
OG_07520,2.172060882100662,FUN_034090-T1,Peve_00037070,Pocillopora_meandrina_HIv1___RNAseq.g26061.t1,three_way,75.31133333333334,FUN_034090-T1,Q9I9H8,,,,,36.6,1258.0,6.2000000000000005e-146,520.4,sp|Q9I9H8|APAF_DANRE Apoptotic protease-activating factor 1 OS=Danio rerio OX=7955 GN=apaf1 PE=2 SV=1,,,,,,
OG_07523,1.7966227420073275,FUN_034093-T1,Peve_00037067,Pocillopora_meandrina_HIv1___RNAseq.g26065.t1,three_way,65.31416666666668,FUN_034093-T1,Q641G4,,,,,38.5,642.0,2.6e-94,347.8,sp|Q641G4|CNDH2_XENLA Condensin-2 complex subunit H2 OS=Xenopus laevis OX=8355 GN=ncaph2 PE=1 SV=1,,,,,,
OG_07526,1.9180896494711488,FUN_034096-T1,Peve_00006468,Pocillopora_meandrina_HIv1___TS.g18816.t1b,three_way,49.18933333333333,FUN_034096-T1,E7F211,TTC17_DANRE,,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),Danio rerio (Zebrafish) (Brachydanio rerio),26.7,1249.0,1.1e-72,276.9,sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1,GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371,actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_07528,1.901100989511116,FUN_034098-T1,Peve_00042343,Pocillopora_meandrina_HIv1___RNAseq.g26070.t1,three_way,59.001,FUN_034098-T1,Q9NQ36,SCUB2_HUMAN,,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)",Homo sapiens (Human),41.2,85.0,1.9e-12,75.9,"sp|Q9NQ36|SCUB2_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCUBE2 PE=1 SV=3",GO:0005509; GO:0005576; GO:0005615; GO:0007165; GO:0008289; GO:0009986,signal transduction [GO:0007165],cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; lipid binding [GO:0008289],GO:0005576; GO:0005615; GO:0008289,extracellular region; extracellular space; lipid binding
OG_07533,2.3246115480155134,FUN_034109-T1,Peve_00034853,Pocillopora_meandrina_HIv1___RNAseq.g25962.t1,three_way,67.35366666666667,FUN_034109-T1,P55265,DSRAD_HUMAN,,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),Homo sapiens (Human),33.4,739.0,5.6e-90,334.0,sp|P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530],DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016071; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098542; GO:0140098,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA"
OG_07534,1.5219620872376352,FUN_034110-T1,Peve_00034861,Pocillopora_meandrina_HIv1___RNAseq.g25961.t1,three_way,65.22083333333333,,,,,,,,,,,,,,,,,
OG_07538,1.9951293845067897,FUN_034114-T1,Peve_00034856,Pocillopora_meandrina_HIv1___RNAseq.g25955.t1,three_way,88.02533333333334,FUN_034114-T1,O54747,DPOD1_RAT,,DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-),Rattus norvegicus (Rat),65.3,1059.0,0.0,1419.8,sp|O54747|DPOD1_RAT DNA polymerase delta catalytic subunit OS=Rattus norvegicus OX=10116 GN=Pold1 PE=2 SV=1,GO:0000109; GO:0000166; GO:0000731; GO:0000781; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008296; GO:0008408; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0051539; GO:0055089; GO:0070987; GO:0071897,"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]","chromosome, telomeric region [GO:0000781]; delta DNA polymerase complex [GO:0043625]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]","3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_07539,1.1231690739801643,FUN_034120-T1,Peve_00039587,Pocillopora_meandrina_HIv1___RNAseq.g25948.t2,three_way,82.97233333333334,FUN_034120-T1,A0A0G2K047,ACSS3_RAT,,"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase) (EC 6.2.1.17)",Rattus norvegicus (Rat),54.1,625.0,2.0000000000000002e-212,740.3,"sp|A0A0G2K047|ACSS3_RAT Acyl-CoA synthetase short-chain family member 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acss3 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005759; GO:0006629; GO:0031956; GO:0050218,lipid metabolic process [GO:0006629],mitochondrial matrix [GO:0005759],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0006629; GO:0016874; GO:0140657,catalytic activity; lipid metabolic process; ligase activity; ATP-dependent activity
OG_07540,1.3896398341465,FUN_034121-T1,Peve_00039586,Pocillopora_meandrina_HIv1___RNAseq.g25946.t1,three_way,61.15633333333333,FUN_034121-T1,Q5FVF4,,,,,34.1,460.0,1.1000000000000004e-59,232.6,sp|Q5FVF4|TM7S3_RAT Transmembrane 7 superfamily member 3 OS=Rattus norvegicus OX=10116 GN=Tm7sf3 PE=2 SV=1,,,,,,
OG_07542,1.0684883177404558,FUN_034123-T1,Peve_00039584,Pocillopora_meandrina_HIv1___TS.g18693.t1,three_way,50.32483333333333,FUN_034123-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),44.4,376.0,1.7e-73,279.3,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07548,2.398849222131296,FUN_034130-T1,Peve_00006386,Pocillopora_meandrina_HIv1___RNAseq.g26664.t1,three_way,57.29133333333333,,,,,,,,,,,,,,,,,
OG_07553,2.4185498439899265,FUN_034144-T1,Peve_00018769,Pocillopora_meandrina_HIv1___RNAseq.g26305.t1,three_way,57.939,FUN_034144-T1,Q9UPZ3,HPS5_HUMAN,,BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2),Homo sapiens (Human),32.0,425.0,2.9e-54,216.1,sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2,GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232,blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155],BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769],,GO:0005768; GO:0005829; GO:0031410; GO:0043226,endosome; cytosol; cytoplasmic vesicle; organelle
OG_07554,4.167038406476633,FUN_034149-T1,Peve_00026010,Pocillopora_meandrina_HIv1___TS.g23718.t1b,three_way,50.663833333333336,,,,,,,,,,,,,,,,,
OG_07555,1.56973204718477,FUN_034159-T1,Peve_00018778,Pocillopora_meandrina_HIv1___RNAseq.g26287.t1,three_way,78.49566666666666,FUN_034159-T1,Q8CFE4,SCYL2_MOUSE,,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),Mus musculus (Mouse),55.5,600.0,1.7e-193,677.9,sp|Q8CFE4|SCYL2_MOUSE SCY1-like protein 2 OS=Mus musculus OX=10090 GN=Scyl2 PE=1 SV=1,GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090,brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623],clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07559,2.03014865639572,FUN_034173-T1,Peve_00006812,Pocillopora_meandrina_HIv1___RNAseq.g26278.t1,three_way,85.85433333333333,FUN_034173-T1,Q6UPE0,CHDH_RAT,,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",Rattus norvegicus (Rat),63.8,450.0,6.7e-177,621.7,"sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1",GO:0005743; GO:0008812; GO:0019285; GO:0050660,glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743],choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0006575; GO:0016491,catalytic activity; modified amino acid metabolic process; oxidoreductase activity
OG_07563,1.2097133213271514,FUN_034209-T1,Peve_00027534,Pocillopora_meandrina_HIv1___RNAseq.g26169.t1,three_way,56.48,,,,,,,,,,,,,,,,,
OG_07567,2.1453578856365425,FUN_034229-T1,Peve_00040765,Pocillopora_meandrina_HIv1___RNAseq.g28437.t1,three_way,83.228,FUN_034229-T1,Q8IWQ3,BRSK2_HUMAN,,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),Homo sapiens (Human),50.3,650.0,3.4999999999999997e-169,596.7,sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3,GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0019901; GO:0021953; GO:0030010; GO:0030036; GO:0030182; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807,"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell division [GO:0051301]; central nervous system neuron differentiation [GO:0021953]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005783; GO:0005815; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; microtubule organizing center; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07568,1.64214084492556,FUN_034230-T1,Peve_00000636,Pocillopora_meandrina_HIv1___RNAseq.g28438.t1,three_way,78.84533333333333,FUN_034230-T1,P32780,TF2H1_HUMAN,,General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit),Homo sapiens (Human),42.3,549.0,9e-112,405.6,sp|P32780|TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1,GO:0000079; GO:0000439; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009755; GO:0045893; GO:0046966,DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966],GO:0005654; GO:0006281; GO:0006351; GO:0006355,nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription
OG_07569,2.317255014736909,FUN_034231-T1,Peve_00000637,Pocillopora_meandrina_HIv1___RNAseq.g28439.t1,three_way,80.96333333333334,FUN_034231-T1,Q8VI63,,,,,46.2,212.0,1.0999999999999999e-47,191.4,sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1,,,,,,
OG_07577,1.8170773838172671,FUN_034258-T1,Peve_00009313,Pocillopora_meandrina_HIv1___RNAseq.g26618.t1,three_way,57.11,FUN_034258-T1,A0A386CAB9,NLRP1_DANRE,,"NACHT, LRR and PYD domains-containing protein 1 homolog (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]",Danio rerio (Zebrafish) (Brachydanio rerio),23.4,402.0,5e-16,88.6,"sp|A0A386CAB9|NLRP1_DANRE NACHT, LRR and PYD domains-containing protein 1 homolog OS=Danio rerio OX=7955 GN=nlrp1 PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0006954; GO:0008233; GO:0012501; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0061702; GO:0072558,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07583,1.3153692716809031,FUN_034276-T1,Peve_00035852,Pocillopora_meandrina_HIv1___RNAseq.g26313.t1,three_way,81.86433333333333,FUN_034276-T1,Q8BGC4,PTGR3_MOUSE,,Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2),Mus musculus (Mouse),53.3,349.0,8.2e-107,388.7,sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1,GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522,lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599],mitochondrion [GO:0005739]; peroxisome [GO:0005777],15-oxoprostaglandin 13-oxidase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_07595,2.236196429846314,FUN_034301-T1,Peve_00019147,Pocillopora_meandrina_HIv1___RNAseq.g28498.t1,three_way,69.90066666666667,FUN_034301-T1,Q803M5,,,,,33.4,392.0,1.2e-47,192.6,sp|Q803M5|SAAL1_DANRE Protein saal1 OS=Danio rerio OX=7955 GN=saal1 PE=2 SV=2,,,,,,
OG_07596,2.449890733371639,FUN_034303-T1,Peve_00019148,Pocillopora_meandrina_HIv1___RNAseq.g28500.t1,three_way,76.81366666666666,FUN_034303-T1,Q15256,,,,,35.3,544.0,8.4e-69,263.1,sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2,,,,,,
OG_07598,1.1508544322487164,FUN_034312-T1,Peve_00011305,Pocillopora_meandrina_HIv1___RNAseq.g28493.t1,three_way,91.465,FUN_034312-T1,Q9VSF3,UBC2M_DROME,,Nedd8-conjugating enzyme UbcE2M (EC 2.3.2.34) (Nedd8 carrier protein),Drosophila melanogaster (Fruit fly),74.9,179.0,1.4e-77,290.4,sp|Q9VSF3|UBC2M_DROME Nedd8-conjugating enzyme UbcE2M OS=Drosophila melanogaster OX=7227 GN=UbcE2M PE=1 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0045116; GO:0045879; GO:0061059; GO:0061654,negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein modification process [GO:0036211]; protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07606,1.6138554878997535,FUN_034323-T1,Peve_00015002,Pocillopora_meandrina_HIv1___RNAseq.g28481.t1,three_way,65.10766666666666,FUN_034323-T1,Q3UR85,MYRF_MOUSE,,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",Mus musculus (Mouse),54.0,404.0,1.5000000000000001e-117,425.6,sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2,GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0043565; GO:0045893; GO:0048709; GO:0048714,central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0061024; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; membrane organization; catalytic activity, acting on a protein; transcription regulator activity"
OG_07607,2.530492265216252,FUN_034324-T1,Peve_00013956,Pocillopora_meandrina_HIv1___TS.g8265.t1,three_way,50.318333333333335,,,,,,,,,,,,,,,,,
OG_07611,1.1107776134180696,FUN_034333-T1,Peve_00019134,Pocillopora_meandrina_HIv1___RNAseq.g28458.t2,three_way,68.18866666666666,FUN_034333-T1,Q7ZWY2,,,,,47.7,281.0,4.799999999999999e-75,282.7,sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1,,,,,,
OG_07619,1.7292676731208334,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),37.4,417.0,4.7e-65,251.9,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07619,1.7292676731208334,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),56.3,158.0,7.6e-15,85.1,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07622,1.6370714502565415,FUN_034367-T1,Peve_00036158,Pocillopora_meandrina_HIv1___RNAseq.g26130.t1,three_way,71.85166666666667,FUN_034367-T1,Q6IV56,,,,,34.6,243.0,5.799999999999999e-31,136.0,sp|Q6IV56|RN141_DANRE RING finger protein 141 OS=Danio rerio OX=7955 GN=rnf141 PE=2 SV=2,,,,,,
OG_07623,1.6106367704175542,FUN_034368-T1,Peve_00036157,Pocillopora_meandrina_HIv1___RNAseq.g26131.t2,three_way,72.677,FUN_034368-T1,Q9TW28,,,,,31.6,269.0,1.9e-30,135.6,sp|Q9TW28|MYOM_DICDI Myosin-M heavy chain OS=Dictyostelium discoideum OX=44689 GN=myoM PE=1 SV=1,,,,,,
OG_07624,1.12479929599933,FUN_034370-T1,Peve_00036156,Pocillopora_meandrina_HIv1___TS.g18881.t2,three_way,70.096,FUN_034370-T1,Q4QQM4,,,,,30.7,176.0,1.7e-10,67.8,sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1,,,,,,
OG_07629,1.3070264148892223,FUN_034379-T1,Peve_00027166,Pocillopora_meandrina_HIv1___RNAseq.g26152.t1,three_way,68.00166666666667,FUN_034379-T1,Q86TZ1,,,,,49.0,206.0,4.2e-56,222.6,sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1,,,,,,
OG_07631,3.4939630414289438,FUN_034387-T1,Peve_00027164,Pocillopora_meandrina_HIv1___TS.g18900.t1,three_way,70.562,FUN_034387-T1,Q95K73,ELOV4_MACFA,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),52.3,279.0,3e-77,290.0,sp|Q95K73|ELOV4_MACFA Very long chain fatty acid elongase 4 OS=Macaca fascicularis OX=9541 GN=ELOVL4 PE=2 SV=1,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07632,2.439720175430154,FUN_034388-T1,Peve_00027163,Pocillopora_meandrina_HIv1___RNAseq.g26149.t2,three_way,73.248,FUN_034388-T1,Q9EQC4,ELOV4_MOUSE,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Mus musculus (Mouse),44.2,258.0,3.2e-57,223.4,sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07652,2.038910136125548,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07654,1.0733958544313311,FUN_034488-T1,Peve_00043238,Pocillopora_meandrina_HIv1___RNAseq.g28567.t1,three_way,95.15633333333334,FUN_034488-T1,Q8JFQ2,,,,,74.8,131.0,6.7e-58,224.9,sp|Q8JFQ2|RBTN1_DANRE Rhombotin-1 OS=Danio rerio OX=7955 GN=lmo1 PE=2 SV=1,,,,,,
OG_07659,1.4706741797901444,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07663,2.5882415303602704,FUN_034717-T1,Peve_00014893,Pocillopora_meandrina_HIv1___RNAseq.g28725.t1,three_way,59.878,FUN_034717-T1,Q91754,GCKR_XENLA,,Glucokinase regulatory protein (GKRP) (Glucokinase regulator),Xenopus laevis (African clawed frog),39.5,582.0,8.800000000000001e-111,402.5,sp|Q91754|GCKR_XENLA Glucokinase regulatory protein OS=Xenopus laevis OX=8355 GN=gckr PE=1 SV=1,GO:0001678; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0009750; GO:0019210; GO:0019899; GO:0030246; GO:0033132; GO:0034504; GO:0070095; GO:0141089; GO:1901135,carbohydrate derivative metabolic process [GO:1901135]; intracellular glucose homeostasis [GO:0001678]; negative regulation of glucokinase activity [GO:0033132]; protein localization to nucleus [GO:0034504]; response to fructose [GO:0009750],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; fructose-6-phosphate binding [GO:0070095]; glucose sensor activity [GO:0141089]; kinase inhibitor activity [GO:0019210],GO:0005654; GO:0005739; GO:0005829; GO:0043226; GO:0098772; GO:0140299; GO:1901135,nucleoplasm; mitochondrion; cytosol; organelle; molecular function regulator activity; molecular sensor activity; carbohydrate derivative metabolic process
OG_07671,1.76776080937875,FUN_034738-T1,Peve_00010863,Pocillopora_meandrina_HIv1___RNAseq.g25891.t1,three_way,58.40533333333333,,,,,,,,,,,,,,,,,
OG_07672,1.8674249609628155,FUN_034779-T1,Peve_00043699,Pocillopora_meandrina_HIv1___RNAseq.g6184.t1,three_way,61.442,FUN_034779-T1,Q6P3X3,,,,,35.9,830.0,6.2999999999999996e-136,486.5,sp|Q6P3X3|TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens OX=9606 GN=TTC27 PE=1 SV=1,,,,,,
OG_07676,2.274179314003806,FUN_034785-T1,Peve_00029735,Pocillopora_meandrina_HIv1___RNAseq.g12280.t2,three_way,53.20216666666666,FUN_034785-T1,O08699,PGDH_RAT,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Rattus norvegicus (Rat),39.5,205.0,1.4e-37,157.9,sp|O08699|PGDH_RAT 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Rattus norvegicus OX=10116 GN=Hpgd PE=1 SV=2,GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]",GO:0003824; GO:0005615; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0022414; GO:0048856; GO:0060089,catalytic activity; extracellular space; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; reproductive process; anatomical structure development; molecular transducer activity
OG_07679,3.1403943970890085,FUN_034797-T1,Peve_00007517,Pocillopora_meandrina_HIv1___RNAseq.g12297.t1,three_way,79.21333333333334,FUN_034797-T1,D3ZDI6,MYLIP_RAT,,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Rattus norvegicus (Rat),43.0,440.0,5.1e-96,353.2,sp|D3ZDI6|MYLIP_RAT E3 ubiquitin-protein ligase MYLIP OS=Rattus norvegicus OX=10116 GN=Mylip PE=2 SV=1,GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630,cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07687,1.471833472714612,FUN_034808-T1,Peve_00034936,Pocillopora_meandrina_HIv1___RNAseq.g12307.t1,three_way,87.922,FUN_034808-T1,Q5R4A0,UBA3_PONAB,,NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),68.8,432.0,2.3e-185,649.8,sp|Q5R4A0|UBA3_PONAB NEDD8-activating enzyme E1 catalytic subunit OS=Pongo abelii OX=9601 GN=UBA3 PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0007113; GO:0019781; GO:0032991; GO:0042802; GO:0045116; GO:0046982; GO:0051726,endomitotic cell cycle [GO:0007113]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982],GO:0000278; GO:0003824; GO:0005634; GO:0016874; GO:0043226; GO:0140096; GO:0140657,"mitotic cell cycle; catalytic activity; nucleus; ligase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07689,1.7442255861694511,FUN_034812-T1,Peve_00003622,Pocillopora_meandrina_HIv1___TS.g3642.t1,three_way,57.64416666666666,FUN_034812-T1,Q9BQ04,RBM4B_HUMAN,,RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30),Homo sapiens (Human),48.0,75.0,5.9e-13,75.9,sp|Q9BQ04|RBM4B_HUMAN RNA-binding protein 4B OS=Homo sapiens OX=9606 GN=RBM4B PE=1 SV=1,GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006397; GO:0006417; GO:0007623; GO:0008270; GO:0008380; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; organelle
OG_07692,1.351593135810429,FUN_034819-T1,Peve_00041509,Pocillopora_meandrina_HIv1___RNAseq.g27216.t1,three_way,74.395,FUN_034819-T1,Q9R088,,,,,47.5,204.0,1.1e-52,208.4,"sp|Q9R088|KITM_MOUSE Thymidine kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Tk2 PE=1 SV=2",,,,,,
OG_07696,2.270062242830011,FUN_034829-T1,Peve_00040555,Pocillopora_meandrina_HIv1___RNAseq.g27179.t1,three_way,62.16466666666667,,,,,,,,,,,,,,,,,
OG_07697,1.1043785785621096,FUN_034830-T1,Peve_00022084,Pocillopora_meandrina_HIv1___RNAseq.g27180.t1,three_way,46.66733333333333,,,,,,,,,,,,,,,,,
OG_07698,1.80390818710071,FUN_034832-T1,Peve_00006740,Pocillopora_meandrina_HIv1___TS.g14528.t1,three_way,88.521,FUN_034832-T1,O35242,,,,,46.1,921.0,1.3e-227,791.2,sp|O35242|FAN_MOUSE Protein FAN OS=Mus musculus OX=10090 GN=Nsmaf PE=1 SV=2,,,,,,
OG_07699,1.2278861006466542,FUN_034833-T1,Peve_00010451,Pocillopora_meandrina_HIv1___RNAseq.g27185.t1,three_way,51.098,,,,,,,,,,,,,,,,,
OG_07704,1.716993607952994,FUN_034842-T1,Peve_00037379,Pocillopora_meandrina_HIv1___RNAseq.g27193.t1,three_way,74.40350000000001,FUN_034842-T1,Q7TMC8,FCSK_MOUSE,,L-fucose kinase (Fucokinase) (EC 2.7.1.52),Mus musculus (Mouse),43.7,1102.0,5.899999999999997e-243,842.4,sp|Q7TMC8|FCSK_MOUSE L-fucose kinase OS=Mus musculus OX=10090 GN=Fcsk PE=1 SV=1,GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201,carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352],cytosol [GO:0005829],ATP binding [GO:0005524]; fucokinase activity [GO:0050201],GO:0003824; GO:0005829; GO:0005975; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07707,1.1699329955934423,FUN_034849-T1,Peve_00037374,Pocillopora_meandrina_HIv1___RNAseq.g12146.t1,three_way,54.702333333333335,FUN_034849-T1,Q5ZMS4,,,,,46.5,157.0,1.1e-37,159.8,sp|Q5ZMS4|NCOA7_CHICK Nuclear receptor coactivator 7 OS=Gallus gallus OX=9031 GN=NCOA7 PE=2 SV=1,,,,,,
OG_07711,1.9907679560707376,FUN_034859-T1,Peve_00008084,Pocillopora_meandrina_HIv1___RNAseq.g12156.t1,three_way,75.80933333333333,FUN_034859-T1,Q80V03,,,,,50.4,538.0,3.3e-152,540.0,sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2,,,,,,
OG_07714,1.7226469067604897,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_07722,1.0688184349022511,FUN_034878-T1,Peve_00005698,Pocillopora_meandrina_HIv1___TS.g14511.t1,three_way,82.43299999999999,FUN_034878-T1,Q8NDA8,,,,,34.0,1657.0,1.1e-290,1001.5,sp|Q8NDA8|MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 OS=Homo sapiens OX=9606 GN=MROH1 PE=1 SV=3,,,,,,
OG_07723,3.190653394257204,FUN_034880-T1,Peve_00005696,Pocillopora_meandrina_HIv1___RNAseq.g27166.t1,three_way,80.42966666666666,FUN_034880-T1,Q0VC84,C1GLT_BOVIN,,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",Bos taurus (Bovine),47.3,332.0,1.3999999999999998e-82,308.1,sp|Q0VC84|C1GLT_BOVIN Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Bos taurus OX=9913 GN=C1GALT1 PE=2 SV=1,GO:0000166; GO:0001525; GO:0001822; GO:0006486; GO:0016020; GO:0016263; GO:0030154; GO:0046872,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; kidney development [GO:0001822]; protein glycosylation [GO:0006486],membrane [GO:0016020],glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],GO:0003824; GO:0006486; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; protein glycosylation; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_07724,1.213327548931457,FUN_034882-T1,Peve_00011622,Pocillopora_meandrina_HIv1___RNAseq.g27168.t1,three_way,66.23566666666667,FUN_034882-T1,Q9CY64,BIEA_MOUSE,,Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase),Mus musculus (Mouse),34.7,294.0,4.7000000000000005e-38,159.8,sp|Q9CY64|BIEA_MOUSE Biliverdin reductase A OS=Mus musculus OX=10090 GN=Blvra PE=1 SV=1,GO:0000166; GO:0004074; GO:0005829; GO:0006631; GO:0006641; GO:0006935; GO:0006954; GO:0006979; GO:0008270; GO:0010467; GO:0032094; GO:0032496; GO:0034440; GO:0038178; GO:0042167; GO:0042440; GO:0106276; GO:0106277; GO:0160025; GO:1905237,chemotaxis [GO:0006935]; complement component C5a signaling pathway [GO:0038178]; fatty acid metabolic process [GO:0006631]; gene expression [GO:0010467]; heme catabolic process [GO:0042167]; inflammatory response [GO:0006954]; lipid oxidation [GO:0034440]; pigment metabolic process [GO:0042440]; response to cyclosporin A [GO:1905237]; response to food [GO:0032094]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; sensory perception of itch [GO:0160025]; triglyceride metabolic process [GO:0006641],cytosol [GO:0005829],biliberdin reductase (NAD+) activity [GO:0106276]; biliverdin reductase (NADP+) activity [GO:0106277]; biliverdin reductase [NAD(P)+] activity [GO:0004074]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005829; GO:0006629; GO:0006954; GO:0016491; GO:0050877,immune system process; catalytic activity; cytosol; lipid metabolic process; inflammatory response; oxidoreductase activity; nervous system process
OG_07725,2.144235813480556,FUN_034884-T1,Peve_00011623,Pocillopora_meandrina_HIv1___TS.g14516.t1,three_way,73.757,FUN_034884-T1,Q97MV3,,,,,41.7,72.0,3.9e-08,59.3,sp|Q97MV3|MSRA_CLOAB Peptide methionine sulfoxide reductase MsrA OS=Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / IAM 19013 / LMG 5710 / NBRC 13948 / NRRL B-527 / VKM B-1787 / 2291 / W) OX=272562 GN=msrA PE=3 SV=1,,,,,,
OG_07726,1.1394430136262328,FUN_034887-T1,Peve_00009321,Pocillopora_meandrina_HIv1___RNAseq.g27811.t1,three_way,76.001,FUN_034887-T1,Q5U4I3,,,,,37.3,324.0,1.4e-54,214.9,sp|Q5U4I3|CCDB1_XENLA Cyclin-D1-binding protein 1 homolog OS=Xenopus laevis OX=8355 GN=ccndbp1 PE=2 SV=2,,,,,,
OG_07728,1.0210103597736326,FUN_034889-T1,Peve_00037341,Pocillopora_meandrina_HIv1___RNAseq.g27809.t1,three_way,78.04,FUN_034889-T1,Q6P1X6,,,,,54.9,175.0,1.5e-52,207.6,sp|Q6P1X6|CH082_HUMAN UPF0598 protein C8orf82 OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=2,,,,,,
OG_07737,2.6426802576992428,FUN_034914-T1,Peve_00009290,Pocillopora_meandrina_HIv1___RNAseq.g27121.t1,three_way,69.19466666666666,FUN_034914-T1,B5X4H8,,,,,41.4,452.0,1.5e-80,301.6,sp|B5X4H8|RFT2_SALSA Riboflavin transporter 2 OS=Salmo salar OX=8030 GN=rft2 PE=2 SV=1,,,,,,
OG_07739,1.0258266740973223,FUN_034918-T1,Peve_00039136,Pocillopora_meandrina_HIv1___RNAseq.g12140.t1,three_way,67.611,FUN_034918-T1,Q15650,,,,,50.0,438.0,1.4e-109,398.3,sp|Q15650|TRIP4_HUMAN Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4,,,,,,
OG_07740,1.9075521618367168,FUN_034919-T1,Peve_00039137,Pocillopora_meandrina_HIv1___TS.g3478.t2,three_way,88.44266666666667,FUN_034919-T1,Q5R7R6,COG4_PONAB,,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),53.4,761.0,1.5e-213,744.2,sp|Q5R7R6|COG4_PONAB Conserved oligomeric Golgi complex subunit 4 OS=Pongo abelii OX=9601 GN=COG4 PE=2 SV=1,GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119,"Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119],,GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_07742,1.352540315704228,FUN_034925-T1,Peve_00009317,Pocillopora_meandrina_HIv1___RNAseq.g27813.t1,three_way,63.78083333333333,FUN_034925-T1,P29119,,,,,41.9,558.0,2.1e-121,438.0,sp|P29119|FURI1_XENLA Furin-1 OS=Xenopus laevis OX=8355 GN=furin PE=2 SV=1,,,,,,
OG_07747,1.370021986936118,FUN_034936-T1,Peve_00018032,Pocillopora_meandrina_HIv1___RNAseq.g27830.t1,three_way,67.77,FUN_034936-T1,Q75QN2,INT8_HUMAN,,Integrator complex subunit 8 (Int8) (Protein kaonashi-1),Homo sapiens (Human),29.4,1071.0,1.8e-108,395.6,sp|Q75QN2|INT8_HUMAN Integrator complex subunit 8 OS=Homo sapiens OX=9606 GN=INTS8 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472; GO:0071168; GO:0160232; GO:0160240,protein localization to chromatin [GO:0071168]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],chromatin [GO:0000785]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006355; GO:0016073; GO:0043226,nucleus; nucleoplasm; regulation of DNA-templated transcription; snRNA metabolic process; organelle
OG_07748,1.7543860128499418,FUN_034937-T1,Peve_00018033,Pocillopora_meandrina_HIv1___RNAseq.g27831.t1,three_way,59.422666666666665,FUN_034937-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),34.4,224.0,2.3e-17,91.3,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_07751,1.668499456535927,FUN_034941-T1,Peve_00028352,Pocillopora_meandrina_HIv1___RNAseq.g12180.t1,three_way,86.32333333333334,FUN_034941-T1,Q3KQF4,,,,,48.4,124.0,2.1e-29,131.3,sp|Q3KQF4|LRC69_XENLA Leucine-rich repeat-containing protein 69 OS=Xenopus laevis OX=8355 GN=lrrc69 PE=2 SV=1,,,,,,
OG_07752,1.3840221819553205,FUN_034942-T1,Peve_00028348,Pocillopora_meandrina_HIv1___RNAseq.g12181.t1,three_way,62.79666666666667,FUN_034942-T1,Q91WE2,,,,,50.6,164.0,6.1e-31,136.0,sp|Q91WE2|PIP30_MOUSE PSME3-interacting protein OS=Mus musculus OX=10090 GN=Psme3ip1 PE=1 SV=1,,,,,,
OG_07760,3.6948065230035954,FUN_034954-T1,Peve_00036673,Pocillopora_meandrina_HIv1___RNAseq.g27838.t1,three_way,81.57233333333333,FUN_034954-T1,Q9NXC2,GFOD1_HUMAN,,Glucose-fructose oxidoreductase domain-containing protein 1 (Gfo/Idh/MocA-like oxidoreductase domain-containing protein 1),Homo sapiens (Human),45.3,371.0,7.8e-92,339.0,sp|Q9NXC2|GFOD1_HUMAN Glucose-fructose oxidoreductase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GFOD1 PE=1 SV=1,GO:0000166; GO:0005576; GO:0016491; GO:0042802,,extracellular region [GO:0005576],identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0016491,catalytic activity; extracellular region; oxidoreductase activity
OG_07762,4.314991659498859,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07763,1.1296529058528813,FUN_034957-T1,Peve_00036683,Pocillopora_meandrina_HIv1___RNAseq.g27834.t1,three_way,81.576,FUN_034957-T1,Q1NZ26,,,,,46.5,273.0,1.4e-65,251.1,"sp|Q1NZ26|YSMU_CAEEL Uncharacterized protein F13E9.13, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=F13E9.13 PE=3 SV=1",,,,,,
OG_07764,2.759799350310101,FUN_034958-T1,Peve_00036684,Pocillopora_meandrina_HIv1___RNAseq.g27833.t1,three_way,75.85683333333333,FUN_034958-T1,Q8IXH6,T53I2_HUMAN,,Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U),Homo sapiens (Human),47.5,80.0,5.2e-12,72.8,sp|Q8IXH6|T53I2_HUMAN Tumor protein p53-inducible nuclear protein 2 OS=Homo sapiens OX=9606 GN=TP53INP2 PE=1 SV=2,GO:0000045; GO:0001649; GO:0001894; GO:0005634; GO:0005776; GO:0005829; GO:0006511; GO:0008104; GO:0016605; GO:0031410; GO:0043130; GO:0045893; GO:1903828,autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],ubiquitin binding [GO:0043130],GO:0005634; GO:0005773; GO:0005829; GO:0006355; GO:0030154; GO:0031410; GO:0043226,nucleus; vacuole; cytosol; regulation of DNA-templated transcription; cell differentiation; cytoplasmic vesicle; organelle
OG_07766,1.7115157268072714,FUN_034961-T1,Peve_00028347,Pocillopora_meandrina_HIv1___RNAseq.g12173.t1,three_way,58.9135,FUN_034961-T1,P0C7T6,ATX1L_MOUSE,,Ataxin-1-like (Brother of ataxin-1),Mus musculus (Mouse),46.0,150.0,1.8e-30,135.6,sp|P0C7T6|ATX1L_MOUSE Ataxin-1-like OS=Mus musculus OX=10090 GN=Atxn1l PE=1 SV=1,GO:0000122; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0031208; GO:0035176; GO:0048286; GO:1902035,brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366],dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030198; GO:0043226; GO:0048856; GO:0050877,DNA binding; RNA binding; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; extracellular matrix organization; organelle; anatomical structure development; nervous system process
OG_07769,1.4096975812206107,FUN_034972-T1,Peve_00028365,Pocillopora_meandrina_HIv1___RNAseq.g12164.t1,three_way,71.28216666666667,FUN_034972-T1,Q91820,AURAA_XENLA,,Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265),Xenopus laevis (African clawed frog),63.3,341.0,1.5e-121,437.6,sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis OX=8355 GN=aurka-a PE=1 SV=1,GO:0000212; GO:0000776; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0007052; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0032133; GO:0032465; GO:0046777; GO:0051233; GO:0051301; GO:0090307; GO:0106310,cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_07771,1.5893964026902987,FUN_034974-T1,Peve_00028360,Pocillopora_meandrina_HIv1___RNAseq.g12162.t1,three_way,65.07733333333333,FUN_034974-T1,Q8K4T5,DUS19_MOUSE,,Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1),Mus musculus (Mouse),43.9,198.0,3.4e-40,166.4,sp|Q8K4T5|DUS19_MOUSE Dual specificity protein phosphatase 19 OS=Mus musculus OX=10090 GN=Dusp19 PE=2 SV=1,GO:0004722; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043409; GO:0043410; GO:0046329; GO:0046330,JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410],cytoplasm [GO:0005737],JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0016787; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; hydrolase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07772,1.0344487532325453,FUN_034983-T1,Peve_00009294,Pocillopora_meandrina_HIv1___RNAseq.g12158.t1,three_way,52.6345,FUN_034983-T1,A2A259,PK2L1_MOUSE,,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Mus musculus (Mouse),25.5,509.0,4.6e-40,168.7,sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1,GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0009415; GO:0015269; GO:0015629; GO:0031410; GO:0034703; GO:0034704; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0051262; GO:0051289; GO:0051371; GO:0060170; GO:0071467; GO:0071468; GO:0097730; GO:0098662; GO:0160128; GO:1990760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; smoothened signaling pathway [GO:0007224],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,transporter activity; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_07773,1.2201149161399512,FUN_034984-T1,Peve_00009292,Pocillopora_meandrina_HIv1___TS.g14469.t2,three_way,75.10966666666667,FUN_034984-T1,Q502K2,SAMH1_DANRE,,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,480.0,3.3e-162,573.2,sp|Q502K2|SAMH1_DANRE Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Danio rerio OX=7955 GN=samhd1 PE=2 SV=2,GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0036269; GO:0045087; GO:0045088; GO:0045540; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025,dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; swimming behavior [GO:0036269],nucleus [GO:0005634]; site of double-strand break [GO:0035861],deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0055086; GO:0065003; GO:0098542; GO:1901135,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; defense response to other organism; carbohydrate derivative metabolic process
OG_07775,1.0039199335698668,FUN_034990-T1,Peve_00024609,Pocillopora_meandrina_HIv1___RNAseq.g12120.t1,three_way,92.32533333333332,FUN_034990-T1,O08654,,,,,63.1,295.0,1.8e-106,387.1,sp|O08654|PHAF1_RAT Phagosome assembly factor 1 OS=Rattus norvegicus OX=10116 GN=Phaf1 PE=2 SV=1,,,,,,
OG_07780,1.7816109972884495,FUN_034997-T1,Peve_00024600,Pocillopora_meandrina_HIv1___RNAseq.g4153.t1,three_way,61.30266666666667,FUN_034997-T1,Q8K4Z4,,,,,28.7,310.0,2e-22,108.2,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_07781,1.1703998315107325,FUN_034998-T1,Peve_00024599,Pocillopora_meandrina_HIv1___RNAseq.g12127.t1,three_way,52.55766666666667,FUN_034998-T1,P14316,IRF2_HUMAN,,Interferon regulatory factor 2 (IRF-2),Homo sapiens (Human),48.2,110.0,5.3e-27,124.0,sp|P14316|IRF2_HUMAN Interferon regulatory factor 2 OS=Homo sapiens OX=9606 GN=IRF2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0008283; GO:0045944; GO:0051607; GO:1990837,cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07787,1.5428355828528892,FUN_035008-T1,Peve_00024587,Pocillopora_meandrina_HIv1___RNAseq.g12134.t1,three_way,76.40066666666667,FUN_035008-T1,Q9VCA2,,,,,32.9,538.0,3.9e-72,273.9,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07789,2.8570119319654137,FUN_035010-T1,Peve_00024585,Pocillopora_meandrina_HIv1___RNAseq.g27785.t1,three_way,66.97333333333333,FUN_035010-T1,Q95044,,,,,57.8,147.0,8.999999999999997e-41,167.9,sp|Q95044|UBE2C_SPISO Ubiquitin-conjugating enzyme E2 C OS=Spisula solidissima OX=6584 GN=UBE2C PE=1 SV=1,,,,,,
OG_07790,1.7793684292534622,FUN_035011-T1,Peve_00024584,Pocillopora_meandrina_HIv1___RNAseq.g27784.t1,three_way,86.16116666666666,FUN_035011-T1,A1L252,RANB9_DANRE,,Ran-binding protein 9 (RanBP9),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,503.0,5.9e-155,548.9,sp|A1L252|RANB9_DANRE Ran-binding protein 9 OS=Danio rerio OX=7955 GN=ranbp9 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0007010; GO:0060041,cytoskeleton organization [GO:0007010]; retina development in camera-type eye [GO:0060041],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005886; GO:0007010; GO:0043226; GO:0048856,nucleus; plasma membrane; cytoskeleton organization; organelle; anatomical structure development
OG_07798,2.030551570388257,FUN_035033-T1,Peve_00024625,Pocillopora_meandrina_HIv1___RNAseq.g27759.t1,three_way,65.54933333333334,,,,,,,,,,,,,,,,,
OG_07799,1.572027084902306,FUN_035034-T1,Peve_00024624,Pocillopora_meandrina_HIv1___RNAseq.g27758.t1,three_way,74.63333333333333,FUN_035034-T1,Q3SZ84,,,,,59.0,78.0,1.1e-19,97.4,sp|Q3SZ84|BOLA3_BOVIN BolA-like protein 3 OS=Bos taurus OX=9913 GN=BOLA3 PE=3 SV=1,,,,,,
OG_07800,1.350446762183161,FUN_035035-T1,Peve_00024623,Pocillopora_meandrina_HIv1___RNAseq.g27757.t1,three_way,67.09666666666666,FUN_035035-T1,Q6NRQ1,,,,,39.6,470.0,1.8e-101,371.3,"sp|Q6NRQ1|B3GL2_XENLA UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=b3galnt2 PE=2 SV=1",,,,,,
OG_07807,1.4229274300221937,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_07811,1.7791675187344058,FUN_035058-T1,Peve_00001885,Pocillopora_meandrina_HIv1___RNAseq.g27736.t1,three_way,68.96166666666667,FUN_035058-T1,Q8WNV7,,,,,54.6,282.0,8.5e-74,278.5,sp|Q8WNV7|DHRS4_PIG Dehydrogenase/reductase SDR family member 4 OS=Sus scrofa OX=9823 GN=DHRS4 PE=1 SV=2,,,,,,
OG_07812,1.1494764553921288,FUN_035060-T1,Peve_00026574,Pocillopora_meandrina_HIv1___TS.g15080.t1,three_way,75.726,FUN_035060-T1,Q99L04,,,,,51.1,323.0,2.9000000000000004e-80,300.4,sp|Q99L04|DHRS1_MOUSE Dehydrogenase/reductase SDR family member 1 OS=Mus musculus OX=10090 GN=Dhrs1 PE=1 SV=1,,,,,,
OG_07818,1.4433559007576224,FUN_035070-T1,Peve_00031377,Pocillopora_meandrina_HIv1___RNAseq.g27719.t1,three_way,82.29666666666667,FUN_035070-T1,Q7ZT01,PSF3_XENLA,,DNA replication complex GINS protein PSF3 (GINS complex subunit 3),Xenopus laevis (African clawed frog),43.1,197.0,9.3e-49,194.9,sp|Q7ZT01|PSF3_XENLA DNA replication complex GINS protein PSF3 OS=Xenopus laevis OX=8355 GN=gins3 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902975,DNA replication [GO:0006260]; mitotic DNA replication initiation [GO:1902975],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_07820,1.3369647140972265,FUN_035088-T1,Peve_00037967,Pocillopora_meandrina_HIv1___TS.g15056.t2,three_way,81.78233333333334,FUN_035088-T1,Q92508,PIEZ1_HUMAN,,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),Homo sapiens (Human),32.0,2582.0,4.8e-312,1072.8,sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4,GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391],cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420],mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005783; GO:0005886; GO:0043226,transporter activity; endoplasmic reticulum; plasma membrane; organelle
OG_07828,1.6485524613868452,FUN_035130-T3,Peve_00005902,Pocillopora_meandrina_HIv1___TS.g14990.t1,three_way,58.65316666666666,FUN_035130-T3,Q8TEP8,,,,,32.3,871.0,3.2e-116,422.5,sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3,,,,,,
OG_07835,3.037521944134038,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_07840,1.2226650292862564,FUN_035171-T1,Peve_00036183,Pocillopora_meandrina_HIv1___RNAseq.g27920.t1,three_way,64.12,,,,,,,,,,,,,,,,,
OG_07843,1.4633664835342506,FUN_035180-T1,Peve_00021485,Pocillopora_meandrina_HIv1___TS.g15289.t2,three_way,73.132,FUN_035180-T1,O88665,BRD7_MOUSE,,Bromodomain-containing protein 7 (75 kDa bromodomain protein),Mus musculus (Mouse),37.2,540.0,9.400000000000001e-80,299.7,sp|O88665|BRD7_MOUSE Bromodomain-containing protein 7 OS=Mus musculus OX=10090 GN=Brd7 PE=1 SV=1,GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045892; GO:0070316; GO:0140015; GO:2000045; GO:2000134; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586],histone binding [GO:0042393]; histone H3K14ac reader activity [GO:0140015]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_07844,1.9252725122707128,FUN_035182-T1,Peve_00021488,Pocillopora_meandrina_HIv1___RNAseq.g27944.t1,three_way,78.65466666666667,FUN_035182-T1,Q8NBX0,,,,,49.1,424.0,1.2e-111,404.8,sp|Q8NBX0|SCPDL_HUMAN Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens OX=9606 GN=SCCPDH PE=1 SV=1,,,,,,
OG_07847,1.7325581912707106,FUN_035185-T1,Peve_00036893,Pocillopora_meandrina_HIv1___RNAseq.g27955.t1,three_way,75.83783333333334,FUN_035185-T1,P07090,,,,,41.6,262.0,1.6e-43,177.9,sp|P07090|CALB2_CHICK Calretinin OS=Gallus gallus OX=9031 GN=CALB2 PE=2 SV=3,,,,,,
OG_07848,1.528706678185982,FUN_035190-T1,Peve_00044650,Pocillopora_meandrina_HIv1___RNAseq.g27958.t1,three_way,60.0245,,,,,,,,,,,,,,,,,
OG_07849,1.5055220257855022,FUN_035191-T1,Peve_00044663,Pocillopora_meandrina_HIv1___RNAseq.g27959.t1,three_way,74.12833333333333,FUN_035191-T1,Q9VZF4,FBXW7_DROME,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago),Drosophila melanogaster (Fruit fly),28.8,198.0,1.8e-18,95.5,sp|Q9VZF4|FBXW7_DROME F-box/WD repeat-containing protein 7 OS=Drosophila melanogaster OX=7227 GN=ago PE=1 SV=1,GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381,"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]",nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381],GO:0005634; GO:0006260; GO:0030163; GO:0043226; GO:0048856,nucleus; DNA replication; protein catabolic process; organelle; anatomical structure development
OG_07857,1.0283639887151952,FUN_035212-T1,Peve_00027689,Pocillopora_meandrina_HIv1___RNAseq.g27625.t1,three_way,88.569,FUN_035212-T1,Q6P4W8,,,,,63.3,425.0,6.1e-148,525.4,sp|Q6P4W8|PCH2_XENTR Pachytene checkpoint protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=trip13 PE=2 SV=1,,,,,,
OG_07860,1.3674273011964924,FUN_035215-T1,Peve_00027695,Pocillopora_meandrina_HIv1___RNAseq.g27616.t1,three_way,57.300666666666665,,,,,,,,,,,,,,,,,
OG_07861,3.6122035359019855,FUN_035216-T2,Peve_00035892,Pocillopora_meandrina_HIv1___RNAseq.g27615.t1,three_way,70.04816666666666,FUN_035216-T2,Q503Z8,IRX6A_DANRE,,Iroquois homeobox protein 6a,Danio rerio (Zebrafish) (Brachydanio rerio),47.6,233.0,1.9e-40,168.3,sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0048468,cell development [GO:0048468]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07864,2.674096565782572,FUN_035221-T1,Peve_00035886,Pocillopora_meandrina_HIv1___RNAseq.g27610.t1,three_way,84.449,FUN_035221-T1,Q6DE14,E2F4_XENLA,,Transcription factor E2F4 (E2F-4),Xenopus laevis (African clawed frog),54.9,368.0,1.1e-96,354.8,sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251,centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0006355; GO:0030154; GO:0044782; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; cilium organization; transcription regulator activity
OG_07873,1.6125496836135322,FUN_035233-T1,Peve_00044494,Pocillopora_meandrina_HIv1___RNAseq.g27904.t1,three_way,73.75433333333334,FUN_035233-T1,Q3T0C2,PGDH_BOVIN,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Bos taurus (Bovine),40.9,257.0,7.100000000000001e-48,192.2,sp|Q3T0C2|PGDH_BOVIN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Bos taurus OX=9913 GN=HPGD PE=2 SV=1,GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957],GO:0003824; GO:0006629; GO:0016491; GO:0022414; GO:0060089,catalytic activity; lipid metabolic process; oxidoreductase activity; reproductive process; molecular transducer activity
OG_07876,1.1101202516298012,FUN_035237-T1,Peve_00007098,Pocillopora_meandrina_HIv1___RNAseq.g27900.t1,three_way,84.26833333333333,FUN_035237-T1,Q8NDH3,,,,,61.3,501.0,1.9000000000000002e-180,633.6,sp|Q8NDH3|PEPL1_HUMAN Probable aminopeptidase NPEPL1 OS=Homo sapiens OX=9606 GN=NPEPL1 PE=1 SV=3,,,,,,
OG_07877,2.0715149442265224,FUN_035239-T2,Peve_00042235,Pocillopora_meandrina_HIv1___RNAseq.g27898.t1,three_way,66.54466666666667,FUN_035239-T2,P54278,PMS2_HUMAN,,Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2),Homo sapiens (Human),48.0,891.0,7.499999999999999e-217,755.4,sp|P54278|PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens OX=9606 GN=PMS2 PE=1 SV=2,GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006298; GO:0009410; GO:0016446; GO:0016447; GO:0016887; GO:0032138; GO:0032389; GO:0048298; GO:0048304; GO:0140664,mismatch repair [GO:0006298]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; response to xenobiotic stimulus [GO:0009410]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447],cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_07878,2.053656967975577,FUN_035240-T1,Peve_00042231,Pocillopora_meandrina_HIv1___TS.g15237.t1,three_way,53.185,FUN_035240-T1,Q9CYL5,,,,,40.6,160.0,2.1e-25,117.9,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_07881,1.8198615552969053,FUN_035244-T1,Peve_00042234,Pocillopora_meandrina_HIv1___RNAseq.g27892.t1b,three_way,69.50633333333333,FUN_035244-T1,O32210,,,,,44.7,262.0,5.5e-61,236.1,sp|O32210|GR_BACSU Glyoxal reductase OS=Bacillus subtilis (strain 168) OX=224308 GN=yvgN PE=1 SV=1,,,,,,
OG_07896,1.5941044556374178,FUN_035275-T1,Peve_00044988,Pocillopora_meandrina_HIv1___RNAseq.g27860.t1,three_way,93.55466666666666,FUN_035275-T1,Q9D600,,,,,59.8,179.0,7.3e-58,224.9,sp|Q9D600|PSF2_MOUSE DNA replication complex GINS protein PSF2 OS=Mus musculus OX=10090 GN=Gins2 PE=1 SV=1,,,,,,
OG_07898,2.8063432227713654,FUN_035279-T1,Peve_00001128,Pocillopora_meandrina_HIv1___RNAseq.g10444.t1,three_way,76.0005,FUN_035279-T1,Q9Z2W0,,,,,60.3,441.0,8.4e-151,535.0,sp|Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mus musculus OX=10090 GN=Dnpep PE=1 SV=2,,,,,,
OG_07899,1.1351894563523612,FUN_035293-T1,Peve_00008867,Pocillopora_meandrina_HIv1___RNAseq.g10157.t1,three_way,74.44466666666666,FUN_035293-T1,A0A3M6TIF0,,,,,66.0,426.0,1.7e-166,587.0,sp|A0A3M6TIF0|CGLR_POCDA Cyclic GMP-AMP synthase-like receptor OS=Pocillopora damicornis OX=46731 GN=cGLR PE=1 SV=1,,,,,,
OG_07902,1.5893777268953715,FUN_035339-T1,Peve_00029658,Pocillopora_meandrina_HIv1___RNAseq.g12265.t1,three_way,70.72233333333334,FUN_035339-T1,B7ZBB8,PP13G_HUMAN,,Protein phosphatase 1 regulatory subunit 3G,Homo sapiens (Human),28.0,225.0,2e-09,64.3,sp|B7ZBB8|PP13G_HUMAN Protein phosphatase 1 regulatory subunit 3G OS=Homo sapiens OX=9606 GN=PPP1R3G PE=1 SV=1,GO:0000164; GO:0005978; GO:0005979; GO:0008157; GO:0042593; GO:0045725; GO:2001069,glucose homeostasis [GO:0042593]; glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979],protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157],GO:0005975; GO:0006091,carbohydrate metabolic process; generation of precursor metabolites and energy
OG_07903,1.0485983069458416,FUN_035340-T1,Peve_00029660,Pocillopora_meandrina_HIv1___RNAseq.g12264.t1,three_way,78.014,FUN_035340-T1,Q9VVY3,,,,,41.0,183.0,8.4e-24,112.1,sp|Q9VVY3|GBS76_DROME Glycogen-binding subunit 76A OS=Drosophila melanogaster OX=7227 GN=Gbs-76A PE=1 SV=1,,,,,,
OG_07919,2.0694074851555686,FUN_035404-T1,Peve_00002644,Pocillopora_meandrina_HIv1___TS.g3527.t2,three_way,68.768,FUN_035404-T1,Q9WYX8,,,,,49.4,172.0,3.9e-43,176.4,sp|Q9WYX8|Y508_THEMA Uncharacterized protein TM_0508 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0508 PE=3 SV=1,,,,,,
OG_07923,1.6543784722292425,FUN_035409-T1,Peve_00039846,Pocillopora_meandrina_HIv1___RNAseq.g12196.t1,three_way,78.21966666666667,FUN_035409-T1,A2RT91,,,,,34.3,306.0,3.9e-42,174.9,sp|A2RT91|ANKAR_MOUSE Ankyrin and armadillo repeat-containing protein OS=Mus musculus OX=10090 GN=Ankar PE=2 SV=1,,,,,,
OG_07937,1.739487915777893,FUN_035443-T1,Peve_00002173,Pocillopora_meandrina_HIv1___RNAseq.g9412.t1,three_way,74.024,,,,,,,,,,,,,,,,,
OG_07944,3.2443631896596155,FUN_035462-T1,Peve_00012136,Pocillopora_meandrina_HIv1___RNAseq.g27041.t1,three_way,72.29833333333333,FUN_035462-T1,Q9SY73,PTALR_ARATH,,NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-),Arabidopsis thaliana (Mouse-ear cress),45.1,224.0,2e-55,217.2,sp|Q9SY73|PTALR_ARATH NADPH-dependent pterin aldehyde reductase OS=Arabidopsis thaliana OX=3702 GN=At1g10310 PE=1 SV=1,GO:0005829; GO:0006760; GO:0016616,folic acid-containing compound metabolic process [GO:0006760],cytosol [GO:0005829],"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005829; GO:0006575; GO:0016491,catalytic activity; cytosol; modified amino acid metabolic process; oxidoreductase activity
OG_07946,1.6191948948785309,FUN_035466-T1,Peve_00012134,Pocillopora_meandrina_HIv1___RNAseq.g11796.t1,three_way,51.17766666666667,FUN_035466-T1,Q9JIL9,NBN_RAT,,Nibrin (Nijmegen breakage syndrome protein 1 homolog),Rattus norvegicus (Rat),26.3,753.0,1.1e-56,223.0,sp|Q9JIL9|NBN_RAT Nibrin OS=Rattus norvegicus OX=10116 GN=Nbn PE=1 SV=2,GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001701; GO:0001832; GO:0003684; GO:0005634; GO:0005657; GO:0005730; GO:0006302; GO:0007095; GO:0007405; GO:0008284; GO:0009410; GO:0016605; GO:0030870; GO:0031848; GO:0031860; GO:0032206; GO:0035861; GO:0042393; GO:0042405; GO:0043247; GO:0043539; GO:0045190; GO:0045665; GO:0046597; GO:0048145; GO:0050885; GO:0051321; GO:0062176; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0097681; GO:0110025; GO:0140031; GO:0140297; GO:0140463; GO:1904354; GO:1990166; GO:2000781,blastocyst growth [GO:0001832]; DNA damage checkpoint signaling [GO:0000077]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of symbiont invasion [GO:0046597]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of fibroblast proliferation [GO:0048145]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosome, telomeric region [GO:0000781]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0002376; GO:0003677; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0022414; GO:0032200; GO:0042393; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleolus; DNA repair; DNA recombination; chromatin organization; reproductive process; telomere organization; histone binding; organelle; anatomical structure development; nervous system process; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_07949,1.1778979946569312,FUN_035470-T1,Peve_00012129,Pocillopora_meandrina_HIv1___RNAseq.g27049.t1,three_way,76.12633333333333,FUN_035470-T1,Q1JPD3,,,,,62.9,496.0,8.699999999999999e-181,634.8,"sp|Q1JPD3|D2HDH_BOVIN D-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=D2HGDH PE=2 SV=2",,,,,,
OG_07952,1.2051361541218286,FUN_035478-T1,Peve_00033970,Pocillopora_meandrina_HIv1___TS.g14339.t1,three_way,81.2215,FUN_035478-T1,P08487,,,,,46.2,825.0,3.7e-203,709.9,"sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1",,,,,,
OG_07954,3.217305866824185,FUN_035494-T1,Peve_00033964,Pocillopora_meandrina_HIv1___RNAseq.g26989.t1,three_way,76.04083333333334,FUN_035494-T1,P52171,,,,,53.8,240.0,1.4e-69,265.4,sp|P52171|IMA1_XENLA Importin subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kpna2 PE=1 SV=2,,,,,,
OG_07955,1.539669515354137,FUN_035498-T1,Peve_00033959,Pocillopora_meandrina_HIv1___RNAseq.g26992.t1,three_way,53.365833333333335,,,,,,,,,,,,,,,,,
OG_07956,4.583924774880445,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07958,1.1740476056365163,FUN_035508-T1,Peve_00039971,Pocillopora_meandrina_HIv1___TS.g14356.t2,three_way,47.306,FUN_035508-T1,Q9V5N8,,,,,34.5,592.0,2.5e-66,256.5,sp|Q9V5N8|STAN_DROME Protocadherin-like wing polarity protein stan OS=Drosophila melanogaster OX=7227 GN=stan PE=1 SV=4,,,,,,
OG_07961,1.7352028509863415,FUN_035519-T1,Peve_00007927,Pocillopora_meandrina_HIv1___RNAseq.g26966.t1,three_way,53.88283333333334,FUN_035519-T1,A3KMR8,MAFA_DANRE,,Transcription factor MafAa (Somite Maf1) (SMaf1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,97.0,4.2e-09,63.2,sp|A3KMR8|MAFA_DANRE Transcription factor MafAa OS=Danio rerio OX=7955 GN=mafaa PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07967,2.1544580564611864,FUN_035536-T1,Peve_00026593,Pocillopora_meandrina_HIv1___RNAseq.g27999.t1,three_way,59.93233333333333,FUN_035536-T1,Q9N121,,,,,56.3,126.0,8.6e-37,154.8,"sp|Q9N121|GCSH_RABIT Glycine cleavage system H protein, mitochondrial OS=Oryctolagus cuniculus OX=9986 GN=GCSH PE=2 SV=1",,,,,,
OG_07968,2.023863799004745,FUN_035537-T1,Peve_00026592,Pocillopora_meandrina_HIv1___RNAseq.g28000.t1,three_way,95.7,FUN_035537-T1,Q921M3,,,,,79.5,1222.0,0.0,2003.0,sp|Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=Mus musculus OX=10090 GN=Sf3b3 PE=1 SV=1,,,,,,
OG_07975,1.320091159652891,FUN_035552-T1,Peve_00036916,Pocillopora_meandrina_HIv1___RNAseq.g28024.t1,three_way,68.95633333333333,FUN_035552-T1,Q7M767,UB2V2_RAT,,Ubiquitin-conjugating enzyme E2 variant 2 (Ubiquitin-conjugating enzyme variant MMS2),Rattus norvegicus (Rat),69.6,138.0,2.3e-51,203.0,sp|Q7M767|UB2V2_RAT Ubiquitin-conjugating enzyme E2 variant 2 OS=Rattus norvegicus OX=10116 GN=Ube2v2 PE=1 SV=3,GO:0000729; GO:0005634; GO:0006301; GO:0010976; GO:0031371; GO:0031372; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0070534; GO:1902523; GO:2000781,DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371],,GO:0005634; GO:0006281; GO:0043226,nucleus; DNA repair; organelle
OG_07976,1.970141675335338,FUN_035554-T2,Peve_00036915,Pocillopora_meandrina_HIv1___TS.g15372.t1,three_way,93.07433333333334,FUN_035554-T2,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),67.4,4652.0,0.0,6165.9,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_07982,2.1768780791559728,FUN_035607-T2,Peve_00025644,Pocillopora_meandrina_HIv1___RNAseq.g28044.t1,three_way,64.08733333333333,,,,,,,,,,,,,,,,,
OG_07996,2.018606977822067,FUN_035637-T1,Peve_00029721,Pocillopora_meandrina_HIv1___RNAseq.g28085.t1,three_way,59.298,,,,,,,,,,,,,,,,,
OG_08000,1.22095037456488,FUN_035645-T1,Peve_00022823,Pocillopora_meandrina_HIv1___RNAseq.g12089.t1,three_way,63.82933333333334,FUN_035645-T1,Q94BV5,,,,,38.8,400.0,1.3e-72,276.2,sp|Q94BV5|GSXL4_ARATH Flavin-containing monooxygenase FMO GS-OX-like 4 OS=Arabidopsis thaliana OX=3702 GN=At1g62600 PE=2 SV=1,,,,,,
OG_08003,2.413247445291564,FUN_035652-T1,Peve_00022825,Pocillopora_meandrina_HIv1___RNAseq.g28106.t1,three_way,72.28066666666666,FUN_035652-T1,Q80ZW0,,,,,30.1,335.0,1.1000000000000001e-27,125.6,sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3,,,,,,
OG_08005,2.0130408159239708,FUN_035654-T1,Peve_00028213,Pocillopora_meandrina_HIv1___RNAseq.g28110.t1,three_way,80.874,FUN_035654-T1,Q9H063,MAF1_HUMAN,,Repressor of RNA polymerase III transcription MAF1 homolog,Homo sapiens (Human),50.8,254.0,2.7999999999999997e-63,243.4,sp|Q9H063|MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog OS=Homo sapiens OX=9606 GN=MAF1 PE=1 SV=2,GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0048471; GO:0050811; GO:0060077,negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle
OG_08008,2.771689457319308,FUN_035660-T1,Peve_00020774,Pocillopora_meandrina_HIv1___RNAseq.g28116.t1,three_way,60.16833333333333,,,,,,,,,,,,,,,,,
OG_08013,2.077782503857252,FUN_035667-T1,Peve_00002800,Pocillopora_meandrina_HIv1___RNAseq.g28123.t1,three_way,73.54066666666667,FUN_035667-T1,Q86V88,,,,,52.3,155.0,1.1e-44,181.0,sp|Q86V88|MGDP1_HUMAN Magnesium-dependent phosphatase 1 OS=Homo sapiens OX=9606 GN=MDP1 PE=1 SV=1,,,,,,
OG_08017,1.2236176443432805,FUN_035671-T1,Peve_00002792,Pocillopora_meandrina_HIv1___RNAseq.g28139.t1,three_way,83.45733333333334,FUN_035671-T1,Q561X0,,,,,57.4,122.0,3.5000000000000004e-32,139.0,sp|Q561X0|NEPR1_DANRE Nuclear envelope phosphatase-regulatory subunit 1 OS=Danio rerio OX=7955 GN=cnep1r1 PE=2 SV=1,,,,,,
OG_08020,2.2116056547966223,FUN_035675-T1,Peve_00002795,Pocillopora_meandrina_HIv1___RNAseq.g28142.t1,three_way,59.38916666666667,FUN_035675-T1,Q6NZL6,TONSL_MOUSE,,Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2),Mus musculus (Mouse),29.1,1503.0,7.8e-97,357.5,sp|Q6NZL6|TONSL_MOUSE Tonsoku-like protein OS=Mus musculus OX=10090 GN=Tonsl PE=1 SV=2,GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566,double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861],histone binding [GO:0042393]; histone reader activity [GO:0140566],GO:0006281; GO:0006310; GO:0042393; GO:0060090,DNA repair; DNA recombination; histone binding; molecular adaptor activity
OG_08023,2.068582670393487,FUN_035678-T1,Peve_00033237,Pocillopora_meandrina_HIv1___TS.g15489.t1,three_way,88.24733333333333,FUN_035678-T1,A7SXZ6,OSGEP_NEMVE,,Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep) (tRNA threonylcarbamoyladenosine biosynthesis protein osgep),Nematostella vectensis (Starlet sea anemone),88.9,334.0,1.2e-175,617.1,sp|A7SXZ6|OSGEP_NEMVE Probable tRNA N6-adenosine threonylcarbamoyltransferase OS=Nematostella vectensis OX=45351 GN=osgep PE=3 SV=1,GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0046872; GO:0061711,tRNA threonylcarbamoyladenosine modification [GO:0002949],cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634],metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711],GO:0003824; GO:0005634; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08024,2.1954046546875725,FUN_035679-T1,Peve_00025446,Pocillopora_meandrina_HIv1___RNAseq.g28146.t1,three_way,82.66166666666666,FUN_035679-T1,Q15024,EXOS7_HUMAN,,Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8),Homo sapiens (Human),60.1,291.0,4e-98,359.4,sp|Q15024|EXOS7_HUMAN Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038; GO:0101019,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08028,1.6668801477634378,FUN_035683-T1,Peve_00041296,Pocillopora_meandrina_HIv1___RNAseq.g11803.t1,three_way,70.305,FUN_035683-T1,P20456,IMPA1_BOVIN,,Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1),Bos taurus (Bovine),55.4,271.0,2.1e-80,300.4,sp|P20456|IMPA1_BOVIN Inositol monophosphatase 1 OS=Bos taurus OX=9913 GN=IMPA1 PE=1 SV=1,GO:0000287; GO:0004346; GO:0005737; GO:0006020; GO:0006021; GO:0007165; GO:0008877; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0047954; GO:0052832; GO:0052833; GO:0052834; GO:0103026,inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165],cytoplasm [GO:0005737],fructose-1-phosphatase activity [GO:0103026]; glucose-1-phosphatase activity [GO:0008877]; glucose-6-phosphatase activity [GO:0004346]; glycerol-2-phosphatase activity [GO:0047954]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_08031,1.5230961365910742,FUN_035689-T1,Peve_00041293,Pocillopora_meandrina_HIv1___RNAseq.g11805.t1,three_way,90.49,FUN_035689-T1,Q13884,SNTB1_HUMAN,,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),Homo sapiens (Human),47.2,527.0,2.4e-127,457.2,sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3,GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202,muscle contraction [GO:0006936],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198],GO:0003012; GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0043226,muscle system process; structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_08036,1.1051883430233125,FUN_035709-T1,Peve_00044090,Pocillopora_meandrina_HIv1___RNAseq.g11840.t1,three_way,42.494,,,,,,,,,,,,,,,,,
OG_08040,1.5544454005415256,FUN_035717-T1,Peve_00044097,Pocillopora_meandrina_HIv1___TS.g3184.t1,three_way,69.33633333333333,FUN_035717-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),33.9,245.0,1.3000000000000001e-32,141.7,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_08041,1.225706556308596,FUN_035718-T1,Peve_00044098,Pocillopora_meandrina_HIv1___RNAseq.g11849.t1,three_way,49.524,,,,,,,,,,,,,,,,,
OG_08042,1.6414795520990284,FUN_035719-T1,Peve_00044099,Pocillopora_meandrina_HIv1___RNAseq.g11850.t2,three_way,78.6335,FUN_035719-T1,Q3US41,,,,,38.6,681.0,3.3e-122,440.7,sp|Q3US41|ESRP1_MOUSE Epithelial splicing regulatory protein 1 OS=Mus musculus OX=10090 GN=Esrp1 PE=1 SV=2,,,,,,
OG_08043,1.6291328106312004,FUN_035720-T1,Peve_00044100,Pocillopora_meandrina_HIv1___RNAseq.g11851.t1,three_way,80.81633333333333,FUN_035720-T1,E2RDZ6,,,,,67.2,265.0,2.5e-105,383.3,"sp|E2RDZ6|SIR5_CANLF NAD-dependent protein deacylase sirtuin-5, mitochondrial OS=Canis lupus familiaris OX=9615 GN=SIRT5 PE=3 SV=1",,,,,,
OG_08046,3.69907047635912,FUN_035734-T1,Peve_00044083,Pocillopora_meandrina_HIv1___RNAseq.g11861.t1,three_way,58.831,FUN_035734-T1,Q8C080,,,,,51.9,162.0,2.9e-41,171.0,sp|Q8C080|SNX16_MOUSE Sorting nexin-16 OS=Mus musculus OX=10090 GN=Snx16 PE=1 SV=2,,,,,,
OG_08047,2.1384391241280984,FUN_035735-T1,Peve_00044084,Pocillopora_meandrina_HIv1___RNAseq.g11862.t1,three_way,61.315000000000005,FUN_035735-T1,P57769,SNX16_RAT,,Sorting nexin-16,Rattus norvegicus (Rat),44.3,149.0,4.9000000000000005e-27,124.0,sp|P57769|SNX16_RAT Sorting nexin-16 OS=Rattus norvegicus OX=10116 GN=Snx16 PE=1 SV=2,GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_08051,1.485861835983287,FUN_035742-T1,Peve_00026223,Pocillopora_meandrina_HIv1___RNAseq.g11866.t1,three_way,82.196,FUN_035742-T1,Q9W1Y1,,,,,43.8,130.0,5.1e-26,119.0,sp|Q9W1Y1|EMC89_DROME ER membrane protein complex subunit 8/9 homolog OS=Drosophila melanogaster OX=7227 GN=EMC8-9 PE=1 SV=1,,,,,,
OG_08052,1.1587362148139475,FUN_035743-T1,Peve_00026224,Pocillopora_meandrina_HIv1___TS.g3204.t1,three_way,69.02166666666666,,,,,,,,,,,,,,,,,
OG_08054,1.869559066084337,FUN_035749-T1,Peve_00016720,Pocillopora_meandrina_HIv1___RNAseq.g11875.t1,three_way,66.67133333333334,,,,,,,,,,,,,,,,,
OG_08056,1.82739708735752,FUN_035751-T1,Peve_00044197,Pocillopora_meandrina_HIv1___RNAseq.g11877.t1,three_way,71.535,FUN_035751-T1,P54802,ANAG_HUMAN,,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],Homo sapiens (Human),50.3,708.0,3.1000000000000005e-214,746.5,sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2,GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097696; GO:0099022; GO:1904389; GO:1904390,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020],alpha-N-acetylglucosaminidase activity [GO:0004561],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0006629; GO:0006914; GO:0007040; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; lipid metabolic process; autophagy; lysosome organization; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; carbohydrate derivative metabolic process
OG_08057,3.0486758347266014,FUN_035752-T1,Peve_00044203,Pocillopora_meandrina_HIv1___RNAseq.g11880.t1,three_way,86.57133333333333,FUN_035752-T1,Q64701,RBL1_MOUSE,,Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1),Mus musculus (Mouse),50.0,1056.0,2.6e-275,949.9,sp|Q64701|RBL1_MOUSE Retinoblastoma-like protein 1 OS=Mus musculus OX=10090 GN=Rbl1 PE=1 SV=3,GO:0000122; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0010629; GO:0051726; GO:1990841; GO:2000773,chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],promoter-specific chromatin binding [GO:1990841],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_08058,2.078570760560758,FUN_035753-T1,Peve_00044191,Pocillopora_meandrina_HIv1___RNAseq.g11881.t1,three_way,66.50783333333334,,,,,,,,,,,,,,,,,
OG_08063,1.507977865893923,FUN_035761-T1,Peve_00033438,Pocillopora_meandrina_HIv1___RNAseq.g11890.t1,three_way,66.28783333333334,FUN_035761-T1,O70220,,,,,66.0,94.0,2.7e-33,144.1,sp|O70220|FOXQ1_MOUSE Forkhead box protein Q1 OS=Mus musculus OX=10090 GN=Foxq1 PE=2 SV=3,,,,,,
OG_08065,2.3937958127956573,FUN_035765-T1,Peve_00033443,Pocillopora_meandrina_HIv1___RNAseq.g11894.t1,three_way,90.73666666666666,FUN_035765-T1,Q6GL41,MCM4_XENTR,,DNA replication licensing factor mcm4 (EC 3.6.4.12) (Minichromosome maintenance protein 4),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),68.7,836.0,0.0,1105.1,sp|Q6GL41|MCM4_XENTR DNA replication licensing factor mcm4 OS=Xenopus tropicalis OX=8364 GN=mcm4 PE=2 SV=1,GO:0000785; GO:0001878; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0006270; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to yeast [GO:0001878],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_08066,2.417986395168928,FUN_035767-T1,Peve_00033444,Pocillopora_meandrina_HIv1___RNAseq.g11895.t1,three_way,83.33766666666666,FUN_035767-T1,Q8VI75,,,,,41.1,443.0,5.400000000000001e-89,330.1,sp|Q8VI75|IPO4_MOUSE Importin-4 OS=Mus musculus OX=10090 GN=Ipo4 PE=1 SV=1,,,,,,
OG_08067,2.1363921441708817,FUN_035770-T1,Peve_00027765,Pocillopora_meandrina_HIv1___RNAseq.g11896.t1,three_way,75.35533333333333,FUN_035770-T1,A2VDS1,SCLY_BOVIN,,Selenocysteine lyase (EC 4.4.1.16),Bos taurus (Bovine),57.0,407.0,1.2999999999999999e-129,464.5,sp|A2VDS1|SCLY_BOVIN Selenocysteine lyase OS=Bos taurus OX=9913 GN=SCLY PE=2 SV=1,GO:0005829; GO:0009000; GO:0016740,,cytosol [GO:0005829],selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0016740; GO:0016829,catalytic activity; cytosol; transferase activity; lyase activity
OG_08069,1.3531530657079118,FUN_035773-T1,Peve_00027763,Pocillopora_meandrina_HIv1___RNAseq.g11898.t1,three_way,88.316,,,,,,,,,,,,,,,,,
OG_08070,1.2631065057507624,FUN_035775-T1,Peve_00017724,Pocillopora_meandrina_HIv1___RNAseq.g11904.t1,three_way,71.4095,FUN_035775-T1,Q1LUT1,,,,,33.8,1359.0,3e-127,458.4,sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1,,,,,,
OG_08072,1.036255452676329,FUN_035777-T1,Peve_00017722,Pocillopora_meandrina_HIv1___RNAseq.g11902.t1,three_way,56.0365,FUN_035777-T1,Q68ED3,PAPD5_MOUSE,,Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),Mus musculus (Mouse),56.3,332.0,8.300000000000001e-100,366.3,sp|Q68ED3|PAPD5_MOUSE Terminal nucleotidyltransferase 4B OS=Mus musculus OX=10090 GN=Tent4b PE=1 SV=2,GO:0003677; GO:0003887; GO:0005524; GO:0005730; GO:0005737; GO:0006364; GO:0010587; GO:0031124; GO:0033500; GO:0046872; GO:0051301; GO:0060212; GO:0070568; GO:0071044; GO:0071051; GO:1905870; GO:1990817,carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003677; GO:0003824; GO:0005730; GO:0016071; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleolus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA"
OG_08076,2.2306792818697634,FUN_035800-T1,Peve_00015196,Pocillopora_meandrina_HIv1___RNAseq.g11910.t1a,three_way,62.337,FUN_035800-T1,O13076,,,,,29.1,313.0,8e-19,96.3,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_08080,2.3571980940624155,FUN_035804-T1,Peve_00017708,Pocillopora_meandrina_HIv1___RNAseq.g11921.t1,three_way,69.93833333333333,FUN_035804-T1,Q8NCN5,,,,,39.3,819.0,1e-170,602.1,"sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",,,,,,
OG_08081,1.3621523467886567,FUN_035805-T1,Peve_00033371,Pocillopora_meandrina_HIv1___RNAseq.g11922.t1,three_way,79.60766666666667,FUN_035805-T1,A5PLL7,PEDS1_HUMAN,,Plasmanylethanolamine desaturase 1 (EC 1.14.19.77) (Transmembrane protein 189),Homo sapiens (Human),61.3,238.0,6.7999999999999995e-84,312.0,sp|A5PLL7|PEDS1_HUMAN Plasmanylethanolamine desaturase 1 OS=Homo sapiens OX=9606 GN=PEDS1 PE=1 SV=3,GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0050207,ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],plasmanylethanolamine desaturase activity [GO:0050207],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_08083,2.150009560348287,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_08084,1.8980234739658337,FUN_035813-T1,Peve_00037805,Pocillopora_meandrina_HIv1___RNAseq.g11928.t1,three_way,74.87766666666667,FUN_035813-T1,Q969N2,PIGT_HUMAN,,GPI-anchor transamidase component PIGT (Phosphatidylinositol-glycan biosynthesis class T protein),Homo sapiens (Human),45.6,553.0,4.1e-142,506.5,sp|Q969N2|PIGT_HUMAN GPI-anchor transamidase component PIGT OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0034235; GO:0042765; GO:0051402; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],GPI anchor binding [GO:0034235],GO:0006629; GO:0008289; GO:0012501; GO:0030154; GO:0031410; GO:0043226; GO:0051604; GO:1901135,lipid metabolic process; lipid binding; programmed cell death; cell differentiation; cytoplasmic vesicle; organelle; protein maturation; carbohydrate derivative metabolic process
OG_08086,1.2713952851806638,FUN_035818-T1,Peve_00037796,Pocillopora_meandrina_HIv1___RNAseq.g11926.t1,three_way,85.777,FUN_035818-T1,Q6ZQ89,,,,,69.6,573.0,3.7e-215,749.2,sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2,,,,,,
OG_08087,1.4006222902425032,FUN_035819-T1,Peve_00037795,Pocillopora_meandrina_HIv1___RNAseq.g11925.t1,three_way,66.42033333333333,FUN_035819-T1,Q9CVD2,ATX3_MOUSE,,Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog),Mus musculus (Mouse),53.3,152.0,9.399999999999999e-39,161.8,sp|Q9CVD2|ATX3_MOUSE Ataxin-3 OS=Mus musculus OX=10090 GN=Atxn3 PE=1 SV=2,GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0006515; GO:0010810; GO:0016363; GO:0030036; GO:0031625; GO:0031966; GO:0034198; GO:0034605; GO:0035520; GO:0035640; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904262; GO:1904294; GO:1904327; GO:1990380; GO:2000060,actin cytoskeleton organization [GO:0030036]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex [GO:1904327]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08088,1.3458943988800969,FUN_035820-T1,Peve_00037798,Pocillopora_meandrina_HIv1___RNAseq.g11930.t1,three_way,77.11866666666667,FUN_035820-T1,P0C6T1,,,,,45.4,119.0,3.2000000000000003e-22,105.9,sp|P0C6T1|CTF8_RAT Chromosome transmission fidelity protein 8 homolog OS=Rattus norvegicus OX=10116 GN=Chtf8 PE=3 SV=1,,,,,,
OG_08089,3.9897002278611375,FUN_035821-T1,Peve_00037800,Pocillopora_meandrina_HIv1___RNAseq.g11931.t1,three_way,74.61166666666666,FUN_035821-T1,A8DZE6,WTIP_DANRE,,Wilms tumor protein 1-interacting protein homolog (WT1-interacting protein homolog),Danio rerio (Zebrafish) (Brachydanio rerio),52.4,191.0,1.8e-56,220.7,sp|A8DZE6|WTIP_DANRE Wilms tumor protein 1-interacting protein homolog OS=Danio rerio OX=7955 GN=wtip PE=3 SV=1,GO:0000132; GO:0000932; GO:0001666; GO:0001947; GO:0003140; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0010882; GO:0014032; GO:0022604; GO:0035331; GO:0035844; GO:0036064; GO:0046872; GO:0060271; GO:0061032; GO:0061371,cilium assembly [GO:0060271]; cloaca development [GO:0035844]; cytoskeleton organization [GO:0007010]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; establishment of mitotic spindle orientation [GO:0000132]; heart looping [GO:0001947]; negative regulation of hippo signaling [GO:0035331]; neural crest cell development [GO:0014032]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cell morphogenesis [GO:0022604]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]; visceral serous pericardium development [GO:0061032],adherens junction [GO:0005912]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667],metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005815; GO:0006355; GO:0007010; GO:0043226; GO:0044782; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cytoskeleton organization; organelle; cilium organization; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_08090,2.4699466051191963,FUN_035822-T1,Peve_00037801,Pocillopora_meandrina_HIv1___RNAseq.g11932.t1,three_way,75.45,FUN_035822-T1,Q6PJI9,WDR59_HUMAN,,GATOR2 complex protein WDR59 (WD repeat-containing protein 59),Homo sapiens (Human),39.0,885.0,8.999999999999999e-151,535.8,sp|Q6PJI9|WDR59_HUMAN GATOR2 complex protein WDR59 OS=Homo sapiens OX=9606 GN=WDR59 PE=1 SV=2,GO:0005765; GO:0005774; GO:0005829; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0043231; GO:0061700; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774],signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270],GO:0005829; GO:0043226; GO:0060090,cytosol; organelle; molecular adaptor activity
OG_08091,3.491821280296582,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08093,2.188675625722368,FUN_035828-T1,Peve_00002588,Pocillopora_meandrina_HIv1___RNAseq.g11936.t1,three_way,67.353,FUN_035828-T1,Q60751,IGF1R_MOUSE,,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],Mus musculus (Mouse),48.0,275.0,4.300000000000001e-71,271.6,sp|Q60751|IGF1R_MOUSE Insulin-like growth factor 1 receptor OS=Mus musculus OX=10090 GN=Igf1r PE=1 SV=3,GO:0000165; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005886; GO:0007420; GO:0008544; GO:0009887; GO:0016020; GO:0030238; GO:0030315; GO:0030325; GO:0030879; GO:0031017; GO:0032869; GO:0043235; GO:0043409; GO:0043410; GO:0043491; GO:0043548; GO:0043560; GO:0045840; GO:0045893; GO:0046777; GO:0048009; GO:0048639; GO:0051446; GO:0051897; GO:0051898; GO:0060740; GO:0071333; GO:0098794; GO:0098978; GO:0099170; GO:0120162; GO:0140014,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; insulin-like growth factor receptor signaling pathway [GO:0048009]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; mitotic nuclear division [GO:0140014]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prostate gland epithelium morphogenesis [GO:0060740]; protein autophosphorylation [GO:0046777],glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; T-tubule [GO:0030315],ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005886; GO:0006355; GO:0016740; GO:0022414; GO:0048856; GO:0060089; GO:0140014; GO:0140096,"catalytic activity; structural molecule activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; reproductive process; anatomical structure development; molecular transducer activity; mitotic nuclear division; catalytic activity, acting on a protein"
OG_08095,4.233620918300363,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_08113,1.565577896927366,FUN_035867-T1,Peve_00012616,Pocillopora_meandrina_HIv1___RNAseq.g11976.t1,three_way,85.703,FUN_035867-T1,Q642Q1,,,,,69.7,287.0,2e-117,423.7,sp|Q642Q1|SAE2A_XENLA SUMO-activating enzyme subunit 2-A OS=Xenopus laevis OX=8355 GN=uba2-a PE=2 SV=1,,,,,,
OG_08120,1.746972462471757,FUN_035877-T1,Peve_00014421,Pocillopora_meandrina_HIv1___TS.g3329.t1b,three_way,54.79466666666666,FUN_035877-T1,A5PLK6,RGSL_HUMAN,,Regulator of G-protein signaling protein-like,Homo sapiens (Human),24.2,636.0,4.0999999999999997e-35,152.1,sp|A5PLK6|RGSL_HUMAN Regulator of G-protein signaling protein-like OS=Homo sapiens OX=9606 GN=RGSL1 PE=1 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_08121,1.9576341100743568,FUN_035878-T1,Peve_00014423,Pocillopora_meandrina_HIv1___RNAseq.g11992.t1,three_way,81.17266666666667,FUN_035878-T1,Q01650,LAT1_HUMAN,,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),Homo sapiens (Human),47.3,412.0,9.6e-108,392.1,sp|Q01650|LAT1_HUMAN Large neutral amino acids transporter small subunit 1 OS=Homo sapiens OX=9606 GN=SLC7A5 PE=1 SV=2,GO:0002720; GO:0003333; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010507; GO:0010629; GO:0014850; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015297; GO:0015349; GO:0015804; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0015824; GO:0015827; GO:0015828; GO:0015829; GO:0016020; GO:0016323; GO:0016324; GO:0031528; GO:0032328; GO:0032729; GO:0032740; GO:0032753; GO:0042149; GO:0042605; GO:0042908; GO:0043231; GO:0055093; GO:0060252; GO:0070062; GO:0070327; GO:0071222; GO:0089718; GO:0097421; GO:0098591; GO:0150104; GO:1902024; GO:1903577; GO:1903801; GO:1904556; GO:1905460; GO:1905534; GO:1990184,alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; L-tryptophan transmembrane transport [GO:1904556]; liver regeneration [GO:0097421]; methionine transport [GO:0015821]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of L-leucine import across plasma membrane [GO:1905534]; positive regulation of type II interferon production [GO:0032729]; proline transport [GO:0015824]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908],amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0003013; GO:0005215; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0055085,circulatory system process; transporter activity; cytosol; plasma membrane; organelle; anatomical structure development; transmembrane transport
OG_08124,1.0867609943437058,FUN_035882-T1,Peve_00014426,Pocillopora_meandrina_HIv1___RNAseq.g11996.t1,three_way,76.97966666666666,FUN_035882-T1,Q9QXA6,BAT1_MOUSE,,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",Mus musculus (Mouse),50.3,485.0,5.700000000000001e-124,446.0,"sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1",GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009,L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_08125,1.3233480421410042,FUN_035883-T1,Peve_00014427,Pocillopora_meandrina_HIv1___RNAseq.g11998.t1,three_way,92.58233333333334,FUN_035883-T1,O14662,STX16_HUMAN,,Syntaxin-16 (Syn16),Homo sapiens (Human),51.5,305.0,2.8e-73,276.9,sp|O14662|STX16_HUMAN Syntaxin-16 OS=Homo sapiens OX=9606 GN=STX16 PE=1 SV=3,GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471,"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0043226; GO:0060090; GO:0061024,Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_08130,1.700437684907708,FUN_035890-T2,Peve_00029398,Pocillopora_meandrina_HIv1___RNAseq.g12007.t1,three_way,73.41116666666667,FUN_035890-T2,Q8TEB1,DCA11_HUMAN,,DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23),Homo sapiens (Human),51.1,493.0,1.3e-147,524.6,sp|Q8TEB1|DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1,GO:0003016; GO:0005654; GO:0006979; GO:0007613; GO:0010467; GO:0016567; GO:0035640; GO:0043161; GO:0050821; GO:0080008,exploration behavior [GO:0035640]; gene expression [GO:0010467]; memory [GO:0007613]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; respiratory system process [GO:0003016]; response to oxidative stress [GO:0006979],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654],,GO:0003016; GO:0005654; GO:0030163; GO:0050877,respiratory system process; nucleoplasm; protein catabolic process; nervous system process
OG_08131,2.586120260174345,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_08132,1.7610808951434316,FUN_035892-T1,Peve_00029394,Pocillopora_meandrina_HIv1___RNAseq.g12009.t1,three_way,77.4455,FUN_035892-T1,Q8BH79,,,,,42.9,631.0,1.1e-140,501.9,sp|Q8BH79|ANO10_MOUSE Anoctamin-10 OS=Mus musculus OX=10090 GN=Ano10 PE=1 SV=1,,,,,,
OG_08136,1.086681310185681,FUN_035898-T1,Peve_00029392,Pocillopora_meandrina_HIv1___RNAseq.g12022.t1,three_way,92.744,FUN_035898-T1,A2APC3,TTLL9_MOUSE,,Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9),Mus musculus (Mouse),68.2,444.0,1.6e-175,617.1,sp|A2APC3|TTLL9_MOUSE Probable tubulin polyglutamylase TTLL9 OS=Mus musculus OX=10090 GN=Ttll9 PE=1 SV=2,GO:0005524; GO:0005737; GO:0005874; GO:0030317; GO:0031514; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438,flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005929; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; cilium; microtubule-based movement; ligase activity; reproductive process; organelle; cell motility; catalytic activity, acting on a protein"
OG_08139,2.068139841827547,FUN_035901-T1,Peve_00006712,Pocillopora_meandrina_HIv1___RNAseq.g12026.t1,three_way,63.80683333333334,FUN_035901-T1,Q96H35,,,,,44.4,160.0,6.5e-30,132.1,sp|Q96H35|RBM18_HUMAN Probable RNA-binding protein 18 OS=Homo sapiens OX=9606 GN=RBM18 PE=1 SV=1,,,,,,
OG_08146,1.96816564145978,FUN_035915-T1,Peve_00006727,Pocillopora_meandrina_HIv1___RNAseq.24982_t,three_way,54.92366666666666,,,,,,,,,,,,,,,,,
OG_08148,2.5574369217217967,FUN_035917-T1,Peve_00006725,Pocillopora_meandrina_HIv1___TS.g3382.t1,three_way,58.83166666666667,FUN_035917-T1,Q3ZBF3,,,,,41.2,245.0,2.2e-49,197.6,sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2,,,,,,
OG_08157,1.0342005642847256,FUN_035935-T1,Peve_00036625,Pocillopora_meandrina_HIv1___RNAseq.g12072.t1,three_way,80.009,FUN_035935-T1,P23709,,,,,72.6,212.0,3.8e-87,322.8,"sp|P23709|NDUS3_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS3 PE=1 SV=1",,,,,,
OG_08158,2.4749739012080254,FUN_035936-T1,Peve_00036627,Pocillopora_meandrina_HIv1___RNAseq.g12073.t1,three_way,53.47433333333333,FUN_035936-T1,Q4UB16,,,,,28.3,191.0,4.2e-12,73.2,sp|Q4UB16|RAB1_THEAN Ras-related protein Rab-1 OS=Theileria annulata OX=5874 GN=rab1 PE=3 SV=1,,,,,,
OG_08159,2.4844911539836256,FUN_035940-T1,Peve_00036628,Pocillopora_meandrina_HIv1___RNAseq.g12074.t1,three_way,50.0505,FUN_035940-T1,Q86JC8,,,,,30.0,150.0,1.5e-06,54.7,sp|Q86JC8|RABH_DICDI Ras-related protein RabH OS=Dictyostelium discoideum OX=44689 GN=rabH PE=3 SV=1,,,,,,
OG_08160,1.8486347769766955,FUN_035941-T1,Peve_00036629,Pocillopora_meandrina_HIv1___RNAseq.g12076.t1,three_way,64.244,FUN_035941-T1,P36861,,,,,37.7,175.0,9.300000000000001e-27,122.1,sp|P36861|YPTV2_VOLCA GTP-binding protein yptV2 OS=Volvox carteri OX=3067 GN=YPTV2 PE=3 SV=1,,,,,,
OG_08163,1.0064522215254004,FUN_035945-T1,Peve_00036633,Pocillopora_meandrina_HIv1___RNAseq.g12353.t1,three_way,72.697,FUN_035945-T1,Q5RJV0,,,,,44.9,243.0,8.8e-55,215.3,"sp|Q5RJV0|COQ9_XENTR Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Xenopus tropicalis OX=8364 GN=coq9 PE=2 SV=1",,,,,,
OG_08164,1.5980133036361064,FUN_035947-T1,Peve_00036635,Pocillopora_meandrina_HIv1___RNAseq.g12350.t1,three_way,62.132666666666665,FUN_035947-T1,Q99KW9,,,,,39.8,606.0,8.400000000000001e-111,402.5,sp|Q99KW9|TIP_MOUSE T-cell immunomodulatory protein OS=Mus musculus OX=10090 GN=Itfg1 PE=1 SV=2,,,,,,
OG_08170,2.837531560758053,FUN_035976-T1,Peve_00006611,Pocillopora_meandrina_HIv1___RNAseq.g12335.t1,three_way,78.89066666666666,FUN_035976-T1,Q8BVR6,,,,,56.2,489.0,3e-152,540.0,sp|Q8BVR6|RSPRY_MOUSE RING finger and SPRY domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rspry1 PE=1 SV=1,,,,,,
OG_08178,1.7881054749194996,FUN_036002-T1,Peve_00041842,Pocillopora_meandrina_HIv1___RNAseq.g12326.t1,three_way,67.96933333333334,FUN_036002-T1,O16099,,,,,43.3,506.0,4.3e-112,406.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_08179,1.8056212729659813,FUN_036003-T1,Peve_00041841,Pocillopora_meandrina_HIv1___RNAseq.g12325.t1,three_way,75.89933333333333,FUN_036003-T1,Q0VCJ8,METL9_BOVIN,,Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (Methyltransferase-like protein 9),Bos taurus (Bovine),51.5,262.0,1.7e-76,287.7,sp|Q0VCJ8|METL9_BOVIN Protein-L-histidine N-pros-methyltransferase OS=Bos taurus OX=9913 GN=METTL9 PE=2 SV=1,GO:0005739; GO:0005783; GO:0032259; GO:0106370,methylation [GO:0032259],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],protein-L-histidine N-pros-methyltransferase activity [GO:0106370],GO:0003824; GO:0005739; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08186,1.6608641347187645,FUN_036026-T1,Peve_00011110,Pocillopora_meandrina_HIv1___RNAseq.g27236.t1,three_way,53.73583333333333,FUN_036026-T1,Q9BUB4,,,,,36.3,529.0,4.8e-73,276.9,sp|Q9BUB4|ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens OX=9606 GN=ADAT1 PE=1 SV=1,,,,,,
OG_08191,1.0174116266258388,FUN_036031-T1,Peve_00011103,Pocillopora_meandrina_HIv1___RNAseq.g27241.t1,three_way,81.92866666666667,FUN_036031-T1,A5A779,PGTA_PIG,,Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha),Sus scrofa (Pig),51.5,305.0,3.7e-86,319.7,sp|A5A779|PGTA_PIG Geranylgeranyl transferase type-2 subunit alpha OS=Sus scrofa OX=9823 GN=RABGGTA PE=2 SV=1,GO:0004663; GO:0005737; GO:0005968; GO:0006888; GO:0008270; GO:0018344; GO:0031267,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344],cytoplasm [GO:0005737]; Rab-protein geranylgeranyltransferase complex [GO:0005968],Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_08204,1.446117414568456,FUN_036055-T1,Peve_00043184,Pocillopora_meandrina_HIv1___RNAseq.g27393.t1,three_way,66.97699999999999,FUN_036055-T1,Q3U2U7,MET17_MOUSE,,"Ribosome assembly protein METTL17, mitochondrial (Methyltransferase-like protein 17)",Mus musculus (Mouse),36.6,374.0,3.1e-62,241.1,"sp|Q3U2U7|MET17_MOUSE Ribosome assembly protein METTL17, mitochondrial OS=Mus musculus OX=10090 GN=Mettl17 PE=1 SV=2",GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0042274; GO:0046872; GO:0051539; GO:0097177; GO:0180026; GO:1904047,mitochondrial small ribosomal subunit assembly [GO:0180026]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]",GO:0003824; GO:0005654; GO:0005739; GO:0016740; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; transferase activity; organelle; protein-containing complex assembly
OG_08215,1.0521073006099295,FUN_036073-T1,Peve_00018969,Pocillopora_meandrina_HIv1___TS.g14760.t2,three_way,77.22200000000001,FUN_036073-T1,Q17QH8,,,,,55.4,294.0,1.2e-86,321.2,sp|Q17QH8|D39U1_BOVIN Epimerase family protein SDR39U1 OS=Bos taurus OX=9913 GN=SDR39U1 PE=2 SV=1,,,,,,
OG_08216,2.102742605620706,FUN_036074-T3,Peve_00018966,Pocillopora_meandrina_HIv1___RNAseq.g27412.t1,three_way,78.726,FUN_036074-T3,Q8CG73,FTM_MOUSE,,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),Mus musculus (Mouse),37.4,1341.0,1.0999999999999998e-198,695.7,sp|Q8CG73|FTM_MOUSE Protein fantom OS=Mus musculus OX=10090 GN=Rpgrip1l PE=1 SV=2,GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0016607; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0035108; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515,brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537],axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],thromboxane A2 receptor binding [GO:0031870],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; plasma membrane; cilium; establishment or maintenance of cell polarity; organelle; cilium organization; anatomical structure development
OG_08219,1.9784746836652816,FUN_036081-T1,Peve_00018988,Pocillopora_meandrina_HIv1___RNAseq.g27414.t1,three_way,75.69716666666666,,,,,,,,,,,,,,,,,
OG_08221,1.1357618877886055,FUN_036085-T1,Peve_00041355,Pocillopora_meandrina_HIv1___RNAseq.g27449.t1,three_way,82.33333333333333,FUN_036085-T1,Q6NX12,,,,,53.2,824.0,2.9e-247,856.3,sp|Q6NX12|NUP93_XENTR Nuclear pore complex protein Nup93 OS=Xenopus tropicalis OX=8364 GN=nup93 PE=2 SV=1,,,,,,
OG_08224,1.7700183874813895,FUN_036095-T1,Peve_00032192,Pocillopora_meandrina_HIv1___RNAseq.g27439.t1,three_way,90.405,FUN_036095-T1,Q9EQH3,VPS35_MOUSE,,Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35),Mus musculus (Mouse),69.9,800.0,0.0,1120.5,sp|Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associated protein 35 OS=Mus musculus OX=10090 GN=Vps35 PE=1 SV=1,GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0016020; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032456; GO:0032463; GO:0033365; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0045732; GO:0048471; GO:0050728; GO:0050804; GO:0050882; GO:0060161; GO:0061357; GO:0090128; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098691; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:0150052; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1904377; GO:1905166; GO:2000331,"endocytic recycling [GO:0032456]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse assembly [GO:0150052]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422]",D1 dopamine receptor binding [GO:0031748],GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006886; GO:0007005; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0072659,mitochondrion; lysosome; endosome; vacuole; cytosol; intracellular protein transport; mitochondrion organization; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process; protein maturation; protein localization to plasma membrane
OG_08225,1.0180786736741405,FUN_036096-T1,Peve_00032193,Pocillopora_meandrina_HIv1___RNAseq.g27438.t1,three_way,74.27666666666667,FUN_036096-T1,Q9NP78,ABCB9_HUMAN,,ABC-type oligopeptide transporter ABCB9 (EC 7.4.2.6) (ATP-binding cassette sub-family B member 9) (ATP-binding cassette transporter 9) (ABC transporter 9 protein) (hABCB9) (TAP-like protein) (TAPL),Homo sapiens (Human),47.3,731.0,6.000000000000002e-181,636.0,sp|Q9NP78|ABCB9_HUMAN ABC-type oligopeptide transporter ABCB9 OS=Homo sapiens OX=9606 GN=ABCB9 PE=1 SV=1,GO:0005524; GO:0005764; GO:0005765; GO:0005789; GO:0006518; GO:0015031; GO:0015421; GO:0015440; GO:0015833; GO:0016020; GO:0016887; GO:0022857; GO:0042803; GO:0043231; GO:0055085,peptide metabolic process [GO:0006518]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],ABC-type oligopeptide transporter activity [GO:0015421]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857],GO:0003824; GO:0005215; GO:0005764; GO:0005773; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; lysosome; vacuole; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08226,3.937050286787936,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08227,2.846188029116394,FUN_036099-T1,Peve_00032195,Pocillopora_meandrina_HIv1___RNAseq.g27436.t1,three_way,72.92099999999999,FUN_036099-T1,Q66JZ4,,,,,33.3,475.0,4.2000000000000004e-60,233.8,"sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1",,,,,,
OG_08229,1.2493273124702284,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_08230,2.4558610774320417,FUN_036103-T1,Peve_00003702,Pocillopora_meandrina_HIv1___RNAseq.g27433.t1,three_way,73.634,FUN_036103-T1,P82160,,,,,38.8,147.0,1.8000000000000001e-22,107.8,"sp|P82160|MLE3_CHERA Myosin light chain 3, skeletal muscle isoform OS=Chelon ramada OX=30804 PE=1 SV=1",,,,,,
OG_08231,2.8760016680435982,FUN_036106-T1,Peve_00003695,Pocillopora_meandrina_HIv1___RNAseq.g27429.t1,three_way,71.5815,FUN_036106-T1,Q68D86,C102B_HUMAN,,Coiled-coil domain-containing protein 102B,Homo sapiens (Human),37.2,390.0,5.6e-42,173.7,sp|Q68D86|C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens OX=9606 GN=CCDC102B PE=1 SV=4,GO:0005737; GO:0005814; GO:0010457; GO:0120283,centriole-centriole cohesion [GO:0010457],centriole [GO:0005814]; cytoplasm [GO:0005737],protein serine/threonine kinase binding [GO:0120283],GO:0043226,organelle
OG_08232,1.0057831009902896,FUN_036108-T1,Peve_00003698,Pocillopora_meandrina_HIv1___RNAseq.g27428.t1,three_way,57.653666666666666,FUN_036108-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),49.7,143.0,6.2e-36,153.3,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08235,1.3638499219765905,FUN_036114-T1,Peve_00029949,Pocillopora_meandrina_HIv1___RNAseq.g27425.t1,three_way,66.59783333333334,FUN_036114-T1,Q91XU0,,,,,59.3,467.0,4.2e-148,526.6,sp|Q91XU0|WRIP1_MOUSE ATPase WRNIP1 OS=Mus musculus OX=10090 GN=Wrnip1 PE=1 SV=2,,,,,,
OG_08237,1.4893294114103273,FUN_036116-T1,Peve_00000283,Pocillopora_meandrina_HIv1___RNAseq.g27423.t1,three_way,63.0515,FUN_036116-T1,O34313,NTPES_BACSU,,"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]",Bacillus subtilis (strain 168),27.1,510.0,4.6e-36,154.8,sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1,GO:0000166; GO:0005576; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872,nucleotide catabolic process [GO:0009166],extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",GO:0003824; GO:0005576; GO:0016787; GO:0055086,catalytic activity; extracellular region; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_08240,1.5894970153115515,FUN_036124-T1,Peve_00000288,Pocillopora_meandrina_HIv1___RNAseq.g27452.t1,three_way,65.2255,FUN_036124-T1,Q9UK23,NAGPA_HUMAN,,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),Homo sapiens (Human),47.2,369.0,3.6e-90,334.0,sp|Q9UK23|NAGPA_HUMAN N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGPA PE=1 SV=2,GO:0003944; GO:0005975; GO:0006486; GO:0006622; GO:0007040; GO:0016020; GO:0032580; GO:0033299; GO:0036211,carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944],GO:0003824; GO:0005975; GO:0006486; GO:0006886; GO:0007040; GO:0016787,catalytic activity; carbohydrate metabolic process; protein glycosylation; intracellular protein transport; lysosome organization; hydrolase activity
OG_08242,1.327755521024296,FUN_036149-T1,Peve_00000295,Pocillopora_meandrina_HIv1___RNAseq.g27458.t1,three_way,66.75033333333333,FUN_036149-T1,Q6PIP5,,,,,34.3,601.0,4e-89,330.5,sp|Q6PIP5|NUDC1_MOUSE NudC domain-containing protein 1 OS=Mus musculus OX=10090 GN=Nudcd1 PE=1 SV=2,,,,,,
OG_08255,2.140235583962328,FUN_036165-T1,Peve_00027201,Pocillopora_meandrina_HIv1___RNAseq.g27500.t1,three_way,70.53633333333333,FUN_036165-T1,C7G3A0,,,,,48.3,383.0,1e-99,365.2,sp|C7G3A0|MPPE1_CRIGR Metallophosphoesterase 1 OS=Cricetulus griseus OX=10029 GN=MPPE1 PE=2 SV=1,,,,,,
OG_08257,1.5645283099967509,FUN_036167-T1,Peve_00027204,Pocillopora_meandrina_HIv1___TS.g14851.t1,three_way,60.79866666666666,FUN_036167-T1,Q64093,S6A20_RAT,,Sodium- and chloride-dependent transporter XTRP3 (Sodium/imino-acid transporter 1) (Solute carrier family 6 member 20) (Transporter rB21A),Rattus norvegicus (Rat),35.0,577.0,1.6e-93,345.5,sp|Q64093|S6A20_RAT Sodium- and chloride-dependent transporter XTRP3 OS=Rattus norvegicus OX=10116 GN=Slc6a20 PE=2 SV=1,GO:0005298; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015193; GO:0015199; GO:0015370; GO:0015816; GO:0015824; GO:0015838; GO:0016324; GO:0031526; GO:0035725; GO:0089718; GO:1903804; GO:1904271; GO:1905647,amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; L-proline import across plasma membrane [GO:1904271]; proline import across plasma membrane [GO:1905647]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; amino-acid betaine transmembrane transporter activity [GO:0015199]; L-proline transmembrane transporter activity [GO:0015193]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; proline:sodium symporter activity [GO:0005298]; solute:sodium symporter activity [GO:0015370],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_08260,1.182396212495559,FUN_036172-T1,Peve_00027209,Pocillopora_meandrina_HIv1___RNAseq.g27505.t1,three_way,60.32333333333333,FUN_036172-T1,Q504M2,,,,,34.6,442.0,8.400000000000001e-57,223.0,"sp|Q504M2|PDP2_MOUSE [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial OS=Mus musculus OX=10090 GN=Pdp2 PE=1 SV=1",,,,,,
OG_08268,1.3853543167669535,FUN_036180-T1,Peve_00015591,Pocillopora_meandrina_HIv1___RNAseq.g27514.t1,three_way,71.41016666666667,FUN_036180-T1,Q5R4M2,,,,,37.6,1344.0,2.1e-234,814.3,sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii OX=9601 GN=ULK4 PE=2 SV=1,,,,,,
OG_08271,1.0525388543143002,FUN_036183-T1,Peve_00015587,Pocillopora_meandrina_HIv1___RNAseq.g27377.t1,three_way,72.55316666666667,FUN_036183-T1,Q8R422,CD109_MOUSE,,CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109),Mus musculus (Mouse),33.9,1471.0,4.4000000000000005e-193,677.2,sp|Q8R422|CD109_MOUSE CD109 antigen OS=Mus musculus OX=10090 GN=Cd109 PE=1 SV=1,GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_08276,2.7194617718419463,FUN_036193-T1,Peve_00011114,Pocillopora_meandrina_HIv1___RNAseq.g27368.t2,three_way,60.47933333333333,,,,,,,,,,,,,,,,,
OG_08277,1.9940853422009404,FUN_036195-T1,Peve_00011109,Pocillopora_meandrina_HIv1___RNAseq.g27367.t1,three_way,72.57383333333334,FUN_036195-T1,Q3UMR0,ANR27_MOUSE,,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein),Mus musculus (Mouse),42.3,787.0,1.5999999999999999e-96,355.9,sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2,GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422,early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08283,1.3909430811609278,FUN_036207-T2,Peve_00038732,Pocillopora_meandrina_HIv1___RNAseq.g27355.t1,three_way,77.35466666666666,FUN_036207-T2,Q5RDW1,,,,,48.1,322.0,7.600000000000001e-80,298.9,sp|Q5RDW1|MTG2_PONAB Mitochondrial ribosome-associated GTPase 2 OS=Pongo abelii OX=9601 GN=MTG2 PE=2 SV=1,,,,,,
OG_08288,1.1937368046781716,FUN_036223-T1,Peve_00025943,Pocillopora_meandrina_HIv1___RNAseq.g27546.t2,three_way,69.85516666666668,FUN_036223-T1,Q6GNG3,TMX3_XENLA,,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),Xenopus laevis (African clawed frog),34.3,429.0,2.2999999999999998e-69,264.6,sp|Q6GNG3|TMX3_XENLA Protein disulfide-isomerase TMX3 OS=Xenopus laevis OX=8355 GN=tmx3 PE=2 SV=1,GO:0003756; GO:0005783; GO:0005789; GO:0009986,,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],protein disulfide isomerase activity [GO:0003756],GO:0003824; GO:0005783; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_08294,1.6117750390634638,FUN_036232-T1,Peve_00015682,Pocillopora_meandrina_HIv1___RNAseq.g27553.t2,three_way,83.43166666666666,FUN_036232-T1,O75131,CPNE3_HUMAN,,Copine-3 (Copine III),Homo sapiens (Human),56.6,525.0,3.6e-177,622.9,sp|O75131|CPNE3_HUMAN Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363,cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08297,1.725763497830672,FUN_036246-T1,Peve_00042157,Pocillopora_meandrina_HIv1___RNAseq.g27581.t2,three_way,85.31133333333334,FUN_036246-T1,P08059,,,,,72.2,550.0,9.8e-239,827.4,sp|P08059|G6PI_PIG Glucose-6-phosphate isomerase OS=Sus scrofa OX=9823 GN=GPI PE=1 SV=3,,,,,,
OG_08300,1.5174660276106562,FUN_036249-T1,Peve_00045287,Pocillopora_meandrina_HIv1___RNAseq.g27590.t1,three_way,48.918,,,,,,,,,,,,,,,,,
OG_08303,1.5457018355016172,FUN_036255-T1,Peve_00045292,Pocillopora_meandrina_HIv1___TS.g14937.t1,three_way,66.72966666666667,FUN_036255-T1,Q8BYI6,PCAT2_MOUSE,,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),Mus musculus (Mouse),38.1,491.0,7.4e-84,312.8,sp|Q8BYI6|PCAT2_MOUSE Lysophosphatidylcholine acyltransferase 2 OS=Mus musculus OX=10090 GN=Lpcat2 PE=1 SV=1,GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0061024,membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0047159],GO:0003824; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0043226; GO:0061024,catalytic activity; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; organelle; membrane organization
OG_08314,2.480099042506367,FUN_036524-T1,Peve_00031406,Pocillopora_meandrina_HIv1___RNAseq.g12097.t1,three_way,72.94333333333334,FUN_036524-T1,Q8NG66,NEK11_HUMAN,,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),Homo sapiens (Human),37.1,631.0,1.6e-98,361.7,sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990,intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08325,1.40855316391558,FUN_036755-T1,Peve_00027843,Pocillopora_meandrina_HIv1___RNAseq.g27068.t1,three_way,83.454,FUN_036755-T1,Q9CY50,,,,,53.3,197.0,9.4e-56,218.4,sp|Q9CY50|SSRA_MOUSE Translocon-associated protein subunit alpha OS=Mus musculus OX=10090 GN=Ssr1 PE=1 SV=1,,,,,,
OG_08326,2.1347597986172797,FUN_036756-T1,Peve_00001059,Pocillopora_meandrina_HIv1___RNAseq.g27066.t1,three_way,84.369,FUN_036756-T1,Q08CH8,,,,,50.0,340.0,3.7e-95,349.7,sp|Q08CH8|ZTRF1_DANRE Zinc finger TRAF-type-containing protein 1 OS=Danio rerio OX=7955 GN=zftraf1 PE=2 SV=2,,,,,,
OG_08327,2.10730377223334,FUN_036757-T1,Peve_00001061,Pocillopora_meandrina_HIv1___RNAseq.g27065.t1,three_way,52.537333333333336,,,,,,,,,,,,,,,,,
OG_08328,2.2822372639254938,FUN_036764-T1,Peve_00006972,Pocillopora_meandrina_HIv1___RNAseq.g10638.t1,three_way,53.79416666666667,,,,,,,,,,,,,,,,,
OG_08329,1.7073525339745592,FUN_036767-T1,Peve_00006967,Pocillopora_meandrina_HIv1___RNAseq.g10634.t1,three_way,71.927,FUN_036767-T1,F1N2K1,,,,,39.2,452.0,1.2999999999999999e-83,312.0,sp|F1N2K1|PCYOX_BOVIN Prenylcysteine oxidase 1 OS=Bos taurus OX=9913 GN=PCYOX1 PE=1 SV=2,,,,,,
OG_08331,1.731234720566752,FUN_036817-T1,Peve_00006527,Pocillopora_meandrina_HIv1___RNAseq.g10617.t1,three_way,69.63,FUN_036817-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.5,2060.0,1.3e-224,782.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08332,1.5399872614944214,FUN_036826-T1,Peve_00006971,Pocillopora_meandrina_HIv1___TS.g13145.t5b,three_way,63.583666666666666,FUN_036826-T1,O15111,IKKA_HUMAN,,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK-1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16),Homo sapiens (Human),35.9,754.0,3.8999999999999995e-129,463.8,sp|O15111|IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens OX=9606 GN=CHUK PE=1 SV=2,GO:0003009; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008384; GO:0008385; GO:0009410; GO:0009615; GO:0009636; GO:0009653; GO:0009898; GO:0010034; GO:0032088; GO:0032727; GO:0033194; GO:0033209; GO:0034142; GO:0035631; GO:0038061; GO:0042803; GO:0043123; GO:0043200; GO:0044877; GO:0045087; GO:0045944; GO:0046982; GO:0051092; GO:0051146; GO:0061847; GO:0071356; GO:0097110; GO:0098586; GO:1990459,anatomical structure morphogenesis [GO:0009653]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to acetate [GO:0010034]; response to amino acid [GO:0043200]; response to cholecystokinin [GO:0061847]; response to hydroperoxide [GO:0033194]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; striated muscle cell differentiation [GO:0051146]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459],GO:0002376; GO:0003012; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0098542; GO:0140096,"immune system process; muscle system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; defense response to other organism; catalytic activity, acting on a protein"
OG_08336,1.0953497253976954,FUN_036841-T1,Peve_00006959,Pocillopora_meandrina_HIv1___TS.g13168.t1,three_way,71.919,FUN_036841-T1,P80457,XDH_BOVIN,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Bos taurus (Bovine),33.5,1310.0,3.4e-197,690.6,sp|P80457|XDH_BOVIN Xanthine dehydrogenase/oxidase OS=Bos taurus OX=9913 GN=XDH PE=1 SV=4,GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949,xanthine catabolic process [GO:0009115],extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_08339,1.3578948064557794,FUN_036853-T1,Peve_00036532,Pocillopora_meandrina_HIv1___RNAseq.g10656.t1,three_way,73.08466666666666,FUN_036853-T1,P21765,,,,,43.4,143.0,7.7e-27,121.7,sp|P21765|GPX5_MOUSE Epididymal secretory glutathione peroxidase OS=Mus musculus OX=10090 GN=Gpx5 PE=2 SV=3,,,,,,
OG_08340,2.5930960171697666,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08341,1.420635740856381,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_08343,1.0510556171612515,FUN_036868-T1,Peve_00004118,Pocillopora_meandrina_HIv1___RNAseq.g10621.t1,three_way,60.080666666666666,FUN_036868-T1,P46616,,,,,28.6,308.0,2.1e-10,68.2,sp|P46616|AA2AR_CAVPO Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1,,,,,,
OG_08345,1.2492201714457822,FUN_036872-T1,Peve_00039758,Pocillopora_meandrina_HIv1___TS.g13142.t1,three_way,53.678333333333335,FUN_036872-T1,O08710,THYG_MOUSE,,Thyroglobulin (Tg),Mus musculus (Mouse),21.6,1359.0,7.8e-40,168.7,sp|O08710|THYG_MOUSE Thyroglobulin OS=Mus musculus OX=10090 GN=Tg PE=1 SV=3,GO:0005179; GO:0005615; GO:0006590; GO:0015705; GO:0030878; GO:0031641; GO:0042403; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0048856; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_08350,1.0417842691040728,FUN_036889-T1,Peve_00018383,Pocillopora_meandrina_HIv1___RNAseq.g10792.t1,three_way,77.267,FUN_036889-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),42.6,251.0,1e-55,218.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_08353,1.0331964154263809,FUN_036897-T1,Peve_00018373,Pocillopora_meandrina_HIv1___RNAseq.g10782.t1,three_way,84.62,FUN_036897-T1,Q9MYP6,,,,,53.5,256.0,1.8e-76,287.3,sp|Q9MYP6|DHB14_BOVIN L-fucose dehydrogenase OS=Bos taurus OX=9913 GN=HSD17B14 PE=2 SV=1,,,,,,
OG_08365,1.228583188095502,FUN_036917-T1,Peve_00018360,Pocillopora_meandrina_HIv1___TS.g13339.t1,three_way,60.458,FUN_036917-T1,Q6DJL7,,,,,32.4,238.0,1e-06,55.8,sp|Q6DJL7|BORA_XENLA Protein aurora borealis OS=Xenopus laevis OX=8355 GN=bora PE=2 SV=1,,,,,,
OG_08366,1.7105247542368454,FUN_036918-T1,Peve_00018356,Pocillopora_meandrina_HIv1___RNAseq.g10823.t1,three_way,84.78133333333334,,,,,,,,,,,,,,,,,
OG_08370,1.506883278381011,FUN_036923-T2,Peve_00026097,Pocillopora_meandrina_HIv1___RNAseq.g10834.t1,three_way,80.37633333333333,FUN_036923-T2,Q3UR70,,,,,41.3,855.0,6.4e-187,656.0,sp|Q3UR70|TGFA1_MOUSE Transforming growth factor-beta receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tgfbrap1 PE=1 SV=1,,,,,,
OG_08372,3.169096158816891,FUN_036925-T1,Peve_00040016,Pocillopora_meandrina_HIv1___TS.g13354.t1,three_way,76.31133333333334,FUN_036925-T1,Q91618,PMYT1_XENLA,,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase),Xenopus laevis (African clawed frog),38.5,550.0,3.8e-86,320.5,sp|Q91618|PMYT1_XENLA Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Xenopus laevis OX=8355 GN=pkmyt1 PE=1 SV=1,GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0007088; GO:0010972; GO:0046872; GO:0051321; GO:0106310; GO:0110031,meiotic cell cycle [GO:0051321]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; regulation of mitotic nuclear division [GO:0007088],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_08373,1.873034432283902,FUN_036934-T1,Peve_00040009,Pocillopora_meandrina_HIv1___RNAseq.g10839.t1,three_way,68.39766666666667,,,,,,,,,,,,,,,,,
OG_08380,1.2512402762293355,FUN_036957-T1,Peve_00040027,Pocillopora_meandrina_HIv1___RNAseq.g10871.t1,three_way,78.528,FUN_036957-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.0,483.0,8.700000000000001e-78,292.7,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08382,2.077585822304415,FUN_036967-T1,Peve_00040021,Pocillopora_meandrina_HIv1___RNAseq.g10880.t1,three_way,57.36033333333334,FUN_036967-T1,Q8NBR6,MINY2_HUMAN,,Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B),Homo sapiens (Human),57.9,328.0,8.6e-100,365.9,sp|Q8NBR6|MINY2_HUMAN Ubiquitin carboxyl-terminal hydrolase MINDY-2 OS=Homo sapiens OX=9606 GN=MINDY2 PE=1 SV=2,GO:0004843; GO:0005654; GO:0006508; GO:0016807; GO:0036435; GO:0070530; GO:0071795; GO:0071796; GO:1990380,proteolysis [GO:0006508],nucleoplasm [GO:0005654],cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked deubiquitinase activity [GO:1990380]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_08387,1.5083736713897156,FUN_036995-T1,Peve_00002140,Pocillopora_meandrina_HIv1___RNAseq.9756_t,three_way,45.89866666666667,FUN_036995-T1,Q9DEQ4,,,,,26.8,317.0,3.5e-20,100.5,sp|Q9DEQ4|SFRP1_CHICK Secreted frizzled-related protein 1 OS=Gallus gallus OX=9031 GN=SFRP1 PE=2 SV=1,,,,,,
OG_08388,1.7911482839635604,FUN_036996-T1,Peve_00002148,Pocillopora_meandrina_HIv1___RNAseq.g26772.t1,three_way,73.63133333333333,FUN_036996-T1,O43826,G6PT1_HUMAN,,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),Homo sapiens (Human),40.1,421.0,3.3000000000000003e-80,300.4,sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513,gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152],GO:0005215; GO:0005783; GO:0005975; GO:0043226; GO:0055085,transporter activity; endoplasmic reticulum; carbohydrate metabolic process; organelle; transmembrane transport
OG_08389,1.1863664936586606,FUN_036997-T1,Peve_00002149,Pocillopora_meandrina_HIv1___RNAseq.g26735.t1,three_way,73.018,FUN_036997-T1,A0A1L8GLK3,,,,,39.7,534.0,6.4e-101,369.8,sp|A0A1L8GLK3|RFW3L_XENLA E3 ubiquitin-protein ligase rfwd3.L OS=Xenopus laevis OX=8355 GN=rfwd3.L PE=1 SV=1,,,,,,
OG_08391,2.588850030987006,FUN_037001-T1,Peve_00002157,Pocillopora_meandrina_HIv1___RNAseq.g26679.t1,three_way,50.65266666666667,,,,,,,,,,,,,,,,,
OG_08398,1.874688092057949,FUN_037046-T1,Peve_00032332,Pocillopora_meandrina_HIv1___RNAseq.g26796.t1,three_way,71.37566666666666,FUN_037046-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),41.5,311.0,2.6999999999999997e-55,217.6,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_08405,1.62634657659045,FUN_037056-T1,Peve_00018389,Pocillopora_meandrina_HIv1___RNAseq.g26785.t1,three_way,92.43566666666666,FUN_037056-T1,P23358,,,,,79.1,163.0,2.6e-70,266.2,sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1,,,,,,
OG_08408,1.97159239899373,FUN_037059-T1,Peve_00018393,Pocillopora_meandrina_HIv1___RNAseq.g26776.t1,three_way,70.49933333333334,,,,,,,,,,,,,,,,,
OG_08417,1.319767464482947,FUN_037075-T1,Peve_00004732,Pocillopora_meandrina_HIv1___RNAseq.g26676.t1,three_way,77.25566666666667,FUN_037075-T1,Q6ZT07,,,,,45.3,1328.0,2.4e-304,1046.6,sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2,,,,,,
OG_08422,1.506570787527816,FUN_037080-T1,Peve_00004726,Pocillopora_meandrina_HIv1___RNAseq.g11151.t1,three_way,82.979,FUN_037080-T1,Q5I0J5,,,,,53.9,232.0,3.1e-69,263.5,sp|Q5I0J5|MITD1_RAT MIT domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Mitd1 PE=2 SV=1,,,,,,
OG_08424,1.17636774893636,FUN_037083-T1,Peve_00004720,Pocillopora_meandrina_HIv1___TS.g13397.t1,three_way,58.36266666666667,,,,,,,,,,,,,,,,,
OG_08425,1.075878751290267,FUN_037084-T1,Peve_00004717,Pocillopora_meandrina_HIv1___RNAseq.g11110.t1,three_way,84.65833333333333,FUN_037084-T1,Q3SZE2,,,,,53.2,111.0,1.1e-22,107.5,sp|Q3SZE2|PFD1_BOVIN Prefoldin subunit 1 OS=Bos taurus OX=9913 GN=PFDN1 PE=2 SV=1,,,,,,
OG_08427,2.024400461263756,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_08430,1.565549372218007,FUN_037093-T1,Peve_00004753,Pocillopora_meandrina_HIv1___RNAseq.g11091.t1,three_way,85.9675,FUN_037093-T1,Q53GS9,UBP39_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein),Homo sapiens (Human),67.1,477.0,6.8e-191,668.3,sp|Q53GS9|UBP39_HUMAN Ubiquitin carboxyl-terminal hydrolase 39 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008270; GO:0008380; GO:0016579; GO:0016787; GO:0046540; GO:0051301,"cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; organelle; protein-containing complex assembly
OG_08435,1.0477263534202534,FUN_037170-T1,Peve_00003252,Pocillopora_meandrina_HIv1___TS.g13578.t1b,three_way,65.45,FUN_037170-T1,P36514,,,,,30.8,494.0,4.5e-60,233.8,sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1,,,,,,
OG_08437,2.532112060040672,FUN_037196-T1,Peve_00004715,Pocillopora_meandrina_HIv1___RNAseq.g11075.t2,three_way,81.52866666666667,FUN_037196-T1,Q15111,PLCL1_HUMAN,,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),Homo sapiens (Human),49.5,1043.0,1.4e-302,1040.4,sp|Q15111|PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens OX=9606 GN=PLCL1 PE=1 SV=3,GO:0004435; GO:0004629; GO:0005737; GO:0007214; GO:0032228; GO:0035556; GO:0046488; GO:0048015; GO:0051209; GO:0120163,"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]",cytoplasm [GO:0005737],"phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]",GO:0003824; GO:0006629; GO:0016787; GO:0023052; GO:0055085,catalytic activity; lipid metabolic process; hydrolase activity; signaling; transmembrane transport
OG_08444,1.1864355149085026,FUN_037206-T1,Peve_00019446,Pocillopora_meandrina_HIv1___RNAseq.g11067.t1,three_way,66.86016666666666,FUN_037206-T1,P41236,IPP2_HUMAN,,Protein phosphatase inhibitor 2 (IPP-2),Homo sapiens (Human),35.5,141.0,3.4e-10,66.6,sp|P41236|IPP2_HUMAN Protein phosphatase inhibitor 2 OS=Homo sapiens OX=9606 GN=PPP1R2 PE=1 SV=2,GO:0004864; GO:0004865; GO:0005977; GO:0006091; GO:0009966; GO:0035556; GO:0140678,generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of signal transduction [GO:0009966],,molecular function inhibitor activity [GO:0140678]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005975; GO:0006091; GO:0098772,carbohydrate metabolic process; generation of precursor metabolites and energy; molecular function regulator activity
OG_08446,1.5174521567362371,FUN_037210-T1,Peve_00039307,Pocillopora_meandrina_HIv1___RNAseq.g11064.t1,three_way,50.45466666666667,,,,,,,,,,,,,,,,,
OG_08449,1.7393028631181182,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,1.7393028631181182,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08451,2.1800554233515093,FUN_037216-T1,Peve_00006684,Pocillopora_meandrina_HIv1___RNAseq.g11058.t1,three_way,62.538,FUN_037216-T1,P55302,AMRP_MOUSE,,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Heparin-binding protein 44) (HBP-44) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),Mus musculus (Mouse),33.9,316.0,3e-27,124.0,sp|P55302|AMRP_MOUSE Alpha-2-macroglobulin receptor-associated protein OS=Mus musculus OX=10090 GN=Lrpap1 PE=1 SV=1,GO:0002091; GO:0005768; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0008201; GO:0009986; GO:0010916; GO:0031904; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0070326; GO:0150093; GO:1900222,amyloid-beta clearance by transcytosis [GO:0150093]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; regulation of receptor-mediated endocytosis [GO:0048259],cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237],heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; very-low-density lipoprotein particle receptor binding [GO:0070326],GO:0005768; GO:0005794; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; Golgi apparatus; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_08454,2.475172049941885,FUN_037221-T1,Peve_00044303,Pocillopora_meandrina_HIv1___RNAseq.g11044.t1,three_way,87.619,FUN_037221-T1,Q9Z120,TRMB_MOUSE,,tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase),Mus musculus (Mouse),65.6,250.0,5.6e-93,342.0,sp|Q9Z120|TRMB_MOUSE tRNA (guanine-N(7)-)-methyltransferase OS=Mus musculus OX=10090 GN=Mettl1 PE=1 SV=1,GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006400; GO:0008176; GO:0033554; GO:0036416; GO:0106004; GO:0106143; GO:0160090,cellular response to stress [GO:0033554]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m7G46) methyltransferase complex [GO:0106143],internal mRNA (guanine-N7-)-methyltransferase activity [GO:0160090]; tRNA (guanine(46)-N7)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08456,2.096688276551983,FUN_037224-T1,Peve_00044309,Pocillopora_meandrina_HIv1___RNAseq.g11042.t1,three_way,59.601333333333336,,,,,,,,,,,,,,,,,
OG_08461,1.9274240684762056,FUN_037230-T1,Peve_00006215,Pocillopora_meandrina_HIv1___RNAseq.g11016.t1a,three_way,72.01233333333333,FUN_037230-T1,P35295,,,,,39.6,212.0,7.6e-33,142.1,sp|P35295|RAB20_MOUSE Ras-related protein Rab-20 OS=Mus musculus OX=10090 GN=Rab20 PE=2 SV=2,,,,,,
OG_08463,1.2531774292167004,FUN_037232-T2,Peve_00006212,Pocillopora_meandrina_HIv1___RNAseq.g11014.t1,three_way,94.32066666666668,FUN_037232-T2,P79101,,,,,70.0,683.0,1.9e-287,989.6,sp|P79101|CPSF3_BOVIN Cleavage and polyadenylation specificity factor subunit 3 OS=Bos taurus OX=9913 GN=CPSF3 PE=1 SV=1,,,,,,
OG_08466,1.2356927215174345,FUN_037278-T1,Peve_00001629,Pocillopora_meandrina_HIv1___RNAseq.g26884.t1,three_way,88.282,FUN_037278-T1,Q14117,DPYS_HUMAN,,Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase),Homo sapiens (Human),66.6,515.0,2.2000000000000004e-201,703.4,sp|Q14117|DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens OX=9606 GN=DPYS PE=1 SV=1,GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0042802; GO:0046050; GO:0046079; GO:0051219; GO:0070062,CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212],cytosol [GO:0005829]; extracellular exosome [GO:0070062],dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08467,1.062119187789401,FUN_037279-T1,Peve_00001637,Pocillopora_meandrina_HIv1___RNAseq.g26883.t1,three_way,45.025666666666666,,,,,,,,,,,,,,,,,
OG_08476,1.2252891624889606,FUN_037299-T1,Peve_00045277,Pocillopora_meandrina_HIv1___RNAseq.g10686.t1,three_way,70.14133333333334,FUN_037299-T1,Q4KLQ5,,,,,39.0,505.0,1.8e-83,311.6,sp|Q4KLQ5|WDR76_XENLA WD repeat-containing protein 76 OS=Xenopus laevis OX=8355 GN=wdr76 PE=2 SV=1,,,,,,
OG_08485,2.030813057724484,FUN_037321-T1,Peve_00006223,Pocillopora_meandrina_HIv1___RNAseq.g10702.t1,three_way,81.63366666666667,FUN_037321-T1,A4IFE4,,,,,53.6,440.0,2.4e-126,454.1,sp|A4IFE4|RGF1B_BOVIN Ras-GEF domain-containing family member 1B OS=Bos taurus OX=9913 GN=RASGEF1B PE=2 SV=1,,,,,,
OG_08488,2.2943388092014354,FUN_037324-T1,Peve_00006231,Pocillopora_meandrina_HIv1___RNAseq.g10699.t1,three_way,65.4175,FUN_037324-T1,Q8CF97,VCIP1_RAT,,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),Rattus norvegicus (Rat),47.3,994.0,4.7e-244,846.3,sp|Q8CF97|VCIP1_RAT Deubiquitinating protein VCPIP1 OS=Rattus norvegicus OX=10116 GN=Vcpip1 PE=1 SV=2,GO:0004843; GO:0005634; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634,DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; synapse [GO:0045202],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005783; GO:0006281; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; DNA repair; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_08491,3.143646314712448,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08493,1.0722290337028475,FUN_037341-T1,Peve_00006166,Pocillopora_meandrina_HIv1___RNAseq.g10757.t1,three_way,60.51666666666667,FUN_037341-T1,Q1MT80,GBP4_DANRE,,Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,370.0,4.899999999999997e-35,151.0,sp|Q1MT80|GBP4_DANRE Guanylate-binding protein 4 OS=Danio rerio OX=7955 GN=gbp4 PE=1 SV=1,GO:0001780; GO:0003924; GO:0005525; GO:0006954; GO:0042742; GO:0042981; GO:0045087; GO:0061702; GO:0070944,defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; neutrophil homeostasis [GO:0001780]; neutrophil-mediated killing of bacterium [GO:0070944]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0002376; GO:0003824; GO:0003924; GO:0006954; GO:0016787; GO:0098542,immune system process; catalytic activity; GTPase activity; inflammatory response; hydrolase activity; defense response to other organism
OG_08505,1.770817283479375,FUN_037404-T1,Peve_00028554,Pocillopora_meandrina_HIv1___RNAseq.g10936.t1,three_way,65.14683333333333,FUN_037404-T1,Q8R2Q6,TECT3_MOUSE,,Tectonic-3,Mus musculus (Mouse),30.9,556.0,8.399999999999998e-55,216.5,sp|Q8R2Q6|TECT3_MOUSE Tectonic-3 OS=Mus musculus OX=10090 GN=Tctn3 PE=1 SV=1,GO:0005634; GO:0006915; GO:0007224; GO:0016020; GO:0043065; GO:0060271,apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224],membrane [GO:0016020]; nucleus [GO:0005634],,GO:0005634; GO:0012501; GO:0043226; GO:0044782,nucleus; programmed cell death; organelle; cilium organization
OG_08507,2.297270582639973,FUN_037415-T1,Peve_00028254,Pocillopora_meandrina_HIv1___RNAseq.g10939.t1,three_way,73.82433333333333,FUN_037415-T1,A5PJF6,,,,,47.9,303.0,2.3000000000000002e-73,277.3,sp|A5PJF6|HSDL1_BOVIN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Bos taurus OX=9913 GN=HSDL1 PE=2 SV=1,,,,,,
OG_08508,2.4113666581679527,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08509,2.0741879491336093,FUN_037422-T1,Peve_00000594,Pocillopora_meandrina_HIv1___RNAseq.g10949.t1,three_way,81.52333333333333,FUN_037422-T1,Q6QA33,,,,,49.3,306.0,1.5e-71,271.2,sp|Q6QA33|DH12B_DANRE Very-long-chain 3-oxoacyl-CoA reductase-B OS=Danio rerio OX=7955 GN=hsd17b12b PE=2 SV=2,,,,,,
OG_08514,1.2157576268233434,FUN_037440-T1,Peve_00014235,Pocillopora_meandrina_HIv1___RNAseq.22823_t,three_way,64.086,FUN_037440-T1,Q9M9E8,,,,,30.9,269.0,4.400000000000001e-28,127.1,sp|Q9M9E8|JMJ21_ARATH Lysine-specific demethylase JMJ21 OS=Arabidopsis thaliana OX=3702 GN=JMJ21 PE=2 SV=3,,,,,,
OG_08518,1.0500322302854297,FUN_037448-T1,Peve_00027252,Pocillopora_meandrina_HIv1___RNAseq.g10987.t1,three_way,73.10766666666667,FUN_037448-T1,Q8AVL0,,,,,50.8,543.0,6.4e-150,532.3,sp|Q8AVL0|C19L1_XENLA CWF19-like protein 1 OS=Xenopus laevis OX=8355 GN=cwf19l1 PE=2 SV=1,,,,,,
OG_08519,2.803529330523659,FUN_037451-T1,Peve_00044121,Pocillopora_meandrina_HIv1___RNAseq.g1365.t1,three_way,62.06366666666667,,,,,,,,,,,,,,,,,
OG_08520,4.096219398300932,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08522,1.5724566258982182,FUN_037455-T2,Peve_00044122,Pocillopora_meandrina_HIv1___RNAseq.g1369.t1,three_way,78.81866666666667,FUN_037455-T2,B2GUP8,MITOS_XENTR,,"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),59.1,613.0,1.9999999999999999e-193,677.2,sp|B2GUP8|MITOS_XENTR Mitochondrial potassium channel ATP-binding subunit OS=Xenopus tropicalis OX=8364 GN=abcb8 PE=2 SV=1,GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0062157; GO:0071805; GO:0140359,potassium ion transmembrane transport [GO:0071805],mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08528,2.4362700079877,FUN_037469-T1,Peve_00036019,Pocillopora_meandrina_HIv1___RNAseq.g1383.t1,three_way,59.05133333333333,FUN_037469-T1,Q7Z407,CSMD3_HUMAN,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Homo sapiens (Human),27.5,262.0,1.4e-15,85.5,sp|Q7Z407|CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens OX=9606 GN=CSMD3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_08530,2.0424126195687338,FUN_037477-T1,Peve_00020433,Pocillopora_meandrina_HIv1___RNAseq.g1391.t1,three_way,71.99733333333333,FUN_037477-T1,Q3TDN2,FAF2_MOUSE,,FAS-associated factor 2 (UBX domain-containing protein 8),Mus musculus (Mouse),45.3,267.0,3.1e-59,230.3,sp|Q3TDN2|FAF2_MOUSE FAS-associated factor 2 OS=Mus musculus OX=10090 GN=Faf2 PE=1 SV=2,GO:0005783; GO:0005811; GO:0006986; GO:0030674; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035617; GO:0036503; GO:0043130; GO:0043161; GO:0055102,"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005783; GO:0005811; GO:0006886; GO:0030163; GO:0043226; GO:0060090; GO:0098772,endoplasmic reticulum; lipid droplet; intracellular protein transport; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_08535,2.309268930442677,FUN_037485-T2,Peve_00020418,Pocillopora_meandrina_HIv1___RNAseq.g1299.t1,three_way,72.62033333333333,FUN_037485-T2,Q8CHC4,SYNJ1_MOUSE,,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",Mus musculus (Mouse),54.1,1036.0,0.0,1097.0,sp|Q8CHC4|SYNJ1_MOUSE Synaptojanin-1 OS=Mus musculus OX=10090 GN=Synj1 PE=1 SV=3,GO:0003723; GO:0004439; GO:0006836; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0030117; GO:0030118; GO:0030132; GO:0034595; GO:0043195; GO:0046488; GO:0046856; GO:0048015; GO:0048471; GO:0048488; GO:0048489; GO:0097060; GO:0098685; GO:0098978; GO:0099149; GO:1903423,learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of synaptic vesicle recycling [GO:1903423]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506],"phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0006629; GO:0016192; GO:0016787; GO:0050877; GO:0065003,RNA binding; catalytic activity; lipid metabolic process; vesicle-mediated transport; hydrolase activity; nervous system process; protein-containing complex assembly
OG_08543,2.2655086456364386,FUN_037496-T1,Peve_00028565,Pocillopora_meandrina_HIv1___RNAseq.g1312.t1,three_way,79.1105,FUN_037496-T1,P36895,BMR1A_MOUSE,,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (BMP-2/BMP-4 receptor) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),Mus musculus (Mouse),53.0,487.0,2.7e-145,516.9,sp|P36895|BMR1A_MOUSE Bone morphogenetic protein receptor type-1A OS=Mus musculus OX=10090 GN=Bmpr1a PE=1 SV=1,GO:0001525; GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003007; GO:0003148; GO:0003151; GO:0003161; GO:0003171; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0005025; GO:0005524; GO:0005901; GO:0006955; GO:0007179; GO:0007389; GO:0007398; GO:0007399; GO:0007492; GO:0007507; GO:0009897; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010629; GO:0014032; GO:0014912; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048339; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0048598; GO:0048863; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0051216; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060412; GO:0060896; GO:0060914; GO:0060928; GO:0061626; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:2000772,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cartilage development [GO:0051216]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart development [GO:0007507]; heart formation [GO:0060914]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; neural plate pattern specification [GO:0060896]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm structural organization [GO:0048352]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell differentiation [GO:0048863]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025],"ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0002376; GO:0003824; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"immune system process; catalytic activity; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_08545,1.9121291538938965,FUN_037499-T1,Peve_00028563,Pocillopora_meandrina_HIv1___RNAseq.g1314.t1,three_way,52.762,FUN_037499-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),26.9,750.0,3.7e-53,211.8,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_08549,1.2339914096916158,FUN_037517-T1,Peve_00025027,Pocillopora_meandrina_HIv1___RNAseq.g1320.t1,three_way,85.71833333333333,FUN_037517-T1,A4IGP0,,,,,63.3,196.0,1.6e-66,253.8,sp|A4IGP0|HIKES_XENTR Protein Hikeshi OS=Xenopus tropicalis OX=8364 GN=hikeshi PE=2 SV=1,,,,,,
OG_08553,1.2330101562196334,FUN_037529-T1,Peve_00018745,Pocillopora_meandrina_HIv1___RNAseq.g10587.t1,three_way,78.19266666666667,FUN_037529-T1,P97479,,,,,53.2,485.0,6.6e-146,518.8,sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2,,,,,,
OG_08556,1.6474208676451327,FUN_037544-T1,Peve_00032232,Pocillopora_meandrina_HIv1___RNAseq.g10583.t1,three_way,85.05866666666667,FUN_037544-T1,Q8R4C2,,,,,36.0,406.0,1.4e-57,226.1,sp|Q8R4C2|RUFY2_MOUSE RUN and FYVE domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rufy2 PE=1 SV=2,,,,,,
OG_08560,1.2521395942249414,FUN_037548-T1,Peve_00032226,Pocillopora_meandrina_HIv1___RNAseq.g1628.t1,three_way,68.57633333333334,FUN_037548-T1,Q8VC74,,,,,40.3,278.0,1.2e-48,195.3,"sp|Q8VC74|COX18_MOUSE Cytochrome c oxidase assembly protein COX18, mitochondrial OS=Mus musculus OX=10090 GN=Cox18 PE=1 SV=5",,,,,,
OG_08568,1.6577615346247547,FUN_037569-T1,Peve_00035301,Pocillopora_meandrina_HIv1___RNAseq.g1586.t1,three_way,72.47983333333333,FUN_037569-T1,Q9D168,,,,,31.7,259.0,2.5000000000000002e-22,107.8,sp|Q9D168|INT12_MOUSE Integrator complex subunit 12 OS=Mus musculus OX=10090 GN=Ints12 PE=1 SV=1,,,,,,
OG_08575,2.108289824838657,FUN_037586-T1,Peve_00035294,Pocillopora_meandrina_HIv1___RNAseq.g1594.t1,three_way,57.32,FUN_037586-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),30.2,394.0,3.9e-35,151.4,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08576,1.8659256374649784,FUN_037588-T1,Peve_00035293,Pocillopora_meandrina_HIv1___RNAseq.g1595.t1,three_way,69.3425,FUN_037588-T1,P38935,SMBP2_HUMAN,,DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2),Homo sapiens (Human),52.6,831.0,1.4e-215,751.1,sp|P38935|SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3,GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008094; GO:0008186; GO:0008270; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:0140296; GO:1990904,,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08577,2.2832533493395037,FUN_037589-T1,Peve_00035292,Pocillopora_meandrina_HIv1___RNAseq.g1596.t1,three_way,82.638,FUN_037589-T1,P70032,,,,,57.4,608.0,4.1e-204,712.6,sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis OX=8355 GN=plk1 PE=1 SV=1,,,,,,
OG_08579,1.1810099597866262,FUN_037682-T1,Peve_00042425,Pocillopora_meandrina_HIv1___RNAseq.g1612.t1,three_way,55.28383333333333,,,,,,,,,,,,,,,,,
OG_08583,2.287376481772288,FUN_037687-T1,Peve_00042417,Pocillopora_meandrina_HIv1___RNAseq.g1616.t1,three_way,68.82533333333333,FUN_037687-T1,A0A0G2KQY6,S39AE_DANRE,,Metal cation symporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),Danio rerio (Zebrafish) (Brachydanio rerio),38.7,473.0,2.6e-78,294.3,sp|A0A0G2KQY6|S39AE_DANRE Metal cation symporter ZIP14 OS=Danio rerio OX=7955 GN=slc39a14 PE=2 SV=1,GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0006829; GO:0006882; GO:0015086; GO:0015296; GO:0016323; GO:0016324; GO:0030003; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739; GO:0140410,cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_08586,1.3115076817111206,FUN_037690-T1,Peve_00001242,Pocillopora_meandrina_HIv1___RNAseq.g1579.t1,three_way,69.16366666666667,FUN_037690-T1,Q8TEM1,PO210_HUMAN,,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),Homo sapiens (Human),34.5,1584.0,2.7e-254,880.9,sp|Q8TEM1|PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3,GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],,GO:0005635; GO:0006913,nuclear envelope; nucleocytoplasmic transport
OG_08590,1.029327414197838,FUN_037699-T1,Peve_00044124,Pocillopora_meandrina_HIv1___TS.g22767.t1a,three_way,74.662,FUN_037699-T1,A4IH88,,,,,32.0,616.0,2.3e-66,255.0,sp|A4IH88|K2013_XENTR Uncharacterized protein KIAA2013 homolog OS=Xenopus tropicalis OX=8364 PE=2 SV=1,,,,,,
OG_08597,1.6240304935907932,FUN_037739-T1,Peve_00037364,Pocillopora_meandrina_HIv1___RNAseq.g1330.t1,three_way,79.21866666666666,FUN_037739-T1,Q8T293,,,,,40.8,353.0,1.5e-70,268.1,sp|Q8T293|DIAC2_DICDI Probable di-N-acetylchitobiase 2 OS=Dictyostelium discoideum OX=44689 GN=ctbs2 PE=3 SV=1,,,,,,
OG_08598,1.633851284721166,FUN_037740-T1,Peve_00037367,Pocillopora_meandrina_HIv1___RNAseq.g1331.t2,three_way,82.32733333333333,,,,,,,,,,,,,,,,,
OG_08600,1.077544557578372,FUN_037743-T1,Peve_00037357,Pocillopora_meandrina_HIv1___RNAseq.g1333.t1,three_way,65.298,FUN_037743-T1,Q9EP82,,,,,31.0,355.0,1.4e-37,158.7,sp|Q9EP82|WDR4_MOUSE tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Mus musculus OX=10090 GN=Wdr4 PE=1 SV=2,,,,,,
OG_08607,1.2268434756593058,FUN_037753-T1,Peve_00038304,Pocillopora_meandrina_HIv1___RNAseq.g1341.t1,three_way,59.559333333333335,FUN_037753-T1,A7SKJ3,DPH2_NEMVE,,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),Nematostella vectensis (Starlet sea anemone),44.1,313.0,3.200000000000001e-65,250.4,sp|A7SKJ3|DPH2_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Nematostella vectensis OX=45351 GN=dph2 PE=3 SV=1,GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513,protein histidyl modification to diphthamide [GO:0017183],2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513],"2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_08611,1.0220958468293215,FUN_037758-T1,Peve_00014340,Pocillopora_meandrina_HIv1___RNAseq.g1498.t1,three_way,47.662333333333336,,,,,,,,,,,,,,,,,
OG_08615,1.9641579241158764,FUN_037763-T1,Peve_00014331,Pocillopora_meandrina_HIv1___RNAseq.g1494.t1,three_way,49.86833333333333,FUN_037763-T1,Q5ZJX4,,,,,57.6,92.0,4.4e-26,120.2,sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1,,,,,,
OG_08616,2.048585823858128,FUN_037765-T1,Peve_00014329,Pocillopora_meandrina_HIv1___RNAseq.g1491.t1,three_way,56.507,,,,,,,,,,,,,,,,,
OG_08617,2.232530554219521,FUN_037768-T1,Peve_00014328,Pocillopora_meandrina_HIv1___RNAseq.g1480.t1,three_way,79.92966666666668,FUN_037768-T1,O35552,F263_RAT,,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",Rattus norvegicus (Rat),53.4,440.0,1.1000000000000001e-130,468.4,"sp|O35552|F263_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 OS=Rattus norvegicus OX=10116 GN=Pfkfb3 PE=2 SV=1",GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006096; GO:0006110; GO:0006915; GO:0010001; GO:0061744,"apoptotic process [GO:0006915]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; motor behavior [GO:0061744]; regulation of glycolytic process [GO:0006110]",cytosol [GO:0005829]; nucleoplasm [GO:0005654],"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; programmed cell death; transferase activity; hydrolase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08618,1.6944619707768336,FUN_037769-T1,Peve_00014327,Pocillopora_meandrina_HIv1___RNAseq.g1481.t1,three_way,74.75533333333334,FUN_037769-T1,O95147,,,,,47.9,167.0,1.2999999999999998e-43,177.6,sp|O95147|DUS14_HUMAN Dual specificity protein phosphatase 14 OS=Homo sapiens OX=9606 GN=DUSP14 PE=1 SV=1,,,,,,
OG_08619,1.740695997021087,FUN_037772-T1,Peve_00014348,Pocillopora_meandrina_HIv1___RNAseq.g1505.t1,three_way,75.424,FUN_037772-T1,Q32P28,P3H1_HUMAN,,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),Homo sapiens (Human),33.7,692.0,1e-99,365.9,sp|Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2,GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0030199; GO:0030278; GO:0030308; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:0070062; GO:1901874,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of ossification [GO:0030278]; regulation of protein secretion [GO:0050708],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797],GO:0003824; GO:0005634; GO:0005783; GO:0006457; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; protein folding; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08627,2.986049333987641,FUN_037795-T1,Peve_00026136,Pocillopora_meandrina_HIv1___RNAseq.g1555.t3,three_way,71.708,FUN_037795-T1,P51960,,,,,33.6,758.0,4.3e-85,317.4,sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2,,,,,,
OG_08628,1.8247768036048344,FUN_037796-T1,Peve_00026135,Pocillopora_meandrina_HIv1___RNAseq.g1556.t1,three_way,91.083,FUN_037796-T1,Q9CWF6,BBS2_MOUSE,,BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog),Mus musculus (Mouse),66.9,718.0,8.9e-285,980.7,sp|Q9CWF6|BBS2_MOUSE BBSome complex member BBS2 OS=Mus musculus OX=10090 GN=Bbs2 PE=1 SV=1,GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515,adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0003012; GO:0003013; GO:0005815; GO:0005929; GO:0007010; GO:0016192; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,muscle system process; circulatory system process; microtubule organizing center; cilium; cytoskeleton organization; vesicle-mediated transport; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_08630,1.113457120445157,FUN_037799-T1,Peve_00026124,Pocillopora_meandrina_HIv1___RNAseq.27229_t,three_way,73.94533333333334,,,,,,,,,,,,,,,,,
OG_08633,4.218874351481919,FUN_037802-T1,Peve_00026129,Pocillopora_meandrina_HIv1___RNAseq.g1562.t1,three_way,59.398,,,,,,,,,,,,,,,,,
OG_08635,2.54604038894453,FUN_037806-T1,Peve_00003980,Pocillopora_meandrina_HIv1___RNAseq.g1566.t1,three_way,45.65533333333333,,,,,,,,,,,,,,,,,
OG_08639,1.3285001137847865,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08644,2.243359564404362,FUN_037835-T1,Peve_00000571,Pocillopora_meandrina_HIv1___RNAseq.g1459.t1,three_way,87.0945,FUN_037835-T1,A0JNC1,CDS2_BOVIN,,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),Bos taurus (Bovine),57.1,410.0,3.5e-138,493.0,sp|A0JNC1|CDS2_BOVIN Phosphatidate cytidylyltransferase 2 OS=Bos taurus OX=9913 GN=CDS2 PE=2 SV=1,GO:0004605; GO:0005783; GO:0005789; GO:0016020; GO:0016024; GO:0140042,CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_08645,2.960781263599089,FUN_037836-T1,Peve_00000570,Pocillopora_meandrina_HIv1___RNAseq.g1460.t1,three_way,80.37733333333334,FUN_037836-T1,P12004,PCNA_HUMAN,,Proliferating cell nuclear antigen (PCNA) (Cyclin),Homo sapiens (Human),65.3,259.0,5e-100,365.5,sp|P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1,GO:0000122; GO:0000307; GO:0000701; GO:0000781; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0006325; GO:0007507; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990,"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0048856; GO:0098772; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; reproductive process; cell differentiation; telomere organization; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA"
OG_08651,1.909529809422548,FUN_037847-T1,Peve_00023799,Pocillopora_meandrina_HIv1___RNAseq.g1440.t1,three_way,86.37266666666667,FUN_037847-T1,P59015,VPS18_DANRE,,Vacuolar protein sorting-associated protein 18 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,987.0,1.5e-247,857.4,sp|P59015|VPS18_DANRE Vacuolar protein sorting-associated protein 18 homolog OS=Danio rerio OX=7955 GN=vps18 PE=2 SV=2,GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007040; GO:0007634; GO:0008270; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0043485; GO:0045176; GO:0048069; GO:0048284; GO:0048757; GO:0060036,apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; organelle fusion [GO:0048284]; pigment granule maturation [GO:0048757]; vesicle docking involved in exocytosis [GO:0006904],endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270],GO:0005768; GO:0006886; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0060090,endosome; intracellular protein transport; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_08654,1.1248870281718764,FUN_037852-T1,Peve_00024537,Pocillopora_meandrina_HIv1___RNAseq.g1422.t1,three_way,60.72333333333333,,,,,,,,,,,,,,,,,
OG_08658,2.232642774841848,FUN_037870-T1,Peve_00024531,Pocillopora_meandrina_HIv1___RNAseq.g1409.t1,three_way,93.36216666666668,FUN_037870-T1,P08642,,,,,80.5,174.0,5.3e-75,282.0,sp|P08642|RASH_CHICK GTPase HRas OS=Gallus gallus OX=9031 GN=HRAS PE=1 SV=1,,,,,,
OG_08667,1.920602849707576,FUN_037903-T1,Peve_00028717,Pocillopora_meandrina_HIv1___RNAseq.g28653.t1,three_way,61.3495,FUN_037903-T1,Q5XK85,,,,,25.0,1134.0,1.4e-34,150.2,sp|Q5XK85|KATIP_XENLA Protein KATNIP homolog OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08670,1.5223041721061477,FUN_037906-T1,Peve_00004640,Pocillopora_meandrina_HIv1___TS.g3117.t1,three_way,86.05966666666667,FUN_037906-T1,Q8BGX0,TRI23_MOUSE,,E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23),Mus musculus (Mouse),62.5,544.0,6.7e-203,708.4,sp|Q8BGX0|TRI23_MOUSE E3 ubiquitin-protein ligase TRIM23 OS=Mus musculus OX=10090 GN=Trim23 PE=2 SV=1,GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0008270; GO:0010508; GO:0016567; GO:0019003; GO:0042802; GO:0061630,positive regulation of autophagy [GO:0010508]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0003924; GO:0005634; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; GTPase activity; nucleus; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08671,2.157856763486483,FUN_037907-T1,Peve_00004641,Pocillopora_meandrina_HIv1___RNAseq.g17360.t1,three_way,85.071,FUN_037907-T1,Q0VFT9,,,,,56.3,423.0,5.6e-120,432.6,sp|Q0VFT9|TPC13_XENTR Trafficking protein particle complex subunit 13 OS=Xenopus tropicalis OX=8364 GN=trappc13 PE=2 SV=1,,,,,,
OG_08674,3.157323864512279,FUN_037910-T1,Peve_00004651,Pocillopora_meandrina_HIv1___TS.g5680.t1,three_way,79.7845,FUN_037910-T1,Q8IV35,,,,,30.2,865.0,1.6e-100,369.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_08680,1.924119452297001,FUN_037920-T1,Peve_00010402,Pocillopora_meandrina_HIv1___RNAseq.g26500.t1,three_way,76.47983333333333,FUN_037920-T1,Q8BIF2,RFOX3_MOUSE,,RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Hexaribonucleotide-binding protein 3) (Fox-3) (Neuronal nuclei antigen) (NeuN antigen),Mus musculus (Mouse),58.4,149.0,1.5e-33,144.8,sp|Q8BIF2|RFOX3_MOUSE RNA binding protein fox-1 homolog 3 OS=Mus musculus OX=10090 GN=Rbfox3 PE=1 SV=2,GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0043025; GO:0043204,"mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; anatomical structure development
OG_08687,2.6666090354784577,FUN_037929-T1,Peve_00005835,Pocillopora_meandrina_HIv1___RNAseq.g26222.t1,three_way,56.6,,,,,,,,,,,,,,,,,
OG_08688,2.3491182867244573,FUN_037931-T1,Peve_00015637,Pocillopora_meandrina_HIv1___RNAseq.g26217.t1,three_way,82.56883333333333,FUN_037931-T1,A7M7B9,NTH_CHICK,,Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),Gallus gallus (Chicken),64.4,225.0,3.1999999999999997e-85,316.6,sp|A7M7B9|NTH_CHICK Endonuclease III-like protein 1 OS=Gallus gallus OX=9031 GN=NTHL1 PE=2 SV=1,GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078,"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289]",mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]",GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_08689,2.594916528813407,FUN_037932-T1,Peve_00015636,Pocillopora_meandrina_HIv1___RNAseq.g26216.t1,three_way,64.56266666666667,FUN_037932-T1,F4KFT7,TENAC_ARATH,,"Bifunctional TH2 protein, mitochondrial (THIAMINE REQUIRING 2) [Includes: Thiamine phosphate phosphatase (EC 3.1.3.100); Aminopyrimidine aminohydrolase (EC 3.5.99.2)]",Arabidopsis thaliana (Mouse-ear cress),27.5,298.0,3.8999999999999995e-28,127.1,"sp|F4KFT7|TENAC_ARATH Bifunctional TH2 protein, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=TH2 PE=1 SV=1",GO:0005739; GO:0005829; GO:0009228; GO:0042131; GO:0050334,thiamine biosynthetic process [GO:0009228],cytosol [GO:0005829]; mitochondrion [GO:0005739],thiaminase activity [GO:0050334]; thiamine phosphate phosphatase activity [GO:0042131],GO:0003824; GO:0005739; GO:0005829; GO:0006766; GO:0006790; GO:0016787; GO:0043226,catalytic activity; mitochondrion; cytosol; vitamin metabolic process; sulfur compound metabolic process; hydrolase activity; organelle
OG_08691,1.7938164600822757,FUN_037935-T1,Peve_00015640,Pocillopora_meandrina_HIv1___RNAseq.g26204.t1,three_way,78.68583333333333,,,,,,,,,,,,,,,,,
OG_08694,1.638508905176159,FUN_037938-T1,Peve_00027269,Pocillopora_meandrina_HIv1___RNAseq.g26201.t1,three_way,89.87166666666667,FUN_037938-T1,Q76MZ1,,,,,68.1,282.0,7.8e-115,414.8,sp|Q76MZ1|CYH1_CHLAE Cytohesin-1 OS=Chlorocebus aethiops OX=9534 GN=CYTH1 PE=2 SV=1,,,,,,
OG_08697,1.8432097924045496,FUN_037943-T2,Peve_00027812,Pocillopora_meandrina_HIv1___RNAseq.g26522.t1,three_way,43.655,,,,,,,,,,,,,,,,,
OG_08698,1.4669324394471457,FUN_037944-T1,Peve_00040741,Pocillopora_meandrina_HIv1___RNAseq.g26521.t1,three_way,95.45466666666668,FUN_037944-T1,Q32KN5,,,,,79.8,94.0,7.6e-42,171.0,sp|Q32KN5|DNAL4_BOVIN Dynein axonemal light chain 4 OS=Bos taurus OX=9913 GN=DNAL4 PE=3 SV=1,,,,,,
OG_08699,1.431414668489203,FUN_037945-T1,Peve_00031504,Pocillopora_meandrina_HIv1___TS.g19268.t1,three_way,71.524,FUN_037945-T1,Q8C9A2,ENDOV_MOUSE,,Endonuclease V (EC 3.1.26.-),Mus musculus (Mouse),58.4,243.0,5e-79,295.8,sp|Q8C9A2|ENDOV_MOUSE Endonuclease V OS=Mus musculus OX=10090 GN=Endov PE=1 SV=2,GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891,DNA repair [GO:0006281],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; RNA endonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; single-stranded RNA binding [GO:0003727]",GO:0003677; GO:0003723; GO:0003824; GO:0005730; GO:0006281; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleolus; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_08701,1.47859988822794,FUN_037950-T1,Peve_00040736,Pocillopora_meandrina_HIv1___RNAseq.g26516.t1,three_way,47.437000000000005,,,,,,,,,,,,,,,,,
OG_08703,1.847379480501083,FUN_037952-T1,Peve_00040734,Pocillopora_meandrina_HIv1___RNAseq.g26514.t2,three_way,73.35300000000001,FUN_037952-T1,Q6PIF6,MYO7B_HUMAN,,Unconventional myosin-VIIb,Homo sapiens (Human),26.7,797.0,3.1000000000000003e-66,255.4,sp|Q6PIF6|MYO7B_HUMAN Unconventional myosin-VIIb OS=Homo sapiens OX=9606 GN=MYO7B PE=1 SV=2,GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0030154; GO:0051015; GO:0090651; GO:1904970,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146],GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0016853; GO:0030154; GO:0043226; GO:0050877; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; isomerase activity; cell differentiation; organelle; nervous system process; ATP-dependent activity
OG_08704,2.684220354226817,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_08705,2.235922632570086,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_08706,1.3471701546865504,FUN_037956-T1,Peve_00040731,Pocillopora_meandrina_HIv1___RNAseq.g26511.t1,three_way,46.48166666666667,,,,,,,,,,,,,,,,,
OG_08714,1.1833973343179,FUN_037966-T1,Peve_00009699,Pocillopora_meandrina_HIv1___RNAseq.g26235.t1,three_way,47.697,,,,,,,,,,,,,,,,,
OG_08715,2.140248144409391,FUN_037967-T1,Peve_00012656,Pocillopora_meandrina_HIv1___RNAseq.g26236.t1,three_way,59.54,FUN_037967-T1,Q09630,,,,,24.1,906.0,2.2e-38,162.5,sp|Q09630|GRM1_CAEEL Probable metabotropic glutamate receptor mgl-1 OS=Caenorhabditis elegans OX=6239 GN=mgl-1 PE=3 SV=1,,,,,,
OG_08718,3.286621291117657,FUN_037970-T1,Peve_00032390,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1a,three_way,78.12766666666666,FUN_037970-T1,D4D448,,,,,26.9,458.0,2.1999999999999996e-24,115.2,sp|D4D448|EASE_TRIVH FAD-linked oxidoreductase easE OS=Trichophyton verrucosum (strain HKI 0517) OX=663202 GN=easE PE=3 SV=1,,,,,,
OG_08724,1.5284379145359166,FUN_037977-T1,Peve_00019559,Pocillopora_meandrina_HIv1___RNAseq.g26186.t1,three_way,79.00166666666667,FUN_037977-T1,A0JP70,,,,,42.9,1940.0,0.0,1565.1,sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1,,,,,,
OG_08726,1.924253850772064,FUN_037979-T1,Peve_00018336,Pocillopora_meandrina_HIv1___RNAseq.g26195.t1,three_way,82.28633333333333,FUN_037979-T1,P51570,GALK1_HUMAN,,Galactokinase (EC 2.7.1.6) (Galactose kinase),Homo sapiens (Human),60.5,385.0,5.799999999999999e-129,462.2,sp|P51570|GALK1_HUMAN Galactokinase OS=Homo sapiens OX=9606 GN=GALK1 PE=1 SV=1,GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019402; GO:0033499; GO:0061623; GO:0070062,"galactitol metabolic process [GO:0019402]; galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020],ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08728,1.7498302339150316,FUN_037983-T1,Peve_00026785,Pocillopora_meandrina_HIv1___RNAseq.g26190.t1,three_way,60.70233333333333,FUN_037983-T1,Q8BTK5,SMYD4_MOUSE,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Mus musculus (Mouse),28.3,600.0,9.799999999999999e-55,216.5,sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_08730,1.452142583393129,FUN_037986-T1,Peve_00025061,Pocillopora_meandrina_HIv1___RNAseq.g26274.t1,three_way,63.13133333333333,FUN_037986-T1,Q8BX80,,,,,37.7,703.0,9.5e-121,436.0,sp|Q8BX80|ENASE_MOUSE Cytosolic endo-beta-N-acetylglucosaminidase OS=Mus musculus OX=10090 GN=Engase PE=1 SV=1,,,,,,
OG_08735,1.3010048544661426,FUN_037992-T1,Peve_00023490,Pocillopora_meandrina_HIv1___RNAseq.g26267.t1,three_way,59.86366666666667,,,,,,,,,,,,,,,,,
OG_08737,1.952091512163474,FUN_037996-T1,Peve_00021252,Pocillopora_meandrina_HIv1___RNAseq.g26261.t1,three_way,74.359,FUN_037996-T1,B4F7A1,,,,,45.2,84.0,7.5e-15,81.3,sp|B4F7A1|LYRM7_RAT Complex III assembly factor LYRM7 OS=Rattus norvegicus OX=10116 GN=Lyrm7 PE=3 SV=1,,,,,,
OG_08739,1.2038429586596944,FUN_037998-T1,Peve_00021258,Pocillopora_meandrina_HIv1___RNAseq.g26259.t1,three_way,71.65033333333334,FUN_037998-T1,Q5HZT0,DXO_XENLA,,Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-),Xenopus laevis (African clawed frog),39.8,369.0,5.7e-79,296.2,sp|Q5HZT0|DXO_XENLA Decapping and exoribonuclease protein OS=Xenopus laevis OX=8355 GN=dxo PE=2 SV=1,GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005829; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090304; GO:0110152; GO:0110155,mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid metabolic process [GO:0090304]; RNA destabilization [GO:0050779],cytosol [GO:0005829]; nucleus [GO:0005634],5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA 5'-diphosphatase activity [GO:0034353]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08743,1.7601509946973266,FUN_038003-T1,Peve_00021250,Pocillopora_meandrina_HIv1___RNAseq.g26254.t1,three_way,76.49766666666667,FUN_038003-T1,Q6DJF8,,,,,51.0,210.0,5.999999999999999e-62,238.8,sp|Q6DJF8|MET23_XENLA Histone-arginine methyltransferase METTL23 OS=Xenopus laevis OX=8355 GN=mettl23 PE=2 SV=1,,,,,,
OG_08748,1.0242636668604188,FUN_038013-T1,Peve_00013505,Pocillopora_meandrina_HIv1___RNAseq.g26527.t1,three_way,72.60583333333334,,,,,,,,,,,,,,,,,
OG_08749,1.0003030141979186,FUN_038016-T1,Peve_00013503,Pocillopora_meandrina_HIv1___RNAseq.g26529.t1,three_way,82.377,FUN_038016-T1,Q91XV4,,,,,61.6,242.0,8.500000000000001e-78,291.6,sp|Q91XV4|DCXR_MESAU L-xylulose reductase OS=Mesocricetus auratus OX=10036 GN=DCXR PE=1 SV=1,,,,,,
OG_08750,1.222128410262756,FUN_038017-T1,Peve_00009818,Pocillopora_meandrina_HIv1___RNAseq.g26530.t2,three_way,84.67783333333334,FUN_038017-T1,A6NCI4,VWA3A_HUMAN,,von Willebrand factor A domain-containing protein 3A,Homo sapiens (Human),37.6,1172.0,1.8000000000000002e-227,791.2,sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3,GO:0005576,,extracellular region [GO:0005576],,GO:0005576,extracellular region
OG_08757,1.4080644044397586,FUN_038028-T1,Peve_00002131,Pocillopora_meandrina_HIv1___TS.g19287.t1a,three_way,79.5965,FUN_038028-T1,Q80U30,CL16A_MOUSE,,Protein CLEC16A,Mus musculus (Mouse),42.5,1092.0,9.9e-206,718.8,sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2,GO:0006914; GO:0031648; GO:0032434; GO:0032435; GO:0036020; GO:0043161; GO:1901098; GO:1901525,autophagy [GO:0006914]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],endolysosome membrane [GO:0036020],,GO:0006914; GO:0030163,autophagy; protein catabolic process
OG_08765,1.9917250045469512,FUN_038040-T1,Peve_00024877,Pocillopora_meandrina_HIv1___RNAseq.g26549.t1,three_way,88.22833333333332,FUN_038040-T1,Q5DU02,UBP22_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),Mus musculus (Mouse),61.3,530.0,6.3e-179,628.6,sp|Q5DU02|UBP22_MOUSE Ubiquitin carboxyl-terminal hydrolase 22 OS=Mus musculus OX=10090 GN=Usp22 PE=1 SV=2,GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005737; GO:0006282; GO:0006357; GO:0006511; GO:0008270; GO:0010485; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950,G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; histone H4 acetyltransferase activity [GO:0010485]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0006355; GO:0016740; GO:0016787; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; regulation of DNA-templated transcription; transferase activity; hydrolase activity; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_08771,1.9719222631338795,FUN_038055-T1,Peve_00018151,Pocillopora_meandrina_HIv1___TS.g5314.t1,three_way,87.48233333333333,FUN_038055-T1,Q3UJZ3,,,,,44.1,170.0,8.999999999999999e-32,138.3,sp|Q3UJZ3|ARMC7_MOUSE Armadillo repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Armc7 PE=1 SV=2,,,,,,
OG_08772,1.8570226030543824,FUN_038056-T1,Peve_00018152,Pocillopora_meandrina_HIv1___TS.g5315.t2,three_way,86.20166666666667,FUN_038056-T1,Q9D2C6,,,,,63.4,202.0,3.3e-75,282.7,sp|Q9D2C6|RPC8_MOUSE DNA-directed RNA polymerase III subunit RPC8 OS=Mus musculus OX=10090 GN=Polr3h PE=1 SV=2,,,,,,
OG_08775,1.773699020964776,FUN_038060-T1,Peve_00000948,Pocillopora_meandrina_HIv1___RNAseq.g795.t1,three_way,78.47183333333334,FUN_038060-T1,Q70CQ4,UBP31_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),Homo sapiens (Human),42.1,537.0,7.000000000000003e-110,399.4,sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2,GO:0004843; GO:0005634; GO:0006508; GO:0016579,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08776,1.3799324659101888,FUN_038062-T1,Peve_00000949,Pocillopora_meandrina_HIv1___TS.g5325.t1b,three_way,70.5955,,,,,,,,,,,,,,,,,
OG_08777,1.5286822152798485,FUN_038063-T1,Peve_00032860,Pocillopora_meandrina_HIv1___TS.g5325.t1a,three_way,74.28,FUN_038063-T1,Q80YF0,,,,,28.1,734.0,6.599999999999999e-49,197.2,sp|Q80YF0|MD1L1_CRIGR Mitotic spindle assembly checkpoint protein MAD1 OS=Cricetulus griseus OX=10029 GN=MAD1L1 PE=2 SV=1,,,,,,
OG_08778,1.2733913159811432,FUN_038064-T1,Peve_00031820,Pocillopora_meandrina_HIv1___RNAseq.g792.t1,three_way,45.79133333333333,,,,,,,,,,,,,,,,,
OG_08779,2.6516157050341858,FUN_038065-T1,Peve_00010941,Pocillopora_meandrina_HIv1___RNAseq.g789.t1,three_way,67.371,FUN_038065-T1,O66515,,,,,27.3,388.0,2.3e-27,125.9,sp|O66515|AMT_AQUAE Ammonium transporter OS=Aquifex aeolicus (strain VF5) OX=224324 GN=amt PE=1 SV=1,,,,,,
OG_08780,1.8261264833223256,FUN_038066-T1,Peve_00010943,Pocillopora_meandrina_HIv1___RNAseq.g788.t1,three_way,58.48233333333334,FUN_038066-T1,O43184,,,,,37.5,637.0,5.4e-120,433.3,sp|O43184|ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ADAM12 PE=1 SV=3,,,,,,
OG_08781,2.088076819605233,FUN_038067-T1,Peve_00010945,Pocillopora_meandrina_HIv1___RNAseq.g787.t1,three_way,64.63766666666666,,,,,,,,,,,,,,,,,
OG_08788,1.5063435667342775,FUN_038080-T1,Peve_00030065,Pocillopora_meandrina_HIv1___RNAseq.g805.t1,three_way,70.712,FUN_038080-T1,A7SLC8,,,,,63.6,176.0,5.8e-59,228.8,sp|A7SLC8|NAT9_NEMVE N-acetyltransferase 9-like protein OS=Nematostella vectensis OX=45351 GN=nat9 PE=3 SV=1,,,,,,
OG_08789,1.0214210182939163,FUN_038081-T1,Peve_00004950,Pocillopora_meandrina_HIv1___RNAseq.g806.t1,three_way,60.84433333333333,FUN_038081-T1,O75689,ADAP1_HUMAN,,Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25),Homo sapiens (Human),42.3,364.0,2.9000000000000004e-80,300.4,sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2,GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043231; GO:0043533; GO:1902936,cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0043226; GO:0098772,nucleus; cytosol; plasma membrane; lipid binding; organelle; molecular function regulator activity
OG_08791,1.5490809949734732,FUN_038087-T1,Peve_00036442,Pocillopora_meandrina_HIv1___TS.g5341.t2,three_way,72.54633333333332,,,,,,,,,,,,,,,,,
OG_08792,1.6915057587529931,FUN_038088-T1,Peve_00007106,Pocillopora_meandrina_HIv1___RNAseq.g815.t1,three_way,76.33416666666666,FUN_038088-T1,P54922,ADPRH_HUMAN,,ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1),Homo sapiens (Human),57.1,350.0,2.3e-116,420.2,sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1,GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725,protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211],extracellular space [GO:0005615],ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08795,1.8407048669967088,FUN_038091-T1,Peve_00007109,Pocillopora_meandrina_HIv1___RNAseq.g818.t1,three_way,94.97433333333332,FUN_038091-T1,A6QLG5,RS9_BOVIN,,Small ribosomal subunit protein uS4 (40S ribosomal protein S9),Bos taurus (Bovine),90.0,170.0,6.9e-83,308.1,sp|A6QLG5|RS9_BOVIN Small ribosomal subunit protein uS4 OS=Bos taurus OX=9913 GN=RPS9 PE=2 SV=1,GO:0003735; GO:0005730; GO:0006412; GO:0019843; GO:0022627; GO:0032040; GO:0042274; GO:1990904,ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_08798,1.4476910657529782,FUN_038100-T1,Peve_00025352,Pocillopora_meandrina_HIv1___TS.g5371.t2,three_way,85.98966666666666,FUN_038100-T1,P05696,KPCA_RAT,,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),Rattus norvegicus (Rat),67.3,652.0,6.6e-269,927.9,sp|P05696|KPCA_RAT Protein kinase C alpha type OS=Rattus norvegicus OX=10116 GN=Prkca PE=1 SV=3,GO:0000302; GO:0001525; GO:0001938; GO:0002026; GO:0002062; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006874; GO:0006937; GO:0007155; GO:0007611; GO:0008270; GO:0008283; GO:0008285; GO:0008289; GO:0009612; GO:0009636; GO:0010595; GO:0010613; GO:0014704; GO:0016020; GO:0017148; GO:0018107; GO:0019899; GO:0021955; GO:0030335; GO:0030424; GO:0030425; GO:0030593; GO:0031666; GO:0031966; GO:0032355; GO:0032991; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0036064; GO:0043025; GO:0043409; GO:0043434; GO:0043536; GO:0044305; GO:0045177; GO:0045184; GO:0045471; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045921; GO:0045931; GO:0046325; GO:0046627; GO:0046716; GO:0048471; GO:0048661; GO:0048863; GO:0050729; GO:0050930; GO:0051412; GO:0051965; GO:0070374; GO:0070528; GO:0070555; GO:0071322; GO:0090330; GO:0097193; GO:0099171; GO:0099523; GO:0106310; GO:0110063; GO:0120199; GO:1904627; GO:1990917; GO:2000300; GO:2000707,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to carbohydrate stimulus [GO:0071322]; central nervous system neuron axonogenesis [GO:0021955]; chondrocyte differentiation [GO:0002062]; desmosome assembly [GO:0002159]; establishment of protein localization [GO:0045184]; induction of positive chemotaxis [GO:0050930]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; learning or memory [GO:0007611]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of D-glucose import [GO:0046325]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of translation [GO:0017148]; neutrophil chemotaxis [GO:0030593]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of angiotensin-activated signaling pathway [GO:0110063]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; regulation of muscle contraction [GO:0006937]; regulation of platelet aggregation [GO:0090330]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of the force of heart contraction [GO:0002026]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; stem cell differentiation [GO:0048863],alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical part of cell [GO:0045177]; axon [GO:0030424]; calyx of Held [GO:0044305]; ciliary basal body [GO:0036064]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; intercalated disc [GO:0014704]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991],"ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; enzyme binding [GO:0019899]; histone H3T6 kinase activity [GO:0035403]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0005886; GO:0007155; GO:0008289; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048870; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; plasma membrane; cell adhesion; lipid binding; transferase activity; cell differentiation; cell junction organization; organelle; cell motility; nervous system process; catalytic activity, acting on a protein"
OG_08802,2.230292003085912,FUN_038118-T1,Peve_00025357,Pocillopora_meandrina_HIv1___RNAseq.g836.t1,three_way,55.861,,,,,,,,,,,,,,,,,
OG_08803,1.2839429496775447,FUN_038122-T1,Peve_00003003,Pocillopora_meandrina_HIv1___RNAseq.g28329.t1,three_way,90.11766666666666,FUN_038122-T1,Q9H1Z4,,,,,48.8,363.0,1.7e-85,317.8,sp|Q9H1Z4|WDR13_HUMAN WD repeat-containing protein 13 OS=Homo sapiens OX=9606 GN=WDR13 PE=1 SV=3,,,,,,
OG_08806,2.605474770447094,FUN_038127-T1,Peve_00003031,Pocillopora_meandrina_HIv1___RNAseq.g770.t1,three_way,67.37616666666666,FUN_038127-T1,Q9FKY3,,,,,25.2,373.0,1.3999999999999999e-24,115.9,sp|Q9FKY3|AVT3A_ARATH Amino acid transporter AVT3A OS=Arabidopsis thaliana OX=3702 GN=AVT3A PE=1 SV=1,,,,,,
OG_08813,2.338185388806272,FUN_038139-T1,Peve_00043370,Pocillopora_meandrina_HIv1___RNAseq.g761.t1,three_way,73.74383333333333,FUN_038139-T1,Q12767,,,,,33.1,1424.0,3.2e-177,624.4,sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1,,,,,,
OG_08818,1.3340274037608912,FUN_038146-T1,Peve_00026422,Pocillopora_meandrina_HIv1___RNAseq.g752.t1,three_way,48.41766666666667,,,,,,,,,,,,,,,,,
OG_08820,1.1043545056791255,FUN_038148-T1,Peve_00044178,Pocillopora_meandrina_HIv1___RNAseq.g1064.t1,three_way,76.99816666666666,FUN_038148-T1,O70157,,,,,53.0,1054.0,0.0,1084.3,sp|O70157|TOP3A_MOUSE DNA topoisomerase 3-alpha OS=Mus musculus OX=10090 GN=Top3a PE=2 SV=1,,,,,,
OG_08824,1.88831786930132,FUN_038161-T1,Peve_00033052,Pocillopora_meandrina_HIv1___RNAseq.g1154.t1,three_way,72.33833333333334,FUN_038161-T1,Q8BHY8,SNX14_MOUSE,,Sorting nexin-14,Mus musculus (Mouse),35.9,892.0,3e-144,514.2,sp|Q8BHY8|SNX14_MOUSE Sorting nexin-14 OS=Mus musculus OX=10090 GN=Snx14 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0030425; GO:0031902; GO:0045202; GO:0080025; GO:0097352; GO:0098794; GO:0099170,autophagosome maturation [GO:0097352]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein transport [GO:0015031],cytosol [GO:0005829]; dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; postsynapse [GO:0098794]; synapse [GO:0045202],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]",GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0008289; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_08825,1.4443128795921878,FUN_038162-T1,Peve_00038319,Pocillopora_meandrina_HIv1___RNAseq.g1076.t1,three_way,58.09933333333333,,,,,,,,,,,,,,,,,
OG_08828,1.9223692186734835,FUN_038165-T1,Peve_00025795,Pocillopora_meandrina_HIv1___RNAseq.g1068.t1,three_way,82.789,FUN_038165-T1,P04047,,,,,61.3,173.0,8.000000000000002e-57,221.5,"sp|P04047|KITH_CHICK Thymidine kinase, cytosolic OS=Gallus gallus OX=9031 GN=TK1 PE=1 SV=1",,,,,,
OG_08831,2.4038246962506853,FUN_038168-T1,Peve_00025789,Pocillopora_meandrina_HIv1___RNAseq.g1071.t1,three_way,77.63566666666667,,,,,,,,,,,,,,,,,
OG_08836,1.6729446948385651,FUN_038180-T1,Peve_00009434,Pocillopora_meandrina_HIv1___RNAseq.g964.t1,three_way,80.498,FUN_038180-T1,E3SCZ8,BIRC5_CAVPO,,Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor survivin),Cavia porcellus (Guinea pig),50.4,125.0,7.1e-31,134.8,sp|E3SCZ8|BIRC5_CAVPO Baculoviral IAP repeat-containing protein 5 OS=Cavia porcellus OX=10141 GN=BIRC5 PE=1 SV=1,GO:0000226; GO:0000775; GO:0000776; GO:0004869; GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0007059; GO:0007127; GO:0007346; GO:0007605; GO:0030496; GO:0043066; GO:0043524; GO:0046872; GO:0051233; GO:0051301; GO:0061178; GO:0061469,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiosis I [GO:0007127]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of mitotic cell cycle [GO:0007346]; regulation of type B pancreatic cell proliferation [GO:0061469]; sensory perception of sound [GO:0007605],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]",cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872],GO:0005634; GO:0007010; GO:0007059; GO:0012501; GO:0022414; GO:0043226; GO:0050877; GO:0098772; GO:0140013,nucleus; cytoskeleton organization; chromosome segregation; programmed cell death; reproductive process; organelle; nervous system process; molecular function regulator activity; meiotic nuclear division
OG_08840,1.9023426284645824,FUN_038184-T1,Peve_00006348,Pocillopora_meandrina_HIv1___RNAseq.g948.t1,three_way,86.82066666666667,FUN_038184-T1,A0A0R4IVA4,CC14A_DANRE,,Dual specificity protein phosphatase CDC14AB (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog AB),Danio rerio (Zebrafish) (Brachydanio rerio),44.8,344.0,1.1e-73,278.5,sp|A0A0R4IVA4|CC14A_DANRE Dual specificity protein phosphatase CDC14AB OS=Danio rerio OX=7955 GN=cdc14ab PE=3 SV=1,GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005813; GO:0007096; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686,cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096],centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005730; GO:0005815; GO:0005929; GO:0007010; GO:0016787; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleolus; microtubule organizing center; cilium; cytoskeleton organization; hydrolase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_08850,1.4683829332686893,FUN_038213-T1,Peve_00038850,Pocillopora_meandrina_HIv1___RNAseq.g897.t1,three_way,68.68866666666666,FUN_038213-T1,Q7Z402,,,,,32.1,639.0,1e-79,299.7,sp|Q7Z402|TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens OX=9606 GN=TMC7 PE=1 SV=1,,,,,,
OG_08852,2.405271436303034,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_08853,1.839828340608194,FUN_038218-T1,Peve_00038844,Pocillopora_meandrina_HIv1___RNAseq.g902.t1,three_way,77.83533333333334,FUN_038218-T1,Q08BA6,ALKB5_DANRE,,RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),Danio rerio (Zebrafish) (Brachydanio rerio),59.5,222.0,1.7999999999999994e-68,260.8,sp|Q08BA6|ALKB5_DANRE RNA demethylase ALKBH5 OS=Danio rerio OX=7955 GN=alkbh5 PE=1 SV=1,GO:0001666; GO:0005634; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0035515; GO:0042382; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931,membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283],nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515],GO:0003824; GO:0005634; GO:0016071; GO:0016491; GO:0022414; GO:0043226; GO:0060090; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; oxidoreductase activity; reproductive process; organelle; molecular adaptor activity; catalytic activity, acting on RNA"
OG_08856,2.359555256822595,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08863,1.2965863282533097,FUN_038255-T1,Peve_00007991,Pocillopora_meandrina_HIv1___RNAseq.g920.t1,three_way,62.71116666666666,FUN_038255-T1,Q91ZW6,TMLH_RAT,,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",Rattus norvegicus (Rat),39.7,358.0,4.9e-73,276.6,"sp|Q91ZW6|TMLH_RAT Trimethyllysine dioxygenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Tmlhe PE=1 SV=2",GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353,carnitine biosynthetic process [GO:0045329],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]",GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_08865,2.1618437133915447,FUN_038257-T1,Peve_00007993,Pocillopora_meandrina_HIv1___RNAseq.g918.t1,three_way,71.358,FUN_038257-T1,Q7YR75,,,,,46.6,161.0,9.300000000000001e-27,121.7,sp|Q7YR75|RM12_BOVIN Large ribosomal subunit protein bL12m OS=Bos taurus OX=9913 GN=MRPL12 PE=1 SV=1,,,,,,
OG_08873,1.9363665660005105,FUN_038270-T1,Peve_00007980,Pocillopora_meandrina_HIv1___TS.g21499.t1,three_way,66.01583333333333,FUN_038270-T1,Q8NCG7,DGLB_HUMAN,,Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),Homo sapiens (Human),36.5,698.0,2.7e-105,384.4,sp|Q8NCG7|DGLB_HUMAN Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2,GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0006640; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696,arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727],lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lipase activity [GO:0016298]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005654; GO:0005886; GO:0006629; GO:0016787; GO:0030154,catalytic activity; nucleoplasm; plasma membrane; lipid metabolic process; hydrolase activity; cell differentiation
OG_08882,1.175304560718062,FUN_038284-T1,Peve_00041720,Pocillopora_meandrina_HIv1___RNAseq.g28310.t1,three_way,75.99766666666667,FUN_038284-T1,Q60631,GRB2_MOUSE,,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2),Mus musculus (Mouse),62.0,213.0,1.7000000000000002e-74,280.4,sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1,GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0035987; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379,actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0002376; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0098772,immune system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_08883,1.714247910912729,FUN_038285-T1,Peve_00041722,Pocillopora_meandrina_HIv1___RNAseq.g28309.t1a,three_way,84.59233333333333,FUN_038285-T1,A7SE05,UBE2S_NEMVE,,Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S),Nematostella vectensis (Starlet sea anemone),74.8,206.0,2.1e-82,306.6,sp|A7SE05|UBE2S_NEMVE Ubiquitin-conjugating enzyme E2 S OS=Nematostella vectensis OX=45351 GN=v1g237158 PE=3 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08884,1.7888884619024985,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_08886,1.7803547070478332,FUN_038292-T1,Peve_00041726,Pocillopora_meandrina_HIv1___RNAseq.g28306.t1,three_way,85.80533333333334,FUN_038292-T1,P94598,,,,,64.2,438.0,3.3e-168,592.8,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_08894,1.1307345713706365,FUN_038301-T1,Peve_00000032,Pocillopora_meandrina_HIv1___TS.g8084.t1,three_way,46.3595,FUN_038301-T1,Q1RLU1,BRAT1_DANRE,,Integrator complex assembly factor BRAT1 (BRCA1-associated ATM activator 1) (BRCA1-associated protein required for ATM activation protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),24.8,404.0,4.7e-23,111.7,sp|Q1RLU1|BRAT1_DANRE Integrator complex assembly factor BRAT1 OS=Danio rerio OX=7955 GN=brat1 PE=2 SV=1,GO:0001934; GO:0005634; GO:0005737; GO:0006974; GO:0008283; GO:0008428; GO:0010212; GO:0034504; GO:0160234,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; integrator complex assembly [GO:0160234]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to nucleus [GO:0034504]; response to ionizing radiation [GO:0010212],cytoplasm [GO:0005737]; nucleus [GO:0005634],ribonuclease inhibitor activity [GO:0008428],GO:0005634; GO:0043226; GO:0065003; GO:0098772,nucleus; organelle; protein-containing complex assembly; molecular function regulator activity
OG_08895,2.024279135814242,FUN_038302-T1,Peve_00000035,Pocillopora_meandrina_HIv1___RNAseq.g28304.t1,three_way,90.22033333333331,FUN_038302-T1,F8WK50,,,,,59.3,1273.0,2.6e-295,1016.5,sp|F8WK50|FLII_DANRE Protein flightless-1 homolog OS=Danio rerio OX=7955 GN=flii PE=1 SV=1,,,,,,
OG_08898,3.11932310992341,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.7999999999999996e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_08904,1.0196770475499355,FUN_038333-T1,Peve_00023105,Pocillopora_meandrina_HIv1___RNAseq.g1117.t1,three_way,47.60166666666667,FUN_038333-T1,Q1JPJ9,,,,,41.1,202.0,1.7999999999999998e-35,151.8,sp|Q1JPJ9|EF2KT_BOVIN Protein-lysine N-methyltransferase EEF2KMT OS=Bos taurus OX=9913 GN=EEF2KMT PE=2 SV=2,,,,,,
OG_08905,1.8120134793323928,FUN_038335-T1,Peve_00000103,Pocillopora_meandrina_HIv1___RNAseq.g1115.t1,three_way,73.825,FUN_038335-T1,Q8L8B8,,,,,46.1,180.0,3e-41,169.9,sp|Q8L8B8|LOG3_ARATH Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG3 OS=Arabidopsis thaliana OX=3702 GN=LOG3 PE=1 SV=1,,,,,,
OG_08925,2.657578627877509,FUN_038382-T1,Peve_00000067,Pocillopora_meandrina_HIv1___RNAseq.g28293.t1,three_way,74.66466666666666,FUN_038382-T1,O09118,NET1_MOUSE,,Netrin-1,Mus musculus (Mouse),49.0,571.0,1.2000000000000005e-167,591.3,sp|O09118|NET1_MOUSE Netrin-1 OS=Mus musculus OX=10090 GN=Ntn1 PE=1 SV=3,GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008283; GO:0014009; GO:0015629; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147,"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]",actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202],,GO:0005576; GO:0005654; GO:0005829; GO:0005856; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleoplasm; cytosol; cytoskeleton; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility
OG_08930,3.6713189561389785,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08931,1.2941033362439505,FUN_038393-T1,Peve_00000047,Pocillopora_meandrina_HIv1___RNAseq.g28265.t1,three_way,73.06066666666668,FUN_038393-T1,P22570,ADRO_HUMAN,,"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase) (EC 1.18.1.-)",Homo sapiens (Human),57.3,464.0,8.3e-144,511.9,"sp|P22570|ADRO_HUMAN NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=FDXR PE=1 SV=3",GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203,cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ferredoxin-NADP+ reductase activity [GO:0004324],GO:0003824; GO:0005739; GO:0006091; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; oxidoreductase activity; organelle
OG_08932,2.3050523220148205,FUN_038394-T1,Peve_00000046,Pocillopora_meandrina_HIv1___RNAseq.g28266.t1,three_way,82.16016666666667,FUN_038394-T1,Q9HCN4,,,,,64.7,317.0,5.600000000000002e-111,402.5,sp|Q9HCN4|GPN1_HUMAN GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1,,,,,,
OG_08935,1.315239311692421,FUN_038398-T1,Peve_00000041,Pocillopora_meandrina_HIv1___RNAseq.g28273.t1,three_way,71.20833333333333,FUN_038398-T1,Q4TZY1,KCJ12_BOVIN,,"ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12)",Bos taurus (Bovine),44.9,381.0,2.6e-85,317.4,sp|Q4TZY1|KCJ12_BOVIN ATP-sensitive inward rectifier potassium channel 12 OS=Bos taurus OX=9913 GN=KCNJ12 PE=2 SV=1,GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0034702; GO:0034765; GO:0046872; GO:0051289; GO:1990573,potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765],membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],inward rectifier potassium channel activity [GO:0005242]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_08936,1.2866006331097184,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_08940,1.5350031499130068,FUN_038405-T1,Peve_00000017,Pocillopora_meandrina_HIv1___RNAseq.g28279.t1,three_way,71.28666666666668,FUN_038405-T1,Q6PHN1,,,,,25.6,1091.0,7.9000000000000025e-59,230.7,sp|Q6PHN1|CCD57_MOUSE Coiled-coil domain-containing protein 57 OS=Mus musculus OX=10090 GN=Ccdc57 PE=1 SV=1,,,,,,
OG_08942,2.7539183708433304,FUN_038415-T1,Peve_00000011,Pocillopora_meandrina_HIv1___RNAseq.g1190.t1,three_way,60.18366666666667,FUN_038415-T1,Q9NZS9,,,,,33.4,416.0,1.4e-60,235.3,sp|Q9NZS9|BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens OX=9606 GN=BFAR PE=1 SV=1,,,,,,
OG_08944,1.162061181247652,FUN_038417-T1,Peve_00000007,Pocillopora_meandrina_HIv1___RNAseq.g25849.t1,three_way,58.776,FUN_038417-T1,Q28955,NTAN1_PIG,,Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase),Sus scrofa (Pig),38.5,304.0,1.3e-54,214.9,sp|Q28955|NTAN1_PIG Protein N-terminal asparagine amidohydrolase OS=Sus scrofa OX=9823 GN=NTAN1 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418,adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634],protein-N-terminal asparagine amidohydrolase activity [GO:0008418],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0050877; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; nervous system process; catalytic activity, acting on a protein"
OG_08946,2.210720523688922,FUN_038419-T1,Peve_00000005,Pocillopora_meandrina_HIv1___RNAseq.g1185.t2,three_way,81.85316666666667,FUN_038419-T1,Q5E9X2,MP2K6_BOVIN,,Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6),Bos taurus (Bovine),59.4,342.0,1e-108,394.8,sp|Q5E9X2|MP2K6_BOVIN Dual specificity mitogen-activated protein kinase kinase 6 OS=Bos taurus OX=9913 GN=MAP2K6 PE=2 SV=1,GO:0000165; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006915; GO:0106310,apoptotic process [GO:0006915]; MAPK cascade [GO:0000165],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08947,2.687877544871478,FUN_038420-T1,Peve_00000003,Pocillopora_meandrina_HIv1___RNAseq.g1183.t1,three_way,75.96466666666667,FUN_038420-T1,P49005,DPOD2_HUMAN,,DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50),Homo sapiens (Human),55.6,457.0,3.6e-136,486.5,sp|P49005|DPOD2_HUMAN DNA polymerase delta subunit 2 OS=Homo sapiens OX=9606 GN=POLD2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0043625; GO:0071897,DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276],delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; DNA repair; organelle
OG_08949,1.5507854020495375,FUN_038422-T1,Peve_00000123,Pocillopora_meandrina_HIv1___RNAseq.g1181.t1,three_way,79.913,FUN_038422-T1,Q5ZI23,GLO2_CHICK,,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)",Gallus gallus (Chicken),62.0,295.0,4.0000000000000003e-104,379.4,"sp|Q5ZI23|GLO2_CHICK Hydroxyacylglutathione hydrolase, mitochondrial OS=Gallus gallus OX=9031 GN=HAGH PE=2 SV=1",GO:0004416; GO:0005739; GO:0005759; GO:0006749; GO:0019243; GO:0019853; GO:0046872,glutathione metabolic process [GO:0006749]; L-ascorbic acid biosynthetic process [GO:0019853]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006766; GO:0006790; GO:0016787; GO:0043226; GO:0098754,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; vitamin metabolic process; sulfur compound metabolic process; hydrolase activity; organelle; detoxification
OG_08957,1.163452901195154,FUN_038432-T1,Peve_00029453,Pocillopora_meandrina_HIv1___RNAseq.g880.t1,three_way,75.93416666666667,FUN_038432-T1,Q3T0M9,,,,,45.9,181.0,2.5e-41,170.2,sp|Q3T0M9|ARL4A_BOVIN ADP-ribosylation factor-like protein 4A OS=Bos taurus OX=9913 GN=ARL4A PE=2 SV=1,,,,,,
OG_08958,1.4093727926541313,FUN_038436-T1,Peve_00029448,Pocillopora_meandrina_HIv1___TS.g5415.t2,three_way,79.24033333333334,FUN_038436-T1,Q2TBW2,COQ7_BOVIN,,"NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",Bos taurus (Bovine),67.6,173.0,7.099999999999999e-62,238.4,"sp|Q2TBW2|COQ7_BOVIN NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial OS=Bos taurus OX=9913 GN=COQ7 PE=2 SV=1",GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0031314; GO:0046872; GO:0110142; GO:0160224; GO:2000377,determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142],3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; 3-demethoxyubiquinone 3-hydroxylase (NADH) activity [GO:0160224]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226,catalytic activity; nucleus; oxidoreductase activity; organelle
OG_08968,1.2651252602571024,FUN_038473-T1,Peve_00039889,Pocillopora_meandrina_HIv1___RNAseq.g28228.t1,three_way,77.87266666666666,FUN_038473-T1,Q9QYU4,CRYM_RAT,,Ketimine reductase mu-crystallin (EC 1.5.1.25) (1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase) (P2C/Pyr2C reductase) (EC 1.5.1.1) (CDK108) (NADP-regulated thyroid-hormone-binding protein),Rattus norvegicus (Rat),50.2,299.0,6e-71,269.2,sp|Q9QYU4|CRYM_RAT Ketimine reductase mu-crystallin OS=Rattus norvegicus OX=10116 GN=Crym PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0006839; GO:0007605; GO:0009725; GO:0033280; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070324; GO:0070327,mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to hormone [GO:0009725]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005739; GO:0006355; GO:0006575; GO:0016491; GO:0043226; GO:0050877; GO:0060090; GO:0140110,catalytic activity; nucleus; mitochondrion; regulation of DNA-templated transcription; modified amino acid metabolic process; oxidoreductase activity; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_08971,1.8616871274351072,FUN_038476-T1,Peve_00013532,Pocillopora_meandrina_HIv1___RNAseq.g28225.t1,three_way,74.16799999999999,FUN_038476-T1,Q9SY00,,,,,44.4,117.0,7.4e-26,119.4,sp|Q9SY00|WDR5B_ARATH COMPASS-like H3K4 histone methylase component WDR5B OS=Arabidopsis thaliana OX=3702 GN=WDR5B PE=1 SV=1,,,,,,
OG_08978,1.6315214570714809,FUN_038489-T1,Peve_00013518,Pocillopora_meandrina_HIv1___RNAseq.g28213.t1,three_way,49.112,,,,,,,,,,,,,,,,,
OG_08979,1.0065186026502142,FUN_038496-T1,Peve_00013514,Pocillopora_meandrina_HIv1___RNAseq.g28199.t1,three_way,76.533,FUN_038496-T1,Q9Y6N1,COX11_HUMAN,,"Cytochrome c oxidase assembly protein COX11, mitochondrial",Homo sapiens (Human),67.8,180.0,1.7e-66,254.2,"sp|Q9Y6N1|COX11_HUMAN Cytochrome c oxidase assembly protein COX11, mitochondrial OS=Homo sapiens OX=9606 GN=COX11 PE=1 SV=3",GO:0005507; GO:0005739; GO:0005743; GO:0006754; GO:0009055; GO:0030003; GO:0032991,ATP biosynthetic process [GO:0006754]; intracellular monoatomic cation homeostasis [GO:0030003],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; electron transfer activity [GO:0009055],GO:0005739; GO:0043226; GO:0055086; GO:1901135,mitochondrion; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08982,2.937180336706569,FUN_038500-T1,Peve_00013485,Pocillopora_meandrina_HIv1___RNAseq.g28194.t1,three_way,84.38300000000001,FUN_038500-T1,Q8K4R4,,,,,65.7,251.0,8.2e-100,364.8,sp|Q8K4R4|PITC1_MOUSE Cytoplasmic phosphatidylinositol transfer protein 1 OS=Mus musculus OX=10090 GN=Pitpnc1 PE=1 SV=1,,,,,,
OG_08983,2.934728531651817,FUN_038502-T1,Peve_00013538,Pocillopora_meandrina_HIv1___RNAseq.g28192.t1,three_way,75.99333333333333,FUN_038502-T1,Q7RTV0,PHF5A_HUMAN,,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),Homo sapiens (Human),97.1,104.0,8.6e-59,229.9,sp|Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]",nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_08985,2.1954088902109183,FUN_038504-T1,Peve_00041693,Pocillopora_meandrina_HIv1___TS.g7946.t1,three_way,87.35516666666666,FUN_038504-T1,Q9Y5X2,SNX8_HUMAN,,Sorting nexin-8,Homo sapiens (Human),46.6,399.0,4.6e-97,356.7,sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1,GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231,early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0043226,cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle
OG_08986,1.5978736547678278,FUN_038505-T1,Peve_00041692,Pocillopora_meandrina_HIv1___RNAseq.g28161.t1,three_way,75.56566666666666,FUN_038505-T1,Q9WV68,DECR2_MOUSE,,"Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] (EC 1.3.1.124) (2,4-dienoyl-CoA reductase 2)",Mus musculus (Mouse),55.0,291.0,7.899999999999999e-83,308.5,"sp|Q9WV68|DECR2_MOUSE Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] OS=Mus musculus OX=10090 GN=Decr2 PE=1 SV=1",GO:0005777; GO:0006636; GO:0008670; GO:0009062; GO:0019166; GO:0044877; GO:0051020,fatty acid catabolic process [GO:0009062]; unsaturated fatty acid biosynthetic process [GO:0006636],peroxisome [GO:0005777],"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]",GO:0003824; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_08987,1.7581724256442564,FUN_038507-T2,Peve_00041684,Pocillopora_meandrina_HIv1___RNAseq.g28173.t1,three_way,75.75433333333334,FUN_038507-T2,Q4R7R1,,,,,61.6,357.0,4.3e-122,439.5,sp|Q4R7R1|D42E1_MACFA Short-chain dehydrogenase/reductase family 42E member 1 OS=Macaca fascicularis OX=9541 GN=SDR42E1 PE=2 SV=1,,,,,,
OG_08993,2.3766329623695928,FUN_038523-T1,Peve_00041676,Pocillopora_meandrina_HIv1___RNAseq.g28185.t1,three_way,88.359,FUN_038523-T1,P0C0A3,CHMP6_MOUSE,,Charged multivesicular body protein 6 (Chromatin-modifying protein 6),Mus musculus (Mouse),62.5,168.0,7.5e-51,201.8,sp|P0C0A3|CHMP6_MOUSE Charged multivesicular body protein 6 OS=Mus musculus OX=10090 GN=Chmp6 PE=1 SV=2,GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005828; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0015031; GO:0030496; GO:0031468; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0051469; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005886; GO:0006914; GO:0016192; GO:0043226; GO:0061024,plasma membrane; autophagy; vesicle-mediated transport; organelle; membrane organization
OG_08994,2.207970885935693,FUN_038524-T1,Peve_00041750,Pocillopora_meandrina_HIv1___RNAseq.g28186.t1,three_way,79.337,FUN_038524-T1,Q8BKX6,SMG1_MOUSE,,Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1),Mus musculus (Mouse),37.7,3713.0,0.0,2274.6,sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3,GO:0000184; GO:0004674; GO:0005524; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310,"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]",chromatoid body [GO:0033391]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleoplasm; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08997,2.7971632680627283,FUN_038533-T1,Peve_00013531,Pocillopora_meandrina_HIv1___RNAseq.g28191.t1,three_way,83.86566666666667,FUN_038533-T1,O00116,ADAS_HUMAN,,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",Homo sapiens (Human),58.7,623.0,3.6e-226,785.8,"sp|O00116|ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1",GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949,ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; transferase activity; organelle
OG_08999,1.8820888465424124,FUN_038540-T1,Peve_00009816,Pocillopora_meandrina_HIv1___RNAseq.g28156.t1,three_way,75.49133333333333,FUN_038540-T1,Q9CQY1,ATG12_MOUSE,,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),Mus musculus (Mouse),46.2,130.0,8.7e-29,127.9,sp|Q9CQY1|ATG12_MOUSE Ubiquitin-like protein ATG12 OS=Mus musculus OX=10090 GN=Atg12 PE=1 SV=1,GO:0000045; GO:0005654; GO:0005776; GO:0005829; GO:0006914; GO:0016020; GO:0016236; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0045824; GO:0050687; GO:1901096; GO:1904973; GO:1990234,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234],,GO:0005654; GO:0005773; GO:0005829; GO:0006914; GO:0043226,nucleoplasm; vacuole; cytosol; autophagy; organelle
OG_09002,1.1638686431224636,FUN_038547-T1,Peve_00037482,Pocillopora_meandrina_HIv1___RNAseq.g1037.t1,three_way,73.7495,FUN_038547-T1,Q5U4T9,MBOA7_XENLA,,Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Lysophospholipid acyltransferase 7) (LPLAT 7) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7),Xenopus laevis (African clawed frog),37.2,473.0,4.3e-86,320.1,sp|Q5U4T9|MBOA7_XENLA Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Xenopus laevis OX=8355 GN=mboat7 PE=2 SV=1,GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233],lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_09004,1.0024148374827613,FUN_038550-T1,Peve_00035828,Pocillopora_meandrina_HIv1___RNAseq.g1030.t1,three_way,62.074666666666666,FUN_038550-T1,F1MV99,,,,,30.8,302.0,2.9e-23,110.9,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_09014,1.8344556292059613,FUN_038576-T1,Peve_00012106,Pocillopora_meandrina_HIv1___RNAseq.g1012.t1,three_way,84.76333333333334,FUN_038576-T1,Q17QF0,AGT2_BOVIN,,"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase)",Bos taurus (Bovine),57.4,462.0,1.3e-163,577.8,"sp|Q17QF0|AGT2_BOVIN Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Bos taurus OX=9913 GN=AGXT2 PE=2 SV=1",GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019481; GO:0030170; GO:0047305; GO:2001299,"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299]",mitochondrion [GO:0005739],(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; transferase activity; organelle
OG_09017,1.420350058056903,FUN_038580-T1,Peve_00012104,Pocillopora_meandrina_HIv1___RNAseq.g1008.t1,three_way,76.07866666666666,FUN_038580-T1,Q8BYA0,,,,,54.4,1010.0,0.0,1093.2,sp|Q8BYA0|TBCD_MOUSE Tubulin-specific chaperone D OS=Mus musculus OX=10090 GN=Tbcd PE=1 SV=1,,,,,,
OG_09024,2.2589677948043456,FUN_038614-T1,Peve_00002807,Pocillopora_meandrina_HIv1___RNAseq.g972.t1,three_way,69.6525,FUN_038614-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),43.5,1698.0,3.2999999999999997e-299,1030.0,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09025,1.1313069290669726,FUN_038617-T1,Peve_00042051,Pocillopora_meandrina_HIv1___RNAseq.g971.t1,three_way,90.041,FUN_038617-T1,Q6NRT5,,,,,64.5,476.0,3.4e-176,619.4,sp|Q6NRT5|CSN1_XENLA COP9 signalosome complex subunit 1 OS=Xenopus laevis OX=8355 GN=csn1 PE=2 SV=1,,,,,,
OG_09028,1.607067825076534,FUN_038621-T1,Peve_00042047,Pocillopora_meandrina_HIv1___RNAseq.g1161.t1,three_way,51.117666666666665,FUN_038621-T1,Q5NVA9,,,,,38.2,327.0,3.0999999999999995e-43,178.3,sp|Q5NVA9|EME1_PONAB Structure-specific endonuclease subunit EME1 OS=Pongo abelii OX=9601 GN=EME1 PE=3 SV=1,,,,,,
OG_09029,2.7402614763707285,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_09033,1.9260211215966376,FUN_038633-T1,Peve_00013497,Pocillopora_meandrina_HIv1___RNAseq.g26495.t1,three_way,75.706,FUN_038633-T1,Q5EAE5,JOS1_BOVIN,,Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1),Bos taurus (Bovine),47.4,175.0,6.499999999999999e-43,175.3,sp|Q5EAE5|JOS1_BOVIN Josephin-1 OS=Bos taurus OX=9913 GN=JOSD1 PE=2 SV=1,GO:0004843; GO:0005737; GO:0005886; GO:0006508; GO:0006897; GO:0016579; GO:0044091; GO:0048870; GO:0061024,cell motility [GO:0048870]; endocytosis [GO:0006897]; membrane biogenesis [GO:0044091]; membrane organization [GO:0061024]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005886; GO:0016192; GO:0016787; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; vesicle-mediated transport; hydrolase activity; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_09042,2.558380661236339,FUN_038695-T1,Peve_00013474,Pocillopora_meandrina_HIv1___RNAseq.g26473.t1,three_way,63.010333333333335,,,,,,,,,,,,,,,,,
OG_09043,1.0895842257559445,FUN_038697-T1,Peve_00013468,Pocillopora_meandrina_HIv1___RNAseq.g26461.t2,three_way,78.3395,FUN_038697-T1,Q9Y383,LC7L2_HUMAN,,Putative RNA-binding protein Luc7-like 2,Homo sapiens (Human),60.3,239.0,6.6e-79,295.8,sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004,mRNA splice site recognition [GO:0006376],nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226; GO:0065003,RNA binding; organelle; protein-containing complex assembly
OG_09053,1.1657693630980182,FUN_038734-T1,Peve_00013933,Pocillopora_meandrina_HIv1___RNAseq.g26434.t1,three_way,82.597,FUN_038734-T1,Q8TB22,,,,,50.1,743.0,9.099999999999999e-217,755.0,sp|Q8TB22|SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens OX=9606 GN=SPATA20 PE=1 SV=3,,,,,,
OG_09056,2.104205079218913,FUN_038737-T1,Peve_00009276,Pocillopora_meandrina_HIv1___RNAseq.g26431.t1,three_way,65.04966666666667,FUN_038737-T1,Q5TM57,,,,,43.9,123.0,4.7e-23,109.0,sp|Q5TM57|RPP21_MACMU Ribonuclease P protein subunit p21 OS=Macaca mulatta OX=9544 GN=RPP21 PE=3 SV=1,,,,,,
OG_09062,2.216464359647247,FUN_038769-T1,Peve_00022730,Pocillopora_meandrina_HIv1___RNAseq.g26408.t1,three_way,76.67533333333333,,,,,,,,,,,,,,,,,
OG_09066,1.8496626180692648,FUN_038784-T1,Peve_00007211,Pocillopora_meandrina_HIv1___RNAseq.g26404.t1,three_way,97.22233333333334,FUN_038784-T1,Q962X9,,,,,91.7,144.0,1.5e-77,290.0,sp|Q962X9|BUD31_BRABE Protein BUD31 homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_09071,2.082351733992755,FUN_038799-T1,Peve_00007230,Pocillopora_meandrina_HIv1___RNAseq.g26382.t1,three_way,59.84366666666666,,,,,,,,,,,,,,,,,
OG_09073,2.09916761307827,FUN_038801-T1,Peve_00007226,Pocillopora_meandrina_HIv1___RNAseq.g28547.t1,three_way,79.16683333333334,FUN_038801-T1,E5RQL4,,,,,37.8,185.0,1e-17,92.4,sp|E5RQL4|FONG_HUMAN Formiminotransferase N-terminal subdomain-containing protein OS=Homo sapiens OX=9606 GN=FTCDNL1 PE=2 SV=1,,,,,,
OG_09074,2.328783802696125,FUN_038803-T1,Peve_00007224,Pocillopora_meandrina_HIv1___RNAseq.g28545.t1,three_way,82.41499999999999,FUN_038803-T1,Q8BL48,UNK_MOUSE,,RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5),Mus musculus (Mouse),46.5,778.0,5.4999999999999996e-160,567.0,sp|Q8BL48|UNK_MOUSE RING finger protein unkempt homolog OS=Mus musculus OX=10090 GN=Unk PE=1 SV=1,GO:0001701; GO:0001764; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766,cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],cytoplasm [GO:0005737],mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0003723; GO:0048856; GO:0048870,RNA binding; anatomical structure development; cell motility
OG_09088,1.5600838504371366,FUN_038886-T1,Peve_00028696,Pocillopora_meandrina_HIv1___RNAseq.g28678.t1,three_way,74.4045,FUN_038886-T1,Q9CZT4,,,,,39.5,714.0,3.8e-131,470.3,sp|Q9CZT4|RPC5_MOUSE DNA-directed RNA polymerase III subunit RPC5 OS=Mus musculus OX=10090 GN=Polr3e PE=1 SV=2,,,,,,
OG_09089,1.4618026372598774,FUN_038887-T1,Peve_00028697,Pocillopora_meandrina_HIv1___RNAseq.g28665.t1,three_way,61.27033333333333,FUN_038887-T1,D2HD32,,,,,48.9,131.0,9.9e-26,118.2,sp|D2HD32|ICT1_AILME Large ribosomal subunit protein mL62 OS=Ailuropoda melanoleuca OX=9646 GN=MRPL58 PE=3 SV=1,,,,,,
OG_09093,1.802456864787495,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.6999999999999995e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_09096,2.810383242673841,FUN_038901-T1,Peve_00028737,Pocillopora_meandrina_HIv1___TS.g8477.t1a,three_way,68.12616666666666,FUN_038901-T1,Q6NU40,,,,,42.3,1032.0,7.199999999999999e-189,662.5,sp|Q6NU40|CTF18_XENLA Chromosome transmission fidelity protein 18 homolog OS=Xenopus laevis OX=8355 GN=chtf18 PE=2 SV=1,,,,,,
OG_09098,1.972636849875267,FUN_038913-T1,Peve_00006149,Pocillopora_meandrina_HIv1___RNAseq.g1175.t1,three_way,65.38966666666666,FUN_038913-T1,Q504A5,,,,,36.9,198.0,3.2e-30,133.7,sp|Q504A5|TPMT_DANRE Probable thiopurine S-methyltransferase OS=Danio rerio OX=7955 GN=tpmt PE=2 SV=1,,,,,,
OG_09100,1.042350473450375,FUN_038917-T1,Peve_00004515,Pocillopora_meandrina_HIv1___RNAseq.g1080.t1,three_way,61.212,,,,,,,,,,,,,,,,,
OG_09101,1.6650822298588588,FUN_038918-T1,Peve_00004516,Pocillopora_meandrina_HIv1___RNAseq.g1083.t1,three_way,89.98166666666667,FUN_038918-T1,Q5ZL26,,,,,61.2,366.0,3.8e-122,439.5,sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1,,,,,,
OG_09102,2.113469825668347,FUN_038919-T1,Peve_00023621,Pocillopora_meandrina_HIv1___RNAseq.g1058.t1,three_way,88.84166666666667,FUN_038919-T1,Q9R1C6,DGKE_MOUSE,,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Mus musculus (Mouse),48.7,487.0,5.8999999999999995e-148,525.8,sp|Q9R1C6|DGKE_MOUSE Diacylglycerol kinase epsilon OS=Mus musculus OX=10090 GN=Dgke PE=1 SV=1,GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006654; GO:0006661; GO:0007200; GO:0008270; GO:0016020; GO:0046339; GO:0046834; GO:0050804; GO:0098978,diacylglycerol metabolic process [GO:0046339]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016740,catalytic activity; nucleoplasm; cytosol; lipid metabolic process; transferase activity
OG_09110,2.365498948662069,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_09117,2.3508207417623845,FUN_039101-T1,Peve_00028755,Pocillopora_meandrina_HIv1___RNAseq.g28705.t1,three_way,90.875,FUN_039101-T1,P27600,GNA12_MOUSE,,Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12),Mus musculus (Mouse),67.3,349.0,4.800000000000001e-130,465.7,sp|P27600|GNA12_MOUSE Guanine nucleotide-binding protein subunit alpha-12 OS=Mus musculus OX=10090 GN=Gna12 PE=1 SV=3,GO:0001701; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005834; GO:0007186; GO:0007266; GO:0008217; GO:0008360; GO:0009410; GO:0010762; GO:0016328; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0035556; GO:0042733; GO:0043005; GO:0043025; GO:0046872; GO:0051721; GO:0072542; GO:0160221; GO:1904706; GO:1904753,cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],D5 dopamine receptor binding [GO:0031752]; G protein activity [GO:0003925]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase activator activity [GO:0072542],GO:0003824; GO:0003924; GO:0016787; GO:0030154; GO:0048856; GO:0098772,catalytic activity; GTPase activity; hydrolase activity; cell differentiation; anatomical structure development; molecular function regulator activity
OG_09121,1.164030256184063,FUN_039269-T1,Peve_00002766,Pocillopora_meandrina_HIv1___RNAseq.14855_t,three_way,50.418,FUN_039269-T1,P15384,,,,,32.5,428.0,1e-50,202.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_09126,1.712489377284497,FUN_039319-T2,Peve_00037934,Pocillopora_meandrina_HIv1___TS.g2591.t1,three_way,56.69116666666667,FUN_039319-T2,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),35.0,369.0,2.7e-50,201.4,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09129,2.7364731166294947,FUN_039435-T1,Peve_00012694,Pocillopora_meandrina_HIv1___RNAseq.g15606.t1,three_way,76.65166666666667,FUN_039435-T1,O57321,,,,,48.3,466.0,6.6e-113,409.5,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_09134,1.044549200337744,FUN_039701-T1,Peve_00008100,Pocillopora_meandrina_HIv1___RNAseq.g14123.t1,three_way,57.217333333333336,,,,,,,,,,,,,,,,,
OG_09137,1.795331187445076,FUN_039776-T1,Peve_00017576,Pocillopora_meandrina_HIv1___RNAseq.g7455.t1,three_way,87.746,FUN_039776-T1,O14775,GNB5_HUMAN,,Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5),Homo sapiens (Human),61.0,344.0,9.299999999999999e-94,345.1,sp|O14775|GNB5_HUMAN Guanine nucleotide-binding protein subunit beta-5 OS=Homo sapiens OX=9606 GN=GNB5 PE=1 SV=2,GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007212; GO:0030159; GO:0030425; GO:0031682; GO:0036367; GO:0042734; GO:0043547; GO:0045211; GO:0051087; GO:0051286; GO:0098688; GO:1901386; GO:1902773; GO:1990603,dark adaptation [GO:1990603]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],cell tip [GO:0051286]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein-folding chaperone binding [GO:0051087]; signaling receptor complex adaptor activity [GO:0030159],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0060090; GO:0098772,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; molecular adaptor activity; molecular function regulator activity
OG_09139,1.663704373755812,FUN_039778-T1,Peve_00017603,Pocillopora_meandrina_HIv1___RNAseq.g7459.t1,three_way,79.53533333333333,FUN_039778-T1,Q5E9E4,,,,,44.0,182.0,4e-43,176.0,sp|Q5E9E4|SSRB_BOVIN Translocon-associated protein subunit beta OS=Bos taurus OX=9913 GN=SSR2 PE=2 SV=1,,,,,,
OG_09143,2.3087891996286,FUN_039791-T2,Peve_00017605,Pocillopora_meandrina_HIv1___TS.g1219.t1,three_way,73.25066666666666,FUN_039791-T2,Q8RYE9,,,,,39.4,216.0,1.7999999999999998e-35,151.0,sp|Q8RYE9|GPPL3_ARATH Haloacid dehalogenase-like hydrolase domain-containing protein At2g33255 OS=Arabidopsis thaliana OX=3702 GN=At2g33255 PE=1 SV=1,,,,,,
OG_09145,2.193885669002769,FUN_039793-T1,Peve_00017607,Pocillopora_meandrina_HIv1___RNAseq.g7472.t1,three_way,87.68633333333334,FUN_039793-T1,Q6AZN6,PK3C3_XENLA,,Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3),Xenopus laevis (African clawed frog),66.7,884.0,0.0,1166.0,sp|Q6AZN6|PK3C3_XENLA Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Xenopus laevis OX=8355 GN=pik3c3 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000425; GO:0005524; GO:0005737; GO:0005768; GO:0005777; GO:0006897; GO:0016020; GO:0016303; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0036092; GO:0048015; GO:0051301,autophagosome assembly [GO:0000045]; cell division [GO:0051301]; endocytosis [GO:0006897]; pexophagy [GO:0000425]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],"cytoplasm [GO:0005737]; endosome [GO:0005768]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524],GO:0003824; GO:0005768; GO:0005777; GO:0006629; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226,catalytic activity; endosome; peroxisome; lipid metabolic process; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle
OG_09157,2.075322063978412,FUN_039816-T3,Peve_00039070,Pocillopora_meandrina_HIv1___TS.g1258.t1,three_way,80.97083333333333,FUN_039816-T3,Q9BZC7,ABCA2_HUMAN,,ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2),Homo sapiens (Human),45.9,2470.0,0.0,1970.7,sp|Q9BZC7|ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens OX=9606 GN=ABCA2 PE=1 SV=4,GO:0000166; GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006629; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0009410; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:0150104; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905601; GO:2000008,central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166],GO:0003013; GO:0003824; GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0061024; GO:0098772; GO:0140657; GO:1901135,circulatory system process; catalytic activity; transporter activity; lysosome; endosome; vacuole; microtubule organizing center; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization; molecular function regulator activity; ATP-dependent activity; carbohydrate derivative metabolic process
OG_09170,1.1310917983129072,FUN_039836-T1,Peve_00006312,Pocillopora_meandrina_HIv1___RNAseq.g7301.t1,three_way,84.05966666666666,FUN_039836-T1,Q5R971,HEM2_PONAB,,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.0,326.0,4.3e-125,449.1,sp|Q5R971|HEM2_PONAB Delta-aminolevulinic acid dehydratase OS=Pongo abelii OX=9601 GN=ALAD PE=2 SV=2,GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytosol [GO:0005829],porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016829,catalytic activity; cytosol; lyase activity
OG_09171,1.117215412386321,FUN_039837-T2,Peve_00006311,Pocillopora_meandrina_HIv1___RNAseq.g7300.t1,three_way,76.486,FUN_039837-T2,Q5R7V3,,,,,48.8,80.0,4.4e-16,86.7,sp|Q5R7V3|ACBD5_PONAB Acyl-CoA-binding domain-containing protein 5 OS=Pongo abelii OX=9601 GN=ACBD5 PE=2 SV=1,,,,,,
OG_09172,1.751152713642635,FUN_039848-T1,Peve_00006309,Pocillopora_meandrina_HIv1___TS.g1047.t1,three_way,71.90033333333334,FUN_039848-T1,Q9JHB4,,,,,40.2,306.0,1.3e-50,201.8,sp|Q9JHB4|WDR31_MOUSE WD repeat-containing protein 31 OS=Mus musculus OX=10090 GN=Wdr31 PE=2 SV=1,,,,,,
OG_09177,1.8434345964533323,FUN_039853-T1,Peve_00020651,Pocillopora_meandrina_HIv1___RNAseq.g7295.t2,three_way,71.36883333333333,FUN_039853-T1,Q8QFV0,,,,,43.4,1143.0,3.4999999999999996e-251,869.8,sp|Q8QFV0|KCNT1_CHICK Potassium channel subfamily T member 1 OS=Gallus gallus OX=9031 GN=KCNT1 PE=1 SV=1,,,,,,
OG_09180,2.135281187913197,FUN_039860-T1,Peve_00014924,Pocillopora_meandrina_HIv1___TS.g1030.t3,three_way,76.61816666666667,,,,,,,,,,,,,,,,,
OG_09189,2.1806584637942,FUN_039871-T1,Peve_00011726,Pocillopora_meandrina_HIv1___RNAseq.g7376.t1,three_way,52.6305,FUN_039871-T1,Q54PX0,Y4251_DICDI,,Probable serine/threonine-protein kinase DDB_G0284251 (EC 2.7.11.1),Dictyostelium discoideum (Social amoeba),27.9,201.0,3e-07,58.2,sp|Q54PX0|Y4251_DICDI Probable serine/threonine-protein kinase DDB_G0284251 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0284251 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0046872; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09193,1.1470345620961568,FUN_039875-T1,Peve_00004944,Pocillopora_meandrina_HIv1___RNAseq.g7357.t1,three_way,83.253,FUN_039875-T1,Q3T1G7,,,,,39.1,780.0,1.2e-146,521.9,sp|Q3T1G7|COG7_RAT Conserved oligomeric Golgi complex subunit 7 OS=Rattus norvegicus OX=10116 GN=Cog7 PE=2 SV=1,,,,,,
OG_09195,3.240622413159522,FUN_039878-T1,Peve_00004939,Pocillopora_meandrina_HIv1___RNAseq.g7349.t1,three_way,88.2645,FUN_039878-T1,Q9Z325,DPM2_RAT,,Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2) (DPM synthase subunit 2),Rattus norvegicus (Rat),52.4,82.0,1.3e-17,90.1,sp|Q9Z325|DPM2_RAT Dolichol phosphate-mannose biosynthesis regulatory protein OS=Rattus norvegicus OX=10116 GN=Dpm2 PE=1 SV=3,GO:0000506; GO:0004582; GO:0005783; GO:0005789; GO:0006486; GO:0006506; GO:0008047; GO:0019348; GO:0030234; GO:0031647; GO:0033185; GO:0048471; GO:0180047,dolichol metabolic process [GO:0019348]; dolichol phosphate mannose biosynthetic process [GO:0180047]; GPI anchor biosynthetic process [GO:0006506]; protein glycosylation [GO:0006486]; regulation of protein stability [GO:0031647],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; perinuclear region of cytoplasm [GO:0048471],dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234],GO:0003824; GO:0005783; GO:0006486; GO:0006629; GO:0016740; GO:0043226; GO:0098772; GO:1901135,catalytic activity; endoplasmic reticulum; protein glycosylation; lipid metabolic process; transferase activity; organelle; molecular function regulator activity; carbohydrate derivative metabolic process
OG_09196,1.1667515370488992,FUN_039879-T1,Peve_00004941,Pocillopora_meandrina_HIv1___RNAseq.g7350.t1,three_way,71.38633333333334,FUN_039879-T1,Q9VX10,,,,,61.9,105.0,5e-33,141.7,sp|Q9VX10|SRX_DROME Sulfiredoxin OS=Drosophila melanogaster OX=7227 GN=Srx PE=1 SV=1,,,,,,
OG_09199,1.3977845172758003,FUN_039884-T1,Peve_00021849,Pocillopora_meandrina_HIv1___RNAseq.g7372.t1,three_way,83.127,FUN_039884-T1,Q96NC0,ZMAT2_HUMAN,,Zinc finger matrin-type protein 2,Homo sapiens (Human),65.7,134.0,3.7e-42,172.9,sp|Q96NC0|ZMAT2_HUMAN Zinc finger matrin-type protein 2 OS=Homo sapiens OX=9606 GN=ZMAT2 PE=1 SV=1,GO:0000398; GO:0003677; GO:0005634; GO:0005654; GO:0008270; GO:0046540; GO:0071005,"mRNA splicing, via spliceosome [GO:0000398]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0016071; GO:0043226,DNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_09202,1.2084170128767004,FUN_039887-T1,Peve_00021853,Pocillopora_meandrina_HIv1___RNAseq.g7369.t1,three_way,90.38766666666666,FUN_039887-T1,Q7SXP0,,,,,61.7,214.0,2.3000000000000002e-71,270.0,sp|Q7SXP0|S22BB_DANRE Vesicle-trafficking protein SEC22b-B OS=Danio rerio OX=7955 GN=sec22bb PE=2 SV=1,,,,,,
OG_09205,1.652263667449294,FUN_039893-T1,Peve_00021861,Pocillopora_meandrina_HIv1___RNAseq.g7363.t1,three_way,81.48033333333333,FUN_039893-T1,Q7ZVB2,,,,,62.8,487.0,9.4e-183,641.3,sp|Q7ZVB2|A9A1A_DANRE 4-trimethylaminobutyraldehyde dehydrogenase A OS=Danio rerio OX=7955 GN=aldh9a1a PE=2 SV=1,,,,,,
OG_09210,1.8960991917078511,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_09211,2.0679265925728307,FUN_039924-T1,Peve_00010142,Pocillopora_meandrina_HIv1___RNAseq.g7338.t1,three_way,76.45366666666666,FUN_039924-T1,P58389,PTPA_MOUSE,,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",Mus musculus (Mouse),64.7,295.0,3.3e-115,416.4,sp|P58389|PTPA_MOUSE Serine/threonine-protein phosphatase 2A activator OS=Mus musculus OX=10090 GN=Ptpa PE=1 SV=1,GO:0000159; GO:0003755; GO:0004721; GO:0005102; GO:0005524; GO:0005654; GO:0005737; GO:0008160; GO:0019888; GO:0034704; GO:0042803; GO:0043065; GO:0046872; GO:0051721; GO:1904949,positive regulation of apoptotic process [GO:0043065],ATPase complex [GO:1904949]; calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005654; GO:0016787; GO:0016853; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09225,2.065252532733561,FUN_039947-T1,Peve_00039029,Pocillopora_meandrina_HIv1___RNAseq.g7508.t1,three_way,78.4495,FUN_039947-T1,Q5T280,SPOUT_HUMAN,,28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114) (Ribosomal RNA methyltransferase SPOUT1) (SPOUT domain-containing methyltransferase 1),Homo sapiens (Human),60.8,237.0,1.3e-79,297.7,sp|Q5T280|SPOUT_HUMAN 28S rRNA (uridine-N(3))-methyltransferase OS=Homo sapiens OX=9606 GN=SPOUT1 PE=1 SV=3,GO:0000776; GO:0003723; GO:0005737; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0070042; GO:0070475; GO:0072686; GO:1904047,cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]; rRNA base methylation [GO:0070475],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003723; GO:0003824; GO:0005815; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09232,1.3839635616651005,FUN_039973-T1,Peve_00000409,Pocillopora_meandrina_HIv1___RNAseq.g7541.t1,three_way,75.81366666666666,FUN_039973-T1,A0A1L8GVF0,RA50S_XENLA,,DNA repair protein RAD50.S (EC 3.6.-.-),Xenopus laevis (African clawed frog),38.8,1313.0,5.3e-182,640.2,sp|A0A1L8GVF0|RA50S_XENLA DNA repair protein RAD50.S OS=Xenopus laevis OX=8355 GN=rad50.S PE=1 SV=1,GO:0000722; GO:0000729; GO:0000781; GO:0000794; GO:0003691; GO:0005524; GO:0006302; GO:0007004; GO:0016887; GO:0030870; GO:0035861; GO:0043047; GO:0043539; GO:0046872; GO:0051310; GO:0051880; GO:0062176; GO:0070192; GO:0110025,chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein serine/threonine kinase activator activity [GO:0043539]; single-stranded telomeric DNA binding [GO:0043047],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity
OG_09233,3.843076523134899,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_09237,2.8083593830298303,FUN_039990-T1,Peve_00004422,Pocillopora_meandrina_HIv1___RNAseq.g7562.t1,three_way,81.36533333333333,FUN_039990-T1,Q96CN4,EVI5L_HUMAN,,EVI5-like protein (Ecotropic viral integration site 5-like protein),Homo sapiens (Human),45.3,516.0,1.2e-114,415.2,sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,GO:0005096; GO:0031267; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],,GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_09240,1.3284208409138962,FUN_040028-T1,Peve_00004957,Pocillopora_meandrina_HIv1___RNAseq.g8435.t1,three_way,50.78683333333333,FUN_040028-T1,Q8C1B2,PARPT_MOUSE,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase),Mus musculus (Mouse),32.0,453.0,8.3e-47,190.3,sp|Q8C1B2|PARPT_MOUSE Protein mono-ADP-ribosyltransferase TIPARP OS=Mus musculus OX=10090 GN=Tiparp PE=2 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09246,1.8316554111350576,FUN_040036-T1,Peve_00040432,Pocillopora_meandrina_HIv1___RNAseq.g8455.t1,three_way,69.15733333333333,,,,,,,,,,,,,,,,,
OG_09247,2.5424005858475813,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09249,1.1258861634343391,FUN_040039-T1,Peve_00040428,Pocillopora_meandrina_HIv1___RNAseq.g8458.t1,three_way,71.936,FUN_040039-T1,Q4R7W3,,,,,46.6,567.0,3.6999999999999997e-121,436.8,sp|Q4R7W3|RGPS2_MACFA Ras-specific guanine nucleotide-releasing factor RalGPS2 OS=Macaca fascicularis OX=9541 GN=RALGPS2 PE=2 SV=1,,,,,,
OG_09251,2.390521306036084,FUN_040041-T1,Peve_00040425,Pocillopora_meandrina_HIv1___TS.g20197.t1,three_way,47.19116666666667,,,,,,,,,,,,,,,,,
OG_09252,2.558977917921946,FUN_040042-T1,Peve_00032519,Pocillopora_meandrina_HIv1___RNAseq.g8461.t1,three_way,62.42433333333334,FUN_040042-T1,Q7ZWG9,SGMR1_DANRE,,Sigma non-opioid intracellular receptor 1 (Sigma 1-type opioid receptor) (Sigma1-receptor) (Sigma1R),Danio rerio (Zebrafish) (Brachydanio rerio),51.8,197.0,2.0000000000000002e-60,233.8,sp|Q7ZWG9|SGMR1_DANRE Sigma non-opioid intracellular receptor 1 OS=Danio rerio OX=7955 GN=sigmar1 PE=2 SV=1,GO:0005637; GO:0005640; GO:0005783; GO:0005789; GO:0006869; GO:0009611; GO:0016020; GO:0031410; GO:0036269; GO:0043457; GO:0046548; GO:1905897,lipid transport [GO:0006869]; regulation of cellular respiration [GO:0043457]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; swimming behavior [GO:0036269],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640],,GO:0005783; GO:0031410; GO:0043226; GO:0048856,endoplasmic reticulum; cytoplasmic vesicle; organelle; anatomical structure development
OG_09254,1.6606938293623028,FUN_040053-T1,Peve_00016113,Pocillopora_meandrina_HIv1___RNAseq.g8469.t1,three_way,77.773,,,,,,,,,,,,,,,,,
OG_09260,1.0845527460545157,FUN_040063-T1,Peve_00033906,Pocillopora_meandrina_HIv1___RNAseq.g7704.t1,three_way,56.58866666666667,,,,,,,,,,,,,,,,,
OG_09262,1.2718482114188625,FUN_040067-T1,Peve_00033898,Pocillopora_meandrina_HIv1___RNAseq.g7701.t2,three_way,60.609,FUN_040067-T1,A8VU90,ANKL1_MOUSE,,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),Mus musculus (Mouse),45.4,251.0,4.0999999999999996e-53,210.7,sp|A8VU90|ANKL1_MOUSE Ankyrin repeat and LEM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankle1 PE=2 SV=1,GO:0004519; GO:0005654; GO:0005829; GO:0006611; GO:0045950; GO:1905453; GO:1905456,negative regulation of mitotic recombination [GO:0045950]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453],cytosol [GO:0005829]; nucleoplasm [GO:0005654],endonuclease activity [GO:0004519],GO:0003824; GO:0005654; GO:0005829; GO:0006886; GO:0006913,catalytic activity; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_09266,1.715782095459755,FUN_040071-T1,Peve_00021006,Pocillopora_meandrina_HIv1___RNAseq.g7693.t1,three_way,74.35883333333334,FUN_040071-T1,P17439,GBA1_MOUSE,,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Mus musculus (Mouse),48.2,500.0,5.999999999999999e-140,499.2,sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1,GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295],GO:0002376; GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006091; GO:0006629; GO:0006914; GO:0007005; GO:0007040; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:1901135,immune system process; catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; generation of precursor metabolites and energy; lipid metabolic process; autophagy; mitochondrion organization; lysosome organization; programmed cell death; transferase activity; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; cell motility; nervous system process; carbohydrate derivative metabolic process
OG_09270,1.5593538056229428,FUN_040076-T1,Peve_00011678,Pocillopora_meandrina_HIv1___RNAseq.g7621.t1,three_way,86.5475,FUN_040076-T1,A0JMA9,,,,,57.6,564.0,2.1999999999999998e-169,597.0,sp|A0JMA9|KATL2_XENTR Katanin p60 ATPase-containing subunit A-like 2 OS=Xenopus tropicalis OX=8364 GN=katnal2 PE=2 SV=1,,,,,,
OG_09277,1.6968114442957642,FUN_040087-T1,Peve_00043018,Pocillopora_meandrina_HIv1___RNAseq.g7617.t1,three_way,86.96233333333333,FUN_040087-T1,Q2TBV5,,,,,56.7,187.0,3.4e-61,236.1,sp|Q2TBV5|TF2H2_BOVIN General transcription factor IIH subunit 2 OS=Bos taurus OX=9913 GN=GTF2H2 PE=2 SV=1,,,,,,
OG_09285,2.0449499168016025,FUN_040106-T1,Peve_00037279,Pocillopora_meandrina_HIv1___RNAseq.g8725.t1,three_way,92.27733333333332,FUN_040106-T1,Q9R1A8,COP1_MOUSE,,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Mus musculus (Mouse),62.3,648.0,1.5e-230,800.4,sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2,GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09289,2.095039784253214,FUN_040116-T1,Peve_00043154,Pocillopora_meandrina_HIv1___RNAseq.g8711.t1,three_way,56.97933333333333,FUN_040116-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),35.8,545.0,3.1999999999999997e-85,317.4,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09294,1.4651244071097431,FUN_040140-T1,Peve_00038114,Pocillopora_meandrina_HIv1___RNAseq.g8514.t1,three_way,65.46633333333334,FUN_040140-T1,Q66LN0,PGES2_BOVIN,,Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form],Bos taurus (Bovine),47.7,176.0,2.8e-42,173.7,sp|Q66LN0|PGES2_BOVIN Prostaglandin E synthase 2 OS=Bos taurus OX=9913 GN=PTGES2 PE=1 SV=3,GO:0001516; GO:0005739; GO:0005783; GO:0016020; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220,prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739],12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220],GO:0003824; GO:0005739; GO:0005783; GO:0006629; GO:0016491; GO:0016829; GO:0016853; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity; organelle
OG_09305,1.741465543039523,FUN_040173-T1,Peve_00038124,Pocillopora_meandrina_HIv1___RNAseq.g7732.t2,three_way,76.989,FUN_040173-T1,Q9HAD4,,,,,29.1,433.0,1.6e-50,201.8,sp|Q9HAD4|WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens OX=9606 GN=WDR41 PE=1 SV=3,,,,,,
OG_09306,1.6452328441987558,FUN_040203-T1,Peve_00038111,Pocillopora_meandrina_HIv1___TS.g1483.t1,three_way,55.532,,,,,,,,,,,,,,,,,
OG_09309,2.53635345350709,FUN_040206-T1,Peve_00038134,Pocillopora_meandrina_HIv1___RNAseq.g7739.t1,three_way,73.89966666666666,FUN_040206-T1,Q5EA19,,,,,50.3,181.0,5.1e-47,189.1,sp|Q5EA19|ARL15_BOVIN ADP-ribosylation factor-like protein 15 OS=Bos taurus OX=9913 GN=ARL15 PE=2 SV=1,,,,,,
OG_09315,1.3494412597306775,FUN_040222-T1,Peve_00023454,Pocillopora_meandrina_HIv1___RNAseq.g7759.t1,three_way,64.82433333333333,FUN_040222-T1,Q7TN31,AGGF1_MOUSE,,Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q),Mus musculus (Mouse),45.0,300.0,1.7e-60,235.3,sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1,GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471],identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676],GO:0005576; GO:0007155; GO:0030154,extracellular region; cell adhesion; cell differentiation
OG_09319,1.0427490928570282,FUN_040232-T1,Peve_00013006,Pocillopora_meandrina_HIv1___RNAseq.g7766.t1,three_way,61.32533333333333,FUN_040232-T1,Q9JJI6,,,,,35.0,1137.0,2.200000000000001e-149,531.6,"sp|Q9JJI6|PIGO_MOUSE GPI ethanolamine phosphate transferase 3, catalytic subunit OS=Mus musculus OX=10090 GN=Pigo PE=1 SV=2",,,,,,
OG_09321,1.4399959283779449,FUN_040235-T1,Peve_00021816,Pocillopora_meandrina_HIv1___RNAseq.g7786.t1,three_way,79.80866666666667,FUN_040235-T1,A7S4N4,,,,,48.4,432.0,6.5e-100,365.9,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_09328,1.2337418218250558,FUN_040260-T1,Peve_00029136,Pocillopora_meandrina_HIv1___RNAseq.g7787.t1,three_way,84.27333333333333,FUN_040260-T1,Q5VZE5,NAA35_HUMAN,,"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)",Homo sapiens (Human),51.8,706.0,1.6e-188,661.0,"sp|Q5VZE5|NAA35_HUMAN N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA35 PE=1 SV=1",GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031417; GO:0043066; GO:0048659,negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,GO:0005654; GO:0005829; GO:0005886,nucleoplasm; cytosol; plasma membrane
OG_09331,1.1569763473662271,FUN_040267-T1,Peve_00014979,Pocillopora_meandrina_HIv1___RNAseq.g7811.t1,three_way,61.712,FUN_040267-T1,Q5M824,SHC1_RAT,,SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1),Rattus norvegicus (Rat),35.5,541.0,3.7e-73,277.3,sp|Q5M824|SHC1_RAT SHC-transforming protein 1 OS=Rattus norvegicus OX=10116 GN=Shc1 PE=1 SV=1,GO:0001525; GO:0001666; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005829; GO:0005886; GO:0005925; GO:0006940; GO:0007173; GO:0007507; GO:0008284; GO:0008286; GO:0010008; GO:0030036; GO:0030182; GO:0030971; GO:0031100; GO:0031175; GO:0032868; GO:0032869; GO:0035094; GO:0035556; GO:0042127; GO:0042742; GO:0043066; GO:0043410; GO:0044877; GO:0045892; GO:0045893; GO:0045907; GO:0046875; GO:0048009; GO:0048408; GO:0048661; GO:0051219; GO:0051384; GO:0051721; GO:0070301; GO:0070374; GO:0070435; GO:0071363; GO:0097237; GO:0098609; GO:1904628; GO:1990839,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to insulin stimulus [GO:0032869]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to toxic substance [GO:0097237]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094],cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435],ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0003013; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0030154; GO:0048856; GO:0060090,circulatory system process; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cell differentiation; anatomical structure development; molecular adaptor activity
OG_09334,1.3098549016611496,FUN_040273-T1,Peve_00014971,Pocillopora_meandrina_HIv1___RNAseq.g9069.t1,three_way,63.76,FUN_040273-T1,Q3ZBH3,,,,,27.7,242.0,9e-19,95.5,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_09338,2.6520472992634683,FUN_040301-T1,Peve_00038647,Pocillopora_meandrina_HIv1___RNAseq.g9075.t1,three_way,65.522,FUN_040301-T1,Q80T21,ATL4_MOUSE,,ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1),Mus musculus (Mouse),33.5,731.0,7.7e-109,396.4,sp|Q80T21|ATL4_MOUSE ADAMTS-like protein 4 OS=Mus musculus OX=10090 GN=Adamtsl4 PE=2 SV=1,GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0006915; GO:0030198; GO:0031012; GO:0043065; GO:0070285,apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614],protease binding [GO:0002020],GO:0005576; GO:0012501; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; programmed cell death; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09345,2.528049754358384,FUN_040328-T1,Peve_00025748,Pocillopora_meandrina_HIv1___RNAseq.g9085.t1,three_way,73.42633333333333,,,,,,,,,,,,,,,,,
OG_09348,1.7881943294453944,FUN_040403-T1,Peve_00014974,Pocillopora_meandrina_HIv1___RNAseq.g9090.t1,three_way,76.05033333333334,FUN_040403-T1,A7SGF0,,,,,62.4,133.0,2.3999999999999998e-39,163.3,sp|A7SGF0|BORC8_NEMVE BLOC-1-related complex subunit 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g233178 PE=3 SV=1,,,,,,
OG_09350,1.2104637266902167,FUN_040421-T1,Peve_00014973,Pocillopora_meandrina_HIv1___RNAseq.g9088.t2,three_way,72.28966666666666,FUN_040421-T1,Q8K2V6,,,,,45.0,398.0,6.799999999999999e-96,352.4,sp|Q8K2V6|IPO11_MOUSE Importin-11 OS=Mus musculus OX=10090 GN=Ipo11 PE=1 SV=1,,,,,,
OG_09353,1.371129286842505,FUN_040424-T1,Peve_00004009,Pocillopora_meandrina_HIv1___RNAseq.g6508.t1,three_way,80.8135,FUN_040424-T1,Q13367,,,,,64.1,1065.0,1.8e-297,1023.5,sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2,,,,,,
OG_09354,1.7942814379076022,FUN_040425-T1,Peve_00004010,Pocillopora_meandrina_HIv1___RNAseq.g6509.t1,three_way,76.108,,,,,,,,,,,,,,,,,
OG_09369,1.4700793077110044,FUN_040493-T1,Peve_00015398,Pocillopora_meandrina_HIv1___RNAseq.g6529.t1,three_way,81.2965,FUN_040493-T1,Q69ZF3,GBA2_MOUSE,,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase),Mus musculus (Mouse),52.7,827.0,2.4e-249,863.2,sp|Q69ZF3|GBA2_MOUSE Non-lysosomal glucosylceramidase OS=Mus musculus OX=10090 GN=Gba2 PE=1 SV=2,GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005829; GO:0005975; GO:0006680; GO:0008203; GO:0008422; GO:0016139; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0046527; GO:0050295; GO:0097035,carbohydrate metabolic process [GO:0005975]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295],GO:0003824; GO:0005829; GO:0005975; GO:0006629; GO:0016740; GO:0016787; GO:0048856; GO:0061024; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; lipid metabolic process; transferase activity; hydrolase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_09371,1.2367713720352953,FUN_040525-T2,Peve_00024707,Pocillopora_meandrina_HIv1___RNAseq.g1445.t1,three_way,77.679,,,,,,,,,,,,,,,,,
OG_09372,1.4575584083995403,FUN_040547-T1,Peve_00015401,Pocillopora_meandrina_HIv1___RNAseq.g6506.t1,three_way,82.78766666666667,FUN_040547-T1,P46940,IQGA1_HUMAN,,Ras GTPase-activating-like protein IQGAP1 (p195),Homo sapiens (Human),54.6,1653.0,0.0,1496.9,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990138; GO:1990904,caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057],"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]",GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0061024; GO:0098772,nucleus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_09373,1.5023021802023453,FUN_040548-T1,Peve_00015402,Pocillopora_meandrina_HIv1___RNAseq.g6505.t1,three_way,73.82566666666666,FUN_040548-T1,Q9H267,,,,,45.4,579.0,5.8e-143,509.2,sp|Q9H267|VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens OX=9606 GN=VPS33B PE=1 SV=2,,,,,,
OG_09377,1.2923774493669105,FUN_040610-T1,Peve_00015406,Pocillopora_meandrina_HIv1___TS.g215.t1,three_way,55.4595,,,,,,,,,,,,,,,,,
OG_09379,2.6018813969022085,FUN_040615-T1,Peve_00015411,Pocillopora_meandrina_HIv1___RNAseq.g6470.t1,three_way,87.62333333333333,FUN_040615-T1,E9PV86,,,,,44.3,711.0,1.7e-153,544.7,sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1,,,,,,
OG_09383,2.18994533059652,FUN_040672-T1,Peve_00015418,Pocillopora_meandrina_HIv1___RNAseq.g6459.t1,three_way,56.578833333333336,,,,,,,,,,,,,,,,,
OG_09385,1.2060141028358848,FUN_040674-T1,Peve_00015421,Pocillopora_meandrina_HIv1___RNAseq.g6457.t1,three_way,43.42233333333333,,,,,,,,,,,,,,,,,
OG_09387,1.423358091482401,FUN_040680-T1,Peve_00009589,Pocillopora_meandrina_HIv1___RNAseq.g6447.t1,three_way,74.92949999999999,FUN_040680-T1,Q13972,RGRF1_HUMAN,,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),Homo sapiens (Human),40.1,1471.0,1.8e-260,901.0,sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168,long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0050877; GO:0098772,cytosol; plasma membrane; nervous system process; molecular function regulator activity
OG_09400,1.216412202668688,FUN_040714-T1,Peve_00002273,Pocillopora_meandrina_HIv1___RNAseq.g6550.t1,three_way,90.7025,FUN_040714-T1,A1L3F4,,,,,49.5,552.0,8.6e-96,352.4,sp|A1L3F4|MEX3B_XENLA RNA-binding protein MEX3B OS=Xenopus laevis OX=8355 GN=mex3b PE=2 SV=1,,,,,,
OG_09406,1.0020756442157208,FUN_040856-T2,Peve_00032788,Pocillopora_meandrina_HIv1___RNAseq.g6544.t1,three_way,56.886,,,,,,,,,,,,,,,,,
OG_09407,1.6870021551881338,FUN_040857-T1,Peve_00002299,Pocillopora_meandrina_HIv1___RNAseq.4208_ta,three_way,65.18433333333333,FUN_040857-T1,Q6NRK9,,,,,43.9,223.0,2.5999999999999997e-47,190.3,sp|Q6NRK9|CCNQ_XENLA Cyclin-Q OS=Xenopus laevis OX=8355 GN=ccnq PE=2 SV=2,,,,,,
OG_09409,2.1717062448190525,FUN_040861-T1,Peve_00002298,Pocillopora_meandrina_HIv1___RNAseq.g6554.t1,three_way,84.35516666666666,FUN_040861-T1,Q5RE70,,,,,41.1,995.0,2.5e-211,737.3,sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1,,,,,,
OG_09416,2.332583565949353,FUN_040957-T1,Peve_00031410,Pocillopora_meandrina_HIv1___RNAseq.g27053.t1,three_way,76.98966666666666,FUN_040957-T1,Q9CQ02,,,,,59.0,188.0,2.6000000000000004e-57,223.8,sp|Q9CQ02|COMD4_MOUSE COMM domain-containing protein 4 OS=Mus musculus OX=10090 GN=Commd4 PE=1 SV=1,,,,,,
OG_09417,2.066960694355594,FUN_040958-T1,Peve_00031409,Pocillopora_meandrina_HIv1___RNAseq.g27054.t1,three_way,67.29966666666667,,,,,,,,,,,,,,,,,
OG_09420,1.5684716873310447,FUN_040987-T1,Peve_00031413,Pocillopora_meandrina_HIv1___RNAseq.g12093.t1,three_way,53.817,FUN_040987-T1,Q8TCF1,ZFAN1_HUMAN,,AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1),Homo sapiens (Human),40.6,266.0,4.9e-48,193.0,sp|Q8TCF1|ZFAN1_HUMAN AN1-type zinc finger protein 1 OS=Homo sapiens OX=9606 GN=ZFAND1 PE=1 SV=1,GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843,cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494],proteasome binding [GO:0070628]; zinc ion binding [GO:0008270],GO:0043226,organelle
OG_09424,1.989247961828471,FUN_041213-T1,Peve_00021335,Pocillopora_meandrina_HIv1___RNAseq.g16095.t1,three_way,68.873,FUN_041213-T1,Q5R6R1,EYS_PONAB,,Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,243.0,2.9e-16,89.0,sp|Q5R6R1|EYS_PONAB Protein eyes shut homolog OS=Pongo abelii OX=9601 GN=EYS PE=2 SV=3,GO:0001750; GO:0005509; GO:0005576; GO:0005737; GO:0005813; GO:0005886; GO:0007157; GO:0032991; GO:0033165; GO:0043403; GO:0045197; GO:0050908,detection of light stimulus involved in visual perception [GO:0050908]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; skeletal muscle tissue regeneration [GO:0043403],centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],calcium ion binding [GO:0005509],GO:0005576; GO:0005815; GO:0005886; GO:0007155; GO:0007163; GO:0030312; GO:0031012; GO:0048856,extracellular region; microtubule organizing center; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09425,1.808758932648208,FUN_041214-T1,Peve_00021334,Pocillopora_meandrina_HIv1___TS.g11107.t1,three_way,66.5295,FUN_041214-T1,Q8VEL0,MSPD1_MOUSE,,Motile sperm domain-containing protein 1,Mus musculus (Mouse),48.3,207.0,1.7e-45,184.1,sp|Q8VEL0|MSPD1_MOUSE Motile sperm domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mospd1 PE=1 SV=1,GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0030154; GO:0045944; GO:0048471,cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],,GO:0005634; GO:0006355; GO:0030154; GO:0043226,nucleus; regulation of DNA-templated transcription; cell differentiation; organelle
OG_09427,2.26798189281107,FUN_041311-T1,Peve_00036795,Pocillopora_meandrina_HIv1___RNAseq.g16009.t1,three_way,64.30933333333334,FUN_041311-T1,A7MFZ8,,,,,30.6,288.0,3.9e-34,147.1,sp|A7MFZ8|GHRA_CROS8 Glyoxylate/hydroxypyruvate reductase A OS=Cronobacter sakazakii (strain ATCC BAA-894) OX=290339 GN=ghrA PE=3 SV=1,,,,,,
OG_09429,1.8218539122497348,FUN_041313-T1,Peve_00002269,Pocillopora_meandrina_HIv1___RNAseq.g6990.t1,three_way,68.18166666666667,FUN_041313-T1,P90543,,,,,68.5,108.0,4.9999999999999995e-31,135.6,sp|P90543|H3_EUPCR Histone H3 OS=Euplotes crassus OX=5936 PE=3 SV=3,,,,,,
OG_09434,1.830339627489068,FUN_041404-T1,Peve_00020588,Pocillopora_meandrina_HIv1___RNAseq.g15720.t1,three_way,81.456,,,,,,,,,,,,,,,,,
OG_09435,1.2945206474315742,FUN_041407-T1,Peve_00020004,Pocillopora_meandrina_HIv1___RNAseq.g15728.t1,three_way,74.4565,FUN_041407-T1,Q5HZP1,,,,,41.7,307.0,7.099999999999999e-53,209.1,sp|Q5HZP1|RNH2B_XENLA Ribonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1,,,,,,
OG_09458,1.8980557684092072,FUN_041466-T1,Peve_00028293,Pocillopora_meandrina_HIv1___RNAseq.g15685.t1,three_way,68.417,FUN_041466-T1,Q6NYE7,,,,,35.5,231.0,5.700000000000001e-30,132.9,sp|Q6NYE7|TM192_DANRE Transmembrane protein 192 OS=Danio rerio OX=7955 GN=tmem192 PE=2 SV=1,,,,,,
OG_09469,1.3277212596786625,FUN_041494-T2,Peve_00017071,Pocillopora_meandrina_HIv1___RNAseq.g15664.t2,three_way,87.778,FUN_041494-T2,Q14409,,,,,63.3,542.0,7e-203,708.4,sp|Q14409|GLPK3_HUMAN Glycerol kinase 3 OS=Homo sapiens OX=9606 GN=GK3 PE=1 SV=2,,,,,,
OG_09473,2.52577704099869,FUN_041499-T1,Peve_00007701,Pocillopora_meandrina_HIv1___RNAseq.g15656.t1,three_way,76.57366666666667,FUN_041499-T1,Q8WY91,THAP4_HUMAN,,Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4),Homo sapiens (Human),39.2,166.0,1.3000000000000001e-33,144.4,sp|Q8WY91|THAP4_HUMAN Peroxynitrite isomerase THAP4 OS=Homo sapiens OX=9606 GN=THAP4 PE=1 SV=2,GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026,nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570],cytosol [GO:0005829]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006520; GO:0016853,DNA binding; catalytic activity; nucleoplasm; cytosol; amino acid metabolic process; isomerase activity
OG_09474,2.187696277271737,FUN_041501-T1,Peve_00028685,Pocillopora_meandrina_HIv1___RNAseq.g15660.t1,three_way,84.75066666666666,FUN_041501-T1,P70191,TRAF5_MOUSE,,TNF receptor-associated factor 5,Mus musculus (Mouse),38.3,193.0,2.8e-32,141.0,sp|P70191|TRAF5_MOUSE TNF receptor-associated factor 5 OS=Mus musculus OX=10090 GN=Traf5 PE=1 SV=1,GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0023035; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043123; GO:0048255; GO:0051092; GO:0061630; GO:0097400,apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0006355; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; regulation of DNA-templated transcription; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_09477,1.7234417149725332,FUN_041504-T1,Peve_00021429,Pocillopora_meandrina_HIv1___RNAseq.g15966.t1,three_way,72.34566666666666,FUN_041504-T1,Q9WU81,,,,,54.1,495.0,5.3e-144,512.7,sp|Q9WU81|G6PT3_MOUSE Glucose-6-phosphate exchanger SLC37A2 OS=Mus musculus OX=10090 GN=Slc37a2 PE=1 SV=1,,,,,,
OG_09484,1.6550158498939218,FUN_041516-T1,Peve_00021419,Pocillopora_meandrina_HIv1___RNAseq.g16018.t1,three_way,81.921,FUN_041516-T1,Q5RF33,,,,,65.7,213.0,1.2000000000000001e-80,300.8,sp|Q5RF33|VP26C_PONAB Vacuolar protein sorting-associated protein 26C OS=Pongo abelii OX=9601 GN=VPS26C PE=2 SV=1,,,,,,
OG_09488,1.4797530661182725,FUN_041522-T1,Peve_00024135,Pocillopora_meandrina_HIv1___TS.g10406.t1,three_way,83.81533333333333,FUN_041522-T1,Q5JVF3,PCID2_HUMAN,,PCI domain-containing protein 2 (CSN12-like protein),Homo sapiens (Human),66.0,394.0,1e-149,531.2,sp|Q5JVF3|PCID2_HUMAN PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2,GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0044615; GO:0045579; GO:0045814; GO:0048536; GO:0070390; GO:1905457,"negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II [GO:0006368]",cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390],double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006913; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; chromatin organization; nucleocytoplasmic transport; organelle; anatomical structure development
OG_09489,2.1018484966745663,FUN_041524-T1,Peve_00000980,Pocillopora_meandrina_HIv1___RNAseq.g15379.t1,three_way,54.44833333333333,FUN_041524-T1,O43933,,,,,28.6,255.0,4.9e-20,100.5,sp|O43933|PEX1_HUMAN Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1,,,,,,
OG_09492,1.1902844832908446,FUN_041531-T2,Peve_00017082,Pocillopora_meandrina_HIv1___RNAseq.g15377.t1,three_way,75.96633333333332,FUN_041531-T2,Q5ZKC1,EIF2A_CHICK,,Eukaryotic translation initiation factor 2A (eIF-2A),Gallus gallus (Chicken),56.2,461.0,3.3e-154,546.6,sp|Q5ZKC1|EIF2A_CHICK Eukaryotic translation initiation factor 2A OS=Gallus gallus OX=9031 GN=EIF2A PE=2 SV=1,GO:0000049; GO:0003729; GO:0003743; GO:0005737; GO:0005850; GO:0006417; GO:0022627; GO:0042255; GO:0043022,regulation of translation [GO:0006417]; ribosome assembly [GO:0042255],cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850],mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723,RNA binding
OG_09493,1.630178743818279,FUN_041532-T1,Peve_00017081,Pocillopora_meandrina_HIv1___RNAseq.g15376.t1,three_way,72.252,FUN_041532-T1,Q60525,TCAB1_MESAU,,Telomerase Cajal body protein 1 (Guanine nucleotide-binding protein beta 5) (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog),Mesocricetus auratus (Golden hamster),49.7,346.0,6.4e-92,339.7,sp|Q60525|TCAB1_MESAU Telomerase Cajal body protein 1 OS=Mesocricetus auratus OX=10036 GN=Wrap53 PE=2 SV=1,GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0032212; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0070034; GO:0090666; GO:0090671; GO:0140597; GO:0140691; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034,Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004],"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]",histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005829; GO:0006281; GO:0032200; GO:0042393; GO:0043226; GO:0140104,RNA binding; cytosol; DNA repair; telomere organization; histone binding; organelle; molecular carrier activity
OG_09494,2.1975443974175666,FUN_041533-T1,Peve_00017080,Pocillopora_meandrina_HIv1___RNAseq.g15375.t1,three_way,44.41416666666667,,,,,,,,,,,,,,,,,
OG_09501,1.9233178645457665,FUN_041545-T1,Peve_00000890,Pocillopora_meandrina_HIv1___RNAseq.g15994.t2,three_way,60.269666666666666,FUN_041545-T1,Q80TI0,ASTRB_MOUSE,,Protein Aster-B (GRAM domain-containing protein 1B),Mus musculus (Mouse),34.0,679.0,3.2e-86,321.2,sp|Q80TI0|ASTRB_MOUSE Protein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2,GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268,cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_09502,1.1226203806124615,FUN_041546-T1,Peve_00023189,Pocillopora_meandrina_HIv1___RNAseq.g15991.t1,three_way,94.7,FUN_041546-T1,Q5TTG1,,,,,84.8,613.0,1.2e-309,1063.1,sp|Q5TTG1|VATA_ANOGA V-type proton ATPase catalytic subunit A OS=Anopheles gambiae OX=7165 GN=Vha68-2 PE=3 SV=1,,,,,,
OG_09503,1.5434394479056226,FUN_041547-T1,Peve_00023190,Pocillopora_meandrina_HIv1___RNAseq.g15992.t1,three_way,62.568,FUN_041547-T1,Q6DE06,,,,,52.5,202.0,6.7e-57,222.2,sp|Q6DE06|TM2D3_XENLA TM2 domain-containing protein 3 OS=Xenopus laevis OX=8355 GN=tm2d3 PE=2 SV=1,,,,,,
OG_09507,1.547734216810888,FUN_041552-T1,Peve_00025202,Pocillopora_meandrina_HIv1___RNAseq.g15999.t1,three_way,89.03266666666666,FUN_041552-T1,Q8NBZ7,,,,,78.6,243.0,1.1e-113,411.0,sp|Q8NBZ7|UXS1_HUMAN UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1,,,,,,
OG_09508,1.3145815464311643,FUN_041556-T1,Peve_00033126,Pocillopora_meandrina_HIv1___RNAseq.g16080.t1,three_way,62.22316666666666,FUN_041556-T1,Q6P549,SHIP2_MOUSE,,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",Mus musculus (Mouse),30.0,330.0,1.1e-19,99.0,"sp|Q6P549|SHIP2_MOUSE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Mus musculus OX=10090 GN=Inppl1 PE=1 SV=1",GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0034485; GO:0042169; GO:0043491; GO:0046856; GO:0070371; GO:0097178; GO:0110053,actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],"actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]",GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006629; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016787; GO:0043226,immune system process; catalytic activity; nucleus; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; lipid metabolic process; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; hydrolase activity; organelle
OG_09524,1.9423530364060253,FUN_041586-T1,Peve_00028474,Pocillopora_meandrina_HIv1___RNAseq.g15266.t1,three_way,66.81083333333333,FUN_041586-T1,Q4VSN4,DUSTY_CANLF,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Canis lupus familiaris (Dog) (Canis familiaris),27.4,893.0,3.3000000000000003e-80,301.6,sp|Q4VSN4|DUSTY_CANLF Dual serine/threonine and tyrosine protein kinase OS=Canis lupus familiaris OX=9615 GN=DSTYK PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09529,1.0472578644201065,FUN_041606-T1,Peve_00025723,Pocillopora_meandrina_HIv1___TS.g10333.t1,three_way,67.37066666666666,FUN_041606-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),33.2,304.0,1.2e-38,162.2,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_09535,3.485860298418653,FUN_041622-T1,Peve_00036084,Pocillopora_meandrina_HIv1___TS.g10312.t1b,three_way,81.132,FUN_041622-T1,P41247,PLPL4_HUMAN,,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2),Homo sapiens (Human),48.4,248.0,4.7999999999999995e-61,236.1,sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3,GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088,lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739],"acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806]",GO:0003824; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_09540,1.3975549130157845,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09551,1.334936741835563,FUN_041651-T1,Peve_00000466,Pocillopora_meandrina_HIv1___RNAseq.g14153.t1,three_way,42.71266666666666,,,,,,,,,,,,,,,,,
OG_09555,1.2547803622817888,FUN_041658-T1,Peve_00033089,Pocillopora_meandrina_HIv1___RNAseq.g13859.t2,three_way,82.45566666666667,FUN_041658-T1,Q5XGI1,KMCP1_XENTR,,Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),57.3,293.0,1.7999999999999999e-93,344.0,sp|Q5XGI1|KMCP1_XENTR Kidney mitochondrial carrier protein 1 OS=Xenopus tropicalis OX=8364 GN=slc25a30 PE=2 SV=1,GO:0005452; GO:0005743; GO:0015698,inorganic anion transport [GO:0015698],mitochondrial inner membrane [GO:0005743],solute:inorganic anion antiporter activity [GO:0005452],GO:0005215,transporter activity
OG_09556,2.55841864972435,FUN_041659-T1,Peve_00033090,Pocillopora_meandrina_HIv1___RNAseq.g13858.t1,three_way,62.041,FUN_041659-T1,P39963,,,,,55.5,274.0,1e-79,298.9,sp|P39963|CCNB3_CHICK G2/mitotic-specific cyclin-B3 OS=Gallus gallus OX=9031 GN=CCNB3 PE=2 SV=1,,,,,,
OG_09562,2.616232553693598,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_09564,1.656510998035604,FUN_041674-T1,Peve_00007763,Pocillopora_meandrina_HIv1___RNAseq.g14003.t1,three_way,80.41466666666666,FUN_041674-T1,Q9H0N5,PHS2_HUMAN,,Pterin-4-alpha-carbinolamine dehydratase 2 (PHS 2) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor),Homo sapiens (Human),64.3,126.0,1.1e-36,154.1,sp|Q9H0N5|PHS2_HUMAN Pterin-4-alpha-carbinolamine dehydratase 2 OS=Homo sapiens OX=9606 GN=PCBD2 PE=1 SV=4,GO:0005739; GO:0006729; GO:0008124; GO:0045893,positive regulation of DNA-templated transcription [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729],mitochondrion [GO:0005739],4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124],GO:0003824; GO:0005739; GO:0006355; GO:0016829; GO:0043226,catalytic activity; mitochondrion; regulation of DNA-templated transcription; lyase activity; organelle
OG_09565,1.106390960955008,FUN_041675-T1,Peve_00009958,Pocillopora_meandrina_HIv1___RNAseq.g14004.t1,three_way,61.77533333333333,FUN_041675-T1,Q5R7U2,PEX19_PONAB,,Peroxisomal biogenesis factor 19 (Peroxin-19) (Peroxisomal farnesylated protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,276.0,2.5e-42,174.1,sp|Q5R7U2|PEX19_PONAB Peroxisomal biogenesis factor 19 OS=Pongo abelii OX=9601 GN=PEX19 PE=2 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0016020; GO:0016557; GO:0016559; GO:0032991; GO:0036105; GO:0045046; GO:0050821; GO:0051117; GO:0061077; GO:0140597,chaperone-mediated protein folding [GO:0061077]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991],ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein carrier chaperone [GO:0140597],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0007031; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; peroxisome organization; organelle; molecular carrier activity
OG_09569,1.8331045679506803,FUN_041700-T1,Peve_00004374,Pocillopora_meandrina_HIv1___RNAseq.g13955.t1,three_way,80.44200000000001,FUN_041700-T1,P49585,PCY1A_HUMAN,,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),Homo sapiens (Human),42.7,375.0,6.1e-72,272.7,sp|P49585|PCY1A_HUMAN Choline-phosphate cytidylyltransferase A OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=2,GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006657; GO:0031210; GO:0042100; GO:0042587; GO:0042802; GO:0042803; GO:0045190; GO:0140678,B cell proliferation [GO:0042100]; CDP-choline pathway [GO:0006657]; isotype switching [GO:0045190]; phosphatidylcholine biosynthetic process [GO:0006656],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003824; GO:0005634; GO:0005635; GO:0005783; GO:0005829; GO:0006310; GO:0006629; GO:0008289; GO:0016740; GO:0043226; GO:0098772,immune system process; catalytic activity; nucleus; nuclear envelope; endoplasmic reticulum; cytosol; DNA recombination; lipid metabolic process; lipid binding; transferase activity; organelle; molecular function regulator activity
OG_09572,3.263204992739876,FUN_041703-T1,Peve_00004371,Pocillopora_meandrina_HIv1___RNAseq.g13969.t1,three_way,83.44083333333333,FUN_041703-T1,Q9R062,,,,,48.6,329.0,7.9e-90,332.0,sp|Q9R062|GLYG_MOUSE Glycogenin-1 OS=Mus musculus OX=10090 GN=Gyg1 PE=1 SV=3,,,,,,
OG_09574,1.6738622378124803,FUN_041706-T2,Peve_00001479,Pocillopora_meandrina_HIv1___RNAseq.g13974.t1,three_way,47.231,FUN_041706-T2,Q8BQ48,CE295_MOUSE,,Centrosomal protein of 295 kDa,Mus musculus (Mouse),29.4,452.0,1.2e-32,144.1,sp|Q8BQ48|CE295_MOUSE Centrosomal protein of 295 kDa OS=Mus musculus OX=10090 GN=Cep295 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008017; GO:0010825; GO:0030030; GO:1901985; GO:1903724; GO:1904951; GO:1990498,cell projection organization [GO:0030030]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498],microtubule binding [GO:0008017],GO:0005815; GO:0008092; GO:0043226,microtubule organizing center; cytoskeletal protein binding; organelle
OG_09576,2.5160374523822155,FUN_041711-T1,Peve_00034441,Pocillopora_meandrina_HIv1___RNAseq.g13977.t1,three_way,99.00466666666668,FUN_041711-T1,Q9VC49,,,,,95.5,67.0,5.1e-33,141.0,"sp|Q9VC49|RPAB5_DROME DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Drosophila melanogaster OX=7227 GN=Polr2L PE=1 SV=1",,,,,,
OG_09577,1.1570512641823354,FUN_041712-T1,Peve_00021480,Pocillopora_meandrina_HIv1___RNAseq.g13978.t1,three_way,69.24766666666667,,,,,,,,,,,,,,,,,
OG_09579,1.675614994817754,FUN_041717-T1,Peve_00024455,Pocillopora_meandrina_HIv1___RNAseq.g13945.t1,three_way,63.239333333333335,FUN_041717-T1,O43543,XRCC2_HUMAN,,DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2),Homo sapiens (Human),35.3,252.0,5.1e-35,149.4,sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1,GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269,centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756],centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677],GO:0000278; GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"mitotic cell cycle; DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09580,1.1074790432841422,FUN_041718-T1,Peve_00024454,Pocillopora_meandrina_HIv1___RNAseq.g13944.t1,three_way,59.919,FUN_041718-T1,Q92542,NICA_HUMAN,,Nicastrin,Homo sapiens (Human),35.0,718.0,6.4e-110,399.8,sp|Q92542|NICA_HUMAN Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2,GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0061133; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; endopeptidase activator activity [GO:0061133]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]",GO:0002376; GO:0003824; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0012501; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0051604; GO:0060090; GO:0098772; GO:0140096,"immune system process; catalytic activity; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; programmed cell death; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; protein maturation; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09582,1.4450073038756983,FUN_041720-T1,Peve_00020366,Pocillopora_meandrina_HIv1___RNAseq.g13942.t1,three_way,60.73533333333334,FUN_041720-T1,O45830,,,,,44.8,105.0,3.3e-19,97.1,sp|O45830|NDX1_CAEEL Putative nudix hydrolase 1 OS=Caenorhabditis elegans OX=6239 GN=ndx-1 PE=3 SV=1,,,,,,
OG_09583,2.1403374571633043,FUN_041721-T1,Peve_00020371,Pocillopora_meandrina_HIv1___RNAseq.g13941.t1,three_way,81.38799999999999,FUN_041721-T1,Q61205,PA1B3_MOUSE,,Platelet-activating factor acetylhydrolase IB subunit alpha1 (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma),Mus musculus (Mouse),54.5,165.0,4.8e-51,202.2,sp|Q61205|PA1B3_MOUSE Platelet-activating factor acetylhydrolase IB subunit alpha1 OS=Mus musculus OX=10090 GN=Pafah1b3 PE=1 SV=1,GO:0003847; GO:0005737; GO:0007283; GO:0008247; GO:0016042; GO:0042803; GO:0044877; GO:0046982; GO:0047179,lipid catabolic process [GO:0016042]; spermatogenesis [GO:0007283],1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737],1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0006629; GO:0016740; GO:0016787; GO:0022414,catalytic activity; lipid metabolic process; transferase activity; hydrolase activity; reproductive process
OG_09592,1.8015428049937112,FUN_041737-T1,Peve_00002192,Pocillopora_meandrina_HIv1___RNAseq.g15780.t1,three_way,71.5,FUN_041737-T1,Q61070,EI24_MOUSE,,Etoposide-induced protein 2.4 (p53-induced gene 8 protein),Mus musculus (Mouse),40.5,309.0,4.4e-56,219.9,sp|Q61070|EI24_MOUSE Etoposide-induced protein 2.4 OS=Mus musculus OX=10090 GN=Ei24 PE=1 SV=3,GO:0005789; GO:0005794; GO:0005829; GO:0006914; GO:0008630; GO:0009410; GO:0030308; GO:0031965; GO:0042308; GO:0050885; GO:0061676; GO:0071494; GO:2001244,autophagy [GO:0006914]; cellular response to UV-C [GO:0071494]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cell growth [GO:0030308]; negative regulation of protein import into nucleus [GO:0042308]; neuromuscular process controlling balance [GO:0050885]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965],importin-alpha family protein binding [GO:0061676],GO:0005794; GO:0005829; GO:0006914; GO:0043226; GO:0050877,Golgi apparatus; cytosol; autophagy; organelle; nervous system process
OG_09595,2.4862431977817345,FUN_041741-T2,Peve_00002194,Pocillopora_meandrina_HIv1___TS.g10807.t1,three_way,87.13516666666666,FUN_041741-T2,Q9WVF7,DPOE1_MOUSE,,DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A),Mus musculus (Mouse),61.3,2303.0,0.0,2863.2,sp|Q9WVF7|DPOE1_MOUSE DNA polymerase epsilon catalytic subunit A OS=Mus musculus OX=10090 GN=Pole PE=1 SV=3,GO:0000082; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005654; GO:0005886; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008622; GO:0016787; GO:0048568; GO:0051539,"base-excision repair, gap-filling [GO:0006287]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; nucleotide-excision repair, DNA gap filling [GO:0006297]",epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005886; GO:0006260; GO:0016740; GO:0016787; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; plasma membrane; DNA replication; transferase activity; hydrolase activity; anatomical structure development; catalytic activity, acting on DNA"
OG_09606,3.054679555217005,FUN_041760-T1,Peve_00041568,Pocillopora_meandrina_HIv1___RNAseq.g15241.t1,three_way,74.42366666666666,FUN_041760-T1,A6H7H7,FBX3_BOVIN,,F-box only protein 3,Bos taurus (Bovine),45.3,391.0,5.5e-96,352.8,sp|A6H7H7|FBX3_BOVIN F-box only protein 3 OS=Bos taurus OX=9913 GN=FBXO3 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032496; GO:1990756,protein ubiquitination [GO:0016567]; response to lipopolysaccharide [GO:0032496]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0030163; GO:0043226; GO:0060090,nucleus; protein catabolic process; organelle; molecular adaptor activity
OG_09610,1.2706797742068243,FUN_041768-T1,Peve_00041573,Pocillopora_meandrina_HIv1___RNAseq.g15245.t1,three_way,58.71716666666667,FUN_041768-T1,Q641Q2,WAC2A_HUMAN,,WASH complex subunit 2A,Homo sapiens (Human),43.1,202.0,2.6000000000000002e-37,159.8,sp|Q641Q2|WAC2A_HUMAN WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0071203; GO:1901981; GO:1905394,"endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203],phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394],GO:0005730; GO:0005768; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleolus; endosome; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09611,4.591659837673577,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_09612,1.3433517263802546,FUN_041770-T1,Peve_00041576,Pocillopora_meandrina_HIv1___RNAseq.g15248.t1,three_way,82.624,,,,,,,,,,,,,,,,,
OG_09613,1.369941579711746,FUN_041771-T1,Peve_00021185,Pocillopora_meandrina_HIv1___RNAseq.g15894.t1,three_way,85.66066666666667,FUN_041771-T1,P17870,ARRB1_BOVIN,,Beta-arrestin-1 (Arrestin beta-1) (Arrestin-2),Bos taurus (Bovine),64.8,341.0,1.1000000000000001e-118,427.9,sp|P17870|ARRB1_BOVIN Beta-arrestin-1 OS=Bos taurus OX=9913 GN=ARRB1 PE=1 SV=1,GO:0000822; GO:0001664; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0007165; GO:0015031; GO:0030132; GO:0030276; GO:0031143; GO:0031410; GO:0031623; GO:0032050; GO:0033130; GO:0035612; GO:0036094; GO:0045746; GO:0060090; GO:0070374; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],"acetylcholine receptor binding [GO:0033130]; AP-2 adaptor complex binding [GO:0035612]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; G protein-coupled receptor binding [GO:0001664]; inositol hexakisphosphate binding [GO:0000822]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small molecule binding [GO:0036094]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,nucleus; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_09614,1.348025795942163,FUN_041772-T1,Peve_00014829,Pocillopora_meandrina_HIv1___RNAseq.g15893.t1,three_way,61.36133333333333,FUN_041772-T1,Q80T32,AGRD1_MOUSE,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Mus musculus (Mouse),23.3,270.0,6.5e-12,73.9,sp|Q80T32|AGRD1_MOUSE Adhesion G-protein coupled receptor D1 OS=Mus musculus OX=10090 GN=Adgrd1 PE=2 SV=2,GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016607; GO:0022008,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurogenesis [GO:0022008]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0005886; GO:0030154; GO:0043226; GO:0060089,cytosol; plasma membrane; cell differentiation; organelle; molecular transducer activity
OG_09623,1.6133893768956085,FUN_041787-T1,Peve_00038538,Pocillopora_meandrina_HIv1___RNAseq.g15773.t1,three_way,47.7465,FUN_041787-T1,Q9UT40,,,,,34.3,105.0,4.5e-10,67.0,"sp|Q9UT40|YIQ3_SCHPO Uncharacterized protein C824.03c, mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC824.03c PE=4 SV=1",,,,,,
OG_09624,1.6779117761753597,FUN_041788-T1,Peve_00038539,Pocillopora_meandrina_HIv1___RNAseq.g15771.t1,three_way,71.78066666666666,FUN_041788-T1,Q8BX90,FND3A_MOUSE,,Fibronectin type-III domain-containing protein 3A,Mus musculus (Mouse),35.3,996.0,1.6e-163,578.6,sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3,GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609,cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506],,GO:0005829; GO:0007155; GO:0022414; GO:0031410; GO:0043226; GO:0048856,cytosol; cell adhesion; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development
OG_09628,2.4890341955175272,FUN_041799-T1,Peve_00025729,Pocillopora_meandrina_HIv1___RNAseq.g15850.t2,three_way,48.657,FUN_041799-T1,Q4VSN1,DUSTY_DANRE,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Danio rerio (Zebrafish) (Brachydanio rerio),33.2,265.0,3.3e-27,125.6,sp|Q4VSN1|DUSTY_DANRE Dual serine/threonine and tyrosine protein kinase OS=Danio rerio OX=7955 GN=dstyk PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0048570; GO:0060036; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; notochord cell vacuolation [GO:0060036]; notochord morphogenesis [GO:0048570]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_09631,1.2815224212280336,FUN_041817-T1,Peve_00025201,Pocillopora_meandrina_HIv1___RNAseq.g15801.t1,three_way,78.85666666666667,FUN_041817-T1,Q6PHN7,,,,,45.5,268.0,4.8e-56,219.5,sp|Q6PHN7|TM164_MOUSE Transmembrane protein 164 OS=Mus musculus OX=10090 GN=Tmem164 PE=1 SV=1,,,,,,
OG_09635,1.3531006050222407,FUN_041824-T1,Peve_00039128,Pocillopora_meandrina_HIv1___RNAseq.g15806.t1,three_way,95.95933333333332,FUN_041824-T1,P0C6F1,DYH2_MOUSE,,Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2),Mus musculus (Mouse),72.9,2852.0,0.0,4229.9,sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1,GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0016887; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285,cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_09636,2.4149096783843222,FUN_041827-T1,Peve_00039124,Pocillopora_meandrina_HIv1___RNAseq.g15809.t1,three_way,78.95666666666666,FUN_041827-T1,Q9UL03,,,,,53.7,536.0,5.9e-156,552.4,sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,,,,,,
OG_09640,1.792105157758429,FUN_041835-T1,Peve_00009638,Pocillopora_meandrina_HIv1___RNAseq.g15085.t1,three_way,89.23433333333334,FUN_041835-T1,Q2HJ40,BACE1_BOVIN,,Beta-secretase 1 (EC 3.4.23.46) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),Bos taurus (Bovine),47.6,429.0,8.5e-117,422.2,sp|Q2HJ40|BACE1_BOVIN Beta-secretase 1 OS=Bos taurus OX=9913 GN=BACE1 PE=2 SV=1,GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0009986; GO:0030424; GO:0030425; GO:0030659; GO:0045121; GO:0050435; GO:0055037,amyloid-beta metabolic process [GO:0050435]; membrane protein ectodomain proteolysis [GO:0006509]; proteolysis [GO:0006508],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_09641,1.3448477160660477,FUN_041836-T1,Peve_00009646,Pocillopora_meandrina_HIv1___RNAseq.g15084.t1,three_way,72.85733333333333,FUN_041836-T1,Q8CHP8,PGP_MOUSE,,Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP),Mus musculus (Mouse),45.7,302.0,3.3e-71,270.0,sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1,GO:0000121; GO:0000287; GO:0004725; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721,glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721],,ADP phosphatase activity [GO:0043262]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005975; GO:0006629; GO:0016787; GO:0140096,"catalytic activity; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_09642,1.575477005527523,FUN_041837-T1,Peve_00009647,Pocillopora_meandrina_HIv1___RNAseq.g15083.t1,three_way,77.079,FUN_041837-T1,Q676U5,A16L1_HUMAN,,Autophagy-related protein 16-1 (APG16-like 1),Homo sapiens (Human),34.9,601.0,7.8e-79,296.2,sp|Q676U5|A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=2,GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860,autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0007018; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; microtubule-based movement; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein"
OG_09650,3.6271505230992456,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_09651,1.9686381984330976,FUN_041850-T1,Peve_00010479,Pocillopora_meandrina_HIv1___RNAseq.g15071.t1,three_way,44.224500000000006,FUN_041850-T1,P11279,LAMP1_HUMAN,,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),Homo sapiens (Human),28.6,231.0,2.1e-08,62.0,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,GO:0000421; GO:0001618; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005829; GO:0005886; GO:0007042; GO:0008021; GO:0008200; GO:0009897; GO:0010008; GO:0016020; GO:0019899; GO:0019904; GO:0031902; GO:0035577; GO:0042383; GO:0042470; GO:0043323; GO:0044754; GO:0045954; GO:0048471; GO:0050821; GO:0061474; GO:0070062; GO:0072594; GO:0090160; GO:0101003; GO:0101004; GO:0140507; GO:1902513,establishment of protein localization to organelle [GO:0072594]; Golgi to lysosome transport [GO:0090160]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; lysosomal lumen acidification [GO:0007042]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; protein stabilization [GO:0050821]; regulation of organelle transport along microtubule [GO:1902513],autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagolysosome membrane [GO:0061474]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein domain specific binding [GO:0019904]; virus receptor activity [GO:0001618],GO:0001618; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,virus receptor activity; lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09652,1.2990315451140009,FUN_041852-T1,Peve_00030440,Pocillopora_meandrina_HIv1___TS.g10103.t1,three_way,49.88133333333333,FUN_041852-T1,P05300,,,,,25.1,211.0,3.6e-07,57.0,sp|P05300|LAMP1_CHICK Lysosome-associated membrane glycoprotein 1 OS=Gallus gallus OX=9031 GN=LAMP1 PE=2 SV=1,,,,,,
OG_09653,2.141714714799166,FUN_041854-T1,Peve_00025833,Pocillopora_meandrina_HIv1___RNAseq.g15067.t2,three_way,60.3945,FUN_041854-T1,Q8N137,CNTRB_HUMAN,,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Homo sapiens (Human),35.5,242.0,1.8e-21,106.7,sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0043226,microtubule organizing center; cytosol; organelle
OG_09654,2.4047083871498183,FUN_041857-T1,Peve_00025834,Pocillopora_meandrina_HIv1___RNAseq.g15066.t2,three_way,58.90233333333333,FUN_041857-T1,Q5EA49,,,,,30.3,185.0,2.1e-14,80.9,sp|Q5EA49|MIS12_BOVIN Protein MIS12 homolog OS=Bos taurus OX=9913 GN=MIS12 PE=2 SV=1,,,,,,
OG_09655,2.1235656000295924,FUN_041860-T1,Peve_00030446,Pocillopora_meandrina_HIv1___RNAseq.g15125.t1,three_way,65.9885,FUN_041860-T1,Q9D099,ACER3_MOUSE,,Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC),Mus musculus (Mouse),45.8,249.0,9.999999999999999e-57,221.9,sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1,GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602,ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270],GO:0003824; GO:0006629; GO:0006954; GO:0016787,catalytic activity; lipid metabolic process; inflammatory response; hydrolase activity
OG_09657,1.6175132588484942,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_09660,1.7078114250730838,FUN_041870-T1,Peve_00023975,Pocillopora_meandrina_HIv1___TS.g10144.t1,three_way,73.77166666666666,FUN_041870-T1,Q3B752,KTHY_DANRE,,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),Danio rerio (Zebrafish) (Brachydanio rerio),51.0,206.0,1.7999999999999997e-55,217.6,sp|Q3B752|KTHY_DANRE Thymidylate kinase OS=Danio rerio OX=7955 GN=dtymk PE=2 SV=1,GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006227; GO:0006233; GO:0006235; GO:0006281; GO:0021954,central nervous system neuron development [GO:0021954]; DNA repair [GO:0006281]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; dTMP kinase activity [GO:0004798]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09662,1.8403652431419597,FUN_041873-T1,Peve_00040565,Pocillopora_meandrina_HIv1___TS.g10137.t1b,three_way,58.01883333333333,FUN_041873-T1,Q5R9Y1,,,,,42.6,282.0,1.7000000000000002e-58,228.0,sp|Q5R9Y1|FSTL1_PONAB Follistatin-related protein 1 OS=Pongo abelii OX=9601 GN=FSTL1 PE=2 SV=2,,,,,,
OG_09667,2.1350031955328737,FUN_041884-T1,Peve_00012643,Pocillopora_meandrina_HIv1___RNAseq.g15395.t1,three_way,72.869,FUN_041884-T1,F4IF36,FGT1_ARATH,,Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135),Arabidopsis thaliana (Mouse-ear cress),38.7,1090.0,1.2e-201,705.7,sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1,GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841,chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408],nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_09668,1.055676481701552,FUN_041885-T1,Peve_00033410,Pocillopora_meandrina_HIv1___RNAseq.g15398.t1,three_way,89.648,FUN_041885-T1,Q6PFS7,,,,,65.3,144.0,1.9e-48,193.4,sp|Q6PFS7|ATG3_DANRE Ubiquitin-like-conjugating enzyme ATG3 OS=Danio rerio OX=7955 GN=atg3 PE=2 SV=1,,,,,,
OG_09677,2.239127651015788,FUN_041901-T1,Peve_00017951,Pocillopora_meandrina_HIv1___RNAseq.g15357.t1,three_way,67.588,FUN_041901-T1,Q0P5B7,AAAD_BOVIN,,Arylacetamide deacetylase (EC 3.1.1.3),Bos taurus (Bovine),35.9,337.0,8.299999999999997e-41,169.5,sp|Q0P5B7|AAAD_BOVIN Arylacetamide deacetylase OS=Bos taurus OX=9913 GN=AADAC PE=2 SV=1,GO:0004806; GO:0005789; GO:0006629; GO:0010898; GO:0017171,lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898],endoplasmic reticulum membrane [GO:0005789],serine hydrolase activity [GO:0017171]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_09679,1.233007084816863,FUN_041903-T1,Peve_00030474,Pocillopora_meandrina_HIv1___RNAseq.g15367.t1,three_way,66.04633333333334,FUN_041903-T1,Q80W94,MOGT2_MOUSE,,2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2),Mus musculus (Mouse),40.6,315.0,1.3000000000000002e-60,235.0,sp|Q80W94|MOGT2_MOUSE 2-acylglycerol O-acyltransferase 2 OS=Mus musculus OX=10090 GN=Mogat2 PE=1 SV=1,GO:0003846; GO:0004144; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578],2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005783; GO:0005975; GO:0006629; GO:0016740; GO:0022600; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; lipid metabolic process; transferase activity; digestive system process; organelle
OG_09683,3.459034195268151,FUN_041908-T1,Peve_00007888,Pocillopora_meandrina_HIv1___RNAseq.g15648.t1,three_way,83.73049999999999,FUN_041908-T1,Q17QZ4,,,,,57.2,383.0,2e-95,351.3,sp|Q17QZ4|TFDP1_BOVIN Transcription factor Dp-1 OS=Bos taurus OX=9913 GN=TFDP1 PE=2 SV=1,,,,,,
OG_09685,1.010819141950519,FUN_041912-T1,Peve_00007884,Pocillopora_meandrina_HIv1___RNAseq.g15645.t1,three_way,77.636,FUN_041912-T1,Q86V85,,,,,37.3,415.0,1.4e-64,248.4,sp|Q86V85|GP180_HUMAN Integral membrane protein GPR180 OS=Homo sapiens OX=9606 GN=GPR180 PE=1 SV=1,,,,,,
OG_09692,2.171941386912379,FUN_041921-T1,Peve_00007872,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1a,three_way,76.00366666666666,FUN_041921-T1,Q68F70,,,,,40.3,1001.0,6.6e-185,649.4,sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1,,,,,,
OG_09696,1.7450515073692492,FUN_041927-T1,Peve_00025329,Pocillopora_meandrina_HIv1___RNAseq.g15250.t1,three_way,59.38166666666667,FUN_041927-T1,Q3UPY5,,,,,44.6,630.0,8.2e-144,512.3,sp|Q3UPY5|GLBL2_MOUSE Beta-galactosidase-1-like protein 2 OS=Mus musculus OX=10090 GN=Glb1l2 PE=1 SV=1,,,,,,
OG_09697,1.194602006694696,FUN_041928-T1,Peve_00022682,Pocillopora_meandrina_HIv1___RNAseq.g15696.t1,three_way,66.166,FUN_041928-T1,Q8BG19,TMTC4_MOUSE,,Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4),Mus musculus (Mouse),52.0,481.0,5.7e-131,469.9,sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1,GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584,endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],GO:0003824; GO:0005783; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0050877; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09703,1.1607967299568742,FUN_041935-T1,Peve_00023583,Pocillopora_meandrina_HIv1___RNAseq.g15701.t2,three_way,79.72516666666667,FUN_041935-T1,Q9ES28,,,,,36.5,902.0,1.6e-131,471.9,sp|Q9ES28|ARHG7_MOUSE Rho guanine nucleotide exchange factor 7 OS=Mus musculus OX=10090 GN=Arhgef7 PE=1 SV=2,,,,,,
OG_09707,3.812309298830215,FUN_041944-T1,Peve_00023595,Pocillopora_meandrina_HIv1___RNAseq.g15636.t1,three_way,61.59033333333333,FUN_041944-T1,P25169,,,,,28.7,293.0,1.3e-21,105.1,sp|P25169|AT1B1_ARTSF Sodium/potassium-transporting ATPase subunit beta OS=Artemia franciscana OX=6661 PE=2 SV=1,,,,,,
OG_09709,1.54664062839705,FUN_041947-T1,Peve_00007871,Pocillopora_meandrina_HIv1___TS.g10659.t1,three_way,67.32600000000001,,,,,,,,,,,,,,,,,
OG_09710,3.063520424067152,FUN_041950-T1,Peve_00025328,Pocillopora_meandrina_HIv1___RNAseq.g15251.t1,three_way,82.19333333333333,FUN_041950-T1,Q6PBU5,,,,,49.8,325.0,8.4e-92,338.6,sp|Q6PBU5|GRT1A_DANRE Growth hormone-regulated TBC protein 1-A OS=Danio rerio OX=7955 GN=grtp1a PE=2 SV=1,,,,,,
OG_09711,2.056713588675477,FUN_041951-T1,Peve_00022248,Pocillopora_meandrina_HIv1___RNAseq.g15252.t1,three_way,67.0045,FUN_041951-T1,Q498F0,,,,,52.2,592.0,2.6e-153,544.3,sp|Q498F0|WDR44_XENLA WD repeat-containing protein 44 OS=Xenopus laevis OX=8355 GN=wdr44 PE=2 SV=1,,,,,,
OG_09713,2.1299169945548035,FUN_041958-T2,Peve_00027292,Pocillopora_meandrina_HIv1___RNAseq.g15161.t1,three_way,50.98183333333333,FUN_041958-T2,O93274,,,,,38.8,116.0,7.3e-23,110.2,sp|O93274|FZD8_XENLA Frizzled-8 OS=Xenopus laevis OX=8355 GN=fzd8 PE=1 SV=1,,,,,,
OG_09714,1.643361689711268,FUN_041959-T1,Peve_00043500,Pocillopora_meandrina_HIv1___RNAseq.g15157.t1,three_way,69.572,FUN_041959-T1,P91891,,,,,66.1,336.0,8.800000000000001e-118,424.9,sp|P91891|MO25_DROME Protein Mo25 OS=Drosophila melanogaster OX=7227 GN=Mo25 PE=2 SV=2,,,,,,
OG_09715,1.6612673625958596,FUN_041961-T1,Peve_00043496,Pocillopora_meandrina_HIv1___RNAseq.g15155.t1,three_way,54.928,,,,,,,,,,,,,,,,,
OG_09716,1.7156787390637342,FUN_041962-T1,Peve_00043495,Pocillopora_meandrina_HIv1___RNAseq.g15154.t1,three_way,93.26933333333334,FUN_041962-T1,P20340,RAB6A_HUMAN,,Ras-related protein Rab-6A (Rab-6) (EC 3.6.5.2),Homo sapiens (Human),85.4,205.0,1.1e-94,347.4,sp|P20340|RAB6A_HUMAN Ras-related protein Rab-6A OS=Homo sapiens OX=9606 GN=RAB6A PE=1 SV=3,GO:0000139; GO:0002080; GO:0003924; GO:0005525; GO:0005654; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0016020; GO:0018125; GO:0019882; GO:0019904; GO:0030667; GO:0031175; GO:0031410; GO:0031489; GO:0032588; GO:0034067; GO:0034498; GO:0036064; GO:0042147; GO:0070062; GO:0070381; GO:0072385; GO:1903292,"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; minus-end-directed organelle transport along microtubule [GO:0072385]; neuron projection development [GO:0031175]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",acrosomal membrane [GO:0002080]; ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226,immune system process; catalytic activity; GTPase activity; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_09724,2.363370837585933,FUN_041970-T1,Peve_00028273,Pocillopora_meandrina_HIv1___RNAseq.g15920.t1,three_way,90.77,FUN_041970-T1,P39825,,,,,38.0,129.0,2e-17,90.1,sp|P39825|PROF_SCHPO Profilin OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=cdc3 PE=1 SV=1,,,,,,
OG_09725,1.717349277095244,FUN_041971-T1,Peve_00028271,Pocillopora_meandrina_HIv1___RNAseq.g15921.t1,three_way,89.0265,FUN_041971-T1,Q99J62,,,,,66.6,359.0,8.6e-127,454.9,sp|Q99J62|RFC4_MOUSE Replication factor C subunit 4 OS=Mus musculus OX=10090 GN=Rfc4 PE=1 SV=1,,,,,,
OG_09732,2.4809223148038035,FUN_041991-T1,Peve_00020704,Pocillopora_meandrina_HIv1___RNAseq.g15229.t1,three_way,48.99766666666667,,,,,,,,,,,,,,,,,
OG_09736,2.7937428835237457,FUN_041995-T1,Peve_00023725,Pocillopora_meandrina_HIv1___RNAseq.g15224.t1,three_way,92.50633333333332,FUN_041995-T1,Q7ZXB1,MCM7B_XENLA,,DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B),Xenopus laevis (African clawed frog),74.5,718.0,1.4e-309,1063.1,sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1,GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_09740,3.3039880745619823,FUN_042002-T1,Peve_00016466,Pocillopora_meandrina_HIv1___RNAseq.g15218.t1,three_way,89.01233333333333,FUN_042002-T1,Q96GG9,DCNL1_HUMAN,,DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene),Homo sapiens (Human),68.3,259.0,8.2e-106,385.2,sp|Q96GG9|DCNL1_HUMAN DCN1-like protein 1 OS=Homo sapiens OX=9606 GN=DCUN1D1 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0031396; GO:0031624; GO:0032182; GO:0045116; GO:0097602; GO:2000434; GO:2000436,positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_09742,1.1026868690972864,FUN_042007-T1,Peve_00021044,Pocillopora_meandrina_HIv1___TS.g10228.t1,three_way,79.82566666666666,,,,,,,,,,,,,,,,,
OG_09743,2.72992134365486,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_09744,1.4768723614797503,FUN_042010-T1,Peve_00035507,Pocillopora_meandrina_HIv1___RNAseq.g15214.t1,three_way,59.618,,,,,,,,,,,,,,,,,
OG_09745,1.172001117049564,FUN_042012-T1,Peve_00016467,Pocillopora_meandrina_HIv1___RNAseq.g15217.t1,three_way,92.84933333333332,FUN_042012-T1,Q9UBF6,,,,,87.5,88.0,4.7e-47,188.3,sp|Q9UBF6|RBX2_HUMAN RING-box protein 2 OS=Homo sapiens OX=9606 GN=RNF7 PE=1 SV=1,,,,,,
OG_09749,1.253643537047137,FUN_042018-T1,Peve_00044152,Pocillopora_meandrina_HIv1___RNAseq.g15193.t1,three_way,65.04350000000001,FUN_042018-T1,Q7Z589,EMSY_HUMAN,,BRCA2-interacting transcriptional repressor EMSY,Homo sapiens (Human),63.2,106.0,5.8999999999999994e-31,138.3,sp|Q7Z589|EMSY_HUMAN BRCA2-interacting transcriptional repressor EMSY OS=Homo sapiens OX=9606 GN=EMSY PE=1 SV=2,GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802,chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654],identical protein binding [GO:0042802],GO:0005654; GO:0006281; GO:0006325; GO:0006355,nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription
OG_09755,1.6185786049251396,FUN_042027-T1,Peve_00025064,Pocillopora_meandrina_HIv1___RNAseq.g15172.t1,three_way,61.967,,,,,,,,,,,,,,,,,
OG_09756,2.336472554353559,FUN_042028-T1,Peve_00025065,Pocillopora_meandrina_HIv1___RNAseq.g15173.t1,three_way,82.21866666666666,FUN_042028-T1,Q9VUX2,MIB_DROME,,E3 ubiquitin-protein ligase mind-bomb (EC 2.3.2.27) (Mind bomb homolog) (D-mib) (RING-type E3 ubiquitin transferase mind-bomb),Drosophila melanogaster (Fruit fly),41.3,75.0,1.5e-08,62.4,sp|Q9VUX2|MIB_DROME E3 ubiquitin-protein ligase mind-bomb OS=Drosophila melanogaster OX=7227 GN=mib1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006897; GO:0007219; GO:0007423; GO:0008104; GO:0008270; GO:0008593; GO:0016567; GO:0045179; GO:0045747; GO:0045807; GO:0046331; GO:0061630,endocytosis [GO:0006897]; lateral inhibition [GO:0046331]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423],apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016192; GO:0016740; GO:0023052; GO:0048856; GO:0140096,"catalytic activity; cytosol; vesicle-mediated transport; transferase activity; signaling; anatomical structure development; catalytic activity, acting on a protein"
OG_09757,3.852507093922472,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_09766,1.3686812810579638,FUN_042047-T1,Peve_00025413,Pocillopora_meandrina_HIv1___RNAseq.g15141.t1,three_way,69.27166666666666,FUN_042047-T1,Q8AYS7,,,,,32.5,673.0,4.1e-93,344.0,sp|Q8AYS7|CENPI_CHICK Centromere protein I OS=Gallus gallus OX=9031 GN=CENPI PE=1 SV=1,,,,,,
OG_09767,1.6407775315097393,FUN_042048-T1,Peve_00025414,Pocillopora_meandrina_HIv1___RNAseq.g15142.t1,three_way,77.533,FUN_042048-T1,Q8BH01,,,,,43.5,666.0,3.1e-136,487.3,sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1,,,,,,
OG_09768,1.7916976641258096,FUN_042049-T1,Peve_00025415,Pocillopora_meandrina_HIv1___RNAseq.g15143.t1,three_way,63.039,,,,,,,,,,,,,,,,,
OG_09777,2.2466406199517737,FUN_042107-T1,Peve_00009513,Pocillopora_meandrina_HIv1___RNAseq.g21779.t1,three_way,95.49616666666668,FUN_042107-T1,Q6GQ52,,,,,67.9,84.0,1.4000000000000001e-28,126.7,sp|Q6GQ52|TI10B_XENLA Mitochondrial import inner membrane translocase subunit Tim10-B OS=Xenopus laevis OX=8355 GN=timm10-b PE=3 SV=1,,,,,,
OG_09789,2.8643910552637237,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_09792,2.744155135518213,FUN_042594-T1,Peve_00008122,Pocillopora_meandrina_HIv1___RNAseq.g16865.t1,three_way,78.67766666666667,FUN_042594-T1,Q9D531,NXNL2_MOUSE,,Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2),Mus musculus (Mouse),47.3,146.0,7.7e-34,145.2,sp|Q9D531|NXNL2_MOUSE Nucleoredoxin-like protein 2 OS=Mus musculus OX=10090 GN=Nxnl2 PE=1 SV=1,GO:0007601; GO:0007608; GO:0045494,photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601],,,GO:0050877,nervous system process
OG_09793,1.0559774943641942,FUN_042595-T1,Peve_00008123,Pocillopora_meandrina_HIv1___RNAseq.g16864.t1,three_way,83.503,FUN_042595-T1,Q8T3X9,,,,,67.9,131.0,2.0999999999999997e-43,176.4,"sp|Q8T3X9|ISCA1_DROME Iron-sulfur cluster assembly 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MagR PE=1 SV=1",,,,,,
OG_09795,1.8554337068410536,FUN_042602-T1,Peve_00034908,Pocillopora_meandrina_HIv1___RNAseq.g16851.t1,three_way,67.051,FUN_042602-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),26.5,701.0,3.2999999999999996e-62,241.9,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_09798,2.094332531641298,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_09803,2.983973857156596,FUN_042614-T1,Peve_00034928,Pocillopora_meandrina_HIv1___RNAseq.g17030.t1,three_way,75.631,FUN_042614-T1,A0A1D5PXA5,TRPV4_CHICK,,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC),Gallus gallus (Chicken),20.4,313.0,1.5e-08,63.2,sp|A0A1D5PXA5|TRPV4_CHICK Transient receptor potential cation channel subfamily V member 4 OS=Gallus gallus OX=9031 GN=TRPV4 PE=1 SV=1,GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0017124; GO:0035091; GO:0046872; GO:0098703,actin filament organization [GO:0007015]; calcium ion import across plasma membrane [GO:0098703]; intracellular calcium ion homeostasis [GO:0006874]; osmosensory signaling pathway [GO:0007231],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; phosphatidylinositol binding [GO:0035091]; SH3 domain binding [GO:0017124],GO:0005215; GO:0005886; GO:0005929; GO:0008289; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; lipid binding; organelle; transmembrane transport
OG_09804,1.3028107230548418,FUN_042622-T1,Peve_00029438,Pocillopora_meandrina_HIv1___RNAseq.g11513.t1,three_way,76.01333333333334,FUN_042622-T1,A7YWD2,,,,,36.5,941.0,1.5e-175,618.2,sp|A7YWD2|IPO13_BOVIN Importin-13 OS=Bos taurus OX=9913 GN=IPO13 PE=2 SV=1,,,,,,
OG_09807,3.006532559447515,FUN_042628-T1,Peve_00016195,Pocillopora_meandrina_HIv1___RNAseq.g11508.t1,three_way,45.25,FUN_042628-T1,O95390,GDF11_HUMAN,,Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11),Homo sapiens (Human),29.0,372.0,2.3000000000000002e-33,144.8,sp|O95390|GDF11_HUMAN Growth/differentiation factor 11 OS=Homo sapiens OX=9606 GN=GDF11 PE=1 SV=1,GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0007399; GO:0007498; GO:0008083; GO:0008283; GO:0008285; GO:0021512; GO:0032924; GO:0032991; GO:0035881; GO:0048593; GO:0060021; GO:0060391; GO:0072560; GO:1902870,activin receptor signaling pathway [GO:0032924]; amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of SMAD protein signal transduction [GO:0060391]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; protein-containing complex [GO:0032991],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_09810,1.9517932757491392,FUN_042632-T1,Peve_00030047,Pocillopora_meandrina_HIv1___RNAseq.19517_t,three_way,44.0685,FUN_042632-T1,Q14315,FLNC_HUMAN,,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),Homo sapiens (Human),26.4,208.0,3.7e-09,65.5,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015,sarcomere organization [GO:0045214],costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018],actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09814,2.3073403956826164,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,2.3073403956826164,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09820,2.4554878489606224,FUN_042653-T1,Peve_00038268,Pocillopora_meandrina_HIv1___RNAseq.g16812.t1,three_way,75.381,FUN_042653-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.9,491.0,5.2000000000000004e-89,330.1,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09821,2.293054499223894,FUN_042654-T1,Peve_00031585,Pocillopora_meandrina_HIv1___RNAseq.g4912.t1,three_way,68.26350000000001,FUN_042654-T1,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),45.5,266.0,9.2e-51,202.6,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09822,1.825298586092646,FUN_042655-T1,Peve_00031586,Pocillopora_meandrina_HIv1___RNAseq.g4911.t2,three_way,59.10533333333333,FUN_042655-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.7,546.0,7.899999999999999e-99,362.8,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09823,1.0733814948114964,FUN_042656-T1,Peve_00031588,Pocillopora_meandrina_HIv1___RNAseq.g4910.t1a,three_way,75.37983333333334,FUN_042656-T1,Q5VYK3,ECM29_HUMAN,,Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog),Homo sapiens (Human),44.3,1886.0,0.0,1510.7,sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628,ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248],centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502],molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005815; GO:0030163; GO:0031410; GO:0043226; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; microtubule organizing center; protein catabolic process; cytoplasmic vesicle; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09831,2.063722370809388,FUN_042808-T1,Peve_00003077,Pocillopora_meandrina_HIv1___RNAseq.g7425.t1,three_way,92.786,FUN_042808-T1,Q5F448,GPHR_CHICK,,Golgi pH regulator (Protein GPR89),Gallus gallus (Chicken),68.6,455.0,9.7e-176,617.8,sp|Q5F448|GPHR_CHICK Golgi pH regulator OS=Gallus gallus OX=9031 GN=GPR89 PE=2 SV=1,GO:0000139; GO:0008308; GO:0015031; GO:0030217; GO:0030660; GO:0032580; GO:0034702; GO:0043588; GO:0051452,intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; skin development [GO:0043588]; T cell differentiation [GO:0030217],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; monoatomic ion channel complex [GO:0034702],voltage-gated monoatomic anion channel activity [GO:0008308],GO:0002376; GO:0005215; GO:0030154; GO:0048856,immune system process; transporter activity; cell differentiation; anatomical structure development
OG_09840,1.987295448579714,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_09841,1.4379186790120817,FUN_042822-T2,Peve_00019576,Pocillopora_meandrina_HIv1___TS.g1194.t1,three_way,82.61283333333333,FUN_042822-T2,Q28WQ1,KIF1A_DROPS,,Kinesin-like protein unc-104,Drosophila pseudoobscura pseudoobscura (Fruit fly),47.8,1673.0,0.0,1395.2,sp|Q28WQ1|KIF1A_DROPS Kinesin-like protein unc-104 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=unc-104 PE=3 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489,synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_09844,2.273868183081239,FUN_042829-T1,Peve_00041827,Pocillopora_meandrina_HIv1___RNAseq.g7272.t1,three_way,75.69333333333333,,,,,,,,,,,,,,,,,
OG_09849,2.2201898652798246,FUN_042840-T1,Peve_00007266,Pocillopora_meandrina_HIv1___RNAseq.g7261.t1,three_way,47.549,,,,,,,,,,,,,,,,,
OG_09851,1.4298359736298334,FUN_042842-T1,Peve_00007268,Pocillopora_meandrina_HIv1___RNAseq.g7257.t1,three_way,86.659,FUN_042842-T1,Q800L3,,,,,65.2,135.0,3.700000000000001e-44,179.5,sp|Q800L3|MED22_CHICK Mediator of RNA polymerase II transcription subunit 22 OS=Gallus gallus OX=9031 GN=MED22 PE=3 SV=1,,,,,,
OG_09852,1.344793920255504,FUN_042843-T1,Peve_00023281,Pocillopora_meandrina_HIv1___RNAseq.g7256.t1,three_way,66.93900000000001,FUN_042843-T1,Q6ZZY0,,,,,56.5,483.0,1.4e-176,620.9,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_09854,1.7142208373835015,FUN_042847-T1,Peve_00023278,Pocillopora_meandrina_HIv1___RNAseq.g7253.t2,three_way,70.20666666666666,FUN_042847-T1,Q924L9,,,,,46.9,557.0,1.5e-131,471.5,"sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1",,,,,,
OG_09856,1.3537031125422565,FUN_042850-T1,Peve_00023276,Pocillopora_meandrina_HIv1___RNAseq.g7250.t1,three_way,70.27033333333333,FUN_042850-T1,O94431,,,,,26.4,405.0,1.9000000000000002e-36,155.2,sp|O94431|EGT2_SCHPO Hercynylcysteine sulfoxide lyase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt2 PE=3 SV=1,,,,,,
OG_09857,2.3248407474857293,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,47.2,733.0,1.3e-174,616.7,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09857,2.3248407474857293,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,26.6,466.0,1.1e-35,155.2,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09862,2.8245035410226387,FUN_042871-T1,Peve_00023282,Pocillopora_meandrina_HIv1___RNAseq.g7234.t1,three_way,64.53166666666667,FUN_042871-T1,Q8CAE2,HENMT_MOUSE,,Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) (mHEN1),Mus musculus (Mouse),36.6,366.0,2.9e-54,214.5,sp|Q8CAE2|HENMT_MOUSE Small RNA 2'-O-methyltransferase OS=Mus musculus OX=10090 GN=Henmt1 PE=1 SV=1,GO:0001510; GO:0003723; GO:0005829; GO:0008171; GO:0008173; GO:0034587; GO:0043186; GO:0046872; GO:0090486,piRNA processing [GO:0034587]; RNA methylation [GO:0001510],cytosol [GO:0005829]; P granule [GO:0043186],metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486],GO:0003723; GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09874,2.155948038947991,FUN_042912-T1,Peve_00019289,Pocillopora_meandrina_HIv1___RNAseq.g7196.t1,three_way,79.65833333333333,FUN_042912-T1,B0KWE9,,,,,51.6,225.0,4.9e-63,242.7,sp|B0KWE9|DOPP1_CALJA Dolichyldiphosphatase 1 OS=Callithrix jacchus OX=9483 GN=DOLPP1 PE=3 SV=1,,,,,,
OG_09881,1.047948905788467,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09884,1.8417865464171232,FUN_042957-T1,Peve_00039056,Pocillopora_meandrina_HIv1___RNAseq.g7123.t1,three_way,46.98266666666667,FUN_042957-T1,Q5TM64,,,,,30.0,120.0,2.3e-13,78.2,sp|Q5TM64|CF136_MACMU Uncharacterized protein C6orf136 homolog OS=Macaca mulatta OX=9544 PE=4 SV=1,,,,,,
OG_09888,1.611611355706631,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09893,1.830494473445128,FUN_042972-T1,Peve_00039022,Pocillopora_meandrina_HIv1___RNAseq.g7104.t1,three_way,74.01466666666667,FUN_042972-T1,A5PMR2,UBP33_DANRE,,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33),Danio rerio (Zebrafish) (Brachydanio rerio),44.1,884.0,6.5e-205,715.7,sp|A5PMR2|UBP33_DANRE Ubiquitin carboxyl-terminal hydrolase 33 OS=Danio rerio OX=7955 GN=usp33 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005813; GO:0006508; GO:0006897; GO:0007399; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108,axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0016192; GO:0016787; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; vesicle-mediated transport; hydrolase activity; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09894,1.4233051748293224,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_09895,1.5597721088546077,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09905,1.755009844555157,FUN_043002-T1,Peve_00017780,Pocillopora_meandrina_HIv1___RNAseq.g7026.t1,three_way,77.39216666666667,FUN_043002-T1,P46209,,,,,33.0,179.0,6.8e-14,79.3,sp|P46209|USF_AQUPY Protein usf OS=Aquifex pyrophilus OX=2714 GN=usf PE=4 SV=1,,,,,,
OG_09906,2.5285890272072846,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_09912,2.7535700814901825,FUN_043010-T1,Peve_00017768,Pocillopora_meandrina_HIv1___RNAseq.g7034.t1,three_way,65.28,FUN_043010-T1,Q8CGF6,WDR47_MOUSE,,WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin),Mus musculus (Mouse),31.1,1178.0,1.9e-103,379.0,sp|Q8CGF6|WDR47_MOUSE WD repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Wdr47 PE=1 SV=2,GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168,adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],protein-containing complex binding [GO:0044877],GO:0006914; GO:0007010; GO:0048856; GO:0048870,autophagy; cytoskeleton organization; anatomical structure development; cell motility
OG_09914,1.7562549488541113,FUN_043014-T1,Peve_00017765,Pocillopora_meandrina_HIv1___RNAseq.g7037.t1,three_way,69.486,FUN_043014-T1,Q4R3Y4,S27A4_MACFA,,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),48.2,627.0,1.8e-170,600.9,sp|Q4R3Y4|S27A4_MACFA Long-chain fatty acid transport protein 4 OS=Macaca fascicularis OX=9541 GN=SLC27A4 PE=2 SV=2,GO:0000166; GO:0001579; GO:0005324; GO:0005789; GO:0005886; GO:0031957; GO:0044539; GO:0047676; GO:0090434,long-chain fatty acid import into cell [GO:0044539]; medium-chain fatty acid transport [GO:0001579],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; oleoyl-CoA ligase activity [GO:0090434]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005215; GO:0005886; GO:0016874; GO:0140657,catalytic activity; transporter activity; plasma membrane; ligase activity; ATP-dependent activity
OG_09917,2.461614247529513,FUN_043027-T1,Peve_00026962,Pocillopora_meandrina_HIv1___TS.g790.t1,three_way,57.98016666666667,FUN_043027-T1,Q8AYG3,TTK_DANRE,,Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap),Danio rerio (Zebrafish) (Brachydanio rerio),30.7,960.0,1.6999999999999998e-92,342.4,sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2,GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310,anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246],kinetochore [GO:0000776]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09918,1.7521187753675045,FUN_043029-T2,Peve_00026963,Pocillopora_meandrina_HIv1___RNAseq.g7057.t1,three_way,56.766666666666666,FUN_043029-T2,Q9W6G7,,,,,27.6,428.0,3.2e-37,157.5,"sp|Q9W6G7|DPOG2_XENLA DNA polymerase subunit gamma-2, mitochondrial OS=Xenopus laevis OX=8355 GN=polg2 PE=1 SV=1",,,,,,
OG_09919,1.93988517552677,FUN_043030-T1,Peve_00026964,Pocillopora_meandrina_HIv1___RNAseq.g7058.t1,three_way,69.98333333333333,FUN_043030-T1,Q0P5A6,,,,,35.4,491.0,1.2e-81,305.4,sp|Q0P5A6|PSMD5_BOVIN 26S proteasome non-ATPase regulatory subunit 5 OS=Bos taurus OX=9913 GN=PSMD5 PE=2 SV=1,,,,,,
OG_09920,1.6589357881163205,FUN_043031-T1,Peve_00026965,Pocillopora_meandrina_HIv1___TS.g793.t1,three_way,52.451,FUN_043031-T1,Q9FN03,,,,,28.7,334.0,5.500000000000001e-28,129.0,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_09922,1.046339182948345,FUN_043034-T1,Peve_00026968,Pocillopora_meandrina_HIv1___RNAseq.g7061.t1,three_way,59.995666666666665,,,,,,,,,,,,,,,,,
OG_09923,2.931494042327514,FUN_043035-T1,Peve_00026975,Pocillopora_meandrina_HIv1___RNAseq.g7043.t1,three_way,57.261,FUN_043035-T1,Q9UBN4,,,,,29.3,744.0,3.7999999999999996e-68,261.2,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09924,1.1499928349088804,FUN_043037-T1,Peve_00026463,Pocillopora_meandrina_HIv1___TS.g811.t1,three_way,81.205,FUN_043037-T1,Q3ZBX1,,,,,53.2,280.0,6.7e-72,272.3,sp|Q3ZBX1|PIGC_BOVIN Phosphatidylinositol N-acetylglucosaminyltransferase subunit C OS=Bos taurus OX=9913 GN=PIGC PE=2 SV=1,,,,,,
OG_09925,1.0294391428343237,FUN_043038-T1,Peve_00026462,Pocillopora_meandrina_HIv1___RNAseq.g7077.t1,three_way,42.869166666666665,,,,,,,,,,,,,,,,,
OG_09927,1.9356907878338951,FUN_043082-T1,Peve_00026459,Pocillopora_meandrina_HIv1___TS.g814.t1,three_way,74.149,FUN_043082-T1,P0DX22,,,,,37.1,280.0,7.699999999999999e-49,195.7,"sp|P0DX22|FCNLN_PSEA6 L-fucono-1,5-lactonase OS=Pseudoalteromonas atlantica (strain T6c / ATCC BAA-1087) OX=3042615 GN=Patl_0798 PE=1 SV=1",,,,,,
OG_09928,2.115289412342201,FUN_043084-T1,Peve_00026456,Pocillopora_meandrina_HIv1___RNAseq.g7081.t1,three_way,62.529833333333336,FUN_043084-T1,Q9UBN4,,,,,30.1,742.0,4.2e-83,310.8,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09931,2.11466085485921,FUN_043087-T1,Peve_00001643,Pocillopora_meandrina_HIv1___RNAseq.g7088.t2,three_way,65.04733333333333,FUN_043087-T1,Q8N9H8,,,,,31.9,793.0,2e-93,345.5,sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3,,,,,,
OG_09932,1.1618093738782245,FUN_043089-T1,Peve_00001654,Pocillopora_meandrina_HIv1___RNAseq.g7087.t1,three_way,89.93299999999999,FUN_043089-T1,Q9NX01,TXN4B_HUMAN,,Thioredoxin-like protein 4B (Dim1-like protein),Homo sapiens (Human),75.2,149.0,5.8e-61,235.0,sp|Q9NX01|TXN4B_HUMAN Thioredoxin-like protein 4B OS=Homo sapiens OX=9606 GN=TXNL4B PE=1 SV=1,GO:0000398; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0046540,"mRNA splicing, via spliceosome [GO:0000398]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],,GO:0005654; GO:0005829; GO:0016071,nucleoplasm; cytosol; mRNA metabolic process
OG_09933,1.3912033592356,FUN_043091-T1,Peve_00001653,Pocillopora_meandrina_HIv1___RNAseq.g6995.t1,three_way,75.982,FUN_043091-T1,O95870,ABHGA_HUMAN,,Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5),Homo sapiens (Human),43.3,563.0,5.9e-132,472.6,sp|O95870|ABHGA_HUMAN Phosphatidylserine lipase ABHD16A OS=Homo sapiens OX=9606 GN=ABHD16A PE=1 SV=3,GO:0004620; GO:0006660; GO:0016020; GO:0047372; GO:0052651; GO:1905344,monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344],membrane [GO:0016020],monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],GO:0003824; GO:0006575; GO:0006629; GO:0016787,catalytic activity; modified amino acid metabolic process; lipid metabolic process; hydrolase activity
OG_09939,2.279738112867599,FUN_043099-T1,Peve_00026300,Pocillopora_meandrina_HIv1___RNAseq.g7004.t1,three_way,80.35766666666666,FUN_043099-T1,Q92540,SMG7_HUMAN,,Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog) (hSMG-7),Homo sapiens (Human),43.2,475.0,1.8e-94,348.6,sp|Q92540|SMG7_HUMAN Nonsense-mediated mRNA decay factor SMG7 OS=Homo sapiens OX=9606 GN=SMG7 PE=1 SV=2,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_09948,2.7294527194826146,FUN_043115-T2,Peve_00026298,Pocillopora_meandrina_HIv1___RNAseq.g7890.t1,three_way,78.194,FUN_043115-T2,Q9NQH7,XPP3_HUMAN,,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Homo sapiens (Human),46.0,461.0,1.6e-124,448.0,sp|Q9NQH7|XPP3_HUMAN Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1,GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003014; GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"renal system process; catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09949,2.3942780818029066,FUN_043116-T1,Peve_00026297,Pocillopora_meandrina_HIv1___RNAseq.g7889.t1,three_way,69.772,FUN_043116-T1,O77633,,,,,35.3,744.0,1.4000000000000001e-117,425.2,sp|O77633|ADA10_PIG Disintegrin and metalloproteinase domain-containing protein 10 OS=Sus scrofa OX=9823 GN=ADAM10 PE=2 SV=2,,,,,,
OG_09951,2.133523037395199,FUN_043118-T1,Peve_00026295,Pocillopora_meandrina_HIv1___RNAseq.g7887.t1,three_way,78.261,FUN_043118-T1,P08081,CLCA_RAT,,Clathrin light chain A (Lca),Rattus norvegicus (Rat),34.8,221.0,5.9e-23,109.0,sp|P08081|CLCA_RAT Clathrin light chain A OS=Rattus norvegicus OX=10116 GN=Clta PE=1 SV=1,GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0048488; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978,cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672],clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198],GO:0005198; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0065003,structural molecule activity; lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09957,1.2314159946337482,FUN_043127-T1,Peve_00013592,Pocillopora_meandrina_HIv1___RNAseq.g7874.t2,three_way,84.74233333333333,FUN_043127-T1,P61763,,,,,60.6,589.0,3.7e-196,686.0,sp|P61763|STXB1_BOVIN Syntaxin-binding protein 1 OS=Bos taurus OX=9913 GN=STXBP1 PE=1 SV=1,,,,,,
OG_09958,1.2437445828054523,FUN_043129-T1,Peve_00021467,Pocillopora_meandrina_HIv1___RNAseq.g6873.t1,three_way,80.0845,FUN_043129-T1,Q9V6Y3,,,,,52.3,107.0,2.8e-25,116.3,sp|Q9V6Y3|RT16_DROME Small ribosomal subunit protein bS16m OS=Drosophila melanogaster OX=7227 GN=mRpS16 PE=2 SV=1,,,,,,
OG_09959,1.2026150520013743,FUN_043130-T1,Peve_00013596,Pocillopora_meandrina_HIv1___TS.g613.t1,three_way,62.32033333333334,FUN_043130-T1,Q9JI70,MKKS_MOUSE,,Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog),Mus musculus (Mouse),30.4,586.0,6.2e-74,280.0,sp|Q9JI70|MKKS_MOUSE Molecular chaperone MKKS OS=Mus musculus OX=10090 GN=Mkks PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0033210; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902140; GO:1902636; GO:1905515,artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082],GO:0003012; GO:0003013; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006457; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0065003,muscle system process; circulatory system process; nucleus; microtubule organizing center; cytosol; cilium; protein folding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein-containing complex assembly
OG_09960,1.4532232168909482,FUN_043131-T1,Peve_00021463,Pocillopora_meandrina_HIv1___RNAseq.g6875.t1,three_way,87.29066666666667,FUN_043131-T1,Q9D0W5,PPIL1_MOUSE,,Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1),Mus musculus (Mouse),74.8,151.0,4.2e-65,248.8,sp|Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isomerase-like 1 OS=Mus musculus OX=10090 GN=Ppil1 PE=1 SV=1,GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0071007; GO:0097718; GO:1990403,"embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]",nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007],disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0005634; GO:0006457; GO:0016071; GO:0016853; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; protein folding; mRNA metabolic process; isomerase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09967,2.4510823793625804,FUN_043148-T1,Peve_00044685,Pocillopora_meandrina_HIv1___RNAseq.g6855.t1,three_way,81.35900000000001,FUN_043148-T1,A4QNE9,,,,,54.8,115.0,1.3e-07,57.4,sp|A4QNE9|VATG3_XENTR V-type proton ATPase subunit G 3 OS=Xenopus tropicalis OX=8364 GN=atp6v1g3 PE=3 SV=1,,,,,,
OG_09980,2.672790044015671,FUN_043169-T1,Peve_00025850,Pocillopora_meandrina_HIv1___RNAseq.g6792.t1,three_way,52.61283333333333,,,,,,,,,,,,,,,,,
OG_09981,2.189472030159057,FUN_043171-T1,Peve_00025849,Pocillopora_meandrina_HIv1___RNAseq.g6793.t1,three_way,67.71433333333333,,,,,,,,,,,,,,,,,
OG_09982,1.6131026084904367,FUN_043174-T1,Peve_00025847,Pocillopora_meandrina_HIv1___RNAseq.g6799.t1,three_way,67.927,,,,,,,,,,,,,,,,,
OG_09983,1.7895759342633322,FUN_043175-T1,Peve_00025846,Pocillopora_meandrina_HIv1___RNAseq.g6800.t1,three_way,71.23483333333334,FUN_043175-T1,Q28036,SL9A1_BOVIN,,Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1),Bos taurus (Bovine),47.8,557.0,4.8999999999999995e-141,503.4,sp|Q28036|SL9A1_BOVIN Sodium/hydrogen exchanger 1 OS=Bos taurus OX=9913 GN=SLC9A1 PE=2 SV=2,GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005886; GO:0006883; GO:0006885; GO:0010447; GO:0010613; GO:0010882; GO:0015385; GO:0015386; GO:0016323; GO:0016324; GO:0030346; GO:0035994; GO:0036376; GO:0042802; GO:0045121; GO:0045944; GO:0048306; GO:0048863; GO:0051259; GO:0051453; GO:0055007; GO:0070886; GO:0071468; GO:0071805; GO:0071872; GO:0086092; GO:0090533; GO:0098719; GO:0098735,cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to epinephrine stimulus [GO:0071872]; intracellular sodium ion homeostasis [GO:0006883]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005654; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0055085; GO:0065003,transporter activity; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; transmembrane transport; protein-containing complex assembly
OG_09984,1.206986632716662,FUN_043176-T1,Peve_00025845,Pocillopora_meandrina_HIv1___RNAseq.g6801.t1,three_way,80.18466666666667,FUN_043176-T1,Q6YP21,KAT3_HUMAN,,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),Homo sapiens (Human),55.5,411.0,1.1999999999999999e-132,474.6,sp|Q6YP21|KAT3_HUMAN Kynurenine--oxoglutarate transaminase 3 OS=Homo sapiens OX=9606 GN=KYAT3 PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053,2-oxoglutarate metabolic process [GO:0006103]; amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0016829; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; lyase activity; organelle
OG_09987,1.0443898977918424,FUN_043181-T1,Peve_00043024,Pocillopora_meandrina_HIv1___RNAseq.g18637.t1,three_way,60.36716666666666,FUN_043181-T1,Q8MIQ9,,,,,52.9,493.0,4.6e-133,476.9,sp|Q8MIQ9|P_PIG P protein OS=Sus scrofa OX=9823 GN=Oca2 PE=2 SV=3,,,,,,
OG_09988,1.875129843108898,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_09997,1.4190281416223078,FUN_043222-T1,Peve_00007691,Pocillopora_meandrina_HIv1___RNAseq.g6774.t1a,three_way,69.872,FUN_043222-T1,Q22885,,,,,27.1,362.0,1.3e-21,105.5,sp|Q22885|BROX_CAEEL BRO1 domain-containing protein BROX homolog OS=Caenorhabditis elegans OX=6239 GN=B0507.2 PE=3 SV=2,,,,,,
OG_09998,1.7953844100400806,FUN_043224-T1,Peve_00007692,Pocillopora_meandrina_HIv1___RNAseq.g6773.t1,three_way,90.942,FUN_043224-T1,Q5ZKU5,RAB14_CHICK,,Ras-related protein Rab-14 (EC 3.6.5.2),Gallus gallus (Chicken),80.5,215.0,6.4e-93,341.7,sp|Q5ZKU5|RAB14_CHICK Ras-related protein Rab-14 OS=Gallus gallus OX=9031 GN=RAB14 PE=2 SV=3,GO:0000139; GO:0001845; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006895; GO:0008543; GO:0012505; GO:0031901; GO:0032456; GO:0042742; GO:0045335; GO:0045995; GO:0055037,defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly [GO:0001845]; regulation of embryonic development [GO:0045995],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0006886; GO:0007040; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; cytosol; intracellular protein transport; lysosome organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09999,2.5293262112174544,FUN_043231-T1,Peve_00019451,Pocillopora_meandrina_HIv1___TS.g505.t1,three_way,79.51733333333333,FUN_043231-T1,Q8TDX7,NEK7_HUMAN,,Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),Homo sapiens (Human),83.6,280.0,5.0999999999999996e-138,491.9,sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1,GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227,cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10001,1.7304221251310945,FUN_043234-T1,Peve_00001448,Pocillopora_meandrina_HIv1___RNAseq.g6754.t1,three_way,72.01266666666666,FUN_043234-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),39.5,309.0,3.7e-52,207.2,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_10005,2.2460711016470123,FUN_043240-T1,Peve_00001439,Pocillopora_meandrina_HIv1___RNAseq.g6713.t1,three_way,70.26633333333334,FUN_043240-T1,P28304,,,,,38.9,319.0,9.5e-54,212.2,sp|P28304|QOR1_ECOLI Quinone oxidoreductase 1 OS=Escherichia coli (strain K12) OX=83333 GN=qorA PE=1 SV=1,,,,,,
OG_10009,1.3398193587428533,FUN_043244-T1,Peve_00001455,Pocillopora_meandrina_HIv1___RNAseq.g8844.t1,three_way,80.65866666666668,FUN_043244-T1,Q5ZJF4,PRDX6_CHICK,,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx),Gallus gallus (Chicken),69.4,219.0,2.4e-87,323.2,sp|Q5ZJF4|PRDX6_CHICK Peroxiredoxin-6 OS=Gallus gallus OX=9031 GN=PRDX6 PE=2 SV=3,GO:0004601; GO:0004623; GO:0005615; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920,cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042],cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0006629; GO:0016209; GO:0016491; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; lysosome; vacuole; cytosol; lipid metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; hydrolase activity; organelle
OG_10014,1.4998056499518728,FUN_043251-T1,Peve_00028668,Pocillopora_meandrina_HIv1___RNAseq.g8853.t1,three_way,68.52266666666667,FUN_043251-T1,Q5NU14,,,,,48.7,394.0,4e-85,316.6,sp|Q5NU14|MKRN1_TAKRU Probable E3 ubiquitin-protein ligase makorin-1 OS=Takifugu rubripes OX=31033 GN=mkrn1 PE=2 SV=1,,,,,,
OG_10019,1.5063673821085242,FUN_043260-T1,Peve_00032621,Pocillopora_meandrina_HIv1___TS.g20584.t1,three_way,80.86,FUN_043260-T1,Q32LH4,,,,,54.2,275.0,3.6000000000000004e-86,319.7,sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1,,,,,,
OG_10020,1.850009609113725,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_10021,1.243076402200338,FUN_043262-T1,Peve_00032608,Pocillopora_meandrina_HIv1___RNAseq.g8892.t1,three_way,72.44983333333333,FUN_043262-T1,Q9Z0H0,,,,,35.1,559.0,3.6e-82,307.4,sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2,,,,,,
OG_10027,1.6244624265016516,FUN_043281-T1,Peve_00007453,Pocillopora_meandrina_HIv1___TS.g20595.t1c,three_way,70.7575,FUN_043281-T1,Q8IYH5,ZZZ3_HUMAN,,ZZ-type zinc finger-containing protein 3,Homo sapiens (Human),45.6,450.0,2.1e-88,328.2,sp|Q8IYH5|ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens OX=9606 GN=ZZZ3 PE=1 SV=1,GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672,chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_10028,1.573317960972664,FUN_043283-T1,Peve_00007451,Pocillopora_meandrina_HIv1___RNAseq.g8872.t1,three_way,45.01633333333333,,,,,,,,,,,,,,,,,
OG_10031,2.0799512074413826,FUN_043286-T1,Peve_00007448,Pocillopora_meandrina_HIv1___RNAseq.g8869.t1,three_way,90.06933333333333,FUN_043286-T1,Q5ZKN1,CDK9_CHICK,,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9),Gallus gallus (Chicken),71.5,375.0,2.3e-151,536.6,sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus OX=9031 GN=CDK9 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0008353; GO:0032968; GO:0045944; GO:0070691; GO:0106310; GO:0120187,positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634]; P-TEFb complex [GO:0070691],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10032,1.7396087959378157,FUN_043287-T1,Peve_00007447,Pocillopora_meandrina_HIv1___RNAseq.g8868.t1,three_way,66.945,FUN_043287-T1,Q641F8,,,,,51.9,187.0,1.9e-48,194.1,sp|Q641F8|TYW3_XENLA tRNA wybutosine-synthesizing protein 3 homolog OS=Xenopus laevis OX=8355 GN=tyw3 PE=2 SV=1,,,,,,
OG_10039,2.894660831433586,FUN_043309-T1,Peve_00007495,Pocillopora_meandrina_HIv1___RNAseq.g8924.t1,three_way,66.18766666666667,FUN_043309-T1,P33450,FAT_DROME,,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],Drosophila melanogaster (Fruit fly),27.1,816.0,1.3e-70,270.0,sp|P33450|FAT_DROME Cadherin-related tumor suppressor OS=Drosophila melanogaster OX=7227 GN=ft PE=1 SV=3,GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005739; GO:0005886; GO:0007010; GO:0007155; GO:0007163; GO:0043226; GO:0048856,mitochondrion; plasma membrane; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; organelle; anatomical structure development
OG_10041,2.079806538633924,FUN_043312-T1,Peve_00007499,Pocillopora_meandrina_HIv1___RNAseq.g8928.t1,three_way,77.94933333333333,FUN_043312-T1,P36916,,,,,53.7,488.0,4.9e-143,509.6,sp|P36916|GNL1_MOUSE Guanine nucleotide-binding protein-like 1 OS=Mus musculus OX=10090 GN=Gnl1 PE=1 SV=4,,,,,,
OG_10048,1.3903143112944811,FUN_043322-T1,Peve_00007511,Pocillopora_meandrina_HIv1___RNAseq.g8949.t1,three_way,57.72333333333333,FUN_043322-T1,Q03146,DDR1_MOUSE,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Mus musculus (Mouse),49.6,373.0,3.5e-93,344.7,sp|Q03146|DDR1_MOUSE Epithelial discoidin domain-containing receptor 1 OS=Mus musculus OX=10090 GN=Ddr1 PE=2 SV=2,GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10049,1.7390164025100956,FUN_043323-T1,Peve_00007512,Pocillopora_meandrina_HIv1___RNAseq.g8950.t1,three_way,56.72266666666666,,,,,,,,,,,,,,,,,
OG_10053,1.570875519703625,FUN_043327-T1,Peve_00043037,Pocillopora_meandrina_HIv1___RNAseq.g8955.t1,three_way,55.082,FUN_043327-T1,D6WMX4,PINK1_TRICA,,"Serine/threonine-protein kinase Pink1, mitochondrial (EC 2.7.11.1) (PTEN-induced putative kinase 1)",Tribolium castaneum (Red flour beetle),36.7,450.0,9.499999999999999e-69,262.7,"sp|D6WMX4|PINK1_TRICA Serine/threonine-protein kinase Pink1, mitochondrial OS=Tribolium castaneum OX=7070 GN=Pink1 PE=1 SV=1",GO:0000422; GO:0004674; GO:0005524; GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0031398; GO:0031625; GO:0042981; GO:0046777; GO:0046872; GO:0090141; GO:1904544,autophagy of mitochondrion [GO:0000422]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein ubiquitination [GO:0031398]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005739; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10055,2.466001889118508,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_10059,2.323237819175608,FUN_043355-T1,Peve_00016650,Pocillopora_meandrina_HIv1___TS.g20685.t1a,three_way,62.21816666666667,FUN_043355-T1,A1L1H3,,,,,26.3,758.0,1.4e-48,196.4,sp|A1L1H3|TDRD5_XENLA Tudor domain-containing protein 5 OS=Xenopus laevis OX=8355 GN=tdrd5 PE=2 SV=1,,,,,,
OG_10065,1.3552126968783824,FUN_043369-T1,Peve_00011704,Pocillopora_meandrina_HIv1___RNAseq.g8974.t1,three_way,82.904,FUN_043369-T1,Q6NZR5,,,,,51.1,1307.0,0.0,1185.2,sp|Q6NZR5|SKI2_MOUSE Superkiller complex protein 2 OS=Mus musculus OX=10090 GN=Skic2 PE=2 SV=1,,,,,,
OG_10066,1.397550017927699,FUN_043370-T1,Peve_00004904,Pocillopora_meandrina_HIv1___RNAseq.g8975.t1,three_way,68.366,,,,,,,,,,,,,,,,,
OG_10067,3.1027651109480883,FUN_043371-T1,Peve_00004903,Pocillopora_meandrina_HIv1___RNAseq.g8976.t1,three_way,72.36966666666666,FUN_043371-T1,Q8VHQ9,ACO11_MOUSE,,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2),Mus musculus (Mouse),44.0,550.0,4.4e-114,413.3,sp|Q8VHQ9|ACO11_MOUSE Acyl-coenzyme A thioesterase 11 OS=Mus musculus OX=10090 GN=Acot11 PE=1 SV=1,GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0008289; GO:0009266; GO:0009409; GO:0035556; GO:0047617; GO:0052689; GO:0052816; GO:0120163,fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759],carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816],GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity
OG_10069,1.7653979462066869,FUN_043374-T1,Peve_00004909,Pocillopora_meandrina_HIv1___RNAseq.g8978.t1,three_way,63.316,,,,,,,,,,,,,,,,,
OG_10073,1.3305755367714227,FUN_043379-T1,Peve_00027430,Pocillopora_meandrina_HIv1___RNAseq.g8985.t1,three_way,83.51266666666666,FUN_043379-T1,Q5F3K4,WDR48_CHICK,,WD repeat-containing protein 48 (USP1-associated factor 1),Gallus gallus (Chicken),62.4,697.0,1.0999999999999999e-189,664.8,sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1,GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168,DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283],late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130],GO:0003677; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_10085,1.8008455500217913,FUN_043403-T1,Peve_00007567,Pocillopora_meandrina_HIv1___RNAseq.g9068.t1,three_way,45.621,,,,,,,,,,,,,,,,,
OG_10087,3.392905741194426,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10088,2.0883199547337,FUN_043417-T1,Peve_00026858,Pocillopora_meandrina_HIv1___RNAseq.g7829.t1,three_way,78.89,FUN_043417-T1,Q28DG7,,,,,43.1,390.0,3.9e-66,253.4,sp|Q28DG7|UBAC1_XENTR Ubiquitin-associated domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=ubac1 PE=2 SV=1,,,,,,
OG_10090,2.922563094469737,FUN_043420-T1,Peve_00005576,Pocillopora_meandrina_HIv1___TS.g1600.t1,three_way,92.59866666666667,FUN_043420-T1,Q13813,,,,,59.0,2468.0,0.0,2752.6,"sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",,,,,,
OG_10093,2.700350462762156,FUN_043424-T1,Peve_00022202,Pocillopora_meandrina_HIv1___RNAseq.g7845.t1,three_way,57.81816666666666,,,,,,,,,,,,,,,,,
OG_10099,2.528004657071641,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_10100,1.9564286966689908,FUN_043438-T1,Peve_00028841,Pocillopora_meandrina_HIv1___RNAseq.g7850.t1,three_way,48.59733333333333,FUN_043438-T1,F6RRD7,,,,,49.2,181.0,8.9e-38,159.8,sp|F6RRD7|RPAP2_BOVIN Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Bos taurus OX=9913 GN=RPAP2 PE=2 SV=1,,,,,,
OG_10101,1.7733323016360365,FUN_043439-T1,Peve_00028851,Pocillopora_meandrina_HIv1___RNAseq.g7000.t1,three_way,91.469,FUN_043439-T1,P62167,,,,,65.2,158.0,4.7e-58,225.7,sp|P62167|NCS1_CHICK Neuronal calcium sensor 1 OS=Gallus gallus OX=9031 GN=NCS1 PE=1 SV=2,,,,,,
OG_10105,2.003184610868155,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10117,1.3556809301619213,FUN_043492-T1,Peve_00008687,Pocillopora_meandrina_HIv1___RNAseq.g7961.t1,three_way,79.793,FUN_043492-T1,O95295,,,,,57.5,113.0,2.1e-27,123.2,sp|O95295|SNAPN_HUMAN SNARE-associated protein Snapin OS=Homo sapiens OX=9606 GN=SNAPIN PE=1 SV=1,,,,,,
OG_10119,2.7635805894744667,FUN_043495-T1,Peve_00024915,Pocillopora_meandrina_HIv1___TS.g1707.t3,three_way,64.6395,FUN_043495-T1,Q7Z7A1,CNTRL_HUMAN,,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),Homo sapiens (Human),33.3,916.0,5.599999999999997e-29,132.9,sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],,GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0048856,Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; organelle; anatomical structure development
OG_10124,1.7266559548003233,FUN_043502-T1,Peve_00024903,Pocillopora_meandrina_HIv1___RNAseq.g7968.t1,three_way,87.12333333333333,FUN_043502-T1,Q642A5,,,,,71.7,99.0,8.2e-34,144.8,sp|Q642A5|DPOE3_RAT DNA polymerase epsilon subunit 3 OS=Rattus norvegicus OX=10116 GN=Pole3 PE=1 SV=1,,,,,,
OG_10132,1.3843373202715354,FUN_043515-T1,Peve_00040847,Pocillopora_meandrina_HIv1___RNAseq.g15975.t1,three_way,75.199,,,,,,,,,,,,,,,,,
OG_10133,1.79173561420273,FUN_043517-T1,Peve_00017256,Pocillopora_meandrina_HIv1___RNAseq.g8028.t1,three_way,92.006,FUN_043517-T1,O61491,,,,,66.1,419.0,1.6e-84,314.7,sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1,,,,,,
OG_10134,1.279385550642478,FUN_043519-T1,Peve_00016245,Pocillopora_meandrina_HIv1___RNAseq.g8030.t1,three_way,81.026,FUN_043519-T1,A7RWD2,,,,,79.0,324.0,1.8e-49,198.0,sp|A7RWD2|CIAO1_NEMVE Probable cytosolic iron-sulfur protein assembly protein CIAO1 homolog OS=Nematostella vectensis OX=45351 GN=v1g226592 PE=3 SV=1,,,,,,
OG_10140,1.554424839088041,FUN_043529-T1,Peve_00011972,Pocillopora_meandrina_HIv1___RNAseq.g8039.t1,three_way,62.42733333333334,FUN_043529-T1,P22933,GBRD_MOUSE,,Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) (GABAAR subunit delta),Mus musculus (Mouse),32.4,417.0,2.1e-53,211.5,sp|P22933|GBRD_MOUSE Gamma-aminobutyric acid receptor subunit delta OS=Mus musculus OX=10090 GN=Gabrd PE=2 SV=1,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0030424; GO:0030425; GO:0034707; GO:0043025; GO:0045211; GO:0051932; GO:0098978; GO:0098982; GO:1902711; GO:1904315,"gamma-aminobutyric acid signaling pathway [GO:0007214]; synaptic transmission, GABAergic [GO:0051932]",axon [GO:0030424]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_10141,1.5317239546777304,FUN_043530-T1,Peve_00011963,Pocillopora_meandrina_HIv1___RNAseq.g8041.t1,three_way,88.138,FUN_043530-T1,O35130,NEP1_MOUSE,,Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1),Mus musculus (Mouse),65.8,225.0,6.3e-83,308.5,sp|O35130|NEP1_MOUSE Ribosomal RNA small subunit methyltransferase NEP1 OS=Mus musculus OX=10090 GN=Emg1 PE=1 SV=1,GO:0001824; GO:0005654; GO:0005694; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475,blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843],GO:0003723; GO:0003824; GO:0005654; GO:0005694; GO:0005730; GO:0016740; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; chromosome; nucleolus; transferase activity; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_10142,1.2590316861443562,FUN_043531-T1,Peve_00011964,Pocillopora_meandrina_HIv1___RNAseq.g8001.t1,three_way,71.50766666666667,FUN_043531-T1,Q5R792,ATG5_PONAB,,Autophagy protein 5 (APG5-like),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),62.4,194.0,1.2000000000000001e-74,280.8,sp|Q5R792|ATG5_PONAB Autophagy protein 5 OS=Pongo abelii OX=9601 GN=ATG5 PE=2 SV=1,GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005776; GO:0005930; GO:0006325; GO:0006914; GO:0006995; GO:0009410; GO:0009620; GO:0010659; GO:0010667; GO:0016567; GO:0019776; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0034045; GO:0034274; GO:0034727; GO:0035973; GO:0039689; GO:0042311; GO:0044233; GO:0045060; GO:0045087; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0051607; GO:0055015; GO:0060047; GO:0061908; GO:0070254; GO:0070257; GO:0071500; GO:0098685; GO:0098794; GO:0098930; GO:0098978; GO:0099072; GO:0099170; GO:1901096; GO:1902017; GO:1904093; GO:1904973; GO:2000377,aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axonal transport [GO:0098930]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; heart contraction [GO:0060047]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fungus [GO:0009620]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; glutamatergic synapse [GO:0098978]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],Atg8-family ligase activity [GO:0019776],GO:0002376; GO:0003013; GO:0003824; GO:0005773; GO:0006325; GO:0006914; GO:0007018; GO:0012501; GO:0016740; GO:0043226; GO:0048856; GO:0098542; GO:0140096,"immune system process; circulatory system process; catalytic activity; vacuole; chromatin organization; autophagy; microtubule-based movement; programmed cell death; transferase activity; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on a protein"
OG_10148,2.676862283509725,FUN_043539-T1,Peve_00012551,Pocillopora_meandrina_HIv1___TS.g1775.t1,three_way,61.17516666666667,FUN_043539-T1,Q9DBQ9,,,,,27.4,592.0,6.5e-46,187.6,sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3,,,,,,
OG_10155,1.2082721374538177,FUN_043550-T1,Peve_00009532,Pocillopora_meandrina_HIv1___RNAseq.g8005.t3,three_way,70.52333333333333,FUN_043550-T1,Q5XJS0,,,,,31.4,544.0,1.1000000000000004e-59,232.6,sp|Q5XJS0|MIGA1_DANRE Mitoguardin 1 OS=Danio rerio OX=7955 GN=miga1 PE=2 SV=1,,,,,,
OG_10161,1.344904032045903,FUN_043559-T1,Peve_00022066,Pocillopora_meandrina_HIv1___RNAseq.g8043.t1,three_way,42.258833333333335,,,,,,,,,,,,,,,,,
OG_10162,1.020560980331307,FUN_043561-T1,Peve_00008975,Pocillopora_meandrina_HIv1___RNAseq.g8048.t1,three_way,90.788,FUN_043561-T1,Q27433,MEC2_CAEEL,,Mechanosensory protein 2,Caenorhabditis elegans,76.9,255.0,1.3e-103,377.5,sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1,GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792,detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612],neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_10170,1.633051384411394,FUN_043573-T1,Peve_00011698,Pocillopora_meandrina_HIv1___TS.g1621.t2,three_way,82.74133333333333,FUN_043573-T1,Q5ZIR1,,,,,52.2,364.0,7.2e-94,345.5,sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1,,,,,,
OG_10171,2.394954483349728,FUN_043574-T1,Peve_00011699,Pocillopora_meandrina_HIv1___RNAseq.g7870.t2,three_way,82.55833333333334,FUN_043574-T1,Q5ZKK5,,,,,31.7,703.0,1.4e-15,86.7,sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1,,,,,,
OG_10172,2.2040788865954606,FUN_043581-T1,Peve_00045208,Pocillopora_meandrina_HIv1___RNAseq.g6993.t1,three_way,68.211,FUN_043581-T1,Q803A6,,,,,45.8,631.0,4.3999999999999996e-147,523.1,sp|Q803A6|MCMBP_DANRE Mini-chromosome maintenance complex-binding protein OS=Danio rerio OX=7955 GN=mcmbp PE=2 SV=2,,,,,,
OG_10175,3.0158885210927284,FUN_043584-T1,Peve_00045195,Pocillopora_meandrina_HIv1___RNAseq.g6988.t1,three_way,66.09083333333334,FUN_043584-T1,P21180,CO2_MOUSE,,Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)],Mus musculus (Mouse),25.1,491.0,5.4e-29,131.0,sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0006958; GO:0007584; GO:0032496; GO:0045087; GO:0046872; GO:0097066; GO:2000427,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to thyroid hormone [GO:0097066]",extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_10176,1.7862047066320597,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10184,1.8510041828792403,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10187,1.6472243562905764,FUN_043604-T1,Peve_00040380,Pocillopora_meandrina_HIv1___RNAseq.4608_t,three_way,88.10233333333333,FUN_043604-T1,P55008,AIF1_HUMAN,,Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1),Homo sapiens (Human),55.9,143.0,3.8000000000000004e-36,152.5,sp|P55008|AIF1_HUMAN Allograft inflammatory factor 1 OS=Homo sapiens OX=9606 GN=AIF1 PE=1 SV=1,GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406,"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178]",actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0002376; GO:0005634; GO:0005829; GO:0006954; GO:0008092; GO:0043226; GO:0061024; GO:0065003,immune system process; nucleus; cytosol; inflammatory response; cytoskeletal protein binding; organelle; membrane organization; protein-containing complex assembly
OG_10192,2.010097261288303,FUN_043612-T1,Peve_00040372,Pocillopora_meandrina_HIv1___RNAseq.4603_t,three_way,52.043,FUN_043612-T1,P48970,,,,,38.5,104.0,1.5e-19,98.6,sp|P48970|UNIV_STRPU Univin OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2,,,,,,
OG_10194,2.763107584474724,FUN_043618-T2,Peve_00008246,Pocillopora_meandrina_HIv1___RNAseq.g6933.t1,three_way,53.74066666666667,FUN_043618-T2,P34821,BMP8A_MOUSE,,Bone morphogenetic protein 8A (BMP-8A) (Osteogenic protein 2) (OP-2),Mus musculus (Mouse),32.2,345.0,3.1000000000000002e-34,147.5,sp|P34821|BMP8A_MOUSE Bone morphogenetic protein 8A OS=Mus musculus OX=10090 GN=Bmp8a PE=2 SV=1,GO:0001649; GO:0005125; GO:0005615; GO:0007179; GO:0007281; GO:0007283; GO:0008083; GO:0051216,cartilage development [GO:0051216]; germ cell development [GO:0007281]; osteoblast differentiation [GO:0001649]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular space [GO:0005615],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_10195,2.136193746404821,FUN_043619-T1,Peve_00008225,Pocillopora_meandrina_HIv1___RNAseq.g6932.t1,three_way,88.456,FUN_043619-T1,Q6DJ06,,,,,63.2,125.0,1e-48,194.5,sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1,,,,,,
OG_10196,1.841198844628516,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_10198,2.875951535762977,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_10200,2.0768130929206494,FUN_043628-T1,Peve_00008239,Pocillopora_meandrina_HIv1___TS.g640.t1b,three_way,64.35733333333333,FUN_043628-T1,Q504Y2,PKDCC_HUMAN,,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",Homo sapiens (Human),40.7,243.0,2.7e-47,190.3,sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2,GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005576; GO:0005794; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular region; Golgi apparatus; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10204,1.95585363074402,FUN_043636-T1,Peve_00008249,Pocillopora_meandrina_HIv1___RNAseq.g6909.t1,three_way,53.50783333333334,FUN_043636-T1,Q8NDA2,,,,,26.3,753.0,7.9000000000000025e-59,231.5,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_10214,1.1014325379920449,FUN_043658-T1,Peve_00044842,Pocillopora_meandrina_HIv1___RNAseq.g10606.t1,three_way,50.08533333333333,,,,,,,,,,,,,,,,,
OG_10216,2.167728436171449,FUN_043662-T1,Peve_00001429,Pocillopora_meandrina_HIv1___RNAseq.g7395.t2,three_way,79.739,FUN_043662-T1,P98198,AT8B2_HUMAN,,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),Homo sapiens (Human),52.5,1179.0,0.0,1144.4,sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531,Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
